1994”N“x –k—¢‘åŠwˆãŠw•”E‘åŠw•a‰@Œ¤‹†‹ÆÑW


<<01 ‰ð–UŠw>>

1. mŒ´’˜n Glomus cell differentiation in the carotid body region of chick embryos studied by neuron-specific class ‡VƒÀ-tubulin isotype and Leu-7 monoclonal antibodies. ‹T“c•‡ŽqCŽR’ÑP•Ûi‰ðjC‹T’J“Oi•a—jCA. Frankfurter: J. Comp. Neurol., 348(4): 531`543, 1994.

2. mŒ´’˜n Electron microscopic study on the development of the carotid body and glomus cell groups distributed in the wall of the common carotid artery and its branches in the chicken. ‹T“c•‡Žqi‰ðj: J. Comp. Neurol., 348(4): 544`555, 1994.

3. mŒ´’˜n Improved method for post-embedding cytochemistry using reduced osmium and LR white resin. ‹Ê–؉p–¾CŽR‰È³•½i‰ðj: J. Histochem. Cytochem., 42(9): 1285`1293, 1994.

4. mŒ´’˜n Tight junctional permeability in living cells: Dynamic changes directly visualized by confocal laser microscopy. £ì²‹vi‰ðj: Journal of Electron Microscopy, 43: 290`298, 1994.

5. mŒ´’˜n Development of the conduction system in the rat heart as determined by Leu-7(HNK-1) immunohistochemistry and computer graphics reconstruction. ÂŽR’¼‘Pi“àjC‹Ê–؉p–¾i‰ðjC–Øì“c—²ˆêi“àjCŽR‰È³•½i‰ðj: Lab. Invest., 72(3): 1`12, 1995.

6. mŒ´’˜n ŠÒŒ³ƒIƒXƒ~ƒEƒ€¥LRƒzƒƒCƒg•ï–„–@‚Ì‘½—l«. Ÿ–”CiŒ`‘ÔŒnjC‹Ê–؉p–¾CŽR‰È³•½i‰ðj: ˆãŠw¥¶•¨Šw“dŽqŒ°”÷‹¾‹ZpŒ¤‹†‰ï‰ïŽ, 9(2): 48`49, 1995.

7. mŒ´’˜n Right-left differences in the lengths of human arm and leg bones. •½–{‰Ã•i‰ðj: ‰ð–UŠwŽGŽ, 68(5): 536`543, 1993.

8. mŒ´’˜n ¸ŽqŒ`¬‚É‚¨‚¯‚éƒZƒ‹ƒgƒŠ[(ŽxŽ)×–E‚ƸŽq×–E‚Ì‘ŠŒÝì—p. ŽðˆäNOCŽR‰È³•½i‰ðj: ×–E, 26(9): 9`14, 1994.

9. mŒ´’˜n “ú–{lã˜rœCžôœCŽÚœ‚Ì’·‚³‚̶‰E·. •½–{‰Ã•i‰ðj: l—ÞŠwŽGŽ, 101(5): 473`481, 1993.

10. mŒ´’˜n LRƒzƒƒCƒgŽ÷Ž‰‚ÆŠÒŒ³ƒIƒXƒ~ƒEƒ€‚ð—p‚¢‚½“dŒ°×–E‰»Šw‚ÌŒŸ“¢-Ž©“®•ï–„‘•’u‚ւ̉ž—p-. Ÿ–”CiŒ`‘ÔŒnjC‹Ê–؉p–¾CŽR‰È³•½i‰ðj: •a—‹Zp, 50: 19`21, 1994.

11. mŒ¤‹†•ñi•¶•”Èjn ×–E“àî•ñ“`’BŒn‚É‚æ‚é‘Á‰t•ª”å‚Ì’²ß‹@\: ‹¤Å“_ƒŒ[ƒU[Œ°”÷‹¾‚ð—p‚¢‚½“®“I‰ðÍ. £ì²‹vi‰ðj: •¶•”ȉȊwŒ¤‹†”ïˆê”Ê‚bŒ¤‹†¬‰Ê•ñ‘, 1994.

12. m‘àn ³í‘Á‰t‘B‚Ì\‘¢‚Æ”­¶. £ì²‹vi‰ðj: Ž•‰ÈƒWƒƒ[ƒiƒ‹, 40: 783`792, 1994.

13. muÀn Disorganization of actin bundles of ectoplasmic specialization. ŽðˆäNOCŽR‰È³•½i‰ðj: Develop. Growth and Differ., 37: 21`30, 1995.

14. muÀn ”½‰ž«‚ÆŒ`‘Ô‚É—D‚ꂽ“dŒ°×–E‰»Šw‚̌Œ襕–@. ‹Ê–؉p–¾i‰ðjCŸ–”CiŒ`‘ÔŒnjCŽR‰È³•½i‰ðj: “dŽqŒ°”÷‹¾, 29(2): 137`140, 1994.

15. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj ‚­‚т͉½‚Ì‚½‚ß‚É‚ ‚é‚©; Œz‚Ì”­¶‚Æ\‘¢, p.187`233, £ì²‹vi‰ðj. •—lŽÐC“Œ‹žC95.01.10”­s.

16. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Salivary secretion involves two distinct exocytosis mechanisms regulated by microfilaments and calcium. £ì²‹vi‰ðj: Jacques Monod Conference Mechanisms of Exocytosis i94.05.29j, ƒtƒ‰ƒ“ƒX, —\eW, p.7, 1994.

17. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Post-embedding electron cytochemistry on fine morphological background using reduced osmium and LR white resin. ‹Ê–؉p–¾CŽR‰È³•½i‰ðj: 14th Federative International Congress of Anatomy i94.07.26j, Lisbon, Abstract Book, p.168, 1994.

18. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Stereographic microanatomy with a use of personal computer. ŽR‰È³•½C‹Ê–؉p–¾i‰ðjCÂŽR’¼‘Pi“àj: ‘æ14‰ñ‘Û‰ð–UŠw‰ï‹c i94.07.29j, ƒŠƒXƒ{ƒ“, Abstract Book, p.299, 1994.

19. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Calcium regulates two distinct exocytosis mechanisms in the rat parotid gland. £ì²‹vi‰ðjCHaruo TakemuraiŽD–yˆã‘åj: ‘æ39‰ñŽR“cƒRƒ“ƒtƒ@ƒŒƒ“ƒXCalcium as Cell Signal i94.04.26j, “Œ‹ž, —\eW, p.43, 1994.

20. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Development of the rat conduction system as determined by Leu-7 immunohistochemistry and scanning electron microscopy. ÂŽR’¼‘PC–Øì“c—²ˆêi“àjCŽR‰È³•½i‰ðj: 14th Federative International Congress of Anatomy i94.07.26j, Lisboa-Portugal, Abstract, p.299, 1994.

21. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Cell Junction: ©‚ç“®‚Ö. £ì²‹vi‰ðj: ‘æ47‰ñ“ú–{×–E¶•¨Šw‰ïƒVƒ“ƒ|ƒWƒEƒ€ i94.09.29j, ’·è, Cell Struct. Funct., 19(6): 456, 1994, —\eW, p.67, 1994.

22. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž¨‰º‘B‘B–[×–E‚ÌŠO•ª”å‰ß’ö‚É‹y‚Ú‚·ƒIƒJƒ_Ž_‚ÌŒø‰Ê(Effects of Okadaic acid on the secretory process in rat parotid acinar cells). ‹Ê–؉p–¾CŽR‰È³•½i‰ðj: ‘æ99‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i94.03.30j, ŽRŒ`, ‰ð–UŠwŽGŽ, 69(4): 475, 1994, —\eW, p.52, 1994.

23. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “ú–{l‘å‘Úœ‚Ì”P“]Šp‚ɂ‚¢‚Ä. •½–{‰Ã•i‰ðj: “ú–{‰ð–UŠw‰ï i94.03.30j, ŽRŒ`, ‰ð–UŠwŽGŽ, 69(4): 484, 1994.

24. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒÀ-tubulin isotype‚¨‚æ‚ÑLeu-7’PƒNƒ[ƒiƒ‹R‘Ì‚Æ“dŒ°‚É‚æ‚éƒjƒƒgƒŠéÒŒã‘Ì‚b×–E‚Ì×–E•ª‰». ‹T“c•‡Žqi‰ðj: ‘æ99‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i94.04.01j, ŽRŒ`, ‰ð–UŠwŽGŽ, 69(4): 569, 1994.

25. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Development of the conduction system in malformed hearts induced by hyperthermia. ÂŽR’¼‘Pi“àjCŽR‰È³•½i‰ðj: ‘æ99‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i94.04.01j, ŽRŒ`, ‰ð–UŠwŽGŽ, 69(4): 581, 1994.

26. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆêŽŸ¸•ê×–E‚Ì‚RŽŸŒ³“IŠÏŽ@. ’†–{’¼i‰ðj: ‘æ27‰ñ”­¶¶•¨Šw‰ï i94.05.25j, å‘ä, —vŽ|W, p.133, 1994.

27. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Secretion by absorption: ‘Á‰t‘B…•ª”å‚ÉŠÖ‚·‚éV‚µ‚¢‰¼à‚Ì’ñ¥. £ì²‹vi‰ðj: ‘æ35‰ñŽ•‰ÈŠî‘bˆãŠw‰ï‘‰ï i94.06.17j, ‘åã, Ž•‰ÈŠî‘bˆãŠw‰ïŽGŽ, 36(•â): 103, 1994.

28. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äCœ‰ºŠÖß–Ê‹y‚ÑŠ°œŽ¨ó–Ê‚Ì—ÖŠs‚Ì”äŠrŒŸ“¢‚ÆŒv‘ª. ÷–ØW•Fi‰ðjC“¡“c®i¹ƒ}ƒŠˆã‘åjC’r“c•qŽqi‰ðjC¼àV“Ni“s˜Vl‘‡Œ¤j: ‘æ48‰ñ“ú–{l—ÞŠw‰ïE“ú–{–¯‘°Šw‰ï˜A‡‘å‰ï i94.10.08j, Ž­Ž™“‡.

29. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘Á‰t‘B×–E‚ÌCell Junction‚É‚¨‚æ‚Ú‚·ƒIƒJƒ_Ž_‚ƃJƒŠƒNƒŠƒ“‚`‚̉e‹¿. £ì²‹vi‰ðj: ‘æ59‰ñŒûo•aŠw‰ïŠwp‘å‰ï i94.11.25j, “Œ‹ž, —\eW, p.4, 1994.

30. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘Á‰t•ª”å‚É‚Í‚½‚·‹Øã”ç×–E‚Ì–ðŠ„(‡U)ƒrƒfƒIŒ°”÷‹¾‚É‚æ‚éŠÏŽ@. £ì²‹vC¯ˆä‚Ì‚èŽqCŽR‰È³•½i‰ðj: ‘æ99‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i94.03.30j, ŽRŒ`, ‰ð–UŠwŽGŽ, 69(4): 520, 1994.

31. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Development of the rat heart conduction system; A comparative study on normal and malformed hearts. ÂŽR’¼‘Pi“àjCŽR‰È³•½i‰ðj: “ú–{‰ð–UŠw‰ïŠÖ“Œ’n•û‰ï‘æ‚S‰ñ§˜b‰ï i94.06.11j, “Œ‹ž, ´˜^W, p.8, 1994.

32. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Žå‘è: ¶•¨Šw‚ÌV“WŠJ‚Æ“dŽqŒ°”÷‹¾‡T. Œ`‘Ô‰ðÍ‚ÌÅV‹Z–@; ‚•ª‰ð”\–Ɖu“dŒ°–@‚ÌŠJ”­‚Æ‚»‚̉ž—p. ‹Ê–؉p–¾i‰ðjCŸ–”CiŒ`‘ÔŒnjCŽR‰È³•½i‰ðj: ‘æ19‰ñ“ú–{“dŽqŒ°”÷‹¾Šw‰ïŠÖ“ŒŽx•”u‰‰‰ï i95.03.17j, “Œ‹ž, —\eW, p.12, 1994.

33. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠÒŒ³ƒIƒXƒ~ƒEƒ€¥LRƒzƒƒCƒg•ï–„–@‚Ì‘½—l«. Ÿ–”CiŒ`‘ÔŒnjC‹Ê–؉p–¾CŽR‰È³•½i‰ðj: ‘æ10‰ñˆãŠw¥¶•¨Šw“dŒ°‹ZpŒ¤‹†‰ï i94.06.18j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€¥—\eW, p.60, 1994.


<<02 ¶—Šw>>

34. mŒ´’˜n Ca2+/calmodulin-dependent regulation of the density of Na+ channels in embryonic chick skeletal muscle cells during their development in culture. ²“¡—º•½i¶—jC’†—Ñ—R”üŽqi¶•¨•¨—ŒnjC‰Á”Z³–¾i¶—j: Biochem. Biophys. Res. Commun., 203: 852`856, 1994.

35. mŒ´’˜n An inter-oscillator mechanism modulating circadian clock period in Paramecium populations. ’·’J쌚Ž¡i¶—jC’ËŒ´•Û•vi“Œ–k‘åjC“c’†ŠÚ–¾”Žiˆã—Éq¶jC“‡–{¹˜ai¸jCùŒ´•Žui”÷jCŽO—ÖŒÜ\“ñiˆïé‘åjCI.G. Gleadelli‰œ‰H‘åjC—é–؉p—Yi‘‘åj: Biol. Rhythm Res., 26(1): 68`78, 1995.

36. mŒ¤‹†•ñi•¶•”Èjn ƒ]ƒEƒŠƒ€ƒV‚Ìs“®‚ÌŠT“úƒŠƒYƒ€: ÃŽ~–Œ“dˆÊ‚ÌŠT“ú•Ï‰»‹@\. ’·’J쌚Ž¡i¶—jC“‡–{¹˜ai¸jC¼–{Ÿti“Œ—mˆãŠw‹ZpU‹»à’cj: Merss Report, 9: 18`19, 1994.

37. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ¶•¨‚É‚¨‚¯‚鎞ŠÔ“I’˜‚̈ê”Ê–@‘¥‚ð’T‚é. ’·’J쌚Ž¡i¶—j: Šî‘b¶•¨ŠwŒ¤‹†Š‹¤“¯Œ¤‹†•ñ‘, p.126, 1994.

38. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ¶—“IŽžŠÔ’˜‚Ì”­“W¥ˆÛŽ¥•ö‰ó‚Ì‹@\‰ð–¾‚ÉŒü‚¯‚Ä‚Ìí—ª. ’·’J쌚Ž¡i¶—j: ¶—ŠwŒ¤‹†Š‹¤“¯Œ¤‹†•ñ‘, 1995.

39. m‘àn ¶•¨ŽžŒv‚É‚¨‚¯‚éŠÂóƒkƒNƒŒƒIƒ`ƒh‚Ì–ðŠ„. ’·’J쌚Ž¡i¶—jC“‡–{¹˜ai¸jC¼–{Ÿti“Œ—mˆãŠw‹ZpU‹»à’cjC’ËŒ´•Û•vi“Œ–k‘åj: ”äŠr¶—¶‰»Šw, 11: 170`179, 1994.

40. mŠwp‘n i’P’˜j V¶—Šw‚pƒVƒŠ[ƒY; ’|“ດŽiˆã—pî•ñj. “ú–{ˆãŽ–V•ñŽÐC“Œ‹žC94.04.01”­s.

41. mŠwp‘i‰p•¶jn i•ª’SŽ·•Mj Biomedical Thermosciences; Counter-current blood flow system in fish swimbladder, p.44`48, ¬—ÑO—Si“àj. •ÒW ŽR“cK¶iH‹Æ‹Zp‰@j, “ú–{‹@ŠBŠw‰ïC“Œ‹žC94.07.00”­s.

42. mŠw‰ïi‘Ûjn iƒ[ƒNƒVƒ‡ƒbƒvj Computer simulation of body fluids regulation. ’|“ດŽiˆã—pî•ñjC’r“cŒ›ºiˆã—Éq¶jC²“¡“oŽu˜Yi¶—j: ‘Û•a‘Ô¶—Šw‰ï i94.11.23j, ‹ž“s, Pathophysiology, 1(Suppl.): 351, 1994.

43. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Circadian changes in cyclic nucleotides and resting membrane potential might be driven by biological clock in Paramecium. ’·’J쌚Ž¡i¶—jC’ËŒ´•Û•vi“Œ–k‘åjC“‡–{¹˜ai¸jC¼–{Ÿti“Œ—mˆãŠw‹ZpU‹»à’cjC’†‰ª•Û•viã‘åj: 4th Asian Conference on Ciliate Biology i95.03.28j, “Œ‹ž, —\eW, p.32, 1995.

44. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒ]ƒEƒŠƒ€ƒV‚Ìs“®‚ÌŠT“úƒŠƒYƒ€. ’·’J쌚Ž¡i¶—j: ‘æ6‰ñ‰F’ˆŠî’nˆãŠwŒ¤‹†‰ïƒVƒ“ƒ|ƒWƒEƒ€ i94.06.04j, –¼ŒÃ‰®.

45. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒ]ƒEƒŠƒ€ƒV‚̶•¨ŽžŒv: ‘OŠj×–E¶•¨‚Æ‘½×–E¶•¨‚ÌŠÔ. ’·’J쌚Ž¡i¶—jC“‡–{¹˜ai¸jC¼–{Ÿti“Œ—mˆãŠw‹ZpU‹»à’cjC’†‰ª•Û•viã‘åjC’ËŒ´•Û•vi“Œ–k‘åj: ‘æ5‰ñ“ú–{”äŠr¶—¶‰»Šw‰ï i94.07.02j, “Œ‹ž, ”äŠr¶—¶‰»Šw, 11: 279, 1994.

46. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¶•¨ŽžŒv‚É‚¨‚¯‚éƒAƒfƒjƒŒ[ƒgƒVƒNƒ‰[ƒ[‚Ì–ðŠ„. ’·’J쌚Ž¡i¶—jC“‡–{¹˜ai¸jC“c’†ŠÚ–¾”Žiˆã—Éq¶jC’ËŒ´•Û•vi“Œ–k‘åj: ‘æ71‰ñ“ú–{¶—Šw‰ï i94.03.24j, ‚¼, —\eW, p.85, 1994.

47. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Photons generated from muscle contraction. ‘åŠÑMi¶—jC“c’†ŠÚ–¾”Žiˆã—Éq¶j: ‘æ71‰ñ“ú–{¶—Šw‰ï i94.03.25j, ‚¼, Jpn. J. Physiol., 44(Suppl.): 140, 1994.

48. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Chronic effects of chick brain extract on the development of sodium and calcium channels in cultured chick skeletal muscle cells. ²“¡—º•½i¶—jC’†—Ñ—R”üŽqi¶•¨•¨—ŒnjC‰Á”Z³–¾i¶—j: ‘æ71‰ñ“ú–{¶—Šw‰ï i94.03.25j, ‚¼, Jpn. J. Physiol., 44(Suppl.): 147, 1994.

49. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Inhibitory effects of sapecin B, a novel flesh fly toxin, on K+ channels. —é–ØM”Vi¶—jC‘q“cˈê˜YC–¼Žær“ñi“Œ‘åjC‹g‰ª‹œi‘‘åj: ‘æ71‰ñ“ú–{¶—Šw‰ï i94.03.25j, ‚¼, Jpn. J. Physiol., 44(Suppl.): 22, 1994.

50. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Š^ã”ç•\”瑤–ŒNaƒ`ƒƒƒ“ƒlƒ‹“Á«‚̧Œä‹@\. •Ð‘q—²i¶—j: ‘æ71‰ñ“ú–{¶—Šw‰ï i94.03.25j, ‚¼, Jpn. J. Physiol., 44(Suppl.1): 67, 1994, —\eW, p.184, 1994.

51. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ]ƒEƒŠƒ€ƒV‚ÌÃŽ~–Œ“dˆÊ‚Ͷ•¨ŽžŒv‚É‚æ‚Á‚ħŒä‚³‚ê‚é. ’·’J쌚Ž¡i¶—jC“‡–{¹˜ai¸jC¼–{Ÿti“Œ—mˆãŠw‹ZpU‹»à’cjC’†‰ª•Û•viã‘åjC’ËŒ´•Û•vi“Œ–k‘åj: ‘æ1‰ñ“ú–{ŽžŠÔ¶•¨Šw‰ï i94.09.00j, “Œ‹ž, —\eW, B-3, p.3, 1994.

52. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒnƒG“Å sapecin B ‚Ì GH3 ×–E K+ ƒ`ƒƒƒ“ƒlƒ‹‚Ö‚Ì—}§Œø‰Ê. —é–ØM”Vi¶—jC‘q“cˈê˜YC–¼Žær“ñi“Œ‘åjC“c’†ŠÚ–¾”Žiˆã—Éq¶jCL–ìŽçrC‹g‰ª‹œi‘‘åj: ‘æ32‰ñ“ú–{¶•¨•¨—Šw‰ï i94.09.28`30j, ‰¡•l, ¶•¨•¨—, 34(Suppl.): 17, 1994.

53. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ]ƒEƒŠƒ€ƒV‚ÌÃŽ~–Œ“dˆÊ. ’·’J쌚Ž¡i¶—jC“‡–{¹˜ai¸jC¼–{Ÿti“Œ—mˆãŠw‹ZpU‹»à’cjC’†‰ª•Û•viã‘åjC’ËŒ´•Û•vi“Œ–k‘åj: ‘æ32‰ñ“ú–{¶•¨•¨—Šw‰ï i94.09.28j, ‰¡•l, ¶•¨•¨—, 34: 261, 1994.

54. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ÃŽ~–Œ“dˆÊ‚ÌŠT“ú•Ï‰»‹@\. ’·’J쌚Ž¡i¶—jC“‡–{¹˜ai¸jC¼–{Ÿti“Œ—mˆãŠw‹ZpU‹»à’cjC’ËŒ´•Û•vi“Œ–k‘åj: ‘æ18‰ñ“ú–{_Œo‰ÈŠw‰ï‘å‰ï i94.12.06j, “Œ‹ž, Neurosci. Res., 19(S): 235, 1994.

55. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Sapecin B, a novel flesh fly toxin, blocks K+ channels in pituitary GH3 cells. —é–ØM”Vi¶—jCL–ìŽçri‘‘åjC‘q“cˈê˜YC–¼Žær“ñi“Œ‘åjC‹g‰ª‹œi‘‘åj: ‘æ18‰ñ“ú–{_Œo‰ÈŠwŠw‰ï i94.12.06`08j, “Œ‹ž, Neurosci. Res., 19(Suppl.): 22, 1994.

56. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j A note of the sternohyoid muscle activity associated with pitch lowering during sitterances. “‡“cƒˆêi¶—jCL£”£iˆã—Éq¶Šw•”j: ‘æ72‰ñ“ú–{¶—Šw‰ï i95.03.30j, –¼ŒÃ‰®.

57. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒg‹“á΋؂̔÷¬zŠÂŒn‚É‚¨‚¯‚éŽ_‘f–O˜a“x‚ÆpH‚̕ω». ¬—ÑO—Si“àjC¼“c‘•ci¶•¨•¨—ŒnjC‘ê‘ò’¼’èi¶—j: ‘æ72‰ñ“ú–{¶—Šw‰ï‘å‰ï i95.03.30j, –¼ŒÃ‰®, —\eW, p.30, 1995.

58. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Development of the density of voltage-dependent Na+ channels in cultured chick skeletal muscle cells is regulated by Ca2+/calmodulin system. ²“¡—º•½i¶—jC’†—Ñ—R”üŽqi¶•¨•¨—ŒnjC‰Á”Z³–¾i¶—j: ‘æ5‰ñ“ú–{”äŠr¶—¶‰»Šw‰ï i94.06.30j, “Œ‹ž, ”äŠr¶—¶‰»Šw, 11: 262, 1994.

59. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒEƒTƒM‚ÌS”ƒŠƒYƒ€‚ƌċzƒŠƒYƒ€‚Ì“¯ŠúŒ»Û. ‘ê‘ò’¼’èi¶—jC¬—ÑO—Si“àjC•½“c‹M‘¥C•x“c–LiŒc‘åj: ‘æ72‰ñ“ú–{¶—Šw‰ï i95.03.30j, –¼ŒÃ‰®, —\eW, p.106, 1995.

60. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “dŽq‹³‰È‘ƒVƒXƒeƒ€(¶—Šw). ’|“ດŽiˆã—pî•ñj: ‘æ72‰ñ“ú–{¶—Šw‰ï‘å‰ï i95.03.30j, –¼ŒÃ‰®, —\eW, p.59, 1995.

61. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Š^ã”çƒAƒ~ƒƒ‰ƒCƒhŠ´Žó«Naƒ`ƒƒƒ“ƒlƒ‹“Á«. •Ð‘q—²i¶—j: ‘æ72‰ñ“ú–{¶—Šw‰ï i95.03.31j, –¼ŒÃ‰®, —\eW, p.259, 1995.

62. mŒ¤‹†‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Circadian change in the resting membrane potential might be driven by intracellular pacemaker in Paramecium. ’·’J쌚Ž¡i¶—jC“‡–{¹˜ai¸jC¼–{Ÿti“Œ—mˆãŠw‹ZpU‹»à’cjC’†‰ª•Û•viã‘åjC’ËŒ´•Û•vi“Œ–k‘åj: US-Japan Exchange Seminar i94.07.20j, ƒnƒƒC, —\eW, p.20, 1994.

63. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŠT“úU“®Žq‚ÌŽ©ŒÈ‘gD‰»‚ÆSlowing mechanism. ’·’J쌚Ž¡i¶—jC’ËŒ´•Û•vi“Œ–k‘åj: •½¬6”N“x¶—ŠwŒ¤‹†ŠŒ¤‹†‰ï i94.11.21j, ‰ªè.

64. mŠw‰ïŽåÃi‘ÛŠw‰ïjn ŠwpU‹»‰ï¥“ú•Ä‰ÈŠw‹¦—ÍŽ–‹Æ, US-Japan Exchange Seminar, The Molecular and Cellular Basis of Circadian Clocks, ’·’J쌚Ž¡i¶—j.

65. mŠw‰ïŽåÃi‘“àŠw‰ïjn ‘æ5‰ñ“ú–{”äŠr¶—¶‰»Šw‰ï, ƒVƒ“ƒ|ƒWƒEƒ€uŽž‚ÌŽ©‘RŽ: ¶•¨ŽžŒvv, ’·’J쌚Ž¡i¶—j.

66. mŠw‰ïŽåÃi‚»‚Ì‘¼jn •½¬6”N“x¶—ŠwŒ¤‹†ŠŒ¤‹†‰ï; ¶—“IŽžŠÔ’˜‚Ì”­“W¥ˆÛŽ¥•ö‰ó‚Ì‹@\‰ð–¾‚ÉŒü‚¯‚Ä‚Ìí—ª, ’·’J쌚Ž¡i¶—j.


<<03 ¶‰»Šw>>

67. mŒ´’˜n Dot blot analysis of rat gastric mucin using histochemical staining methods. ŒÜäzsMC–x“c‹±Žqi¶‰»j: Anal. Biochem., 223(1): 274`279, 1994.

68. mŒ´’˜n Effect on gastric mucus of the proton pump inhibitor leminoprazole and its cytoprotective action against ethanol-induced gastric injury in rats. ÎŒ´˜a•Fi‰»jCŽs쑸•¶i¶‰»jC¬Žº—Tˆêi“àjC¬Œ´iC–x“c‹±Žqi¶‰»j: Arzneim. Forsch/Drug Res., 44(‡U-7): 827`830, 1994.

69. mŒ´’˜n Human serum amyloid P component binds to a specific peptide in the presence of calcium. •lèG–¾i¶•¨j: Biochem. Biophys. Res. Commun., 205(2): 1172`1178, 1994.

70. mŒ´’˜n Lipids and myelin proteins in the brains of Coelacanth (Latimeria chalumnae), lungfish (Lepidosiren paradoxa and Protopterus aetiopicus), bichir (Polypterus senegalus), and sturgeon (Acipenser ruthenus) (Osteichthyes): Phylogenetic implications. ‹Êˆä—mˆêC¬“ˆ‹vŽqC‚ŽR‹v”üŽqi¶‰»j: Can. J. Fish. Aquat. Sci., 51: 1265`1272, 1994.

71. mŒ´’˜n Quantitation of the glycation intermediate 3-deoxyglucosone by oxidation with rabbit liver oxoaldehyde dehydrogenase to 2-keto-3-deoxygluconic acid followed by high-performance liquid chromatography. “¡ˆä‰pi“àjCŠâ£m—ECŽPˆèŽqi¶‰»jC–‹`’‰i“àjC–x“c‹±Žqi¶‰»j: J. Chromatogr. B., 660: 265`270, 1994.

72. mŒ´’˜n Effects of Z-300, a new histamine H2 receptor antagonist, on mucin biosynthesis in rat gastric mucosa. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fi‰»jC•û—D”üi“àjC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: Jpn. J. Pharmacol., 65: 63`66, 1994.

73. mŒ´’˜n Prenatal ethanol exposure affects the activity and mRNA expression of neuronal membrane enzymes in rat offspring. ¬“ˆ‹vŽqi¶‰»jC•ô“c—Œbi¶‰»ŒnjCÄ“¡Ø•äŽqi‰q¶Šw•”jCŒIŒ´³i‘n‰¿‘åjC‚‹´N•viVŠƒ‘åjCŒÃŠÚêˆêiŽÀ“®jC”’‘é‘’jiˆã—pî•ñjC’†‘º ˜a¶C‹Êˆä—mˆêi¶‰»j: Life Sci., 55(18): 1433`1442, 1994.

74. mŒ´’˜n Inhibition of neurite outgrowth of neuroblastoma neuro-2A cells by cholera toxin B-subunit and anti-GM1 antibody. G. WuiNew Jersey Med. Sch.jC’†‘º˜a¶i¶‰»jCR.W. LedeeniNew Jersey Med. Sch.j: Mol. Chem. Neuropathol., 21: 259`271, 1994.

75. mŒ´’˜n ŠeŽíH2Žó—e‘ÌhR܂̃€ƒ`ƒ“¶‡¬‚É‹y‚Ú‚·Œø‰Ê‚Ì”äŠrŒŸ“¢. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fi‰»jC•û—D”üCŽðˆä’C•FC“n•Ó•üŒbi“àjC¬Œ´iC–x“c‹±Žqi¶‰»j: –ò—‚ÆŽ¡—Ã, 22: 107`112, 1994.

76. m€Œ´’˜n ˆÝ”S–Œ–hŒä‚É‚¨‚¯‚éƒKƒXƒgƒŠƒ“‚Ì–ðŠ„|”S‰t¶‡¬‚É‹y‚Ú‚·ì—p‚ÉŠÖ‚·‚éŽÀŒ±“IŒŸ“¢|. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fi‰»jC¬Žº—TˆêC•û—D”üCŽðˆä’C•FC“n•Ó•üŒbC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: Therapeutic Research, 15: 131`132, 1994.

77. mŒ¤‹†•ñiŒú¶Èjn CJD‚ÌŠ³ŽÒ‚¨‚æ‚у}ƒEƒX‚É‚¨‚¯‚éTNF‚ÌŒŸ“¢. ‹Êˆä—mˆêC¬“ˆ‹vŽqC’†‘º˜a¶i¶‰»jC‘ê—´—YC“cŒû•¶Íi‰q¶Šw•”jC’·’JìˆêŽqCŒÃ˜a‹vKi“àjCˆä‘òŽu–¼–ìi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: Œú¶È“Á’莾Š³u’x”­«ƒEƒCƒ‹ƒXŠ´õv’²¸Œ¤‹†”Ç•½¬‚U”N“xŒ¤‹†•ñ‘, 1995.

78. m‘àn NSAIDs‚̈ݔS‰t•Ï“®‚É—^‚¦‚é‰e‹¿. ÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: G.I. Research, 2(6): 660`665, 1994.

79. m‘àn ˆÝ”S‰t‚ɑ΂·‚郂ƒmƒNƒ[ƒiƒ‹R‘Ì. ÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: ˆãŠw‚Ì‚ ‚ä‚Ý, 169(2): 144`145, 1994.

80. m‘àn ˆÝ”S‰tŒ¤‹†‚Ì—ðŽj. –x“c‹±Žqi¶‰»jCÎŒ´˜a•Fi‰»j: Á‰»«’×á‡-—Õ°‚ÆŠî‘b-, 13(1): 21`29, 1994.

81. m‘àn ƒEƒCƒ‹ƒX«_ŒoŽ¾Š³‚Æ“œŽ‰Ž¿. ‹Êˆä—mˆêi¶‰»j: —Õ°‰»Šw, 23(2): 94`102, 1994.

82. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn i‹¤’˜j “œ½‚̉Ȋw“ü–å; ¶‘Ì–hŒä‚Æ“œ½, p.105`130, Šâ£m—Ei¶‰»jC‘å¼³Œ’i‹ž“s•{—§‘åjC–Ø‘]^iŠò•Œ‘åjC•½—Ñ‹`—Yi—Œ¤jCŽR–{Œ›“ñi‹ž‘åj. ”|•—ŠÙC“Œ‹žC94.11.30”­s.

83. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn i‹¤’˜j “œ½‚̉Ȋw“ü–å; ƒvƒƒeƒIƒOƒŠƒJƒ“, p.173`186, Šâ£m—Ei¶‰»jC‘å¼³Œ’i‹ž“s•{—§‘åjC–Ø‘]^iŠò•Œ‘åjC•½—Ñ‹`—Yi—Œ¤jCŽR–{Œ›“ñi‹ž‘åj. ”|•—ŠÙC“Œ‹žC94.11.30”­s.

84. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Distinct stimulation of mucin biosynthesis in rat gastric mucosa by gastrin and carbachol. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fi‰»jC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: American Gastroenterological Association i94.05.17j, New Orleans, U.S.A., Gastroenterology, 106: 98, 1994.

85. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effect of dantrolene on dopamine levels of cultured neuronal cells. ‚‹´‰pŽqi¸jC‘åŠÑ—TŽqi¶•¨‰»ŠwŒnjC¬“ˆ‹vŽqi¶‰»jC¬ŠÚTÆiZ—F‹à‘®jC’†‘º˜a¶i¶‰»jC‘å’J‹`•vi¸jC‹Êˆä—mˆêi¶‰»jCŽO‰Y’å‘¥iˆã —Éq¶Šw•”j: ‘æ19‰ñ‘Û_Œo¸_–ò—Šw‰ï i94.06.29j, Washington, D.C., Neuropsychopharmacology, 10(3S): 236, 1994.

86. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effect of dantrolene on monoamine levels in cultured neuronal cells. ‘åŠÑ—TŽqi¶‰»ŒnjC¬“ˆ‹vŽqi¶‰»jC‚‹´‰pŽqi¸jC¬ŠÚTÆiZ—F‹à‘®ƒoƒCƒIƒTƒCƒGƒ“ƒXjC’†‘º˜a¶i¶‰»jC‘å’J‹`•vi¸jC‹Êˆä—mˆêi¶‰»jC ŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: ‘æ12‰ñ‘Û–ò—Šw‰ï i94.07.27j, Montreal, Abstracts, p.430, 1994.

87. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Detection of two distinct mucin species localized in the surface and gland mucous cells of rat gastric mucosa by specific monoclonal antibodies. ÎŒ´˜a•Fi‰»jCŒIŒ´½iŠÖ“Œ‰»ŠwjCŒÜäzsMi¶‰»jC‘¾“c_—ÇCŸŽR“wiM‘åjC–x“c‹±Žqi¶‰»j: 10th World Congress of Gastroenterology i94.10.06j, Los Angeles, Abstract Book ‡U, p.1393, 1994.

88. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Activation of mucin biosynthesis in rat gastric mucosa by FRG-8813 and its structural characterization. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fi‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: 10th World Congress of Gastroenterology i94.10.06j, Los Angeles, U.S.A., Abstract Book ‡U, p.1394, 1994.

89. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effect of aspirin and ethanol on the mucins in the different layers of rat gastric mucosa. –x“c‹±Žqi¶‰»jCŽðˆä’C•Fi“àjCÎŒ´˜a•Fi‰»jC: 10th World Congress of Gastroenterology i94.10.06j, Los Angeles, U.S.A., Abstract Book ‡U, p.1402, 1994.

90. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Novel fucosylated glycosphingolipids in plerocercoids of parasite, Spirometra erinacei. ìã‘×i¶‰»jC¶“c~ŽqC“à“c–¾•FC‘º“c‹`•Fi–ƒ•z‘åjC¬“ˆ‹vŽqC’†‘º˜a¶C‹Êˆä—mˆêi¶‰»j: ‘æ8‰ñ‘ÛŠñ¶’ŽŠw‰ï i94.10.13j, Izmir, ƒgƒ‹ƒR, Abstract, 2: 426, 1994.

91. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝ”S‰t“œ’`”’Ž¿(ƒ€ƒ`ƒ“)¶‡¬‚É‚¨‚¯‚éƒJƒ‹ƒoƒR[ƒ‹‚Ì–ðŠ„-ƒKƒXƒgƒŠƒ“‚Æ‚Ì”äŠr-. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fi‰»jC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ80‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i94.04.23j, _ŒË, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 557, 1994.

92. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ}ƒ“ƒ\ƒ“—ô“ªð’Ž‚Ì“œŽ‰Ž¿: Ž}•ª‚©‚ê\‘¢‚ðŽ‚ƒtƒRƒVƒ‹ƒeƒgƒ‰ƒwƒLƒ\ƒVƒ‹ƒZƒ‰ƒ~ƒh‚Ì“¯’è. ìã‘×C’†‘º˜a¶C¬“ˆ‹vŽqC‹Êˆä—mˆêi¶‰»jC—é–Ø›‰C—é–Ø–¾gCˆîŠ_“~•Fi“s—Õ°Œ¤j: ‘æ36‰ñ“ú–{Ž‰Ž¿¶‰»ŠwŒ¤‹†‰ïW‰ï i94.06.16j, ŽD–y, Ž‰Ž¿¶‰»ŠwŒ¤‹†, 36: 217`220, 1994.

93. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgˆÝƒ€ƒ`ƒ“‚Ì•ª‰æ‚Æ«ó. ŒÜäzsMC–x“c‹±Žqi¶‰»j: ‘æ16‰ñ“œŽ¿ƒVƒ“ƒ|ƒWƒEƒ€ i94.08.29j, Ž­Ž™“‡, —vŽ|W, p.12`13, 1994.

94. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒgŒŒ´IgAlƒqƒ“ƒW“œƒyƒvƒ`ƒh‹y‚Ñ‹C‘Šƒqƒhƒ‰ƒWƒ“•ª‰ð‚É‚æ‚蓾‚ç‚ê‚郀ƒ`ƒ“Œ^“œ½‚ÌMALDI-TOFMS‚É‚æ‚镪Í. Šâ£m—ECŽPˆèŽqC–x“c‹±Žqi¶‰»jC”äŠé”\”ViŠÅŒìŠw•”jC“¡ˆä‰pC¬—Ñ–Li“àjC“c’†~ŽuCŒË“c–FŽqiˆ®‰»¬j: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.07j, ‘åã, ¶‰»Šw, 66(7): 639, 1994.

95. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒg‘å’°ƒ€ƒ`ƒ“‚̶‡¬(‘æ‚Q•ñ). ¬Œ´iCŽs쑸•¶C–x“c‹±Žqi¶‰»j: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.10j, ‘åã, ¶‰»Šw, 66(7): 730, 1994.

96. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝ”S‰t“œ’`”’Ž¿(ƒ€ƒ`ƒ“)¶‡¬˜´iì—p‚ÉŠÖ—^‚·‚é–ò•¨\‘¢‚̉ð–¾. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fi‰»jC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.10.31j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91: 1681, 1994.

97. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •úü‹Û‚̶ŽY‚·‚éV‹Kƒ€ƒ`ƒ“•ª‰ðy‘fendo-GalMAc-ase S|ƒXƒNƒŠ[ƒjƒ“ƒO‚ƶŽY. “c’†–F•C‘呺’qi–k—¢Œ¤jCŽPˆèŽqCŠâ£m—EC–x“c‹±Žqi¶‰»j: “ú–{¶•¨HŠw‰ï‘å‰ï i94.11.00j, _ŒË, —vŽ|W, p,89, 1994.

98. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘ŸŠíMit‚̌ċzŠˆ«‚É‹y‚Ú‚·ƒTƒ‹ƒ`ƒ‹Ž_‚ƃoƒ‹ƒvƒŽ_‚̉e‹¿. “n•Ó“”ü”Ti¶‰»jC‘]ª—R”üŽqi¶‰»Œnj: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.08j, ‘åã, ¶‰»Šw, 66(7): 844, 1994.

99. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŒŒ´ƒAƒ~ƒƒCƒh‚o¬•ª(SAP)‚Ìd‡‚ÉŠÖ—^‚·‚éƒhƒƒCƒ“. •lèG–¾i¶•¨j: “ú–{¶‰»Šw‰ï i94.09.08j, ‘åã, ¶‰»Šw, 66(7): 884, 1994.

100. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Streptomyces sp. OH-11242”|—{‰t’†‚ÉŽY¶‚³‚ê‚éendo-GalNAc-ase-S‚̃VƒAƒ“œƒ^ƒ“ƒpƒNŽ¿‚Ö‚Ìì—p. ŽPˆèŽqCŠâ£m—EC–x“c‹±Žqi¶‰»jC“¡ˆä‰pi“àjCBhavanandan, V.P.iPenn. State Univ.j: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.08j, ‘åã, ¶‰»Šw, 66(7): 886, 1994.

101. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÝ”S‰t×–E—R—ˆƒ€ƒ`ƒ“‚Æ”½‰ž‚·‚éŠeŽíƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚Ì컂Ƃ»‚Ì«ó‚Ì”äŠrŒŸ“¢. ŒIŒ´½iŠÖ“Œ‰»ŠwjCÎŒ´˜a•Fi‰»jC’†–ì—Ï‘¾CŠâã~iŠÖ“Œ‰»ŠwjCŒÜäzsMC–x“c‹±Žqi¶‰»j: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.08j, ‘åã, ¶‰»Šw, 66(7): 888, 1994.

102. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆÝ‘B”S‰t×–E—R—ˆƒ€ƒ`ƒ“‚ð”FŽ¯‚·‚郂ƒmƒNƒ[ƒiƒ‹R‘ÌHIK 1083‚Æ”½‰ž‚·‚éƒuƒ^ˆÝƒ€ƒ`ƒ“—R—ˆ“œ½‚ÌŒŸ“¢. ÎŒ´˜a•Fi‰»jCŒIŒ´½iŠÖ“Œ‰»ŠwjCŒÜäzsMi¶‰»jC‰Y“c’ËMŽqi¶‰»ŒnjC“à“¡³‹KiˆãŠw•”jC–x“c‹±Žqi¶‰»j: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.08j, ‘åã, ¶‰»Šw, 66(7): 888, 1994.

103. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒgˆÝƒ€ƒ`ƒ“‚É”½‰ž‚·‚郂ƒmƒNƒ[ƒiƒ‹R‘Ì(RGM23)‚Ì«ó. ŒÜäzsMi¶‰»jCŒIŒ´½iŠÖ“Œ‰»ŠwjCÎŒ´˜a•Fi‰»jC‰Y“c’ËMŽqi¶‰»ŒnjC–x“c‹±Žqi¶‰»j: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.08j, ‘åã, ¶‰»Šw, 66(7): 888, 1994.

104. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒuƒ^Adult¸‘ƒMicrosome‚©‚ç‚ÌP-450‚̸»•À‚Ñ‚É”«Ž¿‚ɂ‚¢‚Ä. ŒK“c³Li¶‰»jC‘]ª—R”üŽqi¶‰»Œnj: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.08j, ‘åã, ¶‰»Šw, 66(7): 977, 1994.

105. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j PC12×–EƒtƒR[ƒX“]ˆÚy‘f‚Æ“Ë‹NŒ`¬Žž‚ÌŠˆ«•Ï‰». ¬“ˆ‹vŽqC’†‘º˜a¶i¶‰»jC‘]ª—R”üŽqi¶‰»ŒnjC‹Êˆä—mˆêi¶‰»j: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.10j, ‘åã, ¶‰»Šw, 66(7): 1038, 1994.

106. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ}ƒ“ƒ\ƒ“—ô“ªð’Ž‚ÌV‚µ‚¢Œn—ñ‚É‘®‚·‚é“œŽ‰Ž¿. ’†‘º˜a¶C¬“ˆ‹vŽqCìã‘×i¶‰»jC“à“c–¾•FC‘º“c‹`•Fi–ƒ•z‘åjC‹Êˆä—mˆêi¶‰»j: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.10j, ‘åã, ¶‰»Šw, 66(7): 1038, 1994.

107. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒGƒC”]‚̃Kƒ“ƒOƒŠƒIƒVƒh: V‚µ‚¢ƒnƒCƒuƒŠƒbƒhŒ^ƒ|ƒŠƒVƒAƒƒKƒ“ƒOƒŠƒIƒVƒh‚Ì“¯’è. ’†‘º˜a¶C¬“ˆ‹vŽqC‹Êˆä—mˆêi¶‰»j: ‘æ37‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï i94.10.06j, ¼–{, _Œo‰»Šw, 33(1): 354`355, 1994.

108. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j PC12×–E‚Ì_Œo“Ë‹NŒ`¬‚ÉŠÖ—^‚·‚éƒVƒAƒ‹Ž_“]ˆÚy‘f‚Æ‚»‚Ì‘jŠQÜKI-8110‚̉e‹¿. ¬“ˆ‹vŽqC’†‘º˜a¶C‹Êˆä—mˆêi¶‰»j: ‘æ37‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï i94.10.06j, ¼–{, _Œo‰»Šw, 33(1): 356`357, 1994.

109. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆÝ”S‰t‚Æ‚­‚Ƀ€ƒ`ƒ“‚Ì•Ï“®‚ɂ‚¢‚Ä. ÎŒ´˜a•Fi‰»j: ɪŒ§—§‘åŠwŠw’·“Á•ÊŒ¤‹†¢H¶Šˆ‚Æ’·ŽõŒ’N£‚ÉŠÖ‚·‚éƒVƒ“ƒ|ƒWƒEƒ€¢Á‰»ŠÇ‹@”\‚ÆŒ’N£ (95.01.09), ɪ, —\eWi‘æ10‰‰‘èj, 1995.

110. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ˆÝ”S‰t‘ãŽÓ‚Ì—§ê‚©‚ç‚Ý‚½V‹KH2Žó—e‘ÌhRÜFRG-8813‹y‚ÑŠÖ˜A‰»‡•¨‚Ìì—p‚ÉŠÖ‚·‚éŽÀŒ±“IŒŸ“¢. Žs쑸•¶i¶‰»jCÎŒ´˜a•Fi‰»jC¬Žº—TˆêC•û—D”üCŽðˆä’C•FC“n•Ó•üŒbC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ9‰ñ_“ÞìƒTƒCƒgƒvƒƒeƒNƒVƒ‡ƒ“Œ¤‹†‰ï i94.11.17j, ‰¡•l, ´˜^W, p.1, 1994.

111. m“Á‹–¥ˆÓ “o˜^n ”S‰t“œƒ^ƒ“ƒpƒNŽ¿ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì, oŠè”Ô† “ÁŠè•½5-159391(1993-5-26), “Á‹–oŠèŒöŠJ”Ô† “ÁŠJ•½6-335396(1994-12-6), ŒIŒ´½iŠÖ“Œ‰»ŠwjCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j.


<<04 •ªŽq¶•¨Šw>>

112. mŒ´’˜n Suppressive effects on cancer cell proliferation of the enhancement of superoxide dismutase (SOD) activity associated with the protein-bound polysaccharide of coriolus versicolor QUEL. ¬—Ñ—F‹Li“àjCŠå’J˜a”Ni•ª¶jC¼Œ³Ž›Ž—çi“àjC’†‘º‘‰qi•ª¶j: Cancer Biother., 9(2): 171`177, 1994.

113. mŒ´’˜n Enhancement of anti-cancer activity of cisdiaminedichloroplatinum by the protein bound polysaccharide of Coriolus versicolor QUEL (PS-K) in vitro. ¬—Ñ—F‹Li“àjCŠå’J˜a”Ni•ª¶jC¼Œ³Ž›Ž—çi“àjC’†‘º‘‰qi•ª¶j: Cancer Biother., 9(4): 351`358, 1994.

114. mŒ´’˜n Prevention of spontaneous polyarthritis in NZB/KN mice by treatment with a novel thiazole derivative, SM-8849. ¼Šp•¶•viZ—F»–òjC’†‘º‘‰qi•ª¶jC”è’õ•vi“àjCŒÃŠÕ‹`•FiZ—F»–òj: Drugs Exp. Clin. Res., 20(3): 85`92, 1994.

115. mŒ´’˜n The regulatory region and transcription factor required for the expression of rat and salmon pituitary hormone-encoding genes show cell-type and species specificity. ¬–ì‰ë•vC–]ŒŽŒb”üŽqCX—CŽqC‘Š‘ò–¾C’£‘Ö‹MŽui•ª¶j: Gene, 153: 267`271, 1995.

116. mŒ´’˜n Localization of the genes for the 100-kDa complement-activating components of Ra-reactive factor (CRARF and Crarf) to human 3q27-q28 and mouse 16B2-B3. ‚“cŽj’jiŽ™jCè’¼•Fi‚©‚¸‚³DNAŒ¤‹†ŠjC¼“c—mˆêi•úŽËüˆãŠw‘‡Œ¤‹†ŠjC‚ŽR‹g‰iCìã³–çi•ª¶j: Genomics, 25(3): 757`759, 1995.

117. mŒ´’˜n Pituitary-specific transcription factor Pit-1 in the rdw rat with growth hormone- and prolactin-deficient dwarfism. ¬–ì‰ë•vC’£‘Ö‹MŽui•ª¶jCŒÃŠÚêˆêiŽÀ“®j: J. Endocrinol., 143: 479`487, 1994.

118. mŒ´’˜n Substrate specificities of the protease of mouse serum Ra-reactive factor. R.T. OgataCP.J. LowiMedical Institute, La Jolla, CA, USAjCìã³–çi•ª¶j: J. Immunol., 154: 2351`2357, 1995.

119. mŒ´’˜n Scavenging activity of nitric oxide (NO) on hydroxyl radical (¥OH). ‰œ•xr”Vi–ƒjC–쌳‚¯‚¢Žqi¶‰»ŒnjC’†‘º‘‰qi•ª¶jCŒã“¡•¶•vi–ƒj: Magn. Reson. Med., 6: 141`143, 1995.

120. mŒ´’˜n ƒ`ƒIƒyƒ“ƒ^[ƒ‹…—n‰t‚©‚ç”­¶‚·‚éƒqƒhƒƒLƒVƒ‹ƒ‰ƒWƒJƒ‹‚ƶ‘Ì‚É‹y‚Ú‚·‰e‹¿. ‰œ•xr”Vi–ƒjC–쌳‚¯‚¢Žqi¶‰»ŒnjC’†‘º‘‰qi•ª¶jCŒã“¡•¶•vi–ƒj: Ž¥‹C‹¤–‚ƈãŠw, 5: 62`65, 1994.

121. mŒ´’˜n ”’‹àŠÜ—LRŠàÜ‚æ‚è”­¶‚·‚銈«Ž_‘fŽí‚Ì”äŠrŒŸ“¢, ‚¨‚æ‚Ñ•›ì—pŒyŒ¸Ü‚ÌŠˆ«Ž_‘fŽíÁ‹Ž”\. Šå’J˜a”Ni•ª¶jC–쌳‚¯‚¢Žqi¶‰»ŒnjC’†“‡—mˆêC’†‘º‘‰qi•ª¶j: Ž¥‹C‹¤–‚ƈãŠw, 5: 66`70, 1994.

122. mŒ´’˜n Unnecessity of the C1 C1s for the function of serum bactericidal factor, RaRF. Žü“øC‹Gˆç‰Øi•ª¶jC‰£—m”üi¶‰»ŒnjCìã³–çi•ª¶j: –k—¢ˆãŠw, 24(3): 176`182, 1994.

123. mŒ´’˜n Effect of the complement-activating bactericidal factor, Ra-reactive factor, on the activation of serine protease in mouse peritoneal phagocytes. Žü“øi•ª¶jC‰£—m”üi¶‰»ŒnjCìã³–çi•ª¶j: –k—¢ˆãŠw, 24(6): 462`468, 1994.

124. mŒ´’˜n Degradation of Ra-reactive factor by proteases in cells of promonocytic line, U937. Žü“øi•ª¶jC‰£—m”üi¶‰»ŒnjC‹Gˆç‰ØCìã³–çi•ª¶j: –k—¢ˆãŠw, 24(6): 469`474, 1994.

125. mŒ´’˜n ŒŒ´’†‚ÌŽE‹ÛˆöŽqRa-reactive factor‚Ì‘ª’è–@‚ÌŒŸ“¢. ‰£—m”üi¶‰»ŒnjCŽü“øC‹Gˆç‰ØCìã³–çi•ª¶j: –k—¢ˆãŠw, 24(6): 543`549, 1994.

126. m’Z•ñ¥‘¬•ñn ƒ`ƒIƒyƒ“ƒ^[ƒ‹‚ÆŽ_‘fƒ‰ƒWƒJƒ‹, NO‚ÌŠÖ˜A. ‰œ•xr”Vi–ƒjC’†‘º‘‰qi•ª¶j: Molecular Medicine, 32(4): 431`432, 1995.

127. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ”]‰º‚‘̃zƒ‹ƒ‚ƒ“ˆâ“`Žq‚Ì”­Œ»’²ß‹@\. ¬–ì‰ë•vi•ª¶j: …ŽYƒoƒCƒeƒN‹ZpŠî”Õ®”õŽ–‹Æ•ñ‘, p.31`38, 1994.

128. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Pituitary-specific transcription factor pit-1 in rdw rat with GH- and PRL- deficient dwarfism. ¬–ì‰ë•vC’£‘Ö‹MŽui•ª¶jCŒÃŠÚêˆêiŽÀ“®j: ¬’·‰ÈŠw‹¦‰ïŒ¤‹†”N•ñ, 17: 473`486, 1993.

129. m‘àn ˆâ“`ŽqŽ¡—ẪKƒCƒhƒ‰ƒCƒ“. ìã³–çi•ª¶j: ƒtƒ@ƒ‹ƒ}ƒVƒA, 30(9): 1028`1031, 1994.

130. m‘àn ŠjŽ_“d‹C‰j“®‚ÌŒ´—‚Ɖž—p. ìã³–çi•ª¶j: ¶•¨•¨—‰»Šw, 38: 349`353, 1994.

131. m‘àn SOD—lŠˆ«‚ðŽ‚–òÜ‚Æ‚µ‚Ä‚Ì PS-KiƒJƒƒ‰ƒ^ƒP—R—ˆ“œ’`”’Ž¿). ¬—Ñ—F‹LCŠå’J˜a”Ni•ª¶jC¼Œ³Ž›Ž—çi“àjCŠOŽR‹v‘¾˜Yi•½’Ë‹¤Ï•a‰@jCŠô¢‹´“ÄiŒ§—§‚ª‚ñƒZƒ“ƒ^[jC‘OìŒö’ji“ŒŽÅ—ÑŠÔ•a‰@jC’†‘º‘‰qi•ª ¶j: –k—¢ˆãŠw, 24(3): 168`175, 1994.

132. muÀn NZB/KNƒ}ƒEƒXŽ©‘R”­ÇŠÖ߉Š. ’†‘º‘‰qi•ª¶j: ‰ŠÇ‚ƖƉu, 2(3): 87`92, 1994.

133. mŠwp‘i‰p•¶jn i•ª’SŽ·•Mj Fish Physiology, vol.13: Molecular Endocrinology of Fish; The somatolactin gene, p.159`177, ¬–ì‰ë•vi•ª¶jCì“à_Žii…ŽYŠw•”j. •ÒW N.M. Sherwoodiƒ”ƒBƒNƒgƒŠƒA‘奃Jƒiƒ_jCC.L. Hewiƒgƒƒ“ƒg‘奃Jƒiƒ_jC Academic PressCSan DiegoC94.00.00”­s.

134. mŠwp‘n i•ª’SŽ·•Mj …‚ÌÄ”­Œ©, …‚ɑ΂·‚éV‚µ‚¢l‚¦•û‚ÆŽÀØ; g‘Ì‚Æ…, p.111`122, ’†‘º‘‰qi•ª¶j. •ÒW ’†ªŽ C‹v•Û“c¹Ž¡C Œõ—ÔC“Œ‹žC94.07.15”­s.

135. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Scavenging activity of nitric oxide on hydroxyl radical. ‰œ•xr”Vi–ƒjC–쌳‚¯‚¢Žqi¶‰»ŒnjCŒã“¡•¶•vi–ƒjC’†‘º‘‰qi•ª¶j: International Conference on Bioradicals Detected by ESR Spectroscopy i94.06.13j, ŽRŒ`.

136. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Preventive effects of organic germanium compounds on DM-complications induced by streptozotocin in Sprague Dawley rats. ’†‘º‘‰qi•ª¶jC“¡“c–F–Mi“àjC¬—ÑOsCŠ`–{‹I”ŽiƒQƒ‹Œ¤j: 15th International Diabetic Federation Congress i94.11.06`11j, _ŒË.

137. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒƒ`ƒ‹ƒ}ƒƒ“Ž_ŒŒÇ‚ÌV‚½‚Ȉâ“`Žq•ÏˆÙ‚Ì”­Œ©‚Æv‘¬o¶‘Of’f‚Ö‚ÌPCR-SSCP–@‰ž—p‚̉”\«. ‚“cŽj’jiŽ™jC˜a“c’m‰vi—Õ•a—jC‘O“c“OiŠÅŒìŠw•”jC‚ŽR‹g‰iCìã³–çi•ª¶jC¼‰YM•viŽ™j: ‘æ37‰ñ“ú–{æ“V‘ãŽÓˆÙíŠw‰ï i94.11.24j, ‰ªŽR, “ú–{æ“V‘ãŽÓˆÙíŠw‰ïŽGŽ, 10(2): 49, 1994.

138. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —L‹@ƒQƒ‹ƒ}ƒjƒEƒ€‰»‡•¨‚É‚æ‚é“œ”A•a‡•¹Ç‚Ì—}§. ’†‘º‘‰qi•ª¶jC“¡“c–F–Mi“àjC‹{“cŠ²•viŠáj: ‘æ37‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï i94.05.12j, “¿“‡.

139. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j PCR‚É‚æ‚è”­Œ©‚Å‚«‚½ƒƒ`ƒ‹ƒ}ƒƒ“Ž_ŒŒÇ‚ÌV‚µ‚¢Œ^‚̈â“`Žq•ÏˆÙ. ‚“cŽj’jiŽ™jC˜a“c’m‰vi—Õ•a—jC‚ŽR‹g‰iCìã³–çi•ª¶j: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.26j, ŽD–y, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(3): 497, 1994.

140. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j V‚µ‚¢Š´õ–hŒäˆöŽqRa-reactive factor‚Ì•â‘ÌŠˆ«‰»¬•ªP100‚̃qƒg‹y‚у}ƒEƒXˆâ“`ŽqÀˆÊ‚ÌŒˆ’è. ‚“cŽj’jiŽ™jCè’¼•Fi‚©‚¸‚³DNAŒ¤‹†ŠjC¼“c—mˆêi•úŽËüˆãŠw‘‡Œ¤‹†ŠjC‚ŽR‹g‰iCìã³–çi•ª¶j: ‘æ39‰ñ“ú–{l—Þˆâ“`Šw‰ï‘å‰ï i94.10.18j, ç—t, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.66(A-6), 1994.

141. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒƒ`ƒ‹ƒ}ƒƒ“Ž_ŒŒÇ‚ÌV‚µ‚¢Œ^‚̈â“`Žq•ÏˆÙ‚ÆPCR-SSCP‰ðÍ‚É‚æ‚év‘¬f’f–@‚ÌŽŽ‚Ý. ‚“cŽj’jiŽ™jC˜a“c’m‰vi—Õ•a—jC‚ŽR‹g‰iCìã³–çi•ª¶jC¼‰YM•viŽ™j: ‘æ17‰ñ“ú–{¬Ž™ˆâ“`ˆãŠw‰ïŠwpW‰ï i94.11.19j, ’·è, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.31, 1994.

142. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •â‘ÌŠˆ«‰»ŽE‹ÛˆöŽq|RaRF|‚̃ZƒŠƒ“ƒvƒƒeƒA[ƒ[¬•ª(P1OO)‚̈â“`ŽqÀ. ‚ŽR‹g‰ii•ª¶jC‚“cŽj’jiŽ™jCŠÖ’¼•Fi‚©‚¸‚³DNAŒ¤jC¼“c—mˆêi•úˆãŒ¤jCìã³–çi•ª¶j: ‘æ17‰ñ“ú–{•ªŽq¶•¨Šw‰ï”N‰ï i94.12.13j, _ŒË, —vŽ|W, p.241, 1994.

143. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆâ“`Žq•ÏˆÙ‚ª¬Ž™‹•Žã‘ÌŽ¿‚ÌŒ´ˆö‚Æ‚µ‚Ä’–Ú‚³‚ê‚éV‚µ‚¢Š´õ–hŒäˆöŽq; Ra-Reactive Factor‚̈â“`Žq‰ðÍ. ‚“cŽj’jiŽ™jC‚ŽR‹g‰ii•ª¶jC–ì“n‰ë•FC¼‰YM•viŽ™jCìã³–çi•ª¶j: ‘æ98‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i95.03.24`26j, Šò•Œ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 99(1): 391, 1995.

144. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •â‘ÌŠˆ«‰»ŽE‹ÛˆöŽq|RaRF|‚̃ZƒŠƒ“ƒvƒƒeƒA[ƒ[¬•ª(P1OO)‚̈â“`Žq‰ðÍ. ‚ŽR‹g‰ii•ª¶jC‚“cŽj’jC–ì“n³•FiŽ™jC‰£—m”üi¶‰»ŒnjCŽü“øCìã³–çi•ª¶j: ‘æ68‰ñ“ú–{׋ۊw‰ï‘‰ï i95.03.25j, ‹ž“s, “ú–{׋ۊwŽGŽ, 50(1): 146, 1995.

145. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰ßŽ_‰»…‘f‚É‚æ‚éCu, Zn-SOD‚Ì’f•Ð‰»‚Ì‹@\. –쌳‚¯‚¢Žqi¶‰»ŒnjC’†“‡—mˆêC’†‘º‘‰qi•ª¶j: ‘æ67‰ñ“ú–{¶‰»Šw‰ï i94.09.07j, ‘åã.

146. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j (P)ADP-ƒŠƒ{[ƒX‚É‚æ‚éƒAƒ‹ƒhƒ‰[ƒ[‚ÌAffinity-basedƒOƒŠƒP[ƒVƒ‡ƒ“. ’†“‡—mˆêC’†‘º‘‰qi•ª¶j: ‘æ67‰ñ“ú–{¶‰»Šw‰ï i94.09.07j, ‘åã.

147. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Superoxide dismutase (SOD)—lŠˆ«‚ð‚à‚Âcationic porphyrin“Sö‘Ì‚Ì‚ª‚ñ×–E‚ɑ΂·‚éì—p. ’†‘º‘‰qC¬—Ñ—F‹Li•ª¶jCŽ­“‡N_C•À–Ø–ž•vi“Œ”_‘åj: ‘æ2‰ñƒ|ƒ‹ƒtƒBƒŠƒ“ƒVƒ“ƒ|ƒWƒEƒ€ i94.10.24j, “Œ‹ž.

148. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬’·ƒzƒ‹ƒ‚ƒ“¥ƒvƒƒ‰ƒNƒ`ƒ“ˆâ“`Žq‚Ì×–E“ÁˆÙ“I‚È”­Œ»‹@\: ¬’·ƒzƒ‹ƒ‚ƒ“ŽY¶×–E‚Å“àÝ«‚̃vƒƒ‰ƒNƒ`ƒ“ˆâ“`Žq‚ª”­Œ»‚³‚ê‚È‚¢——R. ‘Š‘ò–¾i•ª¶jC•—’£KŽiiŽ™jC•ÄŽR’‰ŽuC¬–ì‰ë•vi•ª¶j: ‘æ17‰ñ“ú–{•ªŽq¶•¨Šw‰ï”N‰ï i94.12.13j, _ŒË, —\eW, p.20, 1994.

149. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬’·ƒzƒ‹ƒ‚ƒ“¥ƒvƒƒ‰ƒNƒ`ƒ“ˆâ“`Žq‚Ì×–E“ÁˆÙ“I‚È”­Œ»‹@\: ƒ‰ƒbƒg¬’·ƒzƒ‹ƒ‚ƒ“ˆâ“`Žq‚ÌDNase‡T‚Š´Žó«•”ˆÊ‚Æ‚»‚̶•¨Šˆ«. ‘Š‘ò–¾C•ÄŽR’‰Žui•ª¶jC•—’£KŽiiŽ™jC¬–ì‰ë•vi•ª¶j: ‘æ17‰ñ“ú–{•ªŽq¶•¨Šw‰ï”N‰ï i94.12.13j, _ŒË, —\eW, p.20, 1994.

150. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒƒ`ƒ‹ƒ}ƒƒ“Ž_ŒŒÇ‚ÌV‚µ‚¢Œ^‚̈â“`Žq•ÏˆÙ‚ÆPCR-SSCP–@‚É‚æ‚év‘¬f’f‚ÌŽŽ‚Ý. ‚“cŽj’jiŽ™jC˜a“c’m‰vi—Õ•a—jC‚ŽR‹g‰ii•ª¶jC¼‰YM•viŽ™jCìã³–çi•ª¶j: ‘æ17‰ñ“ú–{•ªŽq¶•¨Šw‰ï”N‰ï i94.12.15j, _ŒË, ƒvƒƒOƒ‰ƒ€¥u‰‰—vŽ|W, p.408, 1994.

151. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j Š´õ–hŒä‚É‚¨‚¯‚é•â‘ÌŠˆ«‰»ƒŒƒNƒ`ƒ“‚Ì–ðŠ„. ìã³–çi•ª¶j: ‘æ31‰ñ•â‘̃Vƒ“ƒ|ƒWƒEƒ€ i94.09.23j, ŽD–y, •â‘̃Vƒ“ƒ|ƒWƒEƒ€, 31: 13`16, 1994.

152. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ”]‰º‚‘̃zƒ‹ƒ‚ƒ“ˆâ“`Žq‚Ì”­Œ»’²ß. ¬–ì‰ë•vi•ª¶j: ŠC—mŒ¤ƒVƒ“ƒ|ƒWƒEƒ€u‹›—ނ̶ˆç¥“K‰ž‹@”\‚ƈâ“`Žqv i94.11.17j, “Œ‹ž.

153. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j PCR‚É‚æ‚è”­Œ©‚Å‚«‚½ƒƒ`ƒ‹ƒ}ƒƒ“Ž_ŒŒÇ‚ÌV‚µ‚¢Œ^‚̈â“`Žq•ÏˆÙ. ‚“cŽj’jiŽ™jC˜a“c’m‰vi—Õ•a—jC‚ŽR‹g‰ii•ª¶jC¼‰YM•viŽ™jCìã³–çi•ª¶j: ‘æ7‰ñuˆâ“`Žq‚Æ‚»‚ÌŽü•ÓvŒ¤‹†‰ï i94.08.02j, ŠâŽè, —vŽ|W, p.13, 1994.


<<05 –ò—Šw>>

154. mŒ´’˜n Different modes of inhibition of increase in cytosolic calcium and aggregation of rabbit platelets by two thromboxane A2 antagonists. ‰©ˆ¤—æCŽ­ŽæMC쑺“¹ŽqC—›”|ŠâCŒ´“c–FÆi–ò—j: Asia Pacific J. Pharmacol., 9(3): 163`171, 1994.

155. mŒ´’˜n Detection of inducible prostaglandin H synthase-2 in cells in the exudate of rat carrageenin-induced pleurisy. Œ´“c–FÆC”¨’†Œöi–ò—jCÄ“¡^Šói¶‰»ŒnjC”n“ˆ³—²i–ò—jC‰¬–ìŽO’qŽqi¶‰»ŒnjC쑺“¹ŽqC‘å–ì—²C—kH¶CŽ­ŽæMi–ò—jCŽR–{®ŽOi“¿“‡ ‘åj: Biomed. Res., 15(2): 127`130, 1994.

156. mŒ´’˜n Famotidine-associated central nervous system reactions and plasma and cerebrospinal drug concentrations in neurosurgical patients with renal failure. K. YoshimotoCS. Saimai‘—§‘Ûˆã—ÃZƒ“ƒ^[jC‰z‘OGri–ò—jCY. NakamuraCT. KondoCY. YagishitaCT. Ishizakii‘—§‘Ûˆã—ÃZƒ“ƒ^[j: Clin. Pharmacol. Ther., 55(6): 693`700, 1994.

157. mŒ´’˜n Hypertension induced by a nonpressor dose of angiotensin ‡U in kininogen-deficient rats. ”n“ˆ³—²i–ò—jCaãiiŽO•H‰»¬jCŒI—Ñ‹`˜aCŽ­ŽæMi–ò—jC‘åÎKŽqi–òŠw•”j: Hypertension, 24(1): 111`119, 1994.

158. mŒ´’˜n Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes. ‰z‘OGri–ò—jCK. Mochizukii“Œ‘åjC’J¹®CÎè‚Žui‘—§‘Ûˆã—ÃZƒ“ƒ^[j: J. Pharmacol. Exp. Ther., 268(3): 1518`1525, 1994.

159. mŒ´’˜n Metabolic disposition of imipramine in oriental subjects: Relation to metoprolol ƒ¿-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes. E. Koyamai‘—§‘Ûˆã—ÃZƒ“ƒ^[jCD.-R. SohnCS.-G. ShiniŠØ‘jCK. Chibai‘—§‘Ûˆã—ÃZƒ“ƒ^[jCJ.-G. ShinCY.-H. KimiŠØ‘jC‰z‘OGri–ò—jCT. Ishizakii‘—§‘Ûˆã—ÃZƒ“ƒ^[j: J. Pharmacol. Exp. Ther., 271(2): 860`867, 1994.

160. mŒ´’˜n Diuretic and natriuretic effect of ebelactone B in anesthetized rats by inhibition of a urinary carboxypeptidase Y-like kininase. ”n“ˆ³—²CŒI—Ñ‹`˜aC’r“c‘×—Ti–ò—jCˆÀ’BŒhˆêiŽY•wjC‰Á“¡‹v—Yi‘—§zŠÂŠí•aƒZƒ“ƒ^[jCŽ­ŽæMi–ò—jC–ö‚–¾iº˜a–ò‘åj: Jpn. J. Pharmacol., 65: 79`82, 1994.

161. mŒ´’˜n Oxytocin-induced natriuresis mediated by the renal kallikein-kinin system in anesthetized male rats. ˆÀ’BŒhˆêC”n“ˆ³—²CŽ­ŽæMi–ò—jC¼“‡³”ŽiŽY•wj: Jpn. J. Pharmacol., 67: 243`252, 1995.

162. mŒ´’˜n Analyses of neutrophil extravasation in microcirculation of hamster cheek pouch by intravital microscopy. ¬“c—²Ž¡C”¨’†ŒöCŽ­ŽæMi–ò—j: Progress in Microcirculation Research, p.263`266, 1994.

163. mŒ´’˜n Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 syntehsis in vivo in laboratory animals. 쑺“¹ŽqCŒ´“c–FÆCŽ­ŽæMi–ò—j: Thromb. Res., 77(5): 465`474, 1995.

164. m€Œ´’˜i‰p•¶jn Induction of prostaglandin H synthase-2 in rat carrageenin-induced pleurisy and effect of a selective cox-2 inhibitor. Ž­ŽæMCŒ´“c–FÆC”¨’†ŒöC”n“ˆ³—²C쑺“¹ŽqC‘å–ì—²i–ò—jCA. Aizawai¶‰»jCŽR–{®ŽOi“¿“‡‘åj: Adv. Prostaglandin Thromboxane Leukot. Res., 23: 345`347, 1995.

165. m€Œ´’˜i‰p•¶jn Sodium accumulation induced hypertension in kininogen deficient Brown Norway Katholiek rats. ”n“ˆ³—²CŽ­ŽæMi–ò—j: Jpn. Heart J., 35(4): 494`495, 1994.

166. m€Œ´’˜i‰p•¶jn Effects of endothelins on mouse hepatic microvasculature. ˆÉ“¡‹`–çiŠOjCŽ­ŽæMC‘å–ì—²C”¨’†Œöi–ò—jCŠ`“cÍiŠOj: Microcirculation Annual, 10: 51`52, 1994.

167. m€Œ´’˜i‰p•¶jn Multiple actions of endothelin-1 and endothelin-3 on rat gastric mucosal microcirculation. ‘å–ì—²CŽ­ŽæMC—ÑO”üC¼ŽR˜a’ji–ò—jC¼Œ³Ž›Ž—çi“àj: Microcirculation Annual, 10: 53`54, 1994.

168. m€Œ´’˜i‰p•¶jn Inhibitory mechanism of lipo prostaglandin E1. Ž­ŽæMC”¨’†Œöi–ò—j: –¬ŠÇŠw, 34(7): 409`413, 1994.

169. m€Œ´’˜n ƒEƒTƒM“µEŠ‡–ñ‹Ø‚É‚¨‚¯‚éƒGƒ“ƒhƒZƒŠƒ“‚ÌŽûkì—p‚Æ BQ-123‚É‚æ‚éhR. Îì‹ÏC‹g•xŒ’ŽuCÎì“NiŠájCŒ´“c–FÆCŽ­ŽæMi–ò—j: ‚ ‚½‚炵‚¢Šá‰È, 11(4): 584`586, 1994.

170. mŒ¤‹†•ñi•¶•”Èjn NaCl•‰‰×‚ŒŒˆ³Ç”­ÇŽž‚É‚¨‚¯‚éæ“V“IkininogenŒ‡‘¹BN-Katholiekƒ‰ƒbƒg”A’†‚Ì2,3-dinor-6-keto-PGF1ƒ¿ ’l. 쑺“¹ŽqC”n“ˆ³—²CŒ´“c–FÆCŽ­ŽæMi–ò—j: •½¬5”N“xŽŽŒ±Œ¤‹†‚aŒ¤‹†¬‰Ê•ñ‘, ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“¶‘Ì”Z“x‘ª’è–@‚Ì–â‘è“_‚Æ‚»‚Ì•W€‰»‚ÉŠÖ‚·‚錤‹†, p.45`46, 1994.

171. mŒ¤‹†•ñi•¶•”Èjn ‚ŒŒˆ³”­ÇŽž‚Ì~ˆ³Œn‚Æ‚µ‚ẴLƒjƒ“Œn‚Ì–ðŠ„‚ÆV‚µ‚¢R‚ŒŒˆ³–ò‚ÌŠJ”­. ”n“ˆ³—²i–ò—j: •½¬5”N“x•¶•”ȉȊwŒ¤‹†”ï(ˆê”ÊŒ¤‹†‚b)•ñ‘, 1995.

172. mŒ¤‹†•ñiŒú¶Èjn tzŠÂ‚Æ‚»‚ÌáŠQ‹@˜‚ÉŠÖ‚·‚錤‹†. Ž­ŽæMi–ò—j: •½¬5`6”N“xŒú¶È‰ÈŠwŒ¤‹†”ï•â•‹àt•s‘Sˆã—ÃŒ¤‹†Ž–‹ÆŒ¤‹†•ñ‘, p.283`286, 1994.

173. mÇ—á•ñn ŒÇ—§«‰ßŒ`¬«(‰»¶«)ƒ|ƒŠ[ƒv‘ƒ“à‚É‹¤‘¶‚µ‚½‘Šú‘å’°Šà‚Ì1—á. ‘å–ì—²i–ò—jC“n•Ó‹`˜YCˆêŒ´—ºC“n•ÓòCŽR“cL•vCˆäãˆç•vC•Ÿ“c~C’·’JìÍ—Yi¬“cŒ´Žs—§•a‰@j: Progress of Digestive Endoscopy, 45: 125`129, 1994.

174. m‘àn ƒVƒNƒƒIƒLƒVƒQƒi[ƒ[-2|V‚µ‚¢”ñƒXƒeƒƒCƒh«R‰ŠÇ–ò‚̉”\«|. Œ´“c–FÆCŽ­ŽæMi–ò—j: ƒVƒ“ƒ|ƒWƒEƒ€‰ŠÇ‚ƖƉu, 3(1): 52`58, 1994.

175. m‘àn COX1‚ÆCOX-2. Œ´“c–FÆCŽ­ŽæMi–ò—j: Š´õ¥‰ŠÇ¥–Ɖu, 25(1): 50`53, 1995.

176. m‘àn ‰ŠÇ|”’ŒŒ‹…Z‚̃ƒJƒjƒYƒ€|. ”¨’†Œöi–ò—j: Œ»‘ãˆã—Ã, 26(9): 103`107, 1994.

177. m‘àn ‰ŠÇ‚ƃvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“. Ž­ŽæMi–ò—j: Œ»‘ãˆã—Ã, 27(‘‡T): 637`684, 1995.

178. m‘àn ˆ•ûŽž‚Ƀ`ƒFƒbƒN‚Ì•K—v‚È‘g‚݇‚킹‚ÌŽÀÛ—á|ƒ}ƒNƒƒ‰ƒCƒhŒnR¶•¨Ž¿(ƒGƒŠƒXƒƒ}ƒCƒVƒ“‚È‚Ç)‚É‚æ‚é‘ãŽÓ‘jŠQ. ‰z‘OGri–ò—j: Ž¡—Ã, 76(9): 2239`2244, 1994.

179. m‘àn ƒGƒ^ƒm[ƒ‹ŠQŽž‚̈ݔS–Œ”÷¬zŠÂ‚̕ω»‚Æ‚»‚̧Œä. Ž­ŽæMC‘å–ì—²C¼ŽR˜a’ji–ò—j: ŽÀŒ±’×á‡, 21(1): 16`21, 1994.

180. m‘àn ”ñƒXƒeƒƒCƒh«R‰ŠÇ–ò. Œ´“c–FÆi–ò—j: –ò‹Ç, 45(12): 2337`2341, 1994.

181. m‘àn Ž¡—ÃŒv‰æ‚Ì‚½‚ß‚Ì–ò—Šw|”ñƒXƒeƒƒCƒh«R‰ŠÇÜ(1). ‰z‘OGri–ò—j: —Õ°‚Æ–ò•¨Ž¡—Ã, 13(10): 1146`1149, 1994.

182. m‘àn Ž¡—ÃŒv‰æ‚Ì‚½‚ß‚Ì–ò—Šw|”ñƒXƒeƒƒCƒh«R‰ŠÇÜ(2). ‰z‘OGri–ò—j: —Õ°‚Æ–ò•¨Ž¡—Ã, 13(11): 1264`1267, 1994.

183. m‘àn Ž¡—ÃŒv‰æ‚Ì‚½‚ß‚Ì–ò—Šw|ƒJƒ‹ƒVƒEƒ€hRÜ. ‰z‘OGri–ò—j: —Õ°‚Æ–ò•¨Ž¡—Ã, 13(3): 338`341, 1994.

184. m‘àn Ž¡—ÃŒv‰æ‚Ì‚½‚ß‚Ì–ò—Šw|ƒÀŽÕ’fÜ. ‰z‘OGri–ò—j: —Õ°‚Æ–ò•¨Ž¡—Ã, 13(4): 466`469, 1994.

185. m‘àn Ž¡—ÃŒv‰æ‚Ì‚½‚ß‚Ì–ò—Šw|ACE‘jŠQÜ. ‰z‘OGri–ò—j: —Õ°‚Æ–ò•¨Ž¡—Ã, 13(5): 576`583, 1994.

186. m‘àn Ž¡—ÃŒv‰æ‚Ì‚½‚ß‚Ì–ò—Šw|—˜”AÜ. ‰z‘OGri–ò—j: —Õ°‚Æ–ò•¨Ž¡—Ã, 13(6): 692`695, 1994.

187. m‘àn Ž¡—ÃŒv‰æ‚Ì‚½‚ß‚Ì–ò—Šw|H2hRÜ. ‰z‘OGri–ò—j: —Õ°‚Æ–ò•¨Ž¡—Ã, 13(7): 804`807, 1994.

188. m‘àn Ž¡—ÃŒv‰æ‚Ì‚½‚ß‚Ì–ò—Šw|ƒvƒƒgƒ“ƒ|ƒ“ƒvƒCƒ“ƒqƒrƒ^[. ‰z‘OGri–ò—j: —Õ°‚Æ–ò•¨Ž¡—Ã, 13(8): 909`912, 1994.

189. m‘àn Ž¡—ÃŒv‰æ‚Ì‚½‚ß‚Ì–ò—Šw|ŒoŒûŒŒ“œ~‰º–ò‚¨‚æ‚Ñ“œ”A•a–ò. ‰z‘OGri–ò—j: —Õ°‚Æ–ò•¨Ž¡—Ã, 13(9): 1032`1035, 1994.

190. m‘àn Ž¡—ÃŒv‰æ‚Ì‚½‚ß‚Ì–ò—Šw|ƒ}ƒCƒi[ƒgƒ‰ƒ“ƒLƒ‰ƒCƒU[(ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•¨). ‰z‘OGri–ò—j: —Õ°‚Æ–ò•¨Ž¡—Ã, 14(1): 68`71, 1995.

191. m‘àn Ž¡—ÃŒv‰æ‚Ì‚½‚ß‚Ì–ò—Šw|šb‘§Ž¡—Öò(1). ‰z‘OGri–ò—j: —Õ°‚Æ–ò•¨Ž¡—Ã, 14(2): 188`192, 1995.

192. m‘àn ˆùH•¨‚Æ–ò•¨‚Ì‘ŠŒÝì—p(1). ‰z‘OGri–ò—j: —Õ°‰h—{, 84(7): 845`851, 1994.

193. m‘àn ˆùH•¨‚Æ–ò•¨‚Ì‘ŠŒÝì—p(2)ˆùH•¨‚Æ–ò•¨‚ÌŠÌ‘ãŽÓ‚Ì‘ŠŒÝì—p. ‰z‘OGri–ò—j: —Õ°‰h—{, 85(1): 73`79, 1994.

194. m‘àn ˆùH•¨‚Æ–ò•¨‚Ì‘ŠŒÝì—p(3)ˆùH•¨‚Æ–ò•¨‚ÌŠÌ‘ãŽÓ‚É‚¨‚¯‚é‘ŠŒÝì—p. ‰z‘OGri–ò—j: —Õ°‰h—{, 85(2): 209`215, 1994.

195. m‘àn ƒzƒ‹ƒ‚ƒ“‚ƶ—Šˆ«•¨Ž¿ 14.ƒJƒŠƒNƒŒƒCƒ“-ƒLƒjƒ“-ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“Œn 3)ƒƒCƒRƒgƒŠƒGƒ“. Œ´“c–FÆi–ò—j: —Õ°ŒŸ¸, 38(‘11): 255`257, 1994.

196. muÀn ˆÝ”S–ŒŠî’ê•””÷¬zŠÂŠÏŽ@–@. ‘å–ì—²CŽ­ŽæMi–ò—j: “ú–{–ò—ŠwŽGŽ, 103(5): 203`209, 1994.

197. mŠwp‘n i•ª’SŽ·•Mj zŠÂŠí—̈æ‚É‚¨‚¯‚éƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“‚Ì—Õ°; ‡V. ƒAƒ‰ƒLƒhƒ“Ž_‘ãŽÓ‚ÌÅVî•ñ 3.ƒƒCƒRƒgƒŠƒGƒ“‚Æ”÷¬zŠÂ‚¨‚æ‚уvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“Œ¤‹†‚ÌV‚µ‚¢’ª—¬, p.230`250, Ž­ŽæMi–ò—j. •ÒW Žº“c½ˆíi“Œ‹žˆãŽ•‘åjC ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐC“Œ‹žC94.05.00”­s.

198. mŠwp‘n i•ª’SŽ·•Mj KEY WORD 1994-'95‰ŠÇ¥–ƉuŒn; cox-2(PGƒGƒ“ƒhƒyƒ‹ƒIƒLƒVƒh‡¬y‘f-2), p.114`115, Œ´“c–FÆi–ò—j. •ÒW ”è’õ•vi“Œ‹ž—ˆã‘åjCŽº“c½ˆíi“Œ‹žˆãŽ•‘åjC æ’[ˆãŠwŽÐC“Œ‹žC94.07.01”­s.

199. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; –ò•¨‚Ì•›ì—p‚Æ‘ŠŒÝì—p, p.997`1017, ‰z‘OGri–ò—j. •ÒW ˆîŠ_‹`–¾iç—t˜JЕa‰@jC‘½‰ê{K’ji‘½‰ê{Á‰»ŠíjC”öŒ`‰x˜YiŠàŒ¤jC ˆãŠw‘‰@C“Œ‹žC95.02.15”­s.

200. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Multiple actions of endothelin-1 and endothelin-3 on the basal part of mucosal microvasculatures of the rat stomach. Ž­ŽæMC‘å–ì—²i–ò—j: 5th Taisho International Symposium on Gastroenterology i94.04.06`07j, ” ª, Abstracts, p.14, 1994.

201. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Detection of prostaglandin H synthase-2 in cells of rat carrageenin-induced pleurisy and its selective inhibitor. Ž­ŽæMCŒ´“c–FÆC”¨’†ŒöC”n“ˆ³—²C쑺“¹Žqi–ò—j: 9th International Conference on Prostaglandins and Related Compounds i94.06.06`10j, ƒtƒ[ƒŒƒ“ƒX.

202. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Induction of prostaglandin H synthase-2 (Cox-2) in mononuclear cells of rat carrageenin-induced pleurisy and inhibitory effects of a selective cox-2 inhibitor. Ž­ŽæMCŒ´“c–FÆC”¨’†ŒöC”n“ˆ³—²C쑺“¹Žqi–ò—j: 2nd International Congress of Pathophysiology i94.11.19`24j, ‹ž“s, Pathophysiology, 1(Suppl.): 35, 1994.

203. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Pharmacological characterization of endothelin receptor in the rabbit iris sphincter muscle. Îì‹ÏC‹g•xŒ’ŽuiŠájCŒ´“c–FÆCŽ­ŽæMi–ò—jCÎì“NiŠáj: Association for Research in Vision and Ophthalmology i94.05.01`06j, ƒTƒ‰ƒ\ƒ^, Invest. Ophthalmol. Visual Sci., 35(4): 1888, 1994.

204. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j A novel type of anti-hypertensive drugs, poststatin and evelactone B, acting through urinary kininase inhibition. ”n“ˆ³—²CŒI—Ñ‹`˜aCŽ­ŽæMi–ò—j: 12th International Congress of Pharmacology i94.07.24`29j, ƒ‚ƒ“ƒgƒŠƒI[ƒ‹, Can. J. Physiol. Pharmacol., 72(Suppl. 1): 129, 1994.

205. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Detection of prostaglandin H synthase-2 in rat carrageenin-induced pleurisy. Œ´“c–FÆC”¨’†Œöi–ò—jCÄ“¡^Šói¶‰»ŒnjC”n“ˆ³—²i–ò—jC‰¬–ìŽO’qŽqi¶‰»ŒnjC쑺“¹ŽqC‘å–ì—²CŽ­ŽæMi–ò—j: 12th International congress of Pharmacology i94.07.24`29j, ƒ‚ƒ“ƒgƒŠƒI[ƒ‹, Can. J. Physiol. Pharmacol., 72(Suppl. 1): 276, 1994.

206. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Calcitonin gene-related peptide released by intragastric capsaicin prevents ethanol-induced gastric mucosal injury in rats. ‘å–ì—²CŽ­ŽæMC—ÑO”üC¼ŽR˜a’ji–ò—jC¼Œ³Ž›Ž—çi“àj: 10th World Congress of Gastroenterology i94.10.02`07j, ƒƒTƒ“ƒ[ƒ‹ƒX, Abstracts‡U, p.1973, 1994.

207. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Multiple responses of rat gastric mucosal microcirculation to endothelin-1 and endothelin-3. ‘å–ì—²CŒ´“c–FÆCŽ­ŽæMC—ÑO”üi–ò—jC¼Œ³Ž›Ž—çi“àj: 8th International Conference on Ulcer Research i94.11.20`23j, ‹ž“s, Digestion, 55(Suppl. 2): 33, 1994.

208. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Induction of hypertension by sodium accumulation in kininogen-deficient Brown-Norway Katholiek rats. Ž­ŽæMC”n“ˆ³—²i–ò—j: Gordon Research Conference i95.02.05`10j, Ventura (California).

209. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Inhibition of urinary carboxypeptidase Y-like kininase reduces high blood pressure in DOCA-salt treated rats. ”n“ˆ³—²CŽ­ŽæMi–ò—j: Gordon Research Conference i95.02.05`10j, Ventura (California).

210. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒGƒ“ƒhƒgƒLƒVƒ“‚ƉŠÇ‚̃ƒfƒBƒG[ƒ^[. Ž­ŽæMi–ò—j: ‘æ67‰ñ“ú–{׋ۊw‰ï‘‰ï i94.03.29j, “Œ‹ž, “ú–{׋ۊwŽGŽ, 49(1): 1994.

211. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆÝ”S–ŒŠî’ê•””÷¬zŠÂ‚Ìin vivo‚É‚¨‚¯‚éŠÏŽ@‚ƉðÍ|ƒGƒ^ƒm[ƒ‹ˆÝ”S–ŒŠQ‚̉Šú•Ï‰»|. ‘å–ì—²CŽ­ŽæMi–ò—j: ‘æ80‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i94.04.22`24j, _ŒË, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91: 521, 1994.

212. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰ŠÇ”½‰ž‚ÌŽžŠÔŒo‰ß‚ÆR‰ŠÇ–ò. Ž­ŽæMi–ò—j: ‘æ68‰ñ“ú–{–ò—Šw‰ï”N‰ï i95.03.25`28j, –¼ŒÃ‰®, Jpn. J. Pharmacol., 67(Suppl.‡T): 72, 1995.

213. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒVƒNƒƒIƒLƒVƒQƒi[ƒ[-2‚̉ŠÇ‘ƒ‚Ö‚ÌoŒ»‚Æ–ðŠ„. Œ´“c–FÆC”¨’†Œöi–ò—jCÄ“¡^Šói¶‰»ŒnjC”n“ˆ³—²i–ò—jC‰¬–ìŽO’qŽqi¶‰»ŒnjC쑺“¹ŽqC‘å–ì—²CŽ­ŽæMi–ò—j: ‘æ68‰ñ“ú–{–ò—Šw‰ï”N‰ï i95.03.25`28j, –¼ŒÃ‰®, Jpn. J. Pharmacol., 67(Suppl.‡T): 72, 1995.

214. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‰ŠÇ‚É‚¨‚¯‚écox-2‚Ì”­Œ»‚Æ–ðŠ„. Œ´“c–FÆC”¨’†Œöi–ò—jCÄ“¡^Šói¶‰»ŒnjC”n“ˆ³—²C쑺“¹Žqi–ò—jC‰¬–ìŽO’qŽqi¶‰»ŒnjC‘å–ì—²CŽ­ŽæMi–ò—j: ‘æ15‰ñ“ú–{‰ŠÇŠw‰ï i94.07.14`15j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€¥—\eW, p.92, 1994.

215. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒEƒTƒM“µEŠ‡–ñ‹Ø‚¨‚æ‚ÑŽU‘å‹Ø‚É‚¨‚¯‚éƒGƒ“ƒhƒZƒŠƒ“Žó—e‘Ì‚Ì–ò—Šw“I“Á’¥. Îì‹ÏC‹g•xŒ’ŽuCÎì“NiŠájCŒ´“c–FÆCŽ­ŽæMi–ò—j: ‘æ98‰ñ“ú–{Šá‰ÈŠw‰ï i94.04.21j, ‰¡•l.

216. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝ”S–ŒŠî’ê•””÷¬zŠÂ‚É‚¨‚¯‚éƒGƒ“ƒhƒZƒŠƒ“‚Ìì—p. ‘å–ì—²CŽ­ŽæMC—ÑO”üC¼ŽR˜a’ji–ò—jC¼Œ³Ž›Ž—çi“àj: ‘æ19‰ñ“ú–{”÷¬zŠÂŠw‰ï‘‰ï i94.05.26`27j, ¼–{, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.51, 1994.

217. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌ”÷¬zŠÂ‚É‚¨‚¯‚éƒGƒ“ƒhƒZƒŠƒ“‚Ìì—p. ˆÉ“¡‹`–çiŠOjCŽ­ŽæMC‘å–ì—²C”¨’†Œöi–ò—jCŠ`“cÍiŠOj: ‘æ19‰ñ“ú–{”÷¬zŠÂŠw‰ï‘‰ï i94.05.26j, ¼–{, ´˜^W, p.47, 1994.

218. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j V‹KR‰ŠÇ–òƒjƒƒXƒŠƒh‚̇UŒ^ƒVƒNƒƒIƒLƒVƒQƒi[ƒ[‘I‘ð“I—}§ì—p. ’JŒû‹±ÍC’r––Œúri‹vŒõ»–òjCo•£‘–¤C’†‘º•×i‰ÈŒ¤»–òjCŒ´“c–FÆCŽ­ŽæMi–ò—j: ‘æ15‰ñ“ú–{‰ŠÇŠw‰ï i94.07.14`15j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€¥—\eW, p.143, 1994.

219. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆâ“`“IƒLƒjƒ“ŒnŒ‡‘¹ƒ‰ƒbƒg‚É‚¨‚¯‚é‘Ì“àƒiƒgƒŠƒEƒ€’™—¯‚ð‰î‚·‚é‚ŒŒˆ³”­Ç. ”n“ˆ³—²i–ò—jCaãiiŽO•H‰»¬jCŽ­ŽæMi–ò—j: ‘æ17‰ñ“ú–{‚ŒŒˆ³Šw‰ï i94.10.31`11.02j, ‹ž“s, Hypertens. Res., 17(4): 263, 1994.

220. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝ”S–Œ”÷¬zŠÂ‚ɑ΂·‚éƒGƒ“ƒhƒZƒŠƒ“1‚Ìì—p‚̉ðÍ. ‘å–ì—²CŽ­ŽæMC—ÑO”üi–ò—jC¼Œ³Ž›Ž—çi“àj: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.10.31`11.02j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91: 1679, 1994.

221. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒEƒTƒM“øÊ×–E–Œã‚̃Gƒ“ƒhƒZƒŠƒ“ƒŒƒZƒvƒ^[ƒTƒuƒ^ƒCƒv. –ìâç—TC‰Á£Li‹¦˜a”­yjCÎì‹ÏiŠájCŒ´“c–FÆCŽ­ŽæMi–ò—j: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.07`09j, ‘åã, ¶‰»Šw, 66(7): 832, 1994.

222. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠÌ”÷¬zŠÂ‚É‚¨‚¯‚éƒGƒ“ƒhƒZƒŠƒ“-1‚¨‚æ‚уGƒ“ƒhƒZƒŠƒ“-3‚Ì‹ÇŠì—p. ˆÉ“¡‹`–çiŠOjCŽ­ŽæMi–ò—jCŠ`“cÍiŠOj: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.11.01j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 394, 1994.

223. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¶‘ÌŒ°”÷‹¾‚É‚æ‚éƒGƒ“ƒhƒZƒŠƒ“‚̈ݔS–Œ”÷¬zŠÂ‚ɑ΂·‚éì—p‚̉ðÍ. ‘å–ì—²CŽ­ŽæMC—ÑO”üi–ò—j: ‘æ68‰ñ“ú–{–ò—Šw‰ï”N‰ï i95.03.25`28j, –¼ŒÃ‰®, Jpn. J. Pharmacol., 67(Suppl.‡T): 196, 1995.

224. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒLƒjƒmƒQƒ“Œ‡‘¹ƒ‰ƒbƒg‚É‚¨‚¯‚é‘Ì“àƒiƒgƒŠƒEƒ€’™—¯Žž‚ÌŒŒŠÇŽûk•¨Ž¿‚ɑ΂·‚銴Žó«‚Ì‘‘å. ”n“ˆ³—²CˆÀ’BŒhˆêCŒI—Ñ‹`˜aCŽ­ŽæMi–ò—j: ‘æ68‰ñ“ú–{–ò—Šw‰ï”N‰ï i95.03.25`28j, –¼ŒÃ‰®, Jpn. J. Pharmacol., 67(Suppl.‡T): 266, 1995.

225. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒgƒJƒ‰ƒQƒjƒ“‹¹–Œ‰Š‚Ì—V‘–”’ŒŒ‹…‚É‚¨‚¯‚écox-2‚Ì”­Œ». ”¨’†ŒöCŒ´“c–FÆi–ò—jCÄ“¡^Šói¶‰»ŒnjC”n“ˆ³—²i–ò—jC‰¬–ìŽO’qŽqi¶‰»ŒnjC쑺“¹ŽqC‘å–ì—²CŽ­ŽæMi–ò—j: ‘æ68‰ñ“ú–{–ò—Šw‰ï”N‰ï i95.03.25`28j, –¼ŒÃ‰®, Jpn. J. Pharmacol., 67(Suppl.‡T): 286, 1995.

226. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒ‰ƒbƒg”A’†ƒLƒjƒ“•ª‰ðy‘f‘jŠQ–ò‚Ì—˜”A¥~ˆ³ì—p. ”n“ˆ³—²CŒI—Ñ‹`˜aCˆÀ’BŒhˆêi–ò—jCÄ“¡^ŠóC‰¬–ìŽO’qŽqi¶‰»ŒnjCŽ­ŽæMi–ò—j: ‘æ90‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï i94.06.04j, ç—t, “ú–{–ò—ŠwŽGŽ, 104: 78, 1994.

227. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒ}ƒNƒƒ‰ƒCƒhŒnR¶•¨Ž¿‚̈õŠÂ\‘¢‚ƃqƒgŠÌƒ~ƒNƒƒ][ƒ€‚É‚¨‚¯‚éƒWƒ\ƒsƒ‰ƒ~ƒh‘ãŽÓ‘jŠQì—p‚Ì\‘¢Šˆ«‘ŠŠÖ. ‰z‘OGri–ò—jC’J¹®CÎè‚Žui‘—§‘Ûˆã—ÃZƒ“ƒ^[jCŽ­ŽæMi–ò—j: ‘æ91‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï i94.10.15j, ‘å‹{, “ú–{–ò—ŠwŽGŽ, 105(1): 50, 1995.

228. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒGƒ“ƒhƒgƒLƒVƒ“• o“à‹y‚ÑÖ¬“à“Š—^Œã‚ÌTNF-ƒ¿‚¨‚æ‚ÑIL-8ŽY¶‚Ì·. ó—˜–õi‹~–½jC”n“ˆ³—²i–ò—jC™–{Ÿ•FCV“¡³‹PC‘å˜a“c—²i‹~–½jCŽ­ŽæMi–ò—j: ‘æ91‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï i94.10.15j, ‘å‹{, “ú–{–ò—ŠwŽGŽ, 105(1): 51, 1995.

229. mŒ¤‹†‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒ‰ƒbƒg¥ƒJƒ‰ƒQƒjƒ“‹¹–Œ‰Š‚É‚¨‚¯‚éD’†‹…‚Ì–ðŠ„|cox”­Œ»‚ÆPG—ÞŽY¶‚ɂ‚¢‚Ä. ”¨’†Œöi–ò—j: ‘æ‚P‰ñHeterophilŒ¤‹†‰ï i95.02.13`14j, “V“¶.

230. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒGƒ^ƒm[ƒ‹ˆÝ”S–ŒŠQ‚̉Šú‰»|ˆÝ”S–ŒŠî’ê•””÷¬zŠÂ‚Ìin vivoŠÏŽ@‚ƉðÍ|. ‘å–ì—²CŽ­ŽæMC—ÑO”üC¼ŽR˜a’ji–ò—jC¼Œ³Ž›Ž—çi“àj: ‘æ9‰ñÁ‰»Ší•a‘Ô¶—Œ¤‹†‰ï i94.09.07j, “Œ‹ž, ´˜^W, p.12, 1994.

231. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j NSAIDs‚Ìì—p‹@˜‚Æŋ߂̘b‘è. Ž­ŽæMi–ò—j: ‰ªŽRŒ§•a‰@–òÜŽt‰ï i94.04.28j, ‘q•~, ‰ªŽRŒ§•a‰@–òÜŽt‰ï•ñ, 35(4): 4`6, 1994.

232. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j tƒLƒjƒ“¥ƒJƒŠƒNƒŒƒCƒ“Œn‚Æ‚ŒŒˆ³‚Ì”­Ç. Ž­ŽæMi–ò—j: ‘æ17‰ñVŠƒ‚ŒŒˆ³’k˜b‰ï i94.07.08j, VŠƒ.

233. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒ‰ƒbƒg‚̃Jƒ‰ƒQƒjƒ“‹¹–Œ‰Š‚É‚¨‚¯‚éPGH‡¬y‘f-2‚Ì”­Œ»‚Æ–ðŠ„. Œ´“c–FÆC”¨’†Œöi–ò—jCÄ“¡^Šói¶‰»ŒnjC”n“ˆ³—²C쑺“¹Žqi–ò—jC‰¬–ìŽO’qŽqi¶‰»ŒnjC‘å–ì—²CŽ­ŽæMi–ò—j: ‘æ5‰ñ“Œ‹žƒvƒƒXƒ^ƒOƒ‰ƒ“ƒfƒBƒ“Œ¤‹†‰ï i94.06.25j, “Œ‹ž, —\eW, p.8, 1994.


<<06 ”÷¶•¨Šw>>

234. mŒ´’˜n ‚“x‘Ï« MRSAŒÄ‹zŠíŠ´õǂɑ΂·‚é cefuzonam‚Æ imipenem/cilastatin‚Ì•¹—p‚É‚æ‚é–ò“®—ÍŠw“I‚È‚ç‚Ñ‚É—Õ°“IŒŸ“¢. ²“¡“Ä•FC’†–ì–LCç“c‹àŒái•l¼ˆã‘åjC‰ª–{—¹ˆêC”óŒû“OCˆä㼋vi”÷j: Chemotherapy (Jpn.), 42(2): 218`224, 1994.

235. mŒ´’˜n ׋ۊw“I—§ê‚©‚猩‚½ FK037‚ÌR‹Û—͂ɂ‚¢‚Ä. ’·‘]•”‹IŽqi—\–hˆãŠwŒnjC–ìXŽRŸliŽ™jC“‡“àçŒbŽqCˆä㼋vi”÷j: Chemotherapy (Jpn.), 42(Suppl.3): 13`22, 1994.

236. mŒ´’˜n Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections. —ÑòiŠàŒ¤jCˆä㼋vi”÷jC‹´–{ˆêi–kŒ¤j: Drugs Exptl. Clin. Res., 20(6): 225`232, 1994.

237. mŒ´’˜n Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus. ˆä㼋vi”÷jC–ìXŽRŸliŽ™jC‰ª–{—¹ˆêCˆä“cFŽu: Drugs Exptl. Clin. Res., 20(6): 233`240, 1994.

238. mŒ´’˜n Binding affinity of ƒÀ-lactam antibiotics for penicillin-binding protein 2' in methicillin-resistant Staphylococcus aureus. Z“c”\OC[‘ò–œ¶—FCŽO‹´iiƒGƒsŒ¤jCˆä㼋vi”÷j: J. Antimicrob. Chemother., 35(3): 473`481, 1995.

239. mŒ´’˜n The role of duplication of tumour-derived chromosome 15 carrying the rearranged pvt-1 gene in the transformed phenotype of YACUT T cell lymphoma XG4 T-cell line somatic cell hybrids in dictating the terminal differentiation programe of the parential G4 cell. ‹v•Û“cFˆêi”÷jC’†—¢˜a”üi—\–hˆãŠwŒnj: J. Cell Sci., 107(10): 2761`2768, 1994.

240. mŒ´’˜n —Õ°•ª—£‰©FƒuƒhƒE‹…‹Û‚Ì–òÜ‘Ï«‚ƃtƒ@[ƒWŒ^. ‘å‹v•Û–LŽiiŒQ‘åjC‰ª–{—¹ˆêCˆÉ˜¬•”Žu’ÃŽqC‚‹´ˆ»ŽqCŽl•û“cKŒbCˆä㼋vi”÷j: Jpn. J. Antibiot., 47(4): 357`364, 1994.

241. mŒ´’˜n ‹ß”N•ª—£‚³‚ꂽ MRSA‚ÉŠÖ‚·‚é‘S‘“I‰uŠw’²¸. ˆä“cFŽui”÷jC–ìXŽRŸliŽ™jC’·‘]•”‹IŽqi—\–hˆãŠwŒnjC“‡“àçŒbŽqCˆä㼋vi”÷jC‰ª–{—¹ˆê: Jpn. J. Antibiot., 47(6): 585`594, 1994.

242. mŒ´’˜n ‘S‘‹K–Í‚É‚¨‚¯‚é MRSAŠ´õÇ‚ÌŽÀ‘Ô‚Æ arbekacin‚Ì—LŒø«. —ÑòiŠàŒ¤jCˆä㼋vi”÷jC‹´–{ˆêi–kŒ¤j: Jpn. J. Antibiot., 47: 595`605, 1994.

243. mŒ´’˜n ‘S‘‹K–Í‚É‚¨‚¯‚é MRSA‚̃Aƒ“ƒP|ƒg’²¸. —ÑòiŠàŒ¤jCˆä㼋vi”÷jC‹´–{ˆêi–kŒ¤j: Jpn. J. Antibiot., 47: 606`617, 1994.

244. mŒ´’˜n ƒpƒ‹ƒXƒtƒB[ƒ‹ƒh“d‹C‰j“®‚É‚æ‚é Arbekacin‘Ï« MRSA‚̉uŠw“IŒŸ“¢. –ìXŽRŸliŽ™jCˆä“cFŽuC’·‘]•”‹IŽqi—\–hˆãŠwŒnjC“‡“àçŒbŽqCˆä㼋vi”÷jC‰ª–{—¹ˆêC‘å‹v•Û–LŽiiŒQ‘åj: Jpn. J. Antibiotics, 47(6): 627`633, 1994.

245. mŒ´’˜n 1992”N93”N“x“ú–{‚É‚¨‚¯‚鉩FƒuƒhƒE‹…‹Û‚ÌŒ^•Ê‚Æ–òÜŠ´Žó«‚ÌLˆæ’²¸. ‹´–{ˆêi–kŒ¤jCˆä㼋vi”÷jC—ÑòiŠàŒ¤j: Jpn. J. Antibiotics, 47: 618`633, 1994.

246. mŒ´’˜n MRSAŒŸo—p”|’n‚ÌŒŸ“¢. ‘å‹v•Û–LŽiiŒQ‘åjC‰ª–{—¹ˆêCˆÉ˜¬•”Žu’ÃŽqC쓇‹V•½Cˆä㼋vi”÷j: —Õ°‚Æ”÷¶•¨, 21(3): 355`358, 1994.

247. m€Œ´’˜i‰p•¶jn Antibacterial activity of arbekacin against gentamicin- and methicillin-resistant S. aureus. In Recent advances in chemotherapy. ˆä㼋vi”÷jC–ìXŽRŸliŽ™jC’·‘]•”‹IŽqi—\–hˆãŠwŒnjC‰ª–{—¹ˆêCˆä“cFŽui”÷j: Proceedings of the 18th International Congress of Chemotherapy, p.211`212, 1994.

248. m‘àn —Δ^‹Û‚Ì–òÜ‘Ï«“®Œü. ˆä㼋vi”÷j: Progress in Medicine, 14: 7`11, 1994.

249. m‘àn ŒÄ‹zŠíŠ´õÇ‹N‰Š‹Û‚Ì–òÜ‘Ï«‹@˜. “c‘º~Cˆä㼋vi”÷j: ˆãŠw‚Ì‚ ‚ä‚Ý, 172: 41`45, 1995.

250. m‘àn Š´Žó«ŽŽŒ±‚Ì‚½‚ß‚ÌR‹ÛÜ‚Ì’mŽ¯; ƒÀ-ƒ‰ƒNƒ^ƒ€Ü. ˆä㼋vi”÷jC’·‘]•”‹IŽqi—\–hˆãŠwŒnjC“‡“àçŒbŽqCˆä“cFŽui”÷j: ŒŸ¸‚Æ‹Zp, 22: 331`336, 1994.

251. m‘àn Š´Žó«ŽŽŒ±‚Ì‚½‚ß‚ÌR‹ÛÜ‚Ì’mŽ¯|ƒAƒ~ƒmƒOƒŠƒRƒVƒhŒn–òÜ, ƒLƒmƒƒ“Œn–òÜ. ˆä㼋vC“‡“àçŒbŽqCˆä“cFŽui”÷j: ŒŸ¸‚Æ‹Zp, 22: 419`424, 1994.

252. m‘àn Š´Žó«ŽŽŒ±‚Ì‚½‚ß‚ÌR‹ÛÜ‚Ì’mŽ¯|‚»‚Ì‘¼‚Ì–òÜ. ˆä㼋vi”÷jC’·‘]•”‹IŽqi—\–hˆãŠwŒnjC“‡“àçŒbŽqCˆä“cFŽui”÷j: ŒŸ¸‚Æ‹Zp, 22: 501`506, 1994.

253. m‘àn –òÜ‚ðCü‚µ‚Ä‘Ï«‰»‚·‚é‹@\; AGsCüy‘f‚ð’†S‚É. ˆä“cFŽuCˆä㼋vi”÷j: ×–EHŠw, 13: 882`887, 1994.

254. m‘àn “ÁW: Š´õÇ‚ÌŒ»‹µ\‚ǂ̂悤‚ÉR‹Û–ò‚ðŽg‚¤‚©|R‹Û–òŽg—p‚Ö‚ÌŠî‘b“IƒAƒvƒ[ƒ`; R‹Û–ò‚ÌŽg‚¢•û‚É‚æ‚é–òÜ‘Ï«‹Û‚Ì”­¶. ˆä㼋vi”÷jC‰ª–{—¹ˆê: “à‰È, 74(6): 1135`1139, 1994.

255. m‘àn ƒJƒ‹ƒoƒyƒlƒ€–ò‚ÌŒ»‹µ\‚»‚ÌŠî‘b‚Æ—Õ°, ƒJƒ‹ƒoƒyƒlƒ€Ü‚Ì׋ۊw“I“Á’¥. ˆä㼋vi”÷jC–ìXŽRŸliŽ™jCˆä“cFŽuC‰ª–{—¹ˆê: —Õ°‚Æ”÷¶•¨, 21(4): 391`397, 1994.

256. m‘àn MRSA‚Ì‘Ï«‹@˜. ˆä“cFŽuCˆä㼋vi”÷j: —Õ°ˆã, 21: 296`301, 1995.

257. m‘àn “ÁWu‰»Šw—Ö@Ü‚Ì‚·‚ׂÄvR‹Û—Í‚©‚ç‚Ý‚½R‹Û–ò‚Ì“Á«. ˆä㼋vi”÷jC‰ª–{—¹ˆê: —Õ°¬l•a, 24(11): 1550`1556, 1994.

258. mŠwp‘n i•ª’SŽ·•Mj MRSAŠ´õÇ; PCR–@‚É‚æ‚é MRSAv‘¬f’f–@, p.84`90, ‰ª–{—¹ˆêi”÷jC‘å‹v•Û–LŽiiŒQ‘åjCˆä㼋vi”÷j. •ÒW ‰¡“cŒ’C V‹»ˆãŠwo”Å, “Œ‹ž, 94.00.00”­s.

259. mŠwp‘n i•ª’SŽ·•Mj ’°“à׋یQ‚ÌŠî‘b‚Æ—Õ°; Klebsiella pneumoniae‚̃À-ƒ‰ƒNƒ^ƒ€Ü‘Ï«, p.25`34, ‰ª–{—¹ˆêCˆä㼋vi”÷j. •ÒW ŽO‹´iCŒF–{‰x–¾C“‡“cŠ]C ƒ‰ƒCƒtƒTƒCƒGƒ“ƒX¥ƒƒfƒBƒJ, “Œ‹ž, 94.00.00”­s.

260. m‹³‰È‘n i•ª’SŽ·•Mj ”÷¶•¨ƒRƒƒ“ƒ^ƒŠ|; ‰@“àŠ´õ|MRSA, —Δ^‹Û, p.108`111, ˆä㼋vi”÷jC–ìXŽRŸliŽ™j. •ÒW •½¼Œ[ˆêi‡‘åjC“쓇—mˆêi‹{èˆã‘åjC ’†ŠOˆãŠwŽÐ, “Œ‹ž, 94.06.10”­s.

261. m‹³‰È‘n i•ª’SŽ·•Mj ƒGƒbƒZƒ“ƒVƒ„ƒ‹”÷¶•¨; ‰»Šw—Ö@, p.138`160, ˆä㼋vi”÷j. •ÒW “àŠC‘u C‘弎¬C‹à­‘×GCÄ“¡”£C‚–Ø“ÄCV‹Žu˜YC ˆãŽ•–òo”Å, “Œ‹ž, 95.00.00”­s.

262. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Identification of aminoglycoside modifying enzymes and antibacterial activity of arbekacin against MRSA. ˆä㼋vi”÷jC–ìXŽRŸliŽ™jC“‡“àçŒbŽqCˆä“cFŽuC‰ª–{—¹ˆêi”÷j: 6th International Congress for Infectious Diseases i94.04.26`30j, Plaque, Czech Republic, Abstract, No.1381: 422, 1994.

263. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Characterization of MRSA isolated in Japan. ˆä㼋vCˆä“cFŽui”÷jC–ìXŽRŸliŽ™jC“‡“àçŒbŽqC‰ª–{—¹ˆêi”÷j: 4th Western Pacific Congress on Chemotherapy and Infectious Diseases i94.12.04`07j, Manila, Philippines, Abstract, (SS-3): 11, 1994.

264. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Antibacterial activity of arbekacin, a new aminoglycoside antibiotics against gentamicin resistant-MRSA. ˆä㼋vi”÷jC‰ª–{—¹ˆêCˆä“cFŽu: 11th Future Trends in Chemotherapy, Interdisciplinary World Congress on Antimicrobial and Anticancer Drugs i94.04.25`27j, Geneva, Switzerland, Abstract, No.85, 1994.

265. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Nationwide investigation in Japan of the status of MRSA infections and usefulness of ABK. —ÑòiŠàŒ¤jCˆä㼋vi”÷jC‹´–{ˆêi–kŒ¤j: 11th Future Trends in Chemotherapy, Interdisciplinary World Congress on Antimicrobial and Anticancer Drugs i94.04.25`27j, Geneva, Switzerland, Abstract, No.86, 1994.

266. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Resistance pattern of MRSA isolates in Japan during 1992-1993. ‹´–{ˆêi–kŒ¤jCˆä㼋vi”÷jC—ÑòiŠàŒ¤j: 11th Future Trends in Chemotherapy, Interdisciplinary World Congress on Antimicrobial and Anticancer Drugs i94.04.25`27j, Geneva, Switzerland, Abstract, No.87, 1994.

267. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j A study on elimination of nasal carriage of MRSA and recolonization. ¬—ÑŠ°ˆÉi“Œ‘åjCJuji,T.CIwamoto, A.CYoshinoya, S.CTakahashi, K.CIga,T.CNakamura, K.COkuzumi, K.Cˆä㼋vi”÷j: 6th International Congress for Infectious Diseases i94.04.26`30j, Plaque, Czech Republic, Abstract, No.1292: 398, 1994.

268. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Characterization of a novel plasmid mediated extended-broad spectrum ƒÀ-lactamase from Serratia marcescens. ŸO“cçŒbŽqi‘å–Q»–òjCHigashitani, F.CHyodo, A.Cˆä㼋vi”÷j: 34th Interscience Conference on Antimicrobial Agents and Chemotherapy i94.10.04`07j, Orlando, Florida, USA, Abstract, No.C72: p.90, 1994.

269. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j In vitro antibacterial activity of E1100, a new oral cephem. –ìXŽRŸliŽ™jC‰ª–{—¹ˆêC“‡“àçŒbŽqCˆä㼋vi”÷j: 34th Interscience Conference on Antimicrobial Agents and Chemotherapy i94.10.04`07j, Orlando, Florida, USA. Abstract, No.F73: 159, 1994.

270. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j In vitro antibacterial activity of CL 331,928(DMG-DMDOT), a new glycylcycline derivative. ˆä㼋vi”÷jC–ìXŽRŸliŽ™jCWarsa, U.C.C‰ª–{—¹ˆê: 34th Interscience Conference on Antimicrobial Agents and Chemotherapy i94.10.04`07j, Orlando, Florida, USA. Abstract, No.F94: 178, 1994.

271. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒJƒ‹ƒoƒyƒlƒ€\ƒÀ-ƒ‰ƒNƒ^ƒ€‚ÌV‚µ‚¢‰Â”\«‚ð‹‚ß‚Ä\; ƒJƒ‹ƒoƒyƒlƒ€Ü‚Ì׋ۊw“I“Á’¥. ˆä㼋vi”÷j: ‘æ42‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i94.06.10j, •Ÿ‰ª, u‰‰´˜^W, p.73, 1994.

272. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ}ƒEƒX MRSAŠ´õÇ: ƒrƒ‹ƒŒƒ“ƒX‚ÆD’†‹…‹@”\’ቺ‚ÌŠÖŒW. ùŒ´•Žui”÷jCŠÃ—˜’å‰qC’·‘]•”‹IŽqCˆä㼋vi”÷j: ‘æ42‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i94.06.10j, •Ÿ‰ª, u‰‰´˜^W, p.104, 1994.

273. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘S‘‹K–Í‚É‚¨‚¯‚é MRSAƒAƒ“ƒP[ƒg’²¸. —ÑòiŠàŒ¤jCˆä㼋vi”÷jC‹´–{ˆêi–kŒ¤j: ‘æ42‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i94.06.10j, •Ÿ‰ª, u‰‰´˜^W, p.161, 1994.

274. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘S‘‹K–Í‚É‚¨‚¯‚é MRSAŠ´õÇ‚ÌŽÀ‘Ô‚Æ ABK‚Ì—L—p«. —ÑòiŠàŒ¤jCˆä㼋vi”÷jC‹´–{ˆêi–kŒ¤j: ‘æ42‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i94.06.10j, •Ÿ‰ª, u‰‰´˜^W, p.161, 1994.

275. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒZƒtƒFƒ€‘Ï« S.marcescens —R—ˆ“`’B«ƒÀ-lactamase‚Ì«ó. ŸO“cçŒbŽqi‘å–Q»–òjC“Œ’J–[Li”÷jC•º“ªº•vCˆä㼋vi”÷j: ‘æ42‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i94.06.10j, •Ÿ‰ª, u‰‰´˜^W, p.206, 1994.

276. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒÀ-ƒ‰ƒNƒ^ƒ€Ü‚É‚æ‚éGM‘Ï«‚Ì—U“±‚ɂ‚¢‚Ä. ˆä“cFŽui”÷jC–ìXŽRŸliŽ™jC‰ª–{—¹ˆêC²“¡’q–¾i“ŒŠC‘åjC’r“c­ŸC_’J–ÎCˆä㼋vi”÷j: ‘æ42‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i94.06.10j, •Ÿ‰ª, u‰‰´˜^W, p.206, 1994.

277. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j PCR–@‚É‚æ‚é S. aureus‚Ì tet K, tet Mˆâ“`Žq‚ÌŒŸo‚Æ‚»‚Ì”äŠrŒŸ“¢. –ìXŽRŸliŽ™jCWarsa, U.C.iƒCƒ“ƒhƒlƒVƒA‘åjCˆä“cFŽuC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ42‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i94.06.11j, •Ÿ‰ª, u‰‰´˜^W, p.206, 1994.

278. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒtƒ@[ƒW‚Ì—nŒ´‰»‚É‚æ‚éMRSA‚̃tƒ@[ƒWŒ^AƒQƒmƒ^ƒCƒv‚̕ω»‚ÉŠÖ‚·‚錟“¢. “‡“àçŒbŽqi”÷jC–ìXŽRŸliŽ™jCˆä“cFŽuCˆä㼋vi”÷j: ‘æ10‰ñ“ú–{ŠÂ‹«Š´õŠw‰ï i95.02.18j, ‘q•~, u‰‰´˜^W, p.59, 1995.

279. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒLƒmƒƒ“‘Ï«DNA topoisomerase ‡Wˆâ“`Žq. ŽRŠÝƒˆêi”÷jC¬ŽR“c‹`”ŽC“¡–{FˆêC¬“‡‹BC•ž•”G–¾C’†‘ºMˆêi‘å“ú–{»–òjCˆä㼋vi”÷jF ‘æ68‰ñ“ú–{׋ۊw‰ï‘‰ï i95.03.25`27j, ‹ž“s, “ú–{׋ۊwŽGŽ, 50(1): 187, 1995.

280. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Inc Pƒvƒ‰ƒXƒ~ƒh—R—ˆ‚̃ZƒtƒFƒ€‘Ï«ˆâ“`Žq‚ÌDNA‰–Šî”z—ñ‚ɂ‚¢‚Ä. ˆä㼋vi”÷jC²“¡—DŽqC•zŽ{ˆ¤ôC‰ª–{—¹ˆê: ‘æ68‰ñ“ú–{׋ۊw‰ï‘‰ï i95.03.25`27j, ‹ž“s, “ú–{׋ۊwŽGŽ, 50(1): 191, 1995.

281. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j MRSA‚Ì–òÜ‘Ï«Œ^‚ƃtƒ@[ƒW‚É‚æ‚镪—Þ. ‘å‹v•Û–LŽiiŒQ‘åjCˆÉ˜¬•”Žu’ÃŽqCˆä㼋vi”÷j: ‘æ68‰ñ“ú–{׋ۊw‰ï‘‰ï i95.03.25`27j, ‹ž“s, “ú–{׋ۊwŽGŽ, 50(1): 242, 1995.

282. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j MRSA‚Ì’°ŠÇŠ´õ‚ɉe‹¿‚·‚锈öŽq‚ÌŒŸ“¢; 1.’°ŠÇã”ç×–E“àƒŠƒ“ƒp‹…‹@”\‚ð’†S‚Æ‚µ‚Ä. ùŒ´•Žui”÷jC¬¼—mŽqCˆä㼋vi”÷j: ‘æ68‰ñ“ú–{׋ۊw‰ï‘‰ï i95.03.26j, ‹ž“s, “ú–{׋ۊwŽGŽ, 50(1): 139, 1995.

283. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘B‚Ì’âŽ~‚µ‚½YACUTXG4—Z‡×–EƒKƒgƒ‰ƒ“ƒXƒtƒH[ƒ€‚·‚éÛ‚Ì pvt-1ˆâ“`Žq‚ÉMoMuLV‚ª‘g‚Ýž‚܂ꂽŽîᇗR—ˆõF‘Ì15‚Ì–ðŠ„. ‹v•Û“cFˆêC‹Ê“àGˆêi”÷jC’†—¢˜a”üi—\–hˆãŠwŒnj: ‘æ53‰ñ“ú–{ŠàŠw‰ï‘‰ï i94.10.20j, –¼ŒÃ‰®, “ú–{ŠàŠw‰ï‘‰ï‹LŽ–, 53: 263, 1994.

284. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j PCR–@‚É‚æ‚鉩FƒuƒhƒE‹…‹Û‚̃RƒAƒOƒ‰[ƒ[Œ^•Ê. –ìXŽRŸliŽ™jC‰ª–{—¹ˆêCˆä㼋vi”÷j: ‘æ68‰ñ“ú–{׋ۊw‰ï‘‰ï i95.03.25`27j, ‹ž“s, “ú–{׋ۊwŽGŽ, 50(1): 230, 1995.

285. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒvƒ‰ƒXƒ~ƒh«ƒJƒ‹ƒoƒyƒlƒ€Ü‰Á…•ª‰ðy‘f. ˆä㼋vi”÷jC‰ª–{—¹ˆêC’†‘ºŒiŽqC•zŽ{ˆ¤ôC¼“ckŽ¡CoŒû_ˆêi“s‘‡—Õ°ŒŸ¸ƒZƒ“ƒ^-j: ‘æ41‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï i94.11.25j, “Œ‹ž, u‰‰´˜^W, p.61, 1994.

286. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰©FƒuƒhƒE‹…‹Û–òÜ‘Ï«‹@˜; ƒuƒhƒE‹…‹Û‚ɑ΂·‚éƒAƒ‹ƒxƒJƒVƒ“‚ÌR‹Û—Í. ˆä㼋vi”÷j: ‘æ39‰ñƒuƒhƒE‹…‹ÛŒ¤‹†‰ï i94.09.08j, “Œ‹ž, u‰‰´˜^W, p.50, 1994.

287. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j PCR–@‚É‚æ‚鉩FƒuƒhƒE‹…‹Û‚̃RƒAƒOƒ‰[ƒ[Œ^•Ê. –ìXŽRŸliŽ™jCˆø’n®Žqi‰q¶Šw•”jCˆä“cFŽuC“‡“àçŒbŽqCˆä㼋vi”÷j: ‘æ7‰ñuˆâ“`Žq‚Æ‚»‚ÌŽü•ÓvŒ¤‹†‰ï i94.08.02j, ŠâŽè.

288. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j NICU‚ÆŽ¨•@ˆôA‰È•a“‚É‚¨‚¯‚é MRSA‚Ì•@o“à•Û—L󋵂̌Ÿ“¢. “‡“àçŒbŽqi”÷jC–ìXŽRŸliŽ™jCˆî–ØŸ‰piŽ¨•@jCˆä㼋vi”÷j: ‘æ23‰ñ–òÜ‘Ï«‹ÛƒVƒ“ƒ|ƒWƒEƒ€ i94.08.25j, ˆÉ•Û, u‰‰´˜^W, p.20`21, 1994.

289. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Serratia marcescens‚©‚番—£‚³‚ꂽ plasmid«ƒÀ-lactamase‚Ì«ó. •zŽ{ˆ¤ôi”÷jC’†‘ºŒiŽqC¼“ckŽ¡CoŒû_ˆêi“s‘‡—Õ°ŒŸ¸ƒZƒ“ƒ^[jCˆä㼋vi”÷j: ‘æ23‰ñ–òÜ‘Ï«‹ÛƒVƒ“ƒ|ƒWƒEƒ€ i94.08.25j, ˆÉ•Û, u‰‰´˜^W, p.42`43, 1994.

290. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Ž¨•@ˆôA‰È•a“‚É‚¨‚¯‚é MRSA‚Ì•@o“à•Û—L󋵂̌Ÿ“¢. “‡“àçŒbŽqi”÷jCˆî–ØŸ‰piŽ¨•@jC–ìXŽRŸliŽ™jCˆä㼋vi”÷j: ‘æ39‰ñƒuƒhƒE‹…‹ÛŒ¤‹†‰ï i94.09.08j, “Œ‹ž, u‰‰´˜^W, p.14, 1994.

291. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‹ß”N•ª—£‚³‚ꂽ MRSA‚ÉŠÖ‚·‚é‰uŠw“I׋ۊw“IŒŸ“¢. ˆä“cFŽui”÷jCˆä㼋vi”÷jC—ÑòiŠàŒ¤jC‹´–{ˆêi–kŒ¤j: ‘æ39‰ñƒuƒhƒE‹…‹ÛŒ¤‹†‰ï i94.09.08j, “Œ‹ž, u‰‰´˜^W, p.37, 1994.

292. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Ž¨•@ˆôA‰È•a“‚É‚¨‚¯‚éMRSA‚Ì•@o“à•Û—L󋵂̌Ÿ“¢. “‡“àçŒbŽqi”÷jCˆî–ØŸ‰piŽ¨jC–ìXŽRŸliŽ™jCˆä㼋vi”÷j: ‘æ39‰ñƒuƒhƒE‹…‹ÛŒ¤‹†‰ï i94.09.08j, “Œ‹ž, ´˜^W, p.14, 1994.

293. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j —Δ^‹Û—R—ˆ‚̃ZƒtƒFƒ€‘Ï«Inc Pƒvƒ‰ƒXƒ~ƒh‚ɂ‚¢‚Ä. ˆä㼋vi”÷jC²“¡—DŽqC•zŽ{ˆ¤ôC¬“cؔɎ÷iŒ§zŠÂŠí.ŒÄ‹zŠíƒZƒ“ƒ^[jC‰ª–{—¹ˆêi”÷j: ‘æ29‰ñ—Δ^‹ÛŠ´õÇŒ¤‹†‰ï i95.01.19`20j, “Œ‹ž, u‰‰´˜^W, p.43, 1995.

294. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j MRSA oŒ»‚Ì”wŒi. ˆä㼋vi”÷j: ‘æ2‰ñ’·–쌧—Õ°ŒŸ¸‹ZŽt¶ŠU‹³ˆç i94.11.13j, ’·–ì. ˆä㼋v

295. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Genetic studies of cephem resistances in gram-negative bacteria. ˆä㼋vi”÷j: ‘æ‚R‰ñƒƒx|ƒ‹ƒgƒRƒbƒzŒ¤‹†Š¥–k—¢Œ¤‹†Š‡“¯ƒVƒ“ƒ|ƒWƒEƒ€ i94.11.10j, “Œ‹ž.

296. mŠw‰ïŽåÃi‘“àjn ‘æ23‰ñ–òÜ‘Ï«‹ÛƒVƒ“ƒ|ƒWƒEƒ€i94.08.25`26jCˆÉ•ÛC ˆä㼋vi”÷j.


<<07 –ƉuŠw>>

297. mŒ´’˜n Natiue T cells can mediate delayed-type hypersensitivity response in T cell recepter transgenic mice. Sato, T.CùŒ´•Žui”÷jCNakamura, Y.CTadakuma, T.CArata, Y.CKumagai, Y.CKatsuki, M.CHabu, S.: Eur. J. Immunol., 24: 1512`1516, 1994.

298. mŒ´’˜n Unique properties of cytotoxic CDH+ CD8+ intraepitherial T cell line established from the mouse intestinal epithelium. ùŒ´•ŽuC‹Ê“àGˆêC’r˜eM’¼C‹v•Û“cFˆêi”÷j: Microbiol. Immunol., 38(3): 191`199, 1994.

299. mŒ´’˜n Genetic analysis of hydatidiform moles utilizing the oligonucleotide-DNA typing of the HLA-DRB gene. –î•”“TŽqi—Õ•a—jC‘O“c“OiŠÅŒìŠw•”jC”–Ø“oC¬”¦•¶–íi–Ɖuj: Placenta, 15: 541`549, 1994.

300. mŒ´’˜n Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. “n•”_“ñi–ƉujCˆÉ“Œˆê˜Yi—\–hˆãŠwŒnjC‘å’J•¶—YC¬”¦•¶–íi–ƉujC²“¡ŒõŽjCΓc˜a•viŠOjC^è‹`•FCŠÛŽR–ΑPiŽÀ“®ŒnjC”–Ø“oi–Ɖuj: Transplant. Proc., 27(1): 221`224, 1995.

301. mŒ´’˜n ‹¹‘B”ñˆË‘¶“I‚É•ª‰»‚µ‚½’°ŠÇã”ç“à‚sƒŠƒ“ƒp‹…‚̉ðÍ|TcRƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚ð—p‚¢‚Ä|. ‹Ê“àGˆêi”÷jC‘º“c‹M‘¥i‰q¶Šw•”jC¼Œ´—¯”ü“Þi“ŒŠC‘åjCùŒ´•Žui”÷jCŽ›“c‰pŽii‰q¶Šw•”jCˆä㼋vi”÷jC’|“c“ñiã ‘åjCDennis, Y.LohCŠ_¶‰€ŽqiHHMIj: Á‰»Ší‚ƖƉu, 29: 84`89, 1994.

302. m€Œ´’˜n Sequence analysis of the T-cell receptor expressed by renal-allograft infiltrating cells. ¬”¦•¶–íi–ƉujCŠp“c‚Ý‚³‚ði—\–hˆãŠwŒnjCŒF–ì˜a—Yi”åjC‰¶“cŒhŽ¡iŽœŒbˆã‘åjC”–Ø“oi–Ɖuj: Transplant. Proc., 26(2): 861`863, 1994.

303. m€Œ´’˜n T-cell oligoclonality in renal allograft-infiltrating lymphocytes demonstrated by restricted T-cell receptor diversity. ¬”¦•¶–íi–ƉujCŠp“c‚Ý‚³‚ði—\–hˆãŠwŒnjC”Ñ’ËŠî°i–ƉujCŒF–ì˜a—Yi”åjC÷ˆä‰x•vC¬è³–¤i“Œ‹žˆã‘åjC”–Ø“oi–Ɖuj: Transplant. Proc., 27(1): 471`474, 1995.

304. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn SSO–@‚É‚æ‚éHLA-ƒNƒ‰ƒX‡Uˆâ“`Žq‚ÌDNAƒ^ƒCƒsƒ“ƒO(‘æ11‰ñ“ú–{HLAƒ[ƒNƒVƒ‡ƒbƒv‹¤“¯•ñ). ¬”¦•¶–íi–Ɖuj: ¡“ú‚̈ÚA, 7(Suppl.): 56`60, 1994.

305. m‘àn Genetic polymorphism of HLA-DR in the Japanese population. ¬”¦•¶–íi–Ɖuj: Kitasato Arch. Exp. Med., 65(Suppl.): 13`24, 1993.

306. m‘àn ˆâ“`Žq‚ÌŠî‘b‡T: ˆâ“`, ˆâ“`Žq, DNA. ‘å’J•¶—Yi–Ɖuj: ˆãŠwŒŸ¸, 43(11): 1699`1707, 1994.

307. m‘àn ˆâ“`Žq‚ÌŠî‘b‡U: ˆâ“`‚Ì•ªŽq¶•¨Šw. ‘å’J•¶—Yi–Ɖuj: ˆãŠwŒŸ¸, 43(12): 1823`1832, 1994.

308. m‘àn ˆÚARŒ´|HLA‚ÌDNAƒ^ƒCƒsƒ“ƒO. ¬”¦•¶–íi–Ɖuj: Œ»‘㉻Šw, 23(‘Š§): 157`165, 1994.

309. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj –ƉuŽÀŒ±‘€ì–@‡T, ‡U; ‹¹‘BˆÚA|‹¹‘BƒŠƒ“ƒp‹…‚Ìœ‹Ž, 2: 1082`1085, 1097`1102, ‹Ê“àGˆêi”÷jCŠ_¶‰€Žqi“ŒŠC‘åj. •ÒW ‰E“cr‰îi‹à‘ò‘åjC•R“cii‹à‘òˆã‰È‘åjC–{Ž—Ci‹ž‘åjCà_‰ª—˜”Viã‘åjC “ìŒõ“°, “Œ‹ž, 95.03.10”­s.

310. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j T-cell oligoclonality in renal allograft infiltrating lymphocytes demonstrated by restricted T-cell receptor diversity. ¬”¦•¶–íi–ƉujCŠp“c‚Ý‚³‚ði—\–hˆãŠwŒnjCŒF–ì˜a—Yi”åjC÷ˆä‰x•vC¬è³–¤i“Œ‹žˆã‘åjC”–Ø“oi–Ɖuj: ‘æ15‰ñ‘ÛˆÚAŠw‰ï i94.08.30j, ‹ž“s.

311. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. “n•”_“ñi–ƉujCˆÉ“Œˆê˜Yi—\–hˆãŠwŒnjC‘å’J•¶—YC¬”¦•¶–íi–ƉujC²“¡ŒõŽjCΓc˜a•viŠOjC^è‹`•FCŠÛŽR–ΑPiŽÀ“®ŒnjC”–Ø“oi–Ɖuj: 15th World Congress of the Transplantation Society i94.08.30j, ‹ž“s, Abstracts, p.114, 1994.

312. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj V‹K‚Éì‚ç‚ꂽƒLƒ‰[‚s×–EƒnƒCƒuƒŠƒh[ƒ}‚Ì×–EáŠQ‹@\. ‹v•Û“cFˆêi”÷jC’†—¢˜a”üi—\–hˆãŠwŒnjC‹Ê“àGˆêi”÷j: ‘æ24‰ñ“ú–{–ƉuŠw‰ï‘‰ï i94.11.29j, ‹ž“s, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 24: 434, 1994.

313. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj MHCS‘©•ªŽq‚É”ñˆË‘¶“I•ª‰»‚ð‚·‚é’°ŠÇã”ç“àCD8—z«‚sƒŠƒ“ƒp‹…‚̉ðÍ. ‹Ê“àGˆêCˆä㼋vi”÷jC’|“c“ñiã‘åjCŠ_¶‰€Žqi“ŒŠC‘åj: ‘æ24‰ñ“ú–{–ƉuŠw‰ï‘‰ï i94.11.30j, ‹ž“s, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 24: 512, 1994.

314. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒ}ƒEƒXMRSAŠ´õÇ‚É‚¨‚¯‚éD’†‹…‹@”\’ቺ. ùŒ´•Žui”÷jC’r˜eM’¼iŠÅŒìŠw•”jC‹Ê“àGˆêC¬¼—mŽqCˆä㼋vi”÷jC’|“c“ñiã‘åjCŠ_¶‰€Žqi“ŒŠC‘åj: ‘æ24‰ñ“ú–{–ƉuŠw‰ï‘‰ï i94.11.30j, ‹ž“s, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 24: 561, 1994.

315. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒ’†”÷—ʬ“ü×–EŒŸo‚ÌŽŽ‚Ý: HLAˆâ“`Žqƒ^ƒCƒsƒ“ƒO‚É‚æ‚錟“¢. ‹àŽR´Žqi‘—§‘å‘ •a‰@jC¬”¦•¶–íi–ƉujC“c’†’‰•vC’ç‹I•vC‘q“‡•x‘ãCˆÉ“¡Ž¡‰pi‘—§‘å‘ •a‰@jC”–Ø“oi–Ɖuj: ‘æ46‰ñ“ú–{ŽY•wl‰ÈŠw‰ï‘‰ï i94.04.12j, “Œ‹ž.

316. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝŠà”­Ç‚ÆHLA-DP, -DRˆâ“`ŽqŒ^‚Æ‚Ì‘ŠŠÖ‰ðÍ. ¬”¦•¶–íi–ƉujC¶‰z‹ª“ñC²“¡ŒOi“ŒŠC‘åjC‘å‹v•Û‚Ý‚Ç‚èCŠp“c‚Ý‚³‚ði—\–hˆãŠwŒnjC’ÒŒö”üi“ŒŠC‘åjC”–Ø“oi–Ɖuj: ‘æ24‰ñ“ú–{–ƉuŠw‰ïŠwpW‰ï i94.12.01j, ‹ž“s.

317. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –k—¢Ž©‰Æ”ÉBmongrelŒ¢‚ÌŽå—v‘gD“K‡RŒ´(DLA)DRB1ˆâ“`ŽqŒ^‚̉ðÍ. ˆÉ“Œˆê˜Yi—\–hˆãŠwŒnjC“n•”_“ñC‘å’J•¶—Yi–ƉujCŠp“c‚Ý‚³‚ði—\–hˆãŠwŒnjC¬”¦•¶–íi–ƉujC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjC‹àŽq„‹vC”–Ø“oi–Æ ‰ujC˜kì_ŽiiŽÀ“®ŒnjC•“¡Œ’iŽÀ“®j: ‘æ3‰ñ“ú–{‘gD“K‡«Šw‰ï‘å‰ï i94.07.22j, •l¼, “ú–{‘gD“K‡«Šw‰ïŽ, 1(1): 115, 1994.

318. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘ŸŠíˆÚA‚É‚¨‚¯‚é–ƉuŠ°—e‚Ì“±“ü–@‚ɂ‚¢‚Ä. “n•”_“ñi–ƉujCˆÉ“Œˆê˜Yi—\–hˆãŠwŒnjC‘å’J•¶—Yi–ƉujCŠp“c‚Ý‚³‚ðC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjC¬”¦•¶–íC‹àŽq„‹vC”–Ø“oi–ƉujC‚Œ´ÄC ¼—Ñ—²i•új: ‘æ20‰ñ–k—¢ˆãŠw‰ï‘‰ï i94.10.15j, ‘Š–ÍŒ´, –k—¢ˆãŠw, 24(6): 600, 1994.

319. mŒ¤‹†‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ˆÝŠàŠ³ŽÒ‚É‚¨‚¯‚éHLA-DRˆâ“`Žq‚̉ðÍ. ¬”¦•¶–íi–ƉujC¶‰z‹ª“ñC²“¡ŒOi“ŒŠC‘åjC‘å‹v•Û‚Ý‚Ç‚èCŠp“c‚Ý‚³‚ði—\–hˆãŠwŒnjC’ÒŒö”üi“ŒŠC‘åjC”–Ø“oi–Ɖuj: ‘æ3‰ñŠà•a‘ÔŽ¡—ÃŒ¤‹†‰ï i94.05.28j, “Œ‹ž.

320. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒ}ƒEƒXMRSAŠ´õÇ‚É‚¨‚¯‚é’°ŠÇã”ç×–EŠÔƒŠƒ“ƒp‹…‚Ì–ðŠ„. ùŒ´•ŽuCr“‡´ŽqC¬¼—mŽqCˆä㼋vi”÷j: ‘æ31‰ñÁ‰»Ší‚ƖƉuŒ¤‹†‰ï i95.03.04j, “Œ‹ž.

321. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‹¹‘B”ñˆË‘¶“I‚É•ª‰»‚µ‚½’°ŠÇã”ç“à‚sƒŠƒ“ƒp‹…(IEL)‚̉ðÍ(2)|TCRƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚ð—p‚¢‚Ä|. ‹Ê“àGˆêi”÷jC’|“c“ñiã‘åjCŠ_¶‰€Žqi“ŒŠC‘åj: ‘æ31‰ñÁ‰»Ší‚ƖƉuŒ¤‹†‰ï i95.03.04j, “Œ‹ž, ´˜^W, p.11, 1995.

322. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒr[ƒOƒ‹Œ¢Žå—v‘gD“K‡RŒ´(DLA)DRB1ˆâ“`Žq‚ÌDNA‰–Šî”z—ñ. ‘å’J•¶—Yi–ƉujCˆÉ“Œˆê˜YCŠp“c‚Ý‚³‚ði—\–hˆãŠwŒnjC¬”¦•¶–íC“n•”_“ñC”–Ø“oi–Ɖuj: _“ÞìˆÚAŒ¤‹†‰ï i94.06.20j, ‰¡•l.

323. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j –k—¢Ž©‰Æ”ÉBŒ¢‚ÌŽå—v‘gD“K‡RŒ´(DLA)DRB1ˆâ“`ŽqŒ^‚̉ðÍ. ˆÉ“Œˆê˜Yi—\–hˆãŠwŒnjC“n•”_“ñC‘å’J•¶—YC¬”¦•¶–íi–ƉujCŠp“c‚Ý‚³‚ðC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjC‹àŽq„‹vC”–Ø“oi–ƉujC˜kì_ŽiiŽÀ“® ŒnjC•“¡Œ’iŽÀ“®j: ‘æ7‰ñ¢ˆâ“`Žq‚Æ‚»‚ÌŽü•Ó£Œ¤‹†‰ï i94.08.02j, ŽO—¤, u‰‰—vŽ|W, p.26, 1994.

324. mŠw‰ïŽåÃi‘“àŠw‰ïjn ‘æ9‰ñ“ú–{¶B–ƉuŠw‰ï(94.12.17`18), “Œ‹ž, ”–Ø“oi–Ɖuj.


<<08 •a—Šw>>

325. mŒ´’˜n Colocalization of growth hormone (GH) and glycoprotein subunit ƒ¿ in GH-producing pituitary adenoma in acromegalic patient. ŒÃŠø–ÎiŒc‘åjC‹T’J“Oi•a—jC’ß“c’qŽqiŒ`‘ÔŒnjC¬‚•½Ž¡CŒË’Jd—YiŒc‘åj: Acta Neuropathol., 87: 568`571, 1994.

326. mŒ´’˜n Glutamic acid and tryptophan do not prevent vinblastine-induced apoptosis in a human lymphoma cell line. B.V. HarmonCΈä‰pºi•a—jCD.J. Allan: Cell Prolif., 27: 455`464, 1994.

327. mŒ´’˜n Localization of virus in liver biopsy specimen of acute EBV hepatitis using non-isotopic in situ hybridization procedure presence of EBV in hepatocytes and lymphocytes. S. ImotoC‹T’J“OC²“¡—Yˆêi•a—jC²“¡giŒ`‘ÔŒnjCK. InoueCM. Oya: Hepatology Communications, 3: 53`56, 1995.

328. mŒ´’˜n Histopathological study of intrahepatic aberrant vessels in cases of noncirrhotic portal hypertension. ‘å•”½C‰œ•½‰ë•FC“n•Ó´Ž¡C‹àŽq‘C‚ˆä’qŽqi•a—j: Hepatology, 20(2): 302`308, 1994.

329. mŒ´’˜n Taxonomic position of deep-seated, mucosa-associated, and superficial isolates of Trichosporon cutaneum from tricosporonosis patients. Sugita, T.CNishikawa, A.CShinoda, T.C‹v•ÄŒõi•a—j: J. Clin. Microbiol., 33(5): 1368`1370, 1995.

330. mŒ´’˜n Epstein-Barr virus association with early cancers found together with gastric modullary carcinomas demonstrating lymphoid infiltration. ‚–ìN—Yi•a—jCYo KatoiCancer Institutej: J. Pathol., 175: 39`44, 1995.

331. mŒ´’˜n ƒqƒgˆÝ’ᕪ‰»Œ^”S‰tŠà”|—{×–EŠ”‚ÌŽ÷—§‚Æ‚»‚Ì•a—‘gDŠw“IŒŸ“¢. ã™G‰iC’†‰p’ji•a—j: “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 92(1): 19`25, 1995.

332. mŒ´’˜n ƒzƒWƒLƒ“•a‘gD‚É‚¨‚¯‚éEpstein-Barr virus‚ÌŠeŽí“¯’è–@‚Æ‚»‚Ì—L—p«‚ɂ‚¢‚Ä. ”n‰z’q_iŽ¨•@jC²“¡—YˆêC‹T’J“Oi•a—jC‚‹´LbCÝŠy“N–çiŽ¨•@j: –k—¢ˆãŠw, 25(1): 15`23, 1995.

333. m’Z•ñ¥‘¬•ñn Virus‚Ì—L–³‚ÆŽîá‡×–E‚ÌApoptosis‚ÉŠÖ‚·‚éŒ`‘ÔŠw“I‚©‚•ªŽq¶•¨Šw“IŒ¤‹†. Έä‰pºi•a—jC‘q—Ñ—ÇKCבº‘וvC鉺®iŒQ”n‘åj: Š´õÇŠwŽGŽ, 68(3): 461`462, 1994.

334. mŒ¤‹†•ñiŒú¶Èjn ”ñd•Ï«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚éŠÌ•a•Ï‚ÆäB‘Ÿ‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä. ‘å•”½i•a—jC‰œ•½‰ë•Fi“ú–{ƒoƒCƒIƒAƒbƒZƒCŒ¤‹†ƒZƒ“ƒ^[j: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”Ç•½¬5”N“xŒ¤‹†•ñ‘, p.21`23, 1994.

335. mŒ¤‹†•ñiŒú¶Èjn ”ñd•Ï«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚éŠÌ•a•Ï‚ÆäB‘Ÿ‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä|‘æ‚Q•ñ. ‘å•”½i•a—jC‰œ•½‰ë•Fi“ú–{ƒoƒCƒIƒAƒbƒZƒCŒ¤‹†ƒZƒ“ƒ^[j: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”Ç•½¬5”N“xŒ¤‹†•ñ‘, p.41`43, 1994.

336. mÇ—á•ñn Small cell carcinoma of the esophagus with unusual morphological changes following chemotherapy: a case report. Έä‰pºCY. DobashiC›’m–çC£ìŒªˆêC–{‹§C’†‰p’jC‰œ•½‰ë•Fi•a—j: Med. Sci. Res., 22: 811`813, 1994.

337. mÇ—á•ñn ‘Ù”ÕŽîᇋy‚Ñ‚»‚Ì‘Ù”Õ‚É‚æ‚è”­ˆç‚µ‚½V¶Ž™–UŒŸ—á‚Ì1—á. “n•Óƒi•a—j: _“ÞìˆãŠw‰ïŽGŽ, 21(2): 139, 1994.

338. mÇ—á•ñn Pulmonary capillary hemangiomatosis‚Ì1—á. Έä‰pºi•a—j: _“ÞìˆãŠw‰ïŽGŽ, 21(2): 339, 1994.

339. mÇ—á•ñn ‹CŠÇŽx‚ÉŒ´”­‚µ‚½”÷¬G•½ã”ç“àŠà‚Ìš\á‚×–E‘œ‚ðŒŸ“¢‚µ‚½‚P—á. ’†‰p’jC¼ŽR•Û”äŒÃCŽO•xO”VCã™G‰iC˜@–{’q”üi•a—j: “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(6): 1108`1112, 1994.

340. mÇ—á•ñn ã”ç—lŒ‹‡‚ðŽ¦‚·Žîá‡×–EW‰ò‚ªoŒ»‚µ‚½Žq‹{‘Ì•”•½ŠŠ‹Ø“÷Žî‚Ì‚P—á. •ž•”ŠwC‘å–ì‰pŽ¡C‰¡ŽR‘åC–L‰i^Ÿi•a‰@•a—jCŒK”ö’èmi•a—jC‘ –{”ŽsiŽY•wj: “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(6): 1160`1164, 1994.

341. m‘àn R^‹ÛÜ‚Ì•¹—p—Ö@‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†. ‹v•ÄŒõCŽRè•q˜ai•a—jCM‰ª”ü»ŽqC–]ŒŽ^‹|C‘º£¨’ÃŽqi–òÜj: “ú–{ˆã^‹ÛŠw‰ïŽGŽ, 35: 361`364, 1994.

342. m‘àn “ú–{ˆã^‹ÛŠw‰ï•W€‰»ˆÏˆõ‰ï•ñ(1992`1994). ŽRŒû‰p¢C“à“cŸ‹vC‹v•ÄŒõi•a—jCŽÂ“cFŽqC“n•ÓˆêŒ÷C“ír—YC”ä—¯ŠÔ­‘¾˜YCÎèG: “ú–{ˆã^‹ÛŠw‰ïŽGŽ, 36: 61`86, 1995.

343. m‘àn [‰»‚·‚é“à‘Ÿ^‹ÛÇ‚Æ‚»‚ÌŽ¡—Âð‚ß‚®‚Á‚Ä. ‹v•ÄŒõi•a—jCM‰ª”ü»ŽqC–]ŒŽ^‹|C‘º£¨’ÃŽqi–òÜj: “ú–{•a‰@–òÜŽt‰ïŽGŽ, 31(1): 9`15, 1995.

344. m‘àn Á‰»ŠÇÇŒóŒQiH“¹¥ˆÝ¥’°¥’Ž—H¥ãè–åj|‚»‚Ì‘¼‚ÌÁ‰»ŠÇŽ¾Š³‚ðŠÜ‚ß‚Ä|. ’†‰p’jC¼ŽR•Û”äŒÃCã™G‰ii•a—j: “ú–{—Õ°, (—̈æ•ÊÇŒóŒQƒVƒŠ[ƒY No.5): 188`189, 1994.

345. m‘àn äX“‡‚Ì”­¶‚ÆäX“à•ª”åŽîá‡. ‹T’J“Oi•a—j: •a—‚Æ—Õ°, 12(3): 335`342, 1994.

346. m‘àn Žå—v•aŒ´^‹Û‚ÌŒŸ¸–@; ^‹Û‚Ì–òÜŠ´Žó«ŒŸ¸–@•W€‰»‚Ì“®Œü|^‹Û‚Ì–òÜŠ´Žó«ŒŸ¸–@‚ÌŽÀÛ. ‹v•ÄŒõCŽRè•q˜ai•a—j: —Õ°‚Æ”÷¶•¨, 21(5): 56`64, 1994.

347. m‘àn ˆÝ‚Ì—ÇEˆ««‹«ŠE•a•Ï. ’†‰p’jCã™G‰ii•a—j: —Õ°ŒŸ¸, 38(10): 1163`1166, 1994.

348. mŠwp‘n i•ª’SŽ·•Mj “à‘ŸƒJƒ“ƒWƒ_Ç‚ÌŠî‘b‚Æ—Õ°; “à‘ŸƒJƒ“ƒWƒ_ǂ̉uŠw‚Æ—\–h, p.44`52, ‹v•ÄŒõi•a—jC–]ŒŽ^‹|CM‰ª”ü»Žqi–òÜjC’Ë–{GliŠOjCˆ¢•””ü’mŽqi—ÕŒŸjCŽR‰º‚¦‚èŽqi“àj. ‹¦˜aŠé‰æ’ÊMC“Œ‹žC94.04.30”­s.

349. mŠwp‘n i•ª’SŽ·•Mj —Õ°“à•ª”å•a—f’fŠw; •a—Šw“If’f‚Ì‚½‚ß‚ÌŠî‘b’mŽ¯, p.56`62, ‹T’J“Oi•a—j. •ÒW ù–ìLºi“Œ–k‘åj, ˆãŽ•–òo”ÅC“Œ‹žC94.03.20”­s.

350. mŠwp‘n i•ª’SŽ·•Mj Œ»‘ã•a—Šw‘åŒn(‘æ‚SŠªzŠÂáŠQ); ––½áŠQŠe˜_, p.221`232, ŒK”ö’èmC¼ŽR•Ûˆêi•a—j. •ÒW ”Ñ“‡@ˆêiL‘奖¼‘åj, ’†ŽR‘“XC“Œ‹žC94.10.20”­s.

351. m‹³‰È‘n i’P’˜j •a—ŠwƒTƒ}ƒŠ[ƒm[ƒg; ŒK”ö’èmi•a—j. •¶Œõ“°C“Œ‹žC94.08.29”­s.

352. m‹³‰È‘n i•ª’SŽ·•Mj ‘gD•a—ƒAƒgƒ‰ƒX(‘æ‚S”Å); 15.‰º‚‘Ì, ¼‰Ê‘Ì, bó‘B, •›bó‘B, •›t, p.287`310, ‹T’J“Oi•a—j. •ÒW —•‘òiŽœŒbˆã‘åjC‹e’ri•Ÿ‰ª‘åjCŒ´i‚’m‘åjC’¬•Ài“Œ‘åjCŽO•ûiç—t‘åj, •¶Œõ“°C“Œ‹žC95.02.22”­s.

353. m–|–ón i•ª’SŽ·•Mj ƒƒrƒ“ƒXŠî‘b•a—Šw; ‘æ16ÍŠÌ‘Ÿ‹y‚Ñ’_“¹, p.629`680, ‰ªˆÀŒMi•a—j. Lì‘“XC“Œ‹žC95.01.00”­s.

354. mŠw‰ïi‘Ûjn iƒ[ƒNƒVƒ‡ƒbƒvj Highly sensitive detection of growth hormone mRNA by non-radioactive sulfonated in situ hybridization. ¬‚•½Ž¡C‹T’J“OC²“¡—Yˆêi•a—jC’ß“c’qŽqiŒ`‘ÔŒnjCŒÃŠø–Îi•a—j: Joint Meeting of Japan Society of Histochemistry and Cytochemistly and Histochemical Society i94.07.15j, Hawaii, J. Histochem. Cytochem., 42(7): 1011, 1994.

355. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Correlation between expression of NM23 gene product and histologic differentiation of adenocarcinoma of the lung. ‹T’J“OC²“¡—Yˆêi•a—jC‹g‘º”Ž–Mi‹¹ŠOjCŽ™‹Ê“N˜Yi‘—§‚ª‚ñƒZƒ“ƒ^[j: International Congress for Lung Cancer i94.06.24j, ƒAƒeƒl, Abstract, p.181, 1994.

356. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Correlation between expression of the lung. invading the heart or the great vessels. ‹T’J“OC²“¡—Yˆêi•a—jC²“¡giŒ`‘ÔŒnjC‹g‘º”Ž–Mi‹¹ŠOjCŽ™‹Ê“N˜Yi‘—§‚ª‚ñƒZƒ“ƒ^[j: International Congress for Lung Cancer i94.06.25j, ƒAƒeƒl, Program-Abstracts, p.183, 1994.

357. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Platestain technique for immunohistochemistry and its further application. ŒK”ö’èmC‹T’J“Oi•a—j: ‘æ20‰ñ‘Û•a—ƒAƒJƒfƒ~[‘‰ï i94.10.10j, `, Int. J. Surg. Pathol, 2(Suppl.): 384, 1995.

358. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Progressive multifocal leukoencephalopathy arising in a patient with lupus nephropathy under steroid therapy; A case report. “n•Ó´Ž¡i•a—jCÎŒ´DOi“s—§_Œo‘‡Œ¤jC¬—шè•vi”]ŠOjC‰ªˆÀŒMi•a—j: 20th International Congress of the International Academy of Pathology i94.10.12j, Hong Kong, Programme, p.121, 1994.

359. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒAƒ][ƒ‹ŒnR^‹ÛÜ‚Ì•¹—pŒø‰Ê|Šî‘b“I—§ê‚©‚ç|. ‹v•ÄŒõi•a—j: ‘æ42‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i94.06.11j, ”Ž‘½, ´˜^W, p.88, 1994.

360. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j CHX(’`”’‡¬‘jŠQÜ)“Š—^Žž‚É‚¨‚¯‚éŽîá‡×–EŽ€‚ɑ΂·‚éVirusŠ´õ‚̉e‹¿‚ɂ‚¢‚Ä‚ÌŒ¤‹†. Έä‰pºi•a—jC‘q—Ñ—ÇKC鉺®iŒQ”n‘åjC¬“‡Ÿi‘«—˜Ô\Žš•a‰@j: ‘æ83‰ñ“ú–{•a—Šw‰ï‘‰ï i94.03.29j, ‹ž“s, —\eW, p.209, 1994.

361. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Virus‚Ì—L–³‚ÆŽîá‡×–E‚ÌApoptosis‚ÉŠÖ‚·‚éŒ`‘ÔŠw“I‚©‚•ªŽq¶•¨Šw“IŒ¤‹†(2). Έä‰pºi•a—jC‘q—Ñ—ÇKCבº‘וvC鉺®iŒQ”n‘åj: ‘æ68‰ñ“ú–{Š´õÇŠw‰ï i94.04.21j, ’·è, Š´õÇŠwŽGŽ, 68(—Õ‘): 118, 1994.

362. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Silent mixed GH and PRL producing pituitary adenoma; immunohistochemistry (IHC), “dŒ°‹y‚Ñin situ hybridization (ISH)–@‚É‚æ‚éŒ`‘Ô‹y‚Ñ—Õ°‚ÌŒŸ“¢. ¬‚•½Ž¡C‹T’J“OC²“¡—YˆêCŒÃŠø–ÎC‘å’JŒõOCŒË’Jd—Yi•a—j: ‘æ67‰ñ“ú–{“à•ª”åŠw‰ï i94.06.03j, ’·è, “ú–{“à•ª”åŠw‰ïŽGŽ, 70(3): 305, 1994.

363. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žîá‡×–E‚É‚¨‚¯‚éVirusŠ´õ‚ÆApoptosis‚ÉŠÖ‚·‚é’´”÷Œ`‘ÔŠw“IŒ¤‹†. Έä‰pºi•a—jCבº‘וvC‘q—Ñ—ÇKC鉺®iŒQ”n‘åj: ‘æ26‰ñ“ú–{—Õ°“dŽqŒ°”÷‹¾Šw‰ï i94.10.05j, ‚’m, —\eW, p.78, 1994.

364. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •\–ÊŒ^‘å’°smŠà‚ÌisŠà‰Šú•a•Ï‚Æ‚µ‚Ä‚Ìd—v«. ŽO•xO”Vi•a—jCŒÜ\—’³Li“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.18j, ŽD–y.

365. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°‘ŠúŠà‚É‚¨‚¯‚éCathepsin-B”­Œ»‚ÉŠÖ‚·‚é–Ɖu‘gD‰»Šw“IŒŸ“¢|Zæi•”‚Ì•a‘ƒ‚Æ‘gD‹…‚É’…–Ú‚µ‚Ä|. ŽO•xO”VC’†‰p’jC¼ŽR•Û”äŒÃCã™G‰iC‰ªˆÀŒMi•a—jC“à“¡‹g—²CŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.10.31j, å‘ä.

366. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”x‘BŠà‚É‚¨‚¯‚énm23ˆâ“`ŽqŽY•¨”­Œ»‚Æ‘gD•ª‰»“x‚Æ‚Ì‘ŠŠÖ. ²“¡—Yˆêi•a—jC²“¡giŒ`‘ÔŒnjC‹T’J“OCŽ™‹Ê“N˜Yi•a—j: ‘æ35‰ñ“ú–{”xŠàŠw‰ï‘‰ï i94.11.07j, ’·è, ”xŠà, 34(5): 718, 1994.

367. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚·‚ׂĂÌGrowth hormoneŽY¶‘BŽî‚ÍProlactin mRNA‚ð”­Œ»‚·‚é. ¬‚•½Ž¡C‹T’J“OC²“¡—YˆêCŒÃŠø–Îi•a—jC‰ªGGi”]ŠOjC’ß“c’qŽqiŒ`‘ÔŒnjC‘å’JŒõOCŒË’Jd—Y: “ú–{“à•ª”åŠw‰ïH‹GŠwp‘å‰ï i94.11.16j, L“‡, “ú–{“à•ª”åŠw‰ïŽ, 70(7): 729, 1994.

368. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬Ž™‚ÌŠÌŒ´”­mesenchymal tumor‚Ì‚P—á. “n•Ó´Ž¡C‘å•”½i•a—j: ‘æ83‰ñ“ú–{•a—Šw‰ï‘‰ï i94.03.30j, ‹ž“s, “ú–{•a—Šw‰ï‰ïŽ, 83(1): 252, 1994.

369. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{‘Ì•”‚É”­¶‚µ‚½Neuroendocrine carcinoma‚Ì‚P–UŒŸ—á. ŠâŸºŒ[ˆêC‹T’J“Oi•a—j: ‘æ83‰ñ“ú–{•a—Šw‰ï‘‰ï i94.03.30j, ‹ž“s, “ú–{•a—Šw‰ï‰ïŽ, 83(1): 260, 1994.

370. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “Á”­«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚éŠÌ•a•Ï‚ÆäB‘Ÿ‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä. ‘å•”½C“n•Ó´Ž¡i•a—j: ‘æ83‰ñ“ú–{•a—Šw‰ï‘‰ï i94.03.30j, ‹ž“s, “ú–{•a—Šw‰ï‰ïŽ, 83(1): 280, 1994.

371. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žîᇉ»‚É”º‚¤“]ˆÚ—}§ˆâ“`Žqnm23‚̕ω»‚¨‚æ‚Ñ‚»‚Ì”­Œ»‚ÉŠÖ‚·‚鑽Šp“IŒŸõ; AMeX•ï–„‘gD‚Ì—L—p«‚ɂ‚¢‚Ä. ²“¡giŒ`‘ÔŒnjC²“¡—YˆêCŽì‹è—mC”nêG•vCŒK”ö’èmC‹T’J“Oi•a—j: ‘æ83‰ñ“ú–{•a—Šw‰ï‘‰ï i94.04.01j, ‹ž“s, “ú–{•a—Šw‰ï‰ïŽ, 83(1): 330, 1994.

372. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”x‘BŠà‚É‚¨‚¯‚é“]ˆÚ—}§ˆâ“`Žqnm23, Šà—}§ˆâ“`Žqp53‚Ì”­Œ»‚¨‚æ‚ÑDNA ploidy‚Ì‘ŠŠÖ. ì‹v•ÛˆÀ˜NC²“¡—YˆêCŒK”ö’èmC‚—²½C‹T’J“Oi•a—j: ‘æ83‰ñ“ú–{•a—Šw‰ï‘‰ï i94.04.01j, ‹ž“s, “ú–{•a—Šw‰ï‰ïŽ, 83(1): 331, 1994.

373. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{‘ÌŠà‚É‚¨‚¯‚é“]ˆÚ—}§ˆâ“`Žqnm23‚Ì”­Œ»‚ɂ‚¢‚Ä. “n•ÓƒC²“¡—Yˆêi•a—jCì‹v•ÛˆÀ˜NiŠÅŒìŠw•”jC‘ –{”ŽsiŽY•wjCŽì‹è—mi’·è‘åjC‹T’J“Oi•a—j: ‘æ53‰ñ“ú–{ŠàŠw‰ï‘‰ï i94.10.19j, –¼ŒÃ‰®, “ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.326, 1994.

374. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –Ɖuƒuƒƒbƒg–@‚ð—p‚¢‚½ƒqƒg³í‘gD‚É‚¨‚¯‚énm23-H1, H2ƒAƒCƒ\ƒtƒH[ƒ€‚Ì”­Œ»‚ÆŒŸ“¢. ²“¡giŒ`‘ÔŒnjC²“¡—YˆêCŽì‹è—mC”nêG•vC‹T’J“Oi•a—j: ‘æ53‰ñ“ú–{ŠàŠw‰ï‘‰ï i94.10.21j, –¼ŒÃ‰®, “ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.326, 1994.

375. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”x‘BŠà‚É‚¨‚¯‚énm23‚Æp53‚Ì”­Œ»‚¨‚æ‚ÑŠjDNA—Ê‚Ì—\ŒãˆöŽq‚Æ‚ÌŠÖŒW. ì‹v•ÛˆÀ˜NC²“¡—YˆêCŒK”ö’èmC‹T’J“Oi•a—j: ‘æ53‰ñ“ú–{ŠàŠw‰ï‘‰ï i94.10.21j, –¼ŒÃ‰®, “ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.543, 1994.

376. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Expression of bcl-2 gene in all small cell lung carcinomas. Ó¢ˆ®C²“¡—YˆêC‹T’J“Oi•a—j: ‘æ35‰ñ“ú–{”xŠàŠw‰ï‘‰ï i94.11.07j, ’·è, ”xŠà, 34(5): 795, 1994.

377. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j –«‘ŸŠí‰Š‚Æ‚»‚Ì”­Šà: bó‘B‰Š‚ð—á‚Æ‚µ‚Ä. ‰ªˆÀŒMi•a—j: _“ÞìˆãŠw‰ï•ª‰È‰ï¥_“Þ쌧•a—ˆã‰ï‘æ17‰ñ‘‰ï i94.11.25j, ˆÉ¨Œ´, _“Þ쌧ˆãŽt‰ïŽGŽ, 22(1).

378. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j apoptosis‚ÌŠT”O. ‚–ìN—Yi•a—j: •úŽËü‚É‚æ‚駊àƒVƒ“ƒ|ƒWƒEƒ€ i94.06.03j, ·‰ª, —\eW, p.35, 1994.

379. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰º‚‘Ì‘BŽî‚Ì•ª—Þ‚Í‚±‚ê‚Å‚æ‚¢‚©|‰º‚‘Ì‘BŽî‚Ì•ª—Þ‚ÉŠÖ‚·‚éˆê•a—ˆã‚Ì’ñŒ¾. ‹T’J“Oi•a—j: ŠÔ”]‰º‚‘ÌŽîᇌ¤‹†‰ï i95.02.17j, “Œ‹ž, ´˜^W, p.103, 1995.

380. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‰º‚‘ÌŽîᇂÌsilent somatotriph adenomas‚ÌŒ`‘ÔŠw“I“Á’¥; –Ɖu‘gD, “dŒ°‹y‚Ñnon-radioactive in situ hybridization (ISH) ‚É‚æ‚錟“¢. ¬‚•½Ž¡CŒÃŠø–ÎC‘å’JŒõOCŒË’Jd—YC²“¡—Yˆêi•a—jC’ß“c’qŽqiŒ`‘ÔŒnjC‹T’J“Oi•a—j: “ú–{”]Žîᇕa—Œ¤‹†‰ï i94.04.27j, •Ÿˆä, Brain Tumor Pathology, (Suppl.): 54, 1994.

381. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘å’°•\‘wŠg‘åŒ^Žîᇂ̌`‘ÔŒv‘ª. ŒF’J“ñ˜Ni“ŒˆãŽ•‘åjC‰ªˆÀŒMi•a—jC’†‘º‹±ˆêi“ŒˆãŽ•‘åj: ‘æ42‰ñ‘å’°ŠàŒ¤‹†‰ï i95.01.27j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€, p.77.

382. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j –ƉuõF–@‚ÌÅ‹ß‚Ìi•à|‚æ‚è—Ç‚¢–ƉuŽè‹Z‚ÌŠm—§‚ð–ÚŽw‚µ‚Ä|. ŒK”ö’èmi•a—j: ‘æ50‰ñ•a—‹ZpŒ¤‹†‰ï i94.08.07j, “Œ‹ž.

383. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŒŒ´Šw“If’f–@‚ÌŒ»ó. ‹v•ÄŒõi•a—j: ‘æ15‰ñŠÖ“Œˆã^‹Û§˜b‰ï i94.06.25j, “Œ‹ž, ´˜^W, p.9, 1994.

384. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’˜‚µ‚¢—ÖóΊD‰»‘ƒ‚𔺂Á‚½t×–EŠà‚Ì1Žèp—á. ‰Í–씎‹vi•a—j: _“Þì•a—ˆã‰ï—á‰ï i94.09.22j, ‰¡•l.


<<09 ‰q¶ŠwEŒöO‰q¶Šw>>

385. mŒ´’˜n Effects of GaAs and Ga2O3 on magnetometric behavior of iron oxide particles in rabbit lungs. ‘Š‘òDŽ¡C‚“c™¦CŠ¡•”‚ЂƂÝi‰qjC’†‘ºŒ«iˆã—ÎЉïjC¬’J½i“Œ‹ž“d‹@‘åj: Applied Organometallic Chemistry, 8(3): 207`213, 1994.

386. mŒ´’˜n Morbidity rates of complications in persons with spinal cord injury according to the site of injury and with special reference to hypertension. ¡ˆäDC–å˜e•”Žiˆã—Éq¶Šw•”jC‘Š‘òDŽ¡i‰qjC•Ÿ•x˜a•vi‘—§ŒöO‰q¶‰@j: Paraplegia, (32): 246`252, 1994.

387. mŒ´’˜n ì‹ÆŠÖ˜AŽ¾Š³‚ÌŠÇ—. ‘Š‘òDŽ¡i‰qj: ƒXƒgƒŒƒX‰ÈŠw, 9(3): 22`26, 1994.

388. mŒ´’˜n In VitroŽ¥ŠE‘ª’è‚É‚æ‚éŠÉ˜aŒŸ“¢. ¬’J”ŽŽqi‰q¶Šw•”jC‚“c™¦C‘Š‘òDŽ¡CŠ¡•”‚ЂƂÝC‚–ì“Þ“sŽqi‰qjC^‰º‹I”ü‘ãi—\–hˆãŠwŒnj: ƒ}ƒOƒlƒeƒBƒbƒNƒXŒ¤‹†‰ïŽ‘—¿, p.105`108, 1994.

389. mŒ´’˜n In VitroŽ¥ŠE‘ª’è‚É‚æ‚é×–EáŠQ«•]‰¿. ‘Š‘òDŽ¡CŠ¡•”‚ЂƂÝCŽÂŒ´‘i‰qjCˆäã—tŽqC™‰Y—R”üŽqC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjC¬’J½i“Œ‹ž“d‹@‘åj: ƒ}ƒOƒlƒeƒBƒbƒNƒXŒ¤‹†‰ïŽ‘—¿, p.119`126, 1994.

390. mŒ´’˜n Carbon tetrachloride-induced acute liver damage; comparison between rats and mice. Š¡•”‚ЂƂÝC‘Š‘òDŽ¡C‚“c™¦i‰qjC’†‘ºŒ«iˆã—ÎЉïj: “ú–{ЊQˆãŠw‰ï‰ïŽ, 42(12): 928`932, 1994.

391. mŒ´’˜n ‹CŠÇ“à“Š—^Œã‚̃KƒŠƒEƒ€áå‘f‚Ì”rŸ•‚ÉŠÖ‚·‚錤‹†. ’F—mCŠ¡•”‚ЂƂÝC‘Š‘òDŽ¡C‚“c™¦i‰qj: “ú–{ЊQˆãŠw‰ï‰ïŽ, 42(4): 264`269, 1994.

392. m€Œ´’˜n ˜J“­‰q¶ƒRƒ“ƒTƒ‹ƒ^ƒ“ƒg‚É‹‚ß‚ç‚ê‚Ä‚¢‚éE–±‚ÉŠÖ‚·‚élŽ@. ’†‘ºŒ«iˆã—ÎЉïjC‚“c™¦i‰qj: ˆÀ‘S‰q¶ƒRƒ“ƒTƒ‹ƒ^ƒ“ƒg, 15(33): 39`42, 1995.

393. mŒ¤‹†•ñi•¶•”Èjn Ž¥ŠE‘ª’è‚É‚æ‚锼“±‘ÌŠÖ˜A•¨Ž¿‚Ì”x“Å«•]‰¿. ‘Š‘òDŽ¡i‰qjC¬’J½i“Œ‹ž“d‹@‘åjCŠ¡•”‚ЂƂÝi‰qj: •½¬6”N“x‰ÈŠwŒ¤‹†”ï•â•‹àˆê”ÊŒ¤‹†(B)Œ¤‹†¬‰Ê•ñ‘, p.1`57, 1995.

394. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ‚¶‚ñ”x‚Ì”x‹@”\‚ÉŠÖ‚·‚é’²¸•ñ. ¼–{K’jiL“‡“S“¹•a‰@jC‚“c™¦C‘Š‘òDŽ¡i‰qjCŠ£C‘Ri‹ž“sHê•ÛŒ’‰ïjC‰FŠ_Œöîi‰ªŽR˜JЕa‰@jC‘åèé`iŠâŒ©‘ò˜JЕa‰@jC‰Á“¡•Û•viŠò•ŒŽY ‹Æ•ÛŒ’ƒZƒ“ƒ^[jC_•Ó^”ViL‘åjCâ’JŒõ‘¥i‘—§—×{Š‹ß‹E’†‰›•a‰@jC“‡³Œái“¡“c•ÛŒ’‰q¶‘åjC¼–{K’jiL“‡“S“¹•a‰@jC“~–ØrtiŒ]”x˜JЕa ‰@jCŒË“cOˆêi_“Þ쌧—\–hˆãŠw‹¦‰ïjC•y“c’B•vi¼“ú–{ŽY‹Æ‰q¶‰ïj: ‚¶‚ñ”x‚Ì”x‹@”\‚ÉŠÖ‚·‚é’²¸•ñ‘-’†ŠÔ•ñ-, p.1`17, 1994.

395. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn •Â½Œ^ƒhƒ‰ƒCƒNƒŠ[ƒjƒ“ƒO‹@‚É‚æ‚éƒeƒgƒ‰ƒNƒƒƒGƒ`ƒŒƒ“Žc—¯—Ê‚ÌŒŸ“¢. ‚“c™¦C‘Š‘òDŽ¡CŠ¡•”‚ЂƂÝi‰qjCˆäã—tŽqi—\–hˆãŠwŒnjC–å˜e•”ŽC¡ˆäDC•Ð‹Ë—TŽjiˆã—Éq¶Šw•”jC’†‘ºŒ«iˆã—ÎЉïj: •½¬5”N“xƒNƒŠ[ƒjƒ“ƒO‚ÆŒöO‰q¶‚ÉŠÖ‚·‚錤‹†•ñ‘, p.5`12, 1994.

396. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ŒzŒ¨˜rÇŒóŒQ“™—\–h‘ÎôŒŸ“¢. •Ÿ“n–õi‡“V“°‘åjC’†‘ºŒ«iˆã—ÎЉïjCˆÀ•”Œ’i“úŽYŽ©“®ŽÔjC‘匴Œ[Žui‚’mˆã‘åjCŽðˆäˆê”Ži˜J“­‰ÈŠwŒ¤‹†ŠjC’¬“c³•¶i“ú‘åj: •½¬5”N“xŒzŒ¨˜rÇŒóŒQ“™—\–h‘ÎôŒŸ“¢ˆÏˆõ‰ï•ñ‘, p.1`54, 1994.

397. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ˜’É‚Ì—\–h‘Îô‚ÉŠÖ‚·‚é’²¸Œ¤‹†. ŽR–{@•½iŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC‘Š‘òDŽ¡i‰qjC’†‘ºŒ«iˆã—ÎЉïjCŽs‰‰p”ViŽs‰®Œ`ŠO‰È•a‰@jC‘åˆäi—YiŽ©Ž¡ˆã‘åjC¬“c“oi“úŽYŽ©“®ŽÔjC”’ ˆäN³i“ú–{ˆã‰È‘åjC“¿‰i—Í—YiŠÖ¼ˆã‰È‘åjC–{‘½ƒ’ji˜J“­•ŸŽƒŽ–‹Æ’cjC–å”n•qi‘O“cŒšÝH‹ÆjC”ªã‹Žii“Œ‹žŠÈˆÕ•ÛŒ¯‰ïŠÙŒŸfƒZƒ“ƒ^[jC‹v•Û “cCC“c’†KŽ¡CŒÃì—S“ñi˜J“­ÈjC–Ñ—˜“N•vCÄ“¡G–íC쑺ŽO˜Yi’†‰›˜J“­ÐŠQ–hŽ~‹¦‰ïj: •½¬5”N“x˜’É‚Ì—\–h‘Îô‚ÉŠÖ‚·‚é’²¸Œ¤‹†ˆÏˆõ‰ï•ñ‘, p.1`150, 1994.

398. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ¬l•a—\–hŒ’f–¢ŽófŽÒ‚ÌŒ’N¶Šˆ’²¸‚ÉŠÖ‚·‚é’PƒWŒv‚ÌŒ‹‰Ê. ‚“c™¦i‰qjC’†‘ºŒ«iˆã—ÎЉïj: •½¬5”N“x­•{ŠÇ¶Œ’N•ÛŒ¯Ž–‹Æ‚ÌŒø—¦‰»‚ÉŠÖ‚·‚é’²¸Œ¤‹†; •ÛŒ’¥•ŸŽƒŽ{Ý‚ÌŠˆ—p‚ÉŠÖ‚·‚é’²¸, p.7`20, 1994.

399. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ”÷¬ƒAƒXƒxƒXƒg‚Ì‹z“ü‚É‚æ‚鶑̉e‹¿’²¸•ñ. —`dŽ¡i’†‰›˜J“­ÐŠQ–hŽ~‹¦‰ïjC‚“c™¦C‘Š‘òDŽ¡i‰qjC‰|–{^i’†Ð–h“ú–{ƒoƒCƒIƒAƒbƒZƒCŒ¤‹†ƒZƒ“ƒ^[jC_ŽRé•Fi˜J“­ÈjC¬¼iliƒwƒ‹ƒXjC ’J‘¾”ü—YiŽÄ“c‰ÈŠwŠíŠBH‹ÆjC–ìè˜j‰Ei’†Ð–h“ú–{ƒoƒCƒIƒAƒbƒZƒCŒ¤‹†ƒZƒ“ƒ^[j: •½¬5”N“x”÷¬ƒAƒXƒxƒXƒg‚Ì‹z“ü‚É‚æ‚鶑̉e‹¿’²¸•ñ‘, p.1`33, 1994.

400. m‘àn Œ’N‚Ì—\‘ª. ‘Š‘òDŽ¡i‰qj: KAST Report, 6(2): 20`23, 1994.

401. m‘àn ŽY‹Æ•ÛŒ’‚ƖƉuŠw’†“Å. ‘Š‘òDŽ¡i‰qj: ŽY‹ÆˆãŠwƒŒƒrƒ…[, 7(1): 44`57, 1994.

402. m‹³‰È‘n i‹¤’˜j ˜’É‚ð–h‚²‚¤uEê‚É‚¨‚¯‚阒ɗ\–h‘ÎôŽwjv‚̃|ƒCƒ“ƒg; ‘Š‘òDŽ¡i‰qjCŽR–{@•½iŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjCŽs‰‰p”ViŽs‰®Œ`ŠO‰È•a‰@jC‘åˆäi—YiŽ©Ž¡ˆã‘åjC¬“c“oi“úŽYjC”’ˆäN³i“úˆã‘åjC“¿‰i—Í—Y iŠÖ¼ˆã‘åjC–{‘½ƒ’jiŒÎŽR•a‰@jC–å”n•qi‘O“cŒšÝH‹ÆjC”ªã‹Žii“Œ‹žŠÈˆÕ•ÛŒ¯‰ïŠÙj. •ÒW ˜J“­È, ’†‰›˜J“­ÐŠQ–hŽ~‹¦‰ïC“Œ‹žC95.01.05”­s.

403. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj V—Õ°“à‰ÈŠwƒRƒ“ƒpƒNƒg”Å; ˜A½‹…‹ÛŠ´õÇ, p.438`439, ‘Š‘òDŽ¡i‰qj. •ÒW ˜a“cUi“Œ‘åjC‹´–{M–çiŽœŒbˆã‘åj, ˆãŠw‘‰@C“Œ‹žC94.06.15”­s.

404. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj VX”ÅŽY‹Æˆã‚ÌE–± Q & A; Ž––±Eê‚̉q¶ŠÇ—, p.422`436, ‘Š‘òDŽ¡i‰qj. •ÒW ‚“c™¦i‰qjCÎì‚–¾i“ú–{ˆãŽt‰ïjC–„’‰—mˆêiŽO˜a‹âsjC—`dŽ¡i’†‰›˜J“­ÐŠQ–hŽ~‹¦‰ïjC‘‘ŽižÄ“¿i•xŽmƒ[ƒƒbƒNƒXjC“c’†Šì‘ãŽji˜J“­ÈjC¼ Œ´“NŽOi‹Êì•a‰@jC–ìè’å•Fi“ú‘åjCaŒû‰Ã³iŽY‹ÆˆãŠwU‹»à’cj, ŽY‹ÆˆãŠwU‹»à’cC“Œ‹žC94.06.00”­s.

405. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Œ»‘ã˜J“­‰q¶ƒnƒ“ƒhƒuƒbƒN‘•â‰ü’ù‘æ‚Q”Å; ƒ}ƒCƒNƒƒGƒŒƒNƒgƒƒjƒNƒX»‘¢H’ö‚É‚¨‚¯‚é˜J“­‰q¶ã‚Ì”–â‘è, p.382`385, ‘Š‘òDŽ¡i‰qj. •ÒW ŽO‰Y–L•Fi˜J“­‰ÈŠwŒ¤‹†Šj, ˜J“­‰ÈŠwŒ¤‹†ŠC_“ÞìC94.11.15”­s.

406. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆˆãŠˆ“®ƒ}ƒjƒ…ƒAƒ‹‘æ‚Q”Å; ì‹ÆŠÖ˜AŽ¾Š³, p.234`235, ‘Š‘òDŽ¡i‰qj. ˆãŠw‘‰@C“Œ‹žC95.02.01”­s.

407. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆˆãŠˆ“®ƒ}ƒjƒ…ƒAƒ‹‘æ‚Q”Å; ƒg[ƒ^ƒ‹¥ƒwƒ‹ƒX¥ƒvƒƒ‚[ƒVƒ‡ƒ“(THP), p.374`376, ‚“c™¦i‰qj. ˆãŠw‘‰@C“Œ‹žC95.02.01”­s.

408. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆˆãŠˆ“®ƒ}ƒjƒ…ƒAƒ‹‘æ‚Q”Å; Šé‹Æ“àŒ’N•ÛŽ‘i‘̧, p.377`381, ’†‘ºŒ«iˆã—ÎЉïj. ˆãŠw‘‰@C“Œ‹žC95.02.01”­s.

409. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ŽY‹ÆˆãŠˆ“®ƒ}ƒjƒ…ƒAƒ‹‘æ‚Q”Å; ŽY‹Æ•ÛŒ’î•ñ‚ƘA—æ, p.446`460, ‚“c™¦i‰qj. ˆãŠw‘‰@C“Œ‹žC95.02.01”­s.

410. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œ¢‚É‚¨‚¯‚é–h…ƒXƒvƒŒ[‚É‚æ‚é‹}«ŠÌáŠQ‚Ì•a—‘gDŠw“IŒŸ“¢. Š¡•”‚ЂƂÝC‚“c™¦C‘Š‘òDŽ¡i‰qjC™‰Y—R”üŽqC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjC•Ð‹Ë—TŽjC–å˜e•”Žiˆã—Éq¶Šw•”jC‘Š”nˆêˆåC–ؑ¥–¾i‹~–½jC’†‘ºŒ« iˆã—ÎЉïj: ‘æ64‰ñ“ú–{‰q¶Šw‰ï i94.04.07j, ‹à‘ò, “ú–{‰q¶ŠwŽGŽ, 49: 158, 1994.

411. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž¥ŠE‘ª’è‚É‚æ‚é”x–Eƒ}ƒNƒƒtƒ@[ƒWáŠQ•]‰¿. ‘Š‘òDŽ¡C‚“c™¦CŠ¡•”‚ЂƂÝC‚–ì“Þ“sŽqi‰qjC™‰Y—R”üŽqC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjC¬’J½i“Œ‹ž“d‹@‘åjC–å˜e•”ŽC¡ˆäDC•Ð‹Ë—TŽjiˆã—Éq ¶Šw•”j: ‘æ64‰ñ“ú–{‰q¶Šw‰ï i94.04.07j, ‹à‘ò, “ú–{‰q¶ŠwŽGŽ, 49: 262, 1994.

412. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ý‘îˆã—ÂɌ©‚鎾Š³‚Æ“úí¶ŠˆŽ©—§“x. ‹ß“¡‚¦‚èC¼–{‹žŽqC‚–ì“Þ“sŽqCˆÀˆä¬‘ãŽqCâ–{–õC‚‹´‰p®Cˆê™³Ž¡i‰qjC–î“ߣM—Yi“àjC—é–Ø_ˆêiŠÖ“Œ˜JЕa‰@j: ‘æ53‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï i94.10.14j, ’¹Žæ, “ú–{ŒöO‰q¶ŽGŽ, 41(10): 518, 1994.

413. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˜VlŒ’fŽófŽÒ‚Ì’ÇÕ’²¸|“Á‚ÉzŠÂŒn‚ɂ‚¢‚Ä|. ‚–ì“Þ“sŽqC¼–{‹žŽqC‹ß“¡‚¦‚èCˆÀˆä¬‘ãŽqCâ–{–õC‚‹´‰p®Cˆê™³Ž¡i‰q¶jC—é–Ø_ˆêiŠÖ“Œ˜JЕa‰@jC–î“ߣM—Yi“àj: ‘æ53‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï i94.10.14j, ’¹Žæ, “ú–{ŒöO‰q¶ŽGŽ, 41(10): 572, 1994.

414. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Eê‚É‚¨‚¯‚郃“ƒ^ƒ‹ƒwƒ‹ƒX‚̑Ήž‚ÉŠÖ‚·‚錟“¢. ’†‘ºŒ«iˆã—ÎЉïjC‘Š‘òDŽ¡CŠ¡•”‚ЂƂÝC‚“c™¦i‰qj: ‘æ10‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï i94.11.02j, “Œ‹ž, ƒXƒgƒŒƒX‰ÈŠw, 9(2): 103, 1994.

415. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆê‰ß‘a’nˆæ‚É‚¨‚¯‚鎀ˆö\‘¢‚Ì•Ï‘J|“Á‚É”]ŒŒŠÇŽ¾Š³‚ɂ‚¢‚Ä|. ¼–{‹žŽqC‚–ì“Þ“sŽqC‹ß“¡‚¦‚èC‚‹´‰p®Cˆê™³Ž¡i‰q¶jC—é–Ø_ˆêiŠÖ“Œ˜JЕa‰@j: ‘æ59‰ñ“ú–{–¯‘°‰q¶Šw‰ï‘‰ï i94.11.11j, ‹à‘ò, –¯‘°‰q¶, 60(•t˜^): 96`97, 1994.

416. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒg‚É‚¨‚¯‚éŽl‰–‰»’Y‘fŽä‹N«–«ŠÌáŠQ‚ɑ΂·‚édibutyryl adenosine 3',5'-monophosphate‚Ì—}§ì—p. Š¡•”‚ЂƂÝC‘Š‘òDŽ¡i‰qjC’†‘ºŒ«iˆã—ÎЉïjC‚“c™¦i‰qjC–å˜e•”Žiˆã—Éq¶Šw•”j: ‘æ42‰ñ“ú–{ЊQˆãŠw‰ï i94.11.18j, ‹à‘ò, “ú–{ЊQˆãŠw‰ï‰ïŽ, 42(—Õ‘): 66, 1994.

417. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠO«Ò‘‘¹ŽÒ‚̜늳Ž¾•a‚Ìc’f“IŒ¤‹†. –å˜e•”ŽC¡ˆäDC•Ð‹Ë—TŽjiˆã—Éq¶Šw•”jCŠ¡•”‚ЂƂÝC‘Š‘òDŽ¡i‰qj: ‘æ42‰ñ“ú–{ЊQˆãŠw‰ï i94.11.18j, ‹à‘ò, “ú–{ЊQˆãŠw‰ï‰ïŽ, 42(—Õ‘): 68, 1994.

418. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ×–EŽ¥ŠE‘ª’è‚ð—p‚¢‚½”¼“±‘ÌÞ—¿•¨Ž¿‚Ì×–EáŠQ•]‰¿‚ɂ‚¢‚Ä. Š¡•”‚ЂƂÝC‘Š‘òDŽ¡CŽÂŒ´‘CŒv—Ç“OC‚“c™¦i‰qjC™‰Y—R”üŽqC^‰º‹I”ü‘ãi—\–hˆãŠwŒnj: ‘æ65‰ñ“ú–{‰q¶Šw‰ï i95.03.30j, –¼ŒÃ‰®, “ú–{‰q¶ŠwŽGŽ, 50(1): 228, 1995.

419. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒg‚Ö‚Ì–h…ƒXƒvƒŒ[–\˜I‚É‚æ‚é—L‹@—nÜ‚Ì‘Ì“à•ª•z. •Ð‹Ë—TŽjC¡ˆäDC–å˜e•”Žiˆã—Éq¶jCˆäã—tŽqi—\–hˆãŠwŒnjC‘Š‘òDŽ¡i‰qjC’†‘ºŒ«iˆã—ÎЉïj: ‘æ65‰ñ“ú–{‰q¶Šw‰ï i95.03.30j, –¼ŒÃ‰®, “ú–{‰q¶ŠwŽGŽ, 50(1): 283, 1995.

420. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j In VitroŽ¥ŠE‘ª’è‚É‚æ‚éŠÉ˜aŒŸ“¢. ¬’J”ŽŽqi‰q¶Šw•”jC‚“c™¦C‘Š‘òDŽ¡CŠ¡•”‚ЂƂÝC‚–ì“Þ“sŽqi‰qjC^‰º‹I”ü‘ãi—\–hˆãŠwŒnj: ƒ}ƒOƒlƒeƒBƒbƒNƒXŒ¤‹†‰ï i94.03.10j, •Ÿ‰ª.

421. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Eê‚É‚¨‚¯‚éTHP‚ƃXƒgƒŒƒXŠÇ—. ’†‘ºŒ«iˆã—ÎЉïj: Informal MeetinguƒXƒgƒŒƒX‚ÆŒ’N|Œ»ó‚Æ“W–]|v i94.11.03j, “Œ‹ž.

422. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j In VitroŽ¥ŠE‘ª’è‚É‚æ‚é×–EáŠQ«•]‰¿. ‘Š‘òDŽ¡CŠ¡•”‚ЂƂÝCŽÂŒ´‘i‰qjCˆäã—tŽqC™‰Y—R”üŽqC^‰º‹I”ü‘ãi—\–hˆãŠwŒnjC¬’J½i“Œ‹ž“d‹@‘åj: ƒ}ƒOƒlƒeƒBƒbƒNƒXŒ¤‹†‰ï i94.11.11j, “Œ‹ž.

423. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Ž¥ŠE‘ª’è‚É‚æ‚鉻Šw•¨Ž¿‚Ì×–EáŠQ«•]‰¿. ‘Š‘òDŽ¡CŠ¡•”‚ЂƂÝCŽÂŒ´‘CŒv—Ç“Oi‰qjC^‰º‹I”ü‘ãi—\–hˆãŠwŒnj: AKPSŒ¤‹†W‰ïu¶•¨ŠÂ‹«‚ƃoƒCƒIƒnƒU[ƒhŒ¤‹†”Çv i95.01.14j, “Œ‹ž.

424. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j —LŠQ•¨¥—LŠQ‹Æ–±‚Ɖq¶ŠÇ—|E‹Æ«Ž¾•a‚ð‚È‚­‚·‚½‚ß‚É|. ‘Š‘òDŽ¡i‰qj: ‘S‘˜J“­‰q¶TŠÔ‘Š–ÍŒ´¥’Ëvˆä’n‹æ„i‘å‰ï i94.09.06j, ‘Š–ÍŒ´.

425. mŠwpÜi‘“àjn ’†‰›˜J“­ÐŠQ–hŽ~‹¦‰ï; —Î\ŽšÜ, ’†‘ºŒ«iˆã—ÎЉïj.


<<10 –@ˆãŠw>>

426. mŒ´’˜n Quantitation of nucleotides, nucleosides and bases in antemortem and postmortem bloodstains by high-performance liquid chromatography. ™]G–¾i–@ˆãjC¼ì—²i—Õ•a—jC‘D”ö’‰Fi–@ˆãj: Forensic Sci. Int., 71: 123`130, 1995.

427. mŒ´’˜n “Ý“IŠO—Í‚É‚æ‚é’°ŠÔ–Œ‚Ì’P“Æ‘¹|‚Æ‚­‚É‚»‚ÌŒ`¬‹@˜‚ÉŠÖ‚·‚錟“¢|. Ä“¡ˆê”VC‚“cˆ»C‘ºˆä’BÆC‘ºˆä’¼Žqié‹Êˆã‘åjC•“c’¼liŒc‘åjCŒIŒ´Ž—Ri–@ˆãjCMŽR^liŽD–yˆã‘åjCŒ´³ºC–î•”ŸOié‹Êˆã‘åjC–ö“cƒ ˆêiŒc‘åjC“n•Ó”ŽŽiié‹Êˆã‘åj: –@ˆãŠw‚ÌŽÀÛ‚ÆŒ¤‹†, 37(6): 373`380, 1994.

428. mŒ¤‹†•ñi•¶•”Èjn ŽOŽŸŒ³‰æ‘œ‰ðÍ‚É‚æ‚é”]Ž€—á‚̬”]è÷—±‘w•ö‰ó‚ÉŠÖ‚·‚é‘gDŒv—Ê“IŒ¤‹†. ŒÃì—FCŒIŒ´Ž—RC‘D”ö’‰Fi–@ˆãj: •½¬6”N“x‰ÈŠwŒ¤‹†”ï•â•‹à(ˆê”ÊŒ¤‹†‚b)Œ¤‹†¬‰Ê•ñ‘.

429. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Studies on examples of drowning with fresh water inhalation|cerebral blood flow and blood electrolyte levels|. ‘òŒû²Žqi“Œ—ˆã‘åjC¬’J~ˆêi–@ˆãjC’†“cLŽqC‘òŒû‘Žqi“Œ—ˆã‘åj: 16th Congress of the International Academy of Legal Medicine and Social Medicine i94.05.31`06.02j, Strasbourg, France, Programme, p.234, 1994.

430. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ÉŽq‘̉t, ‘‰t, S‚Ì‚¤‰t‚̃qƒ|ƒLƒTƒ“ƒ`ƒ“”Z“x‚É‚æ‚鎀ŒãŒo‰ßŽžŠÔ„’è‚ÉŠÖ‚·‚錤‹†. ™]G–¾CŒIŒ´•¶’jC‘D”ö’‰Fi–@ˆãj: ‘æ78ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï i94.05.11`13j, ‘O‹´, “ú–{–@ˆãŠwŽGŽ, 48(•âû): 72, 1994.

431. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j HPTLC‚É‚æ‚é‰ð”M’Á’ÉÁ‰ŠÜ‚Ì•ªÍ(‘æ‚Q•ñ). ŽÂ’Ë’B—YC•ˆäߎqC•“c’¼liŒc‘åjCŒIŒ´Ž—Ri–@ˆãjC–ö“cƒˆêiŒc‘åj: ‘æ78ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï i94.05.12j, ‘O‹´, “ú–{–@ˆãŠwŽGŽ, 48(•âû): 68, 1994.

432. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”]ŒŒ—¬“®‘Ô‚©‚ç‚Ý‚½’‚‘§Ž€‚ÌÄŒŸ“¢(‡\)|“MŽ€Œo‰ßŽžŠÔ‰„’·ƒ‚ƒfƒ‹(’W…“MŽ€—á)‚ɂ‚¢‚Ä. ¬’J~ˆêi–@ˆãjC‘òŒû²Žqi“Œ—ˆã‘åjC‘D”ö’‰Fi–@ˆãjC’†ŽR–ÎMiŽÀ“®ŒnjC‘òŒû‘ŽqC’†“cLŽqC‰zàVˆŸ]Žqi“Œ—ˆã‘åj: ‘æ78ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï i94.05.13j, ‘O‹´, “ú–{–@ˆãŠwŽGŽ, 48(•âû): 208, 1994.

433. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŽOŽŸŒ³‰æ‘œ‰ðÍ‚É‚æ‚é”]Ž€—á‚̬”]‚ÉŠÖ‚·‚é‘gDŒv—Ê“IŒ¤‹†. ŒÃì—FC‘D”ö’‰Fi–@ˆãj: ‘æ78ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï i94.05.13j, ‘O‹´, “ú–{–@ˆãŠwŽGŽ, 48(•âû): 213, 1994.

434. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ãoŒzŒã‚É‘Œz“®–¬ŒŒðǂ𶂶‚½1–UŒŸ—á. ŒIŒ´Ž—Ri–@ˆãjC‘ºˆä’BÆié‹Êˆã‘åjC•“c’¼liŒc‘åjCÄ“¡ˆê”Vié‹Êˆã‘åjCŽÂ’Ë’B—YiŒc‘åjC¼”ö‹`—TC–Ø‘ºšæŽqié‹Êˆã‘åjC–ö“cƒˆêiŒc ‘åj: ‘æ78ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï i94.05.13j, ‘O‹´, “ú–{–@ˆãŠwŽGŽ, 48(•âû): 268, 1994.

435. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒCƒ‰ƒXƒg‚É‚æ‚éŠw¶‚ÌŽ©ŒÈ•\Œ»‚ÌŠJ”­(‡U)’†‘ˆãŠw¶‚Æ“ú–{ˆãŠw¶‚Ì”äŠr. –ö“cƒˆêiŒc‘åjCŽx‘qˆíliˆãŽ•‘åjC‘òŒû²Žqi“Œ—ˆã‘åjCŒIŒ´Ž—Ri–@ˆãjCŽÂ’Ë’B—YC•“c’¼liŒc‘åj: ‘æ78ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï i94.05.13j, ‘O‹´, “ú–{–@ˆãŠwŽGŽ, 48(•âû): 276, 1994.

436. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’‚‘§Ž€‚ÌÄŒŸ“¢|ŽÀŒ±“I‹}«“MŽ€‚ɂ‚¢‚Ä|. ¬’J~ˆêCŒIŒ´Ž—RCŒÃì—FC™]G–¾i–@ˆãjC’†ŽR–ÎMiŽÀ“®Œnj: ‘æ63‰ñ“ú–{–@ˆãŠw‰ïŠÖ“Œ’n•û‰ï i94.10.01j, “Œ‹ž, “ú–{–@ˆãŠwŽGŽ, 49(1): 62, 1995.


<<11 Šñ¶’ŽŠw>>

437. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Actividad tripanocida vegetal (Fase‡U, 1994). A. CaceresCM.B. LopeziƒOƒ@ƒeƒ}ƒ‰‘—§ƒTƒ“ƒJƒ‹ƒƒX‘åjC–qƒiŠñjCT. Yanagii’·è‘åj: Informe Final Proyecto Enfermedad de Chagas: Un Enfoque integral, p.1`17, 1994.

438. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Surveys and preparation for the research on the effects of plant-derived drugs on filariasis in Kenya. –qƒiŠñj: JICA Report on the Project of Research for the Control of Tropical Diseases in Kenya, p.1`6, 1994.

439. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Fundamental studies for the development of chemotherapy of Chagas disease with extracts from medicinal plants in Guatemala. –qƒiŠñjCA. CaceresCM.B. LopezCS. GonzaleziƒOƒ@ƒeƒ}ƒ‰¥ƒTƒ“ƒJƒ‹ƒƒX‘åj: La Mision Japonesa Informe, p.1`15, 1995.

440. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ƒoƒ“ƒNƒƒtƒgŽ…ó’ŽÇŽ¡—Âɂ¨‚¯‚éƒPƒjƒAŽY–ò—pA•¨—˜—p‚ÉŠÖ‚·‚éŠî‘b’²¸. –qƒiŠñj: ‘Û‹¦—ÍŽ–‹Æ’c‘‡•ñ‘, p.1`11, 1994.

441. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ƒOƒ@ƒeƒ}ƒ‰ŽY–ò—pA•¨‚Ì’Šo•¨‚É‚æ‚éƒVƒƒ[ƒKƒX•aŽ¡—ÂɊւ·‚éŠî‘b“IŒ¤‹†. –qƒiŠñj: ‘Û‹¦—ÍŽ–‹Æ’c•ñ‘, p.1`10, 1994.

442. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Second Progress ReportgWhat a Guatemalan-Japanese dream ish. –qƒiŠñjCA. CaceresiƒOƒ@ƒeƒ}ƒ‰‘—§ƒTƒ“ƒJƒ‹ƒƒX‘åj: ‘Û‹¦—ÍŽ–‹Æ’c•ñ‘, p.1`14, 1993.

443. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ð’Ž‚Ì‹ØŽûk’²ß‹@\: ƒ}ƒ“ƒ\ƒ“—ô“ªð’Žƒ~ƒIƒVƒ“‚a‚ÌCa2+’²ß—lŽ®. ’†‘ºŒ’‚`iŠñjC•–¾Žqi—\–hˆãŠwŒnjCŽRŒû³Oi‡‘åj: ‘æ63‰ñ“ú–{Šñ¶’ŽŠw‰ï i94.04.08j, H“c, Šñ¶’ŽŠwŽGŽ, 43(Suppl.): 94, 1994.

444. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒlƒYƒ~•Ú’ŽŠ´õƒ}ƒEƒX‚É‚¨‚¯‚éR‘ÌŽY¶‚̧Œä. ¬ŽR_ˆêCŽOã–[ŽqiŠñjC‹Ê“àGˆêi”÷jCˆÉ“¡—mˆêiŠñj: ‘æ63‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï i94.04.08j, H“c, Šñ¶’ŽŠwŽGŽ, 43(Suppl.): 96, 1994.

445. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒPƒjƒA‚ɉ—‚¯‚é–ò—pA•¨’Šo•¨‚̃oƒ“ƒNƒƒtƒgŽ…ó’ŽÇŽ¡—ÂɊւ·‚錤‹†. –qƒCˆÉ“¡—mˆêiŠñjCKofi-Tsekpo, W.M.iƒPƒjƒA’†‰›ˆãŒ¤jCÔˆäŒ_ˆê˜YiJICAjC“¡ŠªN‹³CŽOˆä‹`‘¥C–؎ŒÈi’·è‘åj: ‘æ36‰ñ“ú–{”M‘шãŠw‰ï‘‰ï i94.12.01j, Ž­Ž™“‡, ´˜^W, 22(‘): 109, 1994.

446. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Guatemala‚É‚¨‚¯‚é—Lçê”X’ŽÇ‚ÌŒŸ“¢. ŽsìG—²CÔ”öM–¾CL. CastilloCE. VelasquezCˆÉ“¡—mˆêiŠñjC•ûˆêŠìC‘½“cŒ÷C‹ß“¡—͌܎Š: ‘æ36‰ñ“ú–{”M‘шãŠw‰ï i94.12.01j, Ž­Ž™“‡, “ú–{”M‘шãŠw‰ïŽGŽ, 22(‘): 95, 1994.

447. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒOƒ@ƒeƒ}ƒ‰‚ɉ—‚¯‚é“`³–ò—pA•¨’Šo•¨‚̃Nƒ‹[ƒY¥ƒgƒŠƒpƒmƒ][ƒ}‚ɑ΂·‚éin vitro‚ÌŒø‰Ê. –qƒCˆÉ“¡—mˆêiŠñjC‘½“cŒ÷i‹ã‘åjC•ûˆêŠìiJICAjCN. GarciaCA. CaceresiƒOƒ@ƒeƒ}ƒ‰¥ƒTƒ“ƒJƒ‹ƒƒX‘åj: ‘æ36‰ñ“ú–{”M‘шãŠw‰ï‘‰ï i94.12.02j, Ž­Ž™“‡, ´˜^W, 22(‘): 129, 1994.

448. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j An approach to studies on effects of extracts from medicinal plants in Guatemala against Trypanosoma cruzi. A. CaceresCV. MattaCM. Eugenia ParedesCC. MonroyCN. GarciaCA.L. YapuriƒOƒ@ƒeƒ}ƒ‰¥ƒTƒ“ƒJƒ‹ƒƒX‘åjC–qƒCˆÉ“¡—mˆêiŠñjC‘½“cŒ÷i‹ã‘åjC•ûˆêŠìiJICAj: ‘æ54‰ñ“ú–{Šñ¶’ŽŠw‰ï“Œ“ú–{‘å‰ï i94.10.01j, “Œ‹ž, ´˜^W, p.33, 1994.

449. mŒ¤‹†‰ïi‘S‘jn ih‘è•ñj ƒZƒ“ƒgƒ‰ƒ‹ƒAƒƒŠƒJ‚ÅŽY‚·‚é–ò‘‚̬•ª‚̃AƒƒŠƒJƒgƒŠƒpƒmƒ\[ƒ}ǂɑ΂·‚鎡—ÃŒø‰Ê‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†. –qƒiŠñj: ‘Û‹¦—ÍŽ–‹Æ’cŒ¤‹†“¢˜_‰ï i94.06.20j, “Œ‹ž.

450. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Šñ¶å¾’Ž‚ÌhŽåN“ü‹@˜‚ÉŠÖ‚·‚éˆêlŽ@. –qƒCˆÉ“¡—mˆêC’†‘ºŒ’‚`C¬ŽR_ˆêiŠñj: ’·è‘åŠw”M‘шãŠwŒ¤‹†ŠŒ¤‹†W‰ïuŠñ¶å¾’Ž‚ÌhŽåN“ü‹@˜v i94.12.27j, ’·è.


<<12 ŽÀŒ±“®•¨Šw>>

451. mŒ´’˜n Effects of bromocriptine (CB-154) treatment on copulatory behavior in hyperprolactinemic adult male rats. Tohei, A.CSaito, T.R.i“ú–{bˆã’{ŽY‘åjCHokao, R.i“®•¨”ÉBŒ¤‹†ŠjCŒÃŠÚêˆêiŽÀ“®jCTakahashi, K.W.: Exp. Anim., 43(3): 427`431, 1994.

452. mŒ´’˜n Induction of ovulation by endothelin-3 in rats. ŒÃŠÚêˆêiŽÀ“®jC^è‹`•FiŽÀ“®ŒnjC•“¡Œ’iŽÀ“®j: J. Endocrinol., 141: 109`112, 1994.

453. mŒ´’˜n Amino acid-induced responses in CNS neurones of normal mouse and Wriggle Magami. Furukawa, K.CAbe, Y.i“Œ–k‘åjC‘å‘òLFi”÷jCOhmura, M.i‘呺ŽÀŒ±“®•¨Œ¤jCAkaike, N.i‹ã‘åj: Neuroreport, 5: 1530`1532, 1994.

454. m’Z•ñ¥‘¬•ñn ƒlƒRŒÂ•ÊŽ”ˆçƒP[ƒW‚ÌŽŽˆÄ. ”¯N—YiŽÀ“®jC‹yì^liƒgƒLƒ‰ÈŠwŠíŠBj: ŽÀŒ±“®•¨‹Zp, 29(2): 145`147, 1994.

455. mŒ¤‹†•ñi•¶•”Èjn ˆâ“`«˜ËŽòǃ‰ƒbƒg(rdw)‚ÌŽ¾Š³ƒ‚ƒfƒ‹“®•¨‚Æ‚µ‚Ä‚Ì—L—p«‚Æ‚»‚Ì•aˆö‰ðÍ. ŒÃŠÚêˆêiŽÀ“®jC¬–ì‰ë•vi•ª¶jC‘åŽR‹XGiŽ™jC•“¡Œ’iŽÀ“®j: •¶•”ȉȊwŒ¤‹†”ï•â•‹àiˆê”Ê‚bjŒ¤‹†¬‰Ê•ñ‘, p.1`26, 1994.

456. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j ŽÀŒ±“®•¨Š´õ•a‚Ì•a—Šw(‚»‚Ì‚P)ŒÄ‹zŠíŒn. •“¡Œ’iŽÀ“®j: ‘æ119‰ñ“ú–{bˆãŠw‰ï i95.03.31j, “Œ‹ž, —vŽ|W, p.249, 1995.

457. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆâ“`«˜ËŽòǃ‰ƒbƒgrdw‚Ìbó‘BŒ´ˆöà. ŒÃŠÚêˆêiŽÀ“®jC¬–ì‰ë•vi•ª¶jC‹g“cCiŽÀ“®ŒnjC—é–Ø‘”üC–¼ŽæP•viSRLjC•“¡Œ’iŽÀ“®j: ‘æ118‰ñ“ú–{bˆãŠw‰ï i94.09.06j, \˜a“c, —vŽ|W, p.116.

458. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆâ“`«˜ËŽòǃ‰ƒbƒgrdw‚Ì•aˆö‚Íbó‘B‚É‘¶Ý‚·‚é‚©H. ŒÃŠÚêˆêiŽÀ“®jC‹g“cCC’†ŽOì’qŒbŽqC㑺”ü²ŽqiŽÀ“®ŒnjC•“¡Œ’iŽÀ“®j: ‘æ41‰ñ“ú–{ŽÀŒ±“®•¨Šw‰ï i94.05.25j, ‚‚­‚Î, —vŽ|W, p.171, 1994.

459. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‚ƒ‹ƒ‚ƒbƒg‚É‹y‚Ú‚·—A‘—‚¨‚æ‚ÑŽ”ˆçŠÂ‹«•Ï‰»‚̉e‹¿‚ɂ‚¢‚Ä. •“¡Œ’iŽÀ“®jC‹g“cCiŽÀ“®ŒnjC‹g‰ª—˜•vCΈ䌒ŽŸ˜YCŽR“c•Û—˜C¬ì•q—Yi—\Œ¤j: ‘æ41‰ñ“ú–{ŽÀŒ±“®•¨Šw‰ï i94.05.27j, ’}”g, —vŽ|W, p.175, 1994.

460. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆâ“`«˜ËŽòǃ‰ƒbƒgrdw‚̸‘ƒd—Ê‚Ì‘‰Á‚ɂ‚¢‚Ä. ŒÃŠÚêˆêiŽÀ“®jCŽðˆäNOi‰ðjC–¼ŽæP•viSRLjC•“¡Œ’iŽÀ“®j: ‘æ86‰ñ‰Æ’{”ÉBŠw‰ï i94.09.09j, \˜a“c, —vŽ|W, p.97.

461. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰Æ“e‚ð—p‚¢‚½”ñŠJ‹¹“Iƒr[ƒY•ÂÇÄŠÁ—¬–@‚ÌŽŽ‚Ý. ”¯N—YiŽÀ“®jC’†ŽR–ÎMC˜kì_ŽiiŽÀ“®ŒnjC•“¡Œ’iŽÀ“®j: ‘æ61‰ñ“ú–{bˆãzŠÂŠíŠw‰ï i94.10.30j, ŽD–y, ´˜^W, p.29, 1994.

462. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “®•¨ŽÀŒ±Ž{Ý”À“üŒ¢‚Ì‹¶Œ¢•aR‘Ì’²¸. ‚‹´ŸºC’r“c’‰¶C‰ï“c—ÇsC“n•Ó‹IsCã°˜aOCŽR‰YàŠˆêi“ú‘åjC˜kì_ŽiiŽÀ“®ŒnjC”¯N—YC•“¡Œ’iŽÀ“®j: ‘æ41‰ñ“ú–{ŽÀŒ±“®•¨Šw‰ï i94.05.25`27j, ’}”g, ´˜^W, p.71, 1994.

463. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒEƒTƒM‚ɂ₳‚µ‚¢‹‹‰aŠí‚ÌŽŽì‚ɂ‚¢‚Ä. ’r“c’‰¶C‰ï“c—ÇsC“¡“c‡ˆêi“ú‘åjC”¯N—YiŽÀ“®jC‹àŽqŠxiV“Œ—mKKj: ‘æ4‰ñŽÀŒ±“®•¨ŠÂ‹«Œ¤‹†‰ï i94.11.16j, “Œ‹ž, ´˜^W, p.1, 1994.

464. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j bó‘BŽ¡—Âɂæ‚éˆâ“`«˜ËŽòǃ‰ƒbƒgrdw‚̉º‚‘Ì‹@”\‰ñ•œ. ŒÃŠÚêˆêiŽÀ“®jC¬–ì‰ë•vi•ª¶jC‹g“cCiŽÀ“®ŒnjC•“¡Œ’iŽÀ“®j: ‘æ7‰ñuˆâ“`Žq‚Æ‚»‚ÌŽü•ÓvŒ¤‹†‰ï i94.08.02j, ŽO—¤’¬, —vŽ|W, p.12.

465. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ˆâ“`«˜ËŽòǃ‰ƒbƒgrdw‚Ìbó‘B‚É‚¨‚¯‚é125I‚ÌŽæ‚èž‚Ý”\. ¼–Šr”ViRIŒnjCŽðˆäNOi‰ðjCŒÃŠÚêˆêiŽÀ“®j: ‘æ14‰ñ–ƒ•zŠÂ‹«‰ÈŠwŒ¤‹†‰ï i94.11.23j, ‘Š–ÍŒ´, —vŽ|W, p.16, 1994.


<<13 ¶•¨•¨—‰»Šw>>

466. mŒ´’˜n Effect of temperature on molecular structure of cyclosporin A. ˜@Œ©‰p¢i¶•¨•¨—‰»jC¼ì—²C‘å’J‰pŽ÷i—Õ•a—j: Biochem. Mol. Biol. Int., 34(3): 505`511, 1994.

467. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Œõ‹zŽû·ƒXƒyƒNƒgƒ‹‚¨‚æ‚ÑCDƒXƒyƒNƒgƒ‹‚©‚ç‚Ý‚½ƒyƒ‹ƒIƒLƒVƒ_[ƒ[‚Æ—L‹@—n”}‚Ì‘ŠŒÝì—p. ˜@Œ©‰p¢i¶•¨•¨—‰»jCŒŽŠÚ–¾Li‰q¶Šw•”jC²“¡NˆêiŒF–{‘åjC×’J“Œˆê˜Yi“Œ—‘åj: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.08j, ‘åã, ¶‰»Šw, 66(7): 902, 1994.

468. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒyƒ‹ƒIƒLƒVƒ_[ƒ[”½‰ž‚Ì‘¬“x‚ɑ΂·‚é—L‹@—n”}‚̉e‹¿. ²“¡NˆêiŒF–{‘åjC˜@Œ©‰p¢i¶•¨•¨—‰»jCŸN“cƒŽŸiŽœŒbˆã‘åjC×’J“Œˆê˜Yi“Œ—‘åj: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.08j, ‘åã, ¶‰»Šw, 66(7): 902, 1994.


<<1401 ?? >>

469. mŒ´’˜n Absence of activating mutations of the RAF1 protooncogene in human lung cancer. ŽO—Ö˜ji“àjCˆÀ“cƒC”ª“‡ˆê•vC–q–ì—éŽqCŠÖ’J„’ji‘—§‚ª‚ñƒZƒ“ƒ^[Œ¤‹†Šj: Biol. Chem. Hoppe-Seyler, 375: 705`709, 1994.

470. mŒ´’˜n Altered postprandial insulin requirement in IDDM patients with gastroparesis. Ishii, M.CNakamura, T.CKasai, F.COnuma, T.iO‘O‘åjC”nêPti“àjCTakebe, K.iO‘O‘åj: Diabetes Care, 17(8): 901`903, 1994.

471. mŒ´’˜n Anaerobic threshold can provoke microalbuminuria in non-insulin-dependent diabetics. “¡“c–F–MC“Iê´˜aCTakeuchi, H.CΈäŒö“¹C–‹`’‰i“àj: Diabetes Res. Clin. Pract., 22: 155`162, 1994.

472. mŒ´’˜n Serum insulin level versus blood pressure: A cross-sectional, case-controlled study in non-obese, middle-aged Japanese subjects with normal glucose tolerance. ”nêPti“àjCKodama, T.CTomiyama, T.iO‘O‘åjCSohn, D-R.CIshizaki, T.i‘—§‘Ûˆã—ÃZƒ“ƒ^[j: Diabetic Med., 11(1): 42`49, 1994.

473. mŒ´’˜n The N-acetyltransferase (NAT) gene: an early risk marker for diabetic nephropathy in Japanese Type 2 diabetic patients? Neugebauer, S.i‘—§‘Ûˆã—ÃZƒ“ƒ^[jC”nêPti“àjCWatanabe, T.i“Œ‘åjCIshizaki, T.i‘—§‘Ûˆã—ÃZƒ“ƒ^[jCKurokawa, K.i“Œ‘åj: Diabetic Med., 11: 783`788, 1994.

474. mŒ´’˜n Demethylation of a repetitive DNA sequence in human cancers. ŽO—Ö˜ji“àjC”ª“‡ˆê•vCŠÖªô•jCŠÖ’J„’ji‘—§‚ª‚ñƒZƒ“ƒ^[j: Electrophoresis, 16: 227`232, 1995.

475. mŒ´’˜n ƒCƒk‹}«‹•ŒŒ¬’°•a•Ï‚Ì“àŽ‹‹¾“I‹y‚Ñ•a—‘gDŠw“IŒŸ“¢|¬’°‘gDŒŒ—¬—ÊŒv‘ª‚àŠÜ‚ß‚Ä|. ŽO•xO”VC’†‰p’jC¼ŽR•Û”äŒÃi•a—jC›’m–çC¼Œ³Ž›Ž—çi“àj: Gasteroenterol. Endosc., 36(5): 927`938, 1994.

476. mŒ´’˜n ׌a’´‰¹”gƒvƒ[ƒu‚É‚æ‚é\“ñŽw’°’×ᇕ`o–@‚ÌŒŸ“¢|ƒ[ƒŠ[’“ü–@‚ƃoƒ‹[ƒ“–@‚Ì”äŠr|. ŽR“cŽŠlCâŒû“NÍC–Ø“cŒõLC–ì“o½CΈäŒ\‘¾C“c•Ó‘C¬ò˜aŽO˜YC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: Gastroenterol. Endosc., 36(12): 2399`2405, 1994.

477. mŒ´’˜n ŽžŒn—ñ‰æ‘œ‹L˜^‚ð—p‚¢‚½ˆÝ’×á‡á­•”‚Ì”S–ŒŒŒ‰t—Ê‚ÌŠÏŽ@|“Á‚É pharmacoendoscopy‚É‚æ‚é•Ï‰»‚ɂ‚¢‚Ä|. ¡òOC‘åˆä“c³lC—ÑO”üC“ú”䌪ˆêCrìä•vCŽRãp‚³‚ä‚èC’†ˆä‹v—YC¼Œ³Ž›Ž—çi“àj: Gastroenterol. Endosc., 36(4): 707`715, 1994.

478. mŒ´’˜n …ávÇ‚É”º‚¤H“¹•a•Ï‚Ì—Õ°“I“àŽ‹‹¾“IŒŸ“¢. ΈäŒ\‘¾CŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: Gastroenterol. Endosc., 36: 1379`1386, 1994.

479. mŒ´’˜n Response of cytosolic free calcium to angiotensin ‡U in individual rat mesangial cells cultured in a medium high in glucose. ‹àXWCˆ¢•”D•¶C“Iê´˜aC–‹`’‰i“àj: Horm. Metab. Res., 26(11): 561`562, 1994.

480. mŒ´’˜n Effect of 4-hour hyperlycaemia and hyperinsulinaemia on plasia atrial natriuretic factor concentrations. ”nêPti“àjCHeinemann, L.CBerger, M.CSawicki, P.iHeinrich-Heine Univ.j: Horm. Metab. Res., 27: 95`99, 1995.

481. mŒ´’˜n Humoral immune response to hypervariable region 1 of a hepatitis C viral envelope glycoprotein (gp70) obtained from an asymptomatic carrier. ’†‘ò‹MGi“àjC‰Á“¡é”Vi‘—§‚ª‚ñƒZƒ“ƒ^[jC“¡‰ª‚OCa’J–¾—²i“àjC‰º‰“–ì–M’‰i‘—§‚ª‚ñƒZƒ“ƒ^[j: Intern. Hepatol. Commun., 3: 77`81, 1995.

482. mŒ´’˜n Characterization of the 5' noncoding and structural region of the hepatitis C virus genome from patients with non-A, non-B hepatitis responding differently to interferon treatment. ’†‘ò‹MGi“àjC‰Á“¡é”Vi‘—§‚ª‚ñƒZƒ“ƒ^[jC‘å‰zÍŒáiVŠƒ‘åjCa’J–¾—²i“àjC‰º‰“–ì–M’‰i‘—§‚ª‚ñƒZƒ“ƒ^[j: J. Hepatol., 20: 623`629, 1994.

483. mŒ´’˜n Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. ‰Á“¡é”VC‘å’ÃŽR—SŽqCŠÖ’Jm”üi‘—§‚ª‚ñƒZƒ“ƒ^[jC‘å‰zÍŒáiVŠƒ‘åjC’†‘ò‹MGi“àjC“y•û½C‰º‰“–ì–M’‰i‘—§‚ª‚ñƒZƒ“ƒ^[j: J. Virol., 68: 4776`4784, 1994.

484. mŒ´’˜n Effects of sarpogrelate on serotonin-induced increases in cytosolic Ca2+ in cultured rat mesangial cells. ‹àXWC“Iê´˜aC–‹`’‰i“àj: Life Sci., 55(18): 365`370, 1994.

485. mŒ´’˜n —¯’uƒXƒlƒA‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. ‚‹´KGCŒÜ\—’³LCŸ–””º‰hC“à“¡‹g—²C²“c”ü˜aCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àjCŽO•xO”Vi•a—j: Prog. Digest. Endosc., 44: 43`45, 1994.

486. mŒ´’˜n ’¼’°”S–Œ’EÇŒóŒQ‚ÌŒo‰ßŠÏŽ@—á‚ÌŒŸ“¢. ²“c”ü˜aCŒÜ\—’³LC“à“¡‹g—²C¼‘q“¿]C‚‹´—T”VCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCŽO•xO”Vi•a—j: Prog. Digest. Endosc., 45(12): 106`109, 1994.

487. mŒ´’˜n 10 mmˆÈ‰º‚Ì’¼’°ƒJƒ‹ƒ`ƒmƒCƒh‚Ì’´‰¹”g“àŽ‹‹¾f’f‚Æ“àŽ‹‹¾“Iƒ|ƒŠƒyƒNƒgƒ~[‚É‚¨‚¯‚é 24ƒ`ƒƒƒ“ƒlƒ‹ƒXƒR[ƒv‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ¬—Ñ´“TCŽR“cL•vi¬“cŒ´Žs—§•a‰@jCŒÜ\—’³LCŸ–””º‰hC“à“¡‹g—²C¼Œ³Ž›Ž—çi“àj: Prog. Digest. Endosc., 45: 101`105, 1994.

488. mŒ´’˜n ”S–ŒØœp‚É‚ÄŽ¡—µ‚½‘Šú‘å’°Šà‚ÌŒŸ“¢. ‚‹´KGCŒÜ\—’³LC“à“¡‹g—²C²“c”ü˜aC¼‘q“¿]CŸ–””º‰hC¼Œ³Ž›Ž—çC¬—Ñ´“Ti“àjCŽO•xO”VC’†‰p’ji•a—j: Ther. Res., 15(Suppl.2): 338`342, 1994.

489. mŒ´’˜n HCC“ÁˆÙ“I ALDH‚̖Ɖu‘gDŠw“IŒ¤‹†. a’J–¾—²i“àjC’|“à“ÖŽqi“Œ•a‰@Œ¤‹†Œnj: ƒAƒ‹ƒR[ƒ‹‚ƈãŠw¶•¨Šw, 14: 102`104, 1994.

490. mŒ´’˜n ELISA–@‚É‚æ‚錌´ ProGRP‘ª’è‚Ì—Õ°“IˆÓ‹`. Ž™‹Ê“N˜Yi‘—§‚ª‚ñƒZƒ“ƒ^[jCˆ¢•”¯ìiŽD–yˆã‘åjCŽRŒûŒšC]ŒûŒ¤“ñi‘—§‚ª‚ñƒZƒ“ƒ^[jC¼Œ³Ž›Ž—çi“àjC‹T’J“Oi•a—jCŠ™“cvŽõi“àjCŽO‘î ‰Ã—Yiƒwƒ‹ƒXƒTƒCƒGƒ“ƒXjC—L‹gŠ°iˆ¤’mŒ§‚ª‚ñƒZƒ“ƒ^[jC’r“c’å—Yi‹ž“sŒj•a‰@jC•Ÿ‰ª³”Ži‘åãŽs—§‘‡ˆã—ÃZƒ“ƒ^[jC‚“cŽÀi‘åã•{—§‰H‰g–ì•a ‰@jC‰ÍŒ´³–¾i‘—§—×{Š‹ß‹E’†‰›•a‰@jC–Ø‘ºˆè˜Yi‰ª‘åjCˆäŒû“Œ˜Yi‘—§•a‰@‹ãB‚ª‚ñƒZƒ“ƒ^[jC‘«—§®“oiŒF‘åj: ˆãŠw‚Æ–òŠw, 32(1): 87`97, 1994.

491. mŒ´’˜n ‘å’°Šà‚𕹑¶‚µ‚½’×ᇫ‘å’°‰ŠÇ—á‚Ì—Õ°“IŒŸ“¢. ’†‘º—zŽqCˆÀ’BŒ£CÄ“¡Œ¤“ñC‹´–{“NC“ˆ’×TCÎìŽåÅCˆäo“NC“n•”K•vCˆÀ•”–¾˜NCó”ö•ŽmC‚‹´r‹Bi‘—§‘Š–ÍŒ´•a‰@jCŒÜ\—’³LCŸ–””º‰h i“àj: ˆã—Ã, 46(1): 16`20, 1994.

492. mŒ´’˜n ’×ᇫ‘å’°‰Š•a‘Ôƒ‚ƒfƒ‹ì»‚ÌŽŽ‚Ý. ¬Œ´ii¶‰»jCŒÜ\—’³LC“n•Ó•üŒbi“àjC–x“c‹±Žqi¶‰»j: ŽÀŒ±’×á‡, 21(2): 98`101, 1994.

493. mŒ´’˜n “àŽ‹‹¾“I“EœŒã‚Ì‘å’°ŽîᇂÌV¶. ŒÜ\—’³LCŸ–””º‰hC“à“¡‹g—²C‚‹´KGC¼Œ³Ž›Ž—çi“àj: Á‰»Ší“àŽ‹‹¾, 6(10): 1411`1417, 1994.

494. mŒ´’˜n _“Þ쌧‘åˆé’¬‚É‚¨‚¯‚é‚bŒ^ŠÌ‰ŠZ–¯ŒŸf‚ÌŒ‹‰Ê‚ɂ‚¢‚Ä. a’J–¾—²CÄ“¡rŽiCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: _“ÞìˆãŠw‰ïŽGŽ, 22(1): 47`51, 1995.

495. mŒ´’˜n ‘å’°‘BŽîA‘å’°‘ŠúŠà‚É‚¨‚¯‚é p53ˆâ“`ŽqŽY•¨‚̖Ɖu‘gDŠw“IŒŸõ. ‚–ظˆêCŠô¢‹´“ÄC–{‹´CC²–ìG–íC´…º’jiŒ§—§‚ª‚ñƒZƒ“ƒ^[j: “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91: 1283`1289, 1994.

496. mŒ´’˜n ‘å’°•\–Ê‘BŽî‚Æ—²‹NŒ^‘BŽî‚Ì•a—‘gDŠw“I“Á’¥‚Ì”äŠrŒŸ“¢. ŽO•xO”VC’†‰p’jCã™G‰iC¼ŽR•Û”äŒÃi•a—jCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOj: “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ, 47(5): 401`412, 1994.

497. mŒ´’˜n Effect of OPC-21268 on cytosolic free calcium in cultured rat mesangial cells. ‹àXWC“Iê´˜aC–‹`’‰i“àj: –k—¢ˆãŠw, 24(2): 92`96, 1994.

498. mŒ´’˜n –«ŠÖ߃ŠƒEƒ}ƒ`‚ɇ•¹‚µ‚½ˆÝ’×ᇂ̌Ÿ“¢|“àŽ‹‹¾ŠŒ©‚ð’†S‚Æ‚µ‚Ä|. ÎìŽåÅCˆÀ’BŒ£C‘“ŒŠ²•vCˆÀ•”–¾˜Ni‘—§‘Š–ÍŒ´•a‰@jCŽR“cº•vC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: –k—¢ˆãŠw, 24(4): 284`290, 1994.

499. mŒ´’˜n ƒAƒCƒ\ƒg[ƒv‚ð—p‚¢‚½ˆÝ”ro”\ŒŸ¸‚É‚¨‚¯‚éŠÈˆÕŽŽŒ±H‚ÌŽŽ‚Ý. ΈäŒ\‘¾C“c•Ó‘CŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: –k—¢ˆãŠw, 24(5): 376`380, 1994.

500. mŒ´’˜n Mucosal protection by Shokyo, a crude drug, against ethanol-induced gastric damage in rat. •û—D”üi“àjCŒÜäzsMi¶‰»jCÎŒ´˜a•Fi‰»ŠwjC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: –k—¢ˆãŠw, 24(5): 381`389, 1994.

501. mŒ´’˜n ƒ‰ƒbƒgˆÝ•\‘w”S‰t×–E’P—£–@‚ÌŠm—§‚Æ’P—£×–E‚É‚¨‚¯‚é”S‰t“œƒ^ƒ“ƒpƒNŽ¿‡¬‚ÌŒŸ“¢. •û—D”üi“àjCŒÜäzsMi¶‰»jCÎŒ´˜a•Fi‰»ŠwjC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: –k—¢ˆãŠw, 24(6): 494`500, 1994.

502. mŒ´’˜n ProstacyclinŽ‘±’“ü‚É‚æ‚éŠÌŒŒs“®‘Ô‚Ì”½‰ž|Œ¢‚É‚æ‚錌—¬‘ª’è|. –{‹´CCŠô¢‹´“ÄiŒ§—§‚ª‚ñƒZƒ“ƒ^[jC¼Œ³Ž›Ž—çi“àjC’†ŽR–ÎMiŽÀ“®Œnj: –k—¢ˆãŠw, 24: 402`408, 1994.

503. mŒ´’˜n ˆÝ”S–Œ‚̃Aƒ‹ƒfƒqƒh’E…‘fy‘f‚ÌŒ¤‹†. ‹à‡Žqi”’‹‰¶ˆã‰È‘åjCa’J–¾—²i“àj: –k—¢ˆãŠw, 25(1): 31`35, 1995.

504. mŒ´’˜n ƒ‰ƒbƒgƒGƒ^ƒm[ƒ‹’×ᇂɂ¨‚¯‚éˆÝ”S‰t“œ’`”’Ž¿‚Ì—Ê“I•Ï“®‚ɑ΂·‚郃`ƒ‹ƒƒ`ƒIƒjƒ“ƒXƒ‹ƒzƒjƒEƒ€ƒNƒƒ‰ƒCƒh(MMSC)‘O“Š—^‚ÌŒø‰Ê. “n•Ó•üŒbi“àjC¬Œ´iCŽs쑸•¶i¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: –ò—‚ÆŽ¡—Ã, 22(10): 155`161, 1994.

505. mŒ´’˜n ƒ‰ƒbƒg‰–Ž_ƒAƒXƒsƒŠƒ“’×ᇂɂ¨‚¯‚éˆÝ”S‰t“œ’`”’Ž¿•Ï“®‚ɑ΂·‚é T-593‘O“Š—^‚ÌŒø‰Ê. Žðˆä’C•Fi“àjCÎŒ´˜a•Fi‰»ŠwjCŽs쑸•¶i¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: –ò—‚ÆŽ¡—Ã, 22(12): 181`187, 1994.

506. mŒ´’˜n NSAIS ’×á‡. ˆÀ’BŒ£CŽR“cº•vi‘—§‘Š–ÍŒ´•a‰@jC¼Œ³Ž›Ž—çi“àj: —Õ°‚Æ–ò•¨Ž¡—Ã, 13(3): 304`306, 1994.

507. mŒ´’˜n Vp3ŠÌ×–EŠàÇ—á‚Ì֬ᎂɑ΂·‚é“àŽ‹‹¾“I֬ᎌ‹ãFp. ‘•ª–ΔŽC‘ºã‹§lCŽRè‚¢‚ÂÝC“‡”ö³•FCΊ_“¿]C¼“c–€–çC‹v•Û“c•q•FC‚“c‰ë”ŽC²“¡³Ž÷C¼–{ˆÌ’jC™–{­’¼Ca’J–¾—²CŽÄ“c‹v—YC¼Œ³Ž›Ž—ç i“àjC‰Á“¡NsC”äŠé”\Ž÷iŠOj: —Õ°ŠO‰È, 49(4): 457`463, 1994.

508. mŒ´’˜n ‚bŒ^–«ŠÌ‰Š‚É‚¨‚¯‚é P1P4R‘Ì’è—Ê‘ª’è‚̈Ӌ`. a’J–¾—²Có–ì˜NC“y‹´Œ’i“àjC÷ˆäŒc‘¢i—ÕŒŸjC’|“à“ÖŽqi“Œ•a‰@Œ¤‹†ŒnjCŽÄ“c‹v—Yi“àj: —Õ°•a—, 43(3): 285`289, 1995.

509. m€Œ´’˜n ‰æ‘œŠÔ‰‰ŽZ‚ð—p‚¢‚½H“¹•\ÝŠà‚Ì[’B“x‚¨‚æ‚ÑZ”͈Íf’f. ’†ˆä‹v—YC‘åˆä“c³lCŽRãp‚³‚ä‚èCΈäŒ\‘¾C¡òOC“ú”䌪ˆêCã™G‰iC¼Œ³Ž›Ž—çi“àj: Prog. Dig. Endosc., 44: 60`63, 1994.

510. m€Œ´’˜n ’Pˆê¶–ò‚̃‰ƒbƒgƒGƒ^ƒm[ƒ‹’×ᇂɑ΂·‚éŒø‰Ê‚ÌŒŸ“¢|“Á‚ɶ›I‚ÌR’×á‡ì—p‚¨‚æ‚шݔS‰t‚ւ̉e‹¿‚ɂ‚¢‚Ä|. •û—D”üi“àjCŒÜäzsMi¶‰»jCÎŒ´˜a•Fi‰»ŠwjCŽs쑸•¶i¶‰»jCŽðˆä’C•FC“n•Ó•üŒbC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: Prog. Med., 14: 2709`2712, 1994.

511. m€Œ´’˜n B-RTO“K‰žŠOŒÇ—§«ˆÝ֬ᎂɑ΂·‚é EVIS‚Ì—L—p«|EIS‚É‘±‚­‚à‚Ì‚ÍEVIS|. ‘•ª–ΔŽC²“c”ü˜aC‘ºã‹§lC¼“c–€–çC‚“c‰ë”ŽC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 7(1): 93`98, 1994.

512. m’Z•ñE‘¬•ñn Virus isolate-specific antibodies against hypervariable region 1 of the hepatitis C virus second envelope protein, gp70. ‰Á“¡é”Vi‘—§‚ª‚ñƒZƒ“ƒ^[jC’†‘ò‹MGi“àjC‘å’ÃŽR—SŽqC™ŽR˜a•vi‘—§‚ª‚ñƒZƒ“ƒ^[jC‘å‰zÍŒáC‰º‰“–ì–M’‰iVŠƒ‘åj: Jpn. J. Cancer Res., 85: 987`991, 1994.

513. m’Z•ñE‘¬•ñn –³ÇŒó«ƒLƒƒƒŠƒA‚É‚¨‚¯‚é‚bŒ^ŠÌ‰ŠƒEƒCƒ‹ƒX‚̃Gƒ“ƒxƒ[ƒv’`”’Ž¿‚ÌŒoŽž“I•ÏˆÙ‚Æ‚»‚̑̉t«–Ɖu‰ž“š. ’†‘ò‹MGi“àjC‰Á“¡é”VCŠÖ’Jm”üi‘—§‚ª‚ñƒZƒ“ƒ^[jC“¡‰ª‚OCa’J–¾—²i“àjC‰º‰“–ì–M’‰i‘—§‚ª‚ñƒZƒ“ƒ^[j: ŠÌ‘Ÿ, 35(6): 463`464, 1994.

514. mŒ¤‹†•ñiŒú¶Èjn Á‰»ŠíŠà‰»Šw—Ö@Ç—á‚ÌŒø‰Ê”»’è‚Ì–â‘è“_‚ÌŒŸ“¢. ¬ò˜aŽO˜Yi“àj: •ª’SŒ¤‹†•ñ‘, 1994.

515. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ˆÝ¥\“ñŽw’°’×ᇂɑ΂·‚éƒIƒƒvƒ‰[ƒ‹‚Ì—Õ°“I—L—p«‚ÌŒŸ“¢|é“ìPPIŒ¤‹†‰ï‹¤“¯Œ¤‹†|. ‰œ‘º–M•Fi“ŒŽÅ•a‰@jCΖÈG•qiΖȃNƒŠƒjƒbƒNjC¬ÀçHi“úŒ’ƒNƒŠƒjƒbƒNjC—é–Ø‘‘ˆêi—é–Ø“à‰ÈjC“à ºi‚½‚­‚ÝŠO‰ÈjC–kžŠ–«i–kžŠˆã‰@jC¼ ˆäG•vi¼ˆä•a‰@jCXˆê˜YiXˆã‰@jC–ö‘ò”üŒõi“úŽYŒú¶‰ï‹Êì•a‰@jCŽR“cŸ‹viŽR“cŠO‰ÈjCH“c‘×iH“cˆã‰@jCΕÍiΕˆã‰@jC‰Á“¡ˆê•Fia ’J“Œ‹}ƒNƒŠƒjƒbƒNjC‹T’J—zi–Ø‘º•a‰@jC‹e’r—Ç’mi“úŽYŒú¶‰ï‹Êì•a‰@jC‹v•Û“c˜a”Ži‹v•Û“cˆã‰@jCŒàŒõ—Yi’†‰›ˆã‰@jC¬âGi“ŒŽÅ•a‰@jC‹ß“¡—² •Fié“쑇•a‰@jC¼žŠŒ³•Fi¼žŠƒNƒŠƒjƒbƒNjCâŒû—FŽŸ˜YiŽsì‘æ“ñ•a‰@jCŽÄ“c”Ž”Vi—ä’¬ˆã‰@jC´…Œbˆê˜Yiˆ¢•”ˆã‰@jC—é–ØL–¾i“ŒŽÅ•a‰@jC —é–Ø‹`”ViŽŠ½‰ï‘æ“ñ•a‰@jC£’곕Fi£’ê“à‰ÈjC“cŒûdmiŠ—“c‘‡•a‰@jCŠp”ö’m»i¼“‡ƒNƒŠƒjƒbƒNjC’†”öš –¾i“ŒŽÅ•a‰@jC•½’˳•i“Œ•iìƒN ƒŠƒjƒbƒNjCŒÃŽs¯“ñ˜YiŒÃŽsƒNƒŠƒjƒbƒNjC‘“c–Α¥i‘“cŠO‰ÈjCŽO‘îNOi‹î‘ò•a‰@jCˆÀ“c—EŽ¡iˆÀ“c•a‰@jCŽR“à‘åŽOiŽR“àˆã‰@jCŽRèˆêMi¬‘q •a‰@jCŽR“cŽŠli“àj: —Õ°‚ÆŒ¤‹†, 71(12): 3257`3262, 1994.

516. mÇ—á•ñn Three cases of sebaceous glands in the esophagus. ΈäŒ\‘¾CŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àjC›’m–çC’†‰p’ji•a—j: Digestive Endosc., 6(2): 201`204, 1994.

517. mÇ—á•ñn ’ZŠúŠÔ‚ÉŽîᇂª’E—Ž‚µ‚½‚ÆŽv‚í‚ê‚éˆÝˆ««ƒŠƒ“ƒpŽî‚Ì‚P—á. “ú”䌪ˆêC“c•Ó‘C¬ò˜aŽO˜YC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìiŠOjCã™G‰iC’†‰p’ji•a—j: Gastroenterol. Endosc., 36(4): 741`749, 1994.

518. mÇ—á•ñn –UŒŸ‚É‚æ‚è“àŽ‹‹¾“IH“¹Ã–¬áŽŒ‹ãFp‚ÌŒø‰Ê‚ÆŠm”F‚µ“¾‚½‚P—á. ŽRè‚¢‚ÂÝC‘ºã‹§lC‘•ª–ΔŽC¼‘q“¿]C‰¡ŽR–õCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC¼ŽR•Û”äŒÃi•a—j: Prog. Dig. Endosc., 44: 102`105, 1994.

519. mÇ—á•ñn \“ñŽw’°‚Ɉí’E‚µ‚½‹‘å‡TŒ^‘ŠúˆÝŠà‚Ì‚P—á. “ú”䌪ˆêC“c•Ó‘C‘åˆä“c³lC¬ò˜aŽO˜YC‰¡ŽR–õC¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìiŠOjCã™G‰ii•a—j: Prog. Dig. Endosc., 45: 192`193, 1994.

520. mÇ—á•ñn ‡TŒ^‘ŠúˆÝŠà‚Ì‚P—á. “c•Ó‘C¬ò˜aŽO˜YC‰¡ŽR–õC¼Œ³Ž›Ž—çi“àjCã™G‰ii•a—j: ˆÝ‚Æ’°, 29(12): 1232`1233, 1994.

521. mÇ—á•ñn [•”Z‚ð’悵‚½‡Ua{‡UcŒ^‘ŠúˆÝŠà‚Ì‚P—á. ¬ò˜aŽO˜YC‹ß“¡ˆê‰pCΈäŒ\‘¾i“àjCã™G‰iCŽO•xO”Vi•a—jC¼Œ³Ž›Ž—çi“àj: ˆÝ‚Æ’°, 29(13): 1350`1351, 1994.

522. mÇ—á•ñn Peutz-Jegher'sÇŒóŒQ‚Ì‚P—á. ŒÜ\—’³LCŸ–””º‰hC“à“¡‹g—²C¼Œ³Ž›Ž—çi“àjCŽO•xO”VC’†‰p’ji•a—j: ˆÝ‚Æ’°, 29(7): 622`623, 1994.

523. mÇ—á•ñn ”ñ“ÁˆÙŒ^‘½”­«¬’°’×á‡Ç‚Ì‚P—á. ¬—Ñ´“TCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: ˆÝ‚Æ’°, 29(9): 868`870, 1994.

524. mÇ—á•ñn –«ŠÖ߃ŠƒEƒ}ƒ`(RA)‚ɇ•¹‚µ‚½ Stenoral ulcerih•Ö’×á‡j‚Ì‚P—á. ’†‘º—zŽqCˆÀ’BŒ£C‘“ŒŠ²•vC“ˆ’×TCÎìŽåÅCˆäo“NC“n•”K•vCˆÀ•”–¾˜NCŽRŒûWOC‘Šì’ŽjCŽR“cº•vi“àjCŒÃ”g‘qŽjŽqC‚‹´r‹BCó”ö•Žmi‘ —§‘Š–ÍŒ´•a‰@jCŽO•xO”Vi•a—j: ˆã—Ã, 49(2): 153`157, 1995.

525. mÇ—á•ñn “àŽ‹‹¾“I“EœpŒãA‹ÇŠÄ”­‚µ‚½‘Šú‘å’°Šà‚Ì‚P—á. ‚‹´KGCŒÜ\—’³LC²“c”ü˜aC¼‘q“¿]C“à“¡‹g—²CŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCH“¡N¶C‘å’J„³iŠOjCŽO•xO”Vi•a—jC¬—Ñ´“Ti“àj: Á‰»Ší“àŽ‹‹¾, 7(2): 305`309, 1995.

526. mÇ—á•ñn ‘½‘B«“à•ª”å•s‘SÇŒóŒQ‚Ü‚½‚ÍdÇ‹Ø–³—ÍÇ‚ð‡•¹‚µ‚½DuaneÇŒóŒQ‚ÌŽo–…—á. –ìŒû‹§ŽqC–ìX‘º–í¶C‹àXWC–‹`’‰Cˆ¢•”D•¶i“àj: “ú–{“à•ª”åŠw‰ïŽGŽ, 70(4): 431`438, 1994.

527. mÇ—á•ñn Osler-Rendu-Weber's disease‚Ì‚P‰ÆŒn. ‰¤ˆ¤•½i’†‘‹g—шãŠw‰@jC¬ò˜aŽO˜YC“ú”䌪ˆêC¡òOCΈäŒ\‘¾C“c•Ó‘C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: –k—¢ˆãŠw, 25(1): 93`99, 1995.

528. m—Õ°Ž¡Œ±n • o‹¾‰ºŠÌŽîᇶŒŸŽž‚ÌoŒŒ‚ɑ΂·‚éƒGƒ`ƒ‹ƒVƒAƒmƒAƒNƒŠƒŒ[ƒg‚É‚æ‚éŽ~ŒŒ–@. ‘åŒIC‘ºã‹§lC”’èŒh“ñC²“¡³Ž÷Ca’J–¾—²C‘•ª–ΔŽCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: Prog. Dig. Endosc., 44: 95`97, 1994.

529. m‘àn The link between insulin resistance and hypertension: effect of antihypertensive and hypolipidaemic drugs on insulin sensitivity. ”nêPti“àjCNeugebauer, S.i‘—§‘Ûˆã—ÃZƒ“ƒ^[j: Drugs, 47(3): 383`404, 1994.

530. m‘àn ˆÝƒXƒLƒ‹ƒX‚Ìf’f¥Ž¡—Â̌»ó: isˆÝŠà¥‰»Šw—Ö@. ¬ò˜aŽO˜YC‹ß“¡ˆê‰pC¼Œ³Ž›Ž—çi“àjCŒIŒ´–«iº˜a‘åj: KARKINOS, 7(6): 529`536, 1994.

531. m‘àn ‘å’°Šà‚̃XƒNƒŠ[ƒjƒ“ƒOŒŸ¸. ŒÜ\—’³Li“àj: Medical News, 1467(2/25): 13`14, 1995.

532. m‘àn “œ”A•atÇ|‘ŠútÇ‚Ìf’fCŒo‰ßŠÏŽ@CŽ¡—Ã|. –‹`’‰C’†“ˆ^ˆêi“àj: Medical Practice, 11(12): 2081`2084, 1994.

533. m‘àn Á‰»«’×ᇂ̈ێ—Ö@¥Ä”­–hŽ~ô‚ƃvƒƒgƒ“ƒ|ƒ“ƒv‘jŠQ–ò. ŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: nanoGIGA, 3(11): 1838`1841, 1994.

534. m‘àn ƒvƒƒgƒ“ƒ|ƒ“ƒv‘jŠQÜ‚Ì“K‰ž‚ÆŽg—pã‚Ì–â‘è“_. ‰¡ŽR–õC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 12(10): 30`33, 1994.

535. m‘àn “œ”A•a«tÇ: ‘Îô‚Æ‚µ‚Ä‚ÌŒŒ“œƒRƒ“ƒgƒ[ƒ‹. ”nêPti“àj: ƒoƒCƒIƒNƒŠƒjƒJ, 9(12): 875`878, 1994.

536. m‘àn H“¹ˆÝ֬᎔j—ô. ‘ºã‹§lC‘•ª–ΔŽi“àj: ‹~‹}ˆãŠw, 18(9): 1013`1018, 1994.

537. m‘àn ƒvƒƒgƒ“ƒ|ƒ“ƒv‘jŠQ–ò‚Ì—Õ°Œø‰Ê|H2hR–ò‚ƑΔ䂵‚Ä|ˆÝ’×á‡. ŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: Ž¡—Êw, 28(4): 397`400, 1994.

538. m‘àn ˆÝŠàŽèpi“àŽ‹‹¾“I”S–ŒØœp). ‰¡ŽR–õi“àjC”äŠé”\Ž÷iŠOj: Á‰»ŠíŠO‰È, 17(5): 724`725, 1994.

539. m‘àn ˆÝ¥\“ñŽw’°oŒŒ‚ɑ΂·‚é“àŽ‹‹¾“IŽ~ŒŒ–@‚Ì‹ô”­Ç‚Æ‚»‚Ì‘Îô. “c•Ó‘C‰¡ŽR–õC¼Œ³Ž›Ž—çi“àjC’Ë–{GlC”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 6(4): 479`484, 1994.

540. m‘àn ’†‹‰ŽÒ‚Ì‚½‚ß‚Ì‘å’°“àŽ‹‹¾|‰ŠÇ«’°Ž¾Š³‚Æ‘å’°“àŽ‹‹¾|. Ÿ–””º‰hCŒÜ\—’³Li“àj: Á‰»Ší“àŽ‹‹¾, 6(7): 859`866, 1994.

541. m‘àn ˆÝ‚Æ‘å’°‚Ì•ª‰»Œ^‘ŠúŠà‚Ì[’B“xf’f|“àŽ‹‹¾“I’´‰¹”gf’f‚Ì”äŠr‚ð’†S‚É|. ¬—Ñ´“TC“à“¡‹g—²CˆÀ’BŒ£C–Ø“cŒõLCŒÜ\—’³LC‘åˆä“c³lCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjC‘å’J„³CŽOd–슰ŠìC”äŠé”\Ž÷iŠOjCã™G‰iCŽO•xO ”Vi•a—j: Á‰»Ší“àŽ‹‹¾, 7(2): 189`199, 1995.

542. m‘àn oŒŒ«ˆÝ’×ᇂ̗\Œã. “c•Ó‘C¼Œ³Ž›Ž—çC“ú”䌪ˆêC‰¡ŽR–õCŽO‹´—˜‰·i“àj: ‘‡—Õ°, 43(10): 2357`2361, 1994.

543. m‘àn H“¹‹@”\ˆÙí. ΈäŒ\‘¾C¼Œ³Ž›Ž—çi“àj: ‘‡—Õ°, 43(10): 2497`2502, 1994.

544. m‘àn ˆ««ƒŠƒ“ƒpŽî‚Ì‚wüf’f. ¬ò˜aŽO˜YC²“c”ü˜aCŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: ‘‡—Õ°, 43(4): 827`834, 1994.

545. m‘àn ‘å’°Šà‚Ì‚wüf’f. ŽO•xO”Vi•a—jCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çCˆÀ’BŒ£i“àj: ‘‡—Õ°, 43(7): 1419`1430, 1994.

546. m‘àn ‘å’°ƒ|ƒŠƒ|[ƒVƒX‚Ì‚wüf’f. ŽO•xO”Vi•a—jCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çCˆÀ’BŒ£C¬—Ñ´“Ti“àj: ‘‡—Õ°, 43(8): 1615`1622, 1994.

547. m‘àn H“¹Šà. ΈäŒ\‘¾C¼Œ³Ž›Ž—çi“àj: ‘‡—Õ°, 43: 1828`1834, 1994.

548. m‘àn “œ”A•a‚ɇ•¹‚·‚é•a‘Ô‚Ö‚Ì‘Îô: ‚ŒŒˆ³‚̬ˆö‚ÆŠÇ—CŽ¡—Ãã‚Ì’ˆÓ. ”nêPti“àjCSabine Neugebaueri‘—§‘Ûˆã—ÃZƒ“ƒ^[j: “à‰È, 73(2): 286`292, 1994.

549. m‘àn ˆÝ¥\“ñŽw’°’×ᇂÌf—ÂƎ¡—Ã. ¼Œ³Ž›Ž—çi“àj: “ú–{ˆãŽ–V•ñ, (3664): 3`7, 1994.

550. m‘àn ˆÝƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ìf’f. ¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj: “ú–{ˆãŽ–V•ñ, (3679): 111`112, 1994.

551. m‘àn “œ”A•a«tÇi—Õ°ˆãŠw‚Ì“W–]: ‘æ‚QÍ). ”nêPti“àj: “ú–{ˆãŽ–V•ñ, (3696): 23`31, 1995.

552. m‘àn Á‰»ŠÇoŒŒ‚̉uŠw. ¼Œ³Ž›Ž—çC“c•Ó‘CŒÜ\—’³Li“àj: “ú–{“à‰ÈŠw‰ïŽGŽ, 83(8): 1247`1252, 1994.

553. m‘àn Á‰»ŠÇÇŒóŒQ|’°ƒJƒ‹ƒ`ƒmƒCƒh|. Ÿ–””º‰hCŒÜ\—’³LC¬—Ñ´“TC¼Œ³Ž›Ž—çi“àj: “ú–{—Õ°, (•Êû6): 393`396, 1994.

554. m‘àn ’×ᇕa•Ï‚ð’†S‚Æ‚µ‚½Á‰»ŠíŽ¾Š³|“Á‚É AGML‚ð’†S‚É|. ŽR“cŽŠlC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: •a‘Ô¶—‚Æf’f¥Ž¡—Ã, 38: 43`46, 1995.

555. m‘àn Ä”­—vˆö‚Æ‘Îô. ŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: —Õ°‚ÆŒ¤‹†, 71(4): 931`935, 1994.

556. m‘àn “fŒŒ‚ƉºŒŒ. “c•Ó‘C‰¡ŽR–õCŒÜ\—’³LC¼Œ³Ž›Ž—çi“àj: —Õ°‚ÆŒ¤‹†, 71(8): 59`62, 1994.

557. m‘àn –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚ÌÁ‰»ŠÇ•a•Ï‚ɂ‚¢‚Ä‹³‚¦‚ĉº‚³‚¢B‚Ü‚½“àŽ‹‹¾ŒŸ¸ŽÀŽ{‚ÌÛ‚É’ˆÓ‚·‚邱‚Æ‚Í‚ ‚è‚Ü‚·‚©H ˆÀ’BŒ£i“àj: —Õ°ˆã, 20(2): 106`108, 1994.

558. m‘àn –òÜ‚É‚æ‚鎡–ü‰ß’ö‚Ì·|“Á‚É H2-BÜ‚Æ PPI‚̑Δä|. ‘åˆä“c³lC¡òOCŽR“cŽŠlC¼Œ³Ž›Ž—çi“àj: —Õ°Á‰»Ší“à‰È, 9(7): 1067`1073, 1994.

559. muÀn Glycotopics: Advanced glycation end products (AGEs) induce glomerular sclerosis and albuminuria in normal rats/V’…˜_•¶Ð‰î. “¡ˆä‰pi“àj: Trend. Glycosci. Glycotechnol., 7(33): 69`71, 1994.

560. muÀn ‘Šú‘å’°Šà1994|ƒXƒgƒŠƒbƒvƒoƒCƒIƒvƒV[|. ŒÜ\—’³LCŸ–””º‰hC“à“¡‹g—²C¼Œ³Ž›Ž—çi“àjCŽO•xO”VC’†‰p’ji•a—jC¬—Ñ´“Ti“àj: ˆÝ‚Æ’°, 29(3): 107`116, 1994.

561. muÀn ˆÝ’×á‡. ‘åˆä“c³lC“ú”䌪ˆêC¼Œ³Ž›Ž—çi“àj: ‘‡—Õ°, 43(5): 1020`1028, 1994.

562. muÀn \“ñŽw’°’×á‡. ‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ‘‡—Õ°, 43(6): 1231`1236, 1994.

563. mŠwp‘n i•ª’SŽ·•Mj ’·Šú“I“W–]‚É‚½‚Á‚½Á‰»«’×ᇎ¡—Â̂ ‚è•û; ’×ᇌ`‘Ô‚©‚ç‚Ý‚½Ä”­—\–h‚ÆŽ¡—Â̂ ‚è•û, p.23`35, ¼Œ³Ž›Ž—çi“àj. •ÒW ó–Ø–Îi“Œ–k‘åjC ˆã–òƒWƒƒ[ƒiƒ‹, ‘åã, 94.04.05”­s.

564. mŠwp‘n i•ª’SŽ·•Mj •\–ÊŒ^‘å’°Žîᇂ̗հ; •\–ÊŒ^‘å’°Žîᇂ̒´‰¹”g“àŽ‹‹¾f’f, p.103`112, ¬—Ñ´“TC“à“¡‹g—²CŽR“cL•vCŸ–””º‰hi“àj. •ÒW ’·‰ôãEi“Œ—ˆã‘åjC‰Á“¡—miŠàŒ¤jC‘哇”Ži“úˆã‘åjC “Œ‹žˆãŠwŽÐ, “Œ‹ž, 94.04.25”­s.

565. mŠwp‘n i•ª’SŽ·•Mj Viral Hepatitis and Liver Disease; Hepatitis C virus hypervariable region may confer escape from immunosurveillance, p.329`333, ‰Á“¡é”Vi‘—§‚ª‚ñƒZƒ“ƒ^[jCŠÖ’Jm”üi“Œ—ˆã‘åjC’†‘ò‹MGi“àjCŽR“àŽ”üC‘å‰zÍŒáCŒSŽir–¾C‰º‰“–ì–M’‰i‘—§‚ª‚ñƒZƒ“ƒ^[j. •ÒW ¼‰ªC—é–ØCŽO‘ãCD“cC Springer-Verlag, “Œ‹ž, 94.07.00”­s.

566. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠÇŽ¾Š³‚Ìŋ߂̃gƒsƒbƒNƒX; ˆÝŠà|f’f‚©‚ç“àŽ‹‹¾“IŽ¡—Â܂Å|, p.135`144, ¼Œ³Ž›Ž—çi“àj. •ÒW •À–س‹`iˆ®ìˆã‘åjC “ú–{Šwp‰ï‹c, “Œ‹ž, 94.10.30”­s.

567. mŠwp‘n i•ª’SŽ·•Mj ‚bŒ^ŠÌ‰Š‚ÌÅVƒKƒCƒh; HCV‚Ì’´‰Â•Ï—̈æ‚Æ‚»‚̈Ӗ¡, p.25`31, ’†‘ò‹MGi“àjC‰Á“¡é”Vi‘—§‚ª‚ñƒZƒ“ƒ^[j. •ÒW ”Ñ–ìŽl˜Yi¹ƒ}ƒŠƒAƒ“ƒiˆã‘åjC “ì]“°, “Œ‹ž, 94.11.15”­s.

568. mŠwp‘n i•ª’SŽ·•Mj ƒƒ“ƒ|ƒCƒ“ƒg“à‰Èf’fŠw; Á‰»ŠÇŽ¾Š³, p.153`181, a’J–¾—²C¼Œ³Ž›Ž—çi“àj. •ÒW –ì“cŠì‘ãˆêi_“Þ쎕‰È‘åjC’Å–¼Wˆêi“Œ‹žˆãŽ•‘åjC‹àŽR³–¾i•½’Ë‹¤Ï•a‰@jC ‹àŒ´o”Å, “Œ‹ž, 95.01.20”­s.

569. mŠwp‘n i•ª’SŽ·•Mj ˆÝŠà|f’f‚ÆŽ¡—Ã|; “àŽ‹‹¾f’f|–ò—Šw“I“àŽ‹‹¾‚É‚æ‚éf’f|, p.302`307, ‘åˆä“c³lC¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj. •ÒW ’O‰HŠ°•¶i–h‰qˆã‘åjC “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 95.01.25”­s.

570. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj1995; ‹}«ˆÝ”S–Œ•a•Ïi‹}«ˆÝ‰ŠC‹}«ˆÝ’×á‡), p.354`355, ‘åˆä“c³li“àj. •ÒW ˆîŠ_‹`–¾iç—t‘åjC‘¼C ˆãŠw‘‰@, “Œ‹ž, 95.02.15”­s.

571. mŠwp‘n i•ª’SŽ·•Mj Á‰»ŠíŠà‚̉»Šw—Ö@; is¥Ä”­ˆÝŠà‚̉»Šw—Ö@, p.84`96, ¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àjCŒIŒ´–«iº˜a‘åj. •ÒW ŒIŒ´–«iº˜a‘åjC ‚Ö‚é‚·o”Å, “Œ‹ž, 95.03.20”­s.

572. mŠwp‘n i•ª’SŽ·•Mj Šà‚̉»Šw—Ö@ Intensive‚© Palliative‚©; isˆÝŠà‚ɑ΂·‚鎡—Õûj, p.11`18, ¬ò˜aŽO˜Yi“àj. •ÒW ƒƒfƒBƒJƒ‹ƒgƒŠƒrƒ…[ƒ“ŽÐC “ú–{ƒAƒNƒZƒ‹EƒVƒ…ƒvƒŠƒ“ƒK[o”Å, “Œ‹ž, 95.03.10”­s.

573. mŠwp‘n i•ª’SŽ·•Mj ˆÝ|Œ`‘Ô‚Æ‚»‚Ì‹@”\‘æ‚Q”Å; ‘æ‡V̓XƒgƒŒƒX‚Æ”S–Œ–hŒä‹@\‚Q. ”S‰t, p.200`203, ÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j. •ÒW ìˆäŒ[Žsi‹ž“s•{—§ˆã‘åj, ˆãŠw‘‰@C“Œ‹žC94.11.15”­s.

574. mŠwp‘n i•ª’SŽ·•Mj ˆÝ-Œ`‘Ô‚Æ‚»‚Ì‹@”\‘æ‚Q”Å; ‘æ‡U͈ݥ\“ñŽw’°‚Ì‹@”\‚T. ”S‰t•ª”å, p.166`171, –x“c‹±Žqi¶‰»jCÎŒ´˜a•Fi‰»j. •ÒW ìˆäŒ[Žsi‹ž“s•{—§ˆã‘åj, ˆãŠw‘‰@C“Œ‹žC94.11.15”­s.

575. mŠwp‘n i•ÒWj ¡“ú‚ÌŽ¡—ÃŽwj, 1995; “àŽ‹‹¾f’f|–ò—Šw“I“àŽ‹‹¾‚É‚æ‚éf’f|, p.302`307, •ÒW ¼Œ³Ž›Ž—çi“àjC‘¼27–¼C ˆãŠw‘‰@, “Œ‹ž, 95.02.15”­s.

576. m‹³‰È‘n i•ª’SŽ·•Mj FocusÁ‰»Ší ¢• •”‹~‹}ˆã—ã; ¬’°oŒŒf’f‚̃Rƒc, p.109`115, Ÿ–””º‰hCŒÜ\—’³Li“àj. •ÒW Š™“c•MC–[–{‰p”Viã‘åjC ’†ŽR‘“X, “Œ‹ž, 94.05.25”­s.

577. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i‹¤’˜j isˆÝŠà‚ɑ΂·‚é 5'DFUR+CDDP•¹—p—Ö@‚ÌŒ»ó‚Æ“W–]. ¬ò˜aŽO˜Yi“àjC“‡“cˆÀ”Ži‘—§‚ª‚ñƒZƒ“ƒ^[jCÔ‘òCŒáié‹Ê‚ª‚ñƒZƒ“ƒ^[jCŒIŒ´–«iº˜a‘åj. •ÒW ƒuƒŠƒXƒgƒ‹ƒ}ƒCƒ„[ƒYƒXƒNƒCƒuC ƒuƒŠƒXƒgƒ‹ƒ}ƒCƒ„[ƒYƒXƒNƒCƒu, “Œ‹ž, 94.00.00”­s.

578. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ª’SŽ·•Mj “úíf—Â̂½‚ß‚Ì“àŽ‹‹¾ŒŸ¸‚ÌŽÀÛ|ã•”Á‰»ŠÇ•Ò|; ŒŸ¸‚Ì‘O‚É, p.8`13, ‘åˆä“c³li“àj. •ÒW ¼Œ³Ž›Ž—çi–k—¢‘åjC “úŒoƒƒfƒBƒJƒ‹, “Œ‹ž, 94.03.25”­s.

579. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ª’SŽ·•Mj isˆÝŠài‘Š‘ΔñŽ¡Øœ—áj‚ɑ΂·‚é5FU+CDDPpŒã•â••¹—p‰»Šw—Ö@; ¬ò˜aŽO˜Yi“àjC“‡“cˆÀ”Ži‘—§‚ª‚ñƒZƒ“ƒ^[jCÔ‘òCŒáié‹Ê‚ª‚ñƒZƒ“ƒ^[jCŒIŒ´–«iº˜a‘åj. •ÒW ƒuƒŠƒXƒgƒ‹ƒ}ƒCƒ„[ƒYƒXƒNƒCƒuC ƒuƒŠƒXƒgƒ‹ƒ}ƒCƒ„[ƒYƒXƒNƒCƒuC“Œ‹ž, 94.00.00”­s.

580. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ª’SŽ·•Mj “úíf—Â̂½‚ß‚Ì“àŽ‹‹¾ŒŸ¸‚ÌŽÀÛ|ã•”Á‰»ŠÇ•Ò|; ã•”Á‰»ŠÇ‚̃XƒNƒŠ[ƒjƒ“ƒO–@, p.14`25, ‘åˆä“c³li“àj. •ÒW ¼Œ³Ž›Ž—çi–k—¢‘åjC “úŒoƒƒfƒBƒJƒ‹, “Œ‹ž, 94.03.25”­s.

581. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ª’SŽ·•Mj “úíf—Â̂½‚ß‚Ì“àŽ‹‹¾ŒŸ¸‚ÌŽÀÛ|ã•”Á‰»ŠÇ•Ò|; “àŽ‹‹¾‚ÌÁ“Å–@, p.27`31, ‘åˆä“c³li“àj. •ÒW ¼Œ³Ž›Ž—çi–k—¢‘åjC “úŒoƒƒfƒBƒJƒ‹, “Œ‹ž, 94.03.25”­s.

582. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ª’SŽ·•Mj “úíf—Â̂½‚ß‚Ì“àŽ‹‹¾ŒŸ¸‚ÌŽÀÛ|ã•”Á‰»ŠÇ•Ò|; “àŽ‹‹¾“IŽ¡—Ãp, p.63`73, ‰¡ŽR–õi“àj. •ÒW ¼Œ³Ž›Ž—çi–k—¢‘åjC “úŒoƒƒfƒBƒJƒ‹, “Œ‹ž, 94.03.25”­s.

583. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ª’SŽ·•Mj “úíf—Â̂½‚ß‚Ì“àŽ‹‹¾ŒŸ¸‚ÌŽÀÛ|ã•”Á‰»ŠÇ•Ò|; ˆÝ—Ç«Ž¾Š³‚ÌŠÓ•ÊC\“ñŽw’°Ž¾Š³‚ÌŠÓ•Ê, p.51`62, “c•Ó‘i“àj. •ÒW ¼Œ³Ž›Ž—çi–k—¢‘åjC “úŒoƒƒfƒBƒJƒ‹, “Œ‹ž, 94.03.25”­s.

584. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ª’SŽ·•Mj “úíf—Â̂½‚ß‚Ì“àŽ‹‹¾ŒŸ¸‚ÌŽÀÛ|ã•”Á‰»ŠÇ•Ò|; ˆÝˆ««Ž¾Š³‚ÌŠÓ•Ê, p.40`50, ¬ò˜aŽO˜Yi“àj. •ÒW ¼Œ³Ž›Ž—çi–k—¢‘åjC “úŒoƒƒfƒBƒJƒ‹, “Œ‹ž, 94.03.25”­s.

585. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ª’SŽ·•Mj “úíf—Â̂½‚ß‚Ì“àŽ‹‹¾ŒŸ¸‚ÌŽÀÛ|ã•”Á‰»ŠÇ•Ò|; H“¹Ž¾Š³‚ÌŠÓ•Ê, p.32`39, ΈäŒ\‘¾i“àj. •ÒW ¼Œ³Ž›Ž—çi–k—¢‘åjC “úŒoƒƒfƒBƒJƒ‹, “Œ‹ž, 94.03.25”­s.

586. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Long term effect of angiotensin-converting enzyme inhibitor on urinary albumin excretion (UAE) and on renal function in normotensive type 2 (non-insulin-dependent) diabetic patients. “Iê´˜aC‹àXWC–‹`’‰i“àj: 30th Meeting of EASD i94.09.26`27j, Dusseldorf, Germany.

587. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ultrastructural study of glomerular basement membrane in diabetic rats by quick-freezing and deep-etching method. –‹`’‰CŽç‰®’B”üC“c’†Œ[Ži‚`C“Iê´˜aC‹àXWi“àj: 4th International Symposium on Hypertension associated with Diabetes Mellitus - A Satellite Symposium of 15th International Diabetes Federation Congress i94.11.04`05j, ‘å’Ã-‘åã.

588. mŠw‰ïi‘Ûjn iƒ[ƒNƒVƒ‡ƒbƒvj The blood supply route to the esophageal varices evaluated by endoscopic varicealography during injection sclerotherapy and its recurrence. ‘•ª–ΔŽC‘ºã‹§lC‚“c‰ë”ŽC¼“c–€–çC¼–{ˆÌ’jC²“¡³Ž÷CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: 2nd International Congress of Pathophysiology i94.11.23j, ‹ž“s, Pathophysiology, 1(Suppl.): 320, 1994.

589. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The N-acetyltransferase (NAT) gene: an early risk marker for diabetic nephropathy in Japanese type 2 (non-insulin-dependent) diabetic patients? Neugebauer, S.i‘—§ˆã—ÃZƒ“ƒ^[jC”nêPti“àjCWatanabe, T.CKurokawa, K.i‘—§ˆã—ÃZƒ“ƒ^[j: 7th Meeting of European Diabetic Nephropathy Study Group i94.05.20j, Zwolle, Holland.

590. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Ultrastructural study of glomerulus in diabetic nephropathy by quick-freezing and deep-etching method. Žç‰®’B”üC–‹`’‰i“àj: 7th Meeting of European Diabetic Nephropathy Study Group i94.05.21j, Zwolle, Holland.

591. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j N-acetyltransferase (NAT) gene and diabetic nephropathy in NIDDM patients in Japan. Neugebauer, S.i‘—§ˆã—ÃZƒ“ƒ^[jC”nêPti“àjCWatanabe, T.CKurokawa, K.i‘—§ˆã—ÃZƒ“ƒ^[j: ‘æ15‰ñ‘Û“œ”A•aŠw‰ï i94.11.10j, _ŒË.

592. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Autoimmunization of colonic mucins induced colonic mucosal damage in rat. ¬Œ´ii¶‰»jCŒÜ\—’³LC“n•Ó•üŒbi“àjC–x“c‹±Žqi¶‰»j: International Conference on Ulcer Research i94.11.22j, ‹ž“s, Digestion, 55(Suppl.2): 32, 1994.

593. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Prognostic factors related to two-year survival in patients with inoperable gastric cancer; Results from Japanese clinical oncology group (JCOG) studies. Miyata, Y.COda, Y.COhtsu, A.CSeki, S.CYoshida, S.CShimada, Y.CSaito, H.CMorise, K.COhkubo, S.CSasai, T.C¬ò˜aŽO˜Yi“àjCKurihara, M.iJCOG): American Society of Clinical Oncology (ASCO) i94.05.15j, ƒ_ƒ‰ƒX, ASCO, 13(3): 216, 1994.

594. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Ulcerative colitis-like mucosal disorder in rat with anti-colonic mucin autoantibodies. ¬Œ´ii¶‰»jCŒÜ\—’³LC“n•Ó•üŒbi“àjC–x“c‹±Žqi¶‰»j: American Gastroenterological Association i94.05.18j, New Orleans, U.S.A., Gastroenterology, 106(4): 747, 1994.

595. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The N-acetyltransferase (NAT) gene and diabetic nephropathy in Japanese type 2 (non-insulin-dependent) diabetic patients. Neugebauer, S.i‘—§ˆã—ÃZƒ“ƒ^[jC”nêPti“àjCWatanabe, T.CKurokawa, K.i‘—§ˆã—ÃZƒ“ƒ^[j: 30th Meeting of EASD i94.09.27`10.01j, Dusseldorf, Germany.

596. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Is follow-up colonoscopy necessary in early colorectal cancer after endoscopic resection? ŒÜ\—’³LCŽO‹´—˜‰·CŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: 8th Congress of Digestive Endoscopy i94.10.04j, Los Angeles, USA.

597. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Mechanism of rat gastric mucus secretion stimulated by gastrin. ¬Žº—Tˆêi“àjCÎŒ´˜a•Fi‰»ŠwjC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: 10th World Congress of Gastroenterology i94.10.05j, Los Angeles, USA, Abstracts, p.1395, 1994.

598. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j A possible mechanism for the gastric protection by Shokyo (Zingiberis rhizoma), a crude herbal drug. •û—D”üi“àjCŒÜäzsMi¶‰»jCÎŒ´˜a•Fi‰»ŠwjC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: 10th World Congress of Gastroenterology i94.10.06j, Los Angeles, USA, Abstracts, p.1985, 1994.

599. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Usefulness of Otsuka Long Evans Tokushima Fatty (OLETF) rat for understanding Mailland reaction in diabetic complications. “¡“c–F–Mi“àjC’†‘º‘‰qi•ª¶jC–쌳‚¯‚¢Žqi¶•¨‰»ŠwŒnjC¬—ÑOsCŽç‰®’B”üC‹àXWC“Iê´˜aC–‹`’‰i“àj: ‘æ15‰ñ‘Û“œ”A•aŠw‰ï i94.11.06j, _ŒË.

600. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j HPLC detection of human serum 2-keto-3-deoxygluconic acid derived from glycation intermediate, 3-deoxyglucosone. “¡ˆä‰pi“àjCŠâ£m—ECŽPˆèŽqi¶‰»jC–‹`’‰i“àjC–x“c‹±Žqi¶‰»j: ‘æ15‰ñ‘Û“œ”A•aŠw‰ï i94.11.07j, _ŒË.

601. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effect of orally administered pig gastric mucin on the protection of gastrin mucosa against ethanol-induced damage in rats. Žðˆä’C•Fi“àjCÎŒ´˜a•Fi‰»ŠwjCŽs쑸•¶i¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: 8th International Conference on Ulcer Research i94.11.22j, ‹ž“s, Digestion, p.37, 1994.

602. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical study on massive hemorrhage in Crohn's disease. ‹g‘º‚Ü‚âŽqCŒÜ\—’³LCŸ–””º‰hC“à“¡‹g—²C¼‘q“¿]C¼Œ³Ž›Ž—çi“àjCŽO•xO”Vi•a—j: International Symposium on Recent Advances in Inflammatory Bowel Disease i94.11.23`24j, ‹ž“s, —\eW, p.83, 1994.

603. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Evaluation of early gastric cancer using infrared ray electronic endoscopy. “c•Ó‘C¬ò˜aŽO˜YC“ú”䌪ˆêCΈäŒ\‘¾C¡òOC‰¡ŽR–õC‘åˆä“c³lCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àjC“ˆ”ömCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjCã™G‰iCŽO •xO”Vi•a—j: ‘æ‚P‰ñ‘ۈ݊à‰ï‹c i95.03.31j, ‹ž“s.

604. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical study of combination therapy with continuous infusion of 5FU, MMC and CDDP (cFMP) in the treatment of advanced gastric cancer. ¬ò˜aŽO˜YC‹ß“¡ˆê‰pC²“c”ü˜aC’†ˆä‹v—YCrìä•vC¡òOC“c•Ó‘C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ‘æ‚P‰ñ‘ۈ݊à‰ï‹c i95.03.31j, ‹ž“s.

605. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j •\–ÊŒ^Žîá‡‚Ì“àŽ‹‹¾f’f. ŒÜ\—’³Li“àj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË.

606. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j –«ƒEƒCƒ‹ƒX«ŠÌ‰Š‚ÌŒo‰ß‚¨‚æ‚уCƒ“ƒ^[ƒtƒFƒƒ“—Ö@‚É‚æ‚éŠÌ•\–Ê”÷׌ŒŠÇ\’z‚̕ω»‚ɂ‚¢‚Ä. a’J–¾—²C”’èŒh“ñi“àj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË.

607. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j oŒŒ«’×ᇂɑ΂·‚é“àŽ‹‹¾“IŽ~ŒŒ–@‚ÌŒÀŠE. “c•Ó‘i“àjC’Ë–{GliŠOj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË, Gastroenterol. Endosc., 36(11): 2302`2304, 1994.

608. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆÝ֬᎔j—ô‚ɑ΂·‚éV‚½‚ÈŽ¡—Ö@; BRTOi—¯’u–@j‚Ì—L—p«. ‘•ª–ΔŽC¼“c–€–çC‚“c‰ë”ŽC‘ºã‹§li“àjC‰““¡‚C¼Šª”ŽCˆé•”‹`Œ›i•új: ‘æ23‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i94.09.09j, ’•ƒ.

609. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰»Šw—Ö@‚ðæs‚·‚闧ꂩ‚ç|5'-DFUR‚ðŠÜ‚Þ CDDP•¹—p—Ö@‚ð’†S‚É|. ¬ò˜aŽO˜Yi“àjCŒIŒ´–«iº˜a‘åjCŽOd–슰ŠìiŠOj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.05j, ‰ªŽR, “ú–{ŠàŽ¡—Êw‰ïŽ, 29(8): 1088, 1994.

610. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j isˆÝŠà‚ɑ΂·‚é‰äX‚ÌŽ¡—Õûj. ¬ò˜aŽO˜Yi“àj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.05j, ‰ªŽR, —\eW, p.2, 1994.

611. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆÝH“¹Ã–¬áŽ‚É‚¨‚¯‚é“àŽ‹‹¾“IŽ¡—Â̌»‹µ|EIS‚Æ EVL¥BRTO‚Ì“K‰ž‚Æ‘I‘ð|. ‘•ª–ΔŽC‘ºã‹§li“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.19j, ŽD–y.

612. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ׌a’´‰¹”gƒvƒ[ƒu(USP)‚É‚æ‚é\“ñŽw’°’×ᇂ̌Ÿ“¢. ŽR“cŽŠlC¼Œ³Ž›Ž—çi“àj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.26j, _ŒË, Gastroenterol. Endosc., 36(12): 2518`2519, 1994.

613. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj “œ”A•a«tÇ‘Šú‚ÌtŽ…‹…‘Ì”÷×\‘¢. “c’†Œ[Ži‚`CŽç‰®’B”üi“àj: “ú–{—Õ°“dŽqŒ°”÷‹¾Šw‰ï i94.10.05j, ‚’m, “ú–{—Õ°“dŽqŒ°”÷‹¾Šw‰ïŽ, 27(‘): 67, 1994.

614. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj • o‹¾‘œ‚©‚猩‚½‚bŒ^–«ŠÌ‰Š‚̃Cƒ“ƒ^[ƒtƒFƒƒ“(IFN)Ž¡—ÃŒø‰Ê‚Ì•]‰¿. a’J–¾—²C²“¡³Ž÷i“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.18j, ŽD–y.

615. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “œ”A•aHŽ–—Ö@‚Ì–â‘è‰ðŒˆŒ^Žw“±‚ÉŠÖ‚·‚錤‹†. –{‹{“N–çC”Ñ“‡—R‰Á—¢C‘å˜a“c—¢C¼ì—mŽqi“àjC‚—Ñ—mˆêCŒŠ‘ò‰€ŽqC‰ªè—ߎqi϶‰ï•a‰@jC‚‘ºGiˆ¢Šê—¯•a‰@j: ‘æ36‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï i93.05.13`15j, å‘ä, “œ”A•a, 36(Suppl.): 203, 1993.

616. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚bŒ^–«ŠÌ‰Š‚É‚¨‚¯‚éIFNŽ¡—ÃŒø‰Ê‚ÆŠÌüˆÛKƒ}[ƒJ[‚Ì„ˆÚ‚ɂ‚¢‚Ä. “ˆ’×TC“n•”K•vC’†‘º—zŽqi‘—§‘Š–ÍŒ´•a‰@jCÎìŽåÅi“àjCˆäo“NCˆÀ•”–¾˜YC“‡–ì‹B”ªCˆÀ’BŒ£Có”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘æ28‰ñ¬l•aŠw‰ï i94.01.14j, “Œ‹ž.

617. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Á‰»«’×ᇂÌÄ”­—¦‚ÆŒŒ´R Hp-IgGR‘̉¿‚ÌŠÖ˜A. ¬ò˜aŽO˜YCˆÀ’BŒ£C’†ˆä‹v—YC‹ß“¡ˆê‰pC“ú”䌪ˆêC²“c”ü˜aCŽRãp‚³‚ä‚èC¡òOCΈäŒ\‘¾C“c•Ó‘C‰¡ŽR–õCŽO‹´—˜‰·C‘åˆä“c³lC¼Œ³Ž›Ž—ç i“àj: ‘æ80‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i94.04.22j, _ŒË, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 51, 1994.

618. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚̈ݕa•Ï‚É‚¨‚¯‚錌’†HPR‘Ì‚ÌŒŸ“¢|ˆÝ’×ᇇ•¹ŒQ‚Æ”ñ‡•¹ŒQ‚Æ‚Ì”äŠr|. ˆÀ’BŒ£C‘“ŒŠ²•vC’†‘º—zŽqC“ˆ’×TCÎìŽåÅCˆäo“NC“n•”K•vCˆÀ•”–¾˜NCŽR“cº•vC¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj: ‘æ80‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i94.04.23j, _ŒË.

619. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’×ᇫ‘å’°‰Š‚ɇ•¹‚µ‚½”畆•a•Ï‚ÌŒŸ“¢. ¼‘q“¿]CŒÜ\—’³LC“à“¡‹g—²C²“c”ü˜aCŸ–””º‰hC¼Œ³Ž›Ž—çC¬—Ñ´“Ti“àjCŽO•xO”Vi•a—j: ‘æ80‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i94.04.23j, _ŒË.

620. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ex-vivo gastric chamber‚É‚æ‚郉ƒbƒgˆÝ‰Â—n«”S‰t•ª”å“®‘Ô‚ÌŒŸ“¢. Žðˆä’C•Fi“àjCÎŒ´˜a•Fi‰»ŠwjC–x“c‹±Žqi¶‰»j: ‘æ80‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i94.04.23j, _ŒË.

621. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠeŽíƒŒƒNƒ`ƒ“‚ð—p‚¢‚½ƒ€ƒ`ƒ“‘ª’è–@‚ÌŒŸ“¢. “n•Ó•üŒbi“àjC¬Œ´iCŽs쑸•¶i¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ80‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i94.04.23j, _ŒË, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 557, 1994.

622. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒKƒXƒgƒŠƒ“‚¨‚æ‚уqƒXƒ^ƒ~ƒ““Š—^‚É‚æ‚é”S‰t“®‘Ô‚Æ”S–Œ–hŒä‚ÌŒŸ“¢|ˆÝ‚Æ\“ñŽw’°‚É‚¨‚¯‚é”äŠr|. ¬Žº—Tˆêi“àjCÎŒ´˜a•Fi‰»ŠwjC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ80‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i94.04.23j, _ŒË, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 653, 1994.

623. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgƒGƒ^ƒm[ƒ‹’×ᇂɑ΂·‚銿•û–ò’PÜ‚ÌŒø‰Ê|ˆÝ”S‰t—Ê•Ï“®‚ÌŒŸ“¢|. •û—D”üi“àjCŒÜäzsMi¶‰»jCÎŒ´˜a•Fi‰»ŠwjCŽs쑸•¶i¶‰»jCŽðˆä’C•FC“n•Ó•üŒbC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ80‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i94.04.23j, _ŒË, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 723, 1994.

624. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “œ”A•a«ˆÝ”roáŠQ‚É‚¨‚¯‚éÁ‰»ŠÇ‰^“®‹@”\ŒŸ¸‚ÌŒŸ“¢. ΈäŒ\‘¾C“c•Ó‘Crìä•vCŽRãp‚³‚ä‚èC’†ˆä‹v—YC‹e’rVC‹ß“¡ˆê‰pC¡òOC¬ò˜aŽO˜YC‰¡ŽR–õC‘åˆä“c³lCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: ‘æ80‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i94.04.23j, _ŒË, —\eW, p.296, 1994.

625. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°—p‚Qƒ`ƒƒƒ“ƒlƒ‹“dŽq“àŽ‹‹¾iƒIƒŠƒ“ƒpƒXŽÐ» XCF-2T200)‚ÌŽg—pŒoŒ±. ‚‹´KGCŒÜ\—’³LC²“c”ü˜aC¼‘q“¿]C“à“¡‹g—²CŸ–””º‰hC¼Œ³Ž›Ž—çC¬—Ñ´“Ti“àj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË.

626. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ÔŠOü“dŽq“àŽ‹‹¾‚É‚æ‚é‰æ‘œ‹­’²‚ÌŒŸ“¢. “c•Ó‘C¬ò˜aŽO˜YC“ú”䌪ˆêCŽRãp‚³‚ä‚èCrìä•vC’†ˆä‹v—YC‹ß“¡ˆê‰pC‹e’rVC¡òOCΈäŒ\‘¾C‘•ª–ΔŽC‰¡ŽR–õC‘åˆä“c³lCŽO‹´—˜‰·C¼Œ³Ž› Ž—çi“àj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË, Gastroenterol. Endosc., 37(1): 151, 1995.

627. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°‘ŠúŠà‚ɑ΂·‚é’´‰¹”g“àŽ‹‹¾f’f‚Ì—Õ°“IˆÓ‹`. ¬—Ñ´“TC“à“¡‹g—²i“àj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË, u‰‰—\eW, p.205, 1994.

628. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ÔŠOü“dŽq“àŽ‹‹¾‚É‚æ‚é‘ŠúˆÝŠàÇ—á‚ÌŒŸ“¢i‘æ‚Q•ñ). “ú”䌪ˆêC“c•Ó‘C¬ò˜aŽO˜YC‹ß“¡ˆê‰pCŽRãp‚³‚ä‚èC’†ˆä‹v—YC¡òOCΈäŒ\‘¾C‰¡ŽR–õCŽO‹´—˜‰·C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìC”äŠé ”\Ž÷iŠOjCŽO•xO”VCã™G‰ii•a—jC•x’Ë–FŒ›i•úŽËü•”j: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË, u‰‰—\eW, p.216, 1994.

629. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰æ‘œ‰ðÍ‚ð—p‚¢‚½‘ŠúˆÝŠà‚Ì”S–ŒŒŒ‰t—Ê‚ÌŒŸ“¢|“Á‚É pharmacoendoscopy‚É‚æ‚éŒoŽž“I•Ï‰»‚ɂ‚¢‚Ä|. ¡òOC‘åˆä“c³lC“ú”䌪ˆêC—ÑO”üCrìä•vCŽRãp‚³‚ä‚èC‹ß“¡ˆê‰pC‹e’rVC’†ˆä‹v—YCΈäŒ\‘¾C“c•Ó‘C¬ò˜aŽO˜YC‰¡ŽR–õCŽO‹´—˜‰·C¼Œ³Ž›Ž —çi“àj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË, u‰‰—\eW, p.55, 1994.

630. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°‹¾‚É‚æ‚éŒo‰ßŠÏŽ@’†”­Œ©‚³‚ꂽ‘å’°Šà‚ÌŒŸ“¢. ²“c”ü˜aCŒÜ\—’³LC¼‘q“¿]C‚‹´KGC“à“¡‹g—²CŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCŽO•xO”VC’†‰p’ji•a—j: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË, “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 36(2): 59, 1994.

631. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j \“ñŽw’°ƒtƒ@ƒCƒo[ƒXƒR[ƒvTJF-30‚ÌŽg—pŒoŒ±. âŒû“NÍC¡òOC¼ŽR˜a’jCó–ì˜NC²”ŒˆÐ’jCŽl‹{—R”üŽqC‘“c‰p–¾CˆË“c•qC¡‘º´ŽqC²“‡Œh´i‰¡•lŽs—§Žs–¯•a‰@jC‘åˆä“c³lC¼Œ³Ž›Ž—ç i“àj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË, —\eW, p.205, 1994.

632. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “àŽ‹‹¾“I֬᎑¢‰e(EVIS)‚ÌŒŸ“¢|‘æ‚V•ñ: Ä”­Ã–¬áŽ‚ÌŒŸ“¢. ‘ºã‹§lC‘•ª–ΔŽC¼“c–€–çCŽ›ÎŒOC‚“c‰ë”ŽCÄ“¡rŽiC¼–{ˆÌ’jC²“¡³Ž÷C”’èŒh“ñC™–{­’¼Ca’J–¾—²CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.26j, _ŒË, —\eW, p.253, 1994.

633. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “œ”A•a«tÇ‚ÌŽ…‹…‘Ì’´”÷\‘¢‚Æt‹@”\‚Æ‚ÌŠÖ˜A. “c’†Œ[Ži‚`CŽç‰®’B”üC•½ˆä–@”ŽC‹àXWC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àjC‘å–ìLˆêiŽR—œˆã‘åj: ‘æ37‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï i94.05.13j, “¿“‡, “œ”A•a, 37(Suppl.): 119, 1994.

634. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j HPLC‚É‚æ‚éƒqƒg‹y‚Ñ“œ”A•aƒ‰ƒbƒgŒŒ‰t’†‚Ì 3-ƒfƒIƒLƒVƒOƒ‹ƒRƒ“Ž_‚Ì‘ª’è. “¡ˆä‰pi“àjCŠâ£m—ECŽPˆèŽqi¶‰»jCŽç‰®’B”üC“c’†Œ[Ži‚`C–‹`’‰i“àjC–x“c‹±Žqi¶‰»j: ‘æ37‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï i94.05.13j, “¿“‡, “œ”A•a, 37(Suppl.1): 368, 1994.

635. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌ×–EŠà‚É“ÁˆÙ“I‚È ALDH‚ɑ΂·‚郂ƒmƒNƒƒi[ƒ‹R‘Ì‚Ì컂¨‚æ‚іƉu‘gDŠw“IŒ¤‹†. a’J–¾—²i“àjC’|“à“ÖŽqi“Œ•a‰@Œ¤‹†ŒnjCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ30‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï i94.07.08j, ˆ®ì, ŠÌ‘Ÿ, 35(Suppl.1): 214, 1994.

636. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j d‰»—Ö@‚É‚æ‚è֬᎓àŽ_‘f•ªˆ³‚ªã¸‚µ‚½‚P—á. ‘ºã‹§lC‘•ª–ΔŽC¼“c–€–çC›–ì‘C‚“c‰ë”ŽCÄ“¡rŽiC¼–{ˆÌ’jC²“¡³Ž÷C”’èŒh“ñCa’J–¾—²CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ‚P‰ñ“ú–{–å–¬ˆ³˜´iÇH“¹Ã–¬áŽŠw‰ï i94.09.27j, “Œ‹ž.

637. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j isˆÝŠà‰»Šw—Ö@‚É‚¨‚¯‚錴”­‘ƒ•]‰¿‚̈Ӌ`. ‘å’ÓÖC“‡“cˆÀ”ŽC‹g“c–κC‹{“c‰À“TCŠÖ–ÎŽ÷CÄ“¡”ŽCX£Œö’åC‘å‹v•ÛrŽ¡CŽÂˆäŠiiŒú¶È¢ŒÅŒ`‚ª‚ñ‚ÌWŠw“IŽ¡—㌤‹†”ÇjC¬ò˜aŽO˜Yi“àjCŒI Œ´–«iº˜a‘åj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.05j, ‰ªŽR, “ú–{ŠàŽ¡—Êw‰ïŽ, 29(8): 1196, 1994.

638. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Øœ•s”\isŠà‚ɑ΂·‚é 5FU, MMC, CDDP (cFMP)—Ö@‚ÌŒŸ“¢. ¬ò˜aŽO˜YC‹ß“¡ˆê‰pC²“c”ü˜aC’†ˆä‹v—YCrìä•vC¡òOC“c•Ó‘C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.05j, ‰ªŽR, “ú–{ŠàŽ¡—Êw‰ïŽ, 29(8): 1197, 1994.

639. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Øœ•s”\ˆÝŠà‚ɑ΂·‚é 5'DFUR, MMC•¹—p‚É‚¨‚¯‚é CDDP‚ÌŽŠ“K“Š—^—Ê‚ÉŠÖ‚·‚é”äŠr—Õ°ŽŽŒ±. ²“¡‰·C’·’Jì_ˆêiisˆÝŠàŽ¡—ÃŒ¤‹†“¯D‰ïjC¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àjC’·“ì–¾“¹Cˆäã–ÎC‹v•Û•Û•FC‘Oì—²ˆê˜YCŠâè—ÇŽOCŽÂˆäŠiC•ŸŽR‰x’jC ŒIŒ´–«CÎì–MŽkCŽOD˜a•vCˆÀ•WˆêC‘ì½iisˆÝŠàŽ¡—ÃŒ¤‹†“¯D‰ïj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.05j, ‰ªŽR, “ú–{ŠàŽ¡—Êw‰ïŽ, 29(8): 1197, 1994.

640. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝ“à•ª”å×–EŠà‡•¹Œ´”­«ŠÌ×–EŠà‚ÉˆÝ“àŽ‹‹¾“IØœp‚Ɖ»Šw—Ö@‚ª’˜Œø‚µ‚½‚P—á. “ú‚‰›CŠOŽR‹v‘¾˜YC¬–öŒõmC’JìˆêŽuC‘ºãK‘¾˜YC’|‹g—R‰ÁŽuC“n•Ó—²ŽiC–{ŠÔ“ñ˜YC–ì“o½C‚“cˆê‘¾˜YC‹àŽR³–¾i•½’Ë‹¤Ï•a‰@jC–kð°li‰¡•l Žs‘åj: ‘æ43‰ñ‹¤ÏŠw‰ï‘‰ï i94.10.12j, –¼ŒÃ‰®.

641. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’EŒŒ‰º‚¨‚æ‚ÑŠÒŒŒ‰º‚ÌŒŒs“®‘Ԃ̕ω»|ŽGŒ¢‚É‚æ‚éŽÀŒ±“IlŽ@|. –{‹´CCŠô¢‹´“ÄC²–ìG–íC‚–ظˆêC¼Œ³Ž›Ž—çi“àjC’†ŽR–ÎMiŽÀ“®Œnj: ‘æ35‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï i94.10.14j, “Œ‹ž, –¬ŠÇŠw, 34: 743, 1994.

642. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j R’×ᇖò‚̈ݒ×á‡á­•”‚Ì”S–ŒŒŒ‰t—Ê‚É—^‚¦‚é‰e‹¿‚ɂ‚¢‚Ä|“Á‚Épharmacoendoscopy‚ð—p‚¢‚½ŒŸ“¢|. ¡òOC‘åˆä“c³lC“ú”䌪ˆêC—ÑO”üCŽRãp‚³‚ä‚èC’†ˆä‹v—YC‹ß“¡ˆê‰pCΈäŒ\‘¾CŽO‘î‰Ã—YC“c•Ó‘C¬ò˜aŽO˜YC‰¡ŽR–õCŽO‹´—˜‰·C¼Œ³Ž›Ž—ç i“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.17j, ŽD–y.

643. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j H“¹ˆÝÖ¬áŽ‚Ì“àŽ‹‹¾f’f‚É‚¨‚¯‚éÔŠOü“dŽq“àŽ‹‹¾‚Ì—L—p«|‘æ2•ñ|d‰»—Ö@‘OŒã‚ÌŒŸ“¢. ‘ºã‹§lC‘•ª–ΔŽC¼“c–€–çC›–ì‘C‹g‘º‚Ü‚âŽqC‹v•Û“c•q•FC‚“c‰ë”ŽCÄ“¡rŽiC¼–{ˆÌ’jC²“¡³Ž÷C”’èŒh“ñCa’J–¾—²CŽÄ“c‹v—YC¼Œ³Ž›Ž—ç i“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.17j, ŽD–y, —\eW, p.190, 1994.

644. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j \“ñŽw’°Šà‚Ì—Õ°“IŒŸ“¢. ’†ˆä‹v—YC¬ò˜aŽO˜YC“ú”䌪ˆêCŽRãp‚³‚ä‚èC‹ß“¡ˆê‰pC‹e’rVCã™G‰iCΈäŒ\‘¾C¡òOC“c•Ó‘CâŒû“NÍCŽR“cŽŠlC‰¡ŽR–õCŽO‹´—˜‰·C‘åˆä“c³ lC¼Œ³Ž›Ž—çi“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.17j, ŽD–y, —\eW, p.48, 1994.

645. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’´‰¹”gƒvƒ[ƒu‚É‚æ‚éã•”Á‰»ŠÇ•a•Ï‚Ìf’f|ƒ[ƒŠ[’“ü–@‚Ì—L—p«‚ɂ‚¢‚Ä|. âŒû“NÍC¼ŽR˜a’jCÄ“¡rŽiCŽl‹{—R”üŽqC²“¡N‰iC‘å˜a“c^‹IŽqC‘“c‰p–¾CˆË“c•qC¡‘º´ŽqC²“‡Œh´C•Ÿ“‡P’jC²–ìm—Ei‰¡•lŽs—§•a‰@jCŽR“c ŽŠlC–Ø“cŒõLC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷CŠ`“cÍiŠOjCŽO•xO”VCã™G‰ii•a—j: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.18j, ŽD–y, —\eW, p.210, 1994.

646. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ^ƒC‘‚æ‚蓾‚ç‚ꂽV‚µ‚¢ HCV genotype. ™ŽR˜a•vi‘—§‚ª‚ñƒZƒ“ƒ^[jC’†‘ò‹MGi“àjC‰Á“¡é”VC‰º‰“–ì–M’‰i‘—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ53‰ñ“ú–{ŠàŠw‰ï‘‰ï i94.10.20j, –¼ŒÃ‰®, u‰‰—vŽ|W, 85: 88, 1994.

647. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒg‰–Ž_ƒAƒXƒsƒŠƒ“’×ᇎ¡–üŠú‚É‚¨‚¯‚éˆÝ”S–ŒŠe‘w‚Ì”S‰t—Ê‚ÌŒoŽž“I•Ï“®‚̉ðÍ. Žðˆä’C•Fi“àjCÎŒ´˜a•Fi‰»ŠwjCŽs쑸•¶i¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.10.31j, å‘ä.

648. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝƒ€ƒ`ƒ“—Ê“I¥Ž¿“I•Ï“®‚©‚ç‚Ý‚½ƒƒ`ƒ‹ƒƒ`ƒIƒjƒ“ƒXƒ‹ƒzƒjƒEƒ€ƒNƒƒ‰ƒCƒh(MMSC)‚̃‰ƒbƒgƒGƒ^ƒm[ƒ‹—U”­«ˆÝ”S–ŒŠQ‚ɑ΂·‚éŒø‰Ê. “n•Ó•üŒbi“àjC¬Œ´iCŽs쑸•¶i¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.10.31j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 1682, 1994.

649. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°‘BŽî“àŠà‚É‚¨‚¯‚é p53ˆâ“`ŽqŽY•¨‚̖Ɖu‘gDŠw“IŒŸõ. ‚–ظˆêC–{‹´CC²–ìG–íCŠô¢‹´“ÄC´…º’jiŒ§—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.10.31j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 249, 1994.

650. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽÀŒ±’×ᇂɂ¨‚¯‚鶛I‚̈ݔS–ŒŠQ—}§‹@\‚ÌŒŸ“¢. •û—D”üi“àjCŒÜäzsMi¶‰»jCÎŒ´˜a•Fi‰»ŠwjCŽs쑸•¶i¶‰»jCŽðˆä’C•FC“n•Ó•üŒbC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.10.31j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91: 1677, 1994.

651. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “œ”A•a«ˆÝ”roáŠQ‚̉ü‘P‚ªŒŒ“œƒRƒ“ƒgƒ[ƒ‹‚É‹y‚Ú‚·‰e‹¿. ΈäŒ\‘¾C“c•Ó‘i“àj: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.10.31j, å‘ä, —\eW, p.1903, 1994.

652. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ׌a’´‰¹”gƒvƒ[ƒu‚É‚æ‚é\“ñŽw’°’×ᇂ̌Ÿ“¢. ŽR“cŽŠlCâŒû“NÍi“àj: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.11.01j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 1665, 1994.

653. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒNƒ[ƒ“•a’·ŠúŒo‰ß—á‚É‚¨‚¯‚é‰h—{—Ö@‚Æ–ò•¨—Ö@‚ÌŽ¡—ÃŒø‰Ê‚Ì”äŠrŒŸ“¢. ¬—Ñ´“TCŽR“cL•vi¬“cŒ´Žs—§•a‰@jC“à“¡‹g—²CŒÜ\—’³LCŸ–””º‰hi“àj: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.11.01j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 1717, 1994.

654. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒˆäX‰t’†‚Ì‘B”S‰t×–EŒ^ƒ€ƒ`ƒ“‚ÌŒŸ“¢. ¼àVŒ«Ž¡CŸŽR“wC‘O“‡M–çC•ìŒš“ñCÔ¼‘׎ŸCŒÃ“c¸ˆêC‘¾“c_—ÇiM‘åjCÎŒ´˜a•Fi‰»jCŒIŒ´½iŠÖ“Œ‰»ŠwjC–x“c‹±Žqi¶‰»j: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.11.01j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 1757, 1994.

655. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éisˆÝŠà•a‘ƒ‹ß–T‚Ì”÷—Ê• …‚Ì—Õ°“IˆÓ‹`. Šô¢‹´“ÄC²–ìG–íC–{‹´CC‚–ظˆêiŒ§—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.11.01j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 228, 1994.

656. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’EŒŒ‰º VasopressinŽ‘±“®’‚É‚æ‚錌s“®‘Ԃ̕ω»|ŽGŒ¢‚É‚æ‚éŽÀŒ±“IlŽ@|. –{‹´CCŠô¢‹´“ÄC²–ìG–íC‚–ظˆêiŒ§—§‚ª‚ñƒZƒ“ƒ^[jC¼Œ³Ž›Ž—çi“àj: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.11.02j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 329, 1994.

657. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgƒGƒ^ƒm[ƒ‹«ˆÝ”S–ŒŠQ—\–h‚ÉŠÖ‚·‚郃`ƒ‹ƒƒ`ƒIƒjƒ“ƒXƒ‹ƒzƒjƒEƒ€ƒNƒƒ‰ƒCƒh(MMSC)‚Ìì—p‹@˜‚ÌŒŸ“¢. “n•Ó•üŒbi“àjC¬Œ´iCŽs쑸•¶i¶‰»jC•û—D”üi“àjCŽðˆä’C•FC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ22‰ñ“ú–{ŽÀŒ±’×ᇊw‰ï i94.11.10j, ‘åã.

658. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`(RA)Š³ŽÒ‚É‚¨‚¯‚éƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“–@‚É‚æ‚éˆÝ”ro”\‘ª’è‚ÌŽŽ‚Ý|ˆÝ’×ᇇ•¹ŒQ‚Æ”ñ‡•¹ŒQ‚Æ‚Ì”äŠr|. ‘“ŒŠ²•vCˆÀ’BŒ£i“àjC”M“c—¹CˆÀ“ŒŽ¡˜Yi‘—§‘Š–ÍŒ´•a‰@jCŽ­ŠÔL–¾i“àjCˆäo“NC“n•”K•vCŽR“cº•vCˆÀ•”–¾˜Yi‘—§‘Š–ÍŒ´•a‰@jC¼Œ³Ž›Ž—ç i“àj: ‘æ49‰ñ‘—§—×{Š‘‡ˆãŠw‰ï i94.11.10j, ’·è.

659. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚̈ݕa•Ï‚É‚¨‚¯‚錌’†RHPR‘Ì‚ÌŒŸ“¢|ˆÝ’×ᇇ•¹ŒQ‚Æ”ñ‡•¹ŒQ‚Æ‚Ì”äŠr|. ˆÀ’BŒ£C‘“ŒŠ²•vi“àjC’†‘º—zŽqC“ˆ’×TCˆäo“NC‘Šì’ŽjC“n•”K•vCŽR“cº•vCˆÀ•”–¾˜Yi‘—§‘Š–ÍŒ´•a‰@jC¼Œ³Ž›Ž—çi“àj: ‘æ49‰ñ‘—§—×{Š‘‡ˆãŠw‰ï i94.11.10j, ’·è.

660. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽÀŒ±’×ᇂɂ¨‚¯‚鶖òŠÃ‘‚̃‰ƒbƒgˆÝ”S–ŒŠQ—}§‹@\‚ÌŒŸ“¢. •û—D”üi“àjCŒÜäzsMi¶‰»jCÎŒ´˜a•Fi‰»ŠwjCŽs쑸•¶i¶‰»jCŽðˆä’C•FC“n•Ó•üŒbC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ22‰ñ“ú–{ŽÀŒ±’×ᇊw‰ï i94.11.10j, ‘åã, ´˜^W, p.36, 1994.

661. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚bŒ^–«ŠÌ‰Š‚Ì IFNŽ¡—Âɂ¨‚¯‚é—\Œã‚ÌŒŸ“¢. “ˆ’×TC“n•”K•vCˆÀ’BŒ£Cˆäo“NC’†‘º—zŽqC‘“ŒŠ²•vCˆÀ“ŒŽ¡˜YCˆÀ•”–¾˜YCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘æ49‰ñ‘—§—×{Š‘‡ˆãŠw‰ï i94.11.11j, ’·è.

662. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚bŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXƒGƒ“ƒxƒ[ƒv’`”’Ž¿ (gp70)“à‚Ì’´‰Â•Ï—̈æ‚P‚ɑ΂·‚éƒEƒCƒ‹ƒXŠ”“ÁˆÙ“IR‘Ì. ‰Á“¡é”Vi‘—§‚ª‚ñƒZƒ“ƒ^[jC’†‘ò‹MGi“àjC‘å’ÃŽR—SŽqC™ŽR˜a•vC…’J“N–çC‘å‰zÍŒáC‰º‰“–ì–M’‰i‘—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ17‰ñ“ú–{•ªŽq¶•¨Šw‰ï”N‰ï i94.12.16j, _ŒË, —vŽ|W, 34: 36, 1994.

663. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éRƒ~ƒgƒRƒ“ƒhƒŠƒAR‘Ì—z«—á‚ÌŒŸ“¢. “ˆ’×TC“n•”K•vi‘—§‘Š–ÍŒ´•a‰@jCˆÀ’BŒ£i“àjCˆäo“NC’†‘º—zŽqC‘“ŒŠ²•vCˆÉ“¡‚©‚¨‚éCˆÀ•”–¾˜YCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘æ29‰ñ“ú–{¬l•aŠw‰ï i95.01.14j, “Œ‹ž.

664. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒg”x‚ª‚ñ‚É‚¨‚¯‚éc-raf 1ˆâ“`Žq‚̉ðÍ. ŽO—Ö˜ji“àjCˆÀ“cƒC–q–ì—éŽqC”’ι•FCŠÖ’J„’ji‘—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ16‰ñ“ú–{•ªŽq¶•¨Šw‰ï”N‰ï i93.12.18j, ç—t, ƒvƒƒOƒ‰ƒ€, p.3122, 1993.

665. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j \“ñŽw’°ˆÝã”牻¶‚É‚¨‚¯‚é Helicobacter pylori‚ÌŒŸ“¢. ’†ˆä‹v—YC¬ò˜aŽO˜YCrìä•vCŽRãp‚³‚ä‚èC‹ß“¡ˆê‰pC‹e’rVCΈäŒ\‘¾C¡òOC“c•Ó‘C‰¡ŽR–õCŽO‹´—˜‰·C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ‘æ80‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï i94.04.23j, _ŒË, —\eW, p.71, 1994.

666. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒƒCƒ‰[ƒh”½‰žŒãŠú¶¬•¨iAGE)‰ðÍ‚Ì‚½‚ß‚ÌŽ©‘R”­Ç‡UŒ^“œ”A•aƒ‰ƒbƒg(OLETF)‚Ì—L—p«‚ɂ‚¢‚Ä. “¡“c–F–Mi“àjC’†‘º‘‰qi•ª¶jC‘å˜a“c—¢C–ìŒû‹§ŽqC‹àXWC–‹`’‰i“àjC‹{“cŠ²•viŠájC¬—ÑOsióˆäƒQƒ‹Œ¤j: ‘æ37‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï i94.05.12j, “¿“‡, “œ”A•a, 37(Suppl.): 1, 1994.

667. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ³íŒŒˆ³“œ”A•aŠ³ŽÒ‚Ì–éŠÔŽžŠÔ”A‚É‚æ‚éƒAƒ‹ƒuƒ~ƒ“”rŸ•—¦‚É‚¨‚æ‚Ú‚· ACE‘jŠQÜ’·Šú“Š—^‚ÌŒø‰Ê. “Iê´˜aC“c’†Œ[Ži‚`C”~‘òTˆêC–ìŒû‹§ŽqC•½ˆä–@”ŽC‘å˜a“c—¢CŽç‰®’B”üC‹àXWC“¡“c–F–MC–‹`’‰i“àj: ‘æ37‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï i94.05.12j, “¿“‡, “œ”A•a, 37(Suppl.1): 331, 1994.

668. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ^ƒC‘‚æ‚蓾‚ç‚ꂽV‚µ‚¢ HCV genotype: ŒŸo—¦‚ª‚‚­ typing‚É“K‚µ‚½ NS5—̈æ‚Ì PCR‚ð—p‚¢‚Ä. ™ŽR˜a•vi‘—§‚ª‚ñƒZƒ“ƒ^[jC’†‘ò‹MGi“àjCó•”LˆêC‰Á“¡é”VC‰º‰“–ì–M’‰i‘—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ30‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï i94.07.09j, ˆ®ì, u‰‰—vŽ|W, 35: 323, 1994.

669. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j HPLC‚É‚æ‚éƒqƒgŒŒ´‹y‚ÑÔŒŒ‹…’†‚Ì 2-ƒPƒg-3-ƒfƒIƒLƒVƒOƒ‹ƒRƒ“Ž_‚Ì‘ª’è. “¡ˆä‰pi“àjCŠâ£m—ECŽPˆèŽqi¶‰»jC–‹`’‰i“àjC–x“c‹±Žqi¶‰»jCŽç‰®’B”üC“c’†Œ[Ži‚`i“àj: ‘æ67‰ñ“ú–{¶‰»Šw‰ï‘å‰ï i94.09.07j, ‘åã, ¶‰»Šw, 66(7): 795, 1994.

670. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j V‚µ‚¢“àŽ‹‹¾‰æ‘œˆ—‘•’u (EVIP-230)‚ð—p‚¢‚½‘ŠúˆÝŠà‚ÌZ”͈Íf’f. ŽRãp‚³‚ä‚èC‘åˆä“c³lC‰¡ŽR–õC“ú”䌪ˆêC›–ì‘C‹ß“¡ˆê‰pC’†ˆä‹v—YCΈäŒ\‘¾C¡òOCŽO‘î‰Ã—YC“c•Ó‘C¬ò˜aŽO˜YCŽO‹´—˜‰·C¼Œ³Ž›Ž—ç i“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.17j, ŽD–y.

671. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Vp3ŠÌ×–EŠàÇ—á‚Ì֬ᎂɑ΂·‚é“àŽ‹‹¾“I֬ᎌ‹ãFp‚ÌŒŸ“¢. ‹g‘º‚Ü‚âŽqC‘ºã‹§lC‘•ª–ΔŽC¼“c–€–çC›–ì‘C‹v•Û“c•q•FC‚“c‰ë”ŽCÄ“¡rŽiC¼–{ˆÌ’jC²“¡³Ž÷C™–{­’¼Ca’J–¾—²CŽÄ“c‹v—YC¼Œ³Ž›Ž—ç i“àjC”äŠé”\Ž÷iŠOj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.18j, ŽD–y.

672. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’¼Ž‹Œ^“dŽq“àŽ‹‹¾‚ÌLŠp‰»‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ›–ì‘C‘åˆä“c³lC“ú”䌪ˆêCŽRãp‚³‚ä‚èC’†ˆä‹v—YC¡òOC“c•Ó‘C¬ò˜aŽO˜YC‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.18j, ŽD–y.

673. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘BŽîØœŒã’·ŠúŒo‰ßŠÏŽ@—á‚ÌŒŸ“¢. ²“c”ü˜aCŒÜ\—’³LC“à“¡‹g—²C‚‹´KGCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCŽO•xO”VC’†‰p’ji•a—j: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.18j, ŽD–y, “ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 36(8): 83, 1994.

674. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’´‰¹”gƒvƒ[ƒu‚É‚æ‚é‘å’°Žîᇫ•a•Ï‚Ìi’B“xf’f‚ÌŒŸ“¢|ƒ[ƒŠ[’“ü–@‚É‚æ‚é|. ¼ŽR˜a’jCâŒû“NÍCˆË“c•qCÄ“¡rŽiCŽl‹{—R”üŽqC²“¡N‰iC‘å˜a“c^‹IŽqC‘“c‰p–¾C¡‘º´ŽqC²“‡Œh´C‹S“ª•¶•FC•Ÿ“‡P’jC²–ìm—Ei‰¡•lŽs—§•a ‰@j: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.18j, ŽD–y, —\eW, p.208, 1994.

675. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ÔŠOü“dŽq“àŽ‹‹¾‚É‚æ‚é Portal Hypertensive Gastropathy‚ÌŒŸ“¢. ‰¡ŽRŒOC“c•Ó‘C‘•ª–ΔŽC¬ò˜aŽO˜YC¡òOC“ú”䌪ˆêCŠâ–xŒöŠîCΈäŒ\‘¾C‘ºã‹§lCa’J–¾—²C‰¡ŽR–õC‘åˆä“c³lCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àjC ”äŠé”\Ž÷iŠOjCã™G‰ii•a—j: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.18j, ŽD–y, —\eW, p.302, 1994

676. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j RLGS–@‚ð—p‚¢‚½ƒqƒgˆ««•FŽî‚É‚¨‚¯‚éˆâ“`ŽqˆÙí‚̉ðÍ. ”ª“‡ˆê•vCŽO—Ö˜ji“àjCŠÖªô•jC—Ñè—ljpCŠÖ’J„’ji‘—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ53‰ñ“ú–{ŠàŠw‰ï‘‰ï i94.10.19j, –¼ŒÃ‰®, “ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.194, 1994.

677. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j RLGS–@‚É‚æ‚é”|—{‚ª‚ñ×–E‚ðŽg‚Á‚½ˆâ“`ŽqˆÙí‚ÌŒŸõ. ŽO—Ö˜ji“àjC”ª“‡ˆê•vC—Ñè—ljpCŠÖªô•jCŠÖ’J„’ji‘—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ53‰ñ“ú–{ŠàŠw‰ï‘‰ï i94.10.19j, –¼ŒÃ‰®, “ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.194, 1994.

678. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j HCVƒGƒ“ƒxƒ[ƒv’`”’Ž¿“à‚Ì’´‰Â•Ï—̈æ‡T‚ɑ΂·‚éƒEƒCƒ‹ƒXŠ”“ÁˆÙ“IR‘Ì. ‘å’ÃŽR—SŽqC‰Á“¡é”Vi‘—§‚ª‚ñƒZƒ“ƒ^[jC’†‘ò‹MGi“àjC™ŽR˜a•vC‘å‰zÍŒáiVŠƒ‘åjC‰º‰“–ì–M’‰i‘—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ53‰ñ“ú–{ŠàŠw‰ï‘‰ï i94.10.20j, –¼ŒÃ‰®, u‰‰—vŽ|W, 85: 121, 1994.

679. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j R‘B”S‰t×–EŒ^ƒ€ƒ`ƒ“R‘Ì(HIK 1083)‚Ì“ÁˆÙ«‚Ì‘gD‰»Šw“IŒŸ“¢. ’†‘º’¼C‘¾“c_—ÇCŸŽR“wiM‘åjCÎŒ´˜a•Fi‰»jCŒIŒ´½iŠÖ“Œ‰»ŠwjC–x“c‹±Žqi¶‰»j: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.10.31j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 1817, 1994.

680. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j •›tŽîá‡f’f‚É‚¨‚¯‚éŠeŽí‰æ‘œŒŸ¸‚Ì—L—p«‚ɂ‚¢‚Ä. –ìŒû‹§ŽqC‹àXWC’†“ˆ^ˆêC“c’†Œ[Ži‚`C_—R‰Á—C”~‘òTˆêC–‹`’‰i“àj: ‘æ67‰ñ“ú–{“à•ª”åŠw‰ïH‹GŠwp‘å‰ï i94.11.16j, L“‡, “ú–{“à•ª”åŠw‰ïŽGŽ, 70(7): 705, 1994.

681. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j PCR-SSCP–@‚É‚æ‚éƒqƒg”x‚ª‚ñ‚É‚¨‚¯‚é P21 WAF1ˆâ“`ŽqˆÙí‚ÌŒŸõ. ´…’CéCŽO—Ö˜jC”Ñ’Ë^—RC”’ι•FCŠÖ’J„’ji‘—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ17‰ñ“ú–{•ªŽq¶•¨Šw‰ï”N‰ï i94.12.15j, _ŒË, ƒvƒƒOƒ‰ƒ€, p.342, 1994.

682. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j RLGS–@‚É‚æ‚éƒqƒg‚ª‚ñ×–E‚É‚¨‚¯‚é DNA•Ï‰»‚̉ðÍ. ŽO—Ö˜jC”ª“‡ˆê•vCŠÖªô•jC—Ñè—ljpCŠÖ’J„’ji‘—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ17‰ñ“ú–{•ªŽq¶•¨Šw‰ï”N‰ï i94.12.15j, _ŒË, ƒvƒƒOƒ‰ƒ€, p.423, 1994.

683. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒg”|—{ƒƒTƒ“ƒMƒEƒ€×–E‚É‚¨‚¯‚é 5-HTzŽó—e‘ÌhR–ò sarpogrelate‚ÌŒø‰Ê. ‹àXWC“Iê´˜aC–‹`’‰i“àj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï i94.12.16j, ç—t, “ú–{t‘ŸŠw‰ïŽ, 36(Suppl.): 199, 1994.

684. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j ã•”Á‰»ŠÇoŒŒ: ‘˜_. ¼Œ³Ž›Ž—çi“àj: ‘æ‚W‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‹ãBƒZƒ~ƒi[ i94.12.11j, ŒF–{.

685. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŠúˆÝŠà‚ɑ΂·‚é HSE‹Ç’‚𕹗p‚µ‚½“àŽ‹‹¾“I”S–ŒØœ–@(ERHSE). ›’m–çi“àjCåMœAi“s—§‹îž•a‰@j: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.08j, “Œ‹ž.

686. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`(RA)Š³ŽÒ‚É‚¨‚¯‚éƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“–@‚É‚æ‚éˆÝ”ro”\‘ª’è‚ÌŽŽ‚Ý. ‘“ŒŠ²•vCˆÀ’BŒ£i“àjC”M“c—¹C“ˆ’×TC’†‘º—zŽqi‘—§‘Š–ÍŒ´•a‰@jCÎìŽåÅi“àjCˆäo“NC“n•”K•vCˆÀ•”–¾˜NC‘Šì’ŽjCŽR“cº•vi‘—§‘Š–ÍŒ´•a ‰@jC¼Œ³Ž›Ž—çi“àj: ‘æ229‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.05.14j, ç—t.

687. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j EMR‚É‚æ‚èØœ‚µ“¾‚½”S–Œ‰º‘wZ‚Ì\“ñŽw’°‹…•”ƒJƒ‹ƒ`ƒmƒCƒh‚Ì‚PÇ—á. ’|“cŒOi“àjC‘OìŒö’ji“ŒŽÅ—ÑŠÔ•a‰@jCù–{‚Ý‚ä‚«C–x]˜aLCˆÉ“¡‹`–çC‰FˆäF‘¾˜YiŠOjC’†‰p’ji•a—j: ‘æ229‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.05.14j, ç—t.

688. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j _“Þ쌧‘åˆé’¬Z–¯ŒŸf‚É‚¨‚¯‚é HCVR‘Ì‚ÌoŒ»‚ɂ‚¢‚Ä. Ä“¡rŽiCa’J–¾—²C‘ºã‹§lC™–{­’¼C‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC¼‹´”Ži_“Þ쌧’†ŒSˆãŽt‰ïj: ‘æ229‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.05.14j, ç—t, —á‰ï´˜^W, p.30, 1994.

689. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’¼’°ƒJƒ‹ƒ`ƒmƒCƒh(10 mmˆÈ‰ºj‚Ì’´‰¹”g“àŽ‹‹¾f’f‚Æ“àŽ‹‹¾“IŽ¡—ÂÌH•v‚ÉŠÖ‚·‚錟“¢. ¬—Ñ´“TCŸ–””º‰hi“àj: ‘æ58‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.06.03j, “Œ‹ž.

690. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Von Recklinghausen•a‚É’¼’°Šà‚ª‡•¹‚µ‚½‚P—á. ‰œ£çWC“c’†N•¶C¼‘q“¿]i“àjC•Ÿ¼N•vC‰Í–ì½CŽu‘òŠì‹vC¡ˆäŽ C瓇—R˜NC²“¡DMC–ì˜C¹ŒÈC“cŠ‰qi‘Š–ÍŒ´‹¦“¯•a‰@j: ‘æ58‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.06.03j, “Œ‹ž.

691. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ERCP‚É‚Ä’_“¹Œn‚ÆŒð’Ê‚ð”F‚ß‚½ŠÌ”^ᇂ̂P—á. ‘å˜a“c^‹IŽqC‘•ª–ΔŽC–ìŒû‘ŽqC‚“c‰ë”ŽC‘ºã‹§lCˆÉ“¡‹ÏCâŒû“NÍC¼Œ³Ž›Ž—çi“àj: ‘æ58‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.06.03j, “Œ‹ž.

692. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’¼’°”S–Œ’EÇŒóŒQ‚ÌŒo‰ßŠÏŽ@—á‚ÌŒŸ“¢. ²“c”ü˜aCŒÜ\—’³LC“à“¡‹g—²C‚‹´KGC¼‘q“¿]C‚‹´—T”VCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCŽO•xO”Vi•a—j: ‘æ58‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.06.03j, “Œ‹ž, u‰‰—\eW, p.13, 1994.

693. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’´‰¹”gƒvƒ[ƒu‚É‚æ‚é‘å’°Žîᇫ•a•Ï‚ÌZ’B“xf’f‚ÌŒŸ“¢|ƒ[ƒŠ[’“ü–@‚É‚æ‚é|. ¼ŽR˜a’jCâŒû“NÍCˆË“c•qC¡òOCŽl‹{—R”üŽqC‘“c‰p–¾C¡‘º´Žqi“àjC²“‡Œh´C‹S“ª•¶•FC•Ÿ“‡P’jC²–ìm—Ei‰¡•lŽs—§Žs–¯•a‰@j: ‘æ58‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.06.03`04j, “Œ‹ž, —\eW, p.45, 1994.

694. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’´‰¹”gƒvƒ[ƒu‚É‚æ‚éã•”Á‰»ŠÇ•a•Ï‚Ìf’f|ƒ[ƒŠ[’“ü–@‚Ì—L—p«‚ɂ‚¢‚Ä|. âŒû“NÍC¡‘º´ŽqC²“‡Œh´C¼ŽR˜a’jCŽl‹{—R”üŽqCÄ“¡rŽiC‘“c‰p–¾CˆË“c•qi‰¡•lŽs—§Žs–¯•a‰@jCŽR“cŽŠlC¼Œ³Ž›Ž—çi“àj: ‘æ58‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.06.03j, “Œ‹ž, —\eW, p.60, 1994.

695. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒ‚ƒmƒNƒ‰æ‘œ‚É‚æ‚é“àŽ‹‹¾“Id‰»—Ö@Œã‚Ì Fo֬᎔­ÔŠŒ©‚ÌŒŸ“¢. ‚“c‰ë”ŽC‘•ª–ΔŽC‘ºã‹§lC‘å˜a“c^‹IŽqC¼“c–€–çC‹v•Û“c•q•FC¼‘q“¿]C¼–{ˆÌ’jC²“¡³Ž÷Ca’J–¾—²C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ‘æ58‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.06.04j, “Œ‹ž.

696. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j \“ñŽw’°‚Ɉí’E‚µ‚½‹‘å‡TŒ^‘ŠúˆÝŠà‚Ì‚P—á. “ú”䌪ˆêC“c•Ó‘C‘åˆä“c³lC‰¤ˆ¤•½CŽRãp‚³‚ä‚èC’†ˆä‹v—YCΈäŒ\‘¾C¡òOC¬ò˜aŽO˜YC‰¡ŽR–õCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àjC’Ò—ºìC“ˆ”ömCŽO d–슰ŠìiŠOjCã™G‰iC’†‰p’ji•a—j: ‘æ58‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.06.04j, “Œ‹ž, u‰‰—\eW, p.67, 1994.

697. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒÄ‹z•s‘S‚É”º‚¢ŠÌ‹@”\‚Ì‘ˆ«‚ðŒJ‚è•Ô‚µ‚Ä‚¢‚é–«ŠÌ‰Ši”ñŠˆ“®Œ^j‚Ì‚P—á. “ú‚‰›CŠOŽR‹v‘¾˜YC¬–öŒõmC›–ì‘C’|‹g—R‰ÁŽuC“n•Ó—²ŽiC–{ŠÔ“ñ˜YC–ì“o½C‚“cˆê‘¾˜Yi•½’Ë‹¤Ï•a‰@jC’·“‡—mŽ¡i‰¡•lŽs‘åj: ‘æ428‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.06.11j, “Œ‹ž.

698. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “àŽ‹‹¾ƒ|ƒŠƒyƒNƒgƒ~[‚Å“Eo‚µ‚½‘å’°ƒŠƒ“ƒpŠÇŽî‚Ì‚P—á. ’|‹g—R‰ÁŽuCŠOŽR‹v‘¾˜Yi•½’Ë‹¤Ï•a‰@jC¬–öŒõmi“àjC’JìˆêŽuC“ú‚‰›C“n•Ó—²ŽiC–{ŠÔ“ñ˜YC–ì“o½C‚“cˆê‘¾˜Yi•½’Ë‹¤Ï•a‰@j: ‘æ429‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.07.09j, “Œ‹ž.

699. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “œ”A•a«t•s‘S‚ɇ•¹‚µ‚½ TENŒ^–ò]‚Ì‚P—á. ”~‘òTˆêC“Iê´˜aC“c’†Œ[Ži‚`C–ìŒû‹§ŽqC‘å˜a“c—¢CŽç‰®’B”üC‹àXWC“¡“c–F–MC–‹`’‰i“àj: ‘æ429‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.07.09j, “Œ‹ž.

700. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ž©ŒÈ–ƉuŒ»Û‚𔺂Á‚½“Á”­«–å–¬ˆ³˜´iÇ (IPH)‚Ì‚P—á. ‹g‘º‚Ü‚âŽqCa’J–¾—²C²“¡³Ž÷C¼–{ˆÌ’jC‘ºã‹§lC‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ429‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.07.09j, “Œ‹ž.

701. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j IFN‘OŒã‚É‚¨‚¯‚é Genotype•Ê‚Ì•a—‘gDŠw“I, •À‚тɃEƒCƒ‹ƒX—ʂ̕ω». “y‹´Œ’C²“¡³Ž÷Ca’J–¾—²C’†‘ò‹MGC‘ºã‹§lC¼–{ˆÌ’jC”’èŒh“ñC‘•ª–ΔŽC¼Œ³Ž›Ž—çCŽÄ“c‹v—Yi“àj: ‘æ29‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï i94.07.16j, “Œ‹ž, —vŽ|W, 35: 59, 1994.

702. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ž¡—Âɂæ‚è‰Â‹t“IŒo‰ß‚ð‚½‚Ç‚Á‚½ƒLƒƒƒŠƒA”­Ç‚aŒ^ŠÌd•Ï‚Ì‚P—á. ‘ºãK‘¾˜YC‚“c‰ë”ŽC¼–{ˆÌ’jC²“¡³Ž÷C‘ºã‹§lC‘•ª–ΔŽCa’J–¾—²CΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ230‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.07.30j, “Œ‹ž.

703. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œ´”­«’_`«ŠÌd•Ïǂɇ•¹‚µ‚½‘’_ŠÇŠà‚Ì‚P—á. ¬–öŒõmCŠOŽR‹v‘¾˜YC’JìˆêŽuC“ú‚‰›C’|‹g—R‰ÁŽui•½’Ë‹¤Ï•a‰@jC“n•Ó—²Žii“àjC–{ŠÔ“ñ˜YC–ì“o½C’†‘òGºC‚“cˆê‘¾˜YC‹àŽR³–¾i•½’Ë‹¤Ï•a ‰@jC²–ìm—Ei‰¡•lŽs‘åj: ‘æ230‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.07.30j, “Œ‹ž.

704. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j oŒŒ«ˆÝ–Ñ׌ŒŠÇŠg’£Ç‚Ì‚P—á. “n•Ó—²Žii“àjCŠOŽR‹v‘¾˜Yi•½’Ë‹¤Ï•a‰@jC¬–öŒõmC’JìˆêŽuC“ú‚‰›C–{ŠÔ“ñ˜Yi“àjC–ì“o½C‚“cˆê‘¾˜Yi•½’Ë‹¤Ï•a‰@j: ‘æ231‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.09.03j, ìè.

705. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚`Œ^‹}«ŠÌ‰Š‚É‚Ä”­Œ©‚³‚ꂽ HBƒLƒƒƒŠƒA‡•¹‚bŒ^ŠÌ‰Š‚Ì‚P—á. –Ø‘º‹žŽqiˆÉ¨Œ´‹¦“¯•a‰@jC¼–Ø–ÎŽ÷i“àjC‘‚ˆê¬C–ìŒû‘ŽqC“c’†”ŽŽuC‹k“c‹P—YC‚‹´—B˜YiˆÉ¨Œ´‹¦“¯•a‰@j: ‘æ231‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.09.03j, ìè.

706. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒAƒ[ƒo«ŠÌ”^ᇂ̂P—á. ²“c”ü˜aC‘•ª–ΔŽC¼Œ³Ž›Ž—çi“àjCˆé•”‹`Œ›i•új: ‘æ231‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.09.03j, ìè, —\eW, p.33, 1994.

707. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒoƒ‹[ƒ“•Âljº‹ts«ŒoÖ¬“IÇðp (BRTO)‚ÌŒø‰Ê”»’è‚ɃJƒ‰[ƒhƒbƒvƒ‰[“àŽ‹‹¾“I’´‰¹”g’f‘w–@ (ECDUS)‚ª—L—p‚Å‚ ‚Á‚½ŒÇ—§«ˆÝ֬ᎂ̂P—á. Š™“c—eŽqC‘•ª–ΔŽC¼“c–€–çC›–ì‘C‚“c‰ë”ŽC“c•Ó‘C¼Œ³Ž›Ž—çi“àj: ‘æ5‰ñ“ú–{’´‰¹”gˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.09.16j, “Œ‹ž.

708. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j dÇŠÌáŠQ‚ðŒJ‚è•Ô‚·_Œo«HŽv•sUÇ‚Ì‚P—á. ”üŒ´ÃCa’J–¾—²CÎìŽåÅC‚“c‰ë”ŽC‘ºã‹§lC²“¡³Ž÷C‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ431‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.10.08j, “Œ‹ž.

709. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Pure sensory stroke‚ð’悵‚½‰„‘[Ç‚Ì‚P—á. ‘‚ˆê¬i“àjCŠÛŽR”ŽŽuiˆÉ¨Œ´‹¦“¯•a‰@jC‰¡ê³“TC–ìŒû‘Žqi“àjC¡è‹M¶C‘å˜a“c—CÎìÍC‹gˆäº•vC‹k“c‹P—YC‚‹´—B˜YiˆÉ¨Œ´‹¦“¯•a ‰@j: ‘æ431‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.10.08j, “Œ‹ž.

710. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j IFN—Ö@‘OŒã‚É‚¨‚¯‚é Genotype•Ê‚Ì•a—‘gDŠw“IA•À‚тɃEƒCƒ‹ƒX—ʂ̕ω». “y‹´Œ’C²“¡³Ž÷Ca’J–¾—²C’†‘ò‹MGC‘ºã‹§lC¼–{ˆÌ’jC”’èŒh“ñC‘•ª–ΔŽC¼Œ³Ž›Ž—çCŽÄ“c‹v—Yi“àj: ‘æ29‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï i94.11.10j, “Œ‹ž, ŠÌ‘Ÿ, 35(2): 59, 1994.

711. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j –«ŠÌŽ¾Š³‚É‚¨‚¯‚éV‚µ‚¢R‘Ì‚ð—p‚¢‚½ŒŒ´‡WŒ^ƒRƒ‰[ƒQƒ“‚Ì‘ª’è. Ä“¡rŽiCa’J–¾—²C“y‹´Œ’C²“¡³Ž÷C‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ29‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï i94.11.10j, “Œ‹ž, ŠÌ‘Ÿ, 35(—Õ‘): 65, 1994.

712. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚bŒ^–«ŠÌ‰Š‚ɑ΂·‚éƒCƒ“ƒ^[ƒtƒFƒƒ“—Ö@Œã‚ÌŠÌ‘gD HCV-RNA‚Ɗ̶ŒŸ‘gDŠŒ©. ‘OìŒö’jCa’J–¾—²C²“¡³Ž÷C’†‘ò‹MGC¼–{ˆÌ’jC‘ºã‹§lC‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ29‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï i94.11.10j, “Œ‹ž, ŠÌ‘Ÿ, 35: 67, 1994.

713. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆÝ‘BG•½ã”çŠà‚É”AŠÇŽîá‡‚ð‡•¹‚µ‚½d•¡Šà‚Ì‚P—á. “n•Ó—²ŽiCŠOŽR‹v‘¾˜YC¬–öŒõmC’JìˆêŽuC“ú‚‰›C’|‹g—R‰ÁŽuC–{ŠÔ“ñ˜YC–ì“o½C‚“cˆê‘¾˜YC‹àŽR³–¾i•½’Ë‹¤Ï•a‰@jC’·“ˆ—mŽ¡i‰¡•lŽs‘åj: ‘æ232‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.12.03j, “Œ‹ž.

714. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆÝŠà‚ƈ݈««ƒŠƒ“ƒpŽî‚𓯎ž‚É•¹”­‚µ‚½‚P—á. ‘å’댘‘¾˜YC²–ìG–íC‚–ظˆêC–{‹´CCŠô¢‹´“ÄC‘½—…”ö˜a˜YC‹ÊˆäÙ•vC‘åìLˆêC‹{ìŒOC¼˜AŽ›ˆÓŒMC¬—Ñ—C–{‹´‹v•FC‹T“c—zˆêiŒ§—§‚ª‚ñƒZƒ“ ƒ^[j: ‘æ232‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.12.03j, “Œ‹ž.

715. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j œ“]ˆÚ‘ƒ¶ŒŸ‚É‚Äf’f‚µ“¾‚½\“ñŽw’°•½ŠŠ‹Ø“÷Žî‚Ì‚P—á. —Ñ“c_–¾C“c•Ó‘C‘•ª–ΔŽC‰¤ˆ¤•½C“ú”䌪ˆêCΈäŒ\‘¾C¡òOC¬ò˜aŽO˜YC‰¡ŽR–õC‘åˆä“c³lCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àjCã™G‰iCŽO•xO”V i•a—j: ‘æ232‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.12.03j, “Œ‹ž.

716. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Sâ|•”’É‚Å”­Ç‚µ‚½ FNH‚Ì‚P—á. ²“¡N‰iCÄ“¡rŽiCâŒû“NÍCŽl‹{—R”üŽqC¼ŽR˜a’jC‘“c‰p–¾CˆË“c•qC¡‘º´ŽqC²“‡Œh´C‚‹´—˜’ÊC‹S“ª•¶•FC•Ÿ“‡P’jC’†‘ºé¶i‰¡•lŽs—§Žs–¯•a ‰@j: ‘æ232‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.12.03j, “Œ‹ž.

717. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j SLE, PSS‚ð‡•¹‚µ‚½–å–¬ˆ³˜´iÇ. ’|‘òŽO‘ãŽqCÎìŽåÅC‘ºã‹§lC“y‹´Œ’C‚“c‰ë”ŽCa’J–¾—²C‘•ª–ΔŽCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ232‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.12.03j, “Œ‹ž.

718. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹}Œƒ‚È• …‚Ì’™—¯‚ð”F‚ß‚½Žá”N—«‚Ì‚P—á. ’JìˆêŽuCŠOŽR‹v‘¾˜YC¬–öŒõmC“ú‚‰›C’|‹g—R‰ÁŽuC“n•Ó—²ŽiC–{ŠÔ“ñ˜YC–ì“o½C‚“cˆê‘¾˜YC‹àŽR³–¾i•½’Ë‹¤Ï•a‰@j: ‘æ27‰ñ_“Þ쌧Á‰»Ší•aˆãŠw‰ï i94.12.03j, ‰¡•l.

719. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’Ž‚‚Ì“à–|‚ÆŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½‰ŠÇ«ƒ|ƒŠ[ƒv‚ð‡•¹‚µ‚½ƒGƒ‹ƒVƒjƒAäX‰Š‚Ì‚P—á. ‹v•Û“c•q•FCŒÜ\—’³LC‚‹´KGC“à“¡‹g—²CŸ–””º‰hC¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjCã™G‰iCŽO•xO”Vi•a—j: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.08j, “Œ‹ž.

720. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Šà‚̇•¹‚ð”F‚ß‚½‰Æ‘°«ˆÝŽá”N«ƒ|ƒŠƒ|[ƒVƒX‚Ì‚P—á. ›–ì‘C‘åˆä“c³lCŽ­ŠÔL–¾C‰¤ˆ¤•½C“ú”䌪ˆêCrìä•vCΈäŒ\‘¾C¡òOC“c•Ó‘C–Ø“cŒõLC¬ò˜aŽO˜YC‰¡ŽR–õCŽO‹´—˜‰·CŸ–””º‰hC¼Œ³Ž›Ž—ç i“àj: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.08j, “Œ‹ž.

721. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘å’°ŒeŽºoŒŒ‚ɑ΂·‚é“àŽ‹‹¾ŒŸ¸‚̈Ӌ`. ‰¡ŽRŒOCŒÜ\—’³LC“¿Œõ—zˆê˜YC›I³LC‚‹´KGC“à“¡‹g—²CŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.08j, “Œ‹ž.

722. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘å’°‘ŠúˆóŠÂ×–EŠà‚Ì‚PØœ—á. ‚ˆä’qŽqC¬—Ñ´“TC¯–ì˜a•FC“n•Ó‹`˜YCˆêŒ´—ºC“n•ÓòCŽR“cL•vCˆäãˆç•vC•Ÿ“c~C’·’JìÍ—Yi¬“cŒ´Žs—§•a‰@j: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.08j, “Œ‹ž.

723. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒq[ƒ^[ƒvƒ[ƒuĎܗÖ@‚ª’˜Œø‚µ‚½ gastric antral vascular ectasia‚Ì‚P—á. “ú”䌪ˆêC“c•Ó‘C‰¤ˆ¤•½CΈäŒ\‘¾C¡òOC¬ò˜aŽO˜YC‰¡ŽR–õCŽO‹´—˜‰·C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjCã™G‰iCŽO•xO”Vi•a—jC‘剪‚Ý‚ä‚«C ’|“cŒOC‘OìŒö’ji“ŒŽÅ—ÑŠÔ•a‰@j: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.08j, “Œ‹ž, —\•ñW, p.48, 1994.

724. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œ‹ßWâÆŒ^•a•Ï‚Ì—Õ°•a—Šw“IŒŸ“¢. ‚‹´KGCŒÜ\—’³LC›I³LC“¿Œõ—zˆê˜YC²“c”ü˜aC‰¡ŽRŒOC“à“¡‹g—²CŸ–””º‰hC¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjCŽO•xO”Vi•a—j: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.09j, “Œ‹ž.

725. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “àŽ‹‹¾ŠŒ©‚É‚æ‚éŠ×‰šŒ^‘Šú‘å’°Šà‚Ɗ׉šŒ^‘BŽî‚Æ‚Ì”äŠrŒŸ“¢. ›I³LCŒÜ\—’³LC“à“¡‹g—²C‚‹´KGC“¿Œõ—zˆê˜YCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCŽO•xO”Vi•a—j: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.09j, “Œ‹ž.

726. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘å’°ƒ|ƒŠƒyƒNƒgƒ~[Œã‚ÌoŒŒ—á‚ÌŒŸ“¢. “¿Œõ—zˆê˜YCŒÜ\—’³LC›I³LC‚‹´KGC“à“¡‹g—²CŸ–””º‰hC¼Œ³Ž›Ž—çi“àj: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.09j, “Œ‹ž.

727. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j • o‹¾‰ºˆÝ”S–Œ‰º“Eœp‚ðŽ{s‚µ‚½‚P—á. ‘å’댘‘¾˜YC²–ìG–íC‚–ظˆêC–{‹´CCŠô¢‹´“ÄC‘½—…”ö˜a˜YC‹ÊˆäÙ•vC‘åìLˆêC‹{ìŒOC¬—Ñ—C¼˜AŽ›ˆÓŒMC‰~’J²C–{‹´‹v•FC”Ñ“cä݈êiŒ§—§‚ª ‚ñƒZƒ“ƒ^[j: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.10j, “Œ‹ž.

728. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹»–¡‚ ‚éŒo‰ß‚ðŽ¦‚µ‚½DŽ_‹…Z«•a•Ï‚Ì‚P—á. ŽRãp‚³‚ä‚èC‘åˆä“c³lC‰¤ˆ¤•½C“ú”䌪ˆêC’†ˆä‹v—YCΈäŒ\‘¾C¡òOC“c•Ó‘C¬ò˜aŽO˜YC‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.10j, “Œ‹ž.

729. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘½”­«ŠÌ“]ˆÚ‹y‚Ñ”]“]ˆÚ‚ð‚«‚½‚µ‚½‰A”X Paget•a‚Ì‚P—á. “ú‚‰›CŠOŽR‹v‘¾˜YC¬–öŒõmC’JìˆêŽuC’|‹g—R‰ÁŽuC“n•Ó—²ŽiC–{ŠÔ“ñ˜YC–ì“o½C‚“cˆê‘¾˜YC‹àŽR³–¾i•½’Ë‹¤Ï•a‰@jC²–ìm—Ei‰¡•lŽs—§‘åj: ‘æ432‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.12.10j, “Œ‹ž.

730. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’s•ð‚ɂĉ”­‚µ‚½Œ‹Šj«‘–Œ‰Š‚Ì‚P—á. –ìŒû‘ŽqCŠÛŽR”ŽŽuC‰¡ê³“TC‘‚ˆê¬C¡è‹M¶CŽRŒû_C–Ø‘º‹žŽqC‹gˆäº•vC‹k“c‹P—YC‚‹´—B˜YiˆÉ¨Œ´‹¦“¯•a‰@j: ‘æ432‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.12.10j, “Œ‹ž.

731. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •›tŒ‹Šj‚Æ‚ÌŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½ angiotrophic lymphoma‚Ì‚P—á. ”~‘òTˆêC“¡“c–F–MC’†“ˆ^ˆêC“c’†Œ[Ži‚`C–ìŒû‹§ŽqC‹àXWC“Iê´˜aC–‹`’‰i“àj: ‘æ432‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.12.10j, “Œ‹ž.

732. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j NIDDM‘Šútǂɑ΂·‚鉖Ž_ƒjƒJƒ‹ƒWƒsƒ“’·Šú“Š—^‚ÌŒø‰Ê. ’†“ˆ^ˆêC“Iê´˜aC“¡ˆä‰pC“c’†Œ[Ži‚`C–ìŒû‹§ŽqC”nêPtC”~‘òTˆêC‹àXWC”nêPtC“¡“c–F–MC–‹`’‰i“àj: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.01.28j, “Œ‹ž.

733. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”xƒAƒXƒyƒ‹ƒMƒ‹ƒX(As)Ç‚É‚æ‚è”ñƒPƒgƒ“«‚Z“§ˆ³«¨‡(NKHC)‚𗈂µ‚½NIDDM‚Ì‚P—á. •Œ´–ƒŽqC•½ˆä–@”ŽC¼‰ªŠ²—YC‰ª‘º~i‰¡{‰ê‹¤Ï•a‰@jC‹àXWC“Iê´˜aC–‹`’‰i“àj: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.01.28j, “Œ‹ž.

734. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “ªŠWˆô“ªŽîpŒã‚É”ñƒPƒgƒ“«‚Z“§ˆ³«¨‡(NKHC)‚ðŒJ‚è•Ô‚·‚P—á. ”~‘òTˆêC‹àXWC“c’†Œ[Ži‚`C“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.01.28j, “Œ‹ž.

735. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘å—ʈùŽð‚ðŒ_‹@‚É“œ”A•a«ƒPƒgƒAƒVƒh[ƒVƒX‚ð•p‰ñ‚ÉŒJ‚è•Ô‚·IDDM‚Ì‚P—á. ‘å˜a“c—¢C‹gˆäº•vC‹k“c‹P—YC‚‹´—B˜YiˆÉ¨Œ´‹¦“¯•a‰@jC‹àXWC–‹`’‰i“àj: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.01.28j, “Œ‹ž.

736. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰»”^«Ò’ʼnŠ‚ð‡•¹‚µ‚½NIDDM‚Ì‚S—á. –ìX‘º–í¶C“c’†º‘¾˜YiŠC˜V–¼‘‡•a‰@jC‹àXWC“c’†Œ[Ži‚`C–‹`’‰i“àj: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.01.28j, “Œ‹ž.

737. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j tŽüˆÍ”^á‡‚ð‡•¹‚µ‚½“œ”A•a‚Ì‚P—á. –ìŒû‹§Žqi‘å˜aŽs—§•a‰@jC‹àXWC–‹`’‰i“àj: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.01.28j, “Œ‹ž.

738. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’˜–¾‚ȃCƒ“ƒXƒŠƒ“’ïR«‚ðŽ¦‚·IDDM‚ð‡•¹‚µ‚½ TurnerÇŒóŒQ‚Ì‚P—á. ‚“c“NGC“¡“c–F–MC’†“ˆ^ˆêC“c’†Œ[Ži‚`C”~‘òTˆêC_—R‰Á—¢C‹àXWC”nêPtC“Iê´˜aC–‹`’‰i“àj: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.01.28j, “Œ‹ž.

739. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’°•ÂÇ‚É‚Ä”­Œ©‚³‚ꂽŽá”NŽÒŒ´”­«Œ‹Šj«• –Œ‰Š‚Ì‚P—á. ‰¡ê³“Ti“àjC“c’†”ŽŽuC‘‚ˆê¬C–ìŒû‘ŽqC–Ø‘º‹žŽqC¼–Ø–ÎŽ÷C‹gˆäº•vC‹k“c‹P—YC‚‹´—B˜YC•ÊŠ—²iˆÉ¨Œ´‹¦“¯•a‰@j: ‘æ434‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i95.02.04j, “Œ‹ž.

740. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠÌ×–EŠà‚ÆŠÓ•Ê¢“ï‚Å‚ ‚Á‚½ŠÌd•Ï‚ɇ•¹‚µ‚½ŠÌŒŒŠÇ“÷Žî‚Ì‚P—á. ‹g‘º‚Ü‚âŽqC²“¡³Ž÷C‘•ª–ΔŽC¼–{ˆÌ’jC‘ºã‹§lCa’J–¾—²CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjCŽO•xO”Vi•a—j: ‘æ233‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i95.02.18j, “Œ‹ž.

741. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “à‰È“IŽ¡—ª‘tŒø‚µ‚½–å–¬Žîá‡Çð(Vp3)‚𔺂¤‚Ñ‚Ü‚ñ«ŠÌ×–EŠà|’·Šú¶‘¶‚Ì‚P—á|. ¼–Ø–ÎŽ÷C–Ø‘º‹žŽqC“c’†”ŽŽuC‹k“c‹P—YC‚‹´—B˜YiˆÉ¨Œ´‹¦“¯•a‰@jCΈäŒö“¹CŸ–””º‰hi“àjC‹e’nŒhˆêi‘—§—×{Š_“Þì•a‰@jC‹g“càˆi‚³‚ª‚Ýz ŠÂŠíƒNƒŠƒjƒbƒNj: ‘æ233‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i95.02.18j, “Œ‹ž.

742. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒJƒ‰[ƒhƒbƒvƒ‰[’´‰¹”g’f‘w–@‚ªf’f‚É—L—p‚Å‚ ‚Á‚½\“ñŽw’°•½ŠŠ‹Ø“÷Žî‚Ì‚P—á. —Ñ“c_–¾C‘•ª–ΔŽC“c•Ó‘C›–ì‘C¼–{ˆÌ’jC–Ø“cŒõLC¼Œ³Ž›Ž—çi“àj: ‘æ6‰ñ“ú–{’´‰¹”gˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.02.25j, “Œ‹ž.

743. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚—î”­Ç‚µ‚½ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì‚P—á. ¡è‹M¶C‰¡ê³“Ti“àjC‘‚ˆê¬C–ìŒû‘ŽqC–Ø‘º‹žŽqCŽRŒû_C‰“ŽR”ŽC‹gˆäº•vC‹k“c‹P—YC‚‹´—B˜YiˆÉ¨Œ´‹¦“¯•a‰@j: ‘æ54‰ñ_“Þ쌧“à‰ÈˆãŠw‰ïW’k‰ï i95.02.26j, ‰¡•l.

744. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j H“¹Ã–¬áŽ‚ð‚«‚½‚µ‚½‘åŽð‰Æ‚Å15”NŒã“ú–{ZŒŒ‹z’ŽÇ‚Æf’f‚µ‚½‚P—á. ’JìˆêŽuCŠOŽR‹v‘¾˜YC“ú‚‰›C“n•Ó—²ŽiC’|‹g—R‰ÁŽuC–{ŠÔ“ñ˜YC–ì“o½C‚“cˆê‘¾˜YC‹àŽR³–¾C‹{é—m•½i•½’Ë‹¤Ï•a‰@j: ‘æ435‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i95.03.11j, ìè.

745. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j BRTOi—¯’u–@j‚ÌŒø‰Ê”»’è‚ɃJƒ‰[ƒhƒbƒvƒ‰[“àŽ‹‹¾“I’´‰¹”g’f‘w–@(ECDUS)‚ð—p‚¢‚½ŒÇ—§«ˆÝ֬ᎂ̂Q—á. ¼“c–€–çC‘•ª–ΔŽC‚“c‰ë”ŽC‘ºã‹§lC²“¡³Ž÷C¼–{ˆÌ’jCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC‰““¡‚C¼Šª”ŽCˆé•”‹`Œ›i•új: ‘æ29‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï i94.11.10j, “Œ‹ž.

746. mŒ¤‹†‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Effects of lansoprazole on gastric ulcer-healing and mucin content. ¬Žº—TˆêCΈäŒ\‘¾CŽO‘î‰Ã—YC“c•Ó‘C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: 2nd International Colloquium on Protein Pump Inhibitors i94.09.29j, ƒqƒ…[ƒXƒgƒ“, USA, Abstracts, p.48`49, 1994.

747. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j ‹•ŒŒ«‘å’°‰Š‚Ì—Õ°. Ÿ–””º‰hi“àj: ‘å’°ŒŸ¸–@Œ¤‹†‘‰ï i94.10.08j, ç—t, —\eW, p.24, 1994.

748. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Dose intensity‚̈قȂé 5'DFUR{CDDP—Ö@‚Ì”äŠr. ¬ò˜aŽO˜Yi“àj: ƒtƒ‹ƒcƒƒ“ˆÝŠàƒVƒ“ƒ|ƒWƒEƒ€ i94.06.04j, “Œ‹ž, ´˜^W, p.10`11, 1994.

749. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘S‘å’°ƒtƒ@ƒCƒo[ƒXƒR[ƒv‘}“üŽè‹Z|‹ê’É‚È‚­‚·‚Ý‚â‚©‚É–Ó’°‚Ü‚Å|. –{ŠÔ“ñ˜Yi•½’Ë‹¤Ï•a‰@jCŒÜ\—’³Li“àj: ‘æ12‰ñ‘å’°ŒŸ¸–@Œ¤‹†‘‰ï i94.10.08j, ç—t.

750. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j PBC‚Ì• o‹¾ŠŒ©|M2R‘Ì—z«—á‚ƉA«—á‚Ì”äŠr|. a’J–¾—²i“àj: • o‹¾§˜b‰ï i94.02.23j, “Œ‹ž.

751. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j B-RTOi—¯’u–@j‚ª’˜Œø‚µ‚½ŒÇ—§«ˆÝ֬ᎂ̂P—á. ¼“c–€–çC‘•ª–ΔŽi“àjCˆé•”‹`Œ›i•új: ‘æ‚P‰ñBRTOŒ¤‹†‰ï i94.04.24j, _ŒË, BRTO•×‹­‰ïŽ, 1(1): 16`20, 1994.

752. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌ×–EŠà‚ɑ΂·‚郊ƒsƒIƒh[ƒ‹¬‡ƒGƒ^ƒm[ƒ‹‹Ç’—Ö@‚ÌŒø‰Ê”»’è|MRI‚Ì—L—p«‚ɂ‚¢‚Ä|. ‚“c‰ë”ŽC‘•ª–ΔŽC¼“c–€–çC‹v•Û“c•q•FC¼–{ˆÌ’jC²“¡³Ž÷C‘ºã‹§lC”’èŒh“ñC™–{­’¼Ca’J–¾—²CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC‰““¡‚C¼Šª ”ŽCˆé•”‹`Œ›i•új: ‘æ30‰ñ“ú–{ŠÌŠàŒ¤‹†‰ï i94.07.07j, ˆ®ì.

753. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Dibutyryl cyclic AMP’P“ƗÖ@‚ðs‚Á‚½‚QÇ—á. ¼–{ˆÌ’jCa’J–¾—²C‚“c‰ë”ŽC²“¡³Ž÷C‘ºã‹§lC‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ30‰ñ“ú–{ŠÌŠàŒ¤‹†‰ï i94.07.07j, ˆ®ì, —vŽ|W, p.86, 1994.

754. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “àŽ‹‹¾“I֬᎑¢‰e (EVIS)‚É‚¨‚¯‚é–å–¬-”xÖ¬•«‡ (PPVA)•`o—á‚ÌŽ¡—ÃŒø‰Ê‚Ƈ•¹Ç‚ɂ‚¢‚Ä. ¼“c–€–çC¼‘q“¿]C‘ºã‹§lC‘•ª–ΔŽC‚“c‰ë”ŽC¼–{ˆÌ’jC²“¡³Ž÷C”’èŒh“ñCa’J–¾—²CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ‚P‰ñ“àŽ‹‹¾“IH“¹ˆÝ֬᎑¢‰eŒ¤‹†‰ï i94.10.19j, ŽD–y, —\eW, p.391, 1994.

755. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒrƒ^ƒ~ƒ“‚t‚̃‰ƒbƒgƒGƒ^ƒm[ƒ‹«ˆÝ”S–ŒŠQ—\–h‚ÉŠÖ‚·‚éì—p‹@˜‚ÌŒŸ“¢. “n•Ó•üŒbC¼Œ³Ž›Ž—çi“àjC¬Œ´iCŽs쑸•¶C–x“c‹±Žqi¶‰»jCÎŒ´˜a•Fi‰»Šwj: ‘æ46‰ñƒyƒvƒVƒ“Œ¤‹†‰ï i95.02.17j, ‹ž“s.

756. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŽÀŒ±“Iautoimmune colitis. ¬Œ´ii¶‰»jCŒÜ\—’³LC“n•Ó•üŒbi“àjC–x“c‹±Žqi¶‰»j: Á‰»Ší‚ƖƉuŒ¤‹†‰ï i95.03.04j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.29, 1995.

757. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Šà‚𔺂¤Œ‹ßWâÆ—l•a•Ï‚ÌŒŸ“¢. ‚‹´KGCŒÜ\—’³LC›I³LC“¿Œõ—zˆê˜YC“à“¡‹g—²CŸ–””º‰hC¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjCŽO•xO”Vi•a—jC¬—Ñ´“Ti“àj: ‘æ42‰ñ‘å’°ŠàŒ¤‹†‰ï i95.01.27j, “Œ‹ž.

758. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ã•”Á‰»ŠÇoŒŒ‚ɑ΂·‚é“àŽ‹‹¾Ž¡—ÃiœH“¹Ã–¬áŽ). “c•Ó‘i“àj: ‘æ‚S‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“ŒƒZƒ~ƒi[ i94.02.20j, ‰¡•l, —vŽ|W, p.72`75, 1994.

759. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éÁ‰»Ší•af’f. ¼Œ³Ž›Ž—çi“àj: “ŒŠC’´‰¹”gŠwpƒtƒH[ƒ‰ƒ€ i94.04.02j, –¼ŒÃ‰®.

760. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j isˆÝŠà‚ɑ΂·‚écFMP—Ö@‚ÌŒŸ“¢. ¬ò˜aŽO˜Yi“àj: “Œ‹ž‚ª‚ñ‰»Šw—Ö@Œ¤‹†‰ï i95.02.21j, “Œ‹ž.

761. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j H“¹ˆÝÖ¬áŽ‚Ì“àŽ‹‹¾Ž¡—Ã|EVIS‚Æ—\Œã‚ð’†S‚É|. ‘•ª–ΔŽi“àj: ”ä‰bŽRƒVƒ“ƒ|ƒWƒEƒ€ i95.03.10j, ‹ž“s.

762. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j • •”CT‚É‚Äportal vein thrombosis‚𔺂Á‚½HCC‚ÆŠÓ•Ê¢“ï‚Å‚ ‚Á‚½ŠÌŠO‚Ì‚P—á. “ˆ’×TC“n•”K•vi‘—§‘Š–ÍŒ´•a‰@jCˆÀ’BŒ£i“àjCˆäo“Ni‘—§‘Š–ÍŒ´•a‰@jCÎìŽåÅi“àjC’†‘º—zŽqC‘“ŒŠ²•vCˆÀ•”–¾˜YC‰““¡‚i‘—§‘Š–ÍŒ´•a ‰@j: ‘æ20‰ñ_“ÞìŠÌ’k˜b‰ï i94.02.19j, ‰¡•l.

763. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j isˆÝŠà‚̉»Šw—Ö@. ¬ò˜aŽO˜YC‹ß“¡ˆê‰pC¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjCŒIŒ´–«iº˜a‘åj: 5th DOM Forum i94.05.26j, ‰¡•l, ´˜^W, p.1, 1994.

764. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’_”XŒ´”­•½ŠŠ‹Ø“÷Žî‚Ì‚P—á. ‚ˆä’qŽqC•½ŠÔË’q¶C¯–ì˜a•FC¬—Ñ´“TCˆêŒ´—ºC“n•Ó‹`˜YC“n•ÓòCŽR“cL•vC•Ÿ“c~C’·’JìÍ—Yi¬“cŒ´Žs—§•a‰@j: ‘æ39‰ñ_“ÞìÁ‰»Ší•aŒ¤‹†‰ï i94.06.18j, ‘Š–ÍŒ´.

765. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j UDCA‘å—Ê“Š—^‚ðs‚Á‚½ PBC‚Ì‚P—á. “n•”K•vi‘—§‘Š–ÍŒ´•a‰@jCˆÀ’BŒ£i“àjCˆäo“NC’†‘º—zŽqC“ˆ’×TC‘“ŒŠ²•vi“àjCˆÀ“ŒŽ¡˜Yi‘—§‘Š–ÍŒ´•a‰@jCŽ­ŠÔL–¾i“àjCˆÀ•”–¾˜YCó”ö• Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘æ39‰ñ_“ÞìÁ‰»Ší•aŒ¤‹†‰ï i94.06.18j, ‘Š–ÍŒ´.

766. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŋߌoŒ±‚µ‚½ˆÝŒ´”­ˆ««_ŒoâŽî‚Ì‚Q—á. ‘å’댘‘¾˜YC¬–쎛½ŒåC¬—Ñ—C¼˜AŽ›ˆÓŒMC–{‹´‹v•FCŠô¢‹´“ÄC‚–ظˆêC–{‹´CC²–ìG–íC”Ñ“cä݈êC‹T“c—zˆêi_“Þ쌧—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ39‰ñ_“ÞìÁ‰»Ší•aŒ¤‹†‰ï i94.06.20j, ‘Š–ÍŒ´.

767. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éisˆÝŠà‹ß–T”÷—Ê• …‚Ì—Õ°“IˆÓ‹`. Šô¢‹´“ÄC²–ìG–íC–{‹´CC‚–ظˆêi_“Þ쌧—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ‚U‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.06.25j, ‰¡•l, ´˜^W, p.15, 1994.

768. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Øœ•s”\isˆÝŠà‚ɑ΂·‚鉻Šw—Ö@Œã‚ÉŽèp‰Â”\‚Æ‚È‚Á‚½Borrmann 4Œ^ˆÝŠà‚Ì‚QÇ—á. ¬ò˜aŽO˜YC‹ß“¡ˆê‰pC“c•Ó‘C’†ˆä‹v—YC¡òOCŽRãp‚³‚ä‚èC¼‘q“¿]CŽO‘î‰Ã’jCΈäŒ\‘¾C‰¡ŽR–õC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìC”äŠé ”\Ž÷iŠOjCã™G‰ii•a—j: ‘æ‚U‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.06.25j, ‰¡•l, —\eW, p.28, 1994.

769. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”xŒ‹ŠjÇ‚ðŒ_‹@‚É”­Ç‚µ‚½‚Æl‚¦‚ç‚ê‚é DKA‚Ì‚P—á|“–‰@‚É‚¨‚¯‚é“œ”A•a‡•¹”xŒ‹ŠjÇŠ³ŽÒ‚ÌŒŸ“¢|. _—R‰Á—C–ìŒû‹§ŽqC’†“ˆ^ˆêC“c’†Œ[Ži‚`C”~‘òTˆêC‹àXWC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ11‰ñ_“Þì“œ”A•aŒ¤‹†‰ï i94.07.02j, ‰¡•l.

770. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j –¯ŠÔ—Ö@‚É‚æ‚èƒCƒ“ƒXƒŠƒ“‚𒆎~‚µ DKA, ‘½‘ŸŠí•s‘S (MOF)‚ÖŽŠ‚Á‚½ IDDM‚Ì‚P—á|. •Œ´–ƒŽqC•½ˆä–@”ŽC¼‰ªŠ²—Yi‰¡{‰ê‹¤Ï•a‰@jC‹àXWC“Iê´˜aC–‹`’‰i“àj: ‘æ11‰ñ_“Þì“œ”A•aŒ¤‹†‰ï i94.07.02j, ‰¡•l.

771. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Ž©ŒÈ–Ɖu«ŠÌ‰Š‚ÉŠÌ×–EŠà‚̇•¹‚µ‚½‚Q—á. ¼–{ˆÌ’jC‘ºã‹§lC²“¡³Ž÷Ca’J–¾—²C‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ21‰ñ_“ÞìŠÌ’k˜b‰ï i94.07.16j, ‰¡•l.

772. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j HCV—z«‚—î’j«‚É‚¨‚¯‚郋ƒ|ƒCƒhŠÌ‰Š‚Ì‚P—á. “n•Ó‹`˜YC¯–ì˜a•FC¬—Ñ´“TCˆêŒ´—ºC“n•ÓòCŽR“cL•vC’·’JìÍ—Yi¬“cŒ´Žs—§•a‰@j: ‘æ21‰ñ_“ÞìŠÌ’k˜b‰ï i94.07.16j, ‰¡•l.

773. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œ´”­«d‰»«’_ŠÇ‰ŠiŠÌ“àŒ^j‚ð’悵‚½–«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚Ì‚P—á. ’†‘º—zŽqCˆÀ“ŒŽ¡˜YCŽ­ŠÔL–¾C‘“ŒŠ²•vC“ˆ’×TCˆäo“NCˆÀ’BŒ£i“àjC“n•”K•vCˆÀ•”–¾˜YC‘Šì’ŽjCŽR“cº•vCŠâ–ì–M’jCó”ö•Žmi‘—§‘Š–ÍŒ´•a ‰@j: ‘æ21‰ñ_“ÞìŠÌ’k˜b‰ï i94.07.16j, ‰¡•l.

774. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Adenomyomatosis‚ɇ•¹‚µ‚½‘Šú’_”XŠà‚Ì‚PŽèp—á. ˆêŒ´—ºC‚ˆä’qŽqC¬—Ñ´“TCŽR“cL•vC’·’JìÍ—Yi¬“cŒ´Žs—§•a‰@j: ‘æ2‰ñ–k—¢ŠÌ¥’_“¹Ž¾Š³Œ¤‹†‰ï i94.07.20j, ’¬“c.

775. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j –å–¬ŒŒð‚𔺂¢ HCC‚ÆŠÓ•Ê¢“ï‚Å‚ ‚Á‚½ŠÌŠO‚Ì‚P—á. “ˆ’×TC“n•”K•vCˆÀ’BŒ£Cˆäo“NC’†‘º—zŽqC‘“ŒŠ²•vCŽ­ŠÔL–¾CˆÀ“ŒŽ¡˜YCˆÀ•”–¾˜Yi“àjC‰““¡‚i•új: ‘æ2‰ñ–k—¢ŠÌ¥’_“¹Ž¾Š³Œ¤‹†‰ï i94.07.20j, ’¬“c.

776. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŒÄ‹z•s‘S‚É”º‚¢ŠÌ‹@”\‚Ì‘ˆ«‚ðŒJ‚è•Ô‚µ‚Ä‚¢‚é–«ŠÌ‰Š(”ñŠˆ“®Œ^j‚Ì‚P—á. “ú‚‰›CŠOŽR‹v‘¾˜YC¬–öŒõmC›–ì‘C’|‹g—R‰ÁŽuC“n•Ó—²ŽiC–{ŠÔ“ñ˜YC–ì“o½C‚“cˆê‘¾˜Yi•½’Ë‹¤Ï•a‰@jC’·“‡—mŽ¡i‰¡•lŽs‘åj: ‘æ2‰ñ–k—¢ŠÌ¥’_“¹Ž¾Š³Œ¤‹†‰ï i94.07.20j, ’¬“c.

777. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒNƒ[ƒ“•a‚̃Œƒ“ƒgƒQƒ“f’f. ŒÜ\—’³Li“àj: ‘æ‚P‰ñ_“Þì IBDŒ¤‹†‰ï i94.09.16j, ‰¡•l.

778. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “ªŠWˆô“ªŽîpŒã‚É”ñƒPƒgƒ“«‚Z“§ˆ³«¨‡‚ðŒJ‚è•Ô‚·‚P—á. ”~‘òTˆêC‹àXWC’F—mC–ìŒû‹§ŽqC–‹`’‰i“àj: ‘æ6‰ñ_“Þì“à•ª”åǗጟ“¢‰ï i94.09.17j, ‰¡•l.

779. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŠÌŠà‚ð‡•¹‚µ‚½ƒAƒ‹ƒR[ƒ‹«ŠÌüˆÛÇ‚Ì‚P—á. —ÀLC¼–{ˆÌ’jC“y‹´Œ’C’†‘ò‹MGC²“¡³Ž÷C‘ºã‹§lCa’J–¾—²C‘•ª–ΔŽi“àj: ‘æ11‰ñ_“ÞìŠÌ‰ŠƒEƒCƒ‹ƒXŒ¤‹†‰ï i94.10.22j, ‰¡•l.

780. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‰æ‘œf’f‚Å HCC‚ð‹^‚¢A•a—‘gD‚É‚Ä Atypical adenomatous hyperplasia‚Æf’f‚³‚ꂽ‚P—á. ’†‘ò‹MGC‘•ª–ΔŽC¼“cçŠGŽqC²“¡³Ž÷i“àj: ‘æ‚P‰ñ_“ÞìŠÌf’fŒ¤‹†‰ï i94.10.28j, ‰¡•l.

781. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j HPLC‚É‚æ‚é“œ”A•aŠ³ŽÒŒŒ´‚¨‚æ‚ÑÔŒŒ‹…’†‚Ì 2-ƒPƒg-3-ƒfƒIƒLƒVƒOƒ‹ƒRƒ“Ž_(3-DGA)‚Ì‘ª’è. “¡ˆä‰pi“àjCŠâ£m—ECŽPˆèŽqi¶‰»jC–‹`’‰i“àjC–x“c‹±Žqi¶‰»j: ‘æ22‰ñ“à•ª”å‘ãŽÓŒ¤‹†‰ï i94.11.12j, “Œ‹ž, —\eW, 22: 9, 1994.

782. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “«‹¹• …‚ɑ΂µ TIPS‚ðŽ{s‚µ‚½ PEITŒã‚ÌŠÌŠà‡•¹ŠÌd•ÏÇ‚Ì‚P—á. ‘ºã‹§lC‘•ª–ΔŽi“àjCˆé•”‹`Œ›i•új: ‘æ‚P‰ñ“Œ‹ž¥_“Þì TIPS•×‹­‰ï i94.11.25j, ‰¡•l.

783. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ³íŒŒˆ³ NIDDMŠ³ŽÒ‚Ì”AƒAƒ‹ƒuƒ~ƒ“”rŸ• (UAE)‚¨‚æ‚Ñt‹@”\‚É‚¨‚æ‚Ú‚·ƒAƒ“ƒMƒIƒeƒ“ƒVƒ“•ÏŠ·y‘f‘jŠQ–ò(ACEI)’·Šú“Š—^‚ÌŒø‰Ê. “Iê´˜aC’†“ˆ^ˆêC“c’†Œ[Ži‚`C”~‘òTˆêC‹àXWC”nêPtC“¡“c–F–MC–‹`’‰i“àj: ‘æ‚U‰ñ“œ”A•a«tÇŒ¤‹†‰ï i94.12.04j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€, p.13, 1994.

784. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j N-acetyltransferase polymorphism‚Æ“œ”A•a«tÇ. ”nêPti“àjCNeugebauer, S.C“n•Ó‹BC•ì´i‘—§ˆã—ÃZƒ“ƒ^[j: ‘æ‚U‰ñ“œ”A•a«tÇŒ¤‹†‰ï i94.12.05j, “Œ‹ž.

785. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ˆÝŠà“]ˆÚ‚É‚æ‚éŠà«ƒŠƒ“ƒpŠÇǂɑ΂µ CDDP{5'-DFUR‚É‚æ‚鉻Šw—Ö@‚ª—LŒø‚Å‚ ‚Á‚½‚P—á. ‰iŒ©–¾¶C“c•Ó‘C¬ò˜aŽO˜YC“ú”䌪ˆêC‹ß“¡ˆê‰pCΈäŒ\‘¾C¡òOC‰¡ŽR–õC‘åˆä“c³lCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOj: ‘æ‚V‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.12.17j, ‰¡•l.

786. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j MTX/5FUŒð‘ã—Ö@‚ª QOL‚̉ü‘P‚É—L—p‚Å‚ ‚Á‚½ Borrmann ‚SŒ^ˆÝŠà‚Ì‚S—á. ‘å’댘‘¾˜YC²–ìG–íC–{‹´CC‚–ظˆêCŠô¢‹´“ÄiŒ§—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ‚V‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.12.17j, ‰¡•l, ´˜^W, p.43, 1994.

787. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Ligating device‚ðŽg—p‚µ‚½“àŽ‹‹¾“IˆÝ”S–ŒØœp(EMRL)|Šî‘bŒ¤‹†‚Æ—Õ°‰ž—p|. –{‹´CC‘å’댘‘¾˜YC²–ìG–íC‚–ظˆêCŠô¢‹´“ÄC‘åìLˆêC‹ÊˆäÙ•viŒ§—§‚ª‚ñƒZƒ“ƒ^[j: ‘æ‚V‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.12.17j, ‰¡•l, ´˜^W, p.53, 1994.

788. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‰æ‘œf’fã, ŠÌŒŒŠÇŽî‚ÆŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½ŠÌ×–EŠà(HCC)‚Ì‚P—á. ¼–Ø–ÎŽ÷C‘å˜a“c—¢C‘‚ˆê¬C–ìŒû‘ŽqC–Ø‘º‹žŽqC“c’†”ŽŽuC‹k“c‹P—YC‚‹´—B˜YiˆÉ¨Œ´‹¦“¯•a‰@j: ‘æ‚R‰ñ–k—¢ŠÌ¥’_“¹Ž¾Š³ŒŸ“¢‰ï i95.01.18j, Œú–Ø.

789. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j —Õ°•a—Šw“I‚É‹»–¡‚ ‚é PBC‚Ì‚P—á. ˆÉ“¡‚©‚¨‚éC“n•”K•vi‘—§‘Š–ÍŒ´•a‰@jCˆÀ’BŒ£i“àjCˆäo“NC’†‘º—zŽqC‘“ŒŠ²•vC“ˆ’×TCˆÀ•”–¾˜YCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘æ‚R‰ñ–k—¢ŠÌ¥’_“¹Ž¾Š³ŒŸ“¢‰ï i95.01.18j, Œú–Ø.

790. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”ñ‘㞊úŠÌd•Ïǂɇ•¹‚µ‚½”A•öÇ‚Ì‚P—á. ”~‘òTˆêC‹àXWC–‹`’‰i“àj: ‘æ‚V‰ñ_“Þì“à•ª”åǗጟ“¢‰ï i95.03.04j, ‰¡•l.

791. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j isˆÝŠà‚ɑ΂·‚é cFMP—Ö@‚ÌŒŸ“¢. ¬ò˜aŽO˜YC‹ß“¡ˆê‰pC“c•Ó‘C¡òOC¼Œ³Ž›Ž—çi“àj: _“ÞìŠàŽ¡—ç˜b‰ï i95.03.11j, ‰¡•l.

792. mŠwpÜi‘“àjn ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï‰ï’·Ü; H“¹ˆÝÖ¬áŽ‚Ì“àŽ‹‹¾f’f‚É‚¨‚¯‚éÔŠOü“dŽq“àŽ‹‹¾‚Ì—L—p«|‘æ‚Q•ñ|d‰»—Ö@‘OŒã‚ÌŒŸ“¢. ‘ºã‹§lC‘•ª–ΔŽC¼“c–€–çC›–ì‘C‹g‘º‚Ü‚âŽqC‹v•Û“c•q•FC‚“c‰ë”ŽCÄ“¡rŽiC¼–{ˆÌ’jC²“¡³Ž÷C”’èŒh“ñCa’J–¾—²CŽÄ“c‹v—YC¼Œ³Ž›Ž—ç i“àj.

793. mŠwpÜi‘“àjn •½¬‚U”N“x“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠw‰ïÜ; ÔŠOü“dŽq“àŽ‹‹¾‚É‚æ‚éˆÝŠàZ”͈Íf’f‚ÌŒŸ“¢. “c•Ó‘C¬ò˜aŽO˜YC‹ß“¡ˆê‰pCΈäŒ\‘¾C‘åˆä“c³lC¼Œ³Ž›Ž—çi“àjC›’m–çC’†‰p’ji•a—j.

794. mŠw‰ïŽåÃi‘“àjn “–”Ô¢˜bl: ‘æ‚P‰ñ“àŽ‹‹¾“IH“¹ˆÝ֬᎑¢‰eŒ¤‹†‰ïi94.10.19j, ŽD–y. ‘•ª–ΔŽi“àj.


<<1402 ?? >>

795. mŒ´’˜n Influence of right coronary artery stenosis on exercise test responses and survival in patients with left main or left main equivalent disease. ìŒû’|’ji“àjCJ. MyersCP.M. RibislCC.K. MorrisCK. UeshimaCJ.H. LinCV.F. Froelicher: Am. Heart J., 127: 39`48, 1994.

796. mŒ´’˜n Massive rhabdomyolysis associated with influenza a infection. Žá—Ñ–õ‹vC’†–ì’qmC‹e–ì—²–¾C‘å˜a“c—²i‹~–½jC–Øì“c—²ˆêi“àj: Intern. Med., 33: 450`453, 1994.

797. mŒ´’˜n Control of glucose utilization in working perfused rat heart. ”’J‹`Gi‹~–½jC²“¡´‹MC“y‰®’¼—²i“àjCThomas, S.CFell, D.A.CVeech, R.L.CPassonneau, J.V.: J. Biol. Chem., 269: 1`13, 1994.

798. mŒ´’˜n Activated charcoal interrupts enteroenteric circulation of phenobarbital. Žá—Ñ–õ‹vi“àjCŠÛŽR–ΑPiŽÀ“®ŒnjC”«‘º˜a’ji—ÕŒŸjC‘å˜a“c—²i‹~–½j: J. Toxicol. Clin. Toxicol., 32(4): 419`424, 1994.

799. mŒ´’˜n Clinico-pathological study of the role of infact expansion in patients with cardiac rupture following acute myocardial infarction. ‰¬Œ´“ÄC¬—Ñ–¾–FCV’Ã’J^li“àjCŒK”ö’èmi•a—jC–Øì“c—²ˆêi“àj: Jpn. Circ. J., 58(10): 743`749, 1994.

800. mŒ´’˜n Investigation of inflammatory cells in tubulointerstitial lesions in IgA nephritin with special reference to tubular lesions. Mangkalanond, K.CEhara, T.iMB‘åjCd¼GˆêC¬—Ñ–Li“àj: Medical Electron Microscopy, 26(3-4): 211`213, 1993.

801. mŒ´’˜n ‹}«S‹Ø[Ç•”ˆÊ‚É‚æ‚éŒoŽž“I 24ŽžŠÔŒŒˆ³‚¨‚æ‚ÑS””‚Ì•Ï“®‚Ì·ˆÙ. ‘ê‘òrŽ÷C´…Š®‰xCX“cGlC‘q“c“TŽqC¬‘òŒ°ˆêC˜Iè‹P•vC–Øì“c—²ˆêi“àj: Ther. Res., 15(8): 3005`3009, 1994.

802. mŒ´’˜n ƒVƒNƒƒXƒ|ƒŠƒ“‚`Žg—ptˆÚAŒã‚ƒRƒŒƒXƒeƒ[ƒ‹ŒŒÇ‚É‚¨‚¯‚錌´Ž‰Ž¿CƒAƒ|’`”’‚¨‚æ‚уŠƒ|’`”’ˆÙí‚Ì“Á’¥. –xˆäºC’Ë–{—Y‰îC‘å‹v•Û[li“àj: ˆÚA, 29(2): 107`115, 1994.

803. mŒ´’˜n ƒGƒ“ƒhƒgƒLƒVƒ“œ‹Ž—pƒ|ƒŠƒ~ƒLƒVƒ“‚aŒÅ’艻‘@ˆÛ[“UƒJƒ‰ƒ€(PMX)‚ÌÝŒv, «”\•]‰¿‚¨‚æ‚Ñ—Õ°‚É‚¨‚¯‚é—L—p«•]‰¿. ¬‹Ê³’qC’J“OC‰Ô‘òˆê–FC•½‘ò”Ž”VCD“c¬lCŒ“â–ÎC‚‹´ˆ¤Ž÷CŽR–{•Û”ŽC‘å’Ë•q•¶C‹àŽq³ŒõC•½“cŒöˆêC‹ÊŒF³‰xC‘Oì˜a•FCŽá—Ñ–õ‹vi“àjC™–{ Š¤: Šî‘b‚Æ—Õ°, 28(5): 1421`1432, 1994.

804. mŒ´’˜n ƒtƒBƒbƒgƒlƒXƒNƒ‰ƒu‚ł̔얞Ǘá‚ɑ΂·‚é‚R‚©ŒŽŠÔ‰^“®—Ö@‚ÌŒø‰Ê. ´…Š®‰xC–Øì“c—²ˆêi“àjCŽ›”ö•Ûi“ŒŠC‘åjC¼˜e—viƒwƒ‹ƒXƒvƒƒ‚[ƒVƒ‡ƒ“jC‚”ö—ljpC‰H’¹—TCXŒh‘¾˜Yi_“Þ쌧ˆãŽt‰ïjCùì—m”V•C‹ž‹É_C ˆÉ“¡‹vŽji‚©‚È‚ª‚팒Nà’cj: f—ÂÆV–ò, 32(3): 541`547, 1995.

805. mŒ´’˜n ƒEƒFƒXƒ^ƒ“ƒuƒƒbƒg–@‚É‚æ‚é—¬ŒŒ’†ƒJƒ“ƒWƒ_R‘̂̉ðÍ. ŽR‰º‚¦‚èŽqi“àj: “ú–{ˆã^‹ÛŠwŽGŽ, 35(3): 269`280, 1994.

806. mŒ´’˜n ¬l”­Ç‚Ì—nŒŒ«”A“ÅÇÇŒóŒQ/ŒŒð«ŒŒ¬”ÂŒ¸­«Ž‡”Á•a(HUS/TTP)‚Ì—Õ°“I“Á’¥. ‚‹´‰fŽqCŠ™“cvŽõC’|“àN—YC–Øì“c—²ˆêi“àjC‘å‹v•Û[li²–ìŒú¶‘‡•a‰@j: “ú–{t‘ŸŠw‰ïŽ, 36(6): 727`739, 1994.

807. mŒ´’˜n is«IgAtÇ‚Ì—\ŒãŒˆ’è—vˆö|’·ŠúŠÏŽ@—á‚Å‚ÌŒŸ“¢. ¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠÚ–샶C¬—Ñ–Li“àj: “ú–{t‘ŸŠw‰ïŽ, 36(7): 823`831, 1994.

808. mŒ´’˜n Œ’íS‚̶Žº‹@”\‚ɑ΂·‚é‰Á—ۂɂ‚¢‚Ä. ì–ì—´•FC•zìTˆê˜YC‘£’qLC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(2): 104`109, 1994.

809. mŒ´’˜n –{‘Ô«‚ŒŒˆ³Ç‚Æ‚­‚É‚‘S––½ŒŒŠÇ’ïRŒ^‚̶SŽûk‹@”\‚ÆŠg’£‹@”\‚ÌáŠQ‚ɂ‚¢‚Ä. ì–ì—´•FC’r“c‘׎qC‘£’qLC‰º—¢ŒöºC‘åŒIŽ¡•FC‹v•Û‹MºC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(2): 110`117, 1994.

810. mŒ´’˜n ˆŸÅ‘å‰^“®Žž‚É‹N‚±‚é•a‘ÔS‚Ì Chronotropic Incompetence|f’f‚Æ”­¶‹@“]|. •zìTˆê˜YC´…Š®‰xC‰Í–쓹¢C˜Iè‹P•vC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(2): 118`129, 1994.

811. mŒ´’˜n ‹}«S‹Ø[ÇŒã‚Ì‹}«Šú‚É‚¨‚¯‚éSŒ`‘Ô‚¨‚æ‚Ñ24ŽžŠÔŒŒˆ³¥S””‚̕ω»‚ɂ‚¢‚Ä. ˆÉ˜@‰ÔC´…Š®‰xC‘ê‘òrŽ÷Cì•Ó•q”VCX“cGlC‘q“c“TŽqC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(3): 183`194, 1994.

812. mŒ´’˜n •Ù\’z‚ɈÙí‚ð‚à‚½‚È‚¢‹•ŒŒ«SŽ¾Š³‚É‚¨‚¯‚é‚S•Ù‹t—¬‚Ì—Õ°“I‚È‚ç‚Ñ‚ÉzŠÂ—ÍŠw“IŒŸ“¢. ‘£’qLC‘º¼€C¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(3): 195`202, 1994.

813. mŒ´’˜n ˆ««’¥Œó‚ð—L‚·‚é‚ŒŒˆ³Ç‚Ìt‹@”\‚ÆzŠÂ“®‘Ԃ̕ω»|‚Æ‚­‚Éf’fŠî€‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä|. •zìTˆê˜YC¬‚L]C‰¬Œ´“ÄCX“cGlC‹g“cTC‹v•Û‹MºC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(3): 210`216, 1994.

814. mŒ´’˜n V‚µ‚¢¶Žº—¬“ü—ÊŽZo–@‚Æ, Œ’í—á‚É‚¨‚¯‚é‘O•‰‰×‘Œ¸Žž¥“™ŽÚ•‰‰×Žž‚̶Žº—¬“ü‘¬“x, —¬“ü—ʂ̕ω»‚ÉŠÖ‚·‚錟“¢. ‘åŒIŽ¡•FC•ìMŒåCù‰ª‘åŽjC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(5): 331`341, 1994.

815. mŒ´’˜n S‹Ø‹•ŒŒ, ÄŠÁ—¬‚É‚¨‚¯‚銈«Ž_‘f‚Ì“®‘ԂƶŽº‹@”\‚Æ‚ÌŠÖŒW. ‚ÎL]C’·’J쉄LC•‘ò—˜˜YC’†‘º‘‰qC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(5): 348`356, 1994.

816. mŒ´’˜n Heymannt‰Š‚Ì•aˆöR‘Ì IgGƒAƒCƒ\ƒ^ƒCƒv‚Ì’·ŠúŠÏŽ@. “à“c–ž”üŽqCŠ™“cvŽõi“àj: –k—¢ˆãŠw, 24(5): 357`367, 1994.

817. mŒ´’˜n ’´‰¹”gƒhƒvƒ‰[–@‚ð—p‚¢‚½¶ŽºŠg’£‘Šú—¬“ü‘¬“x|—¬“ü—ÊŠÖŒW‚É‚æ‚éV‚µ‚¢¶ŽºŠg’£«‚Ì•]‰¿|. ‘åŒIŽ¡•FC•ìMŒåCù‰ª‘åŽjC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(5): 368`375, 1994.

818. mŒ´’˜n ‹}«S‹Ø[ljñ•œŠú‚É‚¨‚¯‚鶎ºŽûk‹@”\‚ƃgƒŒƒbƒhƒ~ƒ‹EƒeƒXƒg‚Ì”Žw•W‚Æ‚­‚É‚q”g‚‚Æ‚ÌŠÖŒW. X“cGlC´…Š®‰xC‘ê‘òrŽ÷C–]ŒŽr’¼C–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(5): 409`420, 1994.

819. mŒ´’˜n ‰ºŒã•Ç[Ç‹}«Šú‚É”F‚ß‚ç‚ê‚é‘O‹¹•”—U“±‚ÌST•ÎˆÊ‚̬ˆö|‚Æ‚­‚ɶŽºŒã•ÇŠÁ—¬Š¥“®–¬‚Æ‚ÌŠÖŒW|. ‹g“cTC¬—Ñ–¾–FC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(5): 421`431, 1994.

820. mŒ´’˜n ‹}«S‹Ø[Ç‚É‚¨‚¯‚éSŽº’x‰„“dˆÊ”­¶‚ɂ‚¢‚Ä‚Ì—Õ°“IŒŸ“¢. ²“¡ŽüC‘º¼€C󌩑C’·’J쉄LC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(6): 475`483, 1994.

821. mŒ´’˜n ‘½”­«œ‘Žî‚Ìt‹@”\áŠQ‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. “à“c–ž”üŽqCŠ™“cvŽõC¬—Ñ–LC‘å‹v•Û[li“àj: –k—¢ˆãŠw, 24(6): 501`512, 1994.

822. mŒ´’˜n Relation of extracelular magnesium to the cardiac function and calcium content of working perfused rat heart. “y‰®’¼—²C²“¡´‹MC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(6): 520`527, 1994.

823. mŒ´’˜n ‹}«S‹Ø[Ç‚É‚¨‚¯‚é opioid peptide•ª”å“®‘Ô‚ÌŒŸ“¢. Š“c”ü—æ”TC•‘ò—˜˜YC’·’J쉄LC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(6): 535`542, 1994.

824. mŒ´’˜n Š¥“®–¬Ž¾Š³‚É‚¨‚¯‚锽‰ž«[ŒŒ‚É‚æ‚銥“®–¬—\”õ”\‚Ì•]‰¿. ‹v•Û‹MºC’·’J쉄LC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(6): 550`558, 1994.

825. mŒ´’˜n ‹}«S‹Ø[Ç‘Šú‚É‚¨‚¯‚é‘̈ʕϊ·Žž‚ÌzŠÂ“®‘Ԃ̕ω»‚Ɖñ•œŠú‚̘Jì‚ɑ΂·‚é‘ãž‹@“]. Ž›’¬—DŽqiŠÅŒìŠw•”jC•‘ò—˜˜YC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 25(1): 46`57, 1995.

826. mŒ´’˜n ƒNƒ‚–Œ‰ºoŒŒ‹}«Šú‚É‚¨‚¯‚鶎º•Ç‰^“®ˆÙí‚Æ”x…Žî‚Ì”­¶‚ɂ‚¢‚Ä. ’r“c‘׎qi“àjC‘“c‘ìC‘å˜a“c—²i‹~–½jC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 25(1): 65`72, 1995.

827. mŒ´’˜n Ž©ŒÈ–ƉuŽ¾Š³ƒ‚ƒfƒ‹ƒ}ƒEƒX MRL/lpr‚Ì”­Ç, i“W, —\Œã‚É‚¨‚¯‚é”ñŽó—e‘̃`ƒƒVƒ“—ÓŽ_‰»y‘f Fyn‚Ì–ðŠ„|fynŒ‡Ž¸‚É‚æ‚é”­Ç—}§Œø‰Ê‚ð’†S‚É|‘æ‚P•ñ: fynŒ‡Ž¸ MRL/lprƒ}ƒEƒX‚ÆtáŠQ. •ìºi“àjC‚‹´ˆÐ•vi–kŒ¤jC‘Š‘òTˆêiŒF–{‘åjC¬—Ñ–Li“àjC•Ð‹Ë‘ñ–çi–kŒ¤j: –k—¢ˆãŠw, 25(1): 73`83, 1995.

828. mŒ´’˜n ‰–Ž_ƒsƒ‹ƒWƒJƒCƒjƒh(ƒTƒ“ƒŠƒYƒ€j‚ÌSŽº«ŠúŠOŽûk‚ɑ΂·‚é•]‰¿. ‰¡ŽR³ˆêC“L–ØP’jC›“c–F•¶CˆÉ“¡ŒúŽmC¬“‡t‹IiÀ’ÃŽs—§•a‰@jC•½¼T‰Ei“àjC–؈ê—YC¼Œ´Œ’“ñC‚ŽR^ˆêCŽÄ“c³ƒC“¡–ظ“ñC‚‹´•¶sCz –K“NC’·è•¶•FCŽR–å•qŽuC•\MŒáC‘êàV–¾Œ›CŽR–{€ŽjiÀ’ÃŽs—§•a‰@j: –ò—‚ÆŽ¡—Ã, 22(11): 4727`4735, 1994.

829. mŒ´’˜n ‚ŒŒˆ³Ç‚ð‡•¹‚·‚é“œ”A•a‚ÌS‹@”\|ŒŒˆ³‚̃Rƒ“ƒgƒ[ƒ‹‚̗ǔۂɂæ‚錟“¢|. ‘£’qLC‘º¼€C¬ã”Ž•¶CŠp’£—Y“ñC–Øì“c—²ˆêi“àj: –ò—‚Æ—Õ°, 4(4): 791`797, 1994.

830. m€Œ´’˜i‰p•¶jn Effect of various antihypertensive therapies on glucose, insulin, and lipid metabolism in patients with essential hypertension. ‘£’qLC‘º¼€C¬ã”Ž•¶C’·’J쉄LC–Øì“c—²ˆêC²“¡ŽüC‹v•Û‹Mºi“àj: 22nd Congress of the International Society of Internal Medicine, p.57`62, 1994.

831. m€Œ´’˜i‰p•¶jn Pulse wave velocity and hemodynamics during chronic treatment of hyperlipidemia with an HMG-CoA reductase inhibitor. ‘º¼€C’·’J쉄LC‘£’qLC²“¡ŽüC󌩑C–Øì“c—²ˆêi“àj: 22nd Congress of the International Society of Internal Medicine, p.79`84, 1994.

832. m€Œ´’˜i‰p•¶jn Clinical factors influencing the ventricular late potential in acute myocardial infarction. ²“¡ŽüC‘º¼€C󌩑C’·’J쉄LC–Øì“c—²ˆêi“àj: 22nd Congress of the International Society of Internal Medicine, p.93`98, 1994.

833. m€Œ´’˜i‰p•¶jn Dietary supplementation of fish oil rich in eicosapentaenoic acid enhance bovine serum albumin induced immune complex nephritis in NZB/W F1 mice. ŠÚ–샶C¬—Ñ–L(“à): Agents Actions, 41: 212`213, 1994.

834. m€Œ´’˜n –{‘Ô«‚ŒŒˆ³‚É‚¨‚¯‚éŠeŽí~ˆ³–òŽ¡—ÃŽž‚ÌŒŒ“œ‚¨‚æ‚уCƒ“ƒXƒŠƒ“‹Èü, ‚È‚ç‚Ñ‚ÉŽ‰Ž¿‘ãŽÓ‚É‹y‚Ú‚·Œø‰Ê‚ɂ‚¢‚Ä. ‘£’qLC‘º¼€C¬ã”Ž•¶C²“¡ŽüC‹v•Û‹MºC–Øì“c—²ˆêi“àj: Prog. Med., 14: 1927`1934, 1994.

835. mŒ¤‹†•ñiŒú¶Èjn IgAtÇ|ƒXƒeƒƒCƒh—Ö@‚Æ‚»‚Ì“K‰ž‚ɂ‚¢‚Ä. ¬—Ñ–LC¬‹v•Û“§C–xˆäºi“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠÚ–샶i“àj: Œú¶È“Á’莾Š³is«táŠQ’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†‹ÆÑ, p.8`14, 1994.

836. mÇ—á•ñn Eosinophilic leukaemia with a t(2;5)(p23;q35) translocation. ²“¡GC’hŒ´Š²¶C“c‘º‰ëli“àjCMorita, M.: Br. J. Haematol., 87: 404`406, 1994.

837. mÇ—á•ñn A case of Recklinghausen neurofibromatosis associated with membranous nephropathy. ¬‹v•Û“§i“àjC”äŠé”\”ViŠÅŒìŠw•”jC–xˆäºC¬—Ñ–Li“àj: Jpn. J. Nephrol., 36(8): 951`954, 1994.

838. mÇ—á•ñn A case of rheumatoid arthritis with renal tubular amyloidosis. ”äŠé”\”ViŠÅŒìŠw•”jC–xˆäºC¬‹v•Û“§i“àjCIshikawa, S.CSugiyama, T.Cd¼GˆêiMB‘åjC¬—Ñ–Li“àj: Nephron, 64: 394`395, 1994.

839. mÇ—á•ñn A case of sarcoidosis revealed in the course of IgA nephropathy. ŠÚ–샶C¬—Ñ–Li“àjCFumiko Kobayashii¬—ÑŠá‰ÈƒNƒŠƒjƒbƒNj: Pathol. Int., 44: 387`390, 1994.

840. mÇ—á•ñn ”x–僊ƒ“ƒpß‚É“]ˆÚ‚ª”F‚ß‚ç‚ꂽˆŸ‹æˆæŽx”­¶‚Ì‹CŠÇŽx•Ç“à‚ÉŒÀ‹Ç‚·‚éG•½ã”çŠà‚Ì‚PØœ—á. ‹g“cTi“àjC‘“ª‰p•vCŽR“ckŽOC“n•ÓŒÃŽu˜YC’rG”VC’†‘ºé¶: ‹CŠÇŽxŠw, 14(1): 38`43, 1992.

841. mÇ—á•ñn Directional coronary atherectomy (DCA)Ž{s’†‚ÉŠ¥“®–¬‰ð—£‚Å‘¤Ž}•ÂÇ‚ð‹N‚±‚µ‚½‚P—á. •½¼T‰EC“cŒ´‰pˆêCV’Ã’J^lC‰¬Œ´“ÄC‹v•Û‹MºC‘º¼€C–Øì“c—²ˆêi“àj: zŠÂŠí‰È, 36: 419`424, 1994.

842. mÇ—á•ñn Southern blot–@‚¨‚æ‚Ñin situ hybridization‚É‚æ‚èƒEƒCƒ‹ƒXƒQƒmƒ€‚ªØ–¾‚³‚ꂽEB(Epstein-Barr)ƒEƒCƒ‹ƒX«S–Œ‰Š‚Ì‚P—á. ù‰ª‘åŽji“àjC²“¡“OC“팴³rCŠ–ì^’jC¬“‡ŸC‘哇FˆêC–Ø‘º³”Vi•Ÿ‰ª‘åj: S‘Ÿ, 26(9): 995`999, 1994.

843. mÇ—á•ñn ƒPƒgƒAƒVƒh[ƒVƒX‚ðŒJ‚è•Ô‚·Žá”N”­ÇƒCƒ“ƒXƒŠƒ“”ñˆË‘¶Œ^“œ”A•a‚Ì‚P—á. ’hŒ´Š²¶i“àjCŠÛŽR‘¾˜YCŠâè—Ç“ñC—é–Ø—T–çié‹Ê’†‰›•a‰@j: “œ”A•a, 37(12): 915`920, 1994.

844. mÇ—á•ñn ‹}«t•s‘S, ‹}«S•s‘S, ¸_•s‰¸‚𕹔­‚µ‚½ƒ}ƒ“ƒjƒg[ƒ‹’†“ÅÇ‚Ì‚P—á. ’|“àN—YCŠ™“cvŽõC“à“c–ž”üŽqC¬—Ñ–Li“àj: “§ÍˆãŠw‰ïŽ, 28(2), 1995.

845. mÇ—á•ñn f’f‚É‹ê—¶‚µ‚½‹U«ƒAƒ‹ƒhƒXƒeƒƒ“Ç‚Ì‚P—á. ‚‹´ŠîC•‘ò—˜˜YC–ؑ¥–¾CŽá—Ñ–õ‹vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 15: 134`136, 1994.

846. mÇ—á•ñn “àƒVƒƒƒ“ƒg•ÂÇ‚ðŒJ‚è•Ô‚µC• –Œ“§Í—Ö@‚ɈÚsŒã—ÇD‚È“§ÍŠÇ—‚ª‰Â”\‚Æ‚È‚Á‚½RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ‚Ì‚P—á. –xˆäºCŠ™“cvŽõC¬‹v•Û“§C‘å‹v•Û[lC¬—Ñ–LC¬—Ñ’¼”Vi“àjC‹g“càˆi‚³‚ª‚ÝzŠÂŠíƒNƒŠƒjƒbƒNj: “ú–{“§ÍˆãŠw‰ïŽGŽ, 27(9): 1267`1272, 1994.

847. mÇ—á•ñn ‹}«S‹Ø[Ç‚Å”­Ç‚µ‚½‹‘劥“®–¬áŽ‚Ì‚P—á|Š¥“®–¬“àƒGƒR[}‚ÆŠ¥“®–¬ƒhƒbƒvƒ‰[–@‚Å‚ÌŠÏŽ@‚ð’†S‚É|. ì–ì—´•FC’|“c’è¶C•Ÿ“c’¼lCˆ¢•”˜jC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(2): 130`134, 1994.

848. mÇ—á•ñn ‹‘å‚È”Xó‰EŠ¥“®–¬áŽ‚ð‡•¹‚µ‚½‰EŠ¥“®–¬-‰EŽºá‘‚Ì‚P—á. ‹v•Û‹MºC¬—Ñ–¾–FC²“¡ŽüCŠ“c”ü—æ”TC‚ÎL]C’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(4): 304`309, 1994.

849. mÇ—á•ñn ‰E”x“®–¬ãs‘å“®–¬‹NŽnÇ‚Ì–{–MÅ‚—î‚Ì‚P—á. Š“c”ü—æ”TC‰¬Œ´“ÄC¬—Ñ–¾–FC’·’J쉄LC•‘ò—˜˜YC‘º¼€C–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, 24(6): 581`586, 1994.

850. mÇ—á•ñn Š®‘S–[ŽºƒuƒƒbƒN‚Å”­Ç‚µ‚½“«S•s‘S‚Ì‚P—á. ¬—Ñ–¾–FC‹g“cTi“àjC‚–ìN—Yi•a—j: –k—¢ˆãŠw, 24(6): 587`589, 1994.

851. mÇ—á•ñn ‚”N—î”­Ç‚µ‚½—nŒŒ«˜A½‹…‹ÛŠ´õŒã‹}«Ž…‹…‘Ìt‰Š‚Ì‚S—á. •ìºC“¡“c”ü‘ãŽqC“c‘º_ŽOCŠ™“cvŽõC¬—Ñ–Li“àj: –k—¢ˆãŠw, 25(1): 100`105, 1995.

852. mÇ—á•ñn ‰‰ñVAD—Ö@‚ª’˜Œø‚ðŽ¦‚µ‚½ Plasmacytic Leukemia‚Ì‚P—á. ’hŒ´Š²¶C²“¡Gi“àj: ˜V”NŽÒ‘¢ŒŒŠíŽ¾Š³Œ¤‹†‰ï‰ïŽ, 3(1): 19`24, 1994.

853. m—Õ°Ž¡Œ±n Ca++hR–ò‚Ì~ˆ³Œø‰Ê•s\•ªÇ—á‚ɑ΂·‚éƒVƒ‰ƒUƒvƒŠƒ‹(ƒCƒ“ƒqƒx[ƒXR)‚Ì•¹—pŽ¡—ÃŒø‰Ê. ‘º¼€C’·’J쉄LC²“¡ŽüC‹v•Û‹MºC–Øì“c—²ˆêi“àj: —Õ°‚ÆŒ¤‹†, 71(5): 1334`1337, 1994.

854. m‘àn t‘Ÿ•a‚Æ”÷—ÊŒ³‘fˆÙí. ’Ë–{—Y‰îi“àj: Biomedical Research on Trace Elements, 5(2): 61`68, 1994.

855. m‘àn •›bó‘B‹@”\˜´iÇ‚Ì–hŽ~‚͉”\‚©(“ÁW)ŽŠ“K“§Í‚ƃJƒ‹ƒVƒEƒ€. ’Ë–{—Y‰îi“àj: Clinical Calcium, 4(6): 753`757, 1994.

856. m‘àn “§ÍŠ³ŽÒ‚Ìœ“®‘Ô. (“ÁW)œ‚Ì“®“IŒ`‘ÔŠw. ’Ë–{—Y‰îi“àj: Clinical Calcium, 4(7): 41`44, 1994.

857. m‘àn t•s‘S‚É‚¨‚¯‚éƒAƒ~ƒmŽ_—Ö@‚ɂ‚¢‚Ä. ’|“àN—Yi“àj: Current Issues in Nutrition, (10): 3`4, 1994.

858. m‘àn zŠÂŠí‚Ì‹}•Ï‚Æ‚»‚Ì‘O‚Ô‚ê‚ðl‚¦‚é. ‘º¼€C²“¡Žüi“àj: Expert Nurse, 10(9): 36`41, 1994.

859. m‘àn ŒŒ´Ca, P”Z“x‚Ì’²ß‹@\. “ÁW: …“d‰ðŽ¿CŽ_‰–Šî•½t‚Ì’²ß‚Æ‚»‚̈Ùí. ’Ë–{—Y‰îi“àj: Medicina, 31(9): 1888`1890, 1994.

860. m‘àn ’áNaŒŒÇ. ’|“àN—YC’Ë–{—Y‰îi“àj: Modern Physician, 14(8): 1001`1005, 1994.

861. m‘àn ƒJƒ‹ƒVƒEƒ€ƒCƒIƒ“ƒgƒ‰ƒ“ƒXƒ|[ƒg. ’Ë–{—Y‰îi“àj: Molecular Medicine, 32: 52`57, 1995.

862. m‘àn –Ɖu‚Ì‚µ‚­‚Ý‚Æ•a‹C: t‘Ÿ•a‚ƖƉu. ¬—Ñ–Li“àj: ‚©‚炾‚̉Ȋw, 182(3): 39`43, 1995.

863. m‘àn ‚—͊³ŽÒ‚Ìœ¥ŠÖß•a•Ï‚ÌŠÇ—. ¼ì‰pŽ÷C–쑺K”ÍC’Ë–{—Y‰îi“àj: ŠÅŒì‹Zp, 40(7): 27`31, 1994.

864. m‘àn ƒ}ƒƒ“Ž_ƒ{ƒsƒ“ƒhƒ[ƒ‹. ‘º¼€i“àj: Œ»‘ãˆã—Ã, 26(7): 2055`2060, 1994.

865. m‘àn —A‰t»Ü‚ð®—Šˆ—p‚·‚é|“ÁW: ƒvƒ‰ƒNƒ`ƒJƒ‹, —A‰t. –쑺K”ÍC’Ë–{—Y‰îi“àj: f’f‚ÆŽ¡—Ã, 82(7): 1089`1095, 1994.

866. m‘àn “C’k: ‚ƒŠƒ“ŒŒÇ, ’჊ƒ“ŒŒÇ‚ð‚ß‚®‚Á‚Ä. —é–ؽC“c’†O”VC’Ë–{—Y‰îi“àj: t‚Æœ‘ãŽÓ, 7(3): 335`349, 1994.

867. m‘àn ‚ƒŠƒ“ŒŒÇ‚Æ“ñŽŸ«•›bó‘B‹@”\˜´iÇ. ’Ë–{—Y‰îi“àj: t‚Æœ‘ãŽÓ, 7: 323`328, 1994.

868. m‘àn •›bó‘B‹@”\’ቺÇ|“ÁW: CaˆÙí‚Ì•a‘Ô‚ÆŽ¡—Ã. ’Ë–{—Y‰îi“àj: t‚Æ“§Í, 37(2): 275`279, 1994.

869. m‘àn Ž…‹…‘Ìt‰Š‚ÌŽÀŒ±ƒ‚ƒfƒ‹: ŠÇŠO‘B«t‰Š. ¬—Ñ–Li“àj: t‚Æ“§Í, 37: 358`360, 1994.

870. m‘àn ƒ‹[ƒvƒXt‰Š|Silent lupus nephritis. –xˆäºC’·ê‘×i“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠÚ–샶C¬—Ñ–Li“àj: t‚Æ“§Í, 38(1): 67`72, 1995.

871. m‘àn ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì—Õ°(‚b): ”xŠO•a•Ï‚Ì‘àƒVƒŠ[ƒY¥ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ìt•a•Ï(–{–MǗᕶŒ£‚ð’†S‚É). ŠÚ–샶C¬—Ñ–Li“àj: “ú–{—Õ°, 52(6): 1613`1618, 1994.

872. m‘àn ’ጌˆ³Çf—ÂÌÅ‹ß‚Ì“®Œü|“Á‚É‹N—§«’²ßáŠQ‚𔺂¤–{‘Ô«’ጌˆ³Ç‚ɂ‚¢‚Ä|. –Øì“c—²ˆêC•½–콈ê˜YC¬‘òŒ°ˆêi“àj: –k—¢ˆãŠw, 24(2): 85`91, 1994.

873. m‘àn ”x^‹ÛÇ. ŽR‰º‚¦‚èŽqi“àjC‹v•ÄŒõi•a—j: —Õ°ˆã, 20: 719`721, 1994.

874. m‘àn •Û‘¶“It•s‘SC–ò•¨—Ö@. ¬—Ñ–LCX‰º“N•vC’·ê‘×Cò“c‚¢‚Ô‚«i“àj: —Õ°ˆã, 21(2): 162`165, 1995.

875. m‘àn is‚·‚é–«Ž…‹…‘Ìt‰Š‚ÌŽ¡—Ã|IgAtÇ‚ð’†S‚É. ¬—Ñ–LC¬‹v•Û“§C–xˆäºi“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠÚ–샶i“àj: —Õ°¬l•a, 24(7): 883`889, 1994.

876. m‘àn “ñŽŸ«•›bó‘B‹@”\˜´iÇ‚É”º‚¤œ•a•Ï (‘æ‚P•”)“§Íœ•a•Ï‚̬ˆö¥•a‘Ô. ’Ë–{—Y‰îC–쑺K”Íi“àj: —Õ°“§Í, 10(5): 585`591, 1994.

877. m‘àn •Û‘¶Šú–«t•s‘S‚ÌŽ¡—ÂƊǗ‚Ìi•à|R‹ÃŒÅ–òCRŒŒ¬”–ò‚ÌŒø‰Ê. ¬—Ñ–Li“àj: —Õ°“§Í, 11(1): 61`68, 1995.

878. muÀn SŽºŠúŠOŽûk(1)’P”­C‘½”­C‚Q˜A”­. ‘£’qLC‘º¼€i“àj: Expert Nurse, 10(10): 82`89, 1994.

879. muÀn SŽºŠúŠOŽûk(2); ‘½Œ¹«CR on T«C•›’²—¥. ‹g“cTC‘º¼€i“àj: Expert Nurse, 10(11): 84`90, 1994.

880. muÀn SŽº•p”. 󌩑C‘º¼€i“àj: Expert Nurse, 10(12): 75`81, 1994.

881. muÀn SŽº×“®. ’·’J쉄LC‘º¼€i“àj: Expert Nurse, 10(14): 84`91, 1994.

882. muÀn “´«•s®–¬(“´‹@”\áŠQ). ‹v•Û‹MºC‘º¼€i“àj: Expert Nurse, 10(4): 92`99, 1994.

883. muÀn S–[ŠúŠOŽûk. ‚ÎL]C‘º¼€i“àj: Expert Nurse, 10(5): 98`105, 1994.

884. muÀn S–[•p”. ’r“c‘׎qC‘º¼€i“àj: Expert Nurse, 10(7): 98`105, 1994.

885. muÀn S–[ד®CS–[‘e“®. ²“¡ŽüC‘º¼€i“àj: Expert Nurse, 10(8): 92`98, 1994.

886. muÀn –[ŽºÚ‡•”«•s®–¬. Š“c”ü—æ”TC‘º¼€i“àj: Expert Nurse, 10(9): 82`89, 1994.

887. muÀn –[ŽºƒuƒƒbƒN. ‰¬Œ´“ÄC‘º¼€i“àj: Expert Nurse, 11(1): 84`91, 1995.

888. muÀn ƒi[ƒX‚Ì‚½‚ß‚ÌS“d}ƒgƒŒ[ƒjƒ“ƒOC•s®–¬•Ò12; ‹rƒuƒƒbƒN. •½¼T‰EC‘º¼€i“àj: Expert Nurse, 11(2): 84`90, 1995.

889. mŠwp‘i‰p•¶jn i•ª’SŽ·•Mj Contribution to Nephrology: IgA Nephropathy-Pathogenesis and Treatment; O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy, 111: 73`84, ”äŠé”\”ViŠÅŒìŠw•”jC–xˆäºi“àjCŠâ£m—EC–x“c‹±Žqi¶‰»jC¬—Ñ–Li“àj. •ÒW Clarkson, A.R., Karger, Basal, 95.00.00”­s.

890. mŠwp‘n i•ª’SŽ·•Mj ƒNƒŠƒjƒJƒ‹¥ƒtƒ@[ƒ}ƒV[‚Ì‚½‚ß‚Ì“à‰ÈŠw; t‘Ÿ, p.82`91, Š™“cvŽõi“àj. •ÒW aŒûGºi“Œ‹ž—ˆã‘åjCŽë–쯌áiŽ©Ž¡ˆã‘åj, ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, “Œ‹ž, 94.11.10”­s.

891. mŠwp‘n i•ª’SŽ·•Mj ê–åˆã‚Ì‚½‚ß‚ÌŽ…‹…‘ÌáŠQ‚Ì‚·‚ׂÄ; ŽÀŒ±–Œ«tÇ‚ÌŽ…‹…‘ÌáŠQ‹@˜, p.348`351, Š™“cvŽõC’|“àN—Yi“àj. “Œ‹žˆãŠwŽÐ, “Œ‹ž, 94.11.30”­s.

892. mŠwp‘n i•ª’SŽ·•Mj t‚Æ“§Í: Ž…‹…‘ÌáŠQ‚Ì‚·‚ׂÄ, ‘æ‚TÍ; Ž…‹…‘ÌŽ¾Š³‚̃^[ƒ~ƒiƒ‹ƒPƒAu’·Šú“§ÍŠ³ŽÒ‚̇•¹Ç‚Æ‘Îô|œŠÖßÇ£, (—Õ‘): 662`665, ’Ë–{—Y‰îi“àj. 94.00.00”­s.

893. mŠwp‘n i•ª’SŽ·•Mj “§Í—Ö@‚É‚¨‚¯‚釕¹Ç; ‘æ‚j•”‘æ‚PÍ‚‚|t«œÇ, “à‰È“IŽ¡—Ö@, p.373`378, ’Ë–{—Y‰îi“àj. •ÒW ‰z캎O, ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, 94.00.00”­s.

894. mŠwp‘n i•ª’SŽ·•Mj Œ¤Cˆãƒm[ƒg; •‚Žî, p.468`469, Žá—Ñ–õ‹vi“àj. •ÒW ‰iˆä—ÇŽOi“Œ‘åjC f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 94.03.15”­s.

895. mŠwp‘n i•ª’SŽ·•Mj Œ¤Cˆãƒm[ƒg; ŒŒ”A, p.464`465, Žá—Ñ–õ‹vi“àj. •ÒW ‰iˆä—ÇŽOi“Œ‘åjC f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 94.03.15”­s.

896. mŠwp‘n i•ª’SŽ·•Mj Œ¤Cˆãƒm[ƒg; ’`”’”A, p.466, Žá—Ñ–õ‹vi“àj. •ÒW ‰iˆä—ÇŽOi“Œ‘åjC f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 94.03.15”­s.

897. mŠwp‘n i•ª’SŽ·•Mj “à‰ÈŽ¡—ÃKƒCƒh'94|Ž¡—Ãí—ª‚Ì—§‚Ä•û‚Æ•a‘Ԃɉž‚¶‚½Ž¡—Â̎ÀÛ; ’ጌˆ³Ç, p.459`464, ˜Iè‹P•vi“àj. •ÒW Medical Practice•ÒWˆÏˆõ‰ï, •¶Œõ“°, “Œ‹ž, 94.04.21”­s.

898. mŠwp‘n i•ª’SŽ·•Mj zŠÂŠíŽ¾Š³|ÅV‚ÌŽ¡—Ã'94-95; Valsalva“´”j—ô, p.226`230, –Øì“c—²ˆêi“àj. •ÒW ™–{P–¾C‘¼, “ì]“°, “Œ‹ž, 94.05.10”­s.

899. mŠwp‘n i•ª’SŽ·•Mj ‚±‚Ì–ò‚Ì‘½Ü•¹—p•›ì—p; ƒÀƒuƒƒbƒJ[‚ƃWƒ\ƒsƒ‰ƒ~ƒh, p.184`187, –Øì“c—²ˆêC¬—Ñ–¾–Fi“àj. •ÒW ¼“cdŽOi’é‹ž‘åj, ˆãŽ•–òo”Å, “Œ‹ž, 94.10.20”­s.

900. mŠwp‘n i•ª’SŽ·•Mj ‚±‚Ì–ò‚Ì‘½Ü•¹—p•›ì—p; ƒJƒ‹ƒVƒEƒ€hR–ò‚ƃŠƒtƒ@ƒ“ƒsƒVƒ“|ƒJƒ‹ƒVƒEƒ€hRì—pŒ¸Žã|, ‘º¼€i“àj. •ÒW ¼“cdŽOi’é‹ž‘åj, ˆãŽ•–òo”Å, “Œ‹ž, 94.10.20”­s.

901. mŠwp‘n i•ª’SŽ·•Mj V‚µ‚¢W’†Ž¡—Â̎wj; Sƒ^ƒ“ƒ|ƒi[ƒf, p.165`170, ‘º¼€i“àj. •ÒW ‹g–î¶liã‘åjC“‡“cNOi–¼‘åj, “ìŽR“°, “Œ‹ž, 94.10.26”­s.

902. m‹³‰È‘n i•ª’SŽ·•Mj V“à‰ÈŠw‹³‰È‘; ’ጌˆ³i‹N—§«’ጌˆ³Ç, ‹N—§«’²ßáŠQ‚ðŠÜ‚Þ), ˜Iè‹P•vi“àj. •ÒW •ì´CÄ“¡‰p•FC–îè‹`—Y, ‹à–F“°, ‹ž“s, 95.01.00”­s.

903. m‹³‰È‘n i•ª’SŽ·•Mj ƒŒƒWƒfƒ“ƒg‚Ì‚½‚ß‚ÌS‘Ÿ•aŠw; S‘Ÿ“Ë‘RŽ€, p.325`335, ‘º¼€C󌩑C•ìMŒåC‰¬Œ´“ÄC•½¼T‰EC¬—Ñ–¾–FC’·’J쉄LC²“¡´‹MC•‘ò—˜˜YCV’Ã’J^li“àjC¼ŽR´Œhi‹¹ŠOj. ˆãŠw‘‰@, “Œ‹ž, 94.07.20”­s.

904. m‹³‰È‘n i•ª’SŽ·•Mj ƒŒƒWƒfƒ“ƒg‚Ì‚½‚ß‚ÌS‘Ÿ•aŠw; S•Ù–ŒÇ, p.246`269, ‘º¼€C󌩑C•ìMŒåC‰¬Œ´“ÄC•½¼T‰EC¬—Ñ–¾–FC’·’J쉄LC²“¡´‹MC•‘ò—˜˜YCV’Ã’J^li“àjC¼ŽR´Œhi‹¹ŠOj. ˆãŠw‘‰@, “Œ‹ž, 94.07.20”­s.

905. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ˆê–Ú‚Å‚í‚©‚é‹•ŒŒ«SŽ¾Š³; ‹}«S‹Ø[Ç‚Ì—Õ°¥f’f, p.34`35; ‹}«S‹Ø[Ç‚ÌSzŠÂ“®‘Ô, p.36`37; ‹}«S‹Ø[Ç‚ÌS“d}•Ï‰», p.38`39; ‘O•ÇS‹Ø[ÇŒQ, p.40`41; ‰º•ÇS‹Ø[ÇŒQ, p.42`43; ”ñ‚p”gS‹Ø[Ç, p.44`45; ‰EŽº[Ç, p.46`47; S–[[Ç, SŽº’†Šu[Ç, p.48`49, ‘º¼€i“àj. ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, 94.05.30”­s.

906. m‚»‚Ì‘¼‚Ì’˜‘n iŠÄCj ˆê–Ú‚Å‚í‚©‚é‹•ŒŒ«SŽ¾Š³, ŠÄC ‘º¼€i“àj, ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, 94.05.30”­s.

907. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj zŠÂŠíf—Ã}ƒjƒ…ƒAƒ‹; ‚wüŒŸ¸, p.48`61, ‘º¼€i“àj. •ÒW ˆÉŽRç°i“Œˆã‘åjCŠÖ”ŽliÓì’Z‘åjC‘º¼€i“àj, ‹àŒ´o”Å, “Œ‹ž, 94.04.30”­s.

908. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj zŠÂŠíf—Ã}ƒjƒ…ƒAƒ‹; S•s‘S, p.154`167, ‘º¼€C’·’J쉄Li“àj. •ÒW ˆÉŽRç°i“Œˆã‘åjCŠÖ”ŽliÓì’Z‘åjC‘º¼€i“àj, ‹àŒ´o”Å, “Œ‹ž, 94.04.30”­s.

909. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj zŠÂŠíf—Ã}ƒjƒ…ƒAƒ‹; S‘ŸŒŒŠÇŽ¾Š³‚ÌÇŒó‚Æ•a‘Ô¶—, p.1`17, ¬ã”Ž•¶i“àj. •ÒW ˆÉŽRç°i“Œˆã‘åjCŠÖ”ŽliÓì’Z‘åjC‘º¼€i“àj, ‹àŒ´o”Å, “Œ‹ž, 94.04.30”­s.

910. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ‰Šúf—ẪsƒbƒgƒtƒH[ƒ‹|f’f‚É–À‚í‚È‚¢‚½‚ß‚É; •p–¬‚Æ‹¹’É”­ì, p.157`162, ˆ°ì˜a‚i¹ƒ}ƒŠˆã‘åjC‘¼C•‘ò—˜˜Yi“àj. •ÒW ˆ°ì˜a‚i¹ƒ}ƒŠˆã‘åjC •¶Œõ“°, “Œ‹ž, 94.06.27”­s.

911. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj “à‘Ÿ^‹ÛÇ‘Îôƒ}ƒjƒ…ƒAƒ‹; Ž¾Š³•ÊŽ¡—ÃŽwj, p.13`15, ŒŒ‰t“à‰È‚É‚¨‚¯‚éR^‹ÛܗÖ@‚̃|ƒCƒ“ƒg, p.33`37, “à‘Ÿ^‹Ûǂ̕╗Ö@‚Æ‚»‚ÌŽÀÛ, p.39`47, ŽR‰º‚¦‚èŽqi“àj. •ÒW Ž›“cKŽOC‹v•ÄŒõi–k—¢‘åjC ‚©‚Ü‚í‚Ê‘–[, “Œ‹ž, 94.03.01”­s.

912. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ÒWj zŠÂŠíf—Ã}ƒjƒ…ƒAƒ‹. •ÒW ˆÉŽRç°i“Œˆã‘åjCŠÖ”ŽliÓì’Z‘åjC‘º¼€i“àj, ‹àŒ´o”Å, “Œ‹ž, 94.04.30”­s.

913. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn i•ª’SŽ·•Mj VS“d}ƒ}ƒjƒ…ƒAƒ‹; ’á“dˆÊ·, p.61`66; “d‹C“IŒðŒÝ–¬, p.67`71; S‹Ø‰Š, p.395`400; S–Œ‰Š, p.401`407; ‰E‹¹S, p.408`411; ‚ŒŒˆ³, 444`450, ‘º¼€i“àj. •ÒW ‘O“c”@–îi‘åãŽs‘åjCÎ싱ŽOiˆÇ—Ñ‘åjC¬’×F‹I—Yi“ú‘åj, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 94.11.25”­s.

914. m–|–ón iŠÄCj ƒŒƒWƒfƒ“ƒg‚Ì‚½‚ß‚ÌS‘Ÿ•aŠw; S“dŠw‚ÌŠî‘b, p.1`32, ‘º¼€i“àjC ŠÄC ‘º¼€i–k—¢‘åj, ˆãŠw‘‰@, “Œ‹ž, 94.07.20”­s.

915. mŠw‰ïi‘Ûjn i“Á•Êu‰‰j Clinical aspects and prognosis of kidney diseases in the Japanese elderly. ¬—Ñ–Li“àj: 2nd Congress of Chinese Elderly Nephrology i94.10.00j, ”J”g,’†‘.

916. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Posttransplant (post-Tx) abnormalities in VLDL metabolism, another feature of hyperlipidemia in cyclosporine (CyA)-treated patients. ‘å‹v•Û[lC–xˆäºCŠ™“cvŽõC’|“àN—YC’Ë–{—Y‰îC¬—Ñ’¼”Vi“àjC²“¡ŒõŽjiŠOjCŒF–ì˜a—YC‰““¡’‰—Yi”åj: ‘æ27‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i94.10.26`29j, Orland, J. Am. Soc. Nephrol., 5(3): 1028, 1994.

917. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The isolation of rat and human ClC-K2 chloride channel expressed in the distally located nephron segments. ’|“àN—Yi“àjC“à“cMˆêC²X–جCŠÛ–Ε¶ºi“ŒˆãŽ•‘åj: ‘æ27‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i94.10.26j, Orland, J. Am. Soc. Nephrol., 5(3): 5, 1994.

918. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j IgG isotypes investigated for class switching in rat pathological autoantibody for Heymann nephritis. “à“c–ž”üŽqCŠ™“cvŽõC’|“àN—YC‚‹´‰fŽqC²“¡’¼”VC¬—Ñ–LC‘å‹v•Û[li“àj: ‘æ27‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i94.10.26`29j, Orland, J. Am. Soc. Nephrol., 5(3): 772, 1994.

919. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Characteristics of R-R interval variabilities seen in diabetic and non-diabetic hemodialyzed patients. ¬—Ñ’¼”VCŠ™“cvŽõi“àjCŒF–ì˜a—Yi”åjC‹g“càˆC¬—Ñ–LC‘å‹v•Û[li“àj: ‘æ27‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i94.10.26`29j, Orland, JASN, 5(3): 518, 1994.

920. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Substrate dependence of the mitochondrial membrane potential in the isolated working rat heart. Keon, C.(OxfordjC“y‰®’¼—²i“àjC”’J‹`Gi‹~–½jC²“¡´‹Mi“àjCClark, K.CRadda, G.iOxfordjCVeech, R.iNIHj: 67th American Heart Association i94.11.14j, Dallas, USA, Circulation, 90(4): 3393, 1994.

921. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Change in glucose, insulin, and lipid levels during treatment of essential hypertension. ‘£’qLC‘º¼€C¬ã”Ž•¶C²“¡ŽüC‹v•Û‹MºC–Øì“c—²ˆêi“àj: ‘æ22‰ñ‘Û“à‰ÈŠw‰ï i94.08.29j, ƒuƒ^ƒyƒXƒgCƒnƒ“ƒKƒŠ[.

922. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Pulse wave velocity and hemodynamics during chronic treatment of hyperlipidemia with an HMG-CoA reductase inhibitor. ‘º¼€C’·’J쉄LC‘£’qLC²“¡ŽüC󌩑C–Øì“c—²ˆêi“àj: ‘æ22‰ñ‘Û“à‰ÈŠw‰ï i94.08.29j, ƒuƒ^ƒyƒXƒgCƒnƒ“ƒKƒŠ[.

923. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical factors influencing the ventricular late potential in acute myocardial infarction. ²“¡ŽüC󌩑C‘º¼€C’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ22‰ñ‘Û“à‰ÈŠw‰ï i94.08.31j, ƒuƒ^ƒyƒXƒgCƒnƒ“ƒKƒŠ[.

924. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j TOFMS analysis for precise structure of O-glycans in IgA hinge region. ”äŠé”\”ViŠÅŒìŠw•”jCŠâ£m—Ei¶‰»jCTanaka, A.CToda, Y.C–xˆäºi“àjC–x“c‹±Žqi¶‰»jC¬—Ñ–Li“àj: ‘æ27‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i94.10.26`29j, Orland, J. Am. Soc. Nephrol., 5(3): 831, 1994.

925. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Steroid therapy in progressive IgA nephropathy|A 10-year follow up study. ¬—Ñ–Li“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠ™“cvŽõCŠÚ–샶i“àj: ‘æ27‰ñƒAƒƒŠƒJt‘ŸŠw‰ï i94.10.26`29j, Orland, J. Am. Soc. Nephrol., 5(3): 839, 1994.

926. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j CAPD‚É‚¨‚¯‚éCa, PiƒRƒ“ƒgƒ[ƒ‹; CAPD‚É‚¨‚¯‚éRODŽ¡—Â̓ÁŽê«. ’Ë–{—Y‰îi“àj: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï i94.07.01`03j, ‘åã.

927. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j œ«œˆÙ‰h—{Ç‚Ìf’f‚ÆŽ¡—Ã|Å‹ß‚Ìi•à; œ‘ãŽÓƒ}[ƒJ[‚É‚æ‚éüˆÛ«œ‰Š‚Ì—\‘ª. ’Ë–{—Y‰îi“àj: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï i94.07.01`03j, ‘åã.

928. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj –³Œ`¬œ. ’Ë–{—Y‰îi“àj: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï i94.07.01`03j, ‘åã.

929. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‚—îŽÒ‚Ì“§Í; ‚—îŽÒ‚ÌœŠÖß•a•Ï‚Ì“Á’¥‚Æ‘Îô. –쑺K”ÍC’Ë–{—Y‰îi“àj: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï i94.07.01j, ‘åã.

930. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‚—͊³ŽÒ‚Ìg‘Ì“I“Á’¥‚ƎЉï“I‰‡•‚Ì•K—v«. Š™“cvŽõi“àj: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.02j, ‘åãC “ú–{“§ÍˆãŠw‰ïŽGŽ, 27(Suppl.): 566, 1994.

931. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj –«t•s‘S•Û‘¶—Ö@Šú‚É‚¨‚¯‚é“ñŽŸ«•›bó‘B‹@”\˜´iÇ‚ÌŽ¡—Ö@‚ÌŒŸ“¢. ’Ë–{—Y‰îC’·ê‘×i“àj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ï‘‰ï i94.12.16`18j, ç—t.

932. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰EŠ¥“®–¬‚È‚¢‚µ¶‰ñùŽ}•ÂÇ‚É”º‚¤‰ºŒã•Ç[Ç‹}«Šú‚Ì ST•ÎˆÊ‚ɂ‚¢‚Ä. ‹g“cTC¬—Ñ–¾–FC•‘ò—˜˜YC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ91‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï i94.04.16j, VŠƒ, “ú–{“à‰ÈŠw‰ïŽGŽ, 83(—Õ‘): 179, 1994.

933. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j HMG-CoAŠÒŒ³y‘f‘jŠQ–ò‚É‚æ‚é‚Ž‰ŒŒÇ‚Ì’·ŠúŽ¡—ÃŽž‚É‚¨‚¯‚é–¬”g‘¬“x‚È‚ç‚Ñ‚ÉSzŠÂ“®‘Ԃ̕ω»‚ɂ‚¢‚Ä. ‘º¼€C²“¡ŽüC󌩑C¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ91‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï i94.04.16j, VŠƒ, “ú–{“à‰ÈŠw‰ïŽGŽ, 83(—Õ‘): 226, 1994.

934. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”xÇðÇ‚Ì—Õ°ŒŸ“¢. ‰º—¢ŒöºC‘º¼€C‘£’qLC󌩑C²“¡ŽüC–Øì“c—²ˆêi“àj: ‘æ91‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï i94.04.16j, VŠƒ, “ú–{“à‰ÈŠw‰ïŽGŽ, 83(—Õ‘): 237, 1994.

935. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«S‹Ø[Ç‚É‚¨‚¯‚éSŽº’x‰„“dˆÊ”­¶‚ɂ‚¢‚Ä‚Ì[Ç•”ˆÊ•ÊŒŸ“¢. ²“¡ŽüC󌩑C‘º¼€C¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ91‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï i94.04.16j, VŠƒ, “ú–{“à‰ÈŠw‰ïŽGŽ, 83(—Õ‘): 248, 1994.

936. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “§ÍŠ³ŽÒ‚Ì”j‰ó«Ò’ÅÇi“W‚É‚¨‚¯‚é Bone morphogenetic peptide (BMP-2) ‚ðŽn‚ß‚Æ‚µ‚½¬’·ˆöŽq‚¨‚æ‚уTƒCƒgƒJƒCƒ“‚Ì–ðŠ„. ’Ë–{—Y‰îCŽç‰®—˜‰ÀC–쑺K”Íi“àj: ‘æ67‰ñ“ú–{“à•ª”åŠw‰ï i94.06.02j, ’·è, “ú–{“à•ª”åŠw‰ïŽGŽ, 70(3): 302, 1995.

937. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”A׊ǂɂ¨‚¯‚éCa pump isoform‚ÌmRNA”­Œ»‚ÉŠÖ‚·‚錟“¢. Žç‰®—˜‰ÀC’Ë–{—Y‰îi“àjC‚ŽR‹g‰iCìã³–çi•ª¶j: ‘æ67‰ñ“ú–{“à•ª”åŠw‰ï i94.06.02j, ’·è, “ú–{“à•ª”åŠw‰ïŽGŽ, 70(3): 352, 1995.

938. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j CAPDŠ³ŽÒ‚É‚¨‚¯‚é24ŽžŠÔŒŒˆ³“ú“à•Ï“®‚ÆzŠÂ“®‘Ԃɂ‚¢‚Ä. ‹g“càˆCŽÄ“cs•vC¬—Ñ’¼”VCŠ™“cvŽõC¬—Ñ–Li“àjCŒF–ì˜a—YCŽðˆä‹Ši”åjC‘å‹v•Û[li“àj: “ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.03j, ‘åã, “ú–{“§ÍˆãŠw‰ïŽGŽ, 27(Suppl.): 722, 1994.

939. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j S‹Ø‹•ŒŒ, ÄŠÁ—¬‚É‚¨‚¯‚éÔŒŒ‹…—R—ˆ‚ÌŠˆ«Ž_‘f‚Ì•Ï“®‚Æ‹ÇŠ•Ç‰^“®‚Æ‚ÌŠÖŒW. ‚ÎL]C’·’J쉄LC•‘ò—˜˜YC‹v•Û‹MºCŠ“c”ü—æ”TC¬—Ñ–¾–FC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ42‰ñ“ú–{S‘Ÿ•aŠw‰ï i94.09.30j, ‰¡•l.

940. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”ì‘åŒ^S‹ØÇŠ³ŽÒ‚Å‚ÌS”xL“WŽó—e‘Ì‹@”\‚¨‚æ‚щº”¼g‰Aˆ³•‰‰×ŽŽŒ±‚ɑ΂·‚é‘Ï—e”\. ´…Š®‰xC–]ŒŽr’¼CX“cGlC‘ê‘òrŽ÷C‘q“c“TŽqC˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ42‰ñ“ú–{S‘Ÿ•aŠw‰ï i94.09.30j, ‰¡•l, J. Cardiol., 24(Suppl.40): 109, 1994.

941. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«S‹Ø[Ç‚É‚¨‚¯‚éSŽº’x‰„“dˆÊ”­¶‚ɂ‚¢‚Ä‚Ì—Õ°“IŒŸ“¢. ²“¡ŽüC󌩑C‘º¼€C’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ42‰ñ“ú–{S‘Ÿ•aŠw‰ï i94.10.01j, ‰¡•l.

942. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j S‹Ø[Ç‹}«Šú‚É‚¨‚¯‚é QRS‰Šú“dˆÊ(IP)‚ÌŒoŽž“I•Ï‰»|LP‚Ƃ̑Δä|. ²“¡ŽüC󌩑C‘º¼€C’·’J쉄LC¬—Ñ–¾–FC–Øì“c—²ˆêi“àj: ‘æ11‰ñ“ú–{S“dŠw‰ï i94.10.14j, ¼], “ú–{S“dŠw‰ïŽ, 14(5): 503, 1994.

943. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘½Ž{Ý‹¤“¯Œ¤‹†‚É‚æ‚éƒCƒ“ƒ^[ƒtƒFƒƒ“-ƒ¿(HLB1)‚ÌCML‚ɑ΂·‚éŒø‰Ê‚ÌŒŸ“¢|‘æ‚R•ñ|. —LX–Îi“ŒŠC‘åjCŽ›“cG•viº˜a‘åjC‰–’J–Îi“àjC‘¼: ‘æ36‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï i94.11.00j, “Œ‹ž, —Õ°ŒŒ‰t, 35: 1161, 1994.

944. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«S‹Ø[Ç‚É‚¨‚¯‚鶎º‹ìo—¦‚Æ TreadmillŽŽŒ±Žž‚ÌS“d}‚q”g‚‚Æ‚ÌŠÖŒW. X“cGlC´…Š®‰xC‘ê‘òrŽ÷C‘q“c“TŽqC‘åŒIŽ¡•FC–]ŒŽr’¼C˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï i94.11.17j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(Suppl.): 94, 1994.

945. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆŸÅ‘å‰^“®Žž‚É‹N‚±‚é•a‘ÔS‚Ì chronotropic incompetence, ‚»‚Ìf’f‚Æ”­¶‹@“]. •zìTˆê˜YC´…Š®‰xC‰Í–쓹¢C–]ŒŽr’¼C¬ã”Ž•¶C‘£’qLCX“cGlC‘ê‘òrŽ÷C˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï i94.11.17j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(Suppl.j: 95, 1994.

946. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –{‘Ô«‚ŒŒˆ³Ç‚ÌzŠÂ“®‘Ô‚É‹y‚Ú‚· Amlodipine besilate ‚̉e‹¿. ˜Iè‹P•vC•zìTˆê˜YC‚ÎL]C²“¡´‹MC‚‹´‚Ý‚Ç‚èC–]ŒŽr’¼C´…Š®‰xC–Øì“c—²ˆêi“àj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï i94.11.18j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(Suppl.): 118, 1994.

947. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚ŒŒˆ³‚Ì‹}«‹y‚Ñ–«~ˆ³‚É‚¨‚¯‚é ECG voltage criteria‚̕ω»‚ɂ‚¢‚Ä|SƒGƒR[ŠŒ©‚̑Δä|. ¬ã”Ž•¶C‘£’qLC’JìˆêŽuCX“cGlC•zìTˆê˜YC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï i94.11.18j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(Suppl.): 119, 1994.

948. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j tˆÚAŒã‚Ž‰ŒŒÇi‘æ‚R•ñ)ƒVƒNƒƒXƒ|ƒŠƒ““Š—^Š³ŽÒ‚É‚¨‚¯‚éVLDL‘ãŽÓˆÙí‚ÌŒŸ“¢. ‘å‹v•Û[lC–xˆäºCŠ™“cvŽõC’|“àN—YC’Ë–{—Y‰îi“àjC²“¡ŒõŽjiŠOjCŒF–ì˜a—YC‰““¡’‰—Yi”åjC¬—Ñ’¼”Vi‘Š–ÍzŠÂŠíƒNƒŠƒjƒbƒNj: “ú–{ˆÚAŠw‰ï i94.11.24j, L“‡, ˆÚA—\eW, 29: 55, 1994.

949. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Heymannt‰Š(HN)‚Ì•aˆöR‘ÌIgGƒAƒCƒ\ƒ^ƒCƒv‚Ì’·ŠúŠÏŽ@. “à“c–ž”üŽqCŠ™“cvŽõC’|“àN—YC‚‹´‰fŽqC²“¡’¼”VC¬—Ñ–LC‘å‹v•Û[li“àj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ï‘‰ï i94.12.16j, ç—t, “ú–{t‘ŸŠw‰ïŽ, 36(Suppl.): 58, 1994.

950. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œ´”­«Š¥“®–¬‰ð—£‚É‚æ‚éS‹Ø[ǂɑ΂µ‚Ä Palmaz-SchatzƒXƒeƒ“ƒg‚ðA‚¦ž‚ñ‚¾‚P—á. •½¼T‰ECV’Ã’J^lC‰¬Œ´“ÄCŒ´‹ÅC‰iˆä‡C‘º¼€C–Øì“c—²ˆêi“àj: ‘æ‚W‰ñ“ú–{Š¥Ž¾Š³Šw‰ï i94.12.17j, “Œ‹ž, ´˜^W, p.73, 1994.

951. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j is«IgAtǂ͈ꎾŠ³ŒQ‚ð\¬‚µ“¾‚é‚©. X‰º“N•vC’·ê‘×Cò“c‚¢‚Ô‚«C¬‹v•Û“§C–xˆäºC•ìºC”äŠé”\”VCŠ™“cvŽõC’Ë–{—Y‰îCŠÚ–샶C¬—Ñ–Li“àj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ï‘‰ï i94.12.17j, ç—t, “út‰ïŽ, 36(´˜^): 40, 1994.

952. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j TOFMS•ªÍ‚É‚æ‚éƒqƒgIgA1ƒqƒ“ƒW•”ƒ€ƒ`ƒ“Œ^“œ½‚Ì\‘¢‰ðÍ‚ÌŽŽ‚Ý. ”äŠé”\”VC–xˆäºC¬—Ñ–Li“àjCŠâ£m—EC–x“c‹±Žqi¶‰»j: ‘æ37‰ñ“ú–{t‘ŸŠw‰ï‘‰ï i94.12.17j, ç—t, “út‰ïŽ, 36(´˜^): 53, 1994.

953. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒgClC-K2ƒNƒƒ‰ƒCƒhƒ`ƒƒƒ“ƒlƒ‹‚̃Nƒ[ƒjƒ“ƒO. ’|“àN—Yi“àjC“à“cMˆêC²X–جCŠÛ–Ε¶ºi“ŒˆãŽ•‘åj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ï‘‰ï i94.12.18j, ç—t, —\eW, p.83.

954. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “§Í—Ö@‚ɈÚs‚µ‚½IgAtÇ‚Ì—Õ°‘œ. ¬—Ñ–LC¬‹v•Û“§CX‰º“N•vC’·ê‘×C–xˆäºC”äŠé”\”VCŠ™“cvŽõC’Ë–{—Y‰îCŠÚ–샶C–Øì“c—²ˆêi“àj: ‘æ91‰ñ“ú–{“à‰ÈŠw‰ïu‰‰‰ï i94.04.15j, VŠƒ, “ú“à‰ïŽ, 83(—Õ‘): 210, 1994.

955. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –{‘Ô«‚ŒŒˆ³‚É‚¨‚¯‚éŠeŽí~ˆ³–òŽ¡—Âɂæ‚錌“œEƒCƒ“ƒXƒŠƒ“‚¨‚æ‚ÑŽ‰Ž¿’l‚̕ω»‚ɂ‚¢‚Ä. ‘£’qLC‘º¼€C¬ã”Ž•¶C–Øì“c—²ˆêi“àj: ‘æ91‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï i94.04.15j, VŠƒ, “ú–{“à‰ÈŠw‰ïŽGŽ, 83(—Õ‘): 189, 1994.

956. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚ŒŒˆ³Ž¡—Âɂ¨‚¯‚é Tilisolol‚ÌzŠÂ—ÍŠw“IŒŸ“¢|’x‰„”½‰ž‚ÉŠÖ˜A‚µ‚Ä|. ˜Iè‹P•vC‚‹´‚Ý‚Ç‚èC¬‚L]C•zìTˆê˜YC‰Í“c—TC”öŒ`’·—YC–]ŒŽr’¼C´…Š®‰xC–Øì“c—²ˆêi“àj: ‘æ91‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï i94.04.15j, VŠƒ, “ú–{“à‰ÈŠw‰ïŽGŽ, 83(—Õ‘): 192, 1994.

957. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŒoŒûÉŽ_Ü‚Ì–«Žg—pŽž‚ÌŒŒˆ³’²ß‚ւ̉e‹¿‚ɂ‚¢‚Ä. –]ŒŽr’¼C´…Š®‰xCX“cGlC‘ê‘òrŽ÷C‘q“c“TŽqC”öŒ`’·—YC˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ91‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï i94.04.16j, VŠƒ, “ú–{“à‰ÈŠw‰ïŽGŽ, 83(—Õ‘): 185, 1994.

958. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆê‰ß«‹•ŒŒ‚ɑ΂·‚銥zŠÂ“®‘Ô‚ÌŒoŽž“I•Ï‰»‚ƶŽºŠg’£IŠúˆ³‚Æ‚ÌŠÖŒW. ‹v•Û‹MºC’·’J쉄LC•‘ò—˜˜YC‚ÎL]CŠ“c”ü—æ”TC¬—Ñ–¾–FC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ42‰ñ“ú–{S‘Ÿ•aŠw‰ï i94.10.01j, ‰¡•l.

959. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –UŒŸ‚É‚æ‚Á‚ÄŠmf‚³‚ꂽ“à‘Ÿ^‹ÛÇ‚Ì—Õ°“I‰ðÍ. ŽR‰º‚¦‚èŽqi“àjC‹v•ÄŒõi•a—j: ‘æ38‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï i94.10.14j, ¼–{, ˆã^‹ÛŽ, 35(Suppl.1): 136, 1994.

960. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”ì‘åŒ^S‹ØÇŠ³ŽÒ‚ł̉º”¼g‰Aˆ³•‰‰×ŽŽŒ±‚É‚æ‚錟“¢. –ö–Εvi‘‡—Õ°ŒnjC´…Š®‰xC–]ŒŽr’¼CX“cGlC‘ê‘òrŽ÷C‘q“c“TŽqC–Øì“c—²ˆêi“àj: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.28j, ·‰ª, —Õ°•a—, 42i•âû): 351, 1994.

961. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j IgAtÇ‚É‚¨‚¯‚émonocyte/macrophage (M)Œn cell line‚Ö‚Ì IgA‚ÌŒ‹‡“Á«. –xˆäºC”äŠé”\”VCÄ“¡”üç‘ãC¬—Ñ–Li“àj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ï‘‰ï i94.12.17j, ç—t, “út‰ïŽ, 36(´˜^): 188, 1994.

962. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j ‚—îŽÒ‚ÌtŽ¾Š³. ¬—Ñ–Li“àj: ‘æ49‰ñ_“Þ쌧“à‰ÈˆãŠw‰ïHŠúŠwp‘‰ï i94.11.12j, ‰¡•l.

963. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j tŽ¾Š³‚É‚¨‚¯‚é”A’`”’’è—Ê‚Ì—Õ°“IˆÓ‹`. Š™“cvŽõi“àj: ‘æ31‰ñŠÖ“ŒbM’n‹æ—Õ°‰q¶ŒŸ¸Šw‰ï i94.09.11j, ‰¡•l.

964. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¬×–EŒ^ˆ««ƒŠƒ“ƒpŽî‚ɑ΂·‚é Interferon’·Šú—Ö@. ŽR‰º‚¦‚èŽqC“¡–ì—R”üC‰–’J–Îi“àj: “ú–{“à‰ÈŠw‰ï i92.05.00j, ¼–{, “ú–{“à‰ÈŠw‰ïŽGŽ, 83(—Õ‘): 161, 1994.

965. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒPƒgƒAƒVƒh[ƒVƒX‚ðŒJ‚è•Ô‚·Žá”N”­Ç“œ”A•a‚Ì‚P—á. ’hŒ´Š²¶i“àjCŠÛŽR‘¾˜YCŠâè—Ç“ñC´…—ÎC—é–Ø—T–çié‹Ê’†‰›•a‰@j: ‘æ30‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i93.01.23j, ’}”g.

966. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Thyrotoxicosis”­ÇŒã¶Žº‹@”\‚̉ü‘P‚ð”F‚ß‚½¶”x–³Œ`¬Ç‚Ì‚P—á. ’hŒ´Š²¶i“àjC—kŽu¬CrìÍŠìC¼Œ´O–¾ié‹Ê’†‰›•a‰@j: ‘æ147‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i93.02.13j, “Œ‹ž.

967. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ž‹—͒ቺ‚Å”­Ç‚µ, ‚X‚©ŒŽŒã•@”S–Œ‘gD‚É‚æ‚èf’f‚µ“¾‚½ˆ««ƒŠƒ“ƒpŽî‚Ì‚P—á. ’·“c˜a”VCŽR‰º‚¦‚èŽqC“¡–ì—R”üC‰–’J–ÎC–Øì“c—²ˆêi“àj: “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i93.05.00j, “Œ‹ž, “ú–{“à‰ÈŠw‰ïŽGŽ, 83(—Õ‘): 1026, 1994.

968. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —‘‘ƒŠàŽ¡—ÃŒã‚É”­Ç‚µ‚½‹}«ƒŠƒ“ƒp«”’ŒŒ•a‚Ì‚P—á. ’hŒ´Š²¶C‰Ô‰ª³lCŽR‰º‚¦‚èŽqC“¡–ì—R”üC‰–’J–ÎC–Øì“c—²ˆêi“àjC`GŽ÷C‘ –{”ŽsiŽY•wj: “ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i93.10.00j, ‰¡•l, “ú–{“à‰ÈŠw‰ïŽGŽ, 83(—Õ‘): 2014, 1994.

969. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Virus like particle‚Ì‚Ý‚ð”F‚ß‚½ silent lupus nephritis‚©‚ç overt lupus nephritis‚Éis‚µ‚½‚Q—á| virus like particle‚̈Ӌ`‚ɂ‚¢‚Ä. ’·ê‘×C–xˆäºi“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠ™“cvŽõCŠÚ–샶C¬—Ñ–Li“àjCd¼GˆêiMB‘åj: ‘æ24‰ñ“ú–{t‘ŸŠw‰ï“Œ•”‘å‰ï i94.05.20j, ‘O‹´.

970. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒXƒeƒƒCƒh—Ö@‚É‚æ‚è—ÇD‚ÈŒo‰ß‚ð‚Æ‚Á‚½c-ANCA, RƒGƒXƒeƒ‰[ƒ[R‘Ì—z«‚Ì‹}‘¬is«Ž…‹…‘Ìt‰Š‚Ì‚P—á. –xˆäºCX‰º“N•vC’·ê‘×i“àjC”äŠé”\”ViŠÅŒìŠw•”jC¬—Ñ–Li“àj: ‘æ24‰ñ“ú–{t‘ŸŠw‰ï“Œ•”‘å‰ï i94.05.20j, ‘O‹´.

971. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Mesangial IgA deposit‚ð”F‚ß‚½‘ƒóŽ…‹…‘Ìd‰»Ç‚Ì‚Q—á. X‰º“N•vC’·ê‘×C–xˆäºi“àjC”äŠé”\”ViŠÅŒìŠw•”jCŠÚ–샶C¬—Ñ–Li“àj: ‘æ24‰ñ“ú–{t‘ŸŠw‰ï“Œ•”‘å‰ï i94.05.20j, ‘O‹´.

972. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆÙíƒwƒ‚ƒOƒƒrƒ“ǂ𔺂Á‚½tÇ‚É‚¨‚¯‚éƒGƒŠƒXƒƒ|ƒGƒ`ƒ“(nh Epo)—Ö@‚Ì“K‰ž‚ÉŠÖ‚·‚錟“¢. ‘å‹v•Û[lC²“¡“Ö‹vC“à“¡^—ç¶C‹g–ì CŠ™“cvŽõi“àj: ‘æ24‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï i94.05.20`21j, ‘O‹´.

973. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j IgG-ƒÈŒ^œ‘Žî‚É”º‚Á‚½’PƒNƒ[ƒ“«ƒNƒŠƒIƒOƒƒuƒŠƒ“ŒŒÇ‚Å”­Ç‚µ‚½MPGN‚Ì‚P—á. ’|“àN—YCŠ™“cvŽõC–xˆäºC”äŠé”\”VCŠÚ–샶C¬—Ñ–Li“àjCd¼GˆêiMB‘åj: ‘æ24‰ñ“ú–{t‘ŸŠw‰ï“Œ•”‘å‰ï i94.05.20j, ‘O‹´C —\eW, p.35.

974. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j • o“àoŒŒ‚É‚æ‚莀–S‚µ‚½ƒEƒGƒWƒi[“÷‰èŽî‚Ì‚P—á. –ؑ¥–¾C㞊‹glC•‘ò—˜˜YC‘“c‘ìCŽá—Ñ–õ‹vC”’èŒh“ñC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ37‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i94.06.25j, _“Þì.

975. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j 69Î FallotŽl’¥Ç‚ɑ΂·‚骎¡ŽèpŽ¡Œ±—á. ì•Ó•q”VCìŒû’|’ji“àjC“c’†‰p•äCˆÀ–쌛ˆêi¬“cŒ´Žs—§•a‰@j: ‘æ153‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.09.10j, “Œ‹ž.

976. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹}«S‹Ø[ljñ•œŠú‚É‚¨‚¯‚鶎ºŽûk‹@”\‚ƃgƒŒƒbƒhƒ~ƒ‹EƒeƒXƒgŽž‚Ì‚q”g‚‚Æ‚ÌŠÖŒW. X“cGlC´…Š®‰xC‘ê‘òrŽ÷C–]ŒŽr’¼C‘q“c“TŽqC–Øì“c—²ˆêi“àj: ‘æ153‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.09.10j, “Œ‹ž.

977. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒŒð‹zˆø—Ö@‚ª‘tŒø‚µ‚½”x“®–¬ŒŒðÇðÇ‚Ì‚Q—á. ¬òŒ’ˆêiÀ’ÃŽs—§•a‰@jC•½¼T‰ECV’Ã’J^lC‰¬Œ´“ÄCŒ´‹ÅC‘º¼€C–Øì“c—²ˆêi“àj: “ú–{zŠÂŠíŠw‰ï‘æ95‰ñ“ŒŠC, ‘æ80‰ñ–k—¤‡“¯’n•û‰ï i94.10.29j, –¼ŒÃ‰®.

978. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •s–¾”M‚Å”­Ç‚µ‚½’j«silent lupus nephritis‚Ì‚P—á. ¡ò’mŽqC–xˆäºC¼“c–€–çC’†ˆä‹v—YC‰œ•xŒ’CŠÚ–샶C¬—Ñ–Li“àjC•Ÿ‰ª‘½”üŽqi•Ÿ‰ªˆã‰@j: ‘æ432‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.11.12j, ˆïé.

979. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹}«S‹Ø[ÇŒã‚ÌŒg‘ÑŒ^Ž©“®ŒŒˆ³Œv‚É‚æ‚é–éŠÔ~ˆ³“x‚ÉŠÖ‚·‚錟“¢. ‘ê‘òrŽ÷C´…Š®‰xC–]ŒŽr’¼CX“cGlC‘q“c“TŽqC˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ154‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ïŠwpW‰ï i94.12.17j, “Œ‹ž.

980. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Emphysematous Pyelonephrotis‚Ì‚P—á. ò“c‚¢‚Ô‚«CŽá—Ñ–õ‹vi“àjC‘“c‘ìC™–{Ÿ•FC–x’rdŽ¡C‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i95.02.25j, “Œ‹ž.

981. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒtƒBƒbƒgƒlƒXƒNƒ‰ƒu‚ł̔얞Ǘá‚ɑ΂·‚é‚R‚©ŒŽŠÔ‰^“®—Ö@‚ÌŒø‰Ê. ´…Š®‰xC–Øì“c—²ˆêi“àjCŽ›”ö•Ûi“ŒŠC‘åjC¼˜e—viƒwƒ‹ƒXƒvƒƒ‚[ƒVƒ‡ƒ“jC‚”ö—ljpC‰H’¹—TCXŒh‘¾˜Yi_“Þ쌧ˆãŽt‰ïjCùì—m”V•C‹ž‹É_C ˆÉ“¡‹vŽji‚©‚È‚ª‚팒Nà’cj: ‘æ17‰ñS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Œ¤‹†‰ï i94.09.03j, “Œ‹ž.

982. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Natural Ca2+ blocker: Mg2+“Š—^‚ÍS‹Ø‘ãŽÓ‚ð‰ü‘P‚·‚é‚©? |S‹ØƒGƒlƒ‹ƒM[‘ãŽÓ’²ß‹@˜‚É‚¨‚¯‚é×–EŠO Mg‚ÌŠÖ—^|. ²“¡´‹MC‘“c‘ìC–Øì“c—²ˆêi“àj: ‘æ17‰ñS‹Ø‘ãŽÓŒ¤‹†‰ï i94.10.07j, ‘åã.

983. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j –{‘Ô«‚ŒŒˆ³Ç‚É‚¨‚¯‚é‘̈ʕϊ·Žž‚ÌŒŒˆ³•Ï‰»‚ÆzŠÂ“®‘Ô‹y‚Ñ~ˆ³—Ö@Žž‚Ì‹N—§«~ˆ³. ˜Iè‹P•vC²“¡´‹MC‚ÎL]C‚‹´‚Ý‚Ç‚èC´…Š®‰xC–Øì“c—²ˆêi“àj: ‘æ‚U‰ñŒŒˆ³ŠÇ—Œ¤‹†‰ï i94.12.10j, ‹ž“s, —\eW, p.17, 1994.

984. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«ƒAƒ‹ƒR[ƒ‹ŒoŒûÛŽæ‚ÌS”xL“WŽó—e‘Ì‹@”\‚¨‚æ‚Ñ‹N—§‘Ï—e”\‚ւ̉e‹¿. ´…Š®‰xC–]ŒŽr’¼C‘ê‘òrŽ÷C‘q“c“TŽqC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ40‰ñzŠÂŠí•‰‰×Œ¤‹†‰ï i95.02.04j, “Œ‹ž.

985. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ROD‚Ìœ¶ŒŸ‚É‚æ‚éf’f‚ÆŽ¡—Ã. ’Ë–{—Y‰îi“àj: ‘æ32‰ñŠÖ¼ƒJƒ‹ƒVƒEƒ€§˜b‰ï i94.04.23j.

986. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “à‰È—̈æ‚É‚¨‚¯‚étŽ¾Š³|‘Šú”­Œ©C‘ŠúŽ¡—Â̕K—v«‚ɂ‚¢‚Ä. ¬—Ñ–Li“àj: Š™‘qŽsˆãŽt‰ï“à‰ÈˆãŠwŠwpu‰‰‰ï i94.07.00j, Š™‘q.

987. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j IgAtÇ‚Ì—\Œã‚ÆŽ¡—Ã. ¬—Ñ–Li“àj: ‘æ23‰ñŒQ”ntŽ¾Š³Œ¤‹†‰ï i95.03.04j, ‘O‹´.

988. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j IgAtÇ‚ÌŽ¡—Ã. ¬—Ñ–Li“àj: ‘æ18‰ñVŠƒt‘Ÿ§˜b‰ï i95.03.18j, VŠƒ.

989. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j zŠÂŠí. ’·’J쉄Li“àj: ‘æ48‰ñ_“Þ쌧“à‰ÈˆãŠw‰ï‘‰ï i94.06.22j, ‰¡•l.

990. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”xÇðÇ‚ÌŽ€ˆö‚É‚¨‚¯‚éÇð‚È‚ç‚Ñ‚ÉS‹@”\‚̉e‹¿‚ɂ‚¢‚Ä. ‰º—¢ŒöºC‘º¼€C‘£’qLC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: _“ÞìS•s‘SŒ¤‹†‰ï i94.06.04j, ‰¡•l.

991. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j RƒJƒ“ƒWƒ_—¬ŒŒ’†R‘̂ƶ‘Ì–hŒä|ƒEƒGƒXƒ^ƒ“ƒuƒƒbƒg–@‚É‚æ‚é‰ðÍ|. ŽR‰º‚¦‚èŽqC‰–’J–Îi“àjC‹v•ÄŒõi•a—j: ‘æ‚P‰ñDermatological Mycology Club—á‰ï i94.06.09j, “Œ‹ž, ^‹Û‚ƶ‘Ì–hŒä, ‹L˜^W, p.24`31, 1994.

992. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j S‹Ø[Ç‚É‚¨‚¯‚éS“d}‚q”g‚˜a‚ƶŽº‹ìo—¦(RI-EF)‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä. ¬ã”Ž•¶C‘º¼€i“àj: ‘æ29‰ñ_“ÞìzŠÂŠíŒ¤‹†‰ï i94.07.09j, ‰¡•l.

993. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j COP-BLAM‡V—Ö@‚ÌŽ¡—ìтƖâ‘è“_. ŽR‰º‚¦‚èŽqi“àj: ‘æ‚P‰ñ_“Þ쌌‰tƒVƒ“ƒ|ƒWƒA i94.07.09j, ‰¡•l.

994. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ¶Žå—vŠ¥“®–¬‚QŽ}‚ª“¯Žž•ÂÇ‚µ”­Ç‚µ‚½‹}«S‹Ø[Ç‚Ì‚P—á. ‰¡“à‘ŽqC´…Š®‰xCù‰ª‘åŽjCŽí“cGŽiC•‘ò—˜˜YC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ10‰ñSŽ¾Š³ƒŠƒXƒNƒtƒ@ƒNƒ^[Œ¤‹†‰ï i94.09.00j, ‰¡•l.

995. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Ž©ŒÈ–Ɖu«ŠÌ‰Š‚ɇ•¹‚µ‚½ƒƒTƒ“ƒMƒEƒ€‘B«Ž…‹…‘Ìt‰Š‚Ì‚P—á. ŠÚ–샶CX‰º“N•vC’·ê‘×Cò“c‚¢‚Ô‚«C”äŠé”\”VCŠ™“cvŽõCa’J–¾—²C¬—Ñ–Li“àj: ‘æ22‰ñ_“Þìt‰ŠŒ¤‹†‰ï i94.09.03j, ‰¡•l.

996. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”ì‘åŒ^S‹Øǂ̶S‹@”\, “Á‚ɉ^“®•‰‰×Žž¶Žº‹ìo—¦‚Ì„ˆÚ. ´…Š®‰xC‘ê‘òrŽ÷CX“cGlC‘q“c“TŽqC–Øì“c—²ˆêi“àj: ‘æ20‰ñ_“ÞìŽáŽèzŠÂŠíˆã‚̉ï i94.09.17j, ‰¡•l.

997. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j –{‘Ô«‚ŒŒˆ³ÇŠ³ŽÒ‚É‚¨‚¯‚é‹}«~ˆ³‚̉^“®•‰‰×ŽŽŒ±‚ɑ΂·‚锽‰ž‚ɂ‚¢‚Ä. ´…Š®‰xC‘ê‘òrŽ÷Cì•Ó•q”VCX“cGlC‘q“c“TŽqC¬—Ñ–¾–FC’·’J쉄LC‘º¼€C˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ12‰ñSŽ¾Š³ƒŠƒXƒNƒtƒ@ƒNƒ^[Œ¤‹†‰ï i95.03.07j, ‰¡•l.


<<1403 ?? >>

998. mŒ´’˜n Diffusion and perfusion limitations in patients suffering fibrosing lung disease. ¬—ÑO—Si“àjCP. Scheidiƒ‹[ƒ‹‘åjC•y“c—FKi“àj: Adv. Exp. Med. Biol., 345: 105`111, 1994.

999. mŒ´’˜n Experimental arthritis induced by continuous infusion of IL-8 into rabbit knee joints. ‰““¡•½miŠÅŒìŠw•”jCÔ¯“§i“àjC¼‘º–¾lC—˜ªì‰ë—˜C‚ŠÝŒ›“ñi®ŠOj, ”è’õ•vCMatsushima K, ‹ß“¡Œ[•¶i“àj: Clin. Exp. Immunol., 96: 31`35, 1994.

1000. mŒ´’˜n Expression of the chemokine superfamily in rheumatoid arthritis. •äâ–ÎCÔ¯“§i“àjC˜a“c’m‰vi—Õ•a—jC‹ß“¡Œ[•¶i“àj: Clin. Exp. Immunol., 97: 451`457, 1994.

1001. mŒ´’˜n “ÁW: ƒvƒŠƒIƒ“•aŒ¤‹†‚ÌÅ‹ß‚Ìi•à; ‰Æ‘°«CJDƒRƒhƒ“200•ÏˆÙÇ—á. ŒÃ‘ò‰p–¾CˆÉ“¡”Ž–¾C’·’JìˆêŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àjC–k–{“N”Vi‹ã‘åj: Dementia, 8(4): 439`446, 1994.

1002. mŒ´’˜n Joseph•a‚̈ÙíŠá‹…‰^“®‚ÉŠÖ‚·‚é—Õ°•a—Šw“IŒŸ“¢|Ž©Œ±—á‚ð’†S‚É|. ’·’JìˆêŽqCŽO•x“N˜YCŒÃ˜a‹vKi“àj: Equilibrium Res., 53(2): 223`228, 1994.

1003. mŒ´’˜n Respiratory muscle compensation for unilateral or bilateral hemidiaphragm paralysis in awake canines. •Ð‹Ë^li“àjCR.N. YoungCR.S. PlattCT.M. KieserCP.A. EastoniƒJƒ‹ƒKƒŠ[‘åj: J. Appl. Physiol., 76(4): 1972`1982, 1994.

1004. mŒ´’˜n Respiratory muscle function during emesis in awake canines. ˆ¢•”’¼i“àjCT.M. KieseriƒJƒ‹ƒKƒŠ[‘åjC•y“c—FKi“àjCP.A. EastoniƒJƒ‹ƒKƒŠ[‘åj: J. Appl. Physiol., 76(6): 2552`2560, 1994.

1005. mŒ´’˜n Costal and crural diaphragm function during panting in awake canines. P.A. EastoniƒJƒ‹ƒKƒŠ[‘åjCˆ¢•”’¼i“àjCR.N. YoungCJ. SmithCA. GuerratyCA.E. GrassinoiƒJƒ‹ƒKƒŠ[‘åj: J. Appl. Physiol., 77(4): 1983`1990, 1994.

1006. mŒ´’˜n Essential involvement of interleukin-8 (IL-8) in acute inflammation. Harada, A.CSekido, N.CÔ¯“§i“àjC˜a“c’m‰vi—Õ•a—jCMukaida, N.CMatsushima, K.: J. Leukocyte Biol., 56: 559`564, 1994.

1007. mŒ´’˜n Relationship between walking ability and risk of falls in community dewelling elderly in Japan. ‘基Cˆêiˆã—Éq¶Šw•”jCShibata, H.CYasumura, S.CSuzuki, T.: J. Phys. Ther. Sic., 6: 39`44, 1994.

1008. mŒ´’˜n Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis. Hakoda M, Taniguchi A, Kamatani N, Ô¯“§i“àjC”è’õ•vi“Œ—ˆã‘åj: J. Rheumatol., 21: 1637`1641, 1994.

1009. mŒ´’˜n Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. ‰““¡•½miŠÅŒìŠw•”jC×–ìF˜YC‹ß“¡Œ[•¶i“àj: J. Rheumatol., 21: 864`870, 1994.

1010. mŒ´’˜n Essential involvement of interleukin-8 in neutrophil recruitment in rabbits with acute experimental arthritis induced by lipopolysaccharide and interleukin-1. Ô¯“§i“àjC‰““¡•½miŠÅŒìŠw•”jC‹ß“¡Œ[•¶i“àjC”è’õ•vCKasahara, T.CMukaida, N.CHarada, A.CMatsushima, K.: Lymphokine Cytokine Res., 13: 113`116, 1994.

1011. mŒ´’˜n Antineuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infection. ˆÉ“¡”Ž–¾C²ŽRߎqC“ü]KŽqi“àjC‹à‘ò’¼”üi“Œ•a‰@Œ¤‹†ŒnjCÄ“¡–L˜aCŒÃ˜a‹vKi“àjC‰H‰ê½ˆêC’r“c˜a•Fi“Œ‹ž“s¸_ˆãŠw‘‡Œ¤‹†Šj: Neurology, 44(8): 1506`1507, 1994.

1012. mŒ´’˜n ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX’†•_ŒoáŠQ‚ɑ΂·‚郃`ƒ‹ƒvƒŒƒhƒjƒ]ƒƒ“ƒpƒ‹ƒX—Ö@. Žsì—zˆêC‹´–{”ŽŽjC”è’õ•vC‹ß“¡Œ[•¶i“àjCHŒŽ³ŽjCŒËŠ‰Ã”ü: ƒŠƒEƒ}ƒ`, 34: 733`743, 1994.

1013. mŒ´’˜n –«ŠÖ߃ŠƒEƒ}ƒ`‚Ì“à‰È“IŽ¡—ẪKƒCƒhƒ‰ƒCƒ“[ŽŽˆÄ](‘æ‚SŽŸ‰ü’ù). ‹´–{–¾C”è’õ•vC‰„‰i³CŽR“cº•vCL£rˆêCˆÀ”{’BCŽR–،˓¹˜YCH“¡—mC‹g–ì–ŠˆêC“à“cºŽ¢CŽðˆäDŒÃCˆäã“N•¶C‚™Œ‰C¼‰ªN•vC‰ª“cƒ i“àjC‰–‘ò˜aŽqC‘ºŽR—²ŽiCaŒû‹`–¾: ƒŠƒEƒ}ƒ`‰È, 11: 183`196, 1994.

1014. mŒ´’˜n äPŒ´•a‚É‚¨‚¯‚鎩ŒÈ–Ɖu«ŠÌŽ¾Š³‚ÌŒŸ“¢. —é–ØŒúCŠÖŽRØ•äi“àjC”ü“c½“ñC¼‰ªN•vC“üŒðºˆê˜Y: ƒŠƒEƒ}ƒ`‰È, 13: 262`266, 1995.

1015. mŒ´’˜n ’á”Z“xŽ_‘f•‰‰×’†‚̉Ɠe‚É‚¨‚¯‚éˆêŽ_‰»’‚‘f‹z“ü”Z“x‚Æ”x“®–¬ˆ³‚¨‚æ‚Ñ“®–¬ŒŒŽ_‘f•ªˆ³‚Æ‚Ì”Z“x-”½‰žŠÖŒW‚ÌŒŸ“¢. ²“¡“N–çC¬—ÑO—SC“c’†’¼•FC•y“c—FKi“àj: ŒÄ‹z, 14(1): 63`71, 1995.

1016. mŒ´’˜n ¸_•ª—ô•a‚ɑ΂·‚éƒXƒgƒŒƒXÆŽã«‚ÌŒŸØ‚ƃXƒgƒŒƒXƒ}ƒl[ƒWƒƒ“ƒgƒ‚ƒfƒ‹‚Ì’ñˆÄ. “y‘òŒ’ˆêiˆã—Éq¶Šw•”jCˆ­”üŒb”ü: ì‹Æ—Ö@, 13(2): 126`132, 1994.

1017. mŒ´’˜n ŽèŽw‹Ø—Í‘ª’è‚ÉŠÖ‚·‚錤‹†|‚‚܂ݗ͑ª’è‚É‚¨‚¯‚éŽwŠÔ‹——£‚ɂ‚¢‚Ä|. Ä“¡˜a•vCÎX—R”üŽqCŽÄŠì’C‘基Cˆêiˆã—Éq¶Šw•”j: ì‹Æ—Ö@, 13: 218`223, 1994.

1018. mŒ´’˜n ‰^“®ƒjƒ…[ƒƒ“Ž¾Š³Ò‘‚É‚¨‚¯‚é×–EŽ¿ƒ_ƒCƒjƒ“‚Ì•Ï“®. –L“‡ŽŠC¬¼^ŽjiH“c‘åjC’·’JìˆêŽqi“àjC³‘vŒ¤iH“c‘åj: _Œo‰»Šw, 33: 472`473, 1994.

1019. mŒ´’˜n ‰^“®ƒjƒ…[ƒƒ“•a‚ÌŠî’êŠj•a•Ï(2);|‘gD‰»Šw“IŒŸ“¢|. ’·’JìˆêŽqi“àj: _Œo‰»Šw, 33: 480`481, 1994.

1020. mŒ´’˜n ”]ŒŒŠÇáŠQŠ³ŽÒ‚É‚¨‚¯‚élH’YŽ_ò—Ü‚É‚æ‚é’YŽ_ƒKƒX‹z“ü‚Æ”]zŠÂ. ¼‰ª³ŒhC‘O“c^Ž¡C³–Ø‚©‚‚çC—ŠZF“ñCf‘ò’BŽui“àj: “ú–{‰·ò‹CŒó•¨——Ö@ˆãŠwŽGŽ, 57: 129`134, 1994.

1021. mŒ´’˜n ƒVƒŠƒRƒ“«’·ŒCŒ^‘•‹ï‚ÌŠJ”­. ‘O“c^Ž¡i“àjCt“ú”ü•ÛC’·‘òOC’Ø“c—R”üC•½‰ê‚悵‚ÝC{“¡^mC“y”ì³”ViPTjC–؉º—Ç•FCH“c‘PsC¬ŠÖ‡‹vi‘å‹{‹`ŽˆŒ¤‹†Šj: “ú–{‹`Žˆ‘•‹ïŠw‰ïŽ, 11: 14`16, 1995.

1022. mŒ´’˜n Œo•@Ž‘±—zˆ³ŒÄ‹z‚ªƒqƒg‰¡Šu–Œ‚̈ʒu‚Æ”x‹C—Ê‚É‹y‚Ú‚·‰e‹¿. ‹g‘º®‚Cˆ¢•”’¼C“팴”Í”VC•y“c—FKi“àj: “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(11): 1043`1048, 1994.

1023. mŒ´’˜n nasal-CPAP‚Æ‚’YŽ_ƒKƒXŒŒÇ‚ªƒqƒgó• ‹ØŒQ‚É‹y‚Ú‚·‰e‹¿. “팴”Í”VCˆ¢•”’¼C‹g‘º®‚C•y“c—FKi“àj: “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(5): 426`432, 1994.

1024. mŒ´’˜n ƒƒTƒRƒŠƒ“‹z“üŽŽŒ±Œã‚Ì’áŽ_‘fŒŒÇ‚Ì‹@˜‚ɂ‚¢‚Ä‚ÌŒŸ“¢. —é–Ø“¹OC¬—ÑO—SC•y“c—FKi“àj: “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(9): 843`850, 1994.

1025. mŒ´’˜n ‹Â‰çˆÊ‚Æ—§ˆÊ‚É‚¨‚¯‚éŒo•@Ž‘±—zˆ³‹C“¹ˆ³‚ɑ΂·‚éƒqƒg• ‹Ø‚Ì”½‰ž. ‹g‘º®‚Cˆ¢•”’¼C•y“c—FKi“àj: “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 33(1): 8`14, 1995.

1026. mŒ´’˜n ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒXŠ³ŽÒŒŒ´’†‚ÌRŒŒ¬”ÂR‘Ì‚ÉŠÖ‚·‚錤‹†. ÎìÍC‰ª“cƒC‹ß“¡Œ[•¶i“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 18: 20`28, 1995.

1027. mŒ´’˜n ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚É‚¨‚¯‚éŠÌáŠQ. —é–ØŒúCŠÖŽRØ•äi“àjC¬ˆäŒË‘¥•FC‘å‘\ªN•vC”ü“c½“ñC¼‰ªN•vC“üŒðºˆê˜Y: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 18: 53`59, 1995.

1028. mŒ´’˜n ”’ŒŒ•aŠ³ŽÒ‚É‚¨‚¯‚铪ŠW“àoŒŒ—á‚ɂ‚¢‚Ä‚ÌŒŸ“¢. HŽR‹v®C–kˆä‘¥•vC”¨—²ŽuCâˆä•¶•FC_“c’¼i“àj: ”]‘²’†, 16(5): 360`364, 1994.

1029. mŒ´’˜n ~ˆ³–òŠJŽnŒã’ZŠúŠÔ‚Ì‚¤‚¿‚É”­Ç‚µ‚½”][ǂɂ‚¢‚Ä‚ÌŒŸ“¢. ”Ñ’Ë‚_C_“c’¼i“àjCˆî•Ÿ“O–çi“Œ‹ž“s϶‰ï’†‰›•a‰@jC”¨—²ŽuCâˆä•¶•Fi“àj: ”]‘²’†, 16: 239`243, 1994.

1030. mŒ´’˜n Clinical and immunological studies of polyneuropathy associated with monoclonal gammopathy. Ä“¡–L˜aC“ü]KŽqC‰¬–ì”üŒbŽqC‰¬–ì—TC‹y”\ŽGCˆÉ“¡”Ž–¾i“àjC‹à‘ò’¼”üi“Œ•a‰@Œ¤‹†ŒnjCŒÃ˜a‹vKi“àj: –k—¢ˆãŠw, 24(5): 390`401, 1994.

1031. mŒ´’˜n ƒ‰ƒbƒg‚Ì”x”÷¬zŠÂ‚É‚¨‚¯‚é’áŽ_‘f•‰‰×Žž‚ÌŒŒŠÇŒa‚̕ω». “c’†’¼•FC¬—ÑO—SC•y“c—FKi“àj: –k—¢ˆãŠw, 24(6): 528`534, 1994.

1032. mŒ´’˜n ‚—îŽÒdÇ‹Ø–³—ÍÇ‚Ì—Õ°“IŒŸ“¢|60Ζ¢–ž”­Ç—á‚Æ‚Ì”äŠr|. ¼‰ª³ŒhCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: –k—¢ˆãŠw, 25(1): 8`14, 1995.

1033. mŒ´’˜n ’E‘«ƒjƒ…[ƒƒpƒ`[‚É‚¨‚¢‚ÄŒŒ´RGM1, GD1bR‘Ì‚ªoŒ»‚·‚é—Õ°“I—vˆö|‘½•Ï—ʉðÍ‚ð—p‚¢‚Ä‚ÌŒŸ“¢|. “ü]KŽqCÄ“¡–L˜ai“àjC‹à‘ò’¼”üi“Œ•a‰@Œ¤‹†ŒnjCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: —Õ°_ŒoŠw, 34(5): 454`460, 1994.

1034. mŒ´’˜n d–Œ“®Ã–¬ŠïŒ`‚É‚æ‚锼–ÓŽ‹–ì“àŒ¶Ž‹‚Ì‚P—á. ˆî•Ÿ“O–çi“Œ‹ž“s϶‰ï’†‰›•a‰@jCâˆä•¶•FCâ–{’qŽqC”Ñ’Ë‚_C_“c’¼i“àj: —Õ°_ŒoŠw, 34: 484`488, 1994.

1035. mŒ´’˜n Œã“ªŠWâ|”]ŒŒŠÇáŠQ‚̊댯ˆöŽq‚ÉŠÖ‚·‚錤‹†. ”¨—²Žui“àj: —Õ°¬l•a, 24(10): 1441`1443, 1994.

1036. mŒ´’˜n ŒÄ‹z•s‘S—á‚̉摜f’f‚Ì—L—p«. ‘Š”nˆêˆåi‹~–½j: —Õ°•úŽËü, 39(13): 1657`1669, 1994.

1037. m€Œ´’˜i‰p•¶jn Expression of monocyte chemotactic and activating factor in rheumatoid arthritis: regulation of its production in synovial cells by interleukin-1 and tumor necrosis factor. Ô¯“§i“àjC˜a“c’m‰vi—Õ•a—jC‰““¡•½miŠÅŒìŠw•”jC•äâ–ÎC‹ß“¡Œ[•¶i“àjC¼“‡jŽ¡i“Œ—ˆã‘åj: Focus on Rheumatology, 1: 68`69, 1994

1038. m€Œ´’˜n Pulmonary microcirculatory changes of rats at hypoxia. “c’†’¼•FC¬—ÑO—SC²“¡“N–çC—é–Ø“¹OC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj: Pulmonary Circulation Research, 4: 99`102, 1994.

1039. m€Œ´’˜n ‹­”çÇt. ‹ß“¡Œ[•¶C‰““¡•½mi“àj: ƒŠƒEƒ}ƒ`, 94: 286`287, 1994.

1040. m€Œ´’˜n ‹¹’Å Flexion myelopathy‚Ì‚P—á. aˆä—߈êC’·’JìˆêŽqi“àjCŽOˆäŒö•Fi‘—§‘Š–ÍŒ´•a‰@jCŽO•x“N˜YC‰Á“¡’m–çCŒÃ˜a‹vKi“àj: “ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ïŽGŽ, 7(1): 44`45, 1994.

1041. m€Œ´’˜n ”]‘²’†•Ð–ƒáƒŠ³ŽÒ‚É‚¨‚¯‚é—§‚¿ã‚ª‚è‰^“®‘¬“x‚ÌŒŸ“¢. ’·‘òOC’Ø“c—R”üC•½‰ê‚悵‚ÝC{“¡^mCt“ú”ü•ÛCŠO“‡—T”V(PT)C‘O“c^Ž¡i“àj: “ú–{Ž„—§ˆã‰È‘åŠw—Šw—Ö@Šw‰ïŽ, 12: 23`25, 1994.

1042. m’Z•ñE‘¬•ñn GM haplotypes in chronic inflammatory demyelinating polyradiculoneuropathy in Japanese patients. ˆÀ“c•i–¼ŒÃ‰®‘æ“ñÔ\Žš•a‰@jC‘c•ƒ]Œ³CŒF‘ò˜a•Fiˆ¤’mˆã‘åjC”nê³”ViO‘O‘åjCÄ“¡–L˜ai“àjC–ö–±i–¼ŒÃ‰®‘æ“ñÔ\Žš•a‰@jC–žŠÔÆ“Tiˆ¤’m ˆã‘åjC‹{è“o‹IŽqiã‘åj: Eur. Neurol., 34: 221`223, 1994.

1043. mŒ¤‹†•ñiŒú¶Èjn “SŒ‡–Rƒ‰ƒbƒgƒ‚ƒfƒ‹‚É‚¨‚¯‚é CoQ10‚Ì‹Ø—Í‚É‹y‚Ú‚·Œø‰Ê|‘æ‚Q•ñ|. ŒÃ˜a‹vKC’·’Jì‚ЂƂÝi“àjCHitomi Beatriz KiyomotoCÄ“¡–L˜ai“àj: Œú¶È‰ÈŠwŒ¤‹†”ï•â•‹àV–òŠJ”­Ž–‹Æƒ~ƒgƒRƒ“ƒhƒŠƒA•aŽ¡—Öò‚ÌŠJ”­Œ¤‹†‚ˆä”Ç•½¬‚T”N“xŒ¤‹†•ñ‘, p.17`21, 1994.

1044. mŒ¤‹†•ñiŒú¶Èjn ƒXƒ‚ƒ“Š³ŽÒ‚̶Šˆ”͈Í, QOLŠg‘å‚Ì‚½‚ß‚Ì‘Ï…«’·ŒCŒ^‘•‹ï‚ÌŠJ”­. ‘O“c^Ž¡Ct“ú”ü•ÛC’·‘òOC’Ø“c—R”üC•½‰ê‚悵‚ÝC{“¡^mC“y”ì³”ViPTjC–؉º—Ç•FCH“c‘PsC¬ŠÖ‡‹v: Œú¶È“Á’莾Š³ƒXƒ‚ƒ“’²¸Œ¤‹†”Ç; •½¬‚T”N“x”ljï‹c, •½¬‚T”N“xŒ¤‹†•ñ‘, p.342`346, 1994.

1045. mŒ¤‹†•ñiŒú¶Èjn ƒXƒ‚ƒ“Š³ŽÒ‚̶Šˆ”͈Í, QOLŠg‘å‚Ì‚½‚ß‚Ì‘Ï…«’·ŒCŒ^‘•‹ï‚ÌŠJ”­i‘æ‚Q•ñ). ‘O“c^Ž¡i“àjCt“ú”ü•ÛC’·‘òOC’Ø“c—R”üC•½‰ê‚悵‚ÝC{“¡^mCŠO“‡—T”ViPTjC–؉º—Ç•FCH“c‘PsC¬ŠÖ‡‹v: Œú¶È“Á’莾Š³ƒXƒ‚ƒ“’²¸Œ¤‹†”Ç; •½¬‚U”N“x”ljï‹c, 1995.

1046. mŒ¤‹†•ñiŒú¶Èjn ŠÖ“Œb‰z’n‹æ‚É‚¨‚¯‚éƒXƒ‚ƒ“Š³ŽÒ‚ÌŒŸf|‘æ‚V•ñ|. “c•Ó“™Cç“cŒõˆêC‚{r–¾CˆÀ“¡“¿•FC‰ÔâėLjêC•ž•”F“¹CŒÃ˜a‹vKC‘O“c^Ž¡i“àjCŒKŒ´••vC’†‘º—²ˆêC¼žŠˆêŽ~C÷ˆä³Ž÷C’O‘òÍ”ªCã“c•qCç –ì’¼ˆêC‰ª–{KŽsC‰ªŽRŒ’ŽŸC“nç³°—YCrèŒ\‰îCÎì—ÇŽ÷C‰–è‹àŽiC¯Žiiˆê: Œú¶È“Á’莾Š³ƒXƒ‚ƒ“’²¸Œ¤‹†”Ç; •½¬‚U”N“x”ljï‹c, 1995.

1047. mŒ¤‹†•ñiŒú¶Èjn _“Þ쌧‚ł̃Xƒ‚ƒ“Š³ŽÒ‚ÌŽÀ‘Ô’²¸|ŒŸfŒ‡ÈŽÒ‚Ì’ÇÕ’²¸|. ŒÃ˜a‹vKC‘O“c^Ž¡C’·’JìˆêŽqC—À³•£CŽO•x“N˜YC¼‰ª³ŒhC‹y”\ŽGCŒ˘aŽqi“àjC–Ø“¡‹žŽqCXìò”üiŠÅŒì•”jC•ŸŽR‰ÃjC‰œŽRFŽqi‘‡‘Š’k •”j: Œú¶È“Á’莾Š³ƒXƒ‚ƒ“’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ‘, p.499`501, 1994.

1048. mŒ¤‹†•ñiŒú¶Èjn ˆâ“`«Ò‘¬”]•Ï«Ç‚É‚¨‚¯‚é slow eye movement‚Ì—Õ°“IˆÓ‹`‚ɂ‚¢‚Ä. ŒÃ˜a‹vKCŽO•x“N˜YC’·’JìˆêŽqC‹y”\ŽGi“àj: Œú¶È“Á’莾Š³‰^“®Ž¸’²Ç’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ‘; 5.‰^“®Ž¸’², p.125`127, 1994.

1049. mŒ¤‹†•ñiŒú¶Èjn Ò‘¬”]•Ï«Ç‚É‚¨‚¯‚é•àsáŠQ‚Ì’è—Ê“I‰ðÍ‚Æ—Õ°Çó‚ÌŒŸ“¢. ŒÃ˜a‹vKCŒÃ‘ò‰p–¾CŽO•x“N˜YC’·’JìˆêŽqi“àj: Œú¶È“Á’莾Š³‰^“®Ž¸’²Ç’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ‘.(5)‰^“®Ž¸’², p.141`143, 1994.

1050. mŒ¤‹†•ñiŒú¶Èjn ”玿«¬”]ˆÞkÇ‚Ì—Õ°•a—Šw“IŒ¤‹†|Ž¾Š³•ª—Þ‚ÌŽŽ‚Ý|. Šâ•£Œ‰i_“Þ쌧‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“jCŽR“cŒ˜ˆêi‘—§–¼ŒÃ‰®•a‰@jC’·’JìˆêŽqi“àjC‚‹´‹ÏiVŠƒ‘åjC’†ŽRGC¬“c‰ë–çi“s—§_Œo•a‰@•a—jC ’r“cŒ¤“ñi“s¸_ˆãŠw‘‡Œ¤‹†ŠjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[j: Œú¶È“Á’莾Š³‰^“®Ž¸’²’²¸Œ¤‹†”Ç1994”N“x”ljï‹c, 1995.

1051. mŒ¤‹†•ñiŒú¶Èjn ”Ó”­«¬”]”玿ˆÞkÇ‚ÌŠá‹…‰^“®áŠQ‚Æ•a—. ŽO•x“N˜YC—À³•£C’·’JìˆêŽqCŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[j: Œú¶È“Á’莾Š³‰^“®Ž¸’²’²¸Œ¤‹†”Ç1994”N“x”ljï‹c, 1995.

1052. mŒ¤‹†•ñiŒú¶Èjn Ò‘¬”]•Ï«Ç‚ɑ΂·‚é L-threonine“à•ž—Ö@‚ÌŒø‰Ê; “ñd–ÓŒŸŒð·ŽŽŒ±‚É‚æ‚é•]‰¿|. ‰º‘º“o‹K•vC‚‹´˜a˜YCŠÛì_ŽqC–k–ì‚ ‚ä‚ÝCŽO“‡’ÃŽqi’¹Žæ‘åjCŒÃ˜a‹vKCŒÃ‘ò‰p–¾C’·’JìˆêŽqi“àj: Œú¶È“Á’莾Š³‰^“®Ž¸’²’²¸Œ¤‹†”Ç1994”N“x”ljï‹c, 1995.

1053. mŒ¤‹†•ñiŒú¶Èjn Ò‘¬”]•Ï«Ç‚ɑ΂·‚é L-threonine“à•ž—Ö@‚ÌŒø‰Ê; (2)“ñd–ÓŒŸŒð·ŽŽŒ±‚É‚æ‚é•]‰¿|. ŒÃ‘ò‰p–¾CŽO•x“N˜YC’ÒrˆêC’·’JìˆêŽqCŒÃ˜a‹vKi“àjC‰º‘º“o‹K•vC‚‹´˜a˜Yi’¹Žæ‘åj: Œú¶È“Á’莾Š³‰^“®Ž¸’²’²¸Œ¤‹†”Ç1994”N“x”ljï‹c, 1995.

1054. mŒ¤‹†•ñiŒú¶Èjn ‹­”çǂ̃ŒƒCƒm[Œ»Û‚ɑ΂·‚éƒxƒ‰ƒvƒƒXƒgƒiƒgƒŠƒEƒ€‚ÌŽ¡—ÃŒoŒ±. ‹ß“¡Œ[•¶CŠÖŽRØ•äC•äâ–Îi“àj: Œú¶È“Á’莾Š³‹­”çÇ’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ‘, p.141`145, 1994.

1055. mŒ¤‹†•ñiŒú¶Èjn ‹­”çÇ‚Ì—\Œã‚ÉŠÖ‚·‚錤‹†. ‹ß“¡Œ[•¶C‚‹´“¹—YC‰ª“cƒi“àj: Œú¶È“Á’莾Š³‹­”çÇ’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ‘, p.166`170, 1994.

1056. mŒ¤‹†•ñiŒú¶Èjn ŽlŽˆ‚Ì’×ᇥ‰óás‚ð‡•¹‚µ‚½RcentromereR‘Ì—z«‚Ì‚VÇ—á. ‹ß“¡Œ[•¶C‚‹´“¹—YC‰ª“cƒCÎìÍi“àj: Œú¶È“Á’莾Š³‹­”çÇ’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ‘, p.216`221, 1994.

1057. mŒ¤‹†•ñiŒú¶Èjn MCTDŒo‰ß’²¸•\(ŽŽˆÄ)‚Ì쬂Ǝ©Œ± MCTD—á‚ÌŽ©‘R—ð‚̉ðÍ. ‹ß“¡Œ[•¶C‚‹´“¹—YCŠp‰Æ–¾•¶C“ŒžŠ‹B: Œú¶È“Á’莾Š³¬‡«Œ‹‡‘gD•a’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ‘, p.21`24, 1994.

1058. mŒ¤‹†•ñiŒú¶Èjn RƒŠƒ“Ž‰Ž¿ÇŒóŒQŠ³ŽÒ‚ÌRbovineŒŒ´ƒÀ2-glycoprotein 1R‘Ì‚ÉŠÖ‚·‚錟“¢. ‰ª“cƒC–쑺³¢C‹ß“¡Œ[•¶i“àj: Œú¶È“Á’莾Š³Ž©ŒÈ–ƉuŽ¾Š³’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ‘, p.110`112, 1994.

1059. mŒ¤‹†•ñiŒú¶Èjn RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ‚ɇ•¹‚µ‚½”]oŒŒ”­Ç‚̊댯ˆöŽq‚ÌŒŸ“¢. ‰ª“cƒCŠp‰Æ–¾•¶C–쑺³¢C‹ß“¡Œ[•¶i“àj: Œú¶È“Á’莾Š³Ž©ŒÈ–ƉuŽ¾Š³’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ‘, p.113`115, 1994.

1060. mŒ¤‹†•ñiŒú¶Èjn _Œo•Ï«Ž¾Š³‚Ì•a—Šw“I‰Á—î•Ï‰»‚ÌŒŸ“¢|‰^“®ƒjƒ…[ƒƒ“•a‚ð’†S‚É|. ŒÃ˜a‹vKC—À³•£C’·’JìˆêŽqi“àjC–ö‰ºŽO˜Yi_“Þ쑇ƒŠƒnƒrƒŠƒZƒ“ƒ^[j: Œú¶È“Á’莾Š³_Œo•Ï«Ž¾Š³’²¸Œ¤‹†”Ç1993”N“xŒ¤‹†•ñ‘, p.150`152, 1994.

1061. mŒ¤‹†•ñiŒú¶Èjn ‰^“®ƒjƒ…[ƒƒ“•a‚ÌŠî’êŠj•a•Ï. ŒÃ˜a‹vKC’·’JìˆêŽqC—À³•£i“àjC–ö‰ºŽO˜Yi_“Þ쑇ƒŠƒnƒrƒŠƒZƒ“ƒ^[j: Œú¶È“Á’莾Š³_Œo•Ï«Ž¾Š³’²¸Œ¤‹†”Ç1993”N“xŒ¤‹†•ñ‘, p.196`198, 1994.

1062. mŒ¤‹†•ñiŒú¶Èjn Šî’êŠjŽ¾Š³‚Æ“S. —À³•£C’·’JìˆêŽqCŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi_“Þ쌧ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•a‰@j: Œú¶È“Á’莾Š³_Œo•Ï«Ž¾Š³’²¸Œ¤‹†”Ç•½¬‚U”N“x”ljï‹c, 1995.

1063. mŒ¤‹†•ñiŒú¶Èjn ‹ØˆÞk«‘¤õd‰»ÇŠ³ŽÒ‚Ì QOL|–k—¢‘åŠw“Œ•a‰@‚Å‚Ì’·ŠúƒtƒHƒ[ƒAƒbƒvƒP[ƒX|. ’·’JìˆêŽqCŒÃ˜a‹vKC—À³•£CŽO•x“N˜YCÄ“¡–L˜ai“àj: Œú¶È“Á’莾Š³_Œo•Ï«Ž¾Š³’²¸Œ¤‹†”Ç•½¬‚U”N“x”ljï‹c, 1995.

1064. mŒ¤‹†•ñiŒú¶Èjn ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX(SLE)‚É‚¨‚¯‚é‘å‘Úœ“ª‰óŽ€Ç‚Ì”­¶‚É‚¨‚¯‚éRƒÀ2 glucoprotein-1R‘Ì‚ÌŠÖ—^. ‰ª“cƒC–쑺³¢C‹ß“¡Œ[•¶i“àjC”è’õ•vi“Œ‹ž—ˆã‘åj: Œú¶È“Á’莾Š³‘å‘Úœ“ª‰óŽ€Ç’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ‘, p.167`169, 1994.

1065. mŒ¤‹†•ñiŒú¶Èjn ݑJƒƒŠ[—A‰t—Ö@‚ð•K—v‚Æ‚µ‚½‹­”çÇŠ³ŽÒ‚Ìݑaf˜AŒg. ‰ª“cƒCrì‰ëŽqCŽÂŒ´–öŽqC‹ß“¡Œ[•¶C—L“c‰pˆê: Œú¶È“Á’莾Š³“ï•a‚̃PƒA¥ƒVƒXƒeƒ€’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ, p.129`133, 1994.

1066. mŒ¤‹†•ñiŒú¶Èjn äPŒ´•a“ï•aŠ³ŽÒ‚ÌäPŒ´•aŽè’ ‚Ì—˜—p‚ÌŒø—p|“±“ü8”NŒã‚ÌŒŸ“¢|. ‰ª“cƒC‹ß“¡Œ[•¶C‰““¡•½mi“àj: Œú¶È“Á’莾Š³“ï•a‚̃PƒA¥ƒVƒXƒeƒ€’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ, p.134`138, 1994.

1067. mŒ¤‹†•ñiŒú¶Èjn RGM2R‘Ì㸂ð’悵‚½ƒTƒCƒgƒƒKƒƒEƒCƒ‹ƒXŠ´õ‚É”º‚¤ Guillain-BarreÇŒóŒQ‚Ì‚RÇ—á. Ä“¡–L˜aC“ü]KŽqi“àjC‹à‘ò’¼”üi“Œ•a‰@Œ¤‹†ŒnjC•y•Û˜aGCf‘ò’BŽuCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: Œú¶È“Á’莾Š³–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†”Ç•½¬‚U”N“x”ljï‹c, 1995.

1068. mŒ¤‹†•ñiŒú¶Èjn IgM-M’`”’ŒŒÇ‚𔺂¤’E‘«ƒjƒ…[ƒƒpƒ`[‚ÌŒŒ´ƒTƒCƒgƒJƒCƒ“‚ÌŒŸ“¢. Ä“¡–L˜aC“ü]KŽqC•y•Û˜aGCf‘ò’BŽuCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àjC‹à‘ò’¼”üi“Œ•a‰@Œ¤‹†Œnj: Œú¶È“Á’莾Š³–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†”Ç•½¬‚U”N“x”ljï‹c, 1995.

1069. mŒ¤‹†•ñiŒú¶Èjn Guillain-BarreÇŒóŒQ‚É‚¨‚¯‚錌´R GQ1bR‘Ì‚ÌŒŸ“¢. “ü]KŽqCÄ“¡–L˜ai“àjC‹à‘ò’¼”üi“Œ•a‰@Œ¤‹†ŒnjCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: Œú¶È“Á’莾Š³–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†”ǖƉu«_ŒoŽ¾Š³‚ÉŠÖ‚·‚錤‹†•½¬‚T”N“xŒ¤‹†•ñ‘, p.228`231, 1994.

1070. mŒ¤‹†•ñiŒú¶Èjn ”]ŒŒŠÇ«’s•ð‚Ì–ò•¨—Ö@|”]‘²’†–«Šú‚Ì’ÇÕ’²¸‚©‚ç‚ÌŒŸ“¢|. âˆä•¶•FC‹ÊˆäL–¾i“àj: ’s•ðŠÖŒWŒ¤‹†”Ç•½¬‚T”N“xŒ¤‹†‹ÆÑW, p.314`317, 1994.

1071. mŒ¤‹†•ñiŒú¶Èjn –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚ÌQOL‚Ì•Ï“®‚ÉŠÖ—^‚·‚é—vˆö. ‹ß“¡Œ[•¶C‰““¡•½mi“àj: •½¬‚T”N“xŒú¶ÈƒŠƒEƒ}ƒ`’²¸Œ¤‹†Ž–‹ÆŒ¤‹†•ñ‘, p.243`245, 1994.

1072. mŒ¤‹†•ñiŒú¶Èjn ŽÀŒ±“Iƒ`ƒAƒ~ƒ“Œ‡–Ró‘Ô‰º‚É‚¨‚¯‚é’mŠo_ŒoŒn‚Ì‘gD‰»Šw“I•Ï‰»i‘æ‚Q•ñ). Ä“¡–L˜aC•y•Û˜aGCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: •½¬‚U”N“xŒú¶È¸_E_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ï; –«is«ƒ|ƒŠƒjƒ…[ƒƒpƒ`[‚̬ˆö‚ÆŽ¡—ÂɊւ·‚錤‹†”ǔljï‹c, 1995.

1073. mŒ¤‹†•ñiŒú¶Èjn –«‰ŠÇ«’E‘«ƒjƒ…[ƒƒpƒ`[‚É‚¨‚¯‚é–ƉuƒOƒƒuƒŠƒ“—Ö@. Ä“¡–L˜aC•y•Û˜aGCf‘ò’BŽuC“ü]KŽqCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: •½¬‚U”N“xŒú¶È¸_E_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ï; –«is«ƒ|ƒŠƒjƒ…[ƒƒpƒ`[‚̬ˆö‚ÆŽ¡—ÂɊւ·‚錤‹†”ǔljï‹c, 1995.

1074. mŒ¤‹†•ñiŒú¶Èjn Ž²õŒ^ƒMƒ‰ƒ“ƒoƒŒ[ÇŒóŒQ‚Ì—\Œã‚ɂ‚¢‚Ä. Ä“¡–L˜aC•y•Û˜aGCf‘ò’BŽuC“ü]KŽqCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: •½¬‚U”N“xŒú¶È¸_E_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ï; –«is«ƒ|ƒŠƒjƒ…[ƒƒpƒ`[‚̬ˆö‚ÆŽ¡—ÂɊւ·‚錤‹†”ǔljï‹c, 1995.

1075. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Œ`ó‹L‰¯ƒvƒ‰ƒXƒ`ƒbƒN‚Ì•â‘•‹ï‚ւ̉ž—p(‘æ‚Q•ñ: ’Z‰ºŽˆ‘•‹ï‚ÌŠJ”­). ‘O“c^Ž¡C²“¡ŒMC“‡“c—²ŽqC’·‘òOCŒã“¡ˆÀŒbC{“¡“Þ”üC’Ø“c—R”üC•½‰ê‚悵‚ÝC“y”ì³”ViPTjC²Ž¡–L•: ’†•_ŒoáŠQ‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‹@Ší‚ÌŠJ”­‚ÉŠÖ‚·‚錤‹†”Ç; •½¬‚T”N“x”ljï‹c,•½¬‚T”N“xŒ¤‹†•ñ‘, p.55`61, 1994.

1076. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Œ`ó‹L‰¯ƒvƒ‰ƒXƒ`ƒbƒN‚Ì•â‘•‹ï‚ւ̉ž—pi‘æ‚R•ñ: ’Z‰ºŽˆ‘•‹ï‚Ì‘Ï‹v«‚ÌŒŸ“¢). ‘O“c^Ž¡i“àjC²“¡ŒMC“‡“c—²ŽqC’·‘òOCŒã“¡ˆÀŒbC{“¡“Þ”üC’Ø“c—R”üC•½‰ê‚悵‚ÝC“y”ì³”ViPTjC²Ž¡–L•: ’†•_ŒoáŠQ‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‹@Ší‚ÌŠJ”­‚ÉŠÖ‚·‚錤‹†”Ç; •½¬‚U”N“x”ljï‹c, 1994.

1077. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ˜V”NŠú’s•ð‚ÌŒ´ˆö|’s•ð‚ð‚«‚½‚·“ÁŽê_ŒoŽ¾Š³‚ÌŽÀ‘Ô|. Ä“¡–L˜aC‹y”\ŽGC³–Ø‚©‚‚çC“ü]KŽqCŒÃ˜a‹vKi“àj: ˜V”NŠú’s•ð‚̉uŠw‚ÉŠÖ‚·‚錤‹†; •½¬‚T”N“x_“Þ쌧ˆÏ‘õŽ–‹Æ˜Vl«’s•ðŽ¾Š³Œ¤‹†Ž–‹Æ•ñ‘Cp.15`25, 1994.

1078. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ƒp[ƒLƒ“ƒ\ƒ“•a‚Ì’m“I‹@”\‚ÌŒŸ“¢|G.B.S.ƒXƒP[ƒ‹‚É‚æ‚é•]‰¿‚Æ‘‰tRGM1R‘Ì‚ÌŒŸõ|. Ä“¡–L˜aC“ü]KŽqCŒÃ˜a‹vKi“àj: ˜V”NŠú’s•ð‚̉uŠw‚ÉŠÖ‚·‚錤‹†”Ç; •½¬‚S”N“x_“Þ쌧ˆÏ‘õŽ–‹Æ˜Vl«’s•ðŽ¾Š³Œ¤‹†Ž–‹Æ•ñ‘, 1994.

1079. mÇ—á•ñn Renal thrombotic microangiopathy in a patients with rheumatoid arthritis and antiphospholipid syndrome: successful treatment with cyclophosphamide pulse therapy and anticoagulant. –쑺³¢C‰ª“cƒCŠÚ–샶C¬—Ñ–LC‹ß“¡Œ[•¶i“àj: Intern. Med., 33: 484`487, 1994.

1080. mÇ—á•ñn Cutaneous vasculitis in a patient with dermatomyositis without muscle involvement. Šp‰Æ–¾•¶CÔ¯“§CŠÖŽRØ•äC•Ûâ–ÎC‹ß“¡Œ[•¶i“àj: Intern. Med., 33: 809`812, 1994.

1081. mÇ—á•ñn –«ŠÖ߃ŠƒEƒ}ƒ`‚ÉŽ©ŒÈ–Ɖu«ŠÌŽ¾Š³‚𔺂Á‚½‚QÇ—á. ‹{’n´ŒõC‘é–첌bŽqCŠÖŽRØ•äC‘¼7–¼: ƒŠƒEƒ}ƒ`, 34: 639`645, 1994.

1082. mÇ—á•ñn —¼‘¤PTB–Ɖב•‹ï‚ðŽg—p‚µ‚Ä‚Ì•às‚ÌŽŽ‚Ý. ŠO“‡—T”V(PT)C‰F–ìNLCŒI‘ºmC‘O“c^Ž¡i“àj: ˆóü‹Çˆã•ñ, 40: 49`51, 1994.

1083. mÇ—á•ñn •àsŽn“®‹@”\•s‘SÇŒóŒQiSyndrome of Gait Ignition Failurej‚Ì‚QÇ—á. ³–Ø‚©‚‚çC‹y”\ŽGCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‰^“®áŠQ(JMDD)C4(1): 33`38, 1994.

1084. mÇ—á•ñn “ÁˆÙ‚ÈŽp¨•ÛŽ‚ʼnü‘P‚³‚ê‚éKinesie Paradoxale ‚Ì’jŽq—á. Ä“¡–L˜aC•y•Û˜aGCf‘ò’BŽuCŒÃ˜a‹vKi“àj: ‰^“®áŠQ(JMMD), 4(2): 55`59, 1994.

1085. mÇ—á•ñn Œã‘å”]“®–¬—̈æ‚Ì”][Ç‚Å”­Ç‚µA‚Ì‚¿‚É”xŠà‚Ì‘¶Ý‚ª–¾‚ç‚©‚Æ‚È‚Á‚½Ç—á. “Œ–M•FC_“c’¼i“àj: zŠÂ‰ÈŠw, 14(4): 424`428, 1994.

1086. mÇ—á•ñn 20”NŠÔ‚ÌŠÉ™‚ÈŒo‰ß‚ðŽ¦‚µ‚½IgM ƒÈŒ^‚l’`”’ŒŒÇ‚É‚æ‚éƒ|ƒŠƒjƒ…[ƒƒpƒ`[. ’†‘º‘½”üŽqCŠâèÊC‰ª–{KŽsC•½ˆärôiŒQ‘åjCÄ“¡–L˜ai“àj: _Œo“à‰È, 41: 119`124, 1994.

1087. mÇ—á•ñn Rheumatoid meningitis. “ú–ì‰p’‰CŒ˘aŽqi“àj: _Œo“à‰È, 42: 70`72, 1995.

1088. mÇ—á•ñn Ž‰–bÇðÇŒóŒQ‚Ì“ª•”MRIŠŒ©. HŽR‹v®C–kˆä‘¥•vi“àjCV“¡³‹PC‰¡ŽRˆê•FC–x’rdŽ¡Có—˜–õC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 15(1): 240`241, 1994.

1089. mÇ—á•ñn LemierreÇŒóŒQ‚Æl‚¦‚ç‚ꂽFusobacterium necroforum”sŒŒÇ‚Ì‚P—á. ‹v•Û“cŸC–{‘½Œ¤–çCò–õOC‰Ô“cL‰pC•Ð‹Ë^lC–î“ߣM—YC•y“c—FKi“àj: “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(11): 1083`1087, 1994.

1090. mÇ—á•ñn 5ppm‚̈êŽ_‰»’‚‘f‹z“ü‚É‚ÄŽ_‘f‰»”\‚̉ü‘P‚ð‚Ý‚½ARDSÇ—á. “c’†’¼•FC¬—ÑO—SC²“¡“N–çC—é–Ø“¹Oi“àjC²“¡ŒõŽjiŠOjC‘Š”nˆêˆåi‹~–½jCL£–«iMEƒZƒ“ƒ^[jC•y“c—FKi“àj: “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(12): 1187`1193, 1994.

1091. mÇ—á•ñn ‰t‘ÌŒo”çÁ‰Š’Á’ÉÜuƒPƒgƒuƒƒtƒFƒ“v“h•z‚É‚æ‚è—U“±‚³‚ꂽƒAƒXƒsƒŠƒ“šb‘§‚Ì‚P—á. “c’†’¼•FC¬—ÑO—SCŽO“¡‹vC²“¡“N–çC¬‘qŒš•vC‚“cM˜aCˆ¢•”’¼C•y“c—FKi“àj: “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(4): 378`381, 1994.

1092. mÇ—á•ñn RƒŠƒ“Ž‰Ž¿R‘Ì—z«‚Ì‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒXŠ³ŽÒ‚É‚Ý‚ç‚ꂽ‘m–X•Ù‹·óÇ(MS)‚Ì‚P—á. ‚‹´“¹—YC‰ª“cƒi“àjC“ü‘ò²mi‹¹ŠOjC‹ß“¡Œ[•¶i“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 18: 90`97, 1995.

1093. mÇ—á•ñn –éŠÔ‚Ì“´’âŽ~Ašq“fA”AŽ¸‹Ö‚È‚Ç‚Ì‘½Ê‚ÈÇó‚ð’悵‚½‡–°Žž–³ŒÄ‹zÇŒóŒQ‚Ì‚PÇ—á. ŽO“¡‹vCˆ¢•”’¼C‹g‘º®‚C¬–ì’‰LCò–õOC‰Ô“cL‰pC‚“cM˜aC•y“c—FKi“àj: —Õ°ŒÄ‹z¶—, 26(1): 29`35, 1994.

1094. mÇ—á•ñn Ä”­«ŠOŠá‹Ø–ƒáƒ, ––½_Œo“`“±ƒuƒƒbƒN, RGM1R‘Ì㸂ð’悵‚½–«‰ŠÇ«’E‘«‘½”­ƒjƒ…[ƒƒpƒ`[‚Ì‚P—á. —À³•£i“àjC‘ˆäL—mi“¡Ž}Žs—§Žu‘¾‘‡•a‰@jC’·’Jì‚ЂƂÝCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: —Õ°_Œo, 34: 702`706, 1994.

1095. mÇ—á•ñn Šá¥ˆô“ªŒ^‹ØƒWƒXƒgƒƒtƒB[‚̉ƌn—á. –약CiɪÔ\Žš•a‰@jC¡ˆä¸i“àjC‰ª•”‘½‰ÁŽuiɪÔ\Žš•a‰@jCà_ŒûŸ•Fié‹Êˆã‘åj: —Õ°_ŒoŠw, 34(5): 461`465, 1994.

1096. m—Õ°Ž¡Œ±n ”x‰ŠE”sŒŒÇ‚ð’†S‚Æ‚µ‚½MRSAŠ´õǂɑ΂·‚éƒAƒxƒJƒVƒ“‚Ì—L—p«‚ÌŒŸ“¢. ¬“cؔɎ÷C‘¼22–¼C‹ß“¡Œ[•¶CŠÖŽRØ•äi“àjC‘¼5–¼: Jpn. J. Antibiotics, 47: 751`762, 1994.

1097. m—Õ°Ž¡Œ±n ƒ‹[ƒvƒXt‰Š‚ɑ΂·‚郃`ƒ‹ƒvƒŒƒhƒjƒ]ƒƒ“—Ö@‚ÆŒoŒûƒvƒŒƒhƒjƒ]ƒƒ“—Ö@‚Ì“ñd–ÓŒŸŒQŠÔ”äŠrŽŽŒ±. –{ŠÔŒõ•vCŽsì—zˆêCHŒŽ³ŽjC”è’õ•vC‹ß“¡Œ[•¶i“àjC‘¼3–¼: ƒŠƒEƒ}ƒ`, 34: 616`627, 1994.

1098. m—Õ°Ž¡Œ±n FPF1100 (‰–Ž_ƒZƒŒƒMƒŠƒ“j‚̃p[ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚ɑ΂·‚é—Õ°“I—L—p«|ƒvƒ‰ƒZƒ{‚ð‘ÎÆ‚Æ‚µ‚½“ñd–ÓŒŸŒQŠÔ”äŠrŽŽŒ±|. ‹ß“¡’q‘Pi‡“V‘åjCŒã“¡Šô¶i‹ã‘åjCŒÃ˜a‹vKi“àjC–ö‘òM•viMB‘åjC‹à‘òˆê˜Yi“Œ‘å”]Œ¤jC¬ì’¨–çiˆ¤•Q‘åjC…–ì”ü–Mi‡“V‘åj: ˆãŠw‚Ì‚ ‚ä‚Ý, 169(2): 00`00, 1994.

1099. m—Õ°Ž¡Œ±n äPŒ´•a‚É”º‚¤”畆’×ᇂɑ΂·‚éƒVƒƒXƒ^ƒ][ƒ‹‚Ì—L—p«. ‹ß“¡Œ[•¶i“àjCXr“ñC–x‰ÃºC”è’õ•vCŽë–쯌áC“c‘㳺: ‰ŠÇ, 14: 537`547, 1994.

1100. m—Õ°Ž¡Œ±n ”]ŒŒŠÇáŠQŒãˆâǂɑ΂·‚é DM-9384 (ƒlƒtƒBƒ‰ƒZƒ^ƒ€)‚Ì’·Šú“Š—^‚É‚æ‚é—Õ°•]‰¿. ’·’JìP•viˆÉ“¤”BŽR‰·ò•a‰@jCù¶rˆêi‘—§—×{Š‹{é•a‰@jCŠÛŽRŸˆêi“Œ—ˆã‘åjCŒÃ‹´‹I‹vi“àjC•½“c‰·C²“¡—YˆêiH“cŒ§—§”]ŒŒŠÇŒ¤‹†ƒZƒ“ ƒ^[jC–Ø‘ºŠii‘—§—×{Š‹{é•a‰@jC”üŒ´”Õi”]ŒŒŠÇŒ¤‹†Š•‘®”üŒ´‹L”O•a‰@jC¬¼–{Œåi‘«—˜Ô\Žš•a‰@jC“c’†‹vŒbi“Œ—ˆã‘åjC‘O“c^Ž¡i“àjC “Œ–M•FC”Š_miˆÉ¨Œ´‹¦“¯•a‰@jCd–ìKŽŸiˆÉ“¤”BŽR‰·ò•a‰@jC‰Í–ìe•vC‚‹´“TŽOi“yŠòŽs—§‘‡•a‰@jC–{‰ª—´•FC’ç–¾iŽs—§‰Á¼•a‰@jCˆø’n–¾ ‹`CD‰i‡“ñC’†‘º–õC²“¡—RŽ÷iL“‡Žs–¯•a‰@jC¼Œ´”ŽŽji‘啪Œ§—§ŽOd•a‰@j: —Õ°ˆã–ò, 10(9): 2087`2106, 1994.

1101. m‘àn ˆãŒ´«”]oŒŒ. ”¨—²Žui“àj: Clin. Neurosci., 12(12): 1390`1394, 1994.

1102. m‘àn Ž„‚̈•û; ˜’É. ŒÃ˜a‹vKi“àj: Clin. Neurosci., 12(12): 1430, 1994.

1103. m‘àn _Œoª‚Ì•a‹C; –ƉuˆÙí. Ä“¡–L˜ai“àj: Clin. Neurosci., 12(7): 778`780, 1994.

1104. m‘àn ˆêŽ_‰»’‚‘f‚É‚æ‚éŒÄ‹z•s‘S‚ÌŽ¡—Ã. ¬—ÑO—Si“àjCL£–«iMEƒZƒ“ƒ^[j: Clinical Engineering, 5(11): 802`807, 1994.

1105. m‘àn ƒ€ƒ`ƒ‰ƒ“ƒX•ÏŒ`‚ð‚à‚Š³ŽÒ‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‘O“c^Ž¡i“àj: J. Clin. Rehabil., (•Êû): 139`141, 1994.

1106. m‘àn ƒŠƒn‘Š’kŽºC‚킽‚µ‚Ȃ炱‚¤‚·‚éC‘½”­«”][Ç‚É‚æ‚é’s•ð. Œ˘aŽqC‘O“c^Ž¡i“àj: J. Clin. Rehabil., 3: 609`611, 1994.

1107. m‘àn ”]ŒŒŠÇ«’s•ð‚Ì—\–h‚Æ‘Îô. ”¨—²Žui“àj: Mebio, 12(3): 82`89, 1995.

1108. m‘àn ƒp[ƒLƒ“ƒ\ƒ“•a‚Æ’s•ð‚ւ̃Aƒvƒ[ƒ`(‚»‚Ì‚Q): ƒp[ƒLƒ“ƒ\ƒ“•a‚ƉÁ—î|f’f‚ÆŽ¡—ÂÌi‚ß‚©‚½|. ’·’JìˆêŽqCŒÃ˜a‹vKi“àj: Medical Practice, 12(3): 316`321, 1995.

1109. m‘àn ƒp[ƒLƒ“ƒ\ƒ“•a‚ƉÁ—î; f’f‚ÆŽ¡—ÂÌi‚ß‚©‚½. ’·’JìˆêŽqCŒÃ˜a‹vKi“àj: Medical Practice, 12(3•Êû): 316`321, 1995.

1110. m‘àn Œƒ‚µ‚¢“ª’É. âˆä•¶•Fi“àj: Medicina, 31(10): 2086`2087, 1994.

1111. m‘àn _Œo’ÉE_Œo‰Š‚ÌŽ¡—Ã}ƒjƒ…ƒAƒ‹, ‘½”­_Œo‰Š‚ÌŽ¡—ÃXƒgƒ‰ƒeƒBƒW[; ƒpƒ‰ƒvƒƒeƒBƒlƒ~ƒA‚É”º‚¤ƒjƒ…[ƒƒpƒ`[. Ä“¡–L˜ai“àj: Modern Physician, 14(4): 497`500, 1994.

1112. m‘àn ƒ‹[ƒvƒXäNã÷‰Š. ‹ß“¡Œ[•¶CŠÖŽRØ•äi“àj: ƒŠƒEƒ}ƒ`‰È, 12: 354`360, 1994.

1113. m‘àn –òŒø•]‰¿‚Ì‚ ‚è•û. ‹ß“¡Œ[•¶i“àj: ƒŠƒEƒ}ƒ`‰È, 13: 246`250, 1995.

1114. m‘àn ”]‘²’†’´‘Šú‚©‚ç‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‘O“c^Ž¡i“àj: ˆãŠw‚Ì‚ ‚ä‚Ý, 170: 1020`1021, 1994.

1115. m‘àn äPŒ´•a‚É‚¨‚¯‚é¸_E_Œo•a•Ï. ‹ß“¡Œ[•¶C‰ª“cƒi“àj: ˆãŠw‚Ì‚ ‚ä‚Ý, 171: 31`34, 1994.

1116. m‘àn ‹CŠÇŽxšb‘§Ž¡—ÃÜ. ‹v•Û“cŸCò–õOC•y“c—FKi“àj: ˆã–òƒWƒƒ[ƒiƒ‹, 30(5): 1359`1362, 1994.

1117. m‘àn ‹­”çÇt. ‹ß“¡Œ[•¶i“àjC‰““¡•½miŠÅŒìŠw•”j: ‰ŠÇ‚ƖƉu, 1: 58`62, 1995.

1118. m‘àn IL-8ƒŒƒZƒvƒ^[‚ÆŽ¾Š³. Ô¯“§i“àj: ‰ŠÇ‚ƖƉu, 3: 33`39, 1995.

1119. m‘àn ƒŒƒCƒm[Œ»Û‚ÌŠÓ•Êf’f‚ÆŽ¡—Ã. ‰ª“cƒC‹ß“¡Œ[•¶i“àj: ŠO‰ÈŽ¡—Ã, 71: 253`258, 1994.

1120. m‘àn ‘–Œ‰Š, ”]‰Š. –kˆä‘¥•vi“àjC‘å˜a“c—²i‹~–½j: ‹~‹}ˆãŠw, 18(10): 1169`1174, 1994.

1121. m‘àn SIRS(‘Sg«‰ŠÇ”½‰žÇŒóŒQ)‚ÆARDS. ‘Š”nˆêˆåi‹~–½j: ŒÄ‹z, 14(1): 28`34, 1995.

1122. m‘àn (“ÁW)Žå‚È_ŒoŽ¾Š³: Å‹ß‚ÌŽ¡—Ã|‘½”­ƒjƒ…[ƒƒpƒ`[‚ÌŽ¡—Ã|. Ä“¡–L˜ai“àj: Ž¡—ÂÌÅ‘Oü, 1(5): 658`663, 1994.

1123. m‘àn ”]‘²’†Š³ŽÒ‚É•K—v‚ÈfŽ@‚ÆŒŸ¸; ‰fæ‚â‹Ù‹}ŠO—ˆ‚ł̑Έ. –kˆä‘¥•vC_“c’¼i“àj: zŠÂ‰ÈŠw, 14(9): 848`851, 1994.

1124. m‘àn Ž…‹…‘ÌŽ¾Š³‚ÌŽå—v•aŒ^‚Æ—Õ°•a—A‚»‚Ì‘¼‚ÌäPŒ´•a. ‹ß“¡Œ[•¶i“àjC‰““¡•½miŠÅŒìŠw•”j: t‚Æ“§Í, 37(Suppl.): 264`268, 1994.

1125. m‘àn ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ìf’f‚ÆŽ¡—Ã. ‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘‡—Õ°, 43: 1110`1114, 1994.

1126. m‘àn –³ÇŒó«”][Ç; •ÂÇ“®–¬‚Æ’èŒ^“IÇŒó. _“c’¼i“àj: ‘‡—Õ°, 43: 2816`2821, 1994.

1127. m‘àn (“ÁW)ÅVŽ¡—Ã}ƒjƒ…ƒAƒ‹; ƒNƒŠƒvƒgƒRƒbƒJƒX‘–Œ‰Š. ŒÃ˜a‹vKi“àj: “à‰È, 73(6): 1325`1329, 1994.

1128. m‘àn ‹­”çÇ‚ÌŽ¡—Ã. ‹ß“¡Œ[•¶i“àj: “à‰È, 73: 673`677, 1994.

1129. m‘àn ˜V”NŽÒ”]ŒŒŠÇáŠQ‚Ì—¯ˆÓ“_. _“c’¼i“àj: “úˆãƒjƒ…[ƒX, (792): 10, 1994.

1130. m‘àn ”ñƒXƒeƒƒCƒhÜ‚Ì•›ì—pA–òÜ‘ŠŒÝì—p. ‹ß“¡Œ[•¶i“àj: “úŒoƒƒfƒBƒJƒ‹, 24: 132`135, 1995.

1131. m‘àn “ª’É‚Ì‘Û•ª—Þ‚Æ•p“x. âˆä•¶•Fi“àj: “ú–{ˆãŽt‰ïŽGŽ, 113(6): 5`8, 1995.

1132. m‘àn (“ÁW)ƒp[ƒLƒ“ƒ\ƒ“•a: f’f‚ÆŽ¡—ÂÌi•à|‚h. —ðŽj“I”wŒi 1.James Parkinson‚Ì‹LڂƉuŠw|. ŒÃ˜a‹vKi“àj: “ú–{“à‰ÈŠw‰ïŽGŽ, 83(4): 524`527, 1994.

1133. m‘àn ŠÖß’É(‰Š): f’f‚ÆŽ¡—ÂÌi•à|ŠÖß’É(‰Š)‚Ìf’f‚ÆŽ¡—à (3)‹}«‘½”­«ŠÖß’É(‰Š)‚Ìf’f‚ÆŽ¡—Ã. ‰ª“cƒi“àj: “ú–{“à‰ÈŠw‰ïŽGŽ, 83: 46`50, 1994.

1134. m‘àn (“ÁW)_Œo–ƉuŠw‚Ìi•à: ˆÙíƒOƒƒuƒŠƒ“ŒŒÇ, ƒ‚ƒmƒNƒƒiƒ‹ƒKƒ“ƒ‚ƒpƒ`[‚𔺂¤ƒjƒ…[ƒƒpƒ`[. Ä“¡–L˜ai“àj: “ú–{—Õ°, 52(11): 2976`2983, 1994.

1135. m‘àn ƒTƒCƒgƒJƒCƒ“‚Ì‚·‚ׂÄ; MCAF. •äâ–ÎCÔ¯“§i“àj: —Õ°–Ɖu, 27(Suppl.16): 155`161, 1995.

1136. m‘àn ”x[Ç. “y‹´‚ä‚©‚èC‚“cM˜aC•y“c—FKi“àj: ˜V‰»‚ÆŽ¾Š³, 8(2): 25`30, 1994.

1137. m‘àn “ª’É¥“ªd‚ð‘i‚¦‚銳ŽÒ‚ւ̑Ήž. âˆä•¶•Fi“àj: ˜V”N¸_ˆãŠwŽGŽ, 5(12): 1491`1495, 1994.

1138. muÀn ƒXƒgƒŒƒX¥¶ŠˆKŠµ‚Æ“ª’É. âˆä•¶•Fi“àj: AOL-News, (47): 2`3, 1994.

1139. muÀn ƒtƒŠ[ƒ‰ƒWƒJƒ‹‚ÆäPŒ´•a. ‰““¡•½miŠÅŒìŠw•”jC‰ª“cƒi“àj: J. Act. Oxyg. Free Rad., 6: 54`61, 1995.

1140. muÀn “ª’É. âˆä•¶•Fi“àj: Just Health, (141): 14`15, 1995.

1141. muÀn ÇŒó•Ê“à‰ÈƒGƒ}[ƒWƒFƒ“ƒV[; áz¹. ”¨—²Žui“àj: Medicina, 31(10): 2088`2091, 1994.

1142. muÀn ˆê”ÊÇó‚©‚ç‚Ý‚½ First-lineŒŸ¸; “ª’É. ”¨—²Žui“àj: Medicina, 31(4): 670`673, 1994.

1143. muÀn RScl-70R‘Ì. ‹ß“¡Œ[•¶i“àj: Medicina, 31(Suppl.): 608`609, 1994.

1144. muÀn “ª’É‚Ì\‘¢‚P; ‚È‚º“ª’É‚Í’É‚¢‚Ì‚©. âˆä•¶•Fi“àj: Scope, 34(1): 20`21, 1995.

1145. muÀn “ª’É‚Ì\‘¢‚Q; “ª’É‚É‚Í‚Ç‚ñ‚ÈŽí—Þ‚ª‚ ‚é‚©. âˆä•¶•Fi“àj: Scope, 34(2): 20`21, 1995.

1146. muÀn “ª’É‚Ì\‘¢‚R; ƒ}ƒjƒ…ƒAƒ‹’Ê‚è‚É‚Í‚¢‚©‚È‚¢. âˆä•¶•Fi“àj: Scope, 34(3): 20`21, 1995.

1147. muÀn “ª’É‚ð–h‚®. âˆä•¶•Fi“àj: ‚«‚傤‚ÌŒ’N, (84): 98`101, 1995.

1148. muÀn ŒÄ‹zŠíŒn‹@”\•s‘SiŒÄ‹z•s‘Sj‚Ì•a‘Ô¥Ž¡—Ã¥ŠÅŒì‚̃|ƒCƒ“ƒg. •Ð‹Ë^li“àj: ƒi[ƒXƒf[ƒ^, 15(12): 102`109, 1994.

1149. muÀn SLE‚Ì—Õ°Çó‚ðŒ©‚é. ‰ª“cƒC–쑺³¢C‹ß“¡Œ[•¶i“àj: ŠÅŒì‹Zp, 40: 1113`1116, 1994.

1150. muÀn Ž_‘f–O˜a“x. ‘Š”nˆêˆåi‹~–½j: ‹~‹}ˆãŠw, 18(5): 600`602, 1994.

1151. muÀn Š´–`ÇŒóŒQ. –ؑ¥–¾C‘Š”nˆêˆåi‹~–½j: ‹~‹}ˆãŠw, 18: 1199`1201, 1994.

1152. muÀn COPD‚Ì—Õ°ŒŸ¸(2) ŒŒ—¬ƒKƒXŠŒ©. ‰Ô“cL‰pC‚“cM˜aC•y“c—FKi“àj: Ž¡—Êw, 28(7): 37`39, 1994.

1153. muÀn Dysthyroid Ophthalmopathy. HŽR‹v®i“àj: “à‰Èê–åˆã‰ïŽ, 6(3): 244`252, 1994.

1154. muÀn œ‘ˆÙŒ`¬ÇŒóŒQ. HŽR‹v®i“àj: “à‰Èê–åˆã‰ïŽ, 6(4): 325`334, 1994.

1155. muÀn œ‘Žî. HŽR‹v®i“àj: “à‰Èê–åˆã‰ïŽ, 7(1): 51`57, 1995.

1156. muÀn RƒŠƒ“Ž‰Ž¿R‘Ì‘ª’è–@‚ÌŒ»‹µ‚Æ–â‘è“_. ‰ª“cƒC“L–Ø~ˆêi“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 17: 1018`1020, 1994.

1157. muÀn f’f‚Ì‚½‚ß‚ÌŒŸ¸Œv‰æ(2)ŒÄ‹zŠíŽ¾Š³3|”x‰»”^Ç. “c’†’¼•FC¬—ÑO—Si“àj: —Õ°ˆã, 20(‘Š§): 710`711, 1994.

1158. muÀn Ž©ŒÈ–ƉuŽ¾Š³‚ÆŒŒŠÇ‰Š. ‰ª“cƒCŠp‰Æ–¾•¶i“àj: —Õ°ˆã, 20: 50`52, 1994.

1159. mŠwp‘n i•ª’SŽ·•Mj Sjogren's syndrome |State of the art-; Hepatitis C virus infection and crioglobulinemia in patients with primary Sjoren's syndrome, p.365`366, ‰ª“cƒC•äâ–ÎCŠp‰Æ–¾•¶C‹ß“¡Œ[•¶i“àj. •ÒW M. Homma, et al.C Kugler Publications, Amsterdam, 94.00.00”­s.

1160. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj1995”N”Å; ŒŒ´•a, p.553`554, Ô¯“§i“àj. ˆãŠw‘‰@, “Œ‹ž, 95.02.15”­s.

1161. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚̈•û(‰ü’ù‘æ‚Q”Å); ƒŠƒEƒ}ƒ`«‘½”­‹Ø’ÉÇ‚È‚Ç, p.447`451, ‹ß“¡Œ[•¶i“àj. •ÒW ‚‹vŽj–›C…“‡—TC “ì]“°, “Œ‹ž, 94.00.00”­s.

1162. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚̈•û(‰ü’ù‘æ‚Q”Å); ¬‡«Œ‹‡‘gD•a ‚È‚Ç, p.454`462, ‹ß“¡Œ[•¶i“àj. •ÒW ‚‹vŽj–›C…“‡—TC “ì]“°, “Œ‹ž, 94.00.00”­s.

1163. mŠwp‘n i•ª’SŽ·•Mj “à‰ÈŽ¡—ÃKƒCƒh94; ƒEƒFƒWƒi[“÷‰èŽîÇ, p.1167`1168, ‹ß“¡Œ[•¶i“àjC‰““¡•½miŠÅŒìŠw•”j. •ÒW ˜a“cUC‘¼C •¶Œõ“°C“Œ‹ž, 94.00.00”­s.

1164. mŠwp‘n i•ª’SŽ·•Mj –«ŠÖ߃ŠƒEƒ}ƒ`Ž¡—ÂÌV‚½‚ȃAƒvƒ[ƒ`; –Ɖu—}§–ò, p.37`46, ‹ß“¡Œ[•¶C‚‹´“¹—Yi“àj. •ÒW ‹{âM”VC æ’[ˆãŠwŽÐ, “Œ‹ž, 94.07.00”­s.

1165. mŠwp‘n i•ª’SŽ·•Mj –ƉuŽ¾Š³|state of arts; Ž©ŒÈ–ƉuŽ¾Š³‚Ì—Õ°‘œC‹­”çÇ, p.366`369, ‹ß“¡Œ[•¶i“àj. •ÒW ¡¼“ñ˜YC‘¼C ˆãŽ•–òo”Å, “Œ‹ž, 95.00.00”­s.

1166. mŠwp‘n i•ª’SŽ·•Mj äPŒ´•aEƒŠƒEƒ}ƒ`‚Ìf—Ã|f•ûEŽ¡‚µ•ûE¶ŠˆŽw“±|; ˆê”ÊŒŸ¸‚Ìi‚ß•ûE“Ç‚Ý•û, p.19`26, ‹ß“¡Œ[•¶i“àj. •ÒW ”è’õ•vC “ì]“°, “Œ‹ž, 94.00.00”­s.

1167. mŠwp‘n i•ª’SŽ·•Mj äPŒ´•aEƒŠƒEƒ}ƒ`‚Ìf—Ã|f•ûEŽ¡‚µ•ûE¶ŠˆŽw“±|; ƒŠƒEƒ}ƒ`”M, p.81`85, ‹ß“¡Œ[•¶i“àj. •ÒW ”è’õ•vC “ì]“°, “Œ‹ž, 94.00.00”­s.

1168. mŠwp‘n i•ª’SŽ·•Mj äPŒ´•aEƒŠƒEƒ}ƒ`‚Ìf—Ã|f•ûEŽ¡‚µ•ûE¶ŠˆŽw“±|; ‘Sg«‹­”çÇ, p.86`96, ‹ß“¡Œ[•¶i“àj. •ÒW ”è’õ•vC “ì]“°, “Œ‹ž, 94.00.00”­s.

1169. mŠwp‘n i•ª’SŽ·•Mj äPŒ´•aEƒŠƒEƒ}ƒ`‚Ìf—Ã|f•ûEŽ¡‚µ•ûE¶ŠˆŽw“±|; –«ŠÖ߃ŠƒEƒ}ƒ`, p.65`76, ‰ª“cƒi“àj. •ÒW ”è’õ•vC “ì]“°, “Œ‹ž, 94.00.00”­s.

1170. mŠwp‘n i•ª’SŽ·•Mj äPŒ´•aEƒŠƒEƒ}ƒ`‚Ìf—Ã|f•ûEŽ¡‚µ•ûE¶ŠˆŽw“±|; ¬l”­ÇStill•a, p.77`80, ‰ª“cƒi“àj. •ÒW ”è’õ•vC “ì]“°, “Œ‹ž, 94.00.00”­s.

1171. mŠwp‘n i•ª’SŽ·•Mj äPŒ´•aEƒŠƒEƒ}ƒ`‚Ìf—Ã|f•ûEŽ¡‚µ•ûE¶ŠˆŽw“±|; –òÜ—U”­ƒ‹[ƒvƒX, p.141`144, ‰ª“cƒi“àj. •ÒW ”è’õ•vC “ì]“°, “Œ‹ž, 94.00.00”­s.

1172. mŠwp‘n i•ª’SŽ·•Mj äPŒ´•aEƒŠƒEƒ}ƒ`‚Ìf—Ã|f•ûEŽ¡‚µ•ûE¶ŠˆŽw“±|; RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ, p.145`147, ‰ª“cƒi“àj. •ÒW ”è’õ•vC “ì]“°, “Œ‹ž, 94.00.00”­s.

1173. mŠwp‘n i•ª’SŽ·•Mj äPŒ´•aEƒŠƒEƒ}ƒ`‚Ìf—Ã|f•ûEŽ¡‚µ•ûE¶ŠˆŽw“±|; RŽ_‹…«‹Ø–Œ‰Š, p.148`151, ‰ª“cƒi“àj. •ÒW ”è’õ•vC “ì]“°, “Œ‹ž, 94.00.00”­s.

1174. mŠwp‘n i•ª’SŽ·•Mj äPŒ´•aEƒŠƒEƒ}ƒ`‚Ìf—Ã|f•ûEŽ¡‚µ•ûE¶ŠˆŽw“±|; Œ‹ß«g”ÁÇŒóŒQ, p.162`164, ŠÖŽRØ•äC¼‰ªN•vi“àj. •ÒW ”è’õ•vC “ì]“°, “Œ‹ž, 94.00.00”­s.

1175. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; ƒrƒ^ƒ~ƒ“‚a12Œ‡–RÇ|ˆŸ‹}«˜A‡•Ï«Ç, ‚Ù‚©, p.600`602, Ä“¡–L˜ai“àj. •ÒW ‹TŽR³–MC‚‘qŒö–¾C ˆãŠw‘‰@C“Œ‹žC94.07.15”­s.

1176. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; ‚Ž-ƒwƒLƒTƒ“’†“Å, p.672`673, Ä“¡–L˜ai“àj. •ÒW ‹TŽR³–MC‚‘qŒö–¾C ˆãŠw‘‰@C“Œ‹žC94.07.15”­s.

1177. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; Ž¸ŒêÇ, p.873`876, ‘O“c^Ž¡i“àj. •ÒW ‹TŽR³–MC‚‘qŒö–¾C ˆãŠw‘‰@C“Œ‹žC94.07.15”­s.

1178. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; Šç–Ê’É, p.73`74, _“c’¼i“àj. •ÒW ‹TŽR³–MC‚‘qŒö–¾CˆãŠw‘‰@C“Œ‹žC94.09.00”­s.

1179. mŠwp‘n i•ª’SŽ·•Mj }à•a‘Ô“à‰ÈuÀ|ŒÄ‹zŠí|‚P; ŒÄ‹z•s‘S, 7: 54`59, •y“c—FKCò–õOi“àj. •ÒW –k‘º—@iŽ©Ž¡ˆã‘åj, Medical ViewC“Œ‹žC94.04.15”­s.

1180. mŠwp‘i‰p•¶jn i•ª’SŽ·•Mj Progress in Microcirculation Research; Oxygen saturation and pH changes in microvessels of rat cremaster muscle, p.247`250, ¬—ÑO—Si“àjC²–ì_ŽjiŒc‘åjC“c’†’¼•Fi“àjC¼“c‘•ci¶•¨•¨—ŒnjC•y“c—FKi“àjC‘ê‘ò’¼’èi¶—j. •ÒW H. VŒ©i‘—§zŠÂŠí•aŒ¤‹†ŠjCM. D“ciŒc‘åjCT. ‘ò“ci‘—§zŠÂŠí•aŒ¤‹†ŠjCR-J, Xiui’†‘ˆãŠwƒAƒJƒfƒ~[j, Pergamon, Oxford, N.Y., “Œ‹žC94.00.00”­s.

1181. mŠwp‘n i•ª’SŽ·•Mj ŒÄ‹zŠíŽ¾Š³ state of arts 1995-'98; ”x–E’኷‹C, p.478`480, •Ð‹Ë^lC•y“c—FKi“àj. •ÒW Œ´‘ò“¹”üi“Œ‹ž’üM•a‰@jC–k‘º—@iŽ©Ž¡ˆã‘åj, ˆãŽ•–òo”ÅC“Œ‹žC94.10.25”­s.

1182. m‹³‰È‘n i•ª’SŽ·•Mj V—Õ°“à‰ÈŠw(ƒRƒ“ƒpƒNƒg”Å); ‘Sg«d‰»Çi‹­”çÇ), p.484`485, ‹ß“¡Œ[•¶i“àj. •ÒW ˜a“cUC‘¼C ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1183. m‹³‰È‘n i•ª’SŽ·•Mj zŠÂŠíf—Ã}ƒjƒ…ƒAƒ‹; ‹~‹}Ž¾Š³i‹Ù‹}Žž‚̉ŠúŽ¡—Ã), ”]‘²’†, p.387`394, –kˆä‘¥•vi“àj. •ÒW ˆÉŽRç°i“Œ‹žˆã‘åjCŠÖ”ŽliÓì’Z‘åjC‘º¼€i–k—¢‘åjC‹àŒ´o”ÅC“Œ‹žC94.04.30”­s.

1184. m‹³‰È‘n i•ª’SŽ·•Mj ƒƒ“ƒ|ƒCƒ“ƒg“à‰Èf’fŠw; ‚¯‚¢‚ê‚ñ, p.352`361, –kˆä‘¥•vi“àjC‘å˜a“c—²i‹~–½j. •ÒW –ì“cŠì‘ãˆêi_“Þ쎕‰È‘åjC’Å–¼Wˆêi“ŒˆãŽ•‘åjC‹àŽR³–¾i•½’Ë‹¤Ï•a‰@jC‹àŒ´o”ÅC“Œ‹žC95.01.20”­s.

1185. m‹³‰È‘n i•ª’SŽ·•Mj —Õ°•a‘ÔŠw; ¸_¥_ŒoŽ¾Š³, ‰^“®ŠíŽ¾Š³i‹ØŽ¾Š³), p.277`290, ’¹‹‡ŽOi“àj. •ÒW ²“¡—Ç’¨Žqi_ŒËí”Õ’Z‘åjC‹g‘ºŠwi‹ž“s•{—§‘åjC“ì]“°C“Œ‹žC00.00.00”­s.

1186. m‹³‰È‘n i•ª’SŽ·•Mj ƒƒ“ƒ|ƒCƒ“ƒg“à‰ÈŽ¡—Â̎ÀÛ; ‰ßŠ·‹CÇŒóŒQ, p.128`130, ‹v•Û“cŸC•y“c—FKi“àj. •ÒW ’Å–¼Wˆêi“ŒˆãŽ•‘åjC‹àŽR³–¾i•½’Ë‹¤Ï•a‰@jCŒÃ‘òV•½i“ƈã‘åjC–Ȉø’è´i•‘ –ìÔ\Žš•a‰@j, ‹àŒ´o”ÅC“Œ‹žC94.11.30”­s.

1187. m‹³‰È‘n i•ª’SŽ·•Mj ”F’è“à‰Èˆã¥”F’è“à‰ÈˆãŽóŒ±‚Ì‚½‚߂̉‰K–â‘è‚Ɖðà; ŒÄ‹zŠí, p.49`61, ‘Š”nˆêˆåi‹~–½j. •ÒW “ú–{“à‰ÈŠw‰ï”F’è“à‰Èê–åˆã‰ïC ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1188. m‹³‰È‘n i•ª’SŽ·•Mj ‹~‹}”F’èˆã‚Ì‚½‚ß‚Ìf—ÃŽwj; ‹}«ŒÄ‹z•s‘S, p.215`220, ‘Š”nˆêˆåi‹~–½j. •ÒW “ú–{‹~‹}ˆãŠw‰ï”F’èˆã”F’èˆÏˆõ‰ïC ‚Ö‚é‚·o”Å, “Œ‹ž, 94.10.01”­s.

1189. m‚»‚Ì‘¼‚Ì’˜‘n i’P’˜j ƒŠƒEƒ}ƒ`‚̶ŠˆƒKƒCƒh; ‘O“c^Ž¡i“àj. ˆãŽ•–òo”ÅC“Œ‹žC94.04.20”­s.

1190. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj Œ¤Cˆãƒm[ƒg|ƒxƒbƒhƒTƒCƒh‚ÌŽè‹Z‚ÆfŽ@|; ‚ß‚Ü‚¢, p.512`513, ’·’JìˆêŽqi“àj. •ÒW ‰iˆä—ÇŽOC f’f‚ÆŽ¡—ÃŽÐC“Œ‹žC94.00.00”­s.

1191. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj Œ¤Cˆãƒm[ƒg|ƒxƒbƒhƒTƒCƒh‚ÌŽè‹Z‚ÆfŽ@|; Ž¨–‚è, p.513`514, ’·’JìˆêŽqi“àj. •ÒW ‰iˆä—ÇŽOC f’f‚ÆŽ¡—ÃŽÐC“Œ‹žC94.00.00”­s.

1192. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj Annual Review|_Œo|1995––½_ŒoŽ¾Š³; ––½_ŒoŽ¾Š³: _Œo‹ØŽ¾Š³‚É‚¨‚¯‚鎩ŒÈR‘Ì|f’fã‚̈Ӌ`‚Æ•aˆö“I–ðŠ„|, p.237`244, Ä“¡–L˜ai“àj. •ÒW ‰iˆä—ÇŽOC ’†ŠOˆãŠwŽÐC“Œ‹žC95.01.20”­s.

1193. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ƒƒ“ƒ|ƒCƒ“ƒg“à‰Èf’fŠw; ‰^“®ŠíŽ¾Š³, p.242`254, ’¹‹‡ŽOi“àj. •ÒW –ì“cŠì‘ãŽqˆêi_“Þ쎕‘åjC’Å–¼Wˆêi“ŒˆãŽ•‘åjC‹àŽR³–¾i•½’Ë‹¤Ï•a‰@jC‹àŒ´o”ÅC“Œ‹žC95.01.20.00”­s.

1194. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Key Word 1994-'95; RScl-70R‘Ì, p.100`101, ‹ß“¡Œ[•¶i“àj. •ÒW ”è’õ•vCŽº“c½ˆíC æ’[ˆãŠwŽÐ, “Œ‹ž, 94.06.00”­s.

1195. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Key Word 1994-'95; RƒZƒ“ƒgƒƒƒAR‘Ì, p.110`111, ‹ß“¡Œ[•¶i“àj. •ÒW ”è’õ•vCŽº“c½ˆíC æ’[ˆãŠwŽÐ, “Œ‹ž, 94.06.00”­s.

1196. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Annual Review; _Œo 1995; •Ð“ª’É‚ÌŽ¡—Ã, p.269`277, ŒÜ\—’‹v‰Ài“àj. •ÒW Œã“¡•¶’jiŒc‘åjC‚‘qŒö–¾i“Œ—ˆã‘åjC–؉º^’ji“Œ–M‘åjC–öàVM•viMB‘åjC´…‹P•vi’é‹ž‘åjC’†ŠOˆãŠwŽÐC“Œ‹žC95.01.20”­s.

1197. mŠw‰ïi‘Ûjn i‹³ˆçu‰‰j Management of tension-type headache. âˆä•¶•Fi“àj: Indonesian Neurological Association i94.09.03j, Jakarta.

1198. mŠw‰ïi‘Ûjn iƒ[ƒNƒVƒ‡ƒbƒvj Paraneoplastic and dysglobulinemic neuropathes; Paraneoplastic syndrome-overview. ŒÃ˜a‹vKi“àj: 8th International Congress on Neuromuscular Diseases i94.07.10`15), ‹ž“s.

1199. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Two autopsy cases with autosomal dominant Parkinson's disease. ’·’JìˆêŽqC—À³•£CŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[j: 11th International Symposium on Parkinson's Disease i94.03.26`30j, Rome.

1200. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j An investigation of horizontal eye-head coordination in patients with Parkinson's disease. ŽO•x“N˜YC’·’JìˆêŽqCŒÃ˜a‹vKCf‘ò’BŽui“àj: 11th International Symposium on Parkinson's Disease i94.03.26`30j, Rome.

1201. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Senile changes in Parkinson's disease: a neuropathologic study. —À³•£C’·’JìˆêŽqCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[j: 11th International Symposium on Parkinson's Disease i94.03.26`30j, Rome.

1202. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The second interim report of an open-label long-term therapy of pergolide for Parkinson's disease. ‹ß“¡’q‘Pi‡“V‘åjCK. Ando(Chubu Hospital)CM. Iwata(University of Tokyo)CŒÃ˜a‹vKi“àjCH. Narabayashi(Neuro. Clinic)C¬ì‹I—Yi‰ª‘åjC–ö‘òM•viMB‘åjC…–ì”ü–Mi‡“V‘åj: 11th International Symposium on Parkinson's Disease i94.03.26`30j, Rome.

1203. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Acute myopathy due to neuromuscular blocking agents and corticosteroids: Electrophysiological and pathological studies. ‰Á“¡’m–çC’·’JìˆêŽqC’¹‹‡ŽOCŒÃ˜a‹vKi“àjCÄ“¡]”üŽqi—ÕŒŸjCˆÀˆä”ü]i‘‡‘Š’k•”jC‹kŽ ‘i”]ŠOj: 8th International Congress on Neuromuscular Diseases i94.07.10`15), ‹ž“s.

1204. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Efficacy of coenzyme Q10 for muscle power in experimental iron deficient rat as mitochondria abnormality model. ’·’Jì‚ЂƂÝCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: 8th International Congress on Neuromuscular Diseases i94.07.10`15), ‹ž“s.

1205. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Extrapyramidal system involvement in amyotrophic lateral sclerosis (ALS): Immunohistochemical studies. ’·’JìˆêŽqCŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[j: 8th International Congress on Neuromuscular Diseases i94.07.10`15), ‹ž“s.

1206. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Anti-ganglioside antibodies in Guillain-Barre syndrome. “ü]KŽqCÄ“¡–L˜ai“àjC‹à‘ò’¼”üi“Œ•a‰@Œ¤‹†ŒnjCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: 8th International Congress on Neuromuscular Diseases i94.07.10`15j, ‹ž“s.

1207. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Where is the lesion in Fishers syndromeE|New finding on 1H MRS and pathology of sural nerve. Isonishi, K., Kamada, K., Kashiwaba, K.(Kashiwaba Neurosurgical Hospital), Ishikawa, K.(Konan Hospital)C’¹‹‡ŽOC’·’JìˆêŽqCŒÃ˜a‹vKi“àj: 8th International Congress on Neuromuscular Diseases i94.07.10`15j, ‹ž“s.

1208. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Experimental neuropathy induced with GM1 immunization. ˆÉ“¡”Ž–¾C‹y”\ŽGC•y•Û˜aGC“ü]KŽqi“àjC‹à‘ò’¼”üCˆÀ“cCˆêi“Œ•a‰@Œ¤‹†ŒnjCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: 8th International Congress on Neuromuscular Diseases i94.07.10`15j, ‹ž“s.

1209. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Histochemical changes in dorsal root ganglion of experimental thiamine deficiency. •y•Û˜aGCˆÉ“¡”Ž–¾CÄ“¡–L˜aCŒÃ˜a‹vKi“àj: 8th International Congress on Neuromuscular Diseases i94.07.10`15j, ‹ž“s.

1210. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Circulating von Willbrand factor and intercellular adhesion molecule-1 in antiphospholipid syndrome. –쑺³¢C‰ª“cƒC‹ß“¡Œ[•¶i“àj: 6th International Symposium on Antiphospholipid Antibodies i94.09.14`17j, Belgium, LUPUS, 3: 347, 1994.

1211. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Anti-bovine glycoprotein antibodies in antiphospholipid syndrome. ‰ª“cƒC–쑺³¢C‹ß“¡Œ[•¶i“àj: 6th International Symposium on Antiphospholipid Antibodies i94.09.14`17j, Belgium, LUPUS, 3: 350, 1994.

1212. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Macrosaccadicoscillation in olivoponto-cerebellar atrophy. f‘ò’BŽuC’·’JìˆêŽqCŒÃ˜a‹vKi“àj: 3rd International Congress of Movement Disosrders i94.11.07`11j, ƒI[ƒ‰ƒ“ƒh, ƒtƒƒŠƒ_.

1213. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j A case of involuntary movement on speaking. ‰Á“¡’m–çC’·’JìˆêŽqCŒÃ˜a‹vKi“àj: 3rd International Congress of Movement Disosrders i94.11.07`11j, ƒI[ƒ‰ƒ“ƒh, ƒtƒƒŠƒ_.

1214. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j At hypoxia endogenous nitric oxide dilates pulmonary venules in rats. “c’†’¼•FC¬—ÑO—SC•y“c—FKi“àj: 2nd International Congress of Pathophysiology i94.11.24j, ‹ž“s, Pathophysiology, 1(Suppl.): 405, 1994.

1215. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Sites of action of inhaled nitric oxide are pulmonary vessels near alveoli in an ovine ARDS model. ¬—ÑO—SC“c’†’¼•Fi“àjCM. WinklerCW.M. Zapoliƒn[ƒo[ƒh‘åj: 2nd International Congress of Pathophysiology i94.11.24j, ‹ž“s, Pathophysiology, 1(Suppl.): 406, 1994.

1216. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Dose-dependent effect of inhaled nitric oxide on pulmonary oxygenation differs from the effect on pulmonary circulation in hypoxic rabbits. ²“¡“N–çC¬—ÑO—SC“c’†’¼•FC•y“c—FKi“àj: 2nd International Congress of Pathophysiology i94.11.24j, ‹ž“s, Pathophysiology, 1(Suppl.): 407, 1994.

1217. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Respiratory muscle response to inspiratory resistive loading in awake diaphragm paralyzed canines. •Ð‹Ë^li“àjCT.M. KieserCP.A. EastoniƒJƒ‹ƒKƒŠ[‘åj: 1994 International Conference of American Lung Association, American Thoracic Society i94.05.22j, Boston, Am. J. Resp. Crit. Care Med., 149(4): 136, 1994.

1218. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Response of individual abdominal muscles to nasal CPAP in supine and upright position in healthy humans. ‹g‘º®‚Cˆ¢•”’¼C“팴”Í”VC•y“c—FKi“àj: 1994 International Conference of American Lung Association, American Thoracic Society i94.05.22j, Boston, Am. J. Resp. Crit. Care Med., 149(4): 133, 1994.

1219. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Salbutamol effects on respiratory muscles in awake canines. “팴”Í”VC•Ð‹Ë^li“àjCB.C. RothwellCP.A. EastoniƒJƒ‹ƒKƒŠ[‘åj: 1994 International Conference of American Lung Association, American Thoracic Society i94.05.22j, Boston, Am. J. Resp. Crit. Care Med., 149(4): 274, 1994.

1220. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The effect of PGF2ƒ¿ on pulmonary vessels with nitric oxide inhalation in an ovine ARDS model. ¬—ÑO—SC“c’†’¼•Fi“àjCM. WinklerCW. Zapoliƒn[ƒo[ƒh‘åj: 1994 International Conference of American Lung Association, American Thoracic Society i94.05.23j, Boston, Am. J. Resp. Crit. Care Med., 149(4): 425, 1994.

1221. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Different dose-dependent effects of nitric oxide inhalation on pulmonary hypertension and hypoxemia in hypoxic rabbits. ²“¡“N–çC¬—ÑO—SC“c’†’¼•FC•y“c—FKi“àj: 1994 International Conference of American Lung Association, American Thoracic Society i94.05.23j, Boston, Am. J. Resp. Crit. Care Med., 149(4): 444, 1994.

1222. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Pulmonary microcirculatory changes of rats under hypoxia. “c’†’¼•FC¬—ÑO—SC²“¡“N–çCò–õOC•y“c—FKi“àj: 1994 International Conference of American Lung Association, American Thoracic Society i94.05.24j, Boston, Am. J. Resp. Crit. Care Med., 149(4): 436, 1994.

1223. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Hypoxemia after methacholine challenge test in asthmatic patients is partly attributable to post hyperventilation hypoxemia. —é–Ø“¹OC¬—ÑO—SC²“¡“N–çC•y“c—FKi“àj: 1994 International Conference of American Lung Association, American Thoracic Society i94.05.24j, Boston, Am. J. Resp. Crit. Care Med., 149, 1994.

1224. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Respiratory muscle function during sighs in awake canines. •Ð‹Ë“ú²ŽqC•Ð‹Ë^li“àjCT.M. KieserCP.A. EastoniƒJƒ‹ƒKƒŠ[‘åj: 1994 International Conference of American Lung Association, American Thoracic Society i94.05.25j, Boston, Am. J. Resp. Crit. Care Med., 149(4): 928, 1994.

1225. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Dilatation of internal carotid artery during cluster headache measured by MRI. ŒÜ\—’‹v‰ÀCâˆä•¶•FC_“c’¼i“àj: 10th Migraine Trust International Symposium i94.09.06j, London.

1226. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Anti-myeloperoxidase antibody induces neutrophil apoptosis through the production of oxygen radicals. ŠÖŽRØ•äCÔ¯“§C‹ß“¡Œ[•¶i“àj: American College of Rheumatology 58th National Scientific Meeting i94.10.23`27j, Minneapolis.

1227. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Circulating intercellular adhesion molecule-1 and expression of adhesion molecules in muscle fibers from patients with polymyositis-dermatomyositis. ‰ª“cƒCŠp‰Æ–¾•¶C–쑺³¢C‹ß“¡Œ[•¶i“àj: American College of Rheumatology 58th National Scientific Meeting i94.10.23`27j, Minneapolis.

1228. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Essential involvement of IL-8 in neutrophil recruitment in rabbits with experimental arthritis induced by IL-1. Ô¯“§i“àjC‰““¡•½miŠÅŒìŠw•”jC•äâ–Îi“àjC‚ŠÝŒ›“ñi®ŠOjC‹ß“¡Œ[•¶i“àjC”è’õ•vi“Œ—ˆã‘åj: American College of Rheumatology 58th National Scientific Meeting i94.10.23`27j, Minneapolis.

1229. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j W’†Ž¡—Âɂ¨‚¯‚鋹•”‰æ‘œf’f. ‘Š”nˆêˆåi‹~–½j: ‘æ22‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï, ƒŠƒtƒŒƒbƒVƒƒ[ƒR[ƒX i95.02.01j, ‘åã.

1230. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j äPŒ´•a‚̓«•a‘Ԃ̃Aƒvƒ[ƒ`‚ÆŽ¡—Ã; ‹­”çÇt. ‹ß“¡Œ[•¶i“àjC‰““¡•½miŠÅŒìŠw•”j: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1231. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j —\–h“IŒ©’n‚©‚ç‚Ý‚½”]‘²’†•Ð–ƒáƒ‚ɑ΂·‚é‹}«Šú—Šw—Ö@‚ÌÝ‚è•û. ’·‘òOC•½‰ê‚悵‚ÝiƒŠƒn•”jC‘O“c^Ž¡i“àj: ‘æ29‰ñ“ú–{—Šw—Ö@ŽmŠw‰ï‘‰ï i94.05.27`28j, ÂX.

1232. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‹­’¼«Ò’ʼnŠ‚ªæs‚µA20”NŒã‚É’×ᇫ‘å’°‰Š‚Æ––½ŠÖ߉Š‚ªoŒ»‚µ‚½HLA-B27—z«—«Š³ŽÒ‚Ì‚P—á. ‚‹´“¹—YC•äâ–ÎC‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1233. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj MCTD‚Ì•ê–º—á‚É‚Ý‚ç‚ꂽ”x‚ŒŒˆ³(PH). ÎìŽçC•äâ–ÎC‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1234. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj RD’†‹…×–EŽ¿R‘Ì‚Ì—Õ°“I—L—p«‚ÌŒŸ“¢. ‰““¡•½miŠÅŒìŠw•”jC×–ìF˜YC‘O“cC¯’qC‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1235. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj RMPOR‘̂ƃTƒCƒgƒJƒCƒ“‚É‚æ‚éD’†‹… apoptosis‚Ì—U“±. Ô¯“§CŠÖŽRØ•äC•äâ–ÎC‰““¡•½mC‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1236. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ(APS)‚ɇ•¹‚µ‚½”]oŒŒ‚ÉŠÖ‚·‚錟“¢. Šp‰Æ–¾•¶C‹yì–¾ŽqC–쑺³¢C‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1237. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ(APS)Š³ŽÒ‚ÌŒŒ´ glycoprotein‚ɑ΂·‚éR‘Ì‚Ì‘½—l«. ‰ª“cƒC–쑺³¢CŠp‰Æ–¾•¶C‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1238. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj RRNPR‘Ì—z«SLE‚ÆMCTD. ‹ß“¡Œ[•¶C‰ª“cƒi“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1239. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj Ú’…•ªŽq‚ÆŽ¾Š³: ŠÖ߉Š‚É‚¨‚¯‚鉊ǫזE‚ÌZ‹@\. Ô¯“§C•äâ–ÎCŠÖŽRØ•äi“àjC‰““¡•½miŠÅŒìŠw•”jC‹ß“¡Œ[•¶i“àj: ‘æ22‰ñ“ú–{—Õ°–ƉuŠw‰ï‘‰ï i94.09.20`22j.

1240. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj uRƒŠƒ“Ž‰Ž¿R‘Ì‘ª’è–@‚ÌŒ»‹µ‚Æ–â‘è“_£: RƒÀ2 glycoprotein, R‘Ì‚Æ lupus anticoagulant‚Ì·ˆÙ; APS‚É‚¨‚¯‚é—¼ŽÒ‚Ì—Õ°“IˆÓ‹`‚ÉŠÖ‚µ‚Ä. ‰ª“cƒC–쑺³¢C‹ß“¡Œ[•¶i“àj: ‘æ22‰ñ“ú–{—Õ°–ƉuŠw‰ï‘‰ï i94.09.20`22j.

1241. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äPŒ´•a‚É‚¨‚¯‚éRƒ‰ƒNƒgƒtƒFƒŠƒ“R‘Ì‚Ì—Õ°“IˆÓ‹`. ‰““¡•½miŠÅŒìŠw•”jC‹ß“¡Œ[•¶i“àj: ‘æ6‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°‘å‰ï i94.04.14`16j, ŒF–{.

1242. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”­”M¸¸–Ú“I‚Å“ü‰@‚µ‚½Š´õ«S“à–Œ‰Š17—á‚Ì—Õ°“I‰ðÍ. ”Ñ‘–í¶CŠp‰Æ–¾•¶C•äâ–ÎC‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ68‰ñ“ú–{Š´õÇŠw‰ï‘‰ï i94.04.21`22j, ’·è.

1243. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX(SLE)‚ÆŒ‹Šj‚̇•¹‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Šp‰Æ–¾•¶C”Ñ‘–í¶C‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ68‰ñ“ú–{Š´õÇŠw‰ï‘‰ï i94.04.21`22j, ’·è.

1244. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆêŽ_‰»’‚‘f‹z“ü‚É‚æ‚é”x“®–¬ˆ³‚¨‚æ‚Ñ“®–¬ŒŒ‰tƒKƒX‚Ì”Z“x¥”½‰žŠÖŒW‚ɂ‚¢‚Ä. ²“¡“N–çC¬—ÑO—SC“c’†’¼•FC¬–ì’‰LC‹g‘º®‚C—é–Ø“¹OC‹v•Û“cŸC¬‘qŒš•vC–î“ߣM—YC•y“c—FKi“àj: ‘æ34‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i94.04.25j, –‹’£, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(‘): 205, 1994.

1245. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒƒTƒRƒŠƒ“‹z“üŽŽŒ±Œã‚Ì’áŽ_‘fŒŒÇ—á‚É‚¨‚¯‚éCO2‹z“ü‚ÌŒø‰Ê‚ɂ‚¢‚Ä. —é–Ø“¹OC²“¡“N–çC“c’†’¼•FCò–õOC‰Ô“cL‰pC•Ð‹Ë“ú²ŽqC¬—ÑO—SC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj: ‘æ34‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i94.04.26j, –‹’£.

1246. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äPŒ´•aŠ³ŽÒ‚ɇ•¹‚µ‚½ƒJƒŠƒj”x‰Š‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò(BAL)‚Ì—L—p«‚ÌŒŸ“¢. ‹v•Û“cŸCŽO“¡‹vC‹g‘º®‚C¬‘qŒš•vC‚“cM˜aC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj: ‘æ34‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i94.04.26j, –‹’£, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 36(‘): 236, 1994.

1247. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`‚ɑ΂·‚éƒI[ƒ‰ƒmƒtƒBƒ“‚ƃƒgƒgƒŒƒLƒT[ƒg‚Ì•¹—p—Ö@A‘½Ž{Ý‹¤“¯Œ¤‹†. HŒŽ³ŽjCŽsì—zˆêC“à“cÙŽ¢C‹ß“¡Œ[•¶i“àjC‘¼: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1248. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚Ì QOL‚Ì prospective’²¸. ‰““¡•½miŠÅŒìŠw•”jC‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1249. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`‚ɑ΂·‚éžô”‰Á‹•“’A‚¨‚æ‚щz›X‰Á‹“’‡–@‚ÌŒø‰Ê. ×–ìF˜YC‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1250. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‹[ƒvƒXäNã÷‰Š‚Ì—Õ°“IŒ¤‹†. ŠÖŽRØ•äC•äâ–ÎCÔ¯“§C‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1251. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘½Ê‚ÈŽ©ŒÈR‘Ì‚ªoŒ»‚µ‚½‹­”çÇ‚Ì‚P—á. “c’†Z–¾C‰““¡•½miŠÅŒìŠw•”jC‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1252. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ (APS)Š³ŽÒ‚ÌRbovineŒŒ´ƒÀ2 glycoprotein-1(ƒÀ2 GP1)R‘Ì‚ÉŠÖ‚·‚錟“¢. –쑺³¢C‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1253. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äPŒ´•a‚É”º‚¤”畆’×ᇂɑ΂·‚éƒVƒƒXƒ^ƒ][ƒ‹‚Ì—L—p«‚ÌŒŸ“¢. ‹ß“¡Œ[•¶i“àjC”è’õ•vCŽë–쯌ái“Œ—Žqˆã‘åj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž.

1254. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a‚É‚¨‚¯‚é‹‘åSEP‚ÌŒŸ“¢. ŠŽi–r•¶i—ÕŒŸjCaˆä—߈êCŽO•x“N˜YC’·’JìˆêŽqCŒÃ˜a‹vKi“àjC‹kŽ ‘i”]ŠOj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1255. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a‚̉^“®ŠÖ˜A“dˆÊi‚Q). aˆä—߈êCŽO•x“N˜YC’·’JìˆêŽqCŒÃ˜a‹vKi“àjCŠŽi–r•¶i—ÕŒŸj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1256. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽÀŒ±“Iƒ`ƒAƒ~ƒ“Œ‡–Ró‘Ô‚É‚¨‚¯‚éÒ‘_Œoß‚Ì‘gD‰»Šw“I•Ï‰». •y•Û˜aGCˆÉ“¡”Ž–¾CÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1257. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j šb‘§dÏ”­ì‚ÌŽ¡—Ã’†‚ɶ‚¶‚½—Õ°‹y‚Ñ“d‹C¶—Šw“IŒŸ“¢. ‰Á“¡’m–çC’·’JìˆêŽqCŒÃ˜a‹vKi“àjC‹kŽ ‘i”]ŠOjCÄ“¡]”üŽqi—ÕŒŸj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1258. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j šb‘§dÏ”­ì‚ÌŽ¡—Ã’†‚ɶ‚¶‚½ŽlŽˆ–ƒáƒ;(2)‹Ø‘gDŠw“IŒŸ“¢. ¼–{MŽqi‘Š–ÍŒ´‹¦“¯•a‰@jC’¹‹‡ŽOi“àjCˆÀˆä”ü]i‘‡—Õ°ŒnjC’†‘ºŒ’‚`iŠñjC’·’JìˆêŽqCŒÃ˜a‹vKi“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1259. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘½”­«d‰»Ç‚É‚¨‚¯‚鑉tƒTƒCƒgƒJƒCƒ“(IL-2R,IL-6)‚Ì“®‘Ô. Ä“¡–L˜ai“àjC‹à‘ò’¼”üi“Œ•a‰@Œ¤‹†ŒnjC“ü]KŽqCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1260. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j GM1–Ɖu‚É‚æ‚éŽÀŒ±“Iƒjƒ…[ƒƒpƒ`[. ˆÉ“¡”Ž–¾C‹y”\ŽGC•y•Û˜aGCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1261. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Gullain-BarreÇŒóŒQ‚É‚¨‚¯‚éRƒKƒ“ƒOƒŠƒIƒVƒhR‘Ì|RGQ1bR‘Ì‚ÆŠá‹…‰^“®áŠQ|. “ü]KŽqCÄ“¡–L˜ai“àjC‹à‘ò’¼”üi“Œ•a‰@Œ¤‹†ŒnjCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1262. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹ØˆÞk«‘¤õd‰»Ç‚É‚¨‚¯‚ésympathetic skin response‚ÌŒŸ“¢. ‹y”\ŽGCˆÉ“¡”Ž–¾CÄ“¡–L˜aCŒÃ˜a‹vKi“àjC‹kŽ ‘i”]ŠOj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1263. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˜V”N”­Ç‚ÌdÇ‹Ø–³—ÍÇ‚Ì—Õ°“IŒŸ“¢|Ž©Œ±Žá”N”­Ç—á‚Æ‚Ì”äŠrŒŸ“¢. ¼‰ª³ŒhCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1264. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰^“®ƒjƒ…[ƒƒ“•a‚É‚¨‚¯‚é‰Á—î‚̉e‹¿ˆê•a—Šw“I‰Á—ω»‚ÌoŒ»‚ɂ‚¢‚Ä. —À³•£C’·’JìˆêŽqCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[j: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1265. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Slow eye movement‚ð’æ‚·‚é•Ï««_ŒoŽ¾Š³‚ÌŠá‹…‰^“®áŠQ‚Ì“Á’¥. ŽO•x“N˜YC’·’JìˆêŽqCf‘ò’BŽuC‹y”\ŽGCŒÃ˜a‹vKi“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1266. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰^“®ƒjƒ…[ƒƒ“•a‚É‚¨‚¯‚éŠî’êŠj•a—i‚Q). ’·’JìˆêŽqC—À³•£CŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[j: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1267. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒAƒ‹ƒR[ƒ‹ŠÖ˜A–â‘è‚ɑ΂·‚éƒ\[ƒVƒƒƒ‹ƒ[ƒJ[ŽÀ‘H•ñ|‘S‰È‚ðŠª‚«ž‚ñ‚¾“yë‚­‚è|. ‘å‹v•Û—¢C¼ŽR^i‘‡‘Š’k•”j: ‘æ14‰ñ“ú–{ŽÐ‰ïˆã—ÕŸŽƒŠw‰ï i94.05.20j, ŽD–y.

1268. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¸_‰ÈƒfƒCƒPƒA“üŠŠî€Ý’è‚É‚¨‚¯‚éƒ\[ƒVƒƒƒ‹ƒ[ƒJ[‚Ì–ðŠ„. Šâ–{‘€C¼ŽR^i‘‡‘Š’k•”j: ‘æ14‰ñ“ú–{ŽÐ‰ïˆã—ÕŸŽƒŠw‰ï i94.05.20j, ŽD–y.

1269. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j One-and-a-halfÇŒóŒQ‚É‚Ý‚ç‚ê‚é‚’¼«Šá‹…‰^“®áŠQ‚ɂ‚¢‚Ä. “¡À–M•FC”¨—²ŽuC”Ñ’Ë‚_C¡ˆä¸C–kˆä‘¥•vC_“c’¼i“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï‘‰ï i94.05.20j, •Ÿ‰ª.

1270. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘åŠw•a‰@‚É‚¨‚¯‚éƒfƒCƒPƒA‰Æ‘°‰ï‚ɂ‚¢‚Ä. ŽR–{–¾”üC”’–ØŒ´ŽsŽŸiƒŠƒn•”j: ‘æ90‰ñ“ú–{¸__ŒoŠw‰ï i94.05.25j, ¼ŽR.

1271. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •às‘¬“x•Ï‰»‚É‚¨‚¯‚é°¥‘«ëŠÔ‹——£. ‘基Cˆêiˆã—Éq¶Šw•”jCŽÄŠì’CÎX—R”üŽq: ‘æ29‰ñ“ú–{—Šw—Ö@ŽmŠw‰ï‘‰ï i94.05.27`28j, ÂX.

1272. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰^“®ƒjƒ…[ƒƒ“•a‚É‚¨‚¯‚é‘å”]”玿•a•Ïi‰Á—ω»oŒ»‚ð’†S‚É). —À³•£C’·’JìˆêŽqCŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[j: ‘æ35‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i94.05.31`06.02j, ŽD–y.

1273. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰^“®ƒjƒ…[ƒƒ“•a‚É‚¨‚¯‚éŠî’êŠj•a•Ï‚ÌŒŸ“¢i‚Q). ’·’JìˆêŽqC—À³•£CŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[j: ‘æ35‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i94.05.31`06.02j, ŽD–y.

1274. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Adult Neuronal Ceroid-LipofuscinosisiKufs•aj‚Ì‚P—á. ’·’JìˆêŽqC—À³•£CŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[j: ‘æ35‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i94.05.31`06.02j, ŽD–y.

1275. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”xŒ‹ŠjÇ‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰tADAŠˆ«‘ª’è‚̈Ӌ`‚ÉŠÖ‚·‚錟“¢. ‹v•Û“cŸCò–õOC—é–Ø“¹OC‰Ô“cL‰pC‚“cM˜aC•Ð‹Ë“ú²ŽqC•Ð‹Ë^lC–î“ߣM—YC•y“c—FKi“àjC‹ß“¡‚¦‚èi‰q¶jC‘Š”nˆêˆåi‹~–½j: ‘æ17‰ñ“ú–{‹CŠÇŽxŠw‰ï‘‰ï i94.06.01j, ‘åã, ‹CŠÇŽxŠw, 16(3): 282, 1994.

1276. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j dÇ‹Ø–³—ÍÇ‚ð‡•¹‚µ, ‹¹oŠO“]ˆÚ‘ƒ‚𔺂Á‚½Z«‹¹‘BŽî‚ÌŽ¡—ÂɊւ·‚錟“¢. Œ˘aŽqC’·’JìˆêŽqCŒÃ˜a‹vKi“àj: ‘æ12‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï i94.06.15`16), ‹ž“s.

1277. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘½Ê‚ÈŒŒŠÇ•a•Ï‚ð’悵‚½ MCTD‚Ì‚P—á. Šp‰Æ–¾•¶C‚‹´“¹—YC‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ26‰ñ“ú–{Œ‹‡‘gDŠw‰ïŠwp‘å‰ï i94.06.16`17j, Šò•Œ.

1278. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@ƒfƒCƒPƒA‚É‚¨‚¯‚邤‚‚̃Oƒ‹[ƒvƒ[ƒN‚Æ‚»‚Ì“Á’¥. ŽR–{–¾”üC—é–؃ŒbCŠâ–{‘€C”’–ØŒ´ŽsŽŸC’Ø“à—R”üCA¼”ü”¿C”’–ØŒ´—tŽqC’·’Jì—D”üŽqiƒŠƒn•”jC‘êì‚é‚ÝŽqi‘‡‘Š’k•”jC’†“‡ß•vi¸j: ‘æ28‰ñ“ú–{ì‹Æ—Ö@ŽmŠw‰ï‘‰ï i94.06.16`17), H“c.

1279. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j S–[ד®‚É”º‚¤”]ÇðÇ‚Ì’·Šú—\Œã. HŽR‹v®C_“c’¼C¡ˆä¸C•Ÿ“c—Ï–çC“¡À–M•FC–kˆä‘¥•vC”¨—²ŽuCâˆä•¶•Fi“àj: ‘æ31‰ñ“ú–{ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ˆãŠw‰ïŠwpW‰ï i94.06.29j, ç—t, ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ˆãŠw, 31: 208, 1994.

1280. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[u–ò•¨‘ŠŒÝì—pv|NSAIDs‚ð’†S‚É| —Õ°‚Ì—§ê‚©‚ç. ‹ß“¡Œ[•¶i“àj: ‘æ15‰ñ“ú–{‰ŠÇŠw‰ï i94.07.14`15j, “Œ‹ž.

1281. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ŠÇ«‹Ø‰Š‚Ì‘gD‚ÌICAM-1”­Œ»‚ÆŒŒ’†‰Â—nICAM-1. ‰ª“cƒCŠp‰Æ–¾•¶C‹ß“¡Œ[•¶i“àj: ‘æ15‰ñ“ú–{‰ŠÇŠw‰ï i94.07.14`15j, “Œ‹ž.

1282. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j D’†‹… apoptosis‚É‹y‚Ú‚·R myeloperoxidaseR‘̂̉e‹¿. Ô¯“§CŠÖŽRØ•äC•äâ–ÎC‰““¡•½mC‹ß“¡Œ[•¶i“àj: ‘æ15‰ñ“ú–{‰ŠÇŠw‰ï i94.07.14`15j, “Œ‹ž.

1283. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j D’†‹… apoptosis‚É‹y‚Ú‚·ŠÖ߉t‚̉e‹¿. ŠÖŽRØ•äCÔ¯“§C‹ß“¡Œ[•¶i“àj: ‘æ15‰ñ“ú–{‰ŠÇŠw‰ï i94.07.14`15j, “Œ‹ž.

1284. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Šˆ«‰»ŒŒ¬”‚ɂæ‚éD’†‹…AŒŒŠÇ“à”ç×–EŽhŒƒì—p. ‰““¡•½miŠÅŒìŠw•”jC‹ß“¡Œ[•¶i“àj ‘æ15‰ñ“ú–{‰ŠÇŠw‰ï i94.07.14`15j, “Œ‹ž.

1285. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒJƒ‹ƒfƒXƒ‚ƒ“”­Œ»‚ɑ΂·‚éƒvƒƒeƒCƒ“ƒLƒi[ƒ[‚bŠˆ«‰»‚̉e‹¿‚ÌŒŸ“¢. ã“cŠ°”VC‰““¡•½mC‹ß“¡Œ[•¶i“àjC”è’õ•vi“Œ—ˆã‘åj: ‘æ15‰ñ“ú–{‰ŠÇŠw‰ï i94.07.14`15j, “Œ‹ž.

1286. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äPŒ´•a‚ÉŒ©‚ç‚ꂽBOOP 6—á‚Ì—Õ°“IŒŸ“¢. “c’†Z–¾CŠÖŽRØ•äC–쑺³¢CÔ¯“§C‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ22‰ñ“ú–{—Õ°–ƉuŠw‰ï‘‰ï i94.09.20`22j.

1287. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ(APS)‹y‚Ñ MCTD‚É‚¨‚¯‚錌’† von Willard Factor‚Æ sICAM-1‚Ì—Õ°“IˆÓ‹`. –쑺³¢C‚‹´“¹—YCŠÖŽRØ•äC‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ22‰ñ“ú–{—Õ°–ƉuŠw‰ï‘‰ï i94.09.20`22j.

1288. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a‚̉^“®ŠÖ˜A“dˆÊ. aˆä—߈êC‰Á“¡’m–çC—À³•£CŽO•x“N˜YC’·’JìˆêŽqCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ36‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i94.09.28j, “Œ‹ž.

1289. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”][Ç”­Ç‚Ì“úŽüŠú‚ɂ‚¢‚Ä‚ÌŒŸ“¢. •Ÿ“c—Ï–çCHŽR‹v®C¡ˆä¸C–kˆä‘¥•vC”¨—²ŽuCâˆä•¶•FC_“c’¼i“àj: ‘æ36‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i94.09.29j, “Œ‹ž.

1290. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹¹’ÅFlexion myelopathy‚Ì‚P—á. ‰Á“¡’m–çCaˆä—߈êCŒ˘aŽqCŽO•x“N˜YC—À³•£C’·’JìˆêŽqCŒÃ˜a‹vKi“àj: ‘æ29‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i94.09.30j, ˆ®ì.

1291. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰^“®ƒjƒ…[ƒƒ“•a‚ÌŠî’êŠj•a•Ïi‚Qj|‘gD‰»Šw“IŒŸ“¢|. ’·’JìˆêŽqi“àj: ‘æ37‰ñ“ú–{_Œo‰»Šw‰ï i94.10.06j, ¼–{.

1292. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹@”\“I‰¹ºáŠQ‚ɑ΂·‚鉹ºŒP—û. ¬—є͎qCL£”£iˆã—Éq¶Šw•”jCŽRŒûG–ç: ‘æ39‰ñ“ú–{‰¹ºŒ¾ŒêˆãŠw‰ï‘‰ï i94.10.07`08j, ‹à‘ò.

1293. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒcƒWARDSƒ‚ƒfƒ‹‚É‚¨‚¯‚éˆêŽ_‰»’‚‘f(NO)‹z“ü‚ÆPGF2ƒ¿Ã’‚Ì”xzŠÂ‚Ö‚ÌŒø‰Ê. “c’†’¼•FC¬—ÑO—SC•y“c—FKi“àjCM. WinklerCW.M. Zapoliƒn[ƒo[ƒh‘åj: “ú–{–¬ŠÇŠw‰ï‘‰ï i94.10.14j, “Œ‹ž, –¬ŠÇŠw, 34(9): 726, 1994.

1294. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j R MPOR‘Ì—z« Wegener“÷‰èŽîÇ‚Ì—Õ°“I“Á’¥. ‰““¡•½miŠÅŒìŠw•”jCŠp‰Æ–¾•¶C‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ44‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï i94.10.26`28j, “Œ‹ž.

1295. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”]ŒŒŠÇáŠQŠ³ŽÒ‚ɑ΂·‚鉹ŠyŽhŒƒ‚É‚¨‚¯‚é”]”gƒgƒ|ƒOƒ‰ƒtƒB[‚ÌŒŸ“¢. Œ˘aŽqC’·’JìˆêŽqCŒÃ‹´‹I‹vi“àjCŠŽi–r•¶i—ÕŒŸj: ‘æ24‰ñ“ú–{”]”gE‹Ø“d}Šw‰ï i94.10.26j, å‘ä.

1296. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’mŠo_ŒoŠˆ“®“dˆÊ SNAP‚ɑ΂·‚é‚Q“_ŽhŒƒ‚Å‚ÌŒŸ“¢; ‘æ‚R•ñ|Guillain-BarreÇŒóŒQ‚Å‚ÌŒŸ“¢|. Ä“¡]”üŽqCr”¦“Äi—ÕŒŸjC’·’JìˆêŽqC’¹‹‡ŽOi“àjC‹kŽ ‘i”]ŠOjC‰ª“‡d—²iˆä“c•a‰@j: ‘æ24‰ñ“ú–{”]”gE‹Ø“d}Šw‰ï i94.10.26j, å‘ä.

1297. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a‚ÅoŒ»‚·‚é‹‘åSEP‚Æ”­Ç”N—î. ŠŽi–r•¶C•P“c‹v”üi—ÕŒŸjC‹g‘º‹vmŽqi“Œ•a‰@Œ¤‹†ŒnjCŒ˘aŽqC’·’JìˆêŽqi“àjC‹kŽ ‘i”]ŠOj: ‘æ24‰ñ“ú–{”]”gE‹Ø“d}Šw‰ï i94.10.26j, å‘ä.

1298. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ã–îóÖ¬“´ŒŒðÇ‚Ì”]”gŠŒ©. •Ÿ“c—Ï–çC”¨—²Žui“àjC‹g–{gŽqC—é–Ø~Žqi—ÕŒŸjCŽí“c^»—Yi¸j: ‘æ24‰ñ“ú–{”]”g‹Ø“d}Šw‰ïŠwp‘å‰ï i94.10.26j, å‘ä.

1299. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j SLEŠ³ŽÒ‚É‚¨‚¯‚é‚s×–ERŒ´Žó—e‘Ì‚uƒÀˆâ“`Žq‘½Œ^‚̉ðÍ. ã“cŠ°”VC” “c‰ë”VC‹ß“¡Œ[•¶i“àjCŒ´‚Ü‚³ŽqCŠ™’J’¼”VC”è’õ•vi“Œ—ˆã‘åj: ‘æ24‰ñ“ú–{–ƉuŠw‰ï‘‰ï i94.11.00j, ‹ž“s.

1300. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Šw“¶`ŽvtŠúŠw¶‚ɶ‚¶‚½Ž¸Œêǂ̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‘O“c^Ž¡CŒÃ‹´‹I‹vi“àj: ‘æ18‰ñ“ú–{Ž¸ŒêÇŠw‰ï‘‰ï i94.11.17`18j, –¼ŒÃ‰®.

1301. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j MRI‚É‚æ‚é”]ŒŒŠÇ”½‰ž«‚ÌŒŸ“¢. ŒÜ\—’‹v‰ÀCâˆä•¶•FC_“c’¼i“àjC›Mˆêi•új: ‘æ6‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï i94.11.21j, “Œ‹ž.

1302. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ò‘¬”]•Ï«ÇŠ³ŽÒ‚Ì•às•ªÍ|•àsŽüŠú‚Æ°”½—Í•ª—Í‚ÌŽžŠÔ“I•Ï“®|. ŒÃ‘ò‰p–¾CŽO•x“N˜YC’·’JìˆêŽqCŒÃ˜a‹vKi“àjCˆ¢•”—EŸi“Œ•a‰@—Õ°ŒŸ¸j: ‘æ53‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i94.11.24`25j, “‡ª.

1303. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 15”N‚ÌŒo‰ß’ÇÕ‚µ–UŒŸ‚ɂĔӔ­«¬”]”玿«ˆÞkÇ(LCCA)‚ÆŠmf‚µ‚½‚P—á. ŽO•x“N˜YC—À³•£Cf‘ò’BŽuC’·’JìˆêŽqCŒÃ˜a‹vKi“àj: ‘æ53‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i94.11.24`25j, “‡ª.

1304. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ò‘¬”]•Ï«ÇŠ³ŽÒ‚Ì•às•ªÍ|•àsŽüŠú‚ÆdS‚ÌŽžŠÔ“I•Ï“®|. ŒÃ‘ò‰p–¾CŽO•x“N˜YC’·’JìˆêŽqCŒÃ˜a‹vKi“àjCˆ¢•”—EŸi—ÕŒŸj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.5.18`20j, •Ÿ‰ª.

1305. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Pneumocystis carinii”x‰Šf’f‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰t(BALF)•ªÍ‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. ‹v•Û“cŸi“àjC‘Š”nˆêˆåi‹~–½jCò–õOC•Ð‹Ë^lC–î“ߣM—YC•y“c—FKi“àj: ‘æ22‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï i95.02.01j, ‘åã, “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 2(‘Š§): 132, 1995.

1306. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”][Ç‹}«Šú‚É‚¨‚¯‚錌Ÿ÷ SODŠˆ«‚ÌŒoŽž“IŒŸ“¢. ¡ˆä¸C•Ÿ“c—Ï–çCHŽR‹v®C”¨—²ŽuCâˆä•¶•FC_“c’¼i“àj: ‘æ20‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i95.03.02j, ‰¡•l.

1307. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”]‘²’†‚̬ˆö‚Æ•aŒ^‚Ì„ˆÚ|Å‹ß10”NŠÔ‚ÌŒŸ“¢|. HŽR‹v®C‘êŽR—eŽqC“¡À–M•FC•Ÿ“c—Ï–çC¡ˆä¸C–kˆä‘¥•vC”¨—²ŽuCâˆä•¶•FC_“c’¼i“àj: ‘æ20‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i95.03.02j, ‰¡•l, —\eW, p.79, 1995.

1308. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Tc-99m-ECD‚É‚æ‚é‹ÇŠ”]ŒŒ—¬‘ª’è|”]ŒŒŠÇáŠQŠ³ŽÒ‚Å‚ÌŒŸ“¢|. –kˆä‘¥•vCâˆä•¶•FC“¡À–M•FCŒÜ\—’‹v‰ÀC_“c’¼i“àj: ‘æ20‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i95.03.03j, ‰¡•l.

1309. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Š¥“®–¬ƒoƒCƒpƒXpŒã‚Ì’†•_Œo‡•¹Ç. ŠC–ì‰ÀŽqCˆ¢‹v’Óñ•vi“àjCˆÀ–쌛ˆêi¬“cŒ´Žs—§•a‰@j: ‘æ20‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i95.03.03j, ‰¡•l.

1310. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒfƒCƒPƒA’ÊŠŠ³ŽÒ‚̗̑͂Ƹ_Çó. ”’–ØŒ´ŽsŽŸC’Ø“à—R”üCŽR–{–¾”üiƒŠƒn•”jCA¼”ü”¿i‘‡‘Š’k•”jC—é–؃ŒbCŠâ–{‘€C’·’Jì—D”üŽqC”’–ØŒ´—tŽqiƒŠƒn•”jC’†“‡ß•vi¸jC“y‘òŒ’ˆê iˆã—Éq¶Šw•”jCŠ}Œ´—FKi¸j: ‘æ15‰ñ“ú–{¸_ˆãŠw‰ï i95.03.16`17j.

1311. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”äŠr“I™–¬‚Ì—Õ°“IŒŸ“¢. ”Ñ‘–í¶C•äâ–ÎCÔ¯“§C‰ª“cƒC‹ß“¡Œ[•¶i“àjC”è’õ•vi“Œ‹ž—ˆã‘åj: ‘æ91‰ñ“ú–{“à‰ÈŠw‰ïu‰‰‰ï i94.04.14`16j, VŠƒ, Abstract, (SS-3): 11, 1994.

1312. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒzƒ‹ƒ^[Œ^ƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^[‚ÌŠJ”­‚Ɖ“Šuƒ‚ƒjƒ^ƒŠƒ“ƒOƒVƒXƒeƒ€. –î“ߣM—YCò–õOi“àjC‹ß“¡‚¦‚èi‰q¶jC‰Ô“cL‰pC‹v•Û“cŸC‚“cM˜aC•Ð‹Ë^lC¬—ÑO—SCˆ¢•”’¼C•y“c—FKi“àjC–ƒ¶–Îi“ú–{Œõ“dj: ‘æ34‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i94.04.26j, –‹’£, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(‘): 307, 1994.

1313. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰¡Šu–Œ–ƒáƒ‚É‚¨‚¯‚éŽc‘¶ŒÄ‹z‹Ø‚Ì‘ãž‹@”\‚ɂ‚¢‚Ä|–«Œ¢‚É‚¨‚¢‚Ä|. •Ð‹Ë^lC•Ð‹Ë“ú²ŽqC•y“c—FKi“àjCP.A. EastoniƒJƒ‹ƒKƒŠ[‘åj: ‘æ34‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i94.04.26j, –‹’£, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(‘): 340, 1994.

1314. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ã• •”ŽèpŒã‚̉¡Šu–Œ‹@”\|–«Œ¢‚É‚¨‚¯‚é[ŒÄ‹z(SIGH)‚ÌŒŸ“¢|. •Ð‹Ë“ú²ŽqC•Ð‹Ë^lC•y“c—FKi“àjCP.A. EastoniƒJƒ‹ƒKƒŠ[‘åj: ‘æ34‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i94.04.26j, –‹’£, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(‘): 340, 1994.

1315. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j CO2Čċz‰º‚̃qƒg• ‹Ø‚Ì”½‰ž. ‹g‘º®‚CŽO“¡‹vC¬–ì’‰LC²“¡“N–çC—é–Ø“¹OC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj: ‘æ34‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i94.04.26j, –‹’£, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(‘): 342, 1994.

1316. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆêŽ_‰»’‚‘f‹z“ü—Ö@‚É‚¨‚¯‚éˆêŽ_‰»’‚‘f‹Ÿ‹‹ƒVƒXƒeƒ€‚̈À‘S«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ¬—ÑO—SC•y“c—FKi“àjCL£–«iMEƒZƒ“ƒ^[jC’†ŽsŽŒÈi“ú–{Œõ“djC–{“cŽüˆêiƒAƒiƒeƒbƒNƒ„ƒiƒRj: ‘æ34‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i94.04.26j, –‹’£, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(‘): 358, 1994.

1317. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒcƒWARDSƒ‚ƒfƒ‹‚É‚¨‚¯‚éˆêŽ_‰»’‚‘f(NO)‹z“ü’†‚ÌPGF2ƒ¿‚Ì”xzŠÂ‚ւ̉e‹¿. “c’†’¼•FC¬—ÑO—SC•y“c—FKi“àjCM. WinklerCW. Zapoliƒn[ƒo[ƒh‘åj: ‘æ34‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i94.04.27j, –‹’£, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 32(‘): 358, 1994.

1318. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’nŽ“IŽ¸”F‚É‚¨‚¯‚锼‘¤‹óŠÔ–³Ž‹ˆêŽ©Œ±—á‚T—á‚ÌŒŸ“¢. ³–Ø‚©‚‚çC‘O“c^Ž¡CŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï i94.05.18`20j, •Ÿ‰ª.

1319. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰¹ŠyŽhŒƒ‚É‚æ‚é”]”gƒgƒ|ƒOƒ‰ƒtƒB[‚ÌŒŸ“¢. Œ˘aŽqi“àjCŠŽi–r•¶i—ÕŒŸjC‘O“c^Ž¡C’·’JìˆêŽqCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï‘‰ï i94.05.18`20j, •Ÿ‰ª.

1320. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚ŽŸ”]‹@”\áŠQ‚ÌŒŒˆ³‹y‚уJƒeƒR[ƒ‹ƒAƒ~ƒ“‚Ì“ú“à•Ï“®‚É‹y‚Ú‚·‰e‹¿. ‹ÊˆäL–¾C“Œ–M•FC•Ÿ“c—Ï–çCHŽR‹v®C_“c’¼i“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï‘‰ï i94.05.18j, •Ÿ‰ª.

1321. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹Ø‹Ù’£«ƒWƒXƒgƒƒtƒB[Ç‚ÌÇó”­Œ»”N—î‚Æ’†•_ŒoáŠQ‚Æ‚ÌŒŸ“¢. ˆ¢‹v’Óñ•vi¬“cŒ´Žs—§•a‰@jCŠC–ì‰ÀŽqi“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï‘‰ï i94.05.19j, •Ÿ‰ª.

1322. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŒQ”­“ª’É”­ì‚É‚¨‚¯‚é“àŒz“®–¬‚̕ω»|MRI‚É‚æ‚錟“¢|. ŒÜ\—’‹v‰ÀCâˆä•¶•FC_“c’¼i“àj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï‘‰ï i94.05.20j, •Ÿ‰ª.

1323. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Monocrotaline‚É‚æ‚é“à”çáŠQ‚Æ”L”]zŠÂ’²ß‹@\‚ɂ‚¢‚Ä. •Ÿ“c—Ï–çC‘êŽR—eŽqC”¨—²ŽuCˆî•Ÿ“O–çCŠÛŽR”ŽŽuC–k‘ººC–kˆä‘¥•vCâˆä•¶•FC_“c’¼i“àj: ‘æ6‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï i94.11.22j, “Œ‹ž.

1324. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”]‘²’†”­ÇŒã‚̉ºŽˆ•ÂÇ«“®–¬d‰»Ç‚É‚æ‚é‰óás. ‘O“c^Ž¡CŒÃ‹´‹I‹vC—ŠZF“ñC³–Ø‚©‚‚çC‰¡ŽRŠÞCŒÃ˜a‹vKi“àj: ‘æ20‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i95.03.02`03j, ‰¡•l.

1325. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j ‹­”çÇ‚Ìf’f‚ÆŽ¡—Ã. ‹ß“¡Œ[•¶i“àj: “ú–{“à‰ÈŠw‰ï–kŠC“¹Žx•”‘æ10‰ñ¶ŠU‹³ˆçu‰‰‰ï i94.06.26j, ŽD–y.

1326. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j “ª’É‚Ì•a‘Ô‚ÆŽ¡—Ã|Å‹ß‚Ìi•à|. âˆä•¶•Fi“àj: “ú–{_ŒoŠw‰ïŠÖ“Œ’n‹æ¶ŠU‹³ˆçu‰‰‰ï i94.12.04j, “Œ‹ž.

1327. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j “ª’É‚Ì•a‘Ô‚ÆŽ¡—Ã|ŋ߂̘b‘è|. âˆä•¶•Fi“àj: “ú–{_ŒoŠw‰ï“ŒŠC–k—¤Žx•”¶ŠU‹³ˆçu‰‰‰ï i95.01.21j, –¼ŒÃ‰®.

1328. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒŒ´RGD1bR‘Ì‚ÆGQ1bR‘Ì‚ª‚’l‚ð’悵, Šá‹Ø–ƒáƒ‚𔺂Á‚½ƒMƒ‰ƒ“ƒoƒŒ[ÇŒóŒQ‚Ì‚P—á. •H“c—Ç•½C”öè—EC••”˜a•vC”nê³”VC¼‰i@—YiO‘O‘åjCÄ“¡–L˜ai“àj: ‘æ54‰ñ“ú–{_ŒoŠw‰ï“Œ–k’n•û‰ï i94.03.12j, å‘ä.

1329. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j RMAGR‘Ì, RGM1R‘Ì, RGD1bR‘Ì‚ð—L‚·‚é IgM paraproteinemic neuropathy‚Ì‚P—á. ²“¡’B˜Ni”ŸŠÙˆãŽt‰ï•a‰@jC”nê³”VC¼‰i@—YC”ª–Ø‹´‘€˜ZiO‘O‘åjCÄ“¡–L˜ai“àj: ‘æ54‰ñ“ú–{_ŒoŠw‰ï–kŠC“¹’n•û‰ï i94.03.26j, ŽD–y.

1330. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”x‚ŒŒˆ³Ç‚ÆtƒNƒŠ[ƒ[‚ª‚Ù‚Ú“¯Žž‚ÉoŒ»‚µ‚½‹­”çÇ‚Ì‚P—á. “c’†Z–¾C•äâ–ÎCŠÖŽRØ•äC‚‹´“¹—YCÔ¯“§C‹ß“¡Œ[•¶i“àj: ‘æ427‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.05.14j, ‘O‹´.

1331. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”]‘²’†•Ð–ƒáƒŠ³ŽÒ‚É‚¨‚¯‚é—§‚¿ã‚ª‚è‰^“®‘¬“x‚ÌŒŸ“¢. ’·‘òOC’Ø“c—R”üC•½‰ê‚悵‚ÝC{“¡^mCt“ú”ü•ÛCŠO“‡—T”ViƒŠƒn•”jC‘O“c^Ž¡i“àj: ‘æ12‰ñ“ú–{Ž„—§ˆã‰È‘åŠw—Šw—Ö@Šw‰ï i94.06.10j, “È–Ø.

1332. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j t᱌´”­‚̈Úsã”çŠà‚É‚æ‚é“]ˆÚ«”xŠà‚Ì‚P–UŒŸ—á. ‚‹´—TŽqCò–õOC‰Ô“cL‰pC‹v•Û“cŸC‚“cM˜aC•Ð‹Ë^lC–î“ߣM—YC¬—ÑO—SCˆ¢•”’¼C•y“c—FKi“àj: ‘æ428‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.06.11j, “Œ‹ž.

1333. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j RHuR‘Ì, RVGCCR‘Ì‚ð”F‚ß‚½Lambert-Eaton‹Ø–³—ÍÇŒóŒQ‚Ì‚P—á. •y•Û˜aGCˆÉ“¡”Ž–¾Caˆä—߈êCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ129‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i94.06.18), “Œ‹ž.

1334. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰ß–°‚É‚ÄÄ”­‚µ‚½‘½”­«d‰»Ç‚Ì‚P—á. “¡À–M•FC•Ÿ“c—Ï–çC”¨—²ŽuCâˆä•¶•FC_“c’¼i“àj: ‘æ129‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i94.06.18j, “Œ‹ž.

1335. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆâ“`Žqf’f‚ª—L—p‚Å‚ ‚Á‚½Ž•óŠj’W‘“‹…ƒ‹ƒC‘̈ÞkÇ(DRPLA)‚Ì‚P—á. Œ´“ÖŽqC•Ÿ“c—Ï–çC”Ñ’Ë‚_C–kˆä‘¥•vC”¨—²ŽuCâˆä•¶•FC_“c’¼i“àj: ‘æ429‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.07.09j, “Œ‹ž.

1336. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j f’fŠm’è‚É‚W‚©ŒŽæs‚·‚éLambert-EatonÇŒóŒQ‚É‚Ä”­Ç‚µ‚½”x¬×–EŠà‚Ì‚P—á. ‘Š’m‹IŽqC‚‹´—TŽqC¬–ì’‰LCò–õOC‹v•Û“cŸC•Ð‹Ë^lC¬—ÑO—SC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj: ‘æ110‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï i94.07.19j, “Œ‹ž.

1337. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ž©ŒÈ–Ɖu«—nŒŒ«•nŒŒ‚ɇ•¹‚µ‚½‹­”çÇ‚Ì‚P—á. ‚‹´“¹—YC–쑺³¢C“c’†Z–¾C‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ430‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.09.10j, “Œ‹ž.

1338. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ã‹C“¹Žèp‚É‚æ‚釖°Žž–³ŒÄ‹z‚̉ü‘P|ƒAƒvƒmƒ‚ƒjƒ^[‚É‚æ‚é•]‰¿|. ’†¼‹vKi—ÕŒŸjCˆ¢•”’¼i“àjC‹v¼’mŽqC‘å–Ø–ƒ‹LŽqCŸ–””ü”gC“¡¶”ü”Ti—ÕŒŸjC¬–ì’‰LC‹g‘º®‚C•Ð‹Ë^li“àjC‰ª–{–qliŽ¨•@jC•y“c—FK i“àj: ‘æ31‰ñŠÖ“ŒbM’n‹æ—Õ°‰q¶ŒŸ¸Šw‰ï i94.09.10j, ‰¡•l.

1339. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚W”NŠÔ‚ɂ킽‚é–«is«’s•ð‚ð’悵, ‚R”NˆÈ㑉t‰ŠÇŠŒ©‚ªŽ‘±‚µ‚½_Œoƒx[ƒ`ƒFƒbƒg•a‚Ì‚P—á. Œ˘aŽqC’·’JìˆêŽqCaˆä—߈êCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ130‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i94.09.17j, “Œ‹ž.

1340. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘½”­«”]_Œo–ƒáƒ‚ð’悵ƒXƒeƒƒCƒhƒzƒ‹ƒ‚ƒ“‚ª’˜Œø‚ðŽ¦‚µ‚½”ìŒú«”]d–Œ‰Š‚Ì‚P—á. ”уP’J”ü•ôC•Ÿ“c—Ï–çC”¨—²ŽuCâˆä•¶•FC_“c’¼i“àj: ‘æ130‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i94.09.17j, “Œ‹ž.

1341. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •a‘Ô¶ŒŸ‹Ø‚É‚¨‚¯‚é‘gD‰»Šw“IŠŒ©‚Æ‹Ø’`”’‰»Šw‚Ì”äŠrŒŸ“¢. ˆÀˆä”ü]i‘‡—Õ°ŒnjC’†‘ºŒ’‚`iŠñjC¼–{MŽqC’¹‹‡ŽOi“àj: ‘æ20‰ñ–k—¢ˆãŠw‰ï‘‰ï i94.10.15j, ‘Š–ÍŒ´, –k—¢ˆãŠw, 24: 1994.

1342. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠO‘¤•Gó‘ÌoŒŒ‚Ì‚QÇ—á. ‰¶“c—ŒbŽqC•Ÿ“c—Ï–çC¡ˆä¸C–kˆä‘¥•vC”¨—²ŽuCâˆä•¶•FC_“c’¼i“àj: ‘æ432‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.11.12j, …ŒË.

1343. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j is«’s•ð‚Ƭ”]Çó‚ð’悵‚½HTLV-1R‘Ì—z«‚Ì‚—î—«—á. •y•Û˜aGCŒÃ‘ò‰p–¾CˆÉ“¡”Ž–¾CÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ131‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i94.12.03j, “Œ‹ž.

1344. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰A•”ƒwƒ‹ƒyƒX‚𔺂í‚È‚¢‚QŒ^’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚É‹Nˆö‚·‚é”]‰Š‚Ì‚P—á. ‘êŽR—eŽqC•Ÿ“c—Ï–çC”¨—²ŽuCâˆä•¶•FC_“c’¼i“àj: “ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i94.12.03j, “Œ‹ž.

1345. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”xoŒŒ‚Æ‹}«t•s‘S‚ð’悵‚½RD’†‹…×–EŽ¿R‘Ì—z«‚Ì‘Sg«d‰»Ç‚Ì‚P—á. Šp‰Æ–¾•¶C”ª–؉f—C‹yì–¾ŽqC“c’†Z–¾C‚‹´“¹—YCÔ¯“§C‹ß“¡Œ[•¶i“àjC‰““¡•½miŠÅŒìŠw•”j: ‘æ433‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.12.10j, “Œ‹ž.

1346. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j CNS-SLE‚É‚¨‚¯‚éRƒŠƒ“Ž‰Ž¿R‘̂̈Ӌ`. ‰ª“cƒC–쑺³¢CŠp‰Æ–¾•¶C‚‹´“¹—YC‹ß“¡Œ[•¶i“àj: ‘æ5‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ïŠÖ“Œ’n•û‰ï i94.12.10j, ç—t.

1347. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒXƒeƒƒCƒh—Ö@‚É”½‰ž‚µ‚½”x‚ŒŒˆ³Ç‡•¹‹­”çÇ‚Ì‚P—á. ¥“´ŒjŽqCŠp‰Æ–¾•¶C“c’†Z–¾C‚‹´“¹—YC–쑺³¢C‹ß“¡Œ[•¶i“àj: ‘æ5‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ïŠÖ“Œ’n•û‰ï i94.12.10j, ç—t.

1348. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j FK506‚Ì–«ŠÖ߃ŠƒEƒ}ƒ`‚ɑ΂·‚é—\”õ“IŒŸ“¢. Œ´‚Ü‚³ŽqC›Œ´KŽqCœA£rˆêC‹ß“¡Œ[•¶i“àjC“üŒðºˆê˜YC“à“cÙŽ¢C‹´–{”ŽŽjC”è’õ•vi“Œ—ˆã‘åj: ‘æ5‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ïŠÖ“Œ’n•û‰ï i94.12.10j, ç—t.

1349. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j SLE”­Ç‚É‚¨‚¯‚é‚s×–ERŒ´Žó—e‘Ì‚uˆâ“`Žq‘½Œ^‚ÌŠÖ—^. ã“cŠ°”VC“ú–춎qC” “c‰ë”VCŒ´‚Ü‚³ŽqCŠ™’J’¼”VC‹ß“¡Œ[•¶i“àjC”è’õ•vi“Œ—ˆã‘åj: ‘æ5‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ïŠÖ“Œ’n•û‰ï i94.12.10j, ç—t.

1350. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ò‘«‹ØˆÞkÇ‚Éis«‚Ìó‘Ô‚É‚ ‚é––½_ŒoáŠQ‚ð‡•¹‚µ‚½’jŽq—á. ³–Ø‚©‚‚çCŒÃ‘ò‰p–¾CÄ“¡–L˜aCŒÃ˜a‹vKC’¹‹‡ŽOi“àj: ‘æ24‰ñ_Œo‹ØƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.12.17j, “Œ‹ž.

1351. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹CŠÇŽx“®–¬– óŒŒŠÇŽî‚Ì‚P—á. –ö‘ò—º“ñC‚‹´—TŽqCŽO“¡‹vCò–õOC‹v•Û“cŸC•Ð‹Ë^lC¬—ÑO—SC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj: ‘æ434‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i95.02.04j, “Œ‹ž.

1352. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j lH“§Í’†‚ÉC-M-T•a—l‚̋؈Þk‚ð’悵‚½‰ŠÇ«’E‘«ƒjƒ…[ƒƒpƒ`[—á. ’ÒrˆêCf‘ò’BŽuCÄ“¡–L˜aCŒÃ˜a‹vKC’¹‹‡ŽOi“àj: ‘æ132‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i95.03.04j, “Œ‹ž.

1353. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j 68΂ʼn‚ß‚Ä”]‘²’†—l”­ì‚ð”F‚ß‚½ HELAS(3243•ÏˆÙj‚Ì‚P—á. ‘êŽR—eŽqC•Ÿ“c—Ï–çC¡ˆä¸C”¨—²ŽuC_“c’¼i“àj: “ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i95.03.04j, “Œ‹ž.

1354. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆâ“`Žqf’f‚ª—L—p‚Å‚ ‚Á‚½ Machado-Joseph•a(MJD)‚Ì‚P—á. ’ËŒ´M–çC•Ÿ“c—Ï–çCHŽR‹v®C–kˆä‘¥•vC”¨—²ŽuCâˆä•¶•FC_“c’¼i“àj: ‘æ435‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i95.03.11j, “Œ‹ž.

1355. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚—îŽÒ‚Ìg‘Ì‹@”\’ቺ‚Æ“]“|‚̈ö‰ÊŠÖŒW‚ɂ‚¢‚Ä|g‘Ì‹@”\‚̒ቺ‚Í“]“|‚̊댯‚ð‘‚·‚Ì‚©|. ‘基Cˆêiˆã—Éq¶Šw•”jCŽÄ“c”Ž: ‘æ12‰ñ_“Þì—Šw—Ö@ŽmŠw‰ï i95.03.18j, ‘Š–ÍŒ´.

1356. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ‘gD‚É‚¨‚¯‚铮Ö¬•¹‘–‚̃KƒXŒðŠ·‚É‚¨‚¯‚éˆÓ‹`. ¬—ÑO—Si“àj: –¬ŠÇŠw‰ïŠÖ˜AŒ¤‹†‰ïA”÷¬zŠÂg–é‚Ì’k˜b‰ïh i94.10.13j, “Œ‹ž.

1357. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ˆêŽ_‰»’‚‘f‹z“ü‚É‚æ‚é”x“®–¬ˆ³‚¨‚æ‚Ñ“®–¬ŒŒ‰tƒKƒX‚Ì”Z“x¥”½‰žŠÖŒW‚ÌŒŸ“¢. ²“¡“N–çC¬—ÑO—SC“c’†’¼•FC•y“c—FKi“àj: ”xzŠÂŒ¤‹†‰ï i94.06.11j, “Œ‹ž.

1358. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚éƒXƒg[ƒ}Š³ŽÒ‚ւ̃\[ƒVƒƒƒ‹ƒ[ƒNŽÀ‘H|‘Sˆõ–ÊÚ‚ð’Ê‚¶‚Ä|. ˆÉ¨“c–¾Žqi‘‡‘Š’k•”j: “ú–{ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒ\[ƒVƒƒƒ‹ƒ[ƒNiRSW)Œ¤‹†‰ï i94.11.18j, “Œ‹ž.

1359. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‹Ù’£Œ^“ª’É‚Ì•a‘Ô‚ÉŠÖ‚·‚錟“¢. ¡ˆä¸Câˆä•¶•FCŒÜ\—’‹v‰ÀC‰¶“c—ŒbŽqC_“c’¼i“àj: ‘æ22‰ñ“ª’ÉŒ¤‹†‰ï i94.11.19j, “Œ‹ž.

1360. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j –«“ª’ɂ̉uŠw“IŒŸ“¢. ŒÜ\—’‹v‰ÀCâˆä•¶•FC_“c’¼i“àj: ‘æ22‰ñ“ª’ÉŒ¤‹†‰ï i94.11.19j, “Œ‹ž.

1361. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒgŒz‹Ø‚Ì‹@”\|fine wire“d‹É‚É‚æ‚錟“¢. ‹g‘º®‚C‘Š’m‹IŽqC“y‹´‚ä‚©‚èC•Ð‹Ë^lCˆ¢•”’¼C•y“c—FKi“àj: ‘æ3‰ñŒÄ‹z‹ØƒRƒ“ƒfƒBƒVƒ‡ƒjƒ“ƒOŒ¤‹†‰ï i94.12.17j, “Œ‹ž.

1362. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Epstein-Barr virusŠ´õ‚Ì_Œo‡•¹Ç|R_ŒoR‘ÌŽY¶‹@˜‚ɂ‚¢‚Ä|. ˆÉ“¡”Ž–¾C•y•Û˜aGC“ü]KŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àjC‹à‘ò’¼”üi“Œ•a‰@Œ¤‹†Œnj: ‘æ‚V‰ñ“ú–{_Œo–ƉuŒ¤‹†‰ïŠwpW‰ï i95.01.25`26j, “Œ‹ž.

1363. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‹­”çÇ‚ÌÅ‹ß‚Ìf’f‚ÆŽ¡—Ã. ‹ß“¡Œ[•¶i“àj: ‘æ5‰ñƒŠƒEƒ}ƒ`EäPŒ´•aŒ¤‹†‰ïi‰¡•l“à‰ÈŠw‰ïj i94.04.27j, ‰¡•l.

1364. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‹­”çÇ‚Ì‚Ý‚©‚½‚ÆÅ‹ß‚ÌŽ¡—Ã. ‹ß“¡Œ[•¶i“àj: ‘æ15‰ñL“‡äPŒ´•aǗጟ“¢‰ï i94.05.19j, L“‡.

1365. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Ý‘îˆã—Â̌»ó‚Æ“W–]. ŒÃ˜a‹vKi“àj: Ý‘îˆã—ÖòÜ‹Ÿ‹‹„iƒ‚ƒfƒ‹Ž–‹ÆŽÀŽ{’n‹æ‡“¯‰ï‹c i95.03.23j, “Œ‹ž.

1366. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‰Æ’ë‚Å‚Å‚«‚郊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‘O“c^Ž¡i“àj: ƒŠƒEƒ}ƒ`—F‚̉ï_“ÞìŽx•”‘‰ï i94.04.13j, ‰¡•l.

1367. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ƒŠƒEƒ}ƒ`‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‘O“c^Ž¡i“àj: ŽÂƒmˆä‘‡•a‰@ƒŠƒEƒ}ƒ`—F‚̉ï i94.10.12j, ’·–ì.

1368. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ƒŠƒEƒ}ƒ`‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‘O“c^Ž¡i“àj: –k—¢‘åŠw•a‰@äPŒ´•a“à‰ÈƒŠƒEƒ}ƒ`—F‚̉ï i94.11.24j, ‘Š–ÍŒ´.

1369. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‰ºŽˆ‘•‹ï‚̈•ûã‚Ì’ˆÓŽ–€‚Æ‚»‚Ì–â‘è“_. ‘O“c^Ž¡i“àj: _“Þ쌧—Šw—Ö@Žm‹¦‰ïŒ¤C‰ï i94.12.12j.

1370. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j Q‚½‚«‚è‚É‚È‚ç‚È‚¢‚½‚ß‚É`”]‘²’†‚ÌŒ´ˆö‚Æ—\–h`. ‰¡ŽRŠÞiƒŠƒn•”j: ‰ï’Îἕی’ŠE‰ï’ÃŽá¼’n‹æŒöO‰q¶‹¦‰ïŽåÃŒ’Nu‰‰‰ï i94.12.17j, ‰ï’ÎἎs.

1371. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŠeX‚Ì•a‘Ô‚É‚¨‚¯‚é”] SPECT Tracer‚Ì‘I‘ð‚Æ‚»‚ÌŒŸ¸ƒvƒƒgƒR[ƒ‹: ”]‰Š‹}«Šú‚Ì•a‘Ô|SPECT‚É‚æ‚錟“¢|. –kˆä‘¥•vCâˆä•¶•Fi“àjCΈ䟌Èi•új: ‘æ5‰ñ“Œ“ú–{ƒZƒŒƒeƒbƒNŒ¤‹†‰ï i95.02.18j, “Œ‹ž.

1372. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j uPSS‚Æ”x•a•ÏvPSS‚É‚¨‚¯‚éŠÔŽ¿«”x•a•Ï‚Ì—Õ°“IˆÓ‹`. ‹ß“¡Œ[•¶C‚‹´“¹—YC–쑺³¢CÎìÍi“àj: ‘æ3‰ñ•l–¼ŒÎƒVƒ“ƒ|ƒWƒEƒ€ i95.03.18j, •l¼.

1373. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œ¾ŒêŽ¡—Âɂ¨‚¯‚éŠî–{“I‚È•û–@‚ɂ‚¢‚Ä. ¬’rŽO“ÞŽqiƒŠƒn•”j: A“EŽÒ’c‘Ì‹â—é‰ï”­ºŽw“±ŽÒŒ¤C‰ï i94.05.28j, “Œ‹ž.

1374. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j RMPOR‘Ì‚ð”F‚ß‹»–¡[‚¢Œo‰ß‚ð‚½‚Ç‚Á‚½ŒŒŠÇ‰ŠÇŒóŒQ‚Ì‚QÇ—á. ‘O“c’å‘¥i“àjC‰““¡•½miŠÅŒìŠw•”jCVˆätŽ}i”çjC‹ß“¡Œ[•¶i“àj: ‘æ35‰ñŠÖ“ŒƒŠƒEƒ}ƒ` i94.07.02j, “Œ‹ž.

1375. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’˜–¾‚È”x‚ŒŒˆ³‚𗈂µ‚½¬lStill•a‚Ì‚P—á. ‹yì–¾ŽqC‘å–ØŠxCŠÖŽRØ•äC‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ35‰ñŠÖ“ŒƒŠƒEƒ}ƒ` i94.07.02j, “Œ‹ž.

1376. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “ÁˆÙ‚ÈŽp¨‚ʼnü‘P‚ð‚Ý‚éKinesie Paradoxale—á. Ä“¡–L˜aC•y•Û˜aGCf‘ò’BŽuCŒÃ˜a‹vKi“àj: ‘æ‚W‰ñ‰^“®áŠQŒ¤‹†‰ï i94.07.23j, “Œ‹ž.

1377. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ˆêŽ_‰»’‚‘f‹z“ü‚Ì—Õ°‰ž—p‚ɂ‚¢‚Ä. ²“¡“N–çC¬—ÑO—SC“c’†’¼•FC•y“c—FKi“àj: _“ÞìŒÄ‹zƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.07.23j, Œú–Ø.

1378. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Rƒ‰ƒNƒgƒtƒFƒŠƒ“R‘Ì‚Ì—Õ°“I—L—p«‚ÌŒŸ“¢. ‰““¡•½miŠÅŒìŠw•”jC‹ß“¡Œ[•¶i“àj: ‘æ9‰ñAA¥ICŒ¤‹†‰ï i94.08.27j, “Œ‹ž.

1379. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j PCR‚Åf’f‚µ“¾‚½ SLE‡•¹ƒJƒŠƒj”x‰Š‚Ì‚P—á. ƒ‰ƒi”ü‘ãŽqC‚“c“NGCŠÖŽRØ•äC‚‹´“¹—YC‰ª“cƒC”Ñ‘–í¶C‹ß“¡Œ[•¶i“àj: ‘æ36‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï i94.08.28j, ‰¡•l.

1380. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œ¾ŒêáŠQŽÒ‚Ƃ̃Rƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‹Z–@. ˆÀ“cØ•äiƒŠƒn•”j: ‘å˜aŽs–K–âŠÅŒì•wŒ»”CŽÒŒ¤C‰ï i94.09.02j, ‘å˜aŽs.

1381. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‰“ˆÊŒ^‹ØƒWƒXƒgƒƒtƒB[iŽODŒ^j‚ÆŽv‚í‚ê‚éÇ—á. ’ÒrˆêC—À³•£CÄ“¡–L˜aCŒÃ˜a‹vKC’¹‹‡ŽOi“àj: ‘æ23‰ñ_Œo‹ØƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.09.03j, “Œ‹ž.

1382. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œ`ó‹L‰¯ƒvƒ‰ƒXƒ`ƒbƒN‚̉ºŽˆ‘•‹ï‚ւ̉ž—p. ‘O“c^Ž¡i“àjC²“¡ŒMC’·‘òOC“‡“c—²ŽqiƒŠƒn•”j: ‘æ37‰ñ_“Þ샊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“Œ¤‹†‰ï i94.09.10j, ‰¡•l.

1383. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‰·ò‚ÌŒø”\‚ɂ‚¢‚Ä. ‰¡ŽRŠÞiƒŠƒn•”j: “ú–{‰·ò—Ö@ˆã‰ï“Œ–k’n‹æŒ¤C‰ï i94.10.09j, ”Ñ≷ò.

1384. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”][Ç‹}«Šú‚É‚¨‚¯‚é SODŠˆ«‚ÌŒoŽž“IŒŸ“¢. ¡ˆä¸i“àj: ‘æ21‰ñŠÖ“Œ’n‹æ”]ŒŒŠÇáŠQ§˜b‰ï i94.10.18j, “Œ‹ž.

1385. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j –«‰ŠÇ«’E‘«ƒjƒ…[ƒƒpƒ`[‚É‚¨‚¯‚é–ƉuƒOƒƒuƒŠƒ“—Ö@. •y•Û˜aGC‹y”\ŽGC“ü]KŽqCŒ˘aŽqCˆÉ“¡”Ž–¾CÄ“¡–L˜ai“àjC¯–ì°•Fi϶‰ï’†‰›•a‰@j: ‘æ22‰ñ_“ÞìNeuroscience Conference i94.10.20j, ‰¡•l.

1386. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j t‰Š‚ÆŽ‡”Á‚ð’悵‚½Š´õ«S“à–Œ‰Š‚Ì‚P—á. “c’†Z–¾C‹Ê–ì—R‰À—C‚‹´“¹—YC–쑺³¢C”Ñ‘–í¶C‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ28‰ñ_“Þ샊ƒEƒ}ƒ`ˆã‰ï i94.10.22j, ‰¡•l.

1387. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹`Žˆ‘•’…‚É“ïa‚µ‚½Š´ŠoáŠQ‚ð—L‚·‚鉺ŽˆØ’f‚Ì‚PÇ—á. {“¡^mC’·‘òOC’Ø“c—R”üC•½‰ê‚悵‚ÝCt“ú”ü•ÛCŠO“‡—T”ViƒŠƒn•”jC‘O“c^Ž¡i“àj: _“Þ쌧PTEOTŽÀ–±Œ¤‹†‰ï i94.10.25j, ‘Š–ÍŒ´.

1388. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‰ñ•œ‚Ì’x‰„‚µ‚½ƒMƒ‰ƒ“ƒoƒŒ[ÇŒóŒQ‚Ì‚PÇ—á. t“ú”ü•ÛC’·‘òOC’Ø“c—R”üC•½‰ê‚悵‚ÝC{“¡^mCŠO“‡—T”ViƒŠƒn•”jC‘O“c^Ž¡i“àj: _“Þ쌧PTEOTŽÀ–±Œ¤‹†‰ï i94.10.25j, ‘Š–ÍŒ´.

1389. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “¹‡áŠQ‚ð’悵‚½Ç—á‚ÌŒP—ûŒoŒ±. “‡“c—²ŽqCŒã“¡ˆÀŒbC{“¡“Þ•ä”üiƒŠƒn•”jC‘O“c^Ž¡i“àj: _“Þ쌧PTEOTŽÀ–±Œ¤‹†‰ï i94.10.25j, ‘Š–ÍŒ´.

1390. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŠO—ˆì‹Æ—Ö@‚Ì‚T”NŠÔ‚Ì“®Œü. ”’–ØŒ´—tŽqC’·’Jì—D”üŽqCŽR–{–¾”üC”’–ØŒ´ŽsŽŸC’Ø“à—R”üiƒŠƒn•”j: _“Þ쌧PTEOTŽÀ–±Œ¤‹†‰ï i94.10.25j, ‘Š–ÍŒ´.

1391. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ¸_‰ÈƒfƒCƒPƒAŠ³ŽÒ‚̗̑͂ƉA«Çó‚ÌŠÖŒW. ”’–ØŒ´ŽsŽŸC’Ø“à—R”üCŽR–{–¾”üC”’–ØŒ´—tŽqC’·’Jì—D”üŽqiƒŠƒn•”jCŠ}Œ´—FKC’†“‡ß•vi¸j: _“Þ쌧PTEOTŽÀ–±Œ¤‹†‰ï i94.10.25j, ‘Š–ÍŒ´.

1392. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”]oŒŒ‚ðŒJ‚è•Ô‚µ‚½œŒ`¬•s‘SÇ‚Ì‚P—á. Œ´“ÖŽqC•Ÿ“c—Ï–çC¡ˆä¸CHŽR‹v®C”¨—²ŽuCâˆä•¶•FC_“c’¼i“àj: •½¬‚U”N“x_“Þì“à‰ÈW’k‰ï i94.11.00j, ‰¡•l.

1393. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Žîᇑ”º«‚Ì‘½”­‹Ø‰Š‚ÌŽ¡—ÃŒã‚É’·Šú‚ɂ킽‚è‹Ø—͒ቺ, ‚CKŒŒÇ‚ªŽ‘±‚µ‚Ä‚¢‚é—«—á. Ä“¡–L˜aC’ÒrˆêCŒÃ‘ò‰p–¾C‘O“c^Ž¡CŒÃ˜a‹vKC’¹‹‡ŽOi“àj: ‘æ24‰ñ_Œo‹ØƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.12.17j, “Œ‹ž.

1394. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’âŽ~, —§ˆÊŽž‚ÌŒã•û“]“|‚ðŽå’¥‚Æ‚µ‚½—«—á. aˆä—߈êC—À³•£CŒÃ‘ò‰p–¾CÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ‚X‰ñ‰^“®Œ¤‹†‰ï i95.01.28j, “Œ‹ž.

1395. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j RAŒz’ÅÇŽlŽˆ–ƒáƒŠ³ŽÒ‚ɑ΂·‚é OTƒAƒvƒ[ƒ`‚ÆQOL. {“¡“Þ•ä”üCŒã“¡ˆÀŒbC“‡“c—²ŽqiƒŠƒn•”jC‘O“c^Ž¡i“àj: ‘æ‚Q‰ñ_“Þ샊ƒEƒ}ƒ`‚̃PƒAŒ¤‹†‰ï i95.01.28j, ‰¡•l.

1396. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j RAlHŠÖß’uŠ·Œã, PTƒvƒƒOƒ‰ƒ€‚É“ïa‚µ‚½Ç—á‚ÌŒoŒ±. ’·‘òOC’Ø“c—R”üC•½‰ê‚悵‚ÝC{“¡^mCt“ú”ü•ÛCŠO“‡—T”ViƒŠƒn•”jC‘O“c^Ž¡i“àj: ‘æ‚Q‰ñ_“Þ샊ƒEƒ}ƒ`‚̃PƒAŒ¤‹†‰ï i95.01.28j, ‰¡•l.

1397. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŽüŠú«ŒŒ¬”ÂŒ¸­‚ð’悵‚½RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ‚Ì‚P—á. ¥“´ŒjŽqCƒ‰ƒi”ü‘ãŽqC“c’†Z–¾C‚‹´“¹—YC‰ª“cƒC‹ß“¡Œ[•¶i“àj: ‘æ29‰ñ_“Þ샊ƒEƒ}ƒ`ˆã‰ï i95.03.04j, ‰¡•l.

1398. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”][Ç‚ÌÄ”­‚Æ’·Šú—\Œã. –kˆä‘¥•vi“àj: ‘æ6‰ñ_“Þ쌌ðǃZƒ~ƒi[ i95.03.09j, ‰¡•l.

1399. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj •›t”玿ƒXƒeƒƒCƒh܂̳‚µ‚¢ˆù‚Ý•û. ‹ß“¡Œ[•¶i“àj: ‘æ17‰ñ“Œ¤Œ¤C‰ï i94.06.08j, ìè.

1400. mŒ¤‹†‰ïi’n•ûjn iŒöŠJu‰‰j Ž¸ŒêÇ‚Ì•û‚Æ‚ÌÚ‚µ•û‚̃Rƒc. ˆÀ“cØ•äiƒŠƒn•”j: ‘Š–ÍŒ´Žsƒ{ƒ‰ƒ“ƒeƒBƒAuÀ i94.07.30j, ‘Š–ÍŒ´.


<<1501 ?? >>

1401. mŒ´’˜n Analyses of protein kinase C isoform expression in a colorectal cancer liver metastases model. ‘ •ÀŸiŠOjCCohen, A.M.CGuillem, J.G.iMemorial Sloan-Kettering Cancer Centerj: Am. J. Surg., 169: 57`64, 1995.

1402. mŒ´’˜n A randomized trial of immunotherapy in combination with chemotherapy for gastric cancer with peritonitis carcinomatosis. ŽO•x—˜•vi“ŒŠC‘åjC–{‹´‹v•FiŒ§—§‚ª‚ñƒZƒ“ƒ^[jC“y‰®Žü“ñi‰¡•lŽs‘åjCŠÛŽR—Y“ñi¹ƒ}ƒŠ‘åjC—é–Økaihoiº˜a‘åjC”äŠé”\Ž÷iŠOjC¼–{º•F i‰¡•lŽs‘åjCŽRì’B˜YiŒc‘åjC™“cMinoruC¬‰z‹ª“ñi“ŒŠC‘åj: Ann. Cancer Res. Ther., 3(1): 35`39, 1994.

1403. mŒ´’˜n ‘ŠúˆÝŠà‚ɑ΂·‚é“àŽ‹‹¾“IƒŒ[ƒU[Ž¡—Â̗L—p«‚Æ‚»‚Ì–ðŠ„. “ˆ”ömC”äŠé”\Ž÷iŠOj: Endosc. Forum Digest. Dis., 10(1): 9`15, 1994.

1404. mŒ´’˜n Differential expression of protein kinase C isoforms in human colorectal cancers. ‘ •ÀŸiŠOjCPowell, C.T.CHug, H.CZerg, Z.CCohen, A.M.CGuillem, J.G.iMemorial Sloan-Kettering Cancer Centerj: J. Surg. Res., 58(2): 233`239, 1995.

1405. mŒ´’˜n • o‹¾‰º’_”X“Eop‚̇•¹Ç‚Æ‚»‚Ì‘Îô; ’_ŠÇ‘¹‚Æ‚»‚Ì‘Îô|‚Ç‚ñ‚È‚Æ‚«‹N‚±‚è‚â‚·‚¢‚©|. ‹g“c@‹IC”äŠé”\Ž÷iŠOj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 12: 1686`1690, 1994.

1406. mŒ´’˜n “–‰@‚É‚¨‚¯‚éˆÝŠàŽèpÇ—á‚Ì—Õ°•a—Šw“I•Ï‘J. ‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqC–¥‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ˆã—Ã, 48(12): 999`1004, 1994.

1407. mŒ´’˜n ŠÌ‘Ÿ‚Ì_Œo‚Ì•Ï«‚ÆĶ‚ÉŠÖ‚·‚é“dŽqŒ°”÷‹¾“IŒ¤‹†. “cŠ•¶•FiŠOjCŽðˆäNOi‰ðjCŠ`“cÍiŠOjCŽR‰È³•½i‰ðj: ‰ð–UŠwŽGŽ, 69(2): 1994.

1408. mŒ´’˜n PHE (Porfimer Sodium)‚¨‚æ‚уGƒLƒVƒ}ƒ_ƒCƒŒ[ƒU[(PDT EDL-1)‚É‚æ‚éH“¹•\ÝŠà‚ɑ΂·‚éPhotodynamic Therapy (PDT)‚Ì—Õ°, ‘æ‡V‘ŠŽŽŒ±. ‹g“cˆê¬C—é–Ø–Îi“Œ—ˆã‘åjCŽO‘ºªŽl˜YCˆê‹½i‘åã•{—§¬l•aƒZƒ“ƒ^[jCŽðˆäŽ¡³i“Œ‹žˆã‰È‘åjC“ˆ”ömiŠOjC‰Á“¡Ž¡•¶i“Œ‹žˆã‰È‘åjCˆÉ“¡Ž ºiˆ¤’mŒ§‚ª‚ñƒZƒ“ƒ^[jC”äŠé”\Ž÷iŠOjC—јa•FC‘º“c—mŽqCŸ˜C‰qCˆäŽè”ŽŽqC‰H¶•xŽm•vi“Œ—ˆã‘åjC‘“c‹`”Ži“Œˆã‰È‘åj: Šà‚Ɖ»Šw—Ö@, 20(13): 2063`2066, 1993.

1409. mŒ´’˜n ”S–ŒØœ–@‚̈âŽc‚ɑ΂·‚é’ljÁƒŒ[ƒU[Ǝ˂̬т©‚ç‚Ý‚½‘ŠúˆÝŠà‚ɑ΂·‚é“àŽ‹‹¾Ž¡—Â̎¡—Õûj. “ˆ”ömC”äŠé”\Ž÷iŠOj: ‘æ14‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘å‰ï˜_•¶W, p.171`174, 1993.

1410. mŒ´’˜n is‘å’°Šà‚Ì—\Œã—\‘ªˆöŽq‚ÌŒŸ“¢C‚Æ‚­‚É PCNA‚ÆAgNORs‚ɂ‚¢‚Ä. ¼”ªŽkiã”ö’†‰›‘‡•a‰@jC‚–ìN—Yi•a—jCŠ`“cÍiŠOj: “ú–{ŠO‰ÈŠw‰ïŽGŽ, 95(11): 797`806, 1994.

1411. mŒ´’˜n Clinical evaluation of determination of the extent of gastrectomy in early cancer in the body of the stomach: Application of endoscopic clipping. ŽOd–슰ŠìC”äŠé”\Ž÷C匴÷C“ˆ”ömC¬—ÑLsC‚‹´ŒúC‚–ì—eKiŠOj: “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 19(4): 52`68, 1994.

1412. mŒ´’˜n “Á”­«H“¹”j—ô‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ‘꓇í‰ëC¼è”ŽsCŽOd–슰ŠìC•½“cŒõ”ŽC‘Oì˜a•FCŠ`“cÍiŠOjC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 5(7): 663`672, 1994.

1413. mŒ´’˜n ‘å’°”S–Œ‰º‘wZ(sm)ŠàÄ”­ŠëŒ¯ˆöŽq‚ÌŒŸ“¢. ˆäŒ´ŒúC‘å’J„³CŒÃì—T‰îC‘êK‹ÏC”äŠé”\Ž÷CŠ`“cÍiŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 27(8): 1954`1960, 1994.

1414. mŒ´’˜n “Ý“IäX‘¹‚É‚¨‚¯‚é• •”—Šw“IŠŒ©oŒ»‚ÉŠÖ—^‚·‚éˆöŽq‚Ì—Õ°“IŒŸ“¢. ‘꓇í‰ëCó—˜–õC•½“cŒõ”ŽCŠ`“cÍiŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 27(9): 2107`2112, 1994.

1415. mŒ´’˜n —A“ü‹r•ÂÇÇ‚Ìf’f‚ÆŽ¡—Ã. ŒÃ“cˆê“¿CŽOd–슰ŠìCâEŠ_½C“ˆ”ömC‘å‹{“Œ¶CŠ`“cÍC”äŠé”\Ž÷iŠOj: “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽGŽ, 55(10): 2491`2498, 1994.

1416. mŒ´’˜n Œ´”­«“ûŠà‚É‚¨‚¯‚éŠjDNA—Ê‚ÌŒŸ“¢. ’Ë–{GlC“n•ÓŒ’Ž™CX£¹Ž÷C‘D–{TìC’|’†°KCΓc˜a•vC‘åê³›ßCŠ`“cÍiŠOj: “ûŠà‚Ì—Õ°, 10(1): 161`166, 1995.

1417. mŒ´’˜n –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚éˆÝŠàŽèpÇ—á|‚Æ‚­‚ɃŠƒ“ƒpß“]ˆÚ‚©‚ç‚Ý‚½k¬Žèp‚Ì“K‰ž‚ɂ‚¢‚Ä|. 匴÷CŽOd–슰ŠìC“ˆ”ömC¬—ÑLsC‚‹´ŒúC‚–ì—eKC”äŠé”\Ž÷iŠOjC’†‰p’ji•a—jC‰Á“¡Nsi‚¢‚·‚¸•a‰@jCâEŠ_½iˆÉ“¤‰º“c•a‰@j: –k—¢ˆãŠw, 24(4): 270`276, 1994.

1418. mŒ´’˜n • •”‘å“®–¬\“ñŽw’°á‘‚ÌÇ—á‚ÌŒŸ“¢. ‘꓇í‰ëC“‡’÷ˆêC•½“cŒõ”ŽCª–{ECŠ`“cÍiŠOjC‘å˜a“c—²i‹~–½j: –¬ŠÇŠw, 35(1): 11`17, 1995.

1419. m€Œ´’˜i‰p•¶jn Production of metalloproteinase-2 (MMP-2) in metastatic colorectal cancer (CRC) is stromal (fibroblast) in origin. ‘ •ÀŸiŠOjCCohen, A.M.CGuillem, C.J.iMemorial Sloan-Kettering Cancer Centerj: Am. College of Surgeons, 1994 Surgical Forum, 45: 551`553, 1994.

1420. m€Œ´’˜i‰p•¶jn Influence of donor factors other than serologic status on transmission of cytomegalovirus to renal transplant recipients. ’†ŽR‹`‰îCAbe, H.CRapaport, F.T.CWaltzer, W.C.iState Univ., N.Y.jCŠ`“cÍiŠOj: Transplant. Proc., 26(2): 936`937, 1994.

1421. m€Œ´’˜i‰p•¶jn Effectiveness of triple regimen immunosuppression of canine pancreatic allotransplantation. ²“¡ŒõŽjC¼‘òŽ“TC¡ˆäŒ‰C¼ˆäŒ’C“cŠ•¶•FC”äŠé”\Ž÷CΓc˜a•vCŠ`“cÍiŠOj: Transplant. Proc., 26(4): 1074`1075, 1994.

1422. m€Œ´’˜i‰p•¶jn Causes of death after renal transplantation: A long term follow up study. ²“¡ŒõŽjC“cŠ•¶•FCΓc˜a•vC¼‘òŽ“TC’†ŽR‹`‰îC‰¡“c˜a•FCŠ`“cÍiŠOjCŒF–ì˜a—YC‰““¡’‰—Yi”åjC’|“àN—YCŠ™“cvŽõC‘å‹v•Û[li“àjC“n•”_ “ñi–Æj: Transplant. Proc., 26(4): 2017`2018, 1994.

1423. m€Œ´’˜n ƒEƒH[ƒ^[ƒWƒFƒbƒg‚ð—p‚¢‚½• o‹¾‰ºŽèp. ‘å‹{“Œ¶Cò‰Æ‹v’¼CŒÃ“cˆê“¿C‹g“c@‹IC‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: BME, 8(1): 22`27, 1994.

1424. m€Œ´’˜n “–‰@‚É‚¨‚¯‚é‹}«’Ž‚‰Š‚ÌŒŸ“¢. ‘åÀ“cŽ¡C¼”ªŽkC’†‘ºlLC‹{“à–M_C“n•Ó—´•FC´…³•vC‘哇s•FC’†‘ºŒõ•viã”ö’†‰›‘‡•a‰@j: é‹ÊŒ§ˆãŠw‰ïŽGŽ, 29(4): 699`701, 1995.

1425. m€Œ´’˜n Á‰»ŠíŠO‰È‚É‚¨‚¯‚é¡“ú‚Ì•W€Ž¡—Ã|‹}«’_”X‰Š|. Š`“cÍC‹g“c@‹IC¼‘òŽ“TC“‡“cŒªCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‚‹´‹BC‘å‹{“Œ¶iŠOj: Á‰»ŠíŠO‰È, 17: 447`450, 1994.

1426. mŒ¤‹†•ñn “àŽ‹‹¾“I”S–ŒØœŒã‚ÉŠO‰ÈŽèp‚ªs‚í‚ꂽ‘ŠúˆÝŠàÇ—á‚ÌŒŸ“¢|ˆÝŠàŒ¤‹†‰ï“àŽ‹‹¾Ž¡—Èψõ‰ï•ñ|. ‘åŽÄŽO˜Yi‘åãˆã‰È‘åjCˆ°“cŒ‰C“c’†‰ë–çC‰œ“c–Îi‘åã•{—§¬l•aƒZƒ“ƒ^[jC¬•”ªŽµ˜Yi‘—§‚ª‚ñƒZƒ“ƒ^[jC‰Á“¡—miŠàŒ¤jCŠì”[—Ei•l¼ˆã‰È ‘åjC‚–Ø‘•vi—ÑŠO‰È•a‰@jC’|˜—²’jiŠàŒ¤jC‘½“c³OiŽRŒû‘åjC’†‘º‹±ˆêi“ŒˆãŽ•‘åjC”nê•Û¹iŠàŒ¤jC•l“c•×iŽÐ‰ï•ÛŒ¯’†‰›‘‡•a‰@jC”äŠé ”\Ž÷iŠOjC“¡“c—Í–çiº˜a‘åjCŠÛŽRŒ\ˆêi‘—§‚ª‚ñƒZƒ“ƒ^[jCŠÛŽR‰ëˆêiŠàŒ¤jCŽO‹÷ŒúMiŒF–{‘åjC–]ŒŽ•ŸŽ¡iå‘äŽsˆã—ÃZƒ“ƒ^[jC”ª”öP—Çi•Ÿ ‰ª‘åjCˆäŒûŒ‰i‹ã‘åjC”’•Ç•F•vi‡“V‘åjC¼–ž³iŠàŒ¤j: ˆÝ‚Æ’°, 29(11): 1162`1170, 1994.

1427. mŒ¤‹†•ñi•¶•”Èjn ŠÌ’_äX—̈æŠg‘åŽèp‚É‚¨‚¯‚éŠÌäX‘ŸŠí‘ŠŠÖ‚ÉŠÖ‚·‚éŽÀŒ±“I‚¨‚æ‚Ñ—Õ°“IŒ¤‹†. ‹g“c@‹ICŠ`“cÍC‚‹´‹BC’Ë–{GlCò‰Æ‹v’¼CŒÃ“cˆê“¿iŠOj: •½¬‚U”N“x‰ÈŠwŒ¤‹†”ï•â•‹àŽÀÑ•ñ‘, 1994.

1428. mŒ¤‹†•ñi•¶•”Èjn ‘½‘ŸŠí•s‘SŠ³ŽÒ‚É‚¨‚¯‚鎊“K“Š—^ƒAƒ~ƒmŽ_‘g¬‚ƃJƒƒŠ[/’‚‘f”ä‚ÌŒŸ“¢. ‘åê³›ßiŠÅŒìŠw•”jC“‡’÷ˆêCŠ`“cÍCΓc˜a•viŠOj: •½¬‚U”N“x‰ÈŠwŒ¤‹†”ï•â•‹àŽÀÑ•ñ‘, 1994.

1429. mŒ¤‹†•ñiŒú¶Èjn ŠÌäX“¯ŽžØœŒÀŠE‚ÉŠÖ‚·‚éŠî‘b“IC—Õ°“IŒ¤‹†. Š`“cÍC‹g“c@‹IC‚‹´‹BCò‰Æ‹v’¼CŒÃ“cˆê“¿C‘å‹{“Œ¶iŠOj: Œú¶È‚ª‚ñŒ¤‹†•â•‹à¢’_“¹‚ª‚ñCäX“ª•”‚ª‚ñ‚ÌŠg‘åØœ‚É‚¨‚¯‚骎¡«‚ƈÀ‘S«Œüã‚ÉŠÖ‚·‚錤‹†£•½¬‚T”N“xŒ¤‹†•ñ‘, p.128`133, 1994.

1430. mŒ¤‹†•ñiŒú¶Èjn ŠÌ“àŒ‹ÎÇ‚É‚¨‚¯‚éŠÌ“à_Œo‚Ì•a‘Ô‚ÉŠÖ‚·‚éŒ`‘ÔŠw“IŒ¤‹†. Š`“cÍC‘å‹{“Œ¶C‹g“c@‹IC‚‹´‹BCò‰Æ‹v’¼C“cŠ•¶•FCŒÃ“cˆê“¿iŠOj: Œú¶È“Á’莾Š³ŠÌ“àŒ‹ÎÇ’²¸Œ¤‹†”Ç•½¬‚T”N“xŒ¤‹†•ñ‘, p.42`48, 1994.

1431. mÇ—á•ñn Cavernous transformation of the portal vein coinciding with early gastric cancer and cholelithiasis. ‚‹´‹BCŠ`“cÍCˆîé‰p“ñCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‹g“c@‹IC‘å‹{“Œ¶iŠOjCˆé•”‹`Œ›i•új: Surgery Today, 24: 840`843, 1994.

1432. mÇ—á•ñn ‘å’°ŠàŠÌ“]ˆÚ‘ƒØœŒã‚Ì—\–h“I“®’‰»Šw—Ö@‚Ì—LŒø«‚ɂ‚¢‚Ä. ŒÃì—T‰îC‘å’J„³CˆäŒ´ŒúC’Ò—ºìC‰ª‘º—¥ŽqC²“¡KˆêC”äŠé”\Ž÷iŠOj: Šà‚Ɖ»Šw—Ö@, 21(Suppl.4): 453`457, 1994.

1433. mÇ—á•ñn ”­ÇŒã‘Šú‚Ì•Û‘¶“IŽ¡—ª‘tŒø‚µ‚½“Á”­«H“¹”j—ô‚Ì‚P—á. ‘꓇í‰ëCŽOd–슰ŠìC’†ŽR‹`‰îC’Ë–{GlCó—˜–õC•½“cŒõ”ŽCâ–{‚¢‚ÂÝC¬ìŒ›ÍC²“¡ŒõŽjC”äŠé”\Ž÷CŠ`“cÍiŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 28(1): 48`52, 1995.

1434. mÇ—á•ñn ŠJ• pŒãAˆÙ•¨‚É‚æ‚é“÷‰èŽî‚Ì‚P—á. ŒÃ“cˆê“¿C‹g“c@‹ICò‰Æ‹v’¼C‚‹´‹BC‘å‹{“Œ¶C”äŠé”\Ž÷CŠ`“cÍiŠOj: “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽGŽ, 55(11): 2952`2957, 1994.

1435. m‘àn ‘’_ŠÇŒ‹ÎÇ. ‹à“cŒå˜YC‚‹´r‹BiŠOj: Ope Nursing, (‰Ä‹G‘Š§): 161`165, 1994.

1436. m‘àn • o‹¾“I’_”X“Eop‚̇•¹Ç‚Æ‚»‚Ì‘Îô, “àŽ‹‹¾‰ºŽèp‚©‚çŠJ• Žèp‚ւ̈Ús|p‘O‰æ‘œf’f‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä|. ‹à“cŒå˜YiŠOj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 12(9): 45`50, 1994.

1437. m‘àn “àŽ‹‹¾‰ºŽèp‚ÌŒ»ó‚Æ«—ˆ. ”äŠé”\Ž÷iŠOj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 12(9): 8`11, 1994.

1438. m‘àn ‹~‹}‰ŠúŽ¡—Ã}ƒjƒ…ƒAƒ‹: ’á—e—Ê«ƒVƒ‡ƒbƒN, _ŒoŒ´«ƒVƒ‡ƒbƒN. ‘꓇í‰ëC‘Oì˜a•FiŠOj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 8(12): 26`29, 1990.

1439. m‘àn Ý‘îŠàŽ¡—Âւ̃Aƒvƒ[ƒ`; ‰»Šw—Ö@iÇ—á2-1). ‘å’J„³iŠOj: Šà‚Ɖ»Šw—Ö@, (Suppl.4): 551`553, 1994.

1440. m‘àn Ý‘îˆã—Ņ̃‚É‚¨‚¯‚éÝ‘î’†SÖ¬‰h—{. ‘å’J„³CŒÃì—T‰îC”äŠé”\Ž÷iŠOj: Ý‘îˆã—ÂƉh—{ŠÇ—, p.2`4, 1995.

1441. m‘àn ‘å’°ˆŸ‘S“E, ‰ñ’°”Xãè–å•«‡‚É‚¨‚¯‚éh-pouchŒ`¬p. ‘å’J„³CŒÃì—T‰îCˆäŒ´ŒúC”äŠé”\Ž÷iŠOj: Žèp, 49(2): 197`201, 1995.

1442. m‘àn ŽüŽYŠú‚Ì—AŒŒ‚Æ‚»‚ÌŽü•Ó|—AŒŒ‚ÌŽÀÛ‚Æ’ˆÓ“_|. ‘꓇í‰ëC‘Oì˜a•FiŠOj: ŽüŽYŠúˆãŠw, 20(8): 95`99, 1990.

1443. m‘àn ’¼’°ãè–å•”ˆ««•FŽî. ‘å’J„³C‘êK‹ÏC”äŠé”\Ž÷iŠOjCŒÜ\—’³LCŸ–””º‰hi“àjC¼ŽR•Û”äŒÃC’†‰p’ji•a—j: Á‰»Ší“à‰ÈƒNƒ‹ƒYƒX“àŽ‹‹¾‚Ì“Ç‚Ý•û, 4: 95`98, 1994.

1444. m‘àn “àŽ‹‹¾‚É‚¨‚¯‚éf’f‚©‚玡—Â܂ł̈êŠÑ«. ”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 6(11): 1551`1554, 1994.

1445. m‘àn • o‹¾‰º’_”X“Eop‚É‚¨‚¯‚éˆÀ‘S‚È’_”X“®–¬‚̈—‚̃Rƒc. ŒÃ“cˆê“¿CŽOd–슰ŠìC”äŠé”\Ž÷C‹g“c@‹ICò‰Æ‹v’¼iŠOj: Á‰»Ší“àŽ‹‹¾, 6(9): 1251`1257, 1994.

1446. m‘àn Á‰»Šíˆ««Ž¾Š³‚ɑ΂·‚é• o‹¾‰ºŽèp‰ž—p‚̉”\«|‚Æ‚­‚É‘ŠúˆÝŠà‚ɂ‚¢‚Ä|. ”äŠé”\Ž÷C“ˆ”ömC¬—ÑLsCŽOd–슰ŠìC匴÷iŠOj: Á‰»Ší“àŽ‹‹¾, 6(9): 1374`1380, 1994.

1447. m‘àn ‹Ù‹}—A‰tE—AŒŒ. ’Ë–{GlC”äŠé”\Ž÷iŠOj: ‘‡—Õ°, 43(10): 2399`2401, 1994.

1448. m‘àn ˆÝ’×á‡ioŒŒ«ˆÝ’×ᇂðŠÜ‚Þ). ’Ë–{GlC”äŠé”\Ž÷iŠOj: ‘‡—Õ°, Á‰»ŠÇÇŒóŒQ(㊪): 351`353, 1994.

1449. m‘àn ˆÝüó’×á‡. 匴÷C”äŠé”\Ž÷iŠOj: ‘‡—Õ°, Á‰»ŠÇÇŒóŒQ(㊪): 477`479, 1994.

1450. m‘àn \“ñŽw’°Œ´”­ Peneth's cell carcinoma. ‚‹´r‹BiŠOj: ‘‡—Õ°, Á‰»ŠÇÇŒóŒQ(㊪): 731`732, 1994.

1451. m‘àn ‘ŠúˆÝŠàŽ¡—Âɂ¨‚¯‚é controversy|Žèp“IŽ¡—ÂƔñŽèp“IŽ¡—Ã|. ¬—ÑLsC“ˆ”ömC”äŠé”\Ž÷iŠOj: —Õ°ŠO‰È, 49(5): 589`594, 1994.

1452. mŠwp‘n i•ª’SŽ·•Mj ŠO‰È—Õ°ƒnƒ“ƒhƒuƒbƒN [2]Šà|Œ»‹µ‚ÆÅVŽ¡—Ã; Ž¡—Ö@‚ÌÅ‘Oü, ƒŒ[ƒU[—Ö@, p.24`30, “ˆ”ömCŽOd–슰ŠìC”äŠé”\Ž÷iŠOj. •ÒW oŒŽN•vi“Œ‘åjC¬–x‰¨ˆê˜Yi‘—§‘Ûˆã—ÃZƒ“ƒ^[jC ’†ŽR‘“X, “Œ‹ž, 94.04.05”­s.

1453. mŠwp‘n i•ª’SŽ·•Mj —Õ°ŽÀ’n‚ÉŠw‚Ô‹}«äX‰Š|¡“ú‚ÌŽ¡—ÃŽwj‚ðŽ¦´‚·‚éÇ—áW|; ERCPŒã‹}«dÇäX‰Š‚Ì‚PŽ¡Œ±—á, p.71`74, ŒÃ“cˆê“¿C‚‹´‹BCò‰Æ‹v’¼C²“¡–ÎC÷–{MˆêC‹g“c@‹IC‘å‹{“Œ¶C”äŠé”\Ž÷CŠ`“cÍiŠOj. •ÒW ‘D‰gF•FC—Ž‡³GCŠÛã‘P‹vi“¡“c•ÛŒ’‰q¶‘åjC ˆãŠw}‘o”Å, “Œ‹ž, 94.04.24”­s.

1454. mŠwp‘n i•ª’SŽ·•Mj ŠO‰È—Õ°ƒnƒ“ƒhƒuƒbƒN(3)“àŽ‹‹¾‰ºŽèp‚ÌÅ‘Oü|Žè‹Z‚ÆÇ—á|; ‹@Ší‚Æ‚»‚ÌŽí—Þ|‹C• ‘•’u, ƒEƒH[ƒ^[ƒWƒFƒbƒgƒƒX, p.2`7, ‹g“c@‹ICŽOd–슰ŠìC”äŠé”\Ž÷iŠOj. •ÒW oŒŽN•vC–œ‘㋱Žki“Œ‘åjC ’†ŽR‘“X, “Œ‹ž, 94.06.10”­s.

1455. mŠwp‘n i•ª’SŽ·•Mj ŠO‰È—Õ°ƒnƒ“ƒhƒuƒbƒN(3)“àŽ‹‹¾‰ºŽèp‚ÌÅ‘Oü|Žè‹Z‚ÆÇ—á|; ‹@Ší‚Æ‚»‚ÌŽí—Þ|ØŠJŠí‹ï, p.46`49, ‘å‹{“Œ¶Cò‰Æ‹v’¼CŒÃ“cˆê“¿iŠOj. •ÒW oŒŽN•vC–œ‘㋱Žki“Œ‘åjC ’†ŽR‘“X, “Œ‹ž, 94.06.10”­s.

1456. mŠwp‘n i•ª’SŽ·•Mj Ope Nursing, '94‰Ä‹G‘Š§, “àŽ‹‹¾Žèpƒ}ƒjƒ…ƒAƒ‹; Á‰»Ší“àŽ‹‹¾Žèp|ˆÝŠà‚̃Œ[ƒU[Ž¡—Ã, p.77`81, “ˆ”ömC”äŠé”\Ž÷iŠOj. •ÒW ¬¼•q˜YC ƒƒfƒBƒJo”Å, ‘åã, 94.08.30”­s.

1457. mŠwp‘n i•ª’SŽ·•Mj Annual Review Á‰»Ší 1995; ˆÝŠà, p.281`284, “ˆ”ömC”äŠé”\Ž÷iŠOj. •ÒW ‰ª”Ži“Œ‹žŒxŽ@•a‰@jCŽO—Ö„i“ŒŠC‘åjCoŒŽN•vié‹Êˆã‰È‘åjC‘å“¡³—Yiç—t‘åjCŒË“c„‘¾˜YiŽœŒb‘åjC ’†ŠOˆãŠwŽÐ, “Œ‹ž, 95.01.20”­s.

1458. mŠwp‘n i•ª’SŽ·•Mj ŽÀ‘H—Õ°“à‰ÈƒVƒŠ[ƒYuäXŽ¾Š³‚Ö‚Ì—Õ°“I’§í£; –«äX‰Š‚ÆäXŠà‚̊ӕʂ̃|ƒCƒ“ƒgCäXŠà‹^f—á‚ÌŽæ‚舵‚¢‚ɂ‚¢‚Ä‹³‚¦‚Ä‚­‚¾‚³‚¢, p.97`100, ‹g“c@‹IiŠOj. •ÒW ˜a“cUC‘å“àˆÑ‹`i“Œ‘åjC ƒƒfƒBƒJƒ‹ˆ¨o”Å, “Œ‹ž, 95.03.24”­s.

1459. m‹³‰È‘n i•ª’SŽ·•Mj ƒrƒWƒ…ƒAƒ‹Á‰»ŠíŠO‰Èƒ}ƒjƒ…ƒAƒ‹; ’°ŠÔ–ŒŒŒŠÇ•ÂÇÇ, p.250`253, ²“¡ŒõŽjiŠOj. •ÒW ÕŒ©—TiˆÇ—Ñ‘åjC‘å“à°ºi‹{錧‚ª‚ñƒZƒ“ƒ^[jC “ú–{—Õ°ŽÐ, ‘åã, 94.07.15”­s.

1460. m‹³‰È‘n i•ª’SŽ·•Mj Á‰»Ší•aŠw; ŠÌŠñ¶’ŽÇ¥Œ´’ŽÇ, p.549`560, Š`“cÍiŠOj. •ÒW ŒË“c„‘¾˜YiŽœŒb‘åjC‘匴‹Bi“Œ‘åjC ˆãŠw‘‰@, “Œ‹ž, 95.03.01”­s.

1461. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj “ú–{—Õ°i•Êûj—̈æ•ÊÇŒóŒQƒVƒŠ[ƒYNo5.Á‰»ŠÇÇŒóŒQ; ˆÝÚ•«’×á‡, ã: 461`463, “ˆ”ömC‚–ì—eKC”äŠé”\Ž÷iŠOj. •ÒW ’O‰HŠ°•¶i–h‰q‘åjC “ú–{—Õ°ŽÐ, ‘åã, 94.11.28”­s.

1462. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj 1995; Œ‹’°ŠàC’¼’°Šà, p.371`372, ‚‹´r‹BiŠOj. •ÒW ˆîŠ_‹`–¾C‘½‰ê{K’jC”öŒ`‰x˜YC ˆãŠw‘‰@, “Œ‹ž, 95.00.00”­s.

1463. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n i•ÒWj • o‹¾‰º’_”X“Eop|‚»‚ÌŒ»ó‚Æ“W–]|; •ÒW –œ‘㋱Žki“Œ‘åjC”äŠé”\Ž÷C‹g“c@‹IiŠOjCŽRì’B˜Yi’é‹ž‘åjC Œ»‘ã•ú‰f, “Œ‹ž, 94.04.00”­s.

1464. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n iŠÄCj “ú–{ˆãŽt‰ïƒrƒfƒIƒ‰ƒCƒuƒ‰ƒŠ[Œo”ç“àŽ‹‹¾ˆÝá‘‘¢Ýp; ŠÄC “ˆ”ömC‚‹´ŒúCâEŠ_½C‹{“à–M_C”äŠé”\Ž÷iŠOj. ‘Ž‰fŠé‰æ, “Œ‹ž, 94.12.00”­s.

1465. mŠw‰ïi‘Ûjn i“Á•Êu‰‰j Minimal invasive therapie bei magenfruhkarzinom. ”äŠé”\Ž÷iŠOj: ƒhƒCƒcÁ‰»Ší•aŠw‰ï i94.09.15j, ƒEƒ‹ƒ€, ƒhƒCƒc.

1466. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Laser palliation and endoscopic dilatation. “ˆ”ömC”äŠé”\Ž÷C匴÷CŽOd–슰ŠìiŠOj: 2nd International Conference on Biology, Prevention and Treatment of Gastrointestinal Malignancy i95.01.11j, ƒPƒ‹ƒ“, ƒhƒCƒc, Abstracts, p.36, 1995.

1467. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Differential expression of protein kinase C isoforms in human colorectal cancers. ‘ •ÀŸiŠOjCPowell, C.T.CHug, H.CZeng, Z.CCohen, A.M.CGuillem, J.G.iMemorial Sloan-Kettering Cancer Centerj: 27th Annual Meeting (The Association for Academic Surgery) i93.11.00j, Pennsylvania, USA, Abstracts, p.100, 1993.

1468. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Analyses of protein kinase C isoform expression in a colorectal cancer liver metastases model. ‘ •ÀŸiŠOjCCohen, A.M.CGuillem, J.G.iMemorial Sloan-Kettering Cancer Centerj: The Society for Surgery of the Alimentary Tract i94.05.00j, New Orleans, USA, Digestive Disease Week, p.1396, 1994.

1469. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Preoperative diganostic techniques for laparoscopic cholecystectomy. ‹à“cŒå˜YCˆî–؉pŽ¡C‹ß“¡Œ«ŽiC‘ŠŒ´¬ºC’çCC‰J‹{–¾•¶CŒÃ”g‘qŽjŽqC–¥‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: 4th World Congress of Endoscopic Surgery i94.06.18j, ‹ž“s.

1470. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Clinicopatholgoical and oncogene products|immunohistochemical study of multiple gastric cancer. Itabashi, M.CHori, M.COota, T.CYoshimi, F.CKoizumi, S.CHirota, T.COguro, Y.CMaruyama, K.C‹e’rŽj˜YiŠOj: 1st International Gastric Cancer Congress i95.03.29`04.01j, ‹ž“s.

1471. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Results after resection in gastric cancer with distant metastasis: Is nodal involvement beyond the regional nodes according to TNM classification distant metastasis? ‹e’rŽj˜YC’Ë–{GlC²“¡ŒõŽjCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: 1st International Gastric Cancer Congress i95.03.29`04.01j, ‹ž“s.

1472. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Follow-up results of endoscopic laser irradiation for early gastric cancer. “ˆ”ömC”äŠé”\Ž÷C匴÷CŽOd–슰ŠìC¬—ÑLsC‚‹´ŒúC‚–ì—eKCŠ`“cÍiŠOjC‘åˆä“c³lC‰¡ŽR–õC¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj: 1st International Gastric Cancer Congress i95.03.30j, ‹ž“s, Abstracts, p.28, 1995.

1473. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Characterization of tissue inhibitor of metalloproteinases (TIMP-1) RNA expression in a colorectal cancer metastases model. ‘ •ÀŸiŠOjCCohen, A.M.CGuillem, J.G.iMemorial Sloan-Kettering Cancer Centerj: 85th Annual Meeting American Association for Cancer Research i93.04.10j, San Francisco, USA, Am. Proc. Assoc. Cancer Res., 35: 422, 1994.

1474. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Treatment of symptom-less gallstone; Influence of the introduction of laparoscopic cholecystectomy. ŒÃ“cˆê“¿C‹g“c@‹IC‚‹´‹BCò‰Æ‹v’¼C‘å‹{“Œ¶C”äŠé”\Ž÷CŠ`“cÍiŠOj: 4th World Congress of Endoscopic Surgery i94.06.17j, ‹ž“s.

1475. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Feasibility study on thoracic splanchnicectomy under video-thoracoscopy in dogs. ‚‹´‹BCŠ`“cÍCò‰Æ‹v’¼CŒÃ“cˆê“¿C‹g“c@‹IC”äŠé”\Ž÷iŠOj: 4th World Congress of Endoscopic Surgery i94.06.18j, ‹ž“s, Surg. Endosc., 8(5): 630, 1994.

1476. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Treatment of intramucosal carcinoma (m carcinoma) of the stomach with lymph node metastasis. ‚–ì—eKCŽOd–슰ŠìC‚‹´ŒúC¬—ÑLsC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC¬ò˜aŽO˜YC‰¡ŽR–õC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: 1st International Gastric Cancer Congress i95.03.31j, ‹ž“s, ƒvƒƒOƒ‰ƒ€, p.85, 1995.

1477. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰º•”H“¹•¬–å•”Šà«‹·ó‚ɑ΂·‚鎎ì‹ü‹ÈŒ^ƒvƒƒe[ƒ[‚Ì—Õ°¬Ñ. “ˆ”ömCŽOd–슰ŠìiŠOj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË, —\eW, p.107, 1994.

1478. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’_“¹Šà‚Ì—\Œã. Š`“cÍiŠOj: “ú–{Šwp‰ï‹c15Šú‘æ‚R‰ñÁ‰»ŠíŠwŒ¤˜AƒVƒ“ƒ|ƒWƒEƒ€ i94.06.25j, ˆ¤’m.

1479. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Á‰»ŠíŽ¾Š³‚̃Œ[ƒU[Ž¡—Ã|Žèp¢“ï‘ŠúˆÝŠà‚ɑ΂·‚é—L—p«|. “ˆ”ömC”äŠé”\Ž÷iŠOj: ‘æ19‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ïŠwpW‰ï i94.06.29j, _ŒË, “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 19(2): 131, 1994.

1480. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ”S–ŒØœŒã‚̈âŽc•a•Ï‚ɑ΂·‚é“àŽ‹‹¾Ž¡—ÃÇ—á‚ÌŒŸ“¢. “ˆ”ömCŽOd–슰ŠìC匴÷iŠOj: ‘æ44‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i94.07.21j, •xŽR, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 27(6): 1262, 1994.

1481. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’_ÎäX‰Š‚ÌŽ¡—Õû–@‚ÌŒŸ“¢|Ž©Œ±—á‚Ì”½È‚©‚ç|. ŒÃ“cˆê“¿C‹g“c@‹IC‚‹´‹BC”Ñ–ì‘Pˆê˜YC‘å‹{“Œ¶C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ23‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i94.09.08j, ’•ƒ, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ, 14: 660, 1994.

1482. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’×ᇫ‘å’°‰Š‚ÌŠO‰ÈŽ¡—Ã|‹Ù‹}Žž‚É‚¨‚¯‚鎡—Õûj|. ‘å’J„³C”äŠé”\Ž÷iŠOj: ‘æ23‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i94.09.09j, ’•ƒ, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ, 14(4): 723, 1994.

1483. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆÝŠàŽ¡—Âɂ¨‚¯‚郌[ƒU[‚Ì–ðŠ„. “ˆ”ömCŽOd–슰ŠìiŠOj: ‘æ15‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘å‰ï i94.10.13j, Ž­Ž™“‡, ´˜^W, p.46, 1994.

1484. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j 80ΈÈã‚Ì‚—îŽÒ‚ÌŽèpÇ—á‚ÌŒŸ“¢. HŽRŒ›‹`C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqC‚‹´r‹BiŠOj: ‘æ49‰ñ‘—§•a‰@—×{Š‘‡ˆãŠw‰ï i94.11.11j, ’·è.

1485. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’×ᇫ‘å’°‰Š‚É‚¨‚¯‚éŽèp“K‰ž‚ÆŽèppŽ®‚ÌŒŸ“¢. ‘å’J„³CŒÃì—T‰îC–ì‘ò’¼ŽjC‘êK‹ÏC¼ŽR•Û”äŒÃCˆäŒ´ŒúC”äŠé”\Ž÷iŠOjCŒÜ\—’³LCŸ–””º‰hi“àj: ‘æ49‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï i94.11.26j, ŽOd, “ú–{‘å’°ãè–åŠw‰ïŽGŽ, 47(8): 702, 1994.

1486. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ä”­Ç—á‚ɑ΂·‚é• o‹¾‰ºƒwƒ‹ƒjƒAC•œpiextraperitoneal approach)‚Ì–â‘è“_(ƒrƒfƒI). ŒÃ“cˆê“¿C”äŠé”\Ž÷C”Ñ–ì‘Pˆê˜YC¬ìŒ›ÍC‚‹´‹BC‹g“c@‹ICŠ`“cÍiŠOj: ‘æ45‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i95.02.23j, ‰¡•l.

1487. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j • o‹¾‰ºŽèp‚ւ̃EƒH[ƒ^[ƒWƒFƒbƒgƒƒX‚Ì“±“ü|• o‹¾‰º’_”X“Eop‚Å‚Ì—L—p«‚ɂ‚¢‚Ä|(ƒrƒfƒI). ‹g“c@‹IC‘å‹{“Œ¶C”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ45‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i95.02.24j, ‰¡•l.

1488. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j • •”‹~‹}‚Æ“àŽ‹‹¾ˆÝá‘‘¢Ý, ‚»‚ÌŽè‹Z‚ƬтɊւ·‚錤‹†. “ˆ”ömC‚‹´ŒúC‚–ì—eKCâEŠ_½C‹{“à–M_C¬—ÑLsCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷C‹e’rŽj˜YC’Ë–{GlCŠ`“cÍiŠOjC‘꓇í‰ëC™–{Ÿ•Fi‹~ –½j: ‘æ24‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i95.03.16j, ‘O‹´, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ, 15(1): 127, 1995.

1489. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ’_”Xƒ|ƒŠ[ƒv—l•a•Ï‚Ì”÷¬ŒŒŠÇ‘œ|”÷¬ŒŒŠÇ‘¢‰e–@‚É‚æ‚錟“¢|. ‹g“c@‹ICŠ`“cÍiŠOj: ‘æ30‰ñ“ú–{’_“¹Šw‰ï‘‰ï i94.04.24j, _ŒË.

1490. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ŠÌØœŒãŠÌ‹@”\‚Ì DOA, DOB‚Ì—L—p«‚Ì”äŠrŒŸ“¢. ŒÃ“cˆê“¿C‹g“c@‹IC‚‹´‹BC”Ñ–ì‘Pˆê˜YCò‰Æ‹v’¼C’|“cCˆÉ“¡“OC’†Œ´T“ñCŠC’ËMŽjC“y‹´½ˆê˜YC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ24‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i95.03.17j, ‘O‹´, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ, 15(1): 134, 1995.

1491. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽèpŽžŠú‚ðˆí‚µ‚½‚ÆŽv‚í‚ê‚éÇ—á‚©‚ç‚Ý‚½ƒCƒŒƒEƒX‚ÌŽèp“K‰ž‚ƃ^ƒCƒ~ƒ“ƒO. ¼‘òŽ“TC’Ë–{GlCŒÃì—T‰îC’©’·“N–íC“n•ÓŒ’Ž™CΓc˜a•vC²“¡ŒõŽjC‘å‹{“Œ¶CŠ`“cÍiŠOj: ‘æ22‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï i94.03.10j, •ó’Ë, “ú–{• •”‹~‹}ˆãŠw‰ïŽ, 14(1): 173, 1994.

1492. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝá‘‘¢Ý‚É‚¨‚¯‚é One Step Button‚Ì—L—p«. ‚‹´ŒúC“ˆ”ömC匴÷CŽOd–슰ŠìC‰Á“¡NsC¬—ÑLsCâEŠ_½C”äŠé”\Ž÷C‹{“à–M_iŠOj: ‘æ47‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.04.25j, _ŒË.

1493. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠJ• —ð‚Ì‚È‚¢¬Ž™’°•ÂÇ«Ž¾Š³—á‚ÌŒŸ“¢. ’©’·“N–íCΓc˜a•vCŠ“cç”ü”TC’†ŒF‘¸ŽmCŠ`“cÍiŠOjC‘å“c„•äC^“º‘¾˜YiŽ™j: ‘æ31‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i94.06.02j, ‚¼, —\eW, p.241, 1994.

1494. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ççŽqƒ`ƒƒƒ“ƒlƒ‹•t‚«d«‹¾‚ð—p‚¢‚½“ñl‚Ås‚¤‚REŽ®• o‹¾‰º’_”X“Eopi‚REŽ®LC)(ƒrƒfƒI). ‹à“cŒå˜YC²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶CŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ47‰ñ“ú–{“àŽ‹‹¾Šw‰ï‘‰ï i94.06.24j, _ŒË.

1495. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌäX“¯ŽžØœŽž‚ÌäXƒzƒ‹ƒ‚ƒ“‚Ì•Ï“®‚ÆŠÌĶ‚Ì‘ŠŠÖ‚ÉŠÖ‚·‚錤‹†. ŒÃ“cˆê“¿CŠ`“cÍC‹g“c@‹IC‚‹´‹BCò‰Æ‹v’¼C”Ñ–ì‘Pˆê˜YC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ30‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï i94.07.08j, ˆ®ì, ŠÌ‘Ÿ, 35(Suppl.): 236, 1994.

1496. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝŠàpŒã’_Δ­¶‚ÌŒŸ“¢. ‚‹´ŒúC’Ë–{GlCâEŠ_½C¬—ÑLsCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj: ‘æ44‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i94.07.21j, •xŽR.

1497. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j H“¹Šàp‘O‰»Šw—Ö@(CDDP, 5FU)Ž{s—á‚Ì—Õ°•a—Šw“IŒŸ“¢. ¬—ÑLsCŽOd–슰ŠìC‚–ì—eKC‚‹´ŒúCâEŠ_½CVˆäLNC’Ë–{GlC–å˜eŒ›C‰Á“¡NsC“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ44‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i94.07.21j, •xŽR, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 27(6): 1204, 1994.

1498. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘ŠúˆÝŠà‚Ì—H–呤ˆÝØœp‚É‚¨‚¯‚é–À‘–_Œo‰·‘¶ƒŠƒ“ƒpߊs´‚̈Ӌ`|Žûk”\‚¨‚æ‚Ñ’_`”ro”\‚Ì—§ê‚©‚ç|. ‰J‹{–¾•¶C²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ44‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i94.07.22j, •xŽR.

1499. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚—îŽÒi80ΈÈãj‘å’°ŠàŽèp‚É‚¨‚¯‚é–â‘è“_‚Æ‘Îô. ˆäŒ´ŒúC‘å’J„³CŒÃì—T‰îC‰ª‘º—¥ŽqC’Ò—ºìC‘êK‹ÏC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ44‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i94.07.22j, •xŽR, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 27(6): 327, 1994.

1500. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’†ŠÔŠú“ûŠà‚Ì—Õ°•a—Šw“IŒŸ“¢. HŽRŒ›‹`C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqC‚‹´r‹BiŠOj: ‘æ‚Q‰ñ“ú–{“ûŠàŠw‰ï‘‰ï i94.09.29j, ŒSŽR.

1501. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “û“ª‰ºØ’f–Ê‚Ìv‘¬ŽC‰º×–Ef‚Æ‘gDf‚Ì—L—p«. ’|’†°KC“n•ÓŒ’Ž™CΓc˜a•vC‘åê³›ßCŠ`“cÍiŠOjC‘å–ì‰pŽ¡i•a‰@•a—jCŠâŸºŒ[ˆêi•a—j: ‘æ‚Q‰ñ“ú–{“ûŠàŠw‰ï‘‰ï i94.09.29j, ŒSŽR.

1502. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “û–[‰·‘¶Žèp(ƒrƒfƒI). ‘D–{TìC–ØìŽOŽl˜YC•½ˆäC“ñC‰z“c‰À•üC’·’J쌒C’|’†°KCŠ`“cÍiŠOj: ‘æ‚Q‰ñ“ú–{“ûŠàŠw‰ï‘‰ï i94.09.30j, ŒSŽR.

1503. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ul({)‘ŠúˆÝŠà‚ɑ΂·‚郌[ƒU[Ž¡—Ã. ‚‹´ŒúC“ˆ”ömC‚–ì—eKC¬—ÑLsCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj: ‘æ15‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘å‰ï i94.10.13j, Ž­Ž™“‡.

1504. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • …Š³ŽÒ‚ɑ΂·‚éˆÝá‘‘¢Ý. ‚‹´ŒúC“ˆ”ömC匴÷CŽOd–슰ŠìC‰Á“¡NsC¬—ÑLsCâEŠ_½C”äŠé”\Ž÷C‹{“à–M_iŠOj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.17j, ŽD–y.

1505. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚r󌋒°Šà‚ð‡•¹‚µ‚½Cronkhite-Canada syndrome‚Ì‚P—á. ’çCC”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘æ49‰ñ‘—§•a‰@—×{Š‘‡ˆãŠw‰ï i94.11.10j, ’·è.

1506. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äX“ª\“ñŽw’°ØœpŒã‚Ì‘ÌŽ‰–b—¦‘ª’è‚̈Ӌ`. ŒÃ“cˆê“¿C‹g“c@‹IC‚‹´‹BC”Ñ–ì‘Pˆê˜YC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚U‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ï i94.11.10j, •ó’Ë, J. Hepato-Baliary-Pencreatic Surg., 1(4): 501, 1994.

1507. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j isH“¹Šà‚É‚¨‚¯‚é“®d‰æ‘œMRI‚É‚æ‚鋹•”‘å“®–¬‚ÌL“W«‚Ɖ“®«‚ÌŒŸ“¢i‘æ‚P•ñ)(ƒrƒfƒI). ‰J‹{–¾•¶C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ49‰ñ‘—§•a‰@—×{Š‘‡ˆãŠw‰ï i94.11.11j, ’·è.

1508. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • o‹¾‰ºŠO‰ÈŽèp‚É‚¨‚¯‚éççŽqƒ`ƒƒƒ“ƒlƒ‹•t‚«ˆ’u—pƒXƒR[ƒv‚Ì—L—p«(ƒrƒfƒI). ‹à“cŒå˜YC”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶CŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ49‰ñ‘—§•a‰@—×{Š‘‡ˆãŠw‰ï i94.11.11j, ’·è.

1509. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆ’u—pƒXƒR[ƒv‚ƃoƒ‹[ƒ“•t‚«“§–¾ƒt[ƒh‚ð—p‚¢‚½• o‹¾‰º• –ŒŠOƒwƒ‹ƒjƒAŽèp‚ÌŒoŒ±(ƒrƒfƒI). ‹à“cŒå˜YC”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶CŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ56‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i94.11.17j, ‰YˆÀ.

1510. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j isH“¹Šà‚É‚¨‚¯‚é“®‰æ‘œMRI‚É‚æ‚鋹•”‘å“®–¬‚ÌL“W«‚Ɖ“®«‚ÌŒŸ“¢i‘æ‚P•ñ)(ƒrƒfƒI). ‰J‹{–¾•¶C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ56‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i94.11.17j, ‰YˆÀ.

1511. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å–Ô“àCastleman's lymphoma‚Ì‚P—á. ¼è”ŽsCŒÃ“cˆê“¿C”‹´_ˆêC”Ñ–ì‘Pˆê˜YC‚‹´‹BC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ56‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i94.11.18j, ‰YˆÀ.

1512. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • o‹¾‰ºƒwƒ‹ƒjƒAC•œp‚Ì“K‰ž‚Æ–â‘è“_(intraperitoneal approach‚Æ extraperitoneal approach). ŒÃ“cˆê“¿C”äŠé”\Ž÷C”Ñ–ì‘Pˆê˜YCò‰Æ‹v’¼C‚‹´‹BC‹g“c@‹IC‘å‹{“Œ¶CŠ`“cÍiŠOj: ‘æ56‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i94.11.18j, ‰YˆÀ.

1513. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’˜‚µ‚¢×–EˆÙŒ^‚ðŽ¦‚µ‚½’ᕪ‰»‚È“ûŠà‚Ì1Ç—á. ‚ŽR–¾ŽqC‘å–ì‰pŽ¡C‰¡ŽR‘åC•ž•”ŠwC–L‰i^Ÿi•a‰@•a—jC‘å•”½CŠâŸºŒ[ˆêi•a—jC’|’†°KiŠOjC‘ –{”ŽsiŽY•wjC‹T’J“Oi•a—j: ‘æ33‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïŠwpW‰ï i94.11.18j, å‘ä, “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(5): 876, 1994.

1514. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j p‘Of’f¢“ï‚Å‚ ‚Á‚½ŠÌŽîᎂ̂P—á. ”Ñ–ì‘Pˆê˜YC‹g“c@‹ICŽ­Žæ³“¹CŒÃ“cˆê“¿Cò‰Æ‹v’¼C‚‹´‹BC‘å‹{“Œ¶C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ56‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i94.11.19j, ‰YˆÀ.

1515. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j CA19-9‚ªˆÙí‚’l‚ð’悵‚½‰©F“÷‰èŽî«’_”X‰Š‚Ì‚PÇ—á. –ØìŽOŽl˜YC‘D–{TìC•½ˆäC“ñC’·’J쌒C‰z“c‰À•üC•½ŠÔŒ³”ŽiŽD–y“¿B‰ï•a‰@jC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ56‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i94.11.19j, •‘•l.

1516. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “ûŠà‚ÌŠm’è‘O‰ñŒŸfŽž‚É‚¨‚¯‚éƒ}ƒ“ƒ‚ƒOƒ‰ƒ€‚ÌŒŸ“¢. HŽRŒ›‹`Cˆî–؉pŽ¡Cù–{_C‰J‹{–¾•¶iŠOj: ‘æ‚S‰ñ“ú–{“ûŠàŒŸfŠw‰ï‘‰ï i94.11.24j, –¼ŒÃ‰®.

1517. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •½¬‚T”N‚Ì“û‘B’´‰¹”gŒŸ¸‚ɂ‚¢‚Ä‚ÌŒŸ“¢. “ì‰_Œ÷C’†‘º‘בãCŽRŒûGŽ÷C“n•ÓoC¬—јaC²“¡–{‘¥C‹ß“¡º“ñCó”ömŽmCHŽRŒ›‹`C‰J‹{–¾•¶i‘—§‘Š–ÍŒ´•a‰@j: ‘æ‚S‰ñ“ú–{“ûŠàŒŸfŠw‰ï‘‰ï i94.11.24j, –¼ŒÃ‰®.

1518. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j tˆÚAŒãŠÌáŠQ‚ÌŒŸ“¢. ˆÉ“¡‹`–çC²“¡ŒõŽjC¼‘òŽ“TCΓc˜a•vCŠ`“cÍiŠOjC‰““¡’‰—YCŒF–ì˜a—Yi”åjC’|“àN—YCŠ™“cvŽõC‘å‹v•Û[li“àj: ‘æ30‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i94.11.25j, L“‡, “ú–{ˆÚAŠw‰ïŽGŽ, 29(—Õ): 277, 1994.

1519. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Crohn•aŽèpÇ—á‚ÌŒŸ“¢. Ž­Žæ³“¹CŽÂŒ´‰›i‘—§‘å‘ •a‰@j: ‘æ49‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï i94.11.27j, Žl“úŽs.

1520. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ICU‚É‚¨‚¯‚éŠÔÚ”M—ÊŒv‚É‚æ‚é‰h—{ŠÇ—. “à“¡CiŠOjC™–{Ÿ•Fi‹~–½jCΓc˜a•viŠOjC‘åê³›ßiŠÅŒìŠw•”jCŠ`“cÍiŠOjC•½“cŒõ”ŽC‘Š”nˆêˆåi‹~–½jC“’óK]C’·’J–õŽqC‹{‰º‰ÀŽqC –Ø–í¶i‰h—{•”j: ‘æ22‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï i95.02.01j, ‘åã, “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 2: 127, 1995.

1521. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äX“ª\“ñŽw’°Øœp‚É‚¨‚¯‚éäX‹ó’°•«‡‚Ì‘Šú‡•¹Ç‚Æ‘Îô|ˆÀ‘S‚ÈäX‹ó’°•«‡‚ÌŒŸ“¢|. ‹g“c@‹ICŠ`“cÍC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‚‹´‹BC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ45‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i95.02.23j, ‰¡•l.

1522. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌd•Ï‡•¹ŠÌŠàpŒã‚ÌŽ€–S—á‚©‚ç‚Ý‚½d•ÏŠÌpŒã‚Ì—\Œã‚ւ̉e‹¿‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ŒÃ“cˆê“¿C‹g“c@‹IC‚‹´‹BC”Ñ–ì‘Pˆê˜YCò‰Æ‹v’¼C”äŠé”\Ž÷CŠ`“cÍC‘å‹{“Œ¶iŠOj: ‘æ45‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i95.02.23j, ‰¡•l.

1523. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹¹o‹¾‰º¶“à‘Ÿ_ŒoØ’fp: is«äXŠà‚É‚æ‚é“à‘Ÿ«áu’ɂɑ΂·‚éŠO‰È“Iœ’É–@. ‚‹´‹BCò‰Æ‹v’¼C”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿CˆÉ“¡‹`–çC‹à“cŒå˜YC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ45‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i95.02.24j, ‰¡•l, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 28(2): 386, 1995.

1524. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌŠà”j—ôÇ—á‚Ìf’f‚ƉŠúŽ¡—Ãã‚Ì–â‘è“_. ˆÉ“¡“OC‚‹´‹BC‹g“c@‹ICŒÃ“cˆê“¿C”Ñ–ì‘Pˆê˜YCò‰Æ‹v’¼CŠ`“cÍC‘å‹{“Œ¶iŠOj: ‘æ24‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i95.03.16j, ‘O‹´, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ, 15(1): 142, 1995.

1525. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”DP’†‚É”­Ç‚µ‚½• •”‹~‹}Ž¾Š³—á‚ÌŒŸ“¢. ŽíŽq“cŠxŽjCΓc˜a•vC’Ë–{GlC‹e’rŽj˜YC²“¡ŒõŽjCŠ`“cÍiŠOj: ‘æ24‰ñ“ú–{• •”‹~‹}ˆãŠw‰ï‘‰ï i95.03.16j, ‘O‹´, “ú–{• •”‹~‹}ˆãŠw‰ïŽGŽ, 15(1): 146, 1995.

1526. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j f’fŽ¡—Âɋꗶ‚µ‚½ƒqƒ‹ƒVƒ…ƒXƒvƒ‹ƒ“ƒO•aÇ—á‚ÌŒŸ“¢. Γc˜a•vC’©’·“N–íCŠ“cç”ü”TCŠ`“cÍiŠOjC¬ŒûO‹BC‘å“c„•äC^“º‘¾˜YiŽ™jCŒK”ö’èmCŠâŸºŒ[ˆêi•a—j: ‘æ31‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i94.06.01j, ‚¼, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽ, 30: 541, 1994.

1527. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j äX“ª\“ñŽw’°Øœp‚É‚¨‚¯‚éäX‹ó’°•«‡‚ÌH•v. ‹g“c@‹ICŠ`“cÍC‚‹´‹BCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ44‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i94.07.21j, •xŽR, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 27(6): 1280, 1994.

1528. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –«“§ÍŠ³ŽÒ‚ÌÁ‰»ŠíŠO‰ÈŽèp‚É‚¨‚¯‚éŽüpŠúŠÇ—‚Æ–â‘è“_. Ž­Žæ³“¹C’Ë–{GlC‚–ì—eKC’|’†°KC¼‘òŽ“TCŒÃ“cˆê“¿C‚‹´‹BC‹g“c@‹IC²“¡ŒõŽjC‘å‹{“Œ¶C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ44‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i94.07.21j, •xŽR, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 27(6): 1638, 1994.

1529. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚—îŽÒoŒŒ«ˆÝ’×ᇋً}Žèp—á‚ÌŒŸ“¢. ’Ë–{GlCâEŠ_½C‚–ì—eKC¬—ÑLsC‘꓇í‰ëC“ˆ”ömCŽOd–슰ŠìC²“¡ŒõŽjC‘å‹{“Œ¶C匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ44‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i94.07.22j, •xŽR, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 27(6): 1708, 1994.

1530. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j • o‹¾‰º’_”X“Eop‚É‚¨‚¯‚ép‘OERC‚Ì—L—p«. ‹v•ÛK—SC’Ò—ºìC¬‘ò³KC‚‹´•‹Xi“Œ‘å˜a•a‰@j: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i94.10.17j, ŽD–y.

1531. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰Æ“e”]Ž€ƒ‚ƒfƒ‹‚É‚¨‚¯‚éŠÌ, äX, t‚̶‰»Šw“I¥Œ`‘ÔŠw“IŒŸ“¢. ¡ˆäŒ‰C²“¡ŒõŽjCΓc˜aŒÈC¼‘òŽ“TC“cŠ•¶•FCˆÉ“¡‹`–çC’†ŽR‹`‰îCΓc˜a•vC‚‹´‹BCŠ`“cÍiŠOj: ‘æ30‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i94.10.24j, L“‡.

1532. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬l‚ÌŒ´”­«¬’°ŽîᇎèpÇ—á‚ÌŒŸ“¢. “n•ÓŒ’Ž™C’Ë–{GlCˆÉ“¡‹`–çC‹e’rŽj˜YCΓc˜a•vC²“¡ŒõŽjCŠ`“cÍiŠOj: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.10.31j, å‘ä.

1533. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Œ´”­«¬’°Šà‚Ì—Õ°‘œ‚Æf’f¥Ž¡—Ãã‚Ì–â‘è“_. ‚‹´‹BC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‹g“c@‹IC‘å’J„³C匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ36‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i94.10.31j, å‘ä, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(—Õ‘): 351, 1994.

1534. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j äX“ª•”Šà‚Æ‚ÌŠÓ•Ê‚É‹ê—¶‚µ‚½–«äX‰Š‚Ì‚T—á. ”Ñ–ì‘Pˆê˜YC‚‹´‹BCŒÃ“cˆê“¿CˆÉ“¡‹`–çC²“¡ŒõŽjC”äŠé”\Ž÷C‹g“c@‹ICŠ`“cÍiŠOj: ‘æ‚U‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ï i94.11.11j, •ó’Ë.

1535. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠÌŠà‚ɑ΂·‚铯Žž«Œo”ç“IŠÌˆŸ‹æˆæÇðp‚ÌŒoŒ±. ‚‹´‹BC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿CˆÉ“¡‹`–çC‹g“c@‹ICŠ`“cÍiŠOjC‰““¡‚Cˆé•”‹`Œ›i•új: ‘æ‚U‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ï i94.11.11j, •ó’Ë, J. Hepato-Biliary-Pencreatic Surg., 1(4): 480, 1994.

1536. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚¤‚•a‚Ì––ŠúŠàŠ³ŽÒ‚ɃCƒŒƒIƒXƒgƒ~[‚ð‘¢Ý‚µA‘Þ‰@‚ðˆí‚µ‚½‚P—á. ¼Œ´N”üCˆäŒ´ŒúCŒÃì—T‰îC‘å’J„³iŠOj: ‘æ12‰ñ“ú–{ƒXƒg[ƒ}ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ï‘‰ï i95.02.04j, ‹ž“s, “ú–{ƒXƒg[ƒ}ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŽ, 10(3): 51, 1994.

1537. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒIƒXƒgƒ~[ƒrƒWƒ^[‚Ì•a‰@ƒ{ƒ‰ƒ“ƒeƒBƒA“±“ü‚ɂ‚¢‚Ä. ’†‘ºG‘ãCŽR–{ŒPŽqC˜a’m‚³‚Æ‚ÝC¼Œ´N”üCˆÉ¨“c–¾ŽqC‘å’J„³iŠOj: ‘æ12‰ñ“ú–{ƒXƒg[ƒ}ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ï‘‰ï i95.02.04j, ‹ž“s, “ú–{ƒXƒg[ƒ}ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŽ, 10(3): 85, 1994.

1538. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒg‘å’°Šà‘gD‚É‚¨‚¯‚é“ÁˆÙ“Iprotein kinase C (PKC) isoform‚Ì”­Œ»‚ÌŒŸ“¢. ‘ •ÀŸC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ45‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i95.02.23j, ‰¡•l.

1539. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠÌØœpŒã‚É‚¨‚¯‚錌’† IL-6‚Ì•Ï“®‚Æ‚»‚̈Ӌ`‚ɂ‚¢‚Ä. –Ø‘º“OC‚‹´‹BC”Ñ–ì‘Pˆê˜YCˆÉ“¡‹`–çCŒÃ“cˆê“¿C‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ45‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i95.02.23j, ‰¡•l, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 28(2): 528, 1995.

1540. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’´‚—îŽÒi85ΈÈãj‚Ì‘å’°ŠàŽèp‚É‚¨‚¯‚é–â‘è“_‚Æ‘Îô. ˆäŒ´ŒúC‘å’J„³CŒÃì—T‰îC‰ª‘º—¥ŽqC’Ò—ºìC‘êK‹ÏC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ45‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i95.02.24j, ‰¡•l, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 28(2): 463, 1995.

1541. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠÌŠà”j—ôÇ—á‚Ì—Õ°‘œ‚Æ‚»‚ÌŽ¡—Ö@‚ÉŠÖ‚·‚élŽ@. ˆÉ“¡“OC‚‹´‹BC‹g“c@‹ICŒÃ“cˆê“¿C”Ñ–ì‘Pˆê˜YCò‰Æ‹v’¼CŠ`“cÍC‘å‹{“Œ¶iŠOj: ‘æ45‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i95.02.24j, ‰¡•l, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 28(2): 589, 1995.

1542. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠO‰È—̈抴õÇ‚É‚¨‚¯‚é Ope-17116‚Ì—Õ°“IŒŸ“¢. ‘ò“cN•vC‘å‹v•Û®C‚‹´‹BC‹´–{ˆÉ‹v—YiŠOj: ‘æ41‰ñ“ú–{‰»Šw—Ö@Šw‰ï¼“ú–{Žx•”‘‰ï i93.12.02j, _ŒË.

1543. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¶tˆÞk‚ð‚«‚½‚µ‚½’¼’°Žq‹{“à–ŒÇ‚Ì‚PŽèp—á. ŒÃ”g‘qŽjŽqCˆî–؉pŽ¡C‹ß“¡Œ«ŽiC‘ŠŒ´¬ºC’çCC‰J‹{–¾•¶C‹à“cŒå˜YC–¥‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ229‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.05.14j, ç—t.

1544. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •Â½Eƒwƒ‹ƒjƒA‚Ì‚P—á. Ε‹§ŽjC‹{–{‰p—YC…–ì—F—TC•Ð‰ª—SˆêC‰|–{‘ñ–ÎC¼–{–LC¬À”ŽC‰¡“c“™CVˆäLNC–å˜eŒ›C¼‘º”ŽsiŠOj: ‘æ14‰ñ“ú–{Á‰»Ší•aŠw‰ïbM‰zŽx•”—á‰ï i94.06.28j, ¼–{.

1545. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •wl‰ÈŽèpŽž“¯ŽžŽ{s‚³‚ꂽ• o‹¾•â•‰ºƒwƒ‹ƒjƒAªŽ¡p. ”¼“cŠì”ü–çC²“¡•˜YC¬‘ò•½‘¾C²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ753‰ñŠO‰ÈW’k‰ï i94.07.02j, “Œ‹ž.

1546. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Paraganglioma‚Ì‚QŽèp—á. ¯–ìOŽ÷C“c’†Œ‰Câ–{M”VC•Ÿ¬M”ŽC“c’†Œ·C‰¡“c˜a•FC•ŸŒõ³siŠOj: ‘æ753‰ñŠO‰ÈW’k‰ï i94.07.02j, “Œ‹ž, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽGŽ, 55(11): 266, 1994.

1547. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠÌØœp‚É‚¨‚¯‚éŠÌ×–E‘BˆöŽq(HGF)‚ÌŒŒ’†”Z“x‚Ì•Ï“®. –Ø‘º“OC‚‹´‹BC”Ñ–ì‘Pˆê˜YCˆÉ“¡‹`–çCŒÃ“cˆê“¿C‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ753‰ñŠO‰ÈW’k‰ï i94.07.02j, “Œ‹ž, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽGŽ, 55(11): 2980, 1994.

1548. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚—îŽÒƒwƒ‹ƒjƒA‚Ì‚Q—á. …–ì—F—TC‹{–{‰p—YC‚£ÅC•Ð‰ª—SˆêC‰|–{‘ñ–ÎC¼–{–LC¬À”ŽC‰¡“c“™CVˆäLNC–å˜eŒ›C¼‘º”ŽsiŠOj: ‘æ51‰ñ’·–쌧”_‘ºˆãŠw‰ï i94.07.03j, ’†–ìŽs.

1549. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —Ç«Žîᇂɑ΂·‚éäX“ª\“ñŽw’°ØœpŒã‚É”­¶‚µ‚½äXŠà‚Ì‚P—á. â–{‚¢‚ÂÝC’Ë–{GlC¬ìŒ›ÍC•Ÿ“cŽ CŒ´‰pC¼ŽR’¼‹vC–k‘º‰ë–çCˆÉ“¡‹`–çC‹e’rŽj˜YC²“¡ŒõŽjCŠ`“cÍiŠOjCŠ“cç”ü”TC‘å•”½i•a—jC‘å‹{“Œ ¶iŠOj: ‘æ230‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.07.30j, “Œ‹ž.

1550. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j úE«’Ž‚‰Š‚ð‚«‚½‚µ‚½”xŠà‚Ì’Ž‚“]ˆÚ‚Ì‚PŽèp—á. ù–{_C²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ230‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.07.30j, “Œ‹ž.

1551. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j PTGBDŒãC‘ÒŠúŽèp‚ðŽ{s‚µ“¾‚½‹}«‹CŽî«’_”X‰Š‚Ì‚P—á. ”¼“cŠì”ü–çC²“¡•˜YC¬‘ò•½‘¾C²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ231‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.09.03j, ìè.

1552. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Žá”NŽÒŠÌ“à’_ŠÇ×–EŠà‚Ì‚P—á. ‰Á“¡—²C’Ë–{GlC²–ØLˆê˜YC¬ìŒ›ÍC–k‘º‰ë–çCŒÃ“cˆê“¿CˆÉ“¡‹`–çC‹e’rŽj˜YC²“¡ŒõŽjCŠ`“cÍiŠOjC“n•Ó´Ž¡C‘å•”½i•a—jC‹{ì’‰ºi‹{ì •a‰@j: ‘æ231‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.09.03j, ìè.

1553. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒÇ—§«ŠÌ“]ˆÚ‘ƒ‚É‚æ‚Á‚Äf’f‚³‚ꂽŒ´”­«‹ó’°Šà‚Ì‚PØœ—á. Ž­Žæ³“¹C‚‹´‹BC‹g“c@‹ICŒÃ“cˆê“¿C”Ñ–ì‘Pˆê˜YC”äŠé”\Ž÷CŠ`“cÍiŠOjC^‹ÊŽõ”ü¶i“àj: ‘æ231‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.09.03j, ìè, ´˜^W, p.5, 1995.

1554. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’_ÎÇ‚Ìp‘O“ïˆÕ“x‚ɑ΂·‚é• •”’´‰¹”gŒŸ¸‚ð—p‚¢‚½ƒXƒRƒA[‰»‚ÌŽŽ‚Ý. ‹à“cŒå˜YC²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶CŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: “ú–{’´‰¹”gŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.09.16j.

1555. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¬’°‘å—ÊØœŒã‚Ì’Z’°ÇŒóŒQ‚ɑ΂·‚é‰h—{ŠÇ—‚ɂ‚¢‚Ä. ‰z“c‰À•üC‘D–{TìC–ØìŽOŽl˜YC•½ˆäC“ñiŠOj: ‘æ61‰ñ–kŠC“¹ŠO‰ÈŠw‰ï i94.09.16j, ŽD–y.

1556. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j úŽh‹zˆø×–Ef‚É‚ÄŠm”F‚µ“¾‚½“ñŽŸ«•›bó‘B‰ßŒ`¬‚Ì1—á. ‰¡ŽR‘åC‘å–ì‰pŽ¡C•ž•”ŠwC‚ŽR–¾ŽqC–L‰i^Ÿi•a‰@•a—jCŠâŸºŒ[ˆêC‘å•”½i•a—jCŒY•”“ŒŽ¡iŠOjC‘ –{”ŽsiŽY•wjC‹T’J“Oi•a—j: ‘æ13‰ñ“ú–{—Õ°×–EŠw‰ï_“Þì’n•û‰ï i94.10.01j, `–ì, ´˜^W, p.19.

1557. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j H“¹‘}ŠÇ‚É‚æ‚Á‚ÄŒoŒûێ悪‰Â”\‚Æ‚È‚Á‚½‹CŠÇŽxá‘•¹”­H“¹Šà‚Ì‚P—á. ’†‘ºlLC“ˆ”ömC’†ŒF‘¸ŽmC‚–ì—eKC‚‹´ŒúC¬—ÑLsCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ20‰ñ–k—¢ˆãŠw‰ï‘‰ï i94.10.15j, ‘Š–ÍŒ´, –k—¢ˆãŠw, 24(6): 601, 1994.

1558. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j äX‚Ì Solid & Cystic TumorØœ—á‚Ì—Õ°•a—Šw“IŒŸ“¢. ’|“cC‹g“c@‹IC”Ñ–ì‘Pˆê˜YCˆÉ“¡‹`–çCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‚‹´‹BC‘å‹{“Œ¶C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ20‰ñ–k—¢ˆãŠw‰ï‘‰ï i94.10.15j, ‘Š–ÍŒ´, –k—¢ˆãŠw, 24(6): 601, 1994.

1559. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠÌØœpŒã‚ÌŒŒ’†ŠÌ×–E‘BˆöŽq‚Ì•Ï“®‚Æ‚»‚Ì—Õ°“IˆÓ‹`. ‚‹´‹BC–Ø‘º“OC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿CˆÉ“¡‹`–çC‹g“c@‹IC²“¡ŒõŽjCŠ`“cÍiŠOj: ‘æ29‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï i94.11.11j, “Œ‹ž.

1560. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j H“¹ŒeŽº«•a•Ï‚𔺂¤‹‘åH“¹•½ŠŠ‹ØŽî‚Ì‚P—á. ŽRª“¹—YC’|“ꊰC“cK˜a’jCŽR‰ªˆêºC™–{Œ\ˆêC¼–{–LC–å˜eŒ›C“c’†—Y“ñ˜YC²“¡çŽji–kM‘‡•a‰@j: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïbM‰z’n•û‰ï i94.11.19j, ¼–{.

1561. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ㉺•”‚É”­¶‚µ‚½bóãŠÇ”X–E‚Ì‚P—á. “à“c‘׎ŠC–{–¼•q˜YC‰F’Öؒ‰mCVˆä^—Cz–KiŠOj: ‘æ29‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.11.19j, ˆÉ¨Œ´.

1562. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘Ù•Ö«• –Œ‰Š‚𔺂Á‚½‘”rŸ•oŒ^½ãè‚Ì‚P—á. Γc˜a•vC’©’·“N–íCŠ`“cÍiŠOjC¬ŒûO‹BiŽ™j: ‘æ29‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.11.19j, ˆÉ¨Œ´.

1563. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚`Œ^H“¹•Â½Ç‚Éæ“V«H“¹‹·óÇ‚ð‡•¹‚µ‚½‚P—á. ’©’·“N–íCΓc˜a•vCŠ“cç”ü”TC’†ŒF‘¸ŽmCŠ`“cÍiŠOjC¬ŒûO‹BiŽ™j: ‘æ29‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.11.19j, ˆÉ¨Œ´, —\eW, p.12, 1994.

1564. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Á‰»ŠíŠà‚ð‡•¹‚µ‚½• •”‘å“®–¬áŽ‚Ì‚Q—á. ²“¡ˆêŠìC‹à鳉ÀCX£¹Ž÷C’†ŒF‘¸ŽmCª–{ECŠ`“cÍiŠOj: ‘æ‚Q‰ñ“ú–{ŒŒŠÇŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.12.01j, ‚è, —\eW, p.14, 1994.

1565. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰ñ–Ó•”ŒeŽº‰Š 21—á‚ÌŒŸ“¢. ’†‘ºlLC‹e’rŽj˜YC’·’J쌒C–Ø‘º“OC’Ë–{GlC²“¡ŒõŽjC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ232‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.12.03j, “Œ‹ž.

1566. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’·ŠúŒo‰ß‚ð‚½‚Ç‚Á‚½äXŒ´”­ˆ««ƒŠƒ“ƒpŽî‚Ì‚P—á. ŠC’ËMŽjCŒÃ“cˆê“¿C’†Œ´T“ñC”Ñ–ì‘Pˆê˜YC‚‹´‹BC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ232‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i94.12.03j, “Œ‹ž.

1567. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ׌a’´‰¹”gƒvƒ[ƒu‚ª—L—p‚Å‚ ‚Á‚½\“ñŽw’°ƒJƒ‹ƒ`ƒmƒCƒh‚Ì‚P—á. ‹à‘òG‹IiŠOjCŽR“cŽŠli“àjC‘êK‹ÏC‰Á“¡NsCŽRãp‚³‚ä‚èC”äŠé”\Ž÷iŠOjC¼Œ³Ž›Ž—çi“àj: ‘æ59‰ñ“ú–{“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.08j, “Œ‹ž.

1568. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘lŒaƒwƒ‹ƒjƒA‚ɑ΂·‚é‰äX‚Ìtotal preperitoneal approach (TPP). ‹à“cŒå˜YC²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶CŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.09j, “Œ‹ž.

1569. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆâ“`«‹…óÔŒŒ‹…Ç(HS)‚ɑ΂·‚é• o‹¾‰ºäB‘Ÿ“Eop. ’çCC²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ59‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï i94.12.09j, “Œ‹ž.

1570. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j äX“ª\“ñŽw’°ØœŒã–å–¬ŒŒðÇ‚ð”­Ç‚µ‚½‚P—á. ’†Œ´T“ñCŒÃ“cˆê“¿C—ÑCCˆÉ“¡“OC’|“cC”Ñ–ì‘Pˆê˜YC‚‹´‹BC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ755‰ñŠO‰ÈW’k‰ï i94.12.10j, ‰¡•l.

1571. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j MNMS‚Ì”­Ç‚ð—\–h‚µ“¾‚½‹}«‰ºŽˆ“®–¬•ÂÇÇ‚Ì‚P—á. â–{‚¢‚ÂÝC‹à鳉ÀCX£¹Ž÷C²“¡ˆêŠìC‹ß“¡Œ«ŽiCŒI“c~C¼ŽR’¼‹vCŠ`“cÍiŠOj: ‘æ755‰ñŠO‰ÈW’k‰ï i94.12.10j, ‰¡•l.

1572. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j CVƒJƒe[ƒeƒ‹—¯’u‚É‚æ‚é‚ÆŽv‚í‚ê‚齜‰ºÃ–¬, “àŒzÖ¬‚ÖL”Í‚ÈŒŒðǂ𶂶‚½‚PÇ—á. Î씎˜aCX£¹Ž÷C²“¡ˆêŠìCŒI“c~Cù–{MKC‹à鳉ÀCª–{ECŠ`“cÍiŠOj: ‘æ755‰ñŠO‰ÈW’k‰ï i94.12.10j, ‰¡•l.

1573. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é¬l‘lŒaƒwƒ‹ƒjƒAŽèp‚Ì”äŠr. ˆî–؉pŽ¡C²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ755‰ñŠO‰ÈW’k‰ï i94.12.10j, ‰¡•l.

1574. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •Û‘¶“IŽ¡—ª—LŒø‚Å‚ ‚Á‚½\“ñŽw’°’×á‡úE‚ÌÇ—á. •½ˆäC“ñC‘D–{TìC–ØìŽOŽl˜YC‰z“c‰À•üCˆÀŠC‹`—jC‚–Ø”Ž”ViŽD–y“Œ“¿B‰ï•a‰@jCŽOd–슰ŠìC”äŠé”\Ž÷CŠ`“cÍiŠOjCŠ‹¼^ˆêC…ŒËœN˜Yiˆ®ìˆã ‘åj: ‘æ62‰ñ–kŠC“¹ŠO‰ÈŠw‰ï i95.01.28j, ŽD–y.

1575. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “«• •Ç”^ᇂ𔺂Á‚½–Ó’°Šà‚Ì‚PÇ—á. ‰z“c‰À•üC‘D–{TìC–ØìŽOŽl˜YC•½ˆäC“ñCˆÀŠC‹`—jC‚–Ø”Ž”VC•½ŠÔŒ³”ŽiŽD–y“Œ“¿B‰ï•a‰@jC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ62‰ñ–kŠC“¹ŠO‰ÈŠw‰ï i95.01.28j, ŽD–y.

1576. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘’_ŠÇŒ‹Î‚ð‡•¹‚µ‚½“©Ší—l’_”X‚Ì‚P—á. ²“¡–qC²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ233‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i95.02.18j, “Œ‹ž.

1577. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚r󌋒°”P“]Ç‚ÌŒŸ“¢. ìãŒhlC’Ë–{GlC‹e’rŽj˜YC’|“cC–ì‘ò’¼ŽjC²“¡ŒõŽjCŠ`“cÍiŠOjC‘꓇í‰ëC™–{Ÿ•Fi‹~–½j: ‘æ233‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï i95.02.18j, “Œ‹ž.

1578. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éúEŒ‹’°ŠàÇ—á‚ÌŒŸ“¢. –Lì‹MŽiC‘哇s•FC•Ÿ“cŽ C“ú‹g—˜ŒõCŒ´‰pC‹{“à–M_C’†‘ºG•viã”ö’†‰›‘‡•a‰@j: ‘æ32‰ñé‹ÊˆãŠw‰ï‘‰ï i95.02.26j, ‰Y˜a.

1579. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éŽá”NŽÒˆÝŠà‚ÌŒŸ“¢. Œ´‰pC‹{“à–M_C•Ÿ“cŽ C“ú‹g—˜ŒõC–Lì‹MŽiC‘哇s•FC’†‘ºG•viã”ö’†‰›‘‡•a‰@j: ‘æ32‰ñé‹ÊˆãŠw‰ï‘‰ï i95.02.26j, ‰Y˜a.

1580. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éÅ‹ß10”NŠÔ‚Ì”xŠà؜Ǘá‚ÌŒŸ“¢. “ú‹g—˜ŒõC•Ÿ“cŽ CŒ´‰pC–Lì‹MŽiC‹{“à–M_C‘哇s•FC’†‘ºG•viã”ö’†‰›‘‡•a‰@j: ‘æ32‰ñé‹ÊˆãŠw‰ï‘‰ï i95.02.26j, ‰Y˜a.

1581. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒŒƒ“ƒƒ‹ÇŒóŒQ‚Ì‚P—á. ”¼“cŠì”ü–çC²“¡•˜YC¬‘ò•½‘¾C²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ756‰ñŠO‰ÈW’k‰ï i95.03.11j, “Œ‹ž.

1582. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Žá”N—«‚É”­¶‚µ‚½ Angiomyolipoma‚Ì‚PŽèp—á. ¯–ìOŽ÷C‰¡“c˜a•FC“c’†Œ·C•½’ËŒ¤”VC•Ÿ¬M”ŽC“c’†Œ‰C•ŸŒõ³siŠOj: ‘æ756‰ñŠO‰ÈW’k‰ï i95.03.11j, “Œ‹ž.

1583. mŒ¤‹†‰ïi‘Ûjn iˆê”Êu‰‰j Production of metalloproteinase-2 (MMP-2) in metastatic colorectal cancer (CRC) is stromal (fibroblast) in origin. ‘ •ÀŸiŠOjCCohen, A.M.CGuillem, J.G.iMemorial Sloan-Ketterirg Cancer Centerj: American College of Surgeons, Surgical Forum i94.10.12j, Chicago, USA, Surgical Forum, 45: 551`553, 1994.

1584. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ˆÚAŒ¤‹†‚ÌŒ»ó. Š`“cÍiŠOj: ‘æ‚V‰ñ”]Ž€”]‘h¶Œ¤‹†‰ï i94.06.17j, ‰¡•l.

1585. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŠÌ×–EŠà‚ɑ΂·‚é• •Ç‚‚èã‚°Ž®• o‹¾‰ºŠÌØœ‚ÌŒoŒ±. ‹g“c@‹IC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‹à“cŒå˜YC‚‹´‹BC‘å‹{“Œ¶C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚V‰ñ“àŽ‹‹¾‰ºŠO‰ÈŽèpŒ¤‹†‰ï i94.11.25j, å‘ä.

1586. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰Æ“e”]Ž€ƒ‚ƒfƒ‹‚É‚¨‚¯‚éäX•Û‘¶ó‘Ô|¶‰»Šw“I, Œ`‘ÔŠw“IŒŸ“¢|. ¡ˆäŒ‰C²“¡ŒõŽjCΓc˜aŒÈC¼‘òŽ“TC“cŠ•¶•FCˆÉ“¡‹`–çC’†ŽR‹`‰îC‚‹´‹BCΓc˜a•vCŠ`“cÍiŠOj: ‘æ22‰ñäXˆÚAŒ¤‹†‰ï i95.02.10j, ‰¡•l.

1587. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌ–å•”’_ŠÇŠàØœ—á‚ÌŠài“W‚ÆŽèp¬Ñ|pŒã’·Šú¶‘¶‚ÉŠñ—^‚·‚éˆöŽq‚Æ•ûô|. ‹g“c@‹ICŠ`“cÍC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‚‹´‹BC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ23‰ñ“ú–{’_“¹ŠO‰ÈŒ¤‹†‰ï i94.05.26j, “Œ‹ž, Proceedings, p.94`95, 1994.

1588. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j p‘Of’f‚µ“¾‚È‚©‚Á‚½’_”XŠà‚ɑ΂·‚é“àŽ‹‹¾“I“àᑉ»‚ÌŽŽ‚Ý. ˆî–؉pŽ¡C²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ40‰ñ’_“¹‚ÌW‚¢ i94.06.10j, “Œ‹ž.

1589. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌäX“¯ŽžØœp‚Ì‘ÏpŒÀŠE‚Ì—\‘ª‚Æ‘ŸŠí‘ŠŠÖ‚ÌŽÀŒ±“IŒŸ“¢. ò‰Æ‹v’¼CŠ`“cÍC‘å‹{“Œ¶C‹g“c@‹IC‚‹´‹BCŒÃ“cˆê“¿C”Ñ–ì‘Pˆê˜YiŠOj: Œú¶È‚ª‚ñŒ¤‹†•¬‹à’_“¹Šà, äX“ª•”Šà‚ÌŠg‘åØœ‚É‚¨‚¯‚骎¡«‚ƈÀ‘S«Œüã‚ÉŠÖ‚·‚錤‹†”Ç‘æ‚P‰ñ”ljï‹c i94.06.15j, “Œ‹ž.

1590. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j •\‘wŠg‘åŒ^H“¹Šà‚Ì‚Q—á‚ɂ‚¢‚Ä. ‚–ì—eKC¬—ÑLsCŽOd–슰ŠìiŠOj: ‘æ31‰ñH“¹F‘fŒ¤‹†‰ï i94.06.22j, •Ÿ‰ª, ´˜^W, p.8, 1994.

1591. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j äX“ª\“ñŽw’°ØœpŒã‚̓«• …‚Ì•a‘Ô‚ÆŽ¡—Ã. ‹g“c@‹IC¼ŽR’¼‹vC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‚‹´‹BC‘å‹{“Œ¶C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ21‰ñ“ú–{äXØŒ¤‹†‰ï i94.06.24j, Ž­Ž™“‡, Proceedings, p.52`53, 1994.

1592. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j CDDP, 5FV•¹—p‚É‚æ‚éH“¹Šàp‘O‰»Šw—Ö@Ž{sÇ—á‚ÌŒŸ“¢. ¬—ÑLsCŽOd–슰ŠìC‚–ì—eKC‚‹´ŒúCâEŠ_½C–å˜eŒ›C‰Á“¡NsC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOj: ‘æ48‰ñH“¹Ž¾Š³Œ¤‹†‰ï i94.06.24j, •Ÿ‰ª, —\eW, p.19, 1994.

1593. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒŠƒ“ƒpß“]ˆÚ—z«ˆÝ”S–Œ“àŠà(m­j‚ÌŒŸ“¢. ‚–ì—eKCŽOd–슰ŠìC¬—ÑLsC‚‹´ŒúCâEŠ_½C‰Á“¡NsC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOjC¬ò˜aŽO˜YC‰¡ŽR–õC‘åˆä“c³lC¼Œ³Ž›Ž—çi“àj: ‘æ63‰ñˆÝŠàŒ¤‹†‰ï i94.07.15j, •l¼, ´˜^W, p.82, 1994.

1594. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘å’°ŠàŠÌ“]ˆÚ‚ɑ΂·‚é“®’‰»Šw—Ö@‚Ì—LŒø«‚ɂ‚¢‚Ä. ŒÃì—T‰îC‘å’J„³CˆäŒ´ŒúC’Ò—ºìC‰ª‘º—¥ŽqC²“¡KˆêCŒ´‰pC–Lì‹MŽiCH“¡N¶C”äŠé”\Ž÷iŠOj: ‘æ‚T‰ñÝ‘îŠàŽ¡—ÃŒ¤‹†‰ï i94.07.16j, “Œ‹ž, —\eW, p.19, 1994.

1595. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j úE«’×ᇂɑ΂·‚éˆÝ‰·‘¶—Ö@Ç—á‚Ì—\Œã. ’Ë–{GlC‚–ì—eKC‚‹´ŒúC‹e’rŽj˜YC¬—ÑLsC“ˆ”ömCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ3‰ñ’×ᇕa‘ÔŒ¤‹†‰ïƒtƒH[ƒ‰ƒ€ i94.09.10j, “Œ‹ž.

1596. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚épŒãŠÌ•s‘S‚ɑ΂·‚錌Ÿ÷ŒðŠ·—Ö@‚ÌŒoŒ±‚Æ¡Œã‚̉ۑè. ”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿CˆÉ“¡‹`–çC‚‹´‹BC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚T‰ñ‹}«ŒŒ‰tò‰»Œ¤‹†‰ï i94.09.30j, ‹v—¯•Ä.

1597. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‰»”^«”A–ŒŠÇ”X–E‚Ì‚P—á. “cŠ•¶•FC”ª\ì—v•½Cã–쑈ê˜YC²“¡KˆêC”‹´_ˆêC•ìƒC‘ˆä‘¥ºiŠOj: ‘æ‚T‰ñ¬Ž™ŠO‰ÈQOLŒ¤‹†‰ï i94.10.15j, H“c, ´˜^W, p.34, 1994.

1598. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘S“à‘Ÿ‹tˆÊÇ‚ð‡•¹‚µ‚½’_Îǂɑ΂µ‚Ä• o‹¾‰º’_“Ep‚ðŽ{s‚µ‚½‚P—á. –ØìŽOŽl˜YC‘D–{TìC•½ˆäC“ñC‰z“c‰À•üCˆÀŠC‹`—jC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚V‰ñ“àŽ‹‹¾‰ºŠO‰ÈŽèpŒ¤‹†‰ï i94.11.25j, å‘ä.

1599. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j • o‹¾‰ºƒwƒ‹ƒjƒAC•œp (Extraperitoneal approach)‚Ì—Õ°‰Û‘è. ŒÃ“cˆê“¿C”Ñ–ì‘Pˆê˜YC’|“cCˆÉ“¡“OC’†Œ´T“ñC‚‹´‹BC‹g“c@‹ICŠ`“cÍC”äŠé”\Ž÷iŠOj: ‘æ‚V‰ñ“àŽ‹‹¾‰ºŠO‰ÈŽèpŒ¤‹†‰ï i94.11.25j, å‘ä.

1600. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Œo‹¹“I‹¹o‹¾‰º¶“à‘Ÿ_ŒoØ’fp|Šà«áu’ɂɑ΂·‚é Surgical palliation|. ‚‹´‹BCò‰Æ‹v’¼C”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿C‹à“cŒå˜YC‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚V‰ñ“àŽ‹‹¾‰ºŠO‰ÈŽèpŒ¤‹†‰ï i94.11.26j, å‘ä.

1601. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌäX“¯ŽžØœŽž‚ÌäXƒzƒ‹ƒ‚ƒ“‚Ì•Ï“®‚ÆŠÌĶ‚Ì‘ŠŠÖ‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†. ŒÃ“cˆê“¿CŠ`“cÍC‹g“c@‹IC‘åÀ“cŽ¡C”Ñ–ì‘Pˆê˜YCˆÉ“¡‹`–çC“cŠ•¶•FCò‰Æ‹v’¼C‚‹´‹BiŠOj: Œú¶È‚ª‚ñŒ¤‹†•¬‹à¢’_“¹Šà, äX“ª•”Šà‚ÌŠg‘åØœ‚É‚¨‚¯‚骎¡«‚ƈÀ‘S«Œüã‚ÉŠÖ‚·‚錤‹†”Ç£‘æ‚Q‰ñ”ljï‹c i94.11.30j, “Œ‹ž.

1602. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j úE«\“ñŽw’°’×ᇂɑ΂·‚éˆÝ‰·‘¶—Ö@Ç—á‚ÌŒŸ“¢. ’Ë–{GlC‚–ì—eKC‚‹´ŒúCX£¹Ž÷C‹e’rŽj˜YC¬—ÑLsC“ˆ”ömCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOjC•½“cŒõ”ŽC‘꓇í‰ëC™–{Ÿ•Fi‹~ –½j: ‘æ24‰ñˆÝŠO‰ÈŒ¤‹†‰ï i95.01.20j, ‰¡•l.

1603. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j •Û‘¶“IŽ¡—Âƕ o‹¾‰ºŽèp‚ð—p‚¢‚½\“ñŽw’°’×á‡úEŽ¡—ÂÌV‚µ‚¢ŽŽ‚Ý. •½ˆäC“ñC‘D–{TìC–ØìŽOŽl˜YC‰z“c‰À•üCˆÀŠC‹`—jC‚–Ø”Ž”ViŽD–y“Œ“¿B‰ï•a‰@jC’Ë–{GlCŽOd–슰ŠìC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ24‰ñˆÝŠO‰ÈŒ¤‹†‰ï i95.01.20j, ‰¡•l.

1604. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ˆÝŒ´”­ˆ««ƒŠƒ“ƒpŽîŽèpÇ—á‚ÌŒŸ“¢. ¬—ÑLsCŽOd–슰ŠìC‚–ì—eKC‚‹´ŒúC–å˜eŒ›C“ˆ”ömC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOjCŸ–””º‰hi“àj: ‘æ24‰ñˆÝŠO‰ÈŒ¤‹†‰ï i95.01.20j, ‰¡•l, —\eW, p.19, 1994.

1605. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌ“àŒ‹ÎÇ‚É‚¨‚¯‚éŠÌ“à_Œo‚Ì•a‘Ô‚ÉŠÖ‚·‚錤‹†|‘æ‚Q•ñ. ”Ñ–ì‘Pˆê˜YCŠ`“cÍC‹g“c@‹ICŒÃ“cˆê“¿Cò‰Æ‹v’¼C‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: Œú¶È“Á’莾Š³ŠÌ“àŒ‹ÎÇ’²¸Œ¤‹†”Ç•½¬‚T”N“x‘æ‚Q‰ñ‘‰ï i95.01.25j, ˜a‰ÌŽR.

1606. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j tˆÚAŒãŠÌáŠQ‚ÌŒŸ“¢|“Á‚ÉHCV‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä|. ˆÉ“¡‹`–çC²“¡ŒõŽjCΓc˜a•vCŠ`“cÍiŠOjC’|“àN—YCŠ™“cvŽõC‘å‹v•Û[li“àjC‰““¡’‰—YCŒF–ì˜a—Yi”åj: ‘æ28‰ñ“ú–{tˆÚA—Õ°Œ¤‹†‰ï i95.01.27j, _“Þì.

1607. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ’·Šú¶‘¶¶’…‚µ‚½“¯• ŒZ’팢‚É‚¨‚¯‚éäX\“ñŽw’°ˆÚA‚ÌŒŸ“¢. ’†ŽR‹`‰îCˆÉ“¡‹`–çC¡ˆäŒ‰C²“¡ŒõŽjCŠ`“cÍiŠOj: ‘æ22‰ñäXˆÚAŒ¤‹†‰ï i95.02.10j, ‰¡•l, ´˜^W, p.24, 1995.

1608. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j pŒã’_ŠÇ‹·ó‚ɑ΂·‚éŽèp“ïa—á. ŒÃ“cˆê“¿CŠ`“cÍC‚‹´‹BC‹g“c@‹ICò‰Æ‹v’¼C”Ñ–ì‘Pˆê˜YiŠOj: ‘æ23‰ñ“ú–{’_“¹ŠO‰ÈŒ¤‹†‰ï i94.05.26j, “Œ‹ž, Proceedings, p.124`125, 1994.

1609. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘å’°ŠàpŒã“]ˆÚ‚ɑ΂·‚鎡—Ö@‚ÌŒŸ“¢. ŒÃì—T‰îC‘å’J„³CˆäŒ´ŒúC–Lì‹MŽiCŒ´‰pC‰ª‘º—¥ŽqC²“¡KˆêCÎì~C‘êK‹ÏC¼ŽR•Û”äŒÃCH“¡N¶CŒÃ”g‘qŽjŽqC‚‹´r‹BC”äŠé”\Ž÷CŠ`“cÍ iŠOj: ‘æ41‰ñ‘å’°ŠàŒ¤‹†‰ï i94.07.29j, “Œ‹ž, —\eW, p.73, 1994.

1610. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’¼’°Šàœ”Õ“à‘¤•û“]ˆÚ‚Ì—Õ°“IŒŸ“¢. ˆäŒ´ŒúC‘å’J„³CŒÃì—T‰îC‘ŠŒ´¬ºC–Lì‹MŽiCŒ´‰pC‘êK‹ÏC¼ŽR•Û”äŒÃC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ42‰ñ‘å’°ŠàŒ¤‹†‰ï i95.01.27j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€, p.58, 1995.

1611. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ˆÝŠà‚ɑ΂·‚é“àŽ‹‹¾“IŽ¡—Ã|ŠO‰È“IŠÏ“_‚©‚ç|. ”äŠé”\Ž÷iŠOj: ‘æ‚V‰ñƒTƒ}[ƒZƒ~ƒi[i“ú–{ˆãŽt‰ï¶ŠU‹³ˆçuÀj i94.07.16j, _ŒË.

1612. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j äXŠO. Š`“cÍiŠOj: ‘æ35‰ñ–kŠC“¹’_äXŽ¾Š³’k˜b‰ï i94.07.23j, ŽD–y.

1613. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ’_“¹Šà‚Ìf’f‚ÆŽ¡—Ã. Š`“cÍiŠOj: ˆãŽt‚̶ŠU‹³ˆçuÀi’·èŒ§ˆãŽt‰ïj i94.10.12j, ’·è.

1614. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‘ŠúˆÝŠà‚Ì“àŽ‹‹¾Ž¡—Âɂ‚¢‚Ä; ÅV‚̘b‘è. ”äŠé”\Ž÷iŠOj: “ú–{ˆãŽt‰ï¶ŠU‹³ˆçuÀŠwpu‰‰‰ï i94.11.22j, ŒF–{.

1615. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‚—îŽÒ‚̃Xƒg[ƒ}ƒPƒA‚ɂ‚¢‚Ä. ”¼“cŠì”ü–çC²“¡•˜YC¬‘ò•½‘¾C²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ17‰ñ_“Þ쌧ƒXƒg[ƒ}Œ¤‹†‰ï i94.12.10j, ‘Š–ÍŒ´.

1616. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j H“¹ŠàpŒã‹“㌋’°’×ᇂ̂P—á. –ì‘ò’¼ŽjC‚–ì—eKCŽOd–슰ŠìC‚‹´ŒúC¬—ÑLsC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOj: ‘æ22‰ñ_“ÞìH“¹Ž¾Š³§˜b‰ï i94.03.09j, ‰¡•l.

1617. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘å’°Šà‚𜂭“]ˆÚ«ŠÌŠàØœ—á‚ÌŒŸ“¢. ¼ŽR’¼‹vC’Ë–{GlC“n•ÓŒ’Ž™C‚‹´ŒúC’|’†°KC‹g“c@‹ICΓc˜a•vCŽOd–슰ŠìC²“¡ŒõŽjC‘å‹{“Œ¶C匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ23‰ñ_“Þ쌧Á‰»ŠíŠO‰ÈŒ¤‹†‰ï i94.04.09j, ‰¡•l.

1618. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “]ˆÚ«ŠÌŠà‚ÆŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½Œ´”­«ŠÌŠà‚Ì‚Q—á. ’çCCˆî–؉pŽ¡C‹ß“¡Œ«ŽiC‘ŠŒ´¬ºC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqC–¥‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ23‰ñ_“Þ쌧Á‰»ŠíŠO‰ÈŒ¤‹†‰ï i94.04.09j, ‰¡•l.

1619. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j p‘O‰»Šw—Ö@¥•úŽËü—Ö@•¹—p‚ÅCR‚Æ‚È‚Á‚½H“¹Šà‚Ì‚P؜Ǘá. ’†ŒF‘¸ŽmC¬—ÑLsC‚–ì—eKC‚‹´ŒúCŽOd–슰ŠìC”äŠé”\Ž÷iŠOj: ‘æ19‰ñ_“ÞìH“¹Ž¾Š³§˜b‰ï i94.06.09j, ‰¡•l, Ç—áW, 2: 19, 1994.

1620. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “Á”­«H“¹”j—ô‚Ì‚P—á. ‹{–{‰p—YC…–ì—F—TC•Ð‰ª—SˆêCΕ‹§ŽjC‰|–{‘ñ–ÎC¼–{–LC¬À”ŽC‰¡“c“™CVˆäLNC–å˜eŒ›C¼‘º”Žsi–kM‘‡•a‰@j: ‘æ83‰ñMBŠO‰ÈW’k‰ï i94.06.12j, ’·–ì.

1621. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j NO‚ÅäX“]ˆÚ‚ð”F‚ß‚½H“¹ˆ««•FŽî‚Ì‚P—á. ²“¡–qCŒÃ”g‘qŽjŽqC”¼“cŠì”ü–çCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YC–¥‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCˆäo“NCˆÀ’BŒ£C“n•”K•vCˆ¢•”–¾ ˜YCó”ö•Žmi“àj: ‘æ39‰ñ_“ÞìÁ‰»Ší•aŒ¤‹†‰ï i94.06.18j, ‘Š–ÍŒ´.

1622. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Jackson–Œ‚ªŒ´ˆö‚Å”­Ç‚µ‚½¬l’°•ÂÇ‚Ì‚P—á. ‘êK‹ÏC‘å’J„³CŒÃ“cˆê“¿CΈ䌒ˆê˜YCa’JŽœ˜YC¼ŽR•Û”äŒÃCŒÃì—T‰îCˆäŒ´ŒúC匴÷C”äŠé”\Ž÷iŠOj: ‘æ39‰ñ_“ÞìÁ‰»Ší•aŒ¤‹†‰ï i94.06.18j, ‘Š–ÍŒ´.

1623. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j •Û‘¶“IŽ¡—ÂŎ¡–ü‚¹‚µ‚ß‚½“Á”­«H“¹”j—ô‚Ì‚P—á. â–{‚¢‚ÂÝC’Ë–{GlC‘꓇í‰ëCa’JŽœ˜YC–Lì‹MŽiC¬ìŒ›ÍCˆÉ“¡‹`–çC‹e’rŽj˜YC’†ŽR‹`‰îCŽOd–슰ŠìC²“¡ŒõŽjC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ39‰ñ_“ÞìÁ‰»Ší•aŒ¤‹†‰ï i94.06.18j, ‘Š–ÍŒ´.

1624. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j FCM—Ö@‚ª’˜Œø‚µ‚½‚o2ˆÝŠà‚Ì‚P—á. ù–{_C²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ‚U‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.06.25j, ‰¡•l.

1625. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘ŠúˆÝŠà‚Ì–À‘–_Œo‰·‘¶Žèp‚É‚¨‚¯‚é’_”XŽûk”\‚¨‚æ‚Ñ’_`”ro”\‚ÌŒŸ“¢. ‰J‹{–¾•¶C²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ‚U‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.06.25j, ‰¡•l.

1626. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ˆÝŠàpŒã’_Δ­¶‚ÌŒŸ“¢. ‚‹´ŒúC‚–ì—eKC¬—ÑLsC“ˆ”ömCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj: ‘æ‚U‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.06.25j, ‰¡•l.

1627. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚épŒãäX‰tá‘‚ÉŠÖ‚·‚錟“¢. ‚–ì—eKC‚‹´ŒúC¬—ÑLsC“ˆ”ömCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj: ‘æ‚U‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.06.25j, ‰¡•l, ´˜^W, p.10, 1994.

1628. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j p‘Of’f¢“ï‚Å‚ ‚Á‚½ŠÌŽîᎂ̂P—á. ”Ñ–ì‘Pˆê˜YC‹g“c@‹ICŽ­Žæ³“¹CŒÃ“cˆê“¿Cò‰Æ‹v’¼C‚‹´‹BC‘å‹{“Œ¶C”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ‚Q‰ñ–k—¢ŠÌ¥’_“¹Ž¾Š³Œ¤‹†‰ï i94.07.20j, “Œ‹ž.

1629. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éÅ‹ß10”NŠÔ¬l‘lŒaƒwƒ‹ƒjƒAŽèp‚ÌŒŸ“¢. ˆî–؉pŽ¡C²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ24‰ñ“Œ‹ž’n‹æ‘—§•a‰@ŠO‰ÈŒ¤‹†‰ï i94.07.30j, “Œ‹ž.

1630. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘½”‚̃GƒR[ŠŒ©‚ð—L‚·‚éÇ—á. ’†‘º‘בãi—ÕŒŸjCHŽRŒ›‹`iŠOj: ‘æ‚Q‰ñ_“Þ쌧“û‘BŽ¾Š³Ç—ጟ“¢‰ï i94.09.16j, ‰¡•l.

1631. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “¯Žž«—¼‘¤“ûŠà‚Ì‚P—á. ²“¡–qC²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ80‰ñ_“Þ쌧—Õ°ŠO‰ÈˆãŠw‰ïW’k‰ï i94.10.01j, _“Þì.

1632. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j • •”‘å“®–¬áŽ‚É—¼‘¤‚Ì‹‘å‘’°œ¥“à’°œ“®–¬áŽ‚𔺂Á‚½‚PŽ¡Œ±—á. ‹à鳉ÀC²“¡ˆêŠìCX£¹Ž÷C‚‹´’õlC’†ŒF‘¸ŽmC¼ŽR’¼‹vCª–{ECŠ`“cÍiŠOj: ‘æ83‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i94.10.22j, “Œ‹ž.

1633. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘½”­«‹¹•”¥• •”‘å“®–¬áŽ‚Ì‚P—á. ª–{ˆê•FC‹à鳉ÀCX£¹Ž÷C²“¡ˆêŠìC²–ØLˆê˜YC¼ŽR’¼‹vCª–{ECŠ`“cÍiŠOj: ‘æ83‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i94.10.22j, “Œ‹ž.

1634. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œ´”­«• –Œ‰Š‚ÆŽv‚í‚ꂽ‚PŽèp—á. ²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ25‰ñ“Œ‹ž’n‹æ‘—§•a‰@ŠO‰ÈŒ¤‹†‰ï i94.10.22j, “Œ‹ž.

1635. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “àŽ‹‹¾‚É‚Äf’f‚µ‚½“Á”­«H“¹”j—ô‚Ì‚P—á. ã–쑈ê˜YC”‹´_ˆêC²“¡KˆêC“cŠ•¶•FC”ª\ì—v•½iŠOj: ‘æ20‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïé‹Ê•”‰ï i94.11.05j, ‘å‹{.

1636. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j f’f¢“ï‚Å‚ ‚Á‚½•›t”玿Šà‚Ì‚P—á. ²“¡KˆêC”ª\ì—v•½C”‹´_ˆêC“cŠ•¶•FCã–쑈ê˜YiŠOj: ‘æ12‰ñé‹ÊŒ§ŠO‰ÈW’k‰ï i94.11.26j, ‰Y˜a.

1637. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒCƒŒƒEƒX‚É‚æ‚è”­Ç‚µ‚½¬’°Šà‚Ì‚Q—á. ”‹´_ˆêC”ª\ì—v•½C²“¡KˆêCã–쑈ê˜YC“cŠ•¶•FiŠOjC‹g“c•ŽjC–{‹§i•a—j: ‘æ12‰ñé‹ÊŒ§ŠO‰ÈW’k‰ï i94.11.26j, ‰Y˜a.

1638. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ˆÝ¬×–EŠà‚Ì‚P—á. •Ÿ“cŽ C‹{“à–M_CŒ´‰pC–Lì‹MŽiC“ú‹g—˜ŒõC‘哇s•FC’†‘º‰p•viã”ö’†‰›‘‡•a‰@j: ‘æ12‰ñé‹ÊŒ§ŠO‰ÈW’k‰ï i94.11.26j, ‰Y˜a.

1639. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Ž©‘R’E—Ž‚µ‚½‚ÆŽv‚í‚ꂽãsŒ‹’°ƒ|ƒŠ[ƒv—l•a•Ï‚Ì‚P—á. ¬‘ò•½‘¾C²“¡•˜YC”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ40‰ñ_“ÞìÁ‰»Ší•aŒ¤‹†‰ï i94.12.03j, ‰¡•l.

1640. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “û‘B Paget•a‚Ì‚P—á. ‰|–{‘ñ–ÎC¬À”ŽC‚£ÅC…–ì—F—TC•Ð‰ª—SˆêC¼–{–LCVˆäLNC‰¡“c“™C‹{–{‰p—YC–å˜eŒ›C¼‘º”ŽsiŠOj: ‘æ84‰ñMBŠO‰ÈW’k‰ï i94.12.04j, ¼–{.

1641. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŠÌŒŒŠÇŽî‚ÌŽèp“K‰ž|Øœ—á‚ÌŒŸ“¢|. ‘åÀ“cŽ¡C‹g“c@‹IC–Ø‘º“OC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿C‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ81‰ñ_“Þ쌧—Õ°ŠO‰ÈˆãŠw‰ïW’k‰ï i94.12.10j, ‰¡•l.

1642. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j • o‹¾‰ºŽèp‚É‚¨‚¯‚é“®•¨ŽÀŒ±‚Ì—Õ°‚Ö‚Ì–ðŠ„. ’çCC²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ81‰ñ_“Þ쌧—Õ°ŠO‰ÈˆãŠw‰ïW’k‰ï i94.12.10j, ‰¡•l.

1643. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‰ŠÇ«’°Ž¾Š³‚ɑ΂·‚é‰ñ’°lHãè–å‚̃PƒA[. ‘ŠŒ´¬ºC‘å’J„³C¼è”ŽsC’†Œ´T“ñC—é–Ø“N‘¾˜YC—ÑCCŒÃì—T‰îCˆäŒ´ŒúC匴÷C”äŠé”\Ž÷C¼Œ´N”üC^–ì“oŠìŽqC’†‘ºG‘ãiŠOj: ‘æ17‰ñ_“Þ쌧ƒXƒg[ƒ}Œ¤‹†‰ï i94.12.10j, ‘Š–ÍŒ´, ´˜^W, p.8, 1994.

1644. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’˜–¾‚ȃŠƒ“ƒpŠÇNP‚𔺂¢’f’[—z«‚Æf’f‚³‚ꂽ Borrmann ‡TŒ^ˆÝŠà‚Ì‚P—á. Î씎˜aC‹e’rŽj˜YC’Ë–{GlC²“¡ŒõŽjCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷CŠ`“cÍiŠOjCŠâŸºŒ[ˆêi•a—j: ‘æ7‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.12.17j, ‰¡•l.

1645. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚ł̈݊à–T‘å“®–¬ƒŠƒ“ƒpߊs´‚̬ŒoŒ±. ‰J‹{–¾•¶C²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ7‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.12.17j, ‰¡•l.

1646. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ¶ŒŸ—z«‚Å‚ ‚è‚È‚ª‚ç•”ˆÊ“¯’è‚É“ïa‚µ‚½‘ŠúˆÝŠàÇ—á. ’çCC²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ7‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.12.17j, ‰¡•l.

1647. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j isˆÝŠà‚ɑ΂·‚éŠg‘åŠs´‚Ì“K‰ž‚Æ•W€pŽ®‚Æ‚Ì”äŠr. ‚–ì—eKC‚‹´ŒúC¬—ÑLsC“ˆ”ömCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj: ‘æ7‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.12.17j, ‰¡•l, ´˜^W, p.3, 1994.

1648. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j p‘O‰»Šw—Ö@‚ª‘tŒø‚µ‚½isˆÝŠà‚Ì‚P—á. ŽRŒû—Tˆê˜YC¬—ÑLsCŽOd–슰ŠìC‚–ì—eKC‚‹´ŒúC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOjC¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj: ‘æ7‰ñ_“ÞìˆÝŠàŽ¡—ÃŒ¤‹†‰ï i94.12.17j, ‰¡•l, —\eW, p.47, 1994.

1649. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Á‘ÞoŒ»‚ðŒJ‚è•Ô‚µ‚½ŠÌŽî᎗l•a•Ï‚Ì‚P—á. ”Ñ–ì‘Pˆê˜YC‚‹´‹BCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ3‰ñ–k—¢ŠÌ¥’_“¹Ž¾Š³ŒŸ“¢‰ï i95.01.18j, Œú–Ø.

1650. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’_Îǂɑ΂·‚é‘’_ŠÇ\“ñŽw’°•«‡pŒã25”N–Ú‚É”­Ç‚µ‚½ŠÌ”^ᇂ̂PØœ—á. ‘åÀ“cŽ¡C‹g“c@‹IC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿C‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ22‰ñ_“ÞìŠÌ’k˜b‰ï i95.01.28j, ‰¡•l.

1651. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŠÓ•Ê¢“ï‚Å‚ ‚Á‚½‹‘å’_”X—²‹N«•a•Ï‚Ì‚PØœ—á. “à“¡CC‹g“c@‹IC‰|–{‘ñ–ÎC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿C‚‹´‹BiŠOj: ‘æ‚T‰ñé“ì¥_“Þì• •”’´‰¹”g“lje‰ï i95.02.07j, “Œ‹ž.

1652. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’áˆÊ‘O•ûØœpŒã‚ÉÄ”­‚𗈂µ‚½’¼’°MPS‚Ì‚P—á. ‰J‹{–¾•¶C²“¡•˜YC¬‘ò•½‘¾C”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ15‰ñ_“Þì‘å’°Ž¾Š³Œ¤‹†‰ï i95.02.09j, ‰¡•l.

1653. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’¼’°ˆ««•FŽî‚Ì‚P—á. Î씎˜aCŒÃì—T‰îCˆäŒ´ŒúC¼ŽR•Û”äŒÃC‘å’J„³C匴÷C”äŠé”\Ž÷iŠOj: ‘æ15‰ñ_“Þì‘å’°Ž¾Š³Œ¤‹†‰ï i95.02.09j, ‰¡•l.

1654. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “àŽ‹‹¾“IŽ~ŒŒ‚ðŽŽ‚Ý‚½ãsŒ‹’°ŒeŽºoŒŒ‚Ì‚P—á. ¬‘ò•½‘¾C²“¡•˜YC”¼“cŠì”ü–çC²“¡–qCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ82‰ñ_“Þì—Õ°ŠO‰ÈW’k‰ï i95.03.04j, ‘å˜a.

1655. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j äBÖ¬•ÂÇ‚É‚æ‚éˆÝ֬ᎂɑ΂µ‚ÄäB“®–¬Çðp‚ª—LŒø‚Å‚ ‚Á‚½‚PÇ—á. ’†ŒF‘¸ŽmC‹g“c@‹ICù–{MKCŽRŒû—Sˆê˜YC“à“¡CC”Ñ–ì‘Pˆê˜YCŒÃ“cˆê“¿C‚‹´‹BC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ82‰ñ_“Þì—Õ°ŠO‰ÈW’k‰ï i95.03.04j, ‘å˜a.

1656. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Ž¡—Âɓïa‚µ‚½ŠÌŽî᎗l•a•Ï‚Ì‚P—á. ”Ñ–ì‘Pˆê˜YC‚‹´‹BCŒÃ“cˆê“¿Cò‰Æ‹v’¼C‹g“c@‹IC”äŠé”\Ž÷CŠ`“cÍiŠOj: ‘æ2‰ñBPƒNƒ‰ƒu i95.03.07j, ‰¡•l.

1657. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j TAE‚ª—LŒø‚Å‚ ‚Á‚½’¼’°ƒJƒ‹ƒ`ƒmƒCƒhŠÌ“]ˆÚ‚Ì‚P—á. ŒÃì—T‰îC‘å’J„³CÎ씎˜aCŽRŒû—Tˆê˜YC’|“cC‘åÀ“cŽ¡CˆäŒ´ŒúC匴÷C”äŠé”\Ž÷iŠOj: ‘æ‚P‰ñ_“Þì‘å’°ãè–厾Š³’k˜b‰ï i95.03.24j, ‰¡•l.

1658. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j • o‹¾‰º‘lŒaƒwƒ‹ƒjƒAC•œp. ŒÃ“cˆê“¿iŠOj: ‘æ‚P‰ñ_“ÞìŠO‰ÈŽèpŽè‹ZŒ¤‹†‰ï i95.03.24j, ‰¡•l.

1659. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j • o‹¾•â•‰º‰ñ–Ó•”Øœ‚ðŽ{s‚µ‚½’Ž‚”S‰tᎂ̂P—á. ²“¡•˜YC¬‘ò•½‘¾C²“¡–qC”¼“cŠì”ü–çCˆî–؉pŽ¡Cù–{_C’çCC‰J‹{–¾•¶C‹à“cŒå˜YCŒÃ”g‘qŽjŽqCHŽRŒ›‹`C‚‹´r‹BiŠOj: ‘æ26‰ñ“Œ‹ž’n‹æ‘—§ŠO‰ÈŒ¤‹†‰ï i95.03.25j, “Œ‹ž.

1660. mŠw‰ïŽåÃi‘“àjn ‘æ22‰ñäXˆÚAŒ¤‹†‰ïi95.02.10j, Š`“cÍiŠOj.

1661. mŠw‰ïŽåÃi‘“àjn ‘æ24‰ñˆÝŠO‰ÈŒ¤‹†‰ïi95.01.20j ”äŠé”\Ž÷iŠOj.


<<1502 ?? >>

1662. mŒ´’˜n Effect of altering cerebrospinal pressure on spinal cord blood flow. •—ŠÔ”Éi‹¹ŠOjC^è‹`•FCŠÛŽR–ΑPiŽÀ“®ŒnjCÎŒ´ºi‹¹ŠOj: Ann. Thorac. Surg., 58: 112`115, 1994.

1663. mŒ´’˜n ƒ|ƒ“ƒvŒ“—pŒ^–ŒŒ^lH”x‚ÌŠJ”­. ‹´–{¬Li¶‘ÌHjC•y‰i½ˆêi‹¹ŠOjC‹g“cŽÀC²X–ØN‡: ƒoƒCƒIƒGƒ“ƒWƒjƒAƒŠƒ“ƒOŠwpu‰‰‰ïu‰‰˜_•¶W, p.82`84, 1994.

1664. mŒ´’˜n Ž©ŒÈ”x“®–¬•Ð‚É‚æ‚é‘“®–¬Š²Ç‚ÌŠO‰ÈŽ¡—Â̬тƖâ‘è“_‚ÌŒŸ“¢. ’†]¢–¾C‰Í“c­–¾C‘q“c“ÄCŠ}Œ´^ŒåC—é–Ø—TŽqC—Ñ@”ŽCÎŒ´ºC‹g‘º”Ž–Mi‹¹ŠOj: “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 42: 1336`1342, 1994.

1665. mŒ´’˜n ‘å“®–¬kóÇ‚É‚¨‚¯‚é Sabclavian flapŽèpŒã‚Ì㎈”­ˆç‚ÆŒŒ—¬•ª•z‚ÌŒo‰ß. “V–ì—²bC’†]¢–¾C’¬ˆä³lC•ŽR’¼Ž÷CŠ}Œ´^ŒåC‘q“c“ÄC“c’†Ž•FC‹g‘º”Ž–MCÎŒ´ºi‹¹ŠOjC•½Î‘C”ª‘ãŒö•viŽ™j: –k—¢ˆãŠw, 24: 513`519, 1994.

1666. mŒ´’˜n Š¥ó“®–¬ƒoƒCƒpƒXŽèp‚ÌH•v. •—ŠÔ”ÉCÎŒ´ºi‹¹ŠOj: –ò—‚Æ—Õ°, 4(7): 1603`1604, 1994.

1667. m’Z•ñE‘¬•ñn Š¥zŠÂŽ©ŒÈ’²ß”\‚Ì•]‰¿|ƒhƒvƒ‰ƒJƒe[ƒeƒ‹‚ð—p‚¢‚Ä|. ”¼’J×YC¼ŽR´ŒhCÎŒ´ºC‹ß“¡‡‹`i‹¹ŠOj: ˆã—p“dŽq‚ƶ‘ÌHŠw, 32(“Á•Ê): 109, 1994.

1668. m’Z•ñE‘¬•ñn Š¥“®–¬“àƒhƒvƒ‰–@‚É‚æ‚銥—\”õ”\‚Ì‘ª’è|‰–Ž_ƒpƒpƒxƒŠƒ““®–¬“à“Š—^‚͈À‘S‚©H|. ‹ß“¡‡‹`C›Œ´ŠîWi“Œ—ˆã‘åjC”¼’J×Yi‹¹ŠOj: ˆã—p“dŽq‚ƶ‘ÌHŠw, 32(“Á•Ê): 138, 1994.

1669. mŒ¤‹†•ñi•¶•”Èjn ƒ|ƒ“ƒsƒ“ƒO‹@”\‚ð—L‚·‚élH”x‚ÌŽŽì-ŠJ”­. •y‰i½ˆêi‹¹ŠOj: •¶•”ȉȊwŒ¤‹†”ïûŽq•ñ(•½¬6”N“x), 1994.

1670. mŒ¤‹†•ñi•¶•”Èjn Š¥“®–¬ƒoƒCƒpƒXƒOƒ‰ƒtƒg“à‚̈³¥—¬—ÊŠÖŒW‚ÉŠî‚­ƒOƒ‰ƒtƒg‚Ì‹@”\•]‰¿‚ÉŠÖ‚·‚錤‹†. ”¼’J×Yi‹¹ŠOj: •½¬‚U”N“x•¶•”ȉȊwŒ¤‹†”ï•â•‹à(ˆê”ÊŒ¤‹†‚b)Œ¤‹†¬‰Ê•ñ‘, p.1`9, 1994.

1671. mŒ¤‹†•ñiŒú¶Èjn ‰ESƒoƒCƒpƒXŽèpŒã‚̉“Šu—\Œã‚ÉŠÖ‚·‚é—Õ°“IŒ¤‹†. ¼“côC¡ˆäN°Cì“cŽu–¾CˆÀ”{\ŽO•vC”ª–ØŒ´rŽC²–ì“N–çC¼‰º‹œC’†]¢–¾i‹¹ŠOjCŽR“cCC—´–쟕F: Œú¶ÈzŠÂŠí•aŒ¤‹†•ñW, 1994.

1672. mÇ—á•ñn Bilateral giant bullae with rapidly increasing fluid in the right bulla following operation| Report a case. ‚ŽRr­C•½ˆäŽO˜Yi‹¹ŠOjCOka, S.CÎŒ´Æ•vCŒFè’qŽiCŽO“‡GNC²“¡OˆêC–î–슲ŽqiŠÖ“Œ’üM•a‰@j: Surgery Today, 24(3): 272`275, 1994.

1673. mÇ—á•ñn ŠJSpŒã¥cŠu‰Š‚ɑ΂·‚é‘Šú‚Ì‘å–Ô[“Up‚Ì3Ž¡Œ±—á. •ŽR’¼Ž÷i‹¹ŠOjCŽðˆäÍC•ž•”—²ŽiC‰ØŽR’¼“ñC‘å‘òŠ²•vi¹—ê•l¼•a‰@j: —Õ°‹¹•”ŠO‰È, 14(5): 417`419, 1994.

1674. m‘àn ‹C“¹‚Ö‚Ì‹à‘®ƒXƒeƒ“ƒg. X“c—TlC•Ð‹ËŽj˜YC‹g‘º”Ž–Mi‹¹ŠOj: ŒÄ‹z‚ÆzŠÂ, 43(2): 153`158, 1995.

1675. muÀn ‹¹o‹¾‰º”x—t•”•ªØœ‚Ìp‘O‚̈’u. ‹yìŒc_iŽD–y“¿B‰ï•a‰@jC‘D–{TìC‹g‘º”Ž–Mi‹¹ŠOj: ƒIƒyƒi[ƒVƒ“ƒO, 10(8): 92`97, 1994.

1676. muÀn ‹¹o‹¾‰º”x—t•”•ªØœ‚Ìp’†¥pŒã‚ÌŠÅŒì. ‹yìŒc_iŽD–y“¿B‰ï•a‰@jC‘D–{TìC‹g‘º”Ž–Mi‹¹ŠOj: ƒIƒyƒi[ƒVƒ“ƒO, 10(9): 92`97, 1994.

1677. muÀn cŠuŽ¾Š³. •i“cƒC‹g‘º”Ž–Mi‹¹ŠOj: —Õ°ŠÅŒì, 20(12): 1781`1786, 1994.

1678. mŠwp‘n i•ª’SŽ·•Mj }à•a‘Ô“à‰ÈŠwuÀ; cŠuŽîá‡, 2: 203`210, ‹g‘º”Ž–Mi‹¹ŠOj. •ÒW –k‘º—@iŽ©Ž¡ˆã‘åj, ƒƒWƒJƒ‹ƒrƒ…[ŽÐC“Œ‹žC94.05.10”­s.

1679. mŠwp‘n i•ª’SŽ·•Mj ŒÄ‹zŠíŽ¾Š³|State for arts; ”x—Ç«Ž¾Š³, ‹g‘º”Ž–Mi‹¹ŠOj. •ÒW Œ´‘ò“¹”üi“s˜V”NˆãŠwŒ¤jC–k‘º—@iŽ©Ž¡ˆã‘åj, ˆãŽ•–òo”ÅC“Œ‹žC94.10.25”­s.

1680. m‹³‰È‘n i•ª’SŽ·•Mj —AŒŒŒãGVHD; ‹}«”x[ÇpŒãÇ—á, p.109`112, •ŽR’¼Ž÷C¼ŽR´ŒhC•y‰i½ˆêi‹¹ŠOj. •ÒW \Žš–Ò’ji“úÔ’†‰›ŒŒ‰tƒZƒ“ƒ^[jCˆÉ“¡˜a•Fi‹ž‘åj, ‹à–F“°C‹ž“sC94.07.10”­s.

1681. m–|–ón i•ª’SŽ·•Mj ƒŒƒWƒfƒ“ƒg‚Ì‚½‚ß‚ÌS‘Ÿ•aŠw; (‘æ18Í) S‘ŸŠO‰È, p.361`368, ¼ŽR´Œhi‹¹ŠOj. ˆãŠw‘‰@C“Œ‹žC94.07.20”­s.

1682. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Surgical correction of the truneus arteriosus using autologous tissue flap in neonate and small infant. ’†]¢–¾C‰Í“c­–¾C•ŽR’¼Ž÷C{“¡‹±ˆêC‹g‘º”Ž–Mi‹¹ŠOj: 3rd Annual Meeting of Asian Society for Cardiovasc. Surg. i95.02.14j, ‰¡•l.

1683. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical study of thymic carcinoma invading the heart or the great vessels. •i“cƒC‹g‘º”Ž–Mi‹¹ŠOjC‹T’J“Oi•a—j: International Congress for Lung Cancer i94.06.25j, ƒAƒeƒl, Program-Abstracts, p.218, 1994.

1684. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Results of the surgical treatment for patients with lung cancer invading the heart or the great vessels. ‹g‘º”Ž–MC•i“cƒi‹¹ŠOjC‹T’J“Oi•a—j: International Congress for Lung Cancer i94.06.25j, ƒAƒeƒl, Program-Abstracts, p.236, 1994.

1685. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Conduit‚ð—p‚¢‚È‚¢‰EŽº—¬o˜HÄŒšp. ’†]¢–¾C‰Í“c­–¾CŠ}Œ´^ŒåC—Ñ@”ŽCŒ´–L“ñi‹¹ŠOj: ‘æ30‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï i94.07.01j, ‰¡•l, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 10: 22, 1994.

1686. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œ´”­«‹¹•ÇŽîᇎèpÇ—á‚ÌŒŸ“¢. •i“cƒC‹g‘º”Ž–MCˆ¢•””\–¾i‹¹ŠOj: ‘æ11‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï i94.05.14j, ‹ž“s, “ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ïŽGŽ, 8(3): 370, 1994.

1687. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹CŠÇŽx‹¾¶ŒŸ‚É‚¨‚¯‚é1Žè‹Z‚ÌŒŸ“¢. X“c—TlC•Ð‹ËŽj˜YC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ17‰ñ“ú–{‹CŠÇŽxŠw‰ï‘‰ï i94.06.01j, ‘åã, ‹CŠÇŽxŠw, 16(3): 225, 1994.

1688. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å“®–¬•Ù‰º‹·ó‚𔺂¤’PSŽº‚Ì‘å“®–¬—¬o˜HŒ`‘Ô‚ÌŒŸ“¢. ’†]¢–¾C‰Í“c­–¾CŠ}Œ´^ŒåC—Ñ@”ŽC‘•c“wCŽOD–LCÎŒ´ºi‹¹ŠOj: ‘æ31‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i94.06.01j, ‚¼, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 30(3): 474, 1994.

1689. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”N­Ž™‚Å‚ÌFontanŒ^Žèp‚ÌŒoŒ±. ‰Í“c­–¾C’†]¢–¾CŠ}Œ´^ŒåC—é–Ø—TŽqC—Ñ@”ŽC‘•c“wCŽOD–LCÎŒ´ºi‹¹ŠOj: ‘æ31‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i94.06.01j, ‚¼, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 30(3): 475, 1994.

1690. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å“®–¬kóÇ‚Ìk󕔈ʂ̕a—‘gDŠw“IŒŸ“¢. Š}Œ´^ŒåC’†]¢–¾C‰Í“c­–¾C—Ñ@”ŽC‘•c“wCŽOD–LCÎŒ´ºi‹¹ŠOj: ‘æ31‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i94.06.01j, ‚¼, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 30(3): 479, 1994.

1691. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å“®–¬k󕔈ʂ̕a—‘gDŠw“IŠŒ©‚Ækó‰ðœpŽ®‚ÌŒŸ“¢. Š}Œ´^ŒåC’†]¢–¾C‰Í“c­–¾C—Ñ@”ŽC‘•c“wCŽOD–LCÎŒ´ºi‹¹ŠOjC•½Î‘CŽO‘òmŽiCãp—z‘¾˜YiŽ™j: ‘æ30‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï i94.06.30j, ‰¡•l, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 10(1): 60, 1994.

1692. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å“®–¬kó‚𔺂¤’PSŽº‚Ì‘å“®–¬—¬o˜HŒ`‘Ô‚ÌŒŸ“¢. ’†]¢–¾C‰Í“c­–¾CŠ}Œ´^ŒåC—Ñ@”ŽC‘•c“wCŽOD–Li‹¹ŠOjC•½Î‘Cãp—z‘¾˜YCŽO‘òmŽiiŽ™jCÎŒ´ºi‹¹ŠOj: ‘æ30‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï i94.07.01j, ‰¡•l, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 10(1): 225, 1994.

1693. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒy[ƒVƒ“ƒOƒŠ[ƒh‚Ì–â‘è“_. •—ŠÔ”ÉC’¬ˆä³lCæѳŠîC–쑺—F´C“V–ì—²bCì~C¼ŒûŽ•FCÎŒ´ºi‹¹ŠOj: ‘æ9‰ñ“ú–{S‘Ÿƒy[ƒVƒ“ƒOŠw‰ïŠwp‘å‰ï i94.08.05j, ‹v—¯•Ä, S‘Ÿƒy[ƒVƒ“ƒO, 10(3): 322, 1994.

1694. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ|ƒ“ƒvŒ“—pŒ^–ŒŒ^lH”x‚ÌŠJ”­. ‹´–{¬Li¶‘ÌHjC•y‰i½ˆêi‹¹ŠOjC‹g“cŽÀC²X–ØN‡: ‘æ6‰ñƒoƒCƒIƒGƒ“ƒWƒjƒAƒŠƒ“ƒOŠwpu‰‰‰ï i94.08.06j, ”MŠC.

1695. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”x‚ŒŒˆ³Ç‚É‚Ý‚ç‚ê‚é‚Q•ô«”x“®–¬‹ìo—¬‘¬”gŒ`‚̬ˆö. ‹ß“¡‡‹`i“Œ—ˆã‘åjC”¼’J×Yi‹¹ŠOj: ‘æ35‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï i94.10.14j, “Œ‹ž, –¬ŠÇŠw, 34(9): 730, 1994.

1696. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰E–[¥‰EŽº pacingŽž‚ÌŠ¥ŒŒ—¬“®‘Ô‚Ì”äŠr•ªÍ|ƒhƒvƒ‰ƒJƒe[ƒeƒ‹‚É‚æ‚錟“¢|. ”¼’J×YC¼ŽR´ŒhC‹ß“¡‡‹`C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ35‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï i94.10.15j, “Œ‹ž, –¬ŠÇŠw, 34(9): 781, 1994.

1697. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å“®–¬•Ù•Â½•s‘S(AR)Ç—á‚ÌŠ¥ŒŒ—¬—lŽ®‚ÌŒŸ“¢|rate stress‚ɑ΂·‚锽‰ž‚ɂ‚¢‚Ä|. ”¼’J×YC‹ß“¡‡‹`C¼ŽR´ŒhC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ35‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï i94.10.15j, “Œ‹ž, –¬ŠÇŠw, 34(9): 782, 1994.

1698. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘“®–¬Š²Ç‚ɑ΂·‚鎩ŒÈ”x“®–¬flapŽèp(Barbero Marcial–@)‚Ì“K‰ž‚ÆŒŒs“®‘Ô‚Ì“Á’¥. ’†]¢–¾C‰Í“c­–¾CŠ}Œ´^ŒåC—Ñ@”ŽC‹{‰i–ÎŽ÷CŽOD–Li‹¹ŠOj: ‘æ47‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï i94.10.25j, ç—t, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 42(Suppl.): 1584, 1994.

1699. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒOƒ‰ƒtƒg“àŠ¥ŒŒŠÇ’ïR‚ÉŠî‚­ƒoƒCƒpƒXƒOƒ‰ƒtƒg‚Ì‹@”\•]‰¿. ”¼’J×YCæѳŠîC‘q“c“ÄC{“¡‹±ˆêC’¬ˆä³lC¼ŽR´ŒhC‹ß“¡‡‹`i‹¹ŠOj: ‘æ47‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï i94.10.25j, ç—t, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 42(Suppl.): 1701, 1994.

1700. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹¹‘BŠà‚Ì—Õ°“IŒŸ“¢. •i“cƒC‹g‘º”Ž–MC‚—²½Cˆ¢•””\–¾CÎŒ´ºi‹¹ŠOj: ‘æ47‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï i94.10.26j, ç—t.

1701. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j CabrolpŒã‚ÌŠ¥“®–¬“àŒŒ—¬•ªÍ|Œ’í—á, CABG—á‚Ƃ̑Δä‚É‚¨‚¯‚錟“¢|. æѳŠîC”¼’J×YC‘q“c“ÄC{“¡‹±ˆêC¼ŽR´ŒhC‹ß“¡‡‹`C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ47‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï i94.10.26j, ç—t, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 42(Suppl.): 1618, 1994.

1702. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å“®–¬•Ù•Â½•s‘SÇ‚É‚¨‚¯‚銥zŠÂ‚ÌŒŸ“¢. {“¡‹±ˆêC”¼’J×YC¼ŽR´ŒhC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï i94.11.17j, ‘åã.

1703. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j PacingŽž‚ÌŠ¥ŒŒ—¬”gŒ`•ªÍ|‰E–[¥‰EŽºpacing‚Ì”äŠr|. ¼ŽR´ŒhC”¼’J×YC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï i94.11.17j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(‘): 79, 1994.

1704. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Valsalva–@‚ªŠ¥“®–¬“àŒŒ—¬‚É—^‚¦‚é‰e‹¿‚ɂ‚¢‚Ä. ”¼’J×YCæѳŠîC‹ß“¡‡‹`C¼ŽR´ŒhC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï i94.11.17j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(‘): 79, 1994.

1705. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œ’í—á, CABG—á‚Æ”äŠr‚µ‚½ CabrolpŒãŠ¥ŒŒ—¬—lŽ®‚Ì•ªÍ. æѳŠîC”¼’J×YC‘q“c“ÄC{“¡‹±ˆêC¼ŽR´ŒhC‹ß“¡‡‹`C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï i94.11.17j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(‘): 80, 1994.

1706. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Rate stress‚ª‘å“®–¬•Ù•Â½•s‘SÇ(AR)‚ÌŠ¥ŒŒ—¬‚É—^‚¦‚é‰e‹¿|Doppler catheter‚É‚æ‚錟“¢|. {“¡‹±ˆêC”¼’J×YC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï i94.11.17j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(‘): 80, 1994.

1707. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Š¥“®–¬“àˆ³‚Ì•ªÍ. ‘q“c“ÄC”¼’J×YC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï i94.11.17j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(‘): 81, 1994.

1708. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰–Ž_ƒpƒpƒxƒŠƒ“Š¥“®–¬“à’“ü‚ªS‹Ø‹@”\‚É‹y‚Ú‚·‰e‹¿. ‹ß“¡‡‹`C›Œ´ŠîWi“Œ—ˆã‘åjC”¼’J×Yi‹¹ŠOj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï i94.11.17j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(‘): 82, 1994.

1709. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”x‚ŒŒˆ³Ç‚É‚Ý‚ç‚ê‚é”x“®–¬“à‚Q•ô«‹ìo—¬‘¬”gŒ`‚Æ”x“®–¬ˆ³–¬”g”½ŽË”g‚Æ‚ÌŠÖ˜A. ‹ß“¡‡‹`i“Œ—ˆã‘åjC”¼’J×YC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï i94.11.17j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(‘): 90, 1994.

1710. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Autologous flap–@‚É‚æ‚é‘“®–¬Š²Ç‚ÌpŒã”x“®–¬˜H‚Ì”­ˆç‚ÌŒø‰Ê. ’†]¢–¾C‰Í“c­–¾CŠ}Œ´^ŒåC•ŽR’¼Ž÷C—Ñ@”ŽC{“¡‹±ˆêCŒ´‰p‘¥C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ25‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ï i95.02.15j, ‰¡•l, “ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŽGŽ, 24(Suppl.): 174, 1995.

1711. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬Ž™ŠJSp‚ɑ΂·‚é–³—AŒŒ‘ÌŠOzŠÂ‚Ì—Õ°“IŒŸ“¢. —Ñ@”ŽC’†]¢–¾C‰Í“c­–¾CŠ}Œ´^ŒåC‘•c“wCŽOD–LCÎŒ´ºi‹¹ŠOjC•½Î‘iŽ™j: ‘æ31‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i94.06.01j, ‚¼, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽGŽ, 30(3): 553, 1994.

1712. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j cŠuŽîá‡. ‹g‘º”Ž–Mi‹¹ŠOj: ‘æ2‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï‹³ˆçƒZƒ~ƒi[ i95.02.25j, “Œ‹ž.

1713. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘m–X•Ù‹y‚Ñ•Ù—Ö‚©‚ç”­¶‚µ‚½¶–[”S‰tŽî. •ŽR’¼Ž÷i‹¹ŠOjCŽðˆäÍCˆ¢•”³ˆêC‰ØŽR’¼“ñC‘å‘òŠ²•vi¹—ê•l¼•a‰@j: ‘æ90‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.06.25j, Š‘ò.

1714. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’¼Ú•«‡–@‚ÆBarbero-Marcial–@‚É‚æ‚éˆêŠú“IC•œp‚ɬŒ÷‚µ‚½‘å“®–¬‹|—£’fǂ𔺂¤‘“®–¬Š²Ç‚Ì1V¶Ž™—á. —Ñ@”ŽC’†]¢–¾C‰Í“c­–¾CŠ}Œ´^ŒåC‹{‰i–ÎŽ÷C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ90‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.06.25j, Š‘ò.

1715. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹‘å‹ÇŒÀ«‹¹–Œ’†”çŽî‚Ì1Žèp—á. ‘•c“wC•i“cƒC—é–Ø—TŽqC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ91‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.09.17j, “Œ‹ž.

1716. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “ñŠK“°Žèp‚É‚æ‚éd-TGA‡VŒ^‚Ì1Ž¡Œ±—á. •ŽR’¼Ž÷C’†]¢–¾C‰Í“c­–¾C{“¡‹±ˆêCŒ´‰p‘¥C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ91‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.09.17j, “Œ‹ž. ‚…

1717. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j PTMCŽž‚ÌŠ¥ŒŒ—¬•ªÍ. “V–ì—²bC”¼’J×YC‹ß“¡‡‹`C¼ŽR´ŒhC‹g‘º”Ž–Mi‹¹ŠOjCÄ“¡Ž iÓ슙‘q•a‰@j: ‘æ154‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.12.17j, “Œ‹ž.

1718. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’á¶S‹@”\Ç—á(EF10%ˆÈ‰º)‚ɑ΂·‚éCABG‚Ì1—á. ‘q“c“ÄC•—ŠÔ”ÉC“V–ì—²bC’¬ˆä³lC¼ŽR´ŒhC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ92‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.12.20j, “Œ‹ž.

1719. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘“®–¬Š²Ç‡VŒ^‚ɑ΂·‚鎩ŒÈ”x“®–¬‚ð—˜—p‚µ‚½ÄŒšŽèp. {“¡‹±ˆêC’†]¢–¾C‰Í“c­–¾C•ŽR’¼Ž÷CŒ´‰p‘¥C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ93‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.02.25j, ‘å‹{.

1720. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹z“üNO—Ö@‚ª‘tŒø‚µ‚½CABGpŒãŒÄ‹z•s‘S‚Ì1—á. ‘q“c“ÄC•—ŠÔ”ÉC’¬ˆä³lC“V–ì—²bC¼ŽR´ŒhC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ93‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.02.25j, ‘å‹{.

1721. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j [ÇŒãÄŠJ’ÊÓ”CŠ¥“®–¬“à‚ÌŒŒ—¬•ªÍ. “V–ì—²bC”¼’J×YC¼ŽR´ŒhC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ155‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.02.25j, “Œ‹ž.

1722. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”xŠà‰»Šw—Ö@‚É‚¨‚¯‚éG-CSF‚ÌŽg—pŒoŒ±. ‹g‘º”Ž–Mi‹¹ŠOj: ‘æ18‰ñŠàŽ¡—ç˜b‰ï i95.03.11j, ‰¡•l.

1723. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j –ñ‚R”NŠÔ‚ÌŒoŒûfuluconazole“Š—^‚É‚Äk¬‚µ‚½ˆâŽc‹¹o“àaspergilloma‚Ì1—á. Œ´‰p‘¥C•i“cƒC—é–Ø—TŽqCŽR‰º‹gdC“à“¡ŽçC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ72‰ñ“ú–{‹CŠÇŽxŠw‰ïŠÖ“ŒŽx•”‰ï i95.03.18j, “Œ‹ž.

1724. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŽóŒã19“ú–ڂɶŽºØŠJ‚©‚ç•Â½p‚ðs‚Á‚½ŠO«SŽº’†ŠuúE‚Ì1Šw“¶—á. ‰Í“c­–¾C’†]¢–¾CŒ´‰p‘¥C{“¡‹±ˆêC•ŽR’¼Ž÷C¡ˆäŠ°C‹g‘º”Ž–Mi‹¹ŠOj: ‘æ3‰ñƒNƒŠƒjƒJƒ‹EƒrƒfƒIƒtƒH[ƒ‰ƒ€ i95.02.03j, “Œ‹ž, ´˜^W, p.37, 1995.


<<1503 ?? >>

1725. mŒ´’˜n Anomaly of venous system in congenital occipital dermal sinus. “c’†–ö…C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC›Mˆêi•újCŽs앶•Fi”]ŠOj: Acta Neurochir., 128: 174`179, 1994.

1726. mŒ´’˜n L-NNA decreases cortical hyperemia and brain cGMP levels following CO2 inhalation in Sprague-Dawley rats. “ü‘qŽŒÈ CMayanard, K.I.CLee, W.S.CMoskowitz, M.A.iStroke Res. Lab., Neurosurgery and Neurology Services, Massachusetts General Hospitalj: Am. J. Physiol., 267: 837`843, 1994.

1727. mŒ´’˜n Cerebral bacterial aneurysm and indications for cerebral angiography in infective endocarditis. ŽR“cŸC‹{â‰À’ji”]ŠOjC‚–ØGi‘å˜aŽs—§•a‰@jC–î“cŒ«ŽOi”]ŠOj: Neurol. Med. Chir., 34: 697`699, 1994.

1728. mŒ´’˜n Experimental saccular aneurysms. ‡U. A new model in swine. G. GuglielmiCC. JiCT.F. MassoudC‘q“c²i”]ŠOjCS.P. LownieCF. VinuelaCJ. Robert(Univ. California): Neuroradiology, 36: 547`550, 1994.

1729. mŒ´’˜n Radiological study of symptomatic Rathke's cleft cysts. ‰ªGGCì–ìM”VCz–K’m–çC–î“cŒ«ŽOi”]ŠOjC›Mˆêi•újC‹T’J“Oi•a—j: Neurosurgery, 35: 632`637, 1994.

1730. mŒ´’˜n Spinal cord intramedullary pressure; A possible factor in syrinx growth. ‹kŽ ‘C–kŒ´s—YC”Ñ“cG•vC–î“cŒ«ŽOi”]ŠOj: Spine, 19: 2174`2179, 1994.

1731. mŒ´’˜n The effects of a carotid-jugular fistula on cerebral blood flow in the cat: An experimental study in the acute period. ‹{â‰À’jCí”ՉÈêC“ü‘qŽŒÈC‘q“c²C“c’†–ö…CXˆä½“ñC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i”]ŠOj: Surg. Neurol., 41: 396`398, 1994.

1732. mŒ´’˜n nj󫃉ƒgƒP—ô”X–E‚Ì—Õ°ŒŸ“¢. ‰ªGGCì–ìM”VCz–K’m–çC–î“cŒ«ŽOi”]ŠOj: ”]ŠOŽ, 3: 324`328, 1994.

1733. mŒ´’˜n ƒ‰ƒbƒg”]‹•ŒŒŽÀŒ±ƒ‚ƒfƒ‹‚É‚¨‚¯‚é basic fibroblast growth factor(bFGF)“Š—^Œø‰Ê‚ɂ‚¢‚Ä. “c’†–ö…C‹{â‰À’ji”]ŠOjCŠÛŽR–ΑPiŽÀ“®ŒnjCŽR“cŸC‘q“c²i”]ŠOj: ”]‘²’†, 16: 186`190, 1994.

1734. mŒ´’˜n Œã“ªŠWâ|AVM‚ɑ΂·‚é“Eop\“Á‚ÉŽ¡—ìѕs—Ç—á‚ÌŒŸ“¢\. ‹{â‰À’jC‘q“c²C“c’†–ö…CŽR“cŸC‰iˆä¬Ž÷Cí”ՉÈêC‘å“ä’mCŽOŽ}GˆÉC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC‹{â‰À’ji”]ŠOj: ”]‘²’†‚ÌŠO‰È, 22: 227`233, 1994.

1735. mŒ´’˜n ”j—ô“®–¬áŽp’†‹ÇŠ”]ŒŒ—¬—Ê‘ª’è‚Ì—L—p«. í”ՉÈêC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ”]‘²’†‚ÌŠO‰È, 22: 385`388, 1994.

1736. mŒ´’˜n Ž©‘RŒo‰ß‚ʼnü‘P‚µ‚½‰ð—£«’Åœ“®–¬áŽ‚ɂ‚¢‚Ä. ‰ªGGCXˆä½“ñi”]ŠOjC‹gìG‹NiŠÖ“Œ˜JЕa‰@j: ”]‘²’†‚ÌŠO‰È, 23: 9`12, 1995.

1737. m€Œ´’˜n ŠO«”]ŒŒŠÇ¹k‚Ì‚Q—á. “c’†’qŽqC‰F’ÖؑC‹g“cF—FC‰““¡¹Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: “ú‹~‹}ˆã‰ïŠÖ“ŒŽ, 15: 494`495, 1994.

1738. m€Œ´’˜n Œz’Å¥Œz‘‘¹‚É‚¨‚¯‚铪•”ŠO‚̇•¹. ”Ñ“cG•vC‹kŽ ‘CŽRè‹`‹éi”]ŠOjC‘å˜a“c—²i‹~–½jC–î“cŒ«ŽOi”]ŠOj: “ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ïŽGŽ, 7: 160`161, 1994.

1739. m€Œ´’˜n ‘¤•ûi“ü–@‚É‚æ‚è‘O•ûœˆ³‚ðŽ{s‚µ‚½“ªŠW’êŠ×“üÇ‚Ì‚P—á. ŽOˆäŒö•Fi‘—§‘Š–ÍŒ´•a‰@jC“c’†ç•Fi”]ŠOj: “ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ïŽGŽ, 7: 218`219, 1994.

1740. m€Œ´’˜n ‘Od–ŒŠO”^ᇂɂæ‚藼㎈–ƒáƒ‚ð’悵‚½“ûŽ™‚Ì‚P—á. ‘O‘ò_C‘ˆä³„C”Ñ“cG•vCŽRè‹`‹éC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: “ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ïŽGŽ, 7: 58`59, 1994.

1741. m€Œ´’˜n Ò‘‘“àŒ‹ŠjŽî‚Ì‚P—á. –kŒ´s—Yi”]ŠOj: “ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ïŽGŽ, 7: 68`69, 1994.

1742. m€Œ´’˜n ‚­‚à–Œ‰ºoŒŒdÇ—á(WFNS GR5)‚É‚¨‚¯‚鎡—Õûj‚ÌŒŸ“¢. ‹g“cF—Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 14: 210`211, 1993.

1743. mŒ¤‹†•ñiŒú¶Èjn ¬”]G“ƒwƒ‹ƒjƒA‚É”º‚¤Ò‘‹ó“´Ç‚ÌŽÀŒ±“IŒ¤‹†. ‹kŽ ‘CŽRè‹`‹éC”Ñ“cG•vC–î“cŒ«ŽOi”]ŠOjC‘¾“cŒ°¬i•újCª–{“TŽqi‘‡—Õ°Œnj: Ò‘‹ó“´Ç‹y‚Ñ“ñ•ªÒ’ÅÇ‚É”º‚¤Ò‘•a‘Ô‹y‚ÑŽ¡—ÂɊւ·‚錤‹†•½¬5”N“xŒ¤‹†•ñ‘, p.5`8, 1994.

1744. mŒ¤‹†•ñiŒú¶Èjn Ò‘L’£‚É”º‚¤Ò‘“àˆ³‚Ìã¸|Anchoring Effect‚ð‹K’è‚·‚éÒ‘‚ˆÊ|. ‹kŽ ‘C”Ñ“cG•vCŽRè‹`‹éC–î“cŒ«ŽOi”]ŠOj: Ò‘‹ó“´Ç‹y‚Ñ“ñ•ªÒ’ÅÇ‚É”º‚¤Ò‘•a‘Ô‹y‚ÑŽ¡—ÂɊւ·‚錤‹†•½¬5”N“xŒ¤‹†•ñ‘, p.41`44, 1994.

1745. mÇ—á•ñn Dural arteriovenous malformation involving the inferior petrosal sinus. ŽR“cŸC‹{â‰À’jC–kŒ´s—YC–î“cŒ«ŽOi”]ŠOjC›Mˆêi•új: Neurol. Med. Chir., 34: 300`303, 1994.

1746. mÇ—á•ñn Aneurysmography for visualizing large aneurysms. ‘q“c²C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC›Mˆêi•új: Neurosurgery, 34: 745`753, 1994.

1747. mÇ—á•ñn Intracranial extracerebral glioma. ‰ªGGCì–ìM”VCXˆä½“ñCz–K’m–çC“ü‘qŽŒÈCÄ“¡•Žui”]ŠOj: ”]Žîᇕa—, 11: 193`200, 1994.

1748. mÇ—á•ñn ‘½”­«”]“]ˆÚ‚ð‚«‚½‚µ‚½‹CŠÇŽxCarcinoid|ŠO‰È“I‚É‘S“E‚µ‚¦‚½Ç—á|. ‚–쮎¡i–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[jCÄ“¡Œ³—ÇC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC‘å•”½i•a—jC‚–ØGi‘å˜aŽs—§•a‰@j: ”]_ŒoŠO‰È, 22: 343`348, 1994.

1749. mÇ—á•ñn Venous Angioma‚Æ‘¼‚Ì”]ŒŒŠÇŠïŒ`‚Ƃ̇•¹Ç—á. “c’†–ö…C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–ö‰ºŽO˜Yi_“Þ샊ƒnƒrƒŠj: ”]_ŒoŠO‰È, 22: 665`669, 1994.

1750. mÇ—á•ñn p‘Of’f‚ª¢“ï‚Å‚ ‚Á‚½Š®‘SŒŒð«––½«’†‘å”]“®–¬áŽ‚Ì‚P—á. ‰ªGGC‘q“c²C‹{â‰À’jC¬—шè•vC‘å“ä’mC–î“cŒ«ŽOCXˆä½“ñi”]ŠOjC›Mˆêi•új: ”]_ŒoŠO‰È, 22: 677`680, 1994.

1751. mÇ—á•ñn d–ŒŠO“®Ã–¬ŠïŒ`‚É‹Nˆö‚µ‚½‹}«Œz‘d–ŒŠOŒŒŽî‚Ì‚P—á. ‚–쮎¡CÄ“¡Œ³—Çi–kŒ¤ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@jC–{‹§i‘å˜aŽs—§•a‰@jC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC‚–ØGi‘å˜aŽs—§•a‰@j: ”]_ŒoŠO‰È, 22: 845`849, 1994.

1752. m‘àn ˆã—É摜‚Ì“ü—Í–@‚Æ Personal filling system. ‰““¡¹Fi”]ŠOj: ‰f‘œî•ñMedical, 26(25): 1408`1411, 1994.

1753. m‘àn ŽèpŒãŠÇ—. ‰““¡¹Fi”]ŠOjC‘å˜a“c—²i‹~–½j: ‹~‹}ˆãŠw, 18(11): 1605`1609, 1994.

1754. muÀn Ò‘Ž¾Š³‚Ì•a‘Ô¶—. ‹kŽ ‘i”]ŠOj: ”]ŠOŽ, 4: 5`10, 1995.

1755. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; ‹~‹}Š³ŽÒ‚̎戵‚¢‚Ɖž‹}ˆ’u\Ò‘ŠO, p.15`16, –î“cŒ«ŽOi”]ŠOj. •ÒW ‹TŽR³–MC‚‘qŒö•üC ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1756. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; ‘ÎÇŽ¡—Ã\‹}«‰¡’f«Ò‘áŠQ, p.74, –î“cŒ«ŽOi”]ŠOj. •ÒW ‹TŽR³–MC‚‘qŒö•üC ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1757. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; ”]Žîá‡\‘½Œ`‰©F¯äPŽî, p.279`280, ì–ìM”Vi”]ŠOj. •ÒW ‹TŽR³–MC‚‘qŒö•üC ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1758. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; “ª•”ŠO, Ò‘¥Ò’ÅŠO\‘½«”]“®–¬áŽ, p.404, ‹kŽ ‘i”]ŠOj. •ÒW ‹TŽR³–MC‚‘qŒö•üC ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1759. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; “ª•”ŠOCÒ‘¥Ò’ÅŠO\‘½«d–Œ“®Ã–¬á‘, p.405, ‹kŽ ‘i”]ŠOj. •ÒW ‹TŽR³–MC‚‘qŒö•üC ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1760. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; “ª•”ŠO, Ò‘¥Ò’ÅŠO\Ò’Å¥Ò‘ŠO–«Šú‚ÌŠÇ—, p.425`427, ‹{â‰À’ji”]ŠOj. •ÒW ‹TŽR³–MC‚‘qŒö•üC ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1761. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; ––½_ŒoŽ¾Š³\––½_Œo‚ÌŠO, p.730, ‹kŽ ‘i”]ŠOj. •ÒW ‹TŽR³–MC‚‘qŒö•üC ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1762. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; ––½_ŒoŽ¾Š³\––½_Œo‚ÌŽîá‡, p.731, ‹kŽ ‘i”]ŠOj. •ÒW ‹TŽR³–MC‚‘qŒö•üC ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1763. mŠwp‘n i•ª’SŽ·•Mj “ªŠW’ê‚ÌŠO‰È; ŠC–ÈÖ¬“´\‘O°“Ë‹N•”Žîᇠ(3)ŠC–ÈÖ¬“´•”‘–ŒŽî‚ÌŽèp, p.273`279, ‹{â‰À’ji”]ŠOj. •ÒW ”’”n–¾CŽR‰Y»C ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1764. mŠwp‘n i•ª’SŽ·•Mj “ª•”CÒ’ÅÒ‘ŠOŽ¡—Ã}ƒjƒ…ƒAƒ‹; Žó’¼Œã‚Ì‹Ù‹}f’fC‹Ù‹}ˆ’u, p.1`20, p.32`35, ‹{â‰À’ji”]ŠOj. •ÒW –î“cŒ«ŽOC‹à“c´ŽuCŽR‰Y», ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1765. mŠwp‘n i•ª’SŽ·•Mj “ª•”CÒ’ÅÒ‘ŠOŽ¡—Ã}ƒjƒ…ƒAƒ‹; ŽOŽŸˆã—Ë@ŠÖ‚ւ̈ڑ—Žž‚̃`ƒFƒbƒNƒ|ƒCƒ“ƒg, p.36`39, ‹{â‰À’ji”]ŠOj. •ÒW –î“cŒ«ŽOC‹à“c´ŽuCŽR‰Y», ˆãŠw‘‰@, “Œ‹ž, 94.00.00”­s.

1766. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Association of head trauma in patients with cervical spine and spinal cord injury. ”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: ‘æ33‰ñ‘Ûƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i94.05.31j, _ŒË.

1767. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j An experimental model of cerebral venous hypertension induced by intracranial arteriovenous shunt in the dog. ŽR“cŸC‹{â‰À’jCí”ՉÈêC“c’†–ö…C‘q“c²C–î“cŒ«ŽOi”]ŠOj: ‘æ1‰ñ“ªŠW“àÖ¬Œn‚ÌŠO‰È‘Ûƒ[ƒNƒVƒ‡ƒbƒv i94.09.12j, ‘åã.

1768. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Draining vein pressure increases and hemorrhage in patients with arteriovenous malformation. ‹{â‰À’jC‘q“c²Cí”ՉÈêC“c’†–ö…CŽR“cŸC‰““¡¹FC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ1‰ñ“ªŠW“àÖ¬Œn‚ÌŠO‰È‘Ûƒ[ƒNƒVƒ‡ƒbƒv i94.09.12j, ‘åã.

1769. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Flexion myelopathy of the cervical spine. ŽOˆäŒö•FC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: ‘æ33‰ñ‘Ûƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i94.06.02j, _ŒË.

1770. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ò‘Ž¾Š³‚Ì•a‘Ô¶—. ‹kŽ ‘i”]ŠOj: ‘æ14‰ñ“ú–{”]_ŒoŠO‰ÈƒRƒ“ƒOƒŒƒX i94.05.28j, å‘ä.

1771. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘gDf’f‚É‚¨‚¯‚éependymoma‚Ì”FŽ¯‚Ìd—v«. ì–ìM”Vi”]ŠOjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠjCŒ´³“¹i‰¡•lŽs—§‘åjC“cŠ‰qi¹ƒ}ƒŠƒAƒ“ƒiˆã‘åj: ‘æ35‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i94.06.02j, ŽD–y.

1772. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j p’† Portable DSA•¹—p‚É‚æ‚é”]“®Ã–¬ŠïŒ`‚Ì“Eop. ‹{â‰À’jC‘q“c²C“c’†–ö…C“c’†ç•FCŽR“cŸCí”ՉÈêC‰““¡¹FC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.26j, “¿“‡.

1773. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘“àŽîᇓEo‚É‚¨‚¯‚é‘“à”÷¬‰ð–U; “Á‚É‘O³’†’†Šu‚ÌŒŸ“¢‚©‚ç. ŽOˆäŒö•Fi‘—§‘Š–ÍŒ´•a‰@jCz–K’m–çi”]ŠOjC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@jC–î“cŒ«ŽOi”]ŠOj: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.28j, “¿“‡.

1774. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Central Neurocytoma‚Ì‚QÇ—á|‚»‚Ì”­¶•ê’n‚ɂ‚¢‚Ä‚ÌlŽ@|. ‰iˆä¬Ž÷C‰““¡¹FCì–ìM”VCˆÉ“¡”ä˜CŽui”]ŠOjC‹T’J“Oi•a—j: ‘æ35‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i94.06.02j, ŽD–y.

1775. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –¢n‚È_ŒoŠOãó—tŒnŽîᇂ̓dŒ°“I¥–Ɖu‘gDŠw“IŒ¤‹†i‘‰èŽîC_Œo‰èŽîC‚¨‚æ‚Ñ–¢•ª‰»äPŽî‚È‚Ç‚ð’†S‚É). –ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠjCì–ìM”Vi”]ŠOjC‹T’J“Oi•a—j: ‘æ35‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i94.06.02j, ŽD–y.

1776. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j d–ŒŠO“®Ã–¬ŠïŒ`‚É‹Nˆö‚µ‚½‹}«Œz‘d–ŒŠOŒŒŽî. ‚–쮎¡i–kŒ¤ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@jCÄ“¡Œ³—Çi”]ŠOj: ‘æ29‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i94.09.30j, ˆ®ì.

1777. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j OPLLÇ—á‚É‚¨‚¯‚éMRI T2‹­’²‰æ‘œ‚Å‚Ì‘“à‚‹P“x—̈æ|‚‹P“x—̈攭¶‚ÉŠÖ‚í‚éˆöŽq‚Æ—Õ°“IˆÓ‹`|. –kŒ´s—YCŽRè‹`‹éC”Ñ“cG•vi”]ŠOj: ‘æ29‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i94.10.01j, ˆ®ì.

1778. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œz’ÅÇ«_ŒoªÇ‚ÍÒ‘Ç‚ÖˆÚs‚·‚é‚©H|—Õ°Ç󂨂æ‚щ摜ŠŒ©‚©‚ç‚ÌŒŸ“¢|. ŽRè‹`‹éC‹kŽ ‘C”Ñ“cG•vC–kŒ´s—YC–î“cŒ«ŽOi”]ŠOj: ‘æ29‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i94.10.01j, ˆ®ì.

1779. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘ΖƒáƒŠ³ŽÒ‚Ö‚ÌFlexor Spasm ‚ÌŒ´ˆö‚Æ‚È‚Á‚½öÝ«‘«ªŠÇÇŒóŒQ‚Ì‚P—á. ‹kŽ ‘CŽRè‹`‹éC–kŒ´s—YC”Ñ“cG•vC–î“cŒ«ŽOi”]ŠOj: ‘æ29‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i94.10.01j, ˆ®ì.

1780. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹ó“´Œ`¬Šú‚Æl‚¦‚ç‚ꂽƒLƒAƒŠ[‡TŒ^Ò‘‹ó“´Ç‚Ì‚P—á. ŽOˆäŒö•FC“c’†’qŽqCz–K’m–çi”]ŠOjC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@j: ‘æ29‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i94.10.01j, ˆ®ì.

1781. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘‰tzŠÂ‚̉ü‘P‚É‚æ‚è‹ó“´‚ªÁŽ¸‚µ‚½‚Æl‚¦‚ç‚ꂽ–ü’…«Ò‘‹ó“´Ç‚Ì‚Q—á. ŽOˆäŒö•FCz–K’m–çi”]ŠOjC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@jC´…‹ÅC“c’†’qŽqi”]ŠOj: ‘æ29‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i94.10.01j, ˆ®ì.

1782. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘æ‡V”]Žº“à“ªŠWˆô“ªŽî‚ÌŽèpŒoŒ±. ì–ìM”VC‰ªGGCz–K’m–çC–î“cŒ«ŽOi”]ŠOjCŽðˆäŽOi‰f‘œî•ñ‰Ûj: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.26j, “¿“‡.

1783. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬”]G“ƒwƒ‹ƒjƒA‚É”º‚¤Ò‘‹ó“´Ç‚ÌŽÀŒ±“IŒ¤‹†. ŽRè‹`‹éC‹kŽ ‘C”Ñ“cG•vC–kŒ´s—YC–î“cŒ«ŽOi”]ŠOj: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.26j, “¿“‡.

1784. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j OPLLÇ—á‚É‚¨‚¯‚éMRI T2 ‹­’²‰æ‘œ‚Å‚Ì‘“à‚‹P“x—̈æ|”­¶‘fˆö‚Æ—Õ°“IˆÓ‹`|. –kŒ´s—YCŽRè‹`‹éC”Ñ“cG•vC‹kŽ ‘i”]ŠOj: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.26j, “¿“‡.

1785. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œz’ŒŊԔƒwƒ‹ƒjƒA‚ÌŽ©‘R‹zŽû. ‹kŽ ‘C–kŒ´s—YCŽRè‹`‹éC”Ñ“cG•vi”]ŠOj: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.26j, “¿“‡.

1786. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒvƒŒƒ[ƒ“ƒe[ƒVƒ‡ƒ“ƒXƒ‰ƒCƒh‚ÌFÊŒv‰æ. ˆÉ“¡”ä˜CŽui‹u®Œ`ŠO‰È•a‰@j: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.26j, “¿“‡.

1787. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “ªŠW“àˆ³‚©‚ç‚Ý‚½dÇ“ª•”ŠO‚Ì‘Šú—\Œã”»’è. ‰““¡¹Fi”]ŠOjC–kŒ´F—Yi‹~–½jC‹g“cF—FC‹{â‰À’ji”]ŠOjC‘å˜a“c—²i‹~–½jC–î“cŒ«ŽOi”]ŠOj: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.27j, “¿“‡, Neurol. Med. Chir., 34: 234, 1994.

1788. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Personal computer‚Å‚Ì CT/MR‰æ‘œ‚̉ðÍ‚¨‚æ‚ÑŠˆ—p. ‰““¡¹FC–î“cŒ«ŽOi”]ŠOj: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.27j, “¿“‡, Neurol. Med. Chir., 34: 234, 1994.

1789. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j d–Œ“®Ã–¬ŠïŒ`‚Æ venous ischemia. ‘q“c²C‹{â‰À’jC¬—шè•vCŽO“‡‘å“¿C•½ŽRŽõC´…‹ÅC–î“cŒ«ŽOi”]ŠOjC›Mˆêi•új: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.28j, “¿“‡.

1790. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰º‚‘Ì macroadenoma‚ÌpŒã•úŽËüÆŽË‚Ì—L—p«‚ÉŠÖ‚·‚éÄ•]‰¿|’·ŠúŠÏŽ@—á‚É‚¨‚¯‚錟“¢|. ‰ªGGCì–ìM”VCz–K’m–çC–î“cŒ«ŽOi”]ŠOjC‘å˜a“c—²i‹~–½jC›Mˆêi•új: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.28j, “¿“‡.

1791. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j bFGF‚ÌŽÀŒ±“I”]‹•ŒŒƒ‚ƒfƒ‹‚É‚¨‚¯‚é[Ç‘ƒk¬Œø‰Ê. “c’†–ö…i”]ŠOjCŠÛŽR–ΑPiŽÀ“®ŒnjC‘ˆä³„C‰iˆä¬Ž÷CŽR“cŸC‘q“c²C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.28j, “¿“‡.

1792. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Šá‹…‰^“®áŠQ‚ð’悵‚½‹‘å“àŒz“®–¬ŠC–ÈÖ¬“´•”“®–¬áŽ—á|ŒŒŠÇ“àŽèp‚Ì—LŒø«‚ɂ‚¢‚Ä|. ´…‹ÅC‘q“c²CˆÀ“úÍCŽO“‡‘å“¿C•½ŽRŽõC¬—шè•vC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjCŒü–ì˜a’jiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï i94.11.18j, ‘åã.

1793. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j bFGF‚̃‰ƒbƒg”]‹•ŒŒŽÀŒ±ƒ‚ƒfƒ‹‚É‚¨‚¯‚é”][Ç‘ƒk¬Œø‰Ê. “c’†–ö…CŽOŽ}GˆÉC‰iˆä¬Ž÷CŽR“cŸC‘q“c²C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ‘æ6‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï i94.11.21j, “Œ‹ž.

1794. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚—îŽÒ”]“®Ã–¬ŠïŒ`‚Ì•a‘Ô‚ÆŽ¡—Ã. ‹{â‰À’jC‹g“cF—FC¬—шè•vCŽR“cŸC“c’†–ö…C“ü‘qŽŒÈC‘q“c²C‰““¡¹FC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ20‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i95.03.02j, ‰¡•l.

1795. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬l”­Çƒ‚ƒ„ƒ‚ƒ„•a‚Ì—Õ°“IŒŸ“¢. “ü‘qŽŒÈCŽR“cŸC“c’†–ö…C‘q“c²C‹{â‰À’jC–î“cŒ«ŽOC‰““¡¹Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC›Mˆêi•új: ‘æ20‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i95.03.02j, ‰¡•l.

1796. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”]Ö¬ˆ³˜´i‚É‚æ‚éÖ¬«”]‹•ŒŒ‹}«Šúƒ‚ƒfƒ‹. ŽR“cŸC‹{â‰À’jC“ü‘qŽŒÈCí”ՉÈêC“c’†–ö…C‘q“c²C–î“cŒ«ŽOi”]ŠOj: ‘æ20‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i95.03.03j, ‰¡•l.

1797. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Œz’ÅÇ«Ò‘Ç‚É‚¨‚¯‚éÓ”C•a‘ƒf’f‚ÌŒŸ“¢|’Pˆê’ÅŠÔ•a•ÏÇ—á‚Ì•ªÍ|. ŽRè‹`‹éC‹kŽ ‘C”Ñ“cG•vC–î“cŒ«ŽOi”]ŠOj: ‘æ35‰ñ“ú–{_ŒoŠw‰ï‘‰ï i94.05.20j, •Ÿ‰ª.

1798. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “ªŠW“à‰ð—£«’Åœ“®–¬áŽ‚Ì•a‘Ô‚ÆŽ¡—Ã|22—á‚ÌŒŸ“¢|. ŽR“cŸC‹{â‰À’jC‘q“c²C–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jCXˆä½“ñiìèŽs—§ˆä“c•a‰@j: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.26j, “¿“‡.

1799. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”j—ô”]“®–¬áŽ‚̃NƒŠƒbƒsƒ“ƒOp’†‚̃‚ƒjƒ^ƒŠƒ“ƒO. í”ՉÈêC‹{â‰À’jCŽOŽ}GˆÉC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.28j, “¿“‡.

1800. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚à‚â‚à‚â•a‚É‚¨‚¯‚铪ŠWŠO“àŒz“®–¬‚ÌŒ`‘Ô“I•Ï‰». ‘ˆä³„C‹{â‰À’jC“c’†–ö…C‰iˆä¬Ž÷C‘q“c²Cí”ՉÈêC‰““¡¹Fi”]ŠOjC‚–ØGi‘å˜aŽs—§•a‰@jC–î“cŒ«ŽOi”]ŠOj: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.28j, “¿“‡.

1801. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Nilvadipine ‚Ì”]ŒŒ—¬‚É‹y‚Ú‚·Œø‰Ê. “c’†–ö…C´…‹ÅC•½ŽRŽõC‹g“cF—FCŽR“cŸC“ü‘qŽŒÈC‘q“c²C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ‘æ20‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i95.03.03j, ‰¡•l.

1802. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j ‚µ‚Ñ‚ê‚Æ‘SgŽ¾Š³. ‹kŽ ‘i”]ŠOj: ‘æ57‰ñò‹æˆãŽt‰ïŠwpu‰‰‰ï i94.09.20j, å‘ä.

1803. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰æ‘œã“ÁˆÙ‚ÈŒo‰ß‚ðŽ¦‚µ‚½“®Ã–¬ŠïŒ`‚Ì‚P—á. ‰F’ÖؑC“’‘òòCŽOŽ}GˆÉC‘q“c²C‹{â‰À’ji”]ŠOj: ‘æ54‰ñ”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.06.11j, “Œ‹ž.

1804. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “ü‰@Œo‰ß’†‚ÉŽîá‡k¬‚ð”F‚ß‚½“ªŠWˆô“ªŽî‚Ì‚PÇ—á. ‘å‚O–«C‚–ì½i”]ŠOjCª–{”Éi“Œ‹žŒxŽ@•a‰@jC¼’J‰ë¶ié‹Êˆã‘åj: ‘æ54‰ñ”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.06.11j, “Œ‹ž.

1805. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’˜–¾‚Èœd‰»‘œ‚𔺂¢, “ªŠW“ài“W‚µ‚½mucocele‚Ì‚P—á. ¼X–Mºi‘—§‘Š–ÍŒ´•a‰@jCŽOˆäŒö•FCz–K’m–çC“c’†’qŽqi”]ŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘æ54‰ñ”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.06.11j, “Œ‹ž.

1806. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠO«”]ŒŒŠÇ¹k‚Ì‚P—á. “c’†’qŽqC‰F’ÖؑC‹g“cF—FC‰““¡¹Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²‘å˜a“c—²i‹~–½j: ‘æ37‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i94.06.25j, ‘åˆé.

1807. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘–Œ‰Š‚É‚Ä”­Ç‚µŽ©‘RÁŽ¸‚ð‚«‚½‚µ‚½”]Žîᇂ̂PÇ—á. ‚–ì½C‘å‚O–«i”]ŠOjC›Mˆêi•új: ‘æ55‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.09.17j, –ìŒû‰p¢‹L”O‰ïŠÙ.

1808. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘¤“ªœ‚É”­¶‚µ‚½Fibrous histiocytoma‚Ì‚P—á. ¼X–Mºi‘—§‘Š–ÍŒ´•a‰@jCŽOˆäŒö•FCz–K’m–çi”]ŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ‘æ55‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.09.17j, –ìŒû‰p¢‹L”O‰ïŠÙ.

1809. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŒŒð‰»‹‘å”]“®–¬áŽ‚ɑ΂·‚éIDCÇðp. ´…‹ÅC¬—шè•vCˆÀ“úÍC‘q“c²C‹{â‰À’ji”]ŠOj: ‘æ55‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.09.17j, –ìŒû‰p¢‹L”O‰ïŠÙ.

1810. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰~ŠW•”‚É”­¶‚µ‚½ giant cell tumor‚Ì‚P—á. z–K’m–çCŽOˆäŒö•Fi”]ŠOjC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@j: ‘æ56‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.11.26j, ’–•c‘ã.

1811. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘½•ûŒü‚Ö•ª‰»‚ðŽ¦‚µ‚½–¢•ª‰»”]Žîᇂ̂P—á. ‰F’ÖؑCŽO“‡‘å“¿C¬—шè•vC‰ªGGCì–ìM”Vi”]ŠOj: ‘æ56‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i94.11.26j, ’–•c‘ã.

1812. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹C“¹”M‚ª‹^‚í‚ꂽ‹CŠÇŽx”x–Eôò‰t‚ªŠÓ•Êf’f‚É—L—p‚Å‚ ‚Á‚½‚PÇ—á. “c’†’qŽqC“Œ‰ªG–¾i”]ŠOjC•½“cŒõ”ŽCHŽR‹v®C•‘ò—˜˜YC‘“c‘ìC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.12.03j, ¼–{.

1813. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚Ä‚ñ‚©‚ñ‚Å”­Ç‚µ‚½”玿Ö¬ŒŒðÇ‚Ì‚P—á. ‚–ì½C‘å‚O–«i”]ŠOjC²X–ؑ׎uiŒö—§º˜a•a‰@j: ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i95.02.25j, “Œ‹ž.

1814. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’†‘å”]“®–¬––½« Giant serpentine aneurysm‚Ì‚P—á. ŽO“‡‘å“¿C“c’†–ö…C•½ŽRŽõC‘q“c²C‹{â‰À’ji”]ŠOj: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i95.03.11j, “Œ‹ž.

1815. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŽlŽˆ–ƒáƒ‚ð‚«‚½‚µ‚½Œ‹Šj«‘–Œ‰Š‚Ì‚P—á. z–K’m–çCŽOˆäŒö•Fi”]ŠOjC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@j: ‘æ57‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i95.03.11j, “Œ‹ž.

1816. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j ƒOƒŠƒI[ƒ}‚Ì•a—‚Æ—Õ°. ì–ìM”Vi”]ŠOj: ‘æ12‰ñ“ú–{”]Žîᇕa—Œ¤‹†‰ï i94.04.27j, •Ÿˆä.

1817. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‚­‚à–Œ‰ºoŒŒÇ—á‚Ì‹}«ŠúŠÇ—‚É‚¨‚¯‚é“àŒzÖ¬Ž_‘f–O˜a“xƒ‚ƒjƒ^[‚Ì—L—p«‚ÆŒÀŠE. ‰““¡¹Fi”]ŠOjC–kŒ´F—Yi‹~–½jC¬—шè•vCŽO“‡‘å“¿C•½ŽRŽõC‹g“cF—FC‰F’ÖؑC‹{â‰À’ji”]ŠOjC‘å˜a“c—²i‹~–½jC–î“cŒ«ŽOi”]ŠOj: ‘æ24‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï i95.02.28j, “Œ‹ž.

1818. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “àŒz“®–¬•ÂǃeƒXƒg‚É‚¨‚¯‚éback pressure‚Ì‘ª’èˆÓ‹`‹y‚Ñ‚»‚Ì•]‰¿. ‘q“c²C‘å“ä’mC“c’†ç•FC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC›Mˆêi•új: ‘æ9‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽèpŒ¤‹†‰ï i93.11.25j, å‘ä.

1819. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j nj󫃉ƒgƒP—ô”X–E‚Æ Ciliated craniopharyngioma‚Ì•a—‘gDŠw“IŒŸ“¢|Ciliated craniopharyngioma‚Ì‹NŒ¹‚ɂ‚¢‚Ä|. ‰ªGGCì–ìM”VCz–K’m–çC–î“cŒ«ŽOi”]ŠOjC‹T’J“Oi•a—jC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠj: ‘æ12‰ñ“ú–{”]Žîᇕa—Œ¤‹†‰ï i94.04.27j, •Ÿˆä.

1820. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Œz’ŒŊԔƒwƒ‹ƒjƒA‚ÌŽ©‘R‹zŽû. ‹kŽ ‘CŽRè‹`‹éC”Ñ“cG•vC–î“cŒ«ŽOi”]ŠOj: ‘æ‚X‰ñ“ú–{Ò‘ŠO‰ÈŒ¤‹†‰ï i94.06.02j, ’ÃŽs.

1821. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ¬”]G“ƒwƒ‹ƒjƒA‚É”º‚¤Ò‘‹ó“´Ç‚ÌŽÀŒ±“IŒ¤‹†. ŽRè‹`‹éC‹kŽ ‘C”Ñ“cG•vC–î“cŒ«ŽOi”]ŠOj: ‘æ‚X‰ñ“ú–{Ò‘ŠO‰ÈŒ¤‹†‰ï i94.06.03j, ’ÃŽs.

1822. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Œo’±Œ`œ“´ppŒã‚̉º‚‘Ì macroadenoma‚ÌÄ”­‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ‰ªGGCì–ìM”VCz–K’m–çi”]ŠOjC‘å˜a“c—²i‹~–½jC›Mˆêi•új: ‘æ‚S‰ñŠÔ”]‰º‚‘ÌŽîᇌ¤‹†‰ï i94.06.09j, ˆ®ì.

1823. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j bFGF‚ÌŽÀŒ±“I”]‹•ŒŒƒ‚ƒfƒ‹‚É‚¨‚¯‚é[Ç‘ƒk¬Œø‰Ê. “c’†–ö…C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ7‰ñ”]Ž€”]‘h¶Œ¤‹†‰ï i94.06.18j, ‰¡•l.

1824. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘¤•ûN“ü‚É‚æ‚é‘O•ûœˆ³‚ðs‚Á‚½“ªŠW’êŠ×“üÇ‚Ì‚P—á. ŽOˆäŒö•Fi”]ŠOjC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@jC“c’†’qŽqCz–K’m–çi”]ŠOj: ‘æ6‰ñ“ú–{“ªŠW’êŠO‰ÈŒ¤‹†‰ï i94.06.30j, –¼ŒÃ‰®.

1825. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Astrocytic tumor‚É‚¨‚¯‚é‘gDŠw“Iˆ««“x•ª—Þ‚ÌÄ•]‰¿. ì–ìM”VC‰ªGGCz–K’m–çC–î“cŒ«ŽOi”]ŠOj: ‘æ3‰ñ“ú–{”]ŽîᇃJƒ“ƒtƒ@ƒ‰ƒ“ƒX i94.11.07j, “ß{‚Œ´.

1826. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘–ŒŽî‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp. ‘q“c²C“c’†ç•FCŽOŽ}GˆÉC‘å“ä’mC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC›Mˆêi•új: ‘æ10‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽèpŒ¤‹†‰ï i94.11.24j, VŠƒ.

1827. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠOŒz“®–¬‚Ì’´‘I‘ð“IÇðp‚ɉ—‚¯‚é”]_Œo–ƒáƒ‚̉ñ”ð‚ɂ‚¢‚Ä. “c’†ç•FC—é–Ø˶C‘q“c²C‹{â‰À’jC¬—шè•vC–î“cŒ«ŽOi”]ŠOjC›Mˆêi•új: ‘æ10‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽèpŒ¤‹†‰ï i94.11.25j, VŠƒ.

1828. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‰æ‘œã‰ð—£«“®–¬áŽ‚ð‹^‚킹‚½”]“®–¬áŽ‚Ì‚PÇ—á. ‚–ì½C‘å‚O–«CŽR“cŸC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ6‰ñ_Œo‹~‹}Œ¤‹†‰ï i94.11.26j, “Œ‹ž.

1829. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ˆã—É摜‚Ì Personal filing system. ‰““¡¹FC–î“cŒ«ŽOi”]ŠOj: ‘æ4‰ñ”]_ŒoŠO‰ÈƒRƒ“ƒsƒ…[ƒ^Œ¤‹†‰ï i95.01.21j, ‘åã.

1830. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ACTHŽY¶×–E¥•›t”玿¬‡«‰º‚‘Ì‘BŽî‚Ì‚P—á. ‰ªGGi”]ŠOjC‹T’J“OC¬‚•½Ž¡i•a—jCì–ìM”VC–î“cŒ«ŽOi”]ŠOjCKalman KovacsiSt. Michael Hosp.j: ‘æ5‰ñŠÔ”]‰º‚‘ÌŽîᇌ¤‹†‰ï i95.02.16j, “Œ‹ž.

1831. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ³í‰º‚‘Ì‘gD‚¨‚æ‚щº‚‘Ì‘BŽî‚É‚¨‚¯‚ébcl-2 ˆâ“`Žq‚Ì”­Œ»‚ɂ‚¢‚Ä. ‰ªGGi”]ŠOjC‹T’J“OC²“¡—YˆêC¬‚•½Ž¡i•a—jCì–ìM”VC–î“cŒ«ŽOi”]ŠOj: ‘æ5‰ñŠÔ”]‰º‚‘ÌŽîᇌ¤‹†‰ï i95.02.17j, “Œ‹ž.

1832. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ’¼’BŽèp¢“ï‚È‹‘å”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp. ‘q“c²C“c’†ç•FC‘å“ä’mC“ü‘qŽŒÈC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—Yi‹~–½j: ‘æ24‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï i95.02.28j, “Œ‹ž.

1833. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŒyÇ‚­‚à–Œ‰ºoŒŒŠ³ŽÒ‚ÌpŒã‚ŽŸ‹@”\. –kŒ´s—YCí”ՉÈêi”]ŠOjCâE–{–¾•Fi¸jC‹g“cF—Fi”]ŠOjC–kŒ´F—Yi‹~–½jC‹{â‰À’ji”]ŠOjC‘å˜a“c—²i‹~–½j: ‘æ24‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï i95.03.01j, “Œ‹ž.

1834. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Granular cell tumor(GCT)—l‚Ì‘gD‘œ‚ð’悵‚½ anaplastic astrocytoma‚Ì‚P—á |Anaplastic astrocytoma with massive oncocytic change|. ¬—шè•vCì–ìM”VC‰F’ÖؑC‚–ì½C‰ªGGCz–K’m–çi”]ŠOjC–ö‰ºŽO˜Yi_“Þ쌧‘‡ƒŠƒnƒrƒŠj: ‘æ12‰ñ“ú–{”]Žîᇕa—Œ¤‹†‰ï i94.04.28j, •Ÿˆä.

1835. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’¼’BŽèp¢“ï‚È‹‘å”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp. ‘q“c²C“c’†ç•FCŽOŽ}GˆÉC‘å“ä’mC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—Yi‹~–½j: ‘æ10‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽèpŒ¤‹†‰ï i94.11.25j, VŠƒ.

1836. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’¼’BŽèp¢“ï‚È‹‘å”]“®–¬áŽ‚ɑ΂·‚ép’†DSA, ”ñ—£’EŒ^ƒoƒ‹[ƒ“‚Ì—L—p«‚ɂ‚¢‚Ä. ‘å“ä’mC“’‘òòi”]ŠOjC’†ŽRŒ«Žii‘‡‘¾“c•a‰@jC‘q“c²C“c’†ç•FC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC›Mˆêi•új: ‘æ10‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽèpŒ¤‹†‰ï i94.11.25j, VŠƒ.

1837. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰æ‘œf’f‚Ì¢“ï‚Å‚ ‚Á‚½ŒŒð‰»––½«’†‘å”]“®–¬‹‘å”]“®–¬áŽ‚Ì‚Q—á. •½ŽRŽõC‘q“c²C¬—шè•vC´…‹ÅC‰F’ÖؑC‰ªGGC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC›Mˆêi•új: ‘æ18‰ñ“ú–{”]_ŒoCIŒ¤‹†‰ï i95.01.28j, ¼ŽR.

1838. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Ò‘¥––½_ŒoáŠQ‚Ì•a‘Ô¶—. ‹kŽ ‘i”]ŠOj: ‘æ23‰ñÒ‘¥––½_Œo¥‹ØŽ¾Š³§˜b‰ï i95.03.10j, ÂX.

1839. mŠw‰ïŽåÃi’n•û‰ïjn ‘æ61‰ñ“Œ‹ž”]Žîᇌ¤‹†‰ïi94.06.24j, ì–ìM”Vi”]ŠOj.

1840. mŠw‰ïŽåÃi’n•û‰ïjn ‘æ62‰ñ“Œ‹ž”]Žîᇌ¤‹†‰ïi94.10.15j, ì–ìM”Vi”]ŠOj.

1841. mŠw‰ïŽåÃi’n•û‰ïjn ‘æ63‰ñ“Œ‹ž”]Žîᇌ¤‹†‰ïi95.02.18j, ì–ìM”Vi”]ŠOj.


<<16 ¬Ž™‰ÈŠw>>

1842. mŒ´’˜n Monozygotic twins of different apparent sex. ‰¡“csŽjiŽ™jCÔª“ÖiŠÖ¼ˆã‘åjC“¡–ìé”ViŽ™jC²“¡–FºC¼M»i‘Š–ÍŒ´‹¦“¯•a‰@jC¼‰YM•viŽ™jC‘O“c“OiŠÅŒìŠw•”jC“cŠ‰qi‘Š–ÍŒ´‹¦“¯•a ‰@jC’†–x–LC’†ž–í’ji“Œ‘åj: Am. J. Med. Genet., 53(1): 52`55, 1994.

1843. mŒ´’˜n Congenital euthyroid goitre with impaired thyroglobulin transport. ‘åŽR‹XGiŽ™jC×’J“Œˆê˜Yiç—t‘åjC‹T’J“Oi•a—jC—é–Ø“¿–¾iç—t‘åjC’†‘ºM–çC•—’£KŽiCŽÄŽRŒ[ŽqC‰¡“csŽjC¼‰YM•viŽ™j: Clin. Endocrinol., 41(1): 129`135, 1994.

1844. mŒ´’˜n ICA and organ specific autoantibodies among Japanese patients with early-onset insulin-dependent diabetes mellitus; the JDS study. ‹M“c‰Ãˆêiˆ¤•Q‘åjCŽO‘ºŒå˜Yi—®‹…‘åjC¬—Ñ“N˜YiŒÕ‚Ì–å•a‰@jC¼‰YM•viŽ™jC–L“c—²Œªi“Œ–k‘åjC–kìÆ’ji“ú‘åjC“ú”äˆí˜Ni‘—§‚±‚Ç‚à•a ‰@jC’r“c‹`—YiŽœŒbˆã‘åjC“y“c—Ei’©“ú˜JЕa‰@jCŠ‹’JŒ’i‹ž‘åjC–ì”É—Yi‘åãŽs‘åjC“yˆä–Mhi_ŒË‘åjC¼ŒüO–¾C‰ú”\Kiˆ¤•Q‘åjCw“à•y ’jiw“à•a‰@jC‘ºãŒ[Ž¡i—®‹…‘åj: Diabetes Res. Clin. Pract., 23(4): 187`193, 1994.

1845. mŒ´’˜n development of proliferative retinopathy in Japanese patients with IDDM; Tokyo Women's Medical College Epidemiologic Study. ‰¡ŽRGŽ÷C“àŠƒˆÀŽqC‘å’J•q‰ÃC–؂©‚¨—¢CŠÛŽR–¾ŽqC–x’å•vi“Œ—ˆã‘åjC¼‰YM•viŽ™jC‘åXˆÀŒbi“Œ—ˆã‘åj: Diabetes Res. Clin. Pract., 24(1): 113`119, 1994.

1846. mŒ´’˜n Hypocomplementemia and membranoproliteraive glomerulonephritis in school urinary screening in Japan. ”Ñ‚Šì‹v—YiŽ™jCŒÜ\—’‚·‚ÝŽqi_“Þ쌧—\–hˆãŠw‹¦‰ïjCŽðˆä‹Ši”åj: Pediatr. Nephrol., 8: 420`422, 1994.

1847. mŒ´’˜n Regional blood flow distribution and left ventricular output during early neonatal life; A quantitative ultrasonographic assessment. ãp—z‘¾˜YC•½Î‘CŽO‘òmŽiCL“c•l•vC–ì“n³•FC”ó‰YDC“¡–ìé”VC¬ŒûO‹BC–xŒû‘דTiŽ™j: Pediatr. Res., 36(6): 805`810, 1994.

1848. mŒ´’˜n Influence of iodine excess due to iodine-containing antiseptics on neonatal screeing for congenital hypothyroidism in Hokkaido prefecture, Japan. Œ´“c³•½CŽsŒ´Š¤Crˆäƒ—C–{ŠÔŠ°i“¹—§‰q¶Œ¤‹†ŠjC¼‰YM•viŽ™jC“¡Ž}Œ›“ñi–k‘åj: Screening, 3(3): 115`123, 1994.

1849. mŒ´’˜n ˆ««Ž¾Š³‚ƬŽ™Š³ŽÒ‚Ö‚Ìà–¾. ¬‘ò”ü˜aC¡ˆäƒDiŽ™jCŽR–{‚ŽqC–û’J˜aŽqiŠÅŒì•”jCX“c¶‹IŽqi¸jC“IꌳOi–ƒj: Ž€‚Ì—Õ°, p.47`52, 1992.

1850. mŒ´’˜n bó‘BŽhŒƒƒzƒ‹ƒ‚ƒ“’l‚ðŽw•W‚Æ‚µ‚½ƒNƒŒƒ`ƒ“ǃ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚̸–§ŒŸ¸Šî€’l‚Ì‘S‘’²¸. Œ´“c³•½CŽsŒ´Š¤CVˆäƒ—C–{ŠÔŠ°i“¹—§‰q¶Œ¤‹†ŠjC¼‰YM•viŽ™jC“¡Ž}Œ›“ñi–k‘åj: “ú–{ƒ}ƒX¥ƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ïŽ, 4(1): 51`59, 1994.

1851. mŒ´’˜n ¬Ž™‚É‚¨‚¯‚錌’†RHelicobacter pyloriR‘Ì‚Ì—Õ°“IŒŸ“¢. ‘å“c„•äC¬“‡–M•FC^“º‘¾˜YC“à“¡„•FiŽ™j: “ú–{¬Ž™‰h—{Á‰»Ší•aŠw‰ïŽGŽ, 8(1): 60`65, 1994.

1852. mŒ´’˜n ¬Ž™Šú‚É‚¨‚¯‚錌´ƒyƒvƒVƒm[ƒQƒ“’l‚ÌŒŸ“¢. “à“¡„•FC^“º‘¾˜YC‘å“c„•äC¬“‡–M•FiŽ™j: “ú–{¬Ž™‰h—{Á‰»Ší•aŠw‰ïŽGŽ, 8(2): 120`125, 1994.

1853. mŒ´’˜n SƒGƒR[}‚É‚æ‚è‘ÙŽ™Šú‚æ‚èŠÏŽ@‚µ“¾‚½—‘‰~E•Â½‚𔺂Á‚½¶S’áŒ`¬ÇŒóŒQˆŸŒ^‚Ì1—á. ŽO‘òmŽiC•½Î‘C¬ŒûO‹BCL“c•l•vC–xŒû‘דTC“¡–ìé”VCãp—z‘¾˜YiŽ™j: “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(8): 1616`1621, 1994.

1854. mŒ´’˜n –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é_Œo‰è×–EŽîƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚ÌŒ»‹µ|NBMS‹^—z«—á‚ÌŒo‰ßŠÏŽ@–@‚ɂ‚¢‚Ä. ¡ˆäƒDCŒIŒ´Œ‰C¬‘ò”ü˜aC“‡–{—R‹IŽqC‰““¡‹I—YiŽ™jCΓc˜a•viŠOj: –k—¢ˆãŠw, 25(1): 58`64, 1995.

1855. m€Œ´’˜i‰p•¶jn The effect of concurrent rectal administration of an antipyretic on the rectal absorption of diazepam suppositories: a study in healthy volunteers. •Ð‹Ë’q–çCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqiŽ™j: Brain Dev., 16(4): 342`343, 1994.

1856. m€Œ´’˜i‰p•¶jn Once-daily dose of zonisamide monotherapy in the control of partial seizures in children with cryptogenic localization-related epilepsies: Clinical effects and their pharmacokinetic basis. דc‚Ì‚¼‚ÝCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çiŽ™j: Jpn. J. Psychiatry Neurol., 48(2): 335`337, 1994.

1857. m€Œ´’˜i‰p•¶jn Thyroid function in mothers and fetus during pregnancy and outcome in the children. ¼‰YM•viŽ™j: New Trends in Neonatal Screening, p.209`211, 1994.

1858. m€Œ´’˜i‰p•¶jn HLA-DR, DQ system and IDDM in Japanese. ¼‰YM•viŽ™jCJ.M.R. AparicioCA. Wakisakai–k‘åj: Standarization of Epidemiologic Studies of Host Susceptibility, p.193`200, 1994.

1859. m€Œ´’˜n “_“ª‚Ä‚ñ‚©‚ñ‚ɑ΂·‚éACTH‚Æclonazepam•¹—p—Ö@‚ÌŒø‰Ê|clonazepamŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚̈Ӌ`|. ”’ˆäGKCŽO‰YŽõ’jC‚—œ‰hC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çiŽ™j: TDMŒ¤‹†, 11(3): 197`198, 1994.

1860. m€Œ´’˜n ƒWƒAƒ[ƒpƒ€¿Ü‚Ì‘Ì“à“®‘Ô‚É‹y‚Ú‚·‰ð”M’Á’Éܿ܂̉e‹¿. ¬—Ñ‹P–¾C‹gŽR—F“ñC’©’·•¶–íi–òÜjC•Ð‹Ë’q–ç, »‰ŸÂC”’ˆäGKCŽO‰YŽõ’jiŽ™jC{“¡–F³C‹g“c´•FCŒSŽi´iZ—F‹à‘®ƒoƒCƒIƒTƒCƒGƒ“ƒXjC—é–ØK—Yiº˜a–ò•i‰»Hj: TDMŒ¤‹†, 11(3): 205`206, 1994.

1861. m€Œ´’˜n Zonisamide’PÜ‚P“ú‚P‰ñ“Š—^–@‚ª–³Œø‚ȬŽ™‚Ì•”•ª”­ì‚ɑ΂·‚écarbamazepine‚ÌŒø‰Ê|—¼–ò•¨ŠÔ‚ÌŒŒ’†”Z“x‘ŠŒÝì—p‚ÌŒŸ“¢‚àŠÜ‚ß‚Ä |. ˆÀ•ÛƒŽqCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêC•ˆäŒ¤“ñiŽ™j: ‘æ‚S‰ñ—Õ°¸__Œo–ò—Šw‰ïƒVƒmƒvƒVƒX, p.16`18, 1995.

1862. m€Œ´’˜n Acetaminophen¿Ü‚Ì•¹—p‚ªdiazepam¿Ü‚Ì’¼’°‚©‚ç‚Ì‹zŽû‚É‚¨‚æ‚Ú‚·‰e‹¿. •Ð‹Ë’q–çCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™jC‹gŽR—F“ñC¬—Ñ‹P–¾C’©’·•¶–íi–òŠw•”•a‰@–ò‹ÇŠwjC‹g“c´•FCŒSŽi´C{“¡–F³iSMIƒuƒŠƒXƒgƒ‹j: ”­’B–ò—¥–ò•¨Ž¡—ÃŒ¤‹†‰ïŽGŽ, 7(1): 40`42, 1994.

1863. m€Œ´’˜n V¶Ž™‘̉·‚Ì“ú“àƒŠƒYƒ€‚ÉŠÖ‚·‚錤‹†. ¼ì²Ž}C‹gŽR—F“ñC¬—Ñ‹P–¾C’©’·•¶–íi–òÜjCŽO‰YŽõ’jiŽ™j: ”­’B–ò—¥–ò•¨Ž¡—ÃŒ¤‹†‰ïŽGŽ, 7(1): 43`45, 1994.

1864. mŒ¤‹†•ñi•¶•”Èjn ¬Ž™‚É‚¨‚¯‚éR‚Ä‚ñ‚©‚ñ–ò‚Ì‘Ì“à“®‘Ôƒ‚ƒjƒ^ƒŠƒ“ƒO. ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqiŽ™j: •½¬‚U”N“x‰ÈŠwŒ¤‹†”ï•â•‹àŽÀÑ•ñ‘, 1995.

1865. mŒ¤‹†•ñiŒú¶Èjn ƒˆ[ƒhŠÜ—LÁ“ÅÜŽg—p’†Ž~‚ªTSHŠî€’lÝ’è‚É‹y‚Ú‚·‰e‹¿, ƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒOƒVƒXƒeƒ€‚Ì•]‰¿•û–@‚ÉŠÖ‚·‚錤‹†. ¼‰YM•viŽ™jCŒ´“c³•½CŽsŒ´Š¤i“¹—§‰q¶Œ¤‹†ŠjC“¡Ž}Œ›“ñi–k‘åj: Œú¶ÈSgáŠQŒ¤‹†•½¬5”N“xŒ¤‹†•ñ‘, p.244`246, 1994.

1866. mŒ¤‹†•ñiŒú¶Èjn VDNAŒ^ƒ¿˜A½‹…‹Û‚Ì‚s×–E‘BŽhŒ‚¨‚æ‚уTƒCƒgƒJƒCƒ“ŽY¶ŽhŒ«‚Ì“ÁˆÙRŒ´‚ɂ‚¢‚Ä. ‘å’Ép“ñiŽ™j: Œú¶ÈSg”Çìè•aŒ¤‹†”Ç(ÅI”N“x1995”N“x•ñW), 1994.

1867. mŒ¤‹†•ñiŒú¶Èjn ¬Ž™‚É‚¨‚¯‚éR‚Ä‚ñ‚©‚ñ–ò‚Ì‘Ì“à“®‘Ôƒ‚ƒjƒ^ƒŠƒ“ƒO: ‘¼Ü–³Œø‚È‚Ä‚ñ‚©‚ñÇ—á‚ɑ΂·‚éacetazolamide‚Ì’·ŠúŒø‰Ê‚Æ•›ì—p. ŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqiŽ™j: Œú¶È¸_E_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ï: “‚Ä‚ñ‚©‚ñ‚ÌŽ¡—Ö@ŠJ”­‚ÉŠÖ‚·‚錤‹†, •½¬‚T”N“xŒ¤‹†•ñ‘, p.133`136, 1994.

1868. mŒ¤‹†•ñiŒú¶Èjn ¬Ž™t•s‘S‚É‚¨‚¯‚鬒·áŠQ‚ÉŠÖ‚·‚錤‹†(“§ÍŠ³Ž™‚Ì”­ˆç‚É—^‚¦‚é‰h—{ó‘Ԃ̉e‹¿‚Ì•]‰¿). ”Ñ‚Šì‹v—YiŽ™jCãŽR‘×~i“s—§´£¬Ž™•a‰@jC“s’zˆê•viŽÐ‰ï•ÛŒ¯’†‹ž•a‰@jC‹gì“¿–Îi_ŒË‘åjCŽO‘ºM‰piŒÕ‚Ì–å•a‰@j: •½¬5”N“xŒú¶‰ÈŠwŒ¤‹†”ï•â•‹à, t•s‘Sˆã—ÃŒ¤‹†Ž–‹ÆŒ¤‹†•ñ‘, p.78`79, 1994.

1869. mŒ¤‹†•ñiŒú¶Èjn –kŠC“¹‚É‚¨‚¯‚鬎™Šú”­ÇIDDM‚̉uŠw|HLA”­ÇŠ´Žó«ˆâ“`Žq‚ðŽw•W‚Æ‚µ‚½ˆâ“`‰uŠw“IŒŸ“¢. ¼‰YM•viŽ™j: •½¬5”N“x“œ”A•a’²¸Œ¤‹†•ñ‘, “œ”A•a‰uŠw’²¸Œ¤‹†, p.15`19, 1994.

1870. mÇ—á•ñn Asphyxiating thoracic dystrophy: Surgical correction and 2-year follow-up in a girl. ‚“cŽj’jiŽ™jCL–ØŒöˆêC‘å싱‹éC¡ò´C•–ؗǘaiŒ§—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[j: Jpn. J. Hum. Genet., 39(2): 269`273, 1994.

1871. mÇ—á•ñn ThyroglobulinŒ‡‘¹Ç(Tg“]‘—ˆÙí)‚ÌÇ—á‚ÉŠÖ‚·‚éˆêlŽ@. ‘åŽR‹XGiŽ™jC×’J“Œˆê˜YC‹T’J“Oi•a—jC—é–Ø“¿ºC’†‘ºM–çCˆÀ•ÛƒŽqCŒ´^lCŠÖª“OC•—’£KŽiCŽÄŽRŒ[ŽqC‰¡“csŽjC¼‰YM•viŽ™j: ƒzƒ‹ƒ‚ƒ“‚Æ—Õ°, 42(‘Š§): 86`88, 1994.

1872. mÇ—á•ñn SRY—z«‚̈ꗑ«ˆÙ«‘o‘Ù‚ÌŽo’í—á. ‰¡“csŽjiŽ™jCÔª“ÖiŠÖ¼ˆã‘åjC“¡–ìé”ViŽ™jC²“¡–FºC¼M»C“cŠ‰qi‘Š–ÍŒ´‹¦“¯•a‰@jC‘O“c“OiŠÅŒìŠw•”jC¼‰YM•viŽ™jC’†ž–í’ji“Œ ‘åj: ƒzƒ‹ƒ‚ƒ“‚Æ—Õ°, 43(‘): 240`243, 1995.

1873. mÇ—á•ñn Acrodysostosis‚ÉŒ´”­«bó‘B‹@”\’á‰ºÇ‚ð‡•¹‚µ‚½3—á. •—’£KŽiC‘åŽR‹XGC•—’£^—R”üCŽÄŽRŒ[ŽqC‰¡“csŽjC¬’r–¾”üC—R—˜Œ«ŽŸC¬’ç‹`’jC¼‰YM•viŽ™j: ƒzƒ‹ƒ‚ƒ“‚Æ—Õ°, 43(“~‹G‘): 110`113, 1995.

1874. mÇ—á•ñn —ô”]Ç(Type‡T)‚Ì”]ŒŒ—¬‰æ‘œ; •Ð‘¤ˆÙíWÏ‘œ‚Ì1—á. •—’£^—R”üC²“¡‰ë•FC^“º‘¾˜YCΊٕ•viŽ™jC‘º“cWˆê˜Yi•újC‚“ˆK’ji‘—§¸__ŒoƒZƒ“ƒ^[j: ¬Ž™‰È—Õ°, 47: 1031`1035, 1994.

1875. mÇ—á•ñn Ž©ŒÈR‘Ì—z«‚Å’·ŠúŒo‰ßŠÏŽ@’†‚Ì11ΗŽ™‚É”­Ç‚µ‚½–Œ«‘B«t‰Š. –{ŽRŽ¡C쌴´”üC²’n•×C¼”ö€—YC쑺’å•vi“Œ–M‘åjC”Ñ‚Šì‹v—YiŽ™j: ¬Ž™“à‰È, 26(3): 157`161, 1994.

1876. mÇ—á•ñn ”]“àΊD‰»‚𗈂µ‚½‹U«•›bó‘B‹@”\’ቺǂhŒ^‚Ì“¯–E—á|6”NŠÔ‚ɂ킽‚é’ÇÕŒo‰ß‚ɂ‚¢‚Ä. ‹v•ÛGŽiiŒF–{‘åjC•“c[lC‰œŒ´GŽ¡C–O’Ñ׎jC‚‹´–Li‘ÑL‹¦‰ï•a‰@jC¼‰YM•viŽ™j: ¬Ž™“à‰È, 26(7): 1311`1315, 1994.

1877. mÇ—á•ñn ‹U«•›bó‘B‹@”\’ቺ‚hŒ^‚Ì‚P‰ÆŒn|6”NŠÔ‚ɂ킽‚銳Ž™Žo–…‚Ì’ÇÕ|. ‹v•ÛGŽiC‰œŒ´GŽ¡C–O’Ñ׎jC‚‹´–Li‘ÑL‹¦‰ï•a‰@jC¼‰YM•viŽ™j: ‘æ11‰ñ¬Ž™‘ãŽÓ«œŽ¾Š³Œ¤‹†‰ï•ñ‘, p.41`43, 1994.

1878. mÇ—á•ñn Leprechaunism‚É‚Æ‚à‚È‚¤•F•\”çŽî‚Ì1—á. ¼‘º˜aŽqC¬ò—zŽqC¼‘º“N—C‘å‰ÍŒ´Íi–k‘åjCª–{Ž¡CXì—æŽqC¬’r–¾”üi“l“ì•a‰@jC¼‰YM•viŽ™j: “ú–{”畆‰ÈŠw‰ïŽGŽ, 104(12): 1447`1451, 1994.

1879. m‘àn ƒCƒ“ƒXƒŠƒ“—Ö@‚Ƈ•¹Ç. ¼‰YM•viŽ™j: ƒCƒ“ƒXƒŠƒ“—Ö@1993/4, Insulin Therapy Annual, 2: 95`109, 1994.

1880. m‘àn ‹~‹}‚É‚¨‚¯‚郃“ƒ^ƒ‹ƒPƒA; ¬Ž™‹s‘Ò|‹~‹}ˆã—Âɂ¨‚¯‚é‰Æ‘°‚ւ̑Ήž|. ‘å“c„•äiŽ™j: ‹~‹}ˆãŠw, 18(13): 1827`1829, 1994.

1881. m‘àn ¬Ž™“œ”A•a(IDDM)Š³ŽÒ‚É‚¨‚¯‚éƒCƒ“ƒXƒŠƒ“—Ö@. ‰¡“csŽjC¼‰YM•viŽ™j: Ž¡—ÂÌÅ‘Oü, 1(3): 42`47, 1994.

1882. m‘àn CAPDŠ³Ž™‚̎Љ‹A‚Ì–â‘è“_. –kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YiŽ™j: ¬Ž™‰È, 35(4): 345`350, 1994.

1883. m‘àn æ“V«•›t‰ßŒ`¬‚Ì—A‰t. ¼‰YM•viŽ™j: ¬Ž™‰Èf—Ã, 57(4): 775`780, 1994.

1884. m‘àn Diazepam¿Ü‚É‚æ‚é”M«‚¯‚¢‚ê‚ñ‚ÌÄ”­—\–h. ŽO‰YŽõ’jiŽ™j: ¬Ž™‰Èf—Ã, 57(9): 1588`1594, 1994.

1885. m‘àn ŠO—ˆ‚ł̬Ž™‹}«“«Ž¾Š³|‚»‚Ìf’f‚Æ‹~‹}ˆ’u|11.ƒCƒ“ƒXƒŠƒ“ˆË‘¶«“œ”A•a. ‰¡“csŽjC¼‰YM•viŽ™j: ¬Ž™‰È—Õ°, 47(12): 2637`2644, 1994.

1886. m‘àn ‹~‹}‹~–½ˆã‚Ì‘˜‹ö‚·‚é”í‹s‘ÒŽ™ÇŒóŒQ. ‘å“c„•äiŽ™j: ¬Ž™ŠO‰È, 26(4): 495`500, 1994.

1887. m‘àn ”xƒVƒ“ƒ`ƒOƒ‰ƒ€. ”~Œ´ŽÀCŽl‘q³”ŽCŠÖª“OiŽ™j: ¬Ž™“à‰È, 26(5): 699`705, 1994.

1888. m‘àn • ’É‚ð’æ‚·‚鎾Š³; ŒŒŠÇ«Ž‡”Á•a. ¬“‡–M•FiŽ™j: ¬Ž™“à‰È, 27(2): 72`76, 1995.

1889. m‘àn ƒŒƒNƒ`ƒ…ƒA6; ‡TŒ^“œ”A•a‚Ì•aˆö‚ÉŠÖ‚·‚éÅ‹ß‚Ì’mŒ©. ¼‰YM•viŽ™j: “œ”A•aŠw‚Ìi•à'94, ‘æ28W: 86`91, 1994.

1890. m‘àn ¬Ž™“§ÍŠ³ŽÒ‚ÌAŠw‚Ì–â‘è|¬’†Šw¶‚ÉŽ‹“_‚ð‚¨‚¢‚Ä|. ”Ñ‚Šì‹v—YC–kžŠ‚Ý‚Ç‚èiŽ™j: “§Íƒtƒƒ“ƒeƒBƒA, 4(3): 2`7, 1994.

1891. m‘àn bó‘B‹@”\‚̕ꎙ‘ŠŠÖ. ¼‰YM•viŽ™j: “ú–{–¢nŽ™V¶Ž™Šw‰ïŽGŽ, 6(1): 43`47, 1994.

1892. m‘àn ”M«‚¯‚¢‚ê‚ñ‚ÌÄ”­—\–h. ŽO‰YŽõ’jiŽ™j: –k—¢ˆãŠw, 24(4): 247`256, 1994.

1893. m‘àn bó‘Bƒzƒ‹ƒ‚ƒ“‚̑ٔՒʉ߫‚Æ‘ÙŽ™‚Ì”]‚Ì”­’B. ¼‰YM•viŽ™j: –k—¢ˆãŠw, 24(5): 321`330, 1994.

1894. m‘àn æ“V«SŽ¾Š³. •½Î‘iŽ™j: —Õ°ŠÅŒì, 20(8): 1168`1171, 1994.

1895. m‘àn ¬Ž™“§Í‚̇•¹Ç; ¬’·áŠQ|CAPD|. ”Ñ‚Šì‹v—YiŽ™j: —Õ°“§Í, (5ŒŽ•Êû): 110`115, 1994.

1896. m‘àn ¬Ž™“§Í‚Ì‚·‚ׂÄ; CAPDŽ¡—Â̌»‹µ. ”Ñ‚Šì‹v—YiŽ™j: —Õ°“§Í, (5ŒŽ•Êû): 25`30, 1994.

1897. muÀn ”M«‚¯‚¢‚ê‚ñ‚ÌÄ”­—\–h. ŽO‰YŽõ’jiŽ™j: International Epilepsy News(“ú–{Œê”Å), (115): 10`11, 1994.

1898. muÀn ŠO«ŠíˆÙí‚Ìf—Ã. ¼‰YM•vC¬ì‰ÄŽqiŽ™j: ¬Ž™‰Èf—Ã, 57(10): 1783`1788, 1994.

1899. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; ‹}«¬”]«Ž¸’²Ç, p.825`827, ŽO‰YŽõ’jiŽ™j. •ÒW ‹TŽR³–MiZ—F•a‰@jC‚‘qŒö–¾i“Œ—ˆã‘åjC ˆãŠw‘‰@, “Œ‹ž, 94.07.15”­s.

1900. mŠwp‘n i•ª’SŽ·•Mj Annual Review, zŠÂŠí1995; ”x“®–¬––½‹·ó, “Á‚É”x“®–¬kó‚Ì•p“x, f’f, Ž¡—Ã, p.171`174, •½Î‘iŽ™j. •ÒW ™–{P–¾C¼–{º•FC™‰º–õ˜YC–åŠÔ˜a•v, ’†ŠOˆãŠwŽÐC94.12.00”­s.

1901. mŠwp‘n i•ª’SŽ·•Mj DNA‘½Œ^; DNA‘½Œ^‚É‚æ‚é—‘«f’f, 2: 108`114, Ôª“ÖC‹g“cŠwC‰«ˆä—TC‹g‘ºŸFC–Ȉø—˜[CŽžˆÀ‘¾‹v–iŠÖ¼ˆã‘åjC‰¡“csŽjiŽ™jC’†–x–LC’†ž–í’ji“Œ‘åjC¼Œ´˜a•vC‚‹´ß“TC–Ø‘ºP“ñ˜Yi“‡ ªˆã‘åj. “Œ—m‘“XC“Œ‹žC94.00.00”­s.

1902. m‹³‰È‘n i•ª’SŽ·•Mj •W€¬Ž™‰ÈŠw: ‘æ‚Q”Å; _ŒoŽ¾Š³: áz¹«Ž¾Š³, p.522`529, ŽO‰YŽõ’jiŽ™j. •ÒW ‘OìŠì•½iŽœŒb‘åjC’Ò–F˜Yi’·è‘åjC‘q”É—²Mi‚’m‘åjC ˆãŠw‘‰@, “Œ‹ž, 94.04.15”­s.

1903. m‹³‰È‘n i•ª’SŽ·•Mj •W€¬Ž™‰ÈŠw‘æ2”Å; ‘æ10Í“à•ª”厾Š³, p.206`245, ¼‰YM•viŽ™j. •ÒW ‘OìŠì•½i“ŒŽœˆã‘åjC’Ò–F˜Yi’·è‘åjC‘q”É—²Mi‚’mˆã‘åj, ˆãŠw‘‰@C“Œ‹žC94.04.15”­s.

1904. m‹³‰È‘n i•ª’SŽ·•Mj ¬Ž™‰ÈŠw‘æ7”Å; ‘ãŽÓ«Ž¾Š³, p.268`287, ¼‰YM•viŽ™j. •ÒW –î“cƒˆêi“Œ‹žˆãŽ•‘åjC’†ŽRŒ’‘¾˜Yi“Œ–M‘åj, •¶Œõ“°C94.00.00”­s.

1905. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj “œ”A•a‡•¹Çf—Ãpƒ[ƒuƒbƒN|•a‘Ô¶—‚ÆŠÇ—¥Ž¡—ẪL[ƒ|ƒCƒ“ƒg; ¬Ž™‚Ì“œ”A•a, p.187`195, ¼‰YM•viŽ™j. •ÒW –x“cé`i–¼ŒÃ‰®‘åjC‹gì—²ˆêiŽ ‰êˆã‘åjC–L“c—²Œªi“Œ–k‘åj, “ì]“°C“Œ‹žC94.08.01”­s.

1906. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj “œ”A•a‚̃}ƒl[ƒWƒƒ“ƒg|ƒ`[ƒ€ƒAƒvƒ[ƒ`‚ÆŠ³ŽÒŽw“±‚ÌŽÀÛ; ¬Ž™‚Ì“œ”A•a, p.207`214, ¼‰YM•viŽ™j. •ÒW •½“cK³i“Œ—ˆã‘åjC”É“cK’jiŽ ‰êˆã‘åjC¼‰ªŒ’•½i“Œ‹žÏ¶‰ï’†‰›•a‰@j, ˆãŠw‘‰@C“Œ‹žC94.10.15”­s.

1907. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj New Mook¬Ž™‰È (7)¬Ž™ƒAƒŒƒ‹ƒM[Ž¾Š³‚ÆRƒAƒŒƒ‹ƒM[Ü; RƒAƒŒƒ‹ƒM[Ü‚Ì“K‰ž‚ÆŽg—p–@‚ÌŽÀÛ|ƒgƒ‰ƒjƒ‰ƒXƒg, 7: 120`125, –¥‰YŽ‘¥iŽ™j. •ÒW ¬—Ñ“oi‘—§¬Ž™•a‰@jC”nêˆê—Yi“ú‘åjCԒˇˆêiŽœŒbˆã‘åjCìŒË‰p•Fi—Ε—‘‘•a‰@j, ‹àŒ´o”ÅC“Œ‹žC94.12.20”­s.

1908. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj1995; ¬lÇ(’ág’·), p.747`748, ¼‰YM•viŽ™j. •ÒW ˆîŠ_‹`–¾iç—t˜JЕa‰@jC‘½‰ê{K’ji‘½‰ê{ƒNƒŠƒjƒbƒNjC”öŒ`‰x˜YiŠàŒ¤•t‘®•a‰@j, ˆãŠw‘‰@C“Œ‹ž, 95.02.15”­s.

1909. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Œü¸_–òƒnƒ“ƒhƒuƒbƒN 1994; ¬Ž™‚É‚¨‚¯‚éŽå—vR‚Ä‚ñ‚©‚ñ–ò‚Ì“Š—^—Ê, ŒŒ’†”¼Œ¸Šú, —LŒøŒŒ’†”Z“x, ’†“ÅŒŒ’†”Z“x‚¨‚æ‚Ñ•›ì—p, p.230`234, ŽO‰YŽõ’jiŽ™j. •ÒW ‘å“ú–{»–ò, ‘å“ú–{»–ò, ‘åã, 94.10.01”­s.

1910. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj •a‹C‚ÆŽ¡—ÂƃNƒXƒŠ; ¬Ž™‚̂Ђ«‚‚¯, p.135`136, ŽO‰YŽõ’jiŽ™j. •ÒW ¬—Ñ‹P–¾C²ìŒ«ˆêi–òÜjC –ò‹ÆŽž•ñŽÐEƒ\ƒVƒ€, “Œ‹ž, 95.03.31”­s.

1911. mŽ‹’®Šo‹³ÞEŽ‹’®Šoo”Å•¨n iŠÄCj ‚Ä‚ñ‚©‚ñ‚Æ”­ì(¶ŠU‹³ˆçƒrƒfƒIƒ‰ƒCƒuƒ‰ƒŠ[10); ŠÄC ŽO‰YŽõ’jiŽ™j. “ú–{–òÜŽtŒ¤CƒZƒ“ƒ^[, “Œ‹ž, 94.12.01”­s.

1912. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Screening and enzyme diagnosis of fatty acid oxidation disorders. ŒüŒã—˜ºCŽR–{d‘¥Cˆ¢•””Ž‹IC‹à‘ò³Ž÷iç—t‘åjC‚–ö³Ž÷iç—tŒ§‚±‚Ç‚à•a‰@jC‘å’|–¾C÷’ë‹ÏC—é–Ø‹`”Vi“s—Õ°ˆãŠw‘‡Œ¤‹†ŠjCŠ`ÀG–¾C²“¡ D”ÍC‰ÔéŒb”üŽqi‘—§—×{Š‰ºŽu’Õa‰@jC‚“cŽj’jC¼‰YM•viŽ™jCV”üm’jiç—t‘åj: 6th International Congress Inborn Errors of Metabolismi‘æ6‰ñ‘Ûæ“V‘ãŽÓˆÙíŠw‰ï‘‰ï) i94.05.27`31j, Milano (Italy).

1913. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Clinical, biochemical, and molecular studies in fatty acid oxidation disorders(1): a Japanese case with carnitine palmitoyltransferase 1 deficiency presenting familial Reye-like episode. ŽR–{d‘¥Cˆ¢•””Ž‹IC‹à‘ò³Ž÷CŒüŒã—˜ºiç—t‘åjC‚–ö³Ž÷iç—tŒ§‚±‚Ç‚à•a‰@jC‘å’|–¾C÷’ë‹ÏC—é–Ø‹`”Vi“s—Õ°ˆãŠw‘‡Œ¤‹†ŠjCŠ`ÀG–¾C²“¡ D”Íi‘—§—×{Š‰ºŽu’Õa‰@jC^’ë‘C‘å“cŒ´r•ãi‰ª‘åjC‚“cŽj’jC¼‰YM•viŽ™jCV”üm’jiç—t‘åj: 6th International Congress Inborn Errors of Metabolism (‘æ6‰ñ‘Ûæ“V‘ãŽÓˆÙíŠw‰ï‘‰ï) i94.05.27`31j, Milano (Italy).

1914. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Pulmonary function tests cannot exactly predict exercise induced hypoxemia in children with chronic lung disease. –¥‰YŽ‘¥C“n•Ó“oC’†“ˆ‰p•FC”~Œ´ŽÀC’·“cŒúCŽl‘q³”ŽCŠÖª“OCŒ´^liŽ™j: 1st International Congress on Pediatric Pulmonology i94.06.02`05j, ƒj[ƒX.

1915. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Discrepancy between ‡T-123 IMP pulmonary imaging and Tc-99m MAA perfusion scintigraphy in pediatric pulmonary disease. ”~Œ´ŽÀCŠÖª“OCŽl‘q³”ŽC“n•Ó“oC’†“ˆ‰p•FiŽ™jCΈ䟌Èi•új: ‘æ6‰ñ¢ŠEŠjˆãŠw‰ï‹c i94.10.27j, Sydney.

1916. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j GAD-Ab, antithyroid Abs, and HLA antigens in Japanese IDDM patients diagnosed before age 15 years. •—’£KŽiC¼‰YM•vC‘åŽR‹XGC‰¡“csŽjC•—’£^—R”üCŽÄŽRŒ[ŽqC•Ÿ“‡’¼Ž÷C¬’r–¾”üCŒ´“c³•½CŽRŒûW¶iŽ™j: 20th Annual Meeting of International Society of Pediatric and Adolescent Diabetes i94.11.02`06j, ”MŠC, Diabetes in the Young, 30(2): 65, 1994.

1917. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Spectrotype of endothelial cell autoantigens in systemic vasculitis. Žç‰®r‰îiŽ™jCKhouri, N.A.CCameron, J.S.CFrampton, G.iGuy's Hosp.j: 5th International ANCA Workshop i93.09.01j, Cambridge, U.K., Clinical and Experimental Immunology, p.26, 1993.

1918. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Moment analysis of multiple breath nitrogen washout in children with chronic lung disease. Žl‘q³”ŽC“n•Ó“oC’†“ˆ‰p•FC”~Œ´ŽÀC–¥‰YŽ‘¥C’·“cŒúCŠÖª“OCŒ´^liŽ™j: 1st International Congress on Pediatric Pulmonology i94.06.03j, ƒj[ƒX, Abstracts, p.157, 1994.

1919. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Serum pepsinogens in children with peptic ulcer. ^“º‘¾˜YCŒÃâÙG—mC“à“¡„•FC‘å“c„•äC¬“‡–M•FiŽ™jCΈ䟌Èi•új: ‘æ4‰ñ”Ä‘¾•½—m¬Ž™‰h—{Á‰»Ší•aŠw‰ï i94.09.05`08j, “Œ‹ž.

1920. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Beneficial effect of intravenous administration of atropine sulfate on hypertrophic pyloric stenosis. “à“¡„•FCŽO{—zŽqCŒÃâÙG—mC‘å“c„•äC^“º‘¾˜YC¬“‡–M•FiŽ™j: ‘æ4‰ñ”Ä‘¾•½—m¬Ž™‰h—{Á‰»Ší•aŠw‰ï i94.09.05`08j, “Œ‹ž, Programme and Abstracts, p.160, 1994.

1921. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Obstruction of the proximal pulmonary artery branches following pulmonary artery banding. •½Î‘CŽO‘òmŽiCãp—z‘¾˜YCL“c•l•vC•“cM—TiŽ™jC’†]¢–¾C‰Í“c­–¾i‹¹ŠOj: ‘æ16‰ñƒˆ[ƒƒbƒpS‘Ÿ•aŠw‰ï i94.09.10j, ƒxƒ‹ƒŠƒ“(ƒhƒCƒc).

1922. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effect of concurrent rectal administration of antipyretic on rectal absorption of diazepam suppositories. ŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽq, •Ð‹Ë’q–çiŽ™j: ‘æ7‰ñ‘Û¬Ž™_ŒoŠw‰ï‹c¥‘æ23‰ñƒAƒƒŠƒJ¬Ž™_ŒoŠw‰ï‡“¯‰ï‹c(7th Congress of the International Child Neurology Association, 23rd National Meeting of the Child Neurology Society and 1st Conjoint Meeting of the Child Neurology Society and International Neurology Association) i94.10.03j, San Francisco, Pediatric Neurology, 11(2): 124, 1994.

1923. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Long-term effectiveness and side effects of acetazolamide as adjunct to other antiepileptic drugs in treatment of refractory epilepsies. ˆÀ•ÛŒ«ˆêCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛƒŽqiŽ™j: ‘æ7‰ñ‘Û¬Ž™_ŒoŠw‰ï‹c¥‘æ23‰ñƒAƒƒŠƒJ¬Ž™_ŒoŠw‰ï‡“¯‰ï‹c (7th Congress of the International Child Neurology Association, 23rd National Meeting of the Child Neurology Society and 1st Conjoint Meeting of the Child Neurology Society and International Neurology Association) i94.10.03j, San Francisco, Pediatric Neurology, 11(2): 124`125, 1994.

1924. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effectiveness and plasma levels of valproic acid with use of new slow-release preparation of sodium valproate. ”’ˆäGKCŽO‰YŽõ’jC‚—œ‰hC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽq, •ˆäŒ¤“ñiŽ™j: ‘æ7‰ñ‘Û¬Ž™_ŒoŠw‰ï‹c¥‘æ23‰ñƒAƒƒŠƒJ¬Ž™_ŒoŠw‰ï‡“¯‰ï‹c (7th Congress of the International Child Neurology Association, 23rd National Meeting of the Child Neurology Society and 1st Conjoint Meeting of the Child Neurology Society and International Neurology Association) i94.10.03j, San Francisco, Pediatric Neurology, 11(2): 125, 1994.

1925. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Molecular nature of IgA binding to specific endothelial cell membrane antigens in IgA nephropathy. Žç‰®r‰îiŽ™jCKhouri, N.A.CCameron, J.S.CFrampton, G.iGuy's Hosp.j: American Society of Nephrology i94.10.27j, Orlando, USA, Abstract, p.838, 1994.

1926. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical study of ‡T-123 IMP pulmonary imaging in bronchopulmonary dysplasia. ŠÖª“OC”~Œ´ŽÀCŽl‘q³”ŽC–¥‰YŽ‘¥C“n•Ó“oC’†“ˆ‰p•FiŽ™jC–x’rdŽ¡CΈ䟌Èi•új: 6th World Congress of the World Federation of Nuclear Medicine & Biology i94.10.28j, Sydney.

1927. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Serum pepsinogens in children with peptic ulcer. ^“º‘¾˜YCŒÃ“¡G—mC“à“¡„•FC‘å“c„•äC¬“‡–M•FiŽ™jCΈ䟌Èi•új: ‘æ6‰ñ¢ŠEŠjˆãŠw‰ï‹c i94.10.28j, Sydney.

1928. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Prognosis in Japanese patients with IDDM diagnosed before the age of 18. ŠÛŽR–¾ŽqC‰¡ŽRGŽ÷C‘å’J•q‰ÃC–؂©‚¨—¢CŠ}Œ´“ÂC“àŠƒˆÀŽqC¼‰YM•vC‘åXˆÀŒbC“c›×®ŽqiŽ™j: 20th Annual Meeting of International Society of Pediatric and Adolescent Diabetes i94.11.02`06j, ”MŠC, Diabetes in the Young, 30(2): 32, 1994.

1929. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Causes of death in Japanese patients with IDDM diagnosed before the age of 30. ŠÛŽR–¾ŽqC“àŠƒˆÀŽqC‰¡ŽRGŽ÷C‘å’J•q‰ÃC–؂©‚¨—¢CŠ}Œ´“ÂC¼‰YM•vC‘åXˆÀŒbiŽ™j: 15th International Diabetes Federation Congress i94.11.06`11j, _ŒË.

1930. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Population-based IDDM registry, aged 0-14 years, in Hokkaido, Japan, 1973-1992. ¼‰YM•viŽ™j: 15th International Diabetes Federation Congress i94.11.06`11j, _ŒË.

1931. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j ¬Ž™––Šút•s‘SŠ³ŽÒ‚ÌŽ¡—Âɂ‚¢‚Ä|20”NŠÔ‚ÌŽ¡—ÃŒoŒ±‚Ì‚Ü‚Æ‚ß|. ”Ñ‚Šì‹v—YiŽ™j: ‘æ29‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï i94.06.16j, ‰ªŽR, —\eW, p.65, 1994.

1932. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j ŽvtŠúIDDM‚Ì–â‘è“_‚Æ‘Îô. ¼‰YM•viŽ™j: ‘æ29‰ñ“ú–{“œ”A•aŠw‰ï(ŽåÃ)“œ”A•aŠw‚Ìi•à i95.02.09`10j, ‚¼, ‘æ29‰ñ“ú–{“œ”A•aŠw‚Ìi•à, p.149, 1995.

1933. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ¬Ž™ŒÄ‹zŠíŽ¾Š³‚Ìf’f‚Ì‚·‚·‚ß•û. ”~Œ´ŽÀiŽ™j: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ïƒTƒeƒ‰ƒCƒgƒ~[ƒeƒBƒ“ƒO i94.05.25j, ŽD–y, “ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ïŽGŽ, 5(2): 49`54, 1994.

1934. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “œ”A•a, ƒVƒ“ƒ|ƒWƒEƒ€‡U: ŠeŽí–«Ž¾Š³‚É‚¨‚¯‚鶊ˆŠÇ—(carry over‚à‚Ó‚­‚ß‚Ä). ¼‰YM•viŽ™j: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.26`28j, ŽD–y, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(3): 400, 1994.

1935. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’´–¢nŽ™‚ÌS‹@”\. ¬ŒûO‹BiŽ™j: ‘æ30‰ñ“ú–{V¶Ž™Šw‰ï i94.07.17j, ɪ, ´˜^W, p.94`95, 1994.

1936. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ˜R“l•”SŽº’†ŠuŒ‡‘¹‚ÌŽ¡—ÃŽwj‚ÌŒŸ“¢: SƒGƒR[f’f‚Ì–ðŠ„‚ÆŒÀŠE. ŽO‘òmŽiC•½Î‘Cãp—z‘¾˜YC“¡–ìé”VC–xŒû‘דTCL“c•l•viŽ™jC‰Í“c­–¾C’†]¢–¾i‹¹ŠOj: ‘æ30‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï i94.06.30j, ‰¡•l, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 10(1): 56, 1994.

1937. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒ[ƒNƒVƒ‡ƒbƒv 3uV¶Ž™ˆã—Â̑ۉ»v. ¬ŒûO‹BiŽ™j: ‘æ39‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ï i94.10.29j, “Œ‹ž, —\eW, p.84, 1994.

1938. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹CŠÇ‹·ó‚ð‚«‚½‚µ‚½BPFM‚Ì1—á. ŠÖª“OC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC–¥‰YŽ‘¥C’·“cŒúCŽl‘q³”ŽCŒ´^liŽ™jC–x’rdŽ¡i•új: ‘æ29‰ñ“ú–{¬Ž™•úŽËüŠw‰ï i93.05.21`22j, ‹à‘ò, “ú–{¬Ž™•úŽËüŠw‰ïŽGŽ, 9(2): 192`193, 1993.

1939. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒCƒ“ƒXƒŠƒ“ˆË‘¶«“œ”A•a(IDDM)‚É‚¨‚¯‚éƒOƒ‹ƒ^ƒ~ƒ“Ž_’E…‘fy‘f(GAD)R‘Ì‘ª’è‚̈Ӌ`. ŽR“c‚ЂƂÝC“yì˜aŽqCŠÛŽR–¾ŽqC‘å’J•q‰ÃCŠ}Œ´“ÂC“àŠƒˆÀŽqC‘åXˆÀŒbC¼‰YM•viŽ™jC•Ÿ“‡’¼Ž÷C‹v•ÛŒõCŽR“cW¶: ‘æ37‰ñ“ú–{“œ”A•aŠw‰ïŠwpW‰ï i94.05.11`13j, “¿“‡, “œ”A•a, 37(Suppl.1): 237, 1994.

1940. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 30Ζ¢–ž”­ÇƒCƒ“ƒXƒŠƒ“ˆË‘¶«“œ”A•aŠ³ŽÒ‚̶–½—\Œã. ŠÛŽR–¾ŽqC‰¡ŽRGŽ÷C–؂©‚¨—¢CŠ}Œ´“ÂCŒ“¼KŽqC‘å’J•q‰ÃC“àŠƒˆÀŽqC¼‰YM•viŽ™jC‘åXˆÀŒbC“c›×®Žq: ‘æ37‰ñ“ú–{“œ”A•aŠw‰ïŠwpW‰ï i94.05.11`13j, “¿“‡, “œ”A•a, 37(Suppl.1): 428, 1994.

1941. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’ÇÕt¶ŒŸ‚Åã”牺deposit‚ªŒ°’˜‚Æ‚È‚Á‚½¬Ž™–Œ«‘B«t‰Š(‡TŒ^)‚Ì1—á. –{ŽRŽ¡C‘哈­–¾C쑺’å•vi“Œ–M‘åjC”Ñ‚Šì‹v—YiŽ™j: ‘æ24‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï i94.05.20`21j, ‘O‹´, —vŽ|W, 36(12): 1386, 1994.

1942. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ™•ú«sodium valproate»Ü(NIK-240) 400 mgù‚P“ú‚P‰ñ“Š—^Žž‚ÌŒŒ’†”Z“x‚ÌŒŸ“¢. ”’ˆäGKCŽO‰YŽõ’jC‚—œ‰hC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çiŽ™j: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.26j, ŽD–y, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(3): 470, 1994.

1943. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ð”M–ò¿Ü‚Ì•¹—p‚ªdiazepam¿Ü‚Ì’¼’°‚©‚ç‚Ì‹zŽû‚É‚¨‚æ‚Ú‚·‰e‹¿. •Ð‹Ë’q–çCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqiŽ™j: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.26j, ŽD–y, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(3): 471, 1994.

1944. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Miller-Dieker(17p13.3)ƒvƒ[ƒu‚ð—p‚¢‚½ŠŠ”]Ç9—á‚Ì•ªŽq×–Eˆâ“`Šw“IŒŸ“¢. •Ÿ“ˆ‹`ŒõC‘å‹´”Ž•¶C“Þ—Ç—²Š°C‘ŠŒ´•q‘¥ié‹ÊŒ§—§¬Ž™ˆã—ÃZƒ“ƒ^[jC’瓈rˆêi‘ÑLŒú¶•a‰@jC‚“cŽj’jiŽ™jC¬‘O—Êi“Œ—ˆã‘åjC‰iˆä•q˜Yi“s ´£¬Ž™•a‰@j: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.26j, ŽD–y, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(3): 506, 1994.

1945. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™ŒŒŠÇ‰Š‚É‚¨‚¯‚éRD’†‹…×–EŒ`Ž¿R‘Ì(AUCA)‚ÌŒŸ“¢. ”Ñ‚Šì‹v—YC’©’·C–kžŠ‚Ý‚Ç‚èC‰º“c‰vOC”Ñ‚Šì‹v—YiŽ™j: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.28j, ŽD–y.

1946. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’´‚‘¬CT‚É‚æ‚éìè•aSŒŒŠÇ•a•Ï‚Ì•]‰¿|‘æ2•ñ|Š¥“®–¬•a•ÏŒŸo‚ÌM—Š«. –xŒû‘דTC”’ˆäGKCˆÀ•ÛŒ«ˆêiŽ™jC•Ÿ“‡“‹`iŠƒ–è“¿B‰ï•a‰@jC•½Î‘CŽO‘òmŽiCãp—z‘¾˜YC“¡–ìé”VCL“c•l•viŽ™j: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.28j, ŽD–y, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(3): 670, 1994.

1947. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™–Œ«‘B«t‰Š‚Ì’·ŠúŠÏŽ@—á. ”Ñ‚Šì‹v—YC’©’·C’†‘ºM–çC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jC‰º“c‰vOCŽðˆä‹Ši”åj: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.28j, ŽD–y, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(3): 686, 1994.

1948. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “_“ª‚Ä‚ñ‚©‚ñ‚ɑ΂·‚é ACTH‚Æ clonazepam•¹—p—Ö@‚ÌŒø‰ÊEŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚̈Ӌ`|. ”’ˆäGKCŽO‰YŽõ’jC‚—œ‰hC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çiŽ™j: ‘æ11‰ñ“ú–{TDMŠw‰ï i94.06.04j, ŽD–y, —vŽ|W, p.58, 1994.

1949. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒWƒAƒ[ƒpƒ€¿Ü‚Ì‘Ì“à“®‘Ô‚É‹y‚Ú‚·‰ð”M’Á’Éܿ܂̉e‹¿. ¬—Ñ‹P–¾C‹gŽR—F“ñC’©’·•¶–íi–òÜjC•Ð‹Ë’q–çC»‰ŸÂC”’ˆäGKCŽO‰YŽõ’jiŽ™jC{“¡–F³C‹g“c´•FCŒSŽi´iZ—F‹à‘®ƒoƒCƒIƒTƒCƒGƒ“ƒXjC—é–ØK —Yiº˜a–ò•i‰»Hj: ‘æ11‰ñ“ú–{TDMŠw‰ï i94.06.04j, ŽD–y, —vŽ|W, p.62, 1994.

1950. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™–Œ«tÇ‚ÌŒŸ“¢. ’©’·C’†‘ºM–çC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºC”Ñ‚Šì‹v—YiŽ™j: ‘æ29‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï i94.06.15j, ‰ªŽR.

1951. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒVƒXƒvƒ‰ƒ`ƒ“‚É‚æ‚é”A׊ǫƒAƒVƒh[ƒVƒX‚ð‹N‚±‚µ‚½’†•«”A•öÇ‚Ì1—á. ’†‘ºM–çCŒ´^lC¡ˆäƒDC“¡–ìé”VC‰¡“csŽjC”Ñ‚Šì‹v—YiŽ™j: ‘æ29‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï i94.06.15j, ‰ªŽR.

1952. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™‚É‚¨‚¯‚éNon-radiolabelled Iothalamate (Io)Ž‘±Ã’–@‚É‚æ‚éGFR‘ª’è. ‰º“c‰vOi”åjC’©’·C”Ñ‚Šì‹v—YiŽ™jCŽðˆä‹Ši”åjC…‘ò—fˆêi“Œ‹žˆãŽ•‘åj: ‘æ29‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï i94.06.15`17j, ‰ªŽR.

1953. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j IDDM‚É•¹”­‚µ‚½ŠÔŽ¿«äNã÷‰Š‚Ì15Î’jŽ™—á. •—’£^—R”üC‰¡“csŽjC•—’£KŽiCŽÄŽRŒ[ŽqC‘åŽR‹XGC”Ñ‚Šì‹v—YC¼‰YM•viŽ™jC‰““¡’‰—Yi”åjC“n•Ó´Ž¡i•a—j: ‘æ29‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï i94.06.15j, ‰ªŽR, ´˜^W, p.135, 1994.

1954. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒXƒeƒƒCƒh’ïR«ƒlƒtƒ[ƒ[ÇŒóŒQ‚ÌŽ¡—Ã. ‰Í¼‹IºC’†‘ºM–çC’©’·C–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YiŽ™jCŽðˆä‹Ši”åj: ‘æ29‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï i94.06.16j, ‰ªŽR, —\eW, p.238, 1994.

1955. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Waterhouse-Friedrichsen syndrome‚Ì–UŒŸ—á. ¬‘ò”ü˜aiŽ™jCŠC˜VŒ´N”ŽC‘åŽR‰hìCÜ‹Œ’Ž¡C•½“c—϶CÄ“¡º•FC^•”~C‘å–î’B’jC×’J—º‘¾C¼‘ºVŽOC²”ŒdŽ÷i¹˜H‰Á‘Û•a‰@j: ‘æ8‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ï i94.06.25j, ˜a‰ÌŽR.

1956. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚鬎™‹s‘Ò‚ÌŒ»‹µ. ‘å“c„•äC’ç–M•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC”~Œ´ŽÀC–åˆäL‹ÅC¼‰YM•viŽ™jCVˆä‘ìCˆÉ“¡ˆèŽqi¸jC–@—R”üŽqi‘‡‘Š’k•”j: ‘æ8‰ñ“ú–{¬Ž™‹~‹}ˆãŠw‰ï i94.06.25j, ˜a‰ÌŽR, ´˜^W, p.36, 1994.

1957. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j dǒጌ“œÇ, S•s‘S, ŒÄ‹z•s‘S‚ð’悵‚½IDM‚Ì1—á. •ÐŽR•¶•FC‰¡“csŽjC“¡–ìé”VC¡ˆäƒDC’†‘ºM–çiŽ™jC²“¡–FºC`˜aŽqiŽY•wj: ‘æ30‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï i94.07.18j, ɪ, ´˜^W, p.217, 1994.

1958. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j G-CSF“Š—^’†‚É‚¯‚¢‚ê‚ñ”­ì‚ð”F‚ß‚½ŽvtŠúALL‚Ì—Ž™—á. ¬‘ò”ü˜aiŽ™jC^•”~C•½“c—϶CÄ“¡º•FCŠC˜VŒ´N”ŽC×’J—º‘¾C¼‘ºVŽOi¹˜H‰Á‘Û•a‰@j: ‘æ36‰ñ“ú–{¬Ž™ŒŒ‰tŠw‰ï i94.09.07j, ŽD–y, “ú–{¬Ž™ŒŒ‰tŠw‰ïŽGŽ, 8(4): 373, 1994.

1959. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Carbamazepine‚Æ zonisamide•¹—pŽž‚ÌŒŒ’†”Z“x‚Ì‘ŠŒÝì—p‚ɂ‚¢‚Ä. ˆÀ•ÛƒŽqCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêC•Ð‹Ë’q–çC•ˆäŒ¤“ñiŽ™j: ‘æ28‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ï i94.10.14j, ‰ªŽR, ‚Ä‚ñ‚©‚ñŒ¤‹†, 13(1): 62, 1995.

1960. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ™•ú« sodium valproate»Ü(NIK-240) 400 mgù‚P“ú‚P‰ñ“Š—^Žž‚ÌŒŒ’†”Z“x‚ÌŒŸ“¢|™•ú«è÷—±Ü“Š—^Žž‚ÌŒŒ’†”Z“x‚Æ‚Ì”äŠr|. ”’ˆäGKCŽO‰YŽõ’jC‚—œ‰hC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çC•ˆäŒ¤“ñiŽ™j: ‘æ28‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ï i94.10.14j, ‰ªŽR, ‚Ä‚ñ‚©‚ñŒ¤‹†, 13(1): 62, 1995.

1961. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒJƒ‹ƒjƒ`ƒ“ƒpƒ‹ƒ~ƒgƒCƒ‹ƒgƒ‰ƒ“ƒXƒtƒFƒ‰[ƒ[‡TŒ‡‘¹Ç‚Ì•ªŽq“IŠî‘b: ƒqƒgcDNA‚Ì\‘¢‰ð͂ƃ‰ƒC—lÇŒóŒQ‚Å”­Ç‚µ‚½“ú–{l2Ç—á‚Ì•ªŽq•a—. ‘å’|–¾C÷’ë‹ÏC—é–Ø‹`”Vi“s—Õ°ˆãŠw‘‡Œ¤‹†ŠjC•–Ø—zŽqC‹TˆäKŽqi“Œ‹žˆãŽ•‘åjCŒüŒã—˜ºC‹à‘ò³Ž÷Cˆ¢•””Ž‹ICŽR–{d‘¥CV”üm’jiç—t‘åjC ‚–ö³Ž÷iç—tŒ§‚±‚Ç‚à•a‰@jC^’ë‘C‘å“cŒ´r•ãi‰ª‘åjC‚“cŽj’jC¼‰YM•viŽ™j: ‘æ39‰ñ“ú–{l—Þˆâ“`Šw‰ï‘å‰ï i94.10.19j, ç—t, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.90(A-54), 1994.

1962. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –kŠC“¹‚É‚¨‚¯‚éƒNƒŒƒ`ƒ“ǃ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚̬Ñ(1978”N`1991”N3ŒŽ). ¼‰YM•viŽ™jCŒ´“c³•½CŽsŒ´Š¤C•ŸŽmŸC‹e’n—R¶Žq: “ú–{“à•ª”åŠw‰ïbó‘B•ª‰È‰ï i94.10.19`21j, b•{, “ú–{“à•ª”åŠw‰ïŽGŽ, 70(7): 856, 1994.

1963. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éPrader-WillizÇŒóŒQ‚ÌŠO—ˆ”ì–žŽw“±‚ɂ‚¢‚Ä. ‰Á“¡ƒ`ƒCC‘¾“c—TŽqC‰|–{’qŒb”üi‰h—{•”jC‚“cŽj’jC¼‰YM•viŽ™jC“c‘ãçŒb”üiˆã—Éq¶j: ‘æ16‰ñ“ú–{—Õ°‰h—{Šw‰ï‘‰ï i94.10.28j, å‘ä, “ú–{—Õ°‰h—{Šw‰ïŽGŽ, 16(3): 69, 1994.

1964. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’´‰¹”g‚É‚æ‚éo¶‘Of’f‚ÌŒ»ó‚Æ–â‘è“_. ¬ŒûO‹BC–ì“n³•FC²“¡‰ë•FCã–ìM–íC‰¬–샑ãCŽR“cr•FCŠ—Œ´FiŽ™jC“V–슮iŽY•wj: ‘æ39‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ï i94.10.28j, “Œ‹ž, —\eW, p.221, 1994.

1965. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘ÙŽ™Šú‚ÉS•s‘S, d“xŽOë•Ù•Â½•s‘S‚ð’悵, ‹~–½‚µ“¾‚½ŽOë•ÙˆÙŒ`¬‚Ì1—á. ŽO{—zŽqC•½Î‘C¬ŒûO‹BC”ó‰YDC²“¡‰ë•FiŽ™j: ‘æ39‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ï i94.10.29j, “Œ‹ž.

1966. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ãO–Ñ–Œ«‘o‘Ù‚É‚¨‚¯‚é”]áŠQ‚Ì‘Ù“à”­Ç‚Ì‰Â”\«‚ɂ‚¢‚Ä. ²“¡‰ë•FC‰¬–샑ãCã–ìM–íCŽR“cr•FC–ì“n³•FCŠ—Œ´FC–åˆäL‹ÅC¬ŒûO‹BiŽ™jC‚“ˆK’ji‘—§¸__ŒoƒZƒ“ƒ^[j: ‘æ39‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ï i94.10.29j, “Œ‹ž, —\eW, p.147.

1967. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •ª•Ø—lŽ®‚Ì·ˆÙ‚É‚æ‚é(ŒoäTvs’éØ)o¶Œã‘Šú‚É‚¨‚¯‚鶎º”o—Ê‚¨‚æ‚Ñ‚»‚ÌŽå—v‘ŸŠíŒŒ—¬•ª•z‚ւ̉e‹¿. ãp—z‘¾˜YC•½Î‘CŽO‘òmŽiC¬ŒûO‹BC“¡–ìé”VC–xŒû‘דTC•“cM—TiŽ™j: ‘æ39‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ï i94.10.29j, “Œ‹ž, —\eW, p.221, 1994.

1968. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Pulmonary capillary hemangiomatosis‚Ì1—á. ‰z–ì_]C’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀCŠÖª“OCã“cN‹vC•½Î‘iŽ™jC–x’rdŽ¡i•újCΈä‰pºCŠâŸºŒ[ˆêi•a—j: ‘æ27‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï i94.11.11j, ‚’m.

1969. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j BPD‚̉摜f’f. ŠÖª“OC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC–¥‰YŽ‘¥C’·“cŒúCŽl‘q³”ŽCŒ´^lCã“cN‹viŽ™jC–x’rdŽ¡i•új: ‘æ27‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï i94.11.11j, ‚’m.

1970. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Zonisamide’PÜ‚P“ú‚P‰ñ“Š—^–@‚ª–³Œø‚ȬŽ™‚Ì•”•ª”­ì‚ɑ΂·‚é carbamazepine‚ÌŒø‰Ê|—¼–ò•¨ŠÔ‚ÌŒŒ’†”Z“x‘ŠŒÝì—p‚ÌŒŸ“¢‚àŠÜ‚ß‚Ä|. ˆÀ•ÛƒŽqCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêC•ˆäŒ¤“ñiŽ™j: ‘æ‚S‰ñ—Õ°¸__Œo–ò—Šw‰ï i94.11.17j, ‹ž“s, ´˜^W, p.14, 1994.

1971. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Reye—lÇŒóŒQ‚É‚Ä”­Ç‚µ‚½carnitine palmitoyltransferase-‡TŒ‡‘¹Ç‚ÌŒZ’í—á. •“cM—TC‚“cŽj’jCãp—z‘¾˜YC‘å“c„•äC¼‰YM•viŽ™jCˆ¢•””Ž‹ICŽR–{d‘¥iç—t‘åjC‚–ö³Ž÷iç—tŒ§‚±‚Ç‚à•a‰@jCŠ`ÀG–¾i‘—§—×{Š‰ºŽu’Õa ‰@jC‘å’|–¾i“Œ‹ž“s—Õ°ˆãŠw‘‡Œ¤‹†Šj: ‘æ37‰ñ“ú–{æ“V‘ãŽÓˆÙíŠw‰ï i94.11.25j, ‰ªŽR, “ú–{æ“V‘ãŽÓˆÙíŠw‰ïŽGŽ, 10(2): 150, 1994.

1972. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒJƒ‹ƒjƒ`ƒ“ƒpƒ‹ƒ~ƒgƒCƒ‹ƒgƒ‰ƒ“ƒXƒtƒFƒ‰[ƒ[‡TŒ‡‘¹Ç: cDNAƒNƒ[ƒjƒ“ƒO‚Æ•ªŽq•a—. •–Ø—zŽqC‘å’|–¾C÷’ë‹Ïi“Œ‹ž“s—Õ°ˆãŠw‘‡Œ¤‹†ŠjCŒüŒã—˜ºC‹à‘ò³Ž÷Cˆ¢•””Ž‹ICŽR–{d‘¥iç—t‘åjC‚–ö³Ž÷iç—tŒ§‚±‚Ç‚à•a‰@jC‚“cŽj’jC ¼‰YM•viŽ™jC‹TˆäKŽqi“Œ‹žˆãŽ•‘åjCV”üm’jiç—t‘åjC—é–Ø‹`”Vi“Œ‹ž“s—Õ°ˆãŠw‘‡Œ¤‹†Šj: ‘æ37‰ñ“ú–{æ“V‘ãŽÓˆÙíŠw‰ï i94.11.25j, ‰ªŽR, “ú–{æ“V‘ãŽÓˆÙíŠw‰ïŽGŽ, 10(2): 153, 1994.

1973. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’á—ÓŒŒ«VD’ïRR«ƒNƒ‹•a‚Ì‘½—l«‚ÆVDŒ‡–R«ƒNƒ‹•a‚Æ‚Ìv‘¬ŠÓ•Ê–@. ¼‰YM•vC‰¡“csŽjC‚“cŽj’jC•“cM—TiŽ™j: ‘æ37‰ñ“ú–{æ“V‘ãŽÓˆÙíŠw‰ï i94.11.25j, ‰ªŽR, “ú–{æ“V‘ãŽÓˆÙíŠw‰ïŽGŽ, 10(2): 95, 1994.

1974. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äNã÷”AŠÇ‹t—¬Ç(VUR)‚Ì—Õ°“IŒŸ“¢. ”Ñ‚Šì‹v—YC’†‘ºM–çC’©’·C–kžŠ‚Ý‚Ç‚èiŽ™jC‰““¡’‰—Yi”åjC–{ŽRŽ¡i“Œ–M‘åjCŽðˆä‹Ši”åj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ï i94.12.18j, ç—t, “ú–{t‘ŸŠw‰ïŽ, 36(Suppl.): 166, 1994.

1975. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™ŠO‚É‚¨‚¯‚éŒÄ‹z•s‘S‚̉ðÍ. ŽO{—zŽqC‘å“c„•äC”~Œ´ŽÀiŽ™jC™–{Ÿ•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï i95.02.02j, ‘åã, ‘æ22‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, p.191, 1995.

1976. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j _Œo‰è×–EŽîƒ}ƒXƒXƒNƒŠ[ƒjƒ“ƒO‚ª—¼e‚É—^‚¦‚é‰e‹¿‚ɂ‚¢‚Ä. ¡ˆäƒDC¬‘ò”ü˜aCŒIŒ´Œ‰C‰““¡‹I—YiŽ™j: ‘æ98‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i95.03.25j, Šò•Œ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 99(1): 269, 1995.

1977. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹¹•”ˆÙí‰A‰e‚Å”­Œ©‚³‚ꉻŠw—Ö@Œã–ñ‚P”N‚Å”]“]ˆÚ‚ð‚«‚½‚µ‚½ãO–ÑŠà‚Ì1’jŽ™—á. ŒIŒ´Œ‰C¡ˆäƒDC¬‘ò”ü˜aCŽO‘îòCã“cN‹vC”~Œ´ŽÀC‰““¡‹I—YiŽ™j: ‘æ98‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i95.03.25j, Šò•Œ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 99(1): 287, 1995.

1978. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’´‚‘¬CT‚É‚æ‚éìè•aSŒŒŠÇ•a•Ï‚Ì•]‰¿|‘æ‚R•ñ: ‰^“®•‰‰×‚ɑ΂·‚éSŒŒs“®‘Ô‚Ì•]‰¿. –xŒû‘דTC”’ˆäGKC“‡ŠÑˆèC“àŽR’q–¾C•½Î‘CŽO‘òmŽiCãp—z‘¾˜YC“¡–ìé”VCL“c•l•viŽ™j: ‘æ98‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i95.03.26j, Šò•Œ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 99(1): 456, 1995.

1979. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬Ž™ŠÔŽ¿«”xŽ¾Š³‚É‚¨‚¯‚éI-123 IMP”xƒVƒ“ƒ`ƒOƒ‰ƒ€‚ÌŒŸ“¢. ŠÖª“OC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC–¥‰YŽ‘¥C’·“cŒúCŽl‘q³”ŽCŒ´^liŽ™jC–x’rdŽ¡CΈ䟌Èi•új: ‘æ26‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï i93.11.06j, ‘åã, “ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ïŽGŽ, 5(1): 104, 1994.

1980. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŽvtŠúIDDMŠ³ŽÒ‚É‚¨‚¯‚éLp(a)‚ÉŠÖ‚·‚錟“¢. •—’£KŽiC‰¡“csŽjC•—’£^—R”üCŽÄŽRŒ[ŽqC‘åŽR‹XGC¼‰YM•viŽ™j: ‘æ37‰ñ“ú–{“œ”A•aŠw‰ïŠwpW‰ï i94.05.11`13j, “¿“‡, “œ”A•a, 37(Suppl.1): 346, 1994.

1981. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒCƒ“ƒXƒŠƒ“’ïR«“œ”A•a‚ɑ΂·‚釬ƒqƒgIGF-1’·Šú“Š—^‚ªŒŒ“œƒRƒ“ƒgƒ[ƒ‹‚É‹y‚Ú‚·‰e‹¿. ¼‰YM•viŽ™j: ‘æ37‰ñ“ú–{“œ”A•aŠw‰ïŠwpW‰ï i94.05.11`13j, “¿“‡, “œ”A•a, 37(Suppl.1): 477, 1994.

1982. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”x“®–¬iNpŒã‚É‚Ý‚ç‚ê‚é‰E”x“®–¬‹·ó‚ÌŒoŽž“IŒŸ“¢. •½Î‘CŽO‘òmŽiCãp—z‘¾˜YCL“c•l•vC“¡–ìé”VC–xŒû‘דTiŽ™jC’†]¢–¾C‰Í“c­–¾i‹¹ŠOj: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.27j, ŽD–y, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(3): 396, 1994.

1983. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j I-123 IMP”xƒVƒ“ƒ`ƒOƒ‰ƒ€‚É‚æ‚éBPD‚Ì”xŠÔŽ¿áŠQ‚Ì•]‰¿. ŠÖª“OC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC–¥‰YŽ‘¥C’·“cŒúCŽl‘q³”ŽCŒ´^liŽ™jC–x’rdŽ¡CΈ䟌Èi•új: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.27j, ŽD–y, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(3): 798, 1994.

1984. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬Ž™Á‰»«’×ᇗá‚É‚¨‚¯‚錌´ƒyƒvƒVƒm[ƒQƒ“’l‚ÌŒŸ“¢. ^“º‘¾˜YCŒÃ“¡G—mC“à“¡„•FC‘å“c„•äC¬“‡–M•FiŽ™jCΈ䟌Èi•új: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.27j, ŽD–y, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(3): 807, 1994.

1985. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˆâ“`«˜ËŽòǃ‰ƒbƒgrdw‚ÌŒŒ’†TSH‚̶•¨Šw“IŠˆ«‚ɂ‚¢‚Ä. ŽÄŽRŒ[ŽqC‘åŽR‹XGiŽ™jCˆ¢•”D•¶i“àjC¬–ì‰ë•vi•ª¶jC¼‰YM•viŽ™jCŒÃŠÚêˆêiŽÀ“®j: ‘æ67‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï i94.06.03j, ’·è, “ú–{“à•ª”åŠw‰ïŽGŽ, 70(3): 343, 1994.

1986. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬Ž™‚Ìöˆö«‹ÇÝŠÖ˜A«‚Ä‚ñ‚©‚ñ‚ɑ΂·‚ézonisamide’PÜ‚P“ú‚P‰ñ“Š—^–@‚Ì•›ì—p|‘½Ü•¹—pÇ—á‚Æ‚Ì”äŠr|. דc‚Ì‚¼‚ÝCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çC•ˆäŒ¤“ñiŽ™j: ‘æ36‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï i94.06.09j, “Œ‹ž, ”]‚Æ”­’B, 26(‘‰ï†): 131, 1994.

1987. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j SƒGƒR[–@‚É‚æ‚é¶, ‰E”x“®–¬Œa, ‹·ó, •Â½‚Ì•]‰¿ (‘æ3•ñ)ƒ`ƒAƒm[ƒ[«SŽ¾Š³(”xŒŒ—¬Œ¸­Œ^)Ç—á‚Ì prospective study. •½Î‘CŽO‘òmŽiCãp—z‘¾˜YCL“c•l•vC–xŒû‘דTC“¡–ìé”VC•“cM—TiŽ™jC’†]¢–¾C‰Í“c­–¾i‹¹ŠOj: ‘æ30‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï i94.06.30j, ‰¡•l.

1988. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘ÙŽ™zŠÂˆâŽcÇ(PFC)‚É‚¨‚¯‚é‰E¶’Z—‚ÌŒoŽž“I•Ï‰»|SƒGƒR[–@‚É‚æ‚錟“¢|. ãp—z‘¾˜YC•½Î‘CŽO‘òmŽiC“¡–ìé”VC–xŒû‘דTCL“c•l•vC•“cM—TiŽ™j: ‘æ30‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï i94.06.30`07.02j, ‰¡•l, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 10(1): 130, 1994.

1989. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’´‚‘¬CT‚É‚æ‚éƒtƒHƒ“ƒ^ƒ“pŒã‚Ì”xzŠÂŽžŠÔ‘ª’è‚̈Ӌ`(‘æ2•ñj‰^“®•‰‰×‚É‚æ‚è”xzŠÂŽžŠÔ‚ª’Zk‚·‚éŒQ‚Æ‘ÎÆŒQ‚Æ‚Ì”äŠr. –xŒû‘דTiŠƒ–è“¿B‰ï•a‰@jC•½Î‘CŽO‘òmŽiCãp—z‘¾˜YC“¡–ìé”VCL“c•l•viŽ™jC’†]¢–¾C‰Í“c­–¾i‹¹ŠOj: ‘æ30‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï i94.07.01j, ‰¡•l, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 10(1): 229, 1994.

1990. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j CAPDŠ³ŽÒ‚É‚¨‚¯‚éƒfƒLƒXƒgƒ‰ƒ“‚ƃAƒ‹ƒuƒ~ƒ“‚ð—p‚¢‚½ƒŠƒ“ƒp‹zŽû”\‚ÌŒŸ“¢. ’©’·C’†‘ºM–çC–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YiŽ™j: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.02j, ‘åã.

1991. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬Ž™‚É‚¨‚¯‚éS‹ØƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚ÌŠjŽí‚É‚æ‚é”äŠr. Š}ˆäG–¾C²“¡³ºi´£¬Ž™•a‰@jCΈ䟌Èi•új: ‘æ34‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï i94.09.29j, ŽD–y, ŠjˆãŠw, 31(7): 829, 1994.

1992. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j IGF-IŽ¡—Âðs‚Á‚½Partial GH insensitivity‚Ì8Î’jŽ™—á. •—’£KŽiC‘åŽR‹XGC•—’£^—R”üCŽÄŽRŒ[ŽqC‰¡“csŽjiŽ™jC’·’Jìs—mi“s—§´£¬Ž™•a‰@jC¼‰YM•viŽ™j: ‘æ28‰ñ“ú–{¬Ž™“à•ª”åŠw‰ï i94.10.06j, ç—t.

1993. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ¬Ž™ƒCƒ“ƒXƒŠƒ“ˆË‘¶«“œ”A•a(IDDM)‚É‚¨‚¯‚éRƒOƒ‹ƒ^ƒ~ƒ“Ž_’E’YŽ_y‘f(GAD)R‘Ì‚ÌŒŸ“¢. •—’£^—R”üC¼‰YM•vC•—’£KŽiCŽÄŽRŒ[ŽqC‰¡“csŽjC‘åŽR‹XGiŽ™j: ‘æ28‰ñ“ú–{¬Ž™“à•ª”åŠw‰ï i94.10.06j, ç—t, ´˜^W, p.83, 1994.

1994. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Zonisamide’PÜŽ¡—ª–³Œø‚ȬŽ™‚Ì•”•ª”­ì‚ɑ΂·‚écarbamazepine ‚ÌŒø‰Ê‚Æ—¼Ü•¹—pŽž‚ÌŒŒ’†”Z“x‚Ì‘ŠŒÝì—p‚ɂ‚¢‚Ä. ˆÀ•ÛƒŽqCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêC•Ð‹Ë’q–çC•ˆäŒ¤“ñiŽ™j: ‘æ98‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i95.03.24j, Šò•Œ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 99(1): 115, 1995.

1995. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰ð”M–ò¿Ü‚Ì•¹—p‚ª diazepam¿Ü‚Ì’¼’°‚©‚ç‚Ì‹zŽû‚É‚¨‚æ‚Ú‚·‰e‹¿|”M«‚¯‚¢‚ê‚ñŠ³Ž™‚Å‚ÌŒŸ“¢|. •ˆäŒ¤“ñCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çiŽ™j: ‘æ98‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i95.03.24j, Šò•Œ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 99(1): 122, 1995.

1996. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j CTã—¼‘¤Ž‹°‚¨‚æ‚щE”íŠk‚É’á‹zŽûˆæ‚ð”F‚ß‚½—Õ°“IReyeÇŒóŒQ‚Ì‚P—á. ”’ˆäGKC–xŒû‘דTCˆÀ•ÛŒ«ˆêC“‡ŠÑˆèC•Ð‹Ë’q–çC•Ÿ“‡’‹`C“àŽR’q–¾iŽ™jC‘å–î’B•vi¹˜H‰Á‘Û•a‰@jC‰Á“¡’B•vCŒÜ“‡•q˜YC¼“‡ˆê“TCŽRŒû–¾Žqi¹ ƒ}ƒŠƒAƒ“ƒiˆã‘åj: ‘æ98‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i95.03.24j, Šò•Œ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 99(1): 125, 1995.

1997. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”ìŒú«—H–å‹·óÇ‚É‚¨‚¯‚é—°Ž_ƒAƒgƒƒsƒ“Ã’—Ö@‚¨‚æ‚ÑŒoŒû—Ö@‚ÌŒŸ“¢. “à“¡„•FC¬“‡–M•FC^“º‘¾˜YC‘å“c„•äCŒÃâÙG—miŽ™j: ‘æ98‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i95.03.24j, Šò•Œ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 99(1): 216, 1995.

1998. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j BPD‚ÌXe‹ÇŠ”x‹@”\ŒŸ¸. ŠÖª“OC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC–¥‰YŽ‘¥C’·“cŒúCŽl‘q³”ŽCŒ´^lCã“cN‹viŽ™jC–x’rdŽ¡CΈ䟌Èi•új: ‘æ98‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i95.03.26j, Šò•Œ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 99(1): 404, 1995.

1999. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘å“®–¬•Ù‹·ó‚ɑ΂·‚éƒoƒ‹[ƒ“•ÙŒ`¬p‚Ì•]‰¿: ’†Šú¥’·Šú—\Œã‚ÌŒŸ“¢. ŽO‘òmŽiC•½Î‘Cãp—z‘¾˜YC“¡–ìé”VC•“cM—TC–xŒû‘דTCL“c•l•viŽ™j: ‘æ98‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i95.03.26j, Šò•Œ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 99(1): 474, 1995.

2000. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é‹Ù‹}’éØ‚Ì”–â‘è|‹Ù‹}’éØ‚Åo¶‚µ‚½V¶Ž™‚ÌŒŸ“¢|. ²“¡‰ë•FC¬ŒûO‹BiŽ™jC¯“c—²C“V–슮C¼“‡³”ŽiŽY•wj: ‘æ304‰ñ“úŽY•w_“Þì’n•û•”‰ï, ‘æ89‰ñ•ª•Ø‚Æ–ƒŒŒ¤‹†‰ï i94.12.17j, ‰¡•l.

2001. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Bronchopulmonary foregut malformations‚ɇ•¹‚µ‚½‹CŠÇ‹·ó‚Ì‚P¬l—á. ŠÖª“OC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC–¥‰YŽ‘¥C’·“cŒúCŽl‘q³”ŽCŒ´^liŽ™j: ‘æ105‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï i93.07.24j, “Œ‹ž.

2002. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j G-CSF“Š—^’†‚É‚¯‚¢‚ê‚ñ”­ì‚ð”F‚ß‚½ŽvtŠúALL‚Ì1—á. ¬‘ò”ü˜aiŽ™jC^•”~CŠC˜VŒ´N”ŽCÄ“¡º•FCÜ‹Œ’Ž¡C•½“c—϶C‘åŽR‰hìC‘å–î’B’jC×’J—º‘¾i¹˜H‰Á‘Û•a‰@j: ‘æ430‰ñ“ú–{¬Ž™‰ÈŠw‰ï“Œ‹ž“s’n•û‰ïu˜a‰ï i94.04.09j, “Œ‹ž.

2003. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Moraxella osloensis ‚É‚æ‚é‘–Œ‰Š‚Ì‚P—á. ”’ˆäGKC–xŒû‘דTCˆÀ•ÛŒ«ˆêC•Ÿ“‡’‹`iŽ™jC“c’†³•FiŠƒ–è“¿F‰ï‘‡•a‰@jCŽç‰®•Û’jiŽç‰®¬Ž™‰Èˆã‰@j: ‘æ208‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i94.04.16j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 22(1): 141, 1995.

2004. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j A“ª“Eo‚Ì“K‰ž‚Æl‚¦‚ç‚ꂽ”]«–ƒáƒ‚Ì‚P—á. •ˆäŒ¤“ñC¬—ÑŒåŽqCŒIŒ´Œ‰C»‰ŸÂCŠÖª“OC”~Œ´ŽÀC“n•Ó“oC’†“ˆ‰p•FCŽO‰YŽõ’jC¼‰YM•viŽ™jC¯–ìŒ÷C•½ŽR•ûriŽ¨•@j: ‘æ208‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i94.04.16j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 22(1)F144, 1995.

2005. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “Á”­«–Œ«tÇ‚ð’悵‚»‚ÌŒã SLE‚Æf’f‚³‚ꂽ‚P’jŽq—á. ’©’·C’†‘ºM–çC–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YiŽ™jC–{ŽRŽ¡i“Œ–M‘åj: ‘æ24‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï i94.05.20`21j, ‘O‹´.

2006. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —cŽ™Šú‚æ‚è’·ŠúŠÏŽ@‚µ“¾‚½Œ´”­«‰“ˆÊ”A׊ǃAƒVƒh[ƒVƒX‚Ì1—á. ‰º“c‰vOi”åjC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ24‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï i94.05.20`21j, ‘O‹´.

2007. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j PCR–@‚É‚æ‚è‘Šú‚ɃEƒCƒ‹ƒX‚ðØ–¾‚µ‚¦‚½‚¨‚½‚Ó‚­‚©‚ºƒƒNƒ`ƒ“ÚŽíŒã‘–Œ‰Š‚Ì‚P—á. “‡ŠÑˆèC”’ˆäGKC–xŒû‘דTCˆÀ•ÛŒ«ˆêC•Ÿ“‡’‹`C“àŽR’q–¾iŽ™jC˜a“c’m‰vi—Õ•a—j: ‘æ209‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i94.06.25j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 22(1)F146, 1995.

2008. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”­”M‚È‚ç‚Ñ‚É”½•œ‚·‚éä`ŽüˆÍ’É‚ðŽå‘i‚ÉŽóf‚µ, ä`‚æ‚è”^”rŸ•‚ð‚Ý‚½”A–ŒŠÇˆâŽcÇ‚Ì13Î’jŽ™—á. “àŽR’q–¾C–xŒû‘דTC”’ˆäGKC“‡ŠÑˆèiŽ™jC²–쌛CXìˆê•FCŽR–{”ŽiŠƒ–è“¿F‰ï‘‡•a‰@j: ‘æ210‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i94.09.17j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 22(1): 151, 1995.

2009. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰¡–ä‹Ø—Z‰ðÇŒã‚É‚CaŒŒÇ‚ð”F‚ß‚½CNSƒ‹[ƒvƒX‚Ì1—á. ¬ì‰ÄŽqCŽO‘îòC’†‘ºM–çCŽç‰®r‰îCŽO‘òmŽiC‰Í¼‹IºC¼‰YM•viŽ™j: ‘æ211‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï i94.11.19j, ‰¡•l.

2010. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘Œv3.0 g/kg BW‚̃Kƒ“ƒ}ƒOƒƒuƒŠƒ““Š—^‚É‚à‚©‚©‚í‚炸‘½”­«‹‘劥“®–¬áŽ‚ðˆâ‚µ‚½ìè•a‚Ì‚P—á. –xŒû‘דTC”’ˆäGKC“‡ŠÑˆèC“àŽR’q–¾iŽ™jC²–쌛iŠƒ–è“¿F‰ï‘‡•a‰@j: ‘æ211‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i94.11.19j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 22(2), 1995.

2011. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “Á”­«cŠu‹CŽî‚ðŒJ‚è•Ô‚µ‚½_Œo«HŽv•sUÇ‚Ì14ΗŽ™—á. ¬—ÑŒåŽqC”’ˆäGKC–xŒû‘דTC“‡ŠÑˆèC“àŽR’q–¾iŽ™jC“cŒ³CŽ™‹ÊŒõŽjiŠƒ–è“¿F‰ï‘‡•a‰@jC‰ª“cGri¸j: ‘æ212‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i94.11.19j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 22(2), 1995.

2012. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”ìŒú«—H–å‹·óÇ‚É‚¨‚¯‚é—°Ž_ƒAƒgƒƒsƒ“—Ö@‚ÌŒŸ“¢. “àŽR’q–¾CŒÃ“¡G—mC“à“¡„•FC‘å“c„•äC^“º‘¾˜YC¬“‡–M•FC¼‰YM•viŽ™j: ‘æ212‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i94.11.19j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 22(2), 1995.

2013. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “à”牺‚æ‚èã”牺‚Ö‚Ì‚“dŽq–§“x‚Ì’¾’…•¨‚̈Ús‚ª”F‚ß‚ç‚ꂽƒ‹[ƒvƒXt‰Š‚Ì1—á. ²”Œ•q—ºC”Ñ‚Šì‹v—YC‰¡ŽR—²•viŽ™j: ‘æ212‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï i95.02.18j, ‰¡•l.

2014. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Clonazepam‚ÅŽ¡—µ‚½¬Ž™Œ‡_‚Ä‚ñ‚©‚ñ‚Ì’·Šú—\Œã. ˆÀ•ÛŒ«ˆêCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛƒŽqC•ˆäŒ¤“ñiŽ™j: ‘æ22‰ñ“ú–{¬Ž™_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i95.03.18j, ¬•½, ´˜^W, p.3, 1995.

2015. mŒ¤‹†‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Need of diabetes education for family problems of IDDM. ¼‰YM•viŽ™j: 3rd International Symposium of Diabetes and Youth Camping i94.11.11`13j, ‘åã.

2016. mŒ¤‹†‰ïi‘Ûjn iˆê”Êu‰‰j Onset-age dependent variation of GAD-AB and IAA in Japanese IDDM. ŽR“c‚ЂƂÝC“àŠƒˆÀŽqC“yì˜aŽqCŠÛŽR–¾ŽqC‘å’J•q‰ÃCŠ}Œ´“ÂCŠâ–{ˆÀ•FC‘åXˆÀŒbC¼‰YM•viŽ™jC•Ÿ“‡’¼Ž÷C‹v•ÛŒõCŽRŒûW¶: 13th International Immunology and Diabetes Workshop i94.05.25`28j, France.

2017. mŒ¤‹†‰ïi‘Ûjn iˆê”Êu‰‰j Molecular markers of high IDDM risk in Japan. ¼‰YM•viŽ™j: International Diabetes Epidemiology Group Himeji Symposium i94.11.12`14j, •P˜H.

2018. mŒ¤‹†‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Nature of IgA binding to specific cell membrane antigens in IgA nephropathy. Žç‰®r‰îiŽ™jCKhouri, N.A.CCameron, J.S.CFrampton, G.iGuy's Hosp.j: IgA Nephropathy International Symposium i94.03.01j, Adelaide, Australia.

2019. mŒ¤‹†‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Spectrotype of endotherial cell autoantigens in IgA nephropathy. Žç‰®r‰îiŽ™jCKhouri, N.A.CCameron, J.S.CFrampton, G.iGuy's Hosp.j: IgA Nephropathy International Symposium i94.03.01j, Adelaide, Australia.

2020. mŒ¤‹†‰ïi‘S‘jn ih‘è•ñj ìè•aŠ³Ž™‚æ‚è‚̘A½‹…‹Û‚Ì•ª—£“¯’è‚ÌŽŽ‚Ý. ‘å’Ép“ñiŽ™jC“¡‘ò—Ï•Fi_“Þ쌧‰q¶Œ¤‹†ŠjC“n•ÓKˆêiƒ„ƒNƒ‹ƒg–{ŽÐ’†‰›Œ¤‹†ŠjC]èFsiŠò•Œ‘åj: ‘æ14‰ñ“ú–{ìè•aŒ¤‹†‰ï i94.10.22j, ˜a‰ÌŽR, ´˜^W, p.13, 1994.

2021. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j R‚Ä‚ñ‚©‚ñ–ò‚ÌTDM. ŽO‰YŽõ’jiŽ™j: ‘æ17‰ñ–ò•¨Ž¡—ƒjƒ^ƒŠƒ“ƒOŒ¤‹†‰ï“Á•Êƒ[ƒ~ƒi[ƒ‹ i94.09.11j, “Œ‹ž, Clinical pharmacokinetics ‚Ì—˜_‚ÆŽÀÛ|’†‹‰•Ò, p.45`54, 1994.

2022. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j –«t‹@”\áŠQ‚ð”F‚ß‚½äNã÷”AŠÇ‹t—¬Ç‚Ì—Õ°“IŒŸ“¢. –kžŠ‚Ý‚Ç‚èC’©’·C’†‘ºM–çC”Ñ‚Šì‹v—YiŽ™jC–{ŽRŽ¡i“Œ–M‘åj: ‘æ16‰ñ¬Ž™t•s‘SŒ¤‹†‰ï i94.09.09j, •ó’Ë, —\eW, p.97, 1994.

2023. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‚¯‚¢‚ê‚ñdÏǂɑ΂·‚é midazolam‚ÌŒø‰Ê|–ò•¨ˆË‘¶‚𶂶—£’E¢“ï‚Å‚ ‚Á‚½‚P—Ž™—á|. •ˆäŒ¤“ñCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çiŽ™j: ‘æ21‰ñ”­’B–ò—E–ò•¨Ž¡—ÃŒ¤‹†‰ï i94.09.10j, , ´˜^W, p.1, 1994.

2024. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Vit. D‘å—ʗÖ@‚ðs‚Á‚½ƒNƒ‹•a‚Ì3—á|Vit. D‘å—ʗÖ@‚Ìf’f“IˆÓ‹`. ŽO‰Í½CÎìM‹`C¼‰YM•viŽ™j: ‘æ12‰ñ¬Ž™‘ãŽÓ«œŽ¾Š³Œ¤‹†‰ï i94.12.03j, _ŒË.

2025. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j dǒጌ“œÇ, dÇS•s‘S, ŒÄ‹z•s‘S‚ð’悵‚½IDM. •ÐŽR•¶•FC‰¡“csŽjC“¡–ìé”VC¡ˆäƒDC’†‘ºM–çiŽ™jC²“¡–FºC`˜aŽqiŽY•wjC¼‰YM•viŽ™j: ‘æ10‰ñ“œ”A•a‚Æ”DP‚ÉŠÖ‚·‚錤‹†‰ï i94.12.03j, “Œ‹ž.

2026. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éIDDM‡•¹”DP•êŽ™‚Ì—Õ°‘œ‚ÉŠÖ‚·‚錟“¢. ²“¡‰ë•FiŽ™jC‚‹´—SŽiiˆãŠw•”jC¬ŒûO‹BC¼‰YM•viŽ™j: ‘æ10‰ñ“œ”A•a‚Æ”DP‚ÉŠÖ‚·‚錤‹†‰ï i94.12.03j, “Œ‹ž, —\eW, p.24, 1994.

2027. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Carbamazepine‚Æzonisamide•¹—pŽž‚ÌŒŒ’†”Z“x‚Ì‘ŠŒÝì—p‚ɂ‚¢‚Ä. ŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çC•ˆäŒ¤“ñiŽ™j: •½¬‚U”N“xŒú¶È¸_E_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ï; “‚Ä‚ñ‚©‚ñ‚ÌŽ¡—Ö@ŠJ”­‚ÉŠÖ‚·‚錤‹†”ljï‹c i94.12.06j, “Œ‹ž, ´˜^W, p.40, 1994.

2028. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‰ð”M–ò¿Ü‚Ì•¹—p‚ªdiazepam¿Ü‚Ì’¼’°‚©‚ç‚Ì‹zŽû‚É‚¨‚æ‚Ú‚·‰e‹¿|—¼¿Ü•¹—pŽž‚ÌdiazepamŒŒ’†”Z“x‚Ì„ˆÚ‚ɂ‚¢‚Ä|. •ˆäŒ¤“ñCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çiŽ™j: ‘æ17‰ñ”M«áz¹§˜b‰ï i94.12.17j, “Œ‹ž, Brain Dev., 17: 1995.

2029. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j MIT, VP161‚É‚ÄŠ°‰ð‚𓾂½ph1—z«mixed lineage leukemia‚Ì1—á. ŽO‘îòC¡ˆäƒDC¬‘ò”ü˜aCŒIŒ´Œ‰C‰““¡‹I—YiŽ™j: ‘æ123‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï—á‰ï i95.01.21j, “Œ‹ž.

2030. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j t‘Ÿ‚Ì‚·‚ׂÄ|¬Ž™tŽ¾Š³‚ÆHŽ–—Ö@|. Žðˆä‹Ši”åj: ’·èŒ§•a‰@‰h—{Žm‹¦‹c‰ïŒ¤C‰ï i94.11.19j, ’·è.

2031. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ¬Ž™Œ´”­«”x‚ŒŒˆ³Ç‚Ì1—á. ŠÖª“OC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀCã“cN‹vC•½Î‘iŽ™jC–x’rdŽ¡CΈ䟌Èi•új: ‘æ9‰ñŠÖ“Œ’n‹æŒÄ‹zŠíŠjˆãŠwŒ¤‹†‰ï i93.09.11j, “Œ‹ž, ŠÖ“Œ’n‹æŒÄ‹zŠíŠjˆãŠwŒ¤‹†‰ïŽ, p.52`53, 1993.

2032. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘Šú‚æ‚èŠJŽn‚µ‚½ƒrƒ^ƒ~ƒ“ B6‘å—ʗÖ@‚ª’˜Œø‚µ‚½öˆö« WestÇŒóŒQ‚Ì‚Q—á. ”’ˆäGKCŽO‰YŽõ’jC–xŒû‘דTC“‡ŠÑˆèC•Ÿ“‡’‹`C“àŽR’q–¾C¬—ÑŒåŽqiŽ™jC•“¡NŽiiŠƒ–è“¿F‰ï‘‡•a‰@jC‘å–î’B•vi¹˜H‰Á‘Û•a‰@j: ‘æ15‰ñ_“Þ쬎™_Œo§˜b‰ï i94.01.14j, ‰¡•l, ´˜^W, p.2, 1995.

2033. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‚¯‚¢‚ê‚ñdÏǂɑ΂·‚émidazolam ‚ÌŒø‰Ê|–ò•¨ˆË‘¶‚𶂶—£’E¢“ï‚Å‚ ‚Á‚½‚P—Ž™—á|. •ˆäŒ¤“ñCŽO‘îòC»‰ŸÂCŽO‰YŽõ’jiŽ™j: ‘æ34‰ñ_“Þì‚Ä‚ñ‚©‚ñ§˜b‰ï i94.07.23j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 22(1): 191, 1995.

2034. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ™•ú«sodium valproate»Ü(NIK-240) 400 mgù‚P“ú‚P‰ñ“Š—^Žž‚ÌŒŒ’†”Z“x‚Ì•Ï“®|™•ú«è÷—±Ü“Š—^Žž‚Ì•Ï“®‚Æ‚Ì”äŠr|. ”’ˆäGKCŽO‰YŽõ’jC‚—œ‰hC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çC•ˆäŒ¤“ñiŽ™j: ‘æ14‰ñ_“Þ쬎™_Œo§˜b‰ï i94.07.30j, ‰¡•l, ´˜^W, p.10, 1994.

2035. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j CTã—¼‘¤Ž‹°‚É’á‹zŽûˆæ‚ð”F‚ß‚½—Õ°“IReyeÇŒóŒQ‚Ì‚P—á. ”’ˆäGKC–xŒû‘דTCˆÀ•ÛŒ«ˆêC“‡ŠÑˆèC•Ð‹Ë’q–çC•Ÿ“‡’‹`C“àŽR’q–¾iŽ™jC‘å–î’B•vi¹˜H‰Á‘Û•a‰@jC‰Á“¡’B•vCŒÜ“‡•q˜Y, ¼“‡ˆê“TCŽRŒû–¾Žqi¹ƒ}ƒŠƒAƒ“ƒiˆã‘åj: ‘æ14‰ñ_“Þ쬎™_Œo§˜b‰ï i94.07.30j, ‰¡•l, ´˜^W, p.4, 1994.

2036. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹¹•”‘½”­Œ‹ßó‰A‰e‚ð’悵‚½ãO–ÑŠà‚Ì1’jŽ™—á. ŒIŒ´Œ‰C¡ˆäƒDC¬‘ò”ü˜aCã“cN‹vC”~Œ´ŽÀC‰““¡‹I—YiŽ™j: ‘æ21‰ñ_“Þ쬎™Žîᇌ¤‹†‰ï i94.09.03j, ‰¡•l.

2037. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒrƒ^ƒ~ƒ“ B6‘å—ʗÖ@‚ª‘tŒø‚µ‚½ WestÇŒóŒQ—ÞŽ—‚̃VƒŠ[ƒYŒ`¬«‹­’¼”­ì‚ðŽ¦‚µ‚½‚P“ûŽ™—á. •ˆäŒ¤“ñCŽO‰YŽõ’jC‚—œ‰hC”’ˆäGKC»‰ŸÂCדc‚Ì‚¼‚ÝCˆÀ•ÛŒ«ˆêCˆÀ•ÛƒŽqC•Ð‹Ë’q–çiŽ™j: ‘æ15‰ñ_“Þ쬎™_Œo§˜b‰ï i95.01.14j, ‰¡•l, ´˜^W, p.3, 1995.

2038. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒoƒ‹ƒvƒŽ_ƒiƒgƒŠƒEƒ€™•ú»Ü•ž—p’†‚É‹}«äX‰Š‚ð’悵‚½‚P—Ž™—á. •ˆäŒ¤“ñCŽO‰YŽõ’jC»‰ŸÂC¬“‡–M•FC^“º‘¾˜YC‘å“c„•äiŽ™j: ‘æ35‰ñ_“Þì‚Ä‚ñ‚©‚ñ§˜b‰ï i95.01.28j, ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, 22(2): 1995.

2039. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ¬Ž™t×–EŠà‚Ì2—á. ¬‘ò”ü˜aC¡ˆäƒDCŒIŒ´Œ‰C“n•Ó’qŽqCŽO‘òmŽiC‰““¡‹I—YiŽ™jC’©’·“N–íCΓc˜a•viŠOj: ‘æ22‰ñ_“Þ쬎™Žîᇌ¤‹†‰ï i95.02.25j, ‰¡•l.

2040. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Ž…‹…‘Ì‘B•a•Ï‚ƃƒTƒ“ƒMƒEƒ€‚Ì’¾’…•¨‚ª‘J‰„‚µ‚½ƒXƒeƒƒCƒh’ïR«ƒlƒtƒ[ƒ[. ‰Í¼‹IºC’†‘ºM–çCŽç‰®r‰îiŽ™j: ‘æ23‰ñ_“Þìt‰ŠŒ¤‹†‰ï i95.02.25j, ‰¡•l, —\eW, p.5, 1995.


<<17 ŽY‰ÈŠw>>

2041. mŒ´’˜n NST. ¼“‡³”ŽC“V–슮iŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 43: 1345`1348, 1994.

2042. mŒ´’˜n œ”Ոʂ̎æ‚舵‚¢•û. “‡“cMGiŽY•wj: ŽY•wl‰ÈŽ¡—Ã, 68(5): 554`560, 1994.

2043. mŒ´’˜n ‘Ù“à”­ˆç’x‰„Ž™‚Ì•aˆö¥•a‘Ô. ¼“‡³”ŽC“V–슮CÄ“¡ŽiŽY•wj: ŽüŽYŠúˆãŠw, 24: 496`500, 1994.

2044. mŒ´’˜n amnioinfusion|“K‰ž‚ÆŒÀŠE. “V–슮C•{•s“ñ’jC¯“c—²C¼“‡³”ŽiŽY•wjCŠ—Œ´FiŽ™j: ŽüŽYŠúŠwƒVƒ“ƒ|ƒWƒEƒ€, (12): 79`88, 1994.

2045. mŒ´’˜n •ª•ØŽž‚̈Ùí‘ÙŽ™S”ƒ‚ƒjƒ^[‚ÌÄ•]‰¿. ¼“‡³”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 46: 235`238, 1994.

2046. mŒ´’˜n ”D•w‚̃qƒgƒpƒ‹ƒ{B19ƒEƒCƒ‹ƒXR‘Ì•Û—L—¦‚ɂ‚¢‚Ä. Ä“¡ŽC›”ŽˆûCŒãŒ«C¯“c—²C“V–슮C“‡“cMGC¼“‡³”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 31(2): 143`147, 1995.

2047. mŒ´’˜n ŽY‰È“IDIC‚ɑ΂·‚éƒAƒ“ƒ`ƒgƒƒ“ƒrƒ“‡V”Zk»Ü‚ÌŽ¡—ÃŒø‰Ê|‘½Ž{Ý‹¤“¯Œ¤‹†¬Ñ. ^–س”ŽiH“cÔ\ŽšŒŒ‰tƒZƒ“ƒ^[jCŽ›”ör•Fi•l¼ˆã‘åjC’rƒmãŽi‹{èˆã‘åjC“¡–{ªˆê˜Yi–k‘åjCH“¡—²ˆêiŽD–yˆã‘åjC¼’JŠÞiŠâŽèˆã‘åjC“c ’†r½iH“c‘åjC–ãài“Œ–k‘åjC²“¡Íi•Ÿ“‡Œ§—§ˆã‘åjC‹Ê“c‘¾˜NiŽ©Ž¡ˆã‘åjCŒFâ‚OiàÕ‹¦ˆã‘åjC²“¡˜a—Yi“ú‘åjC•“c‰À•FC’†—ѳ—Yi“Œ —ˆã‘åjC–î“àŒ´Iiº˜a‘åjC‰J‹{Íi¹ƒ}ƒŠˆã‘åjC¼“‡³”ŽiŽY•wjC¬—Ñ—²•vi‘—§“ŒÃ•a‰@jC‹ÊŽÉ‹P•FiŠò•Œ‘åjC—F“c–Li–¼‘åjC–L“c’·NiŽO d‘åjC‰ª“cO“ñi‹ž“s•{—§ˆã‘åjCž¹–Ø—EiŠÖ¼ˆã‘åjC”‹“cK—Yi‘åãŽs‘åjC–ì“c‹Nˆê˜Yi‹ß‘åjCH“¡®•¶i‰ª‘åjC‘Š—Ç—S•ãi‚’mˆã‘åjC‰ª‘º‹Ï iŒF–{‘åjC”g‘½]³‹IiŽ­Ž™“‡Žs—§•a‰@j: “ú–{ŽY•wl‰È¥V¶Ž™ŒŒ‰tŠw‰ïŽ, 4: 37`49, 1994.

2048. mŒ´’˜n ‘½‘Ù•ª•Ø‚̃gƒ‰ƒuƒ‹. ¼“‡³”ŽC‹gŒ´ˆêiŽY•wj: —Õ°•wl‰ÈŽY‰È, 48: 1484`1486, 1994.

2049. mŒ´’˜n œ”Ոʕª•Ø‚̉uŠw; 1.¬nŽ™. ¼“‡³”ŽC–ì“c–FliŽY•wj: —Õ°•wl‰ÈŽY‰È, 48: 602`604, 1994.

2050. m’Z•ñ¥‘¬•ñn Ž_‘f–O˜a“x‘ª’è‚É‚æ‚镪•ØŽž‚Ì‘ÙŽ™ŠÇ—. “V–슮C¼“‡³”ŽiŽY•wj: ŽY•wl‰ÈŽ¡—Ã, 68(6): 932, 1994.

2051. mŒ¤‹†•ñiŒú¶Èjn ”DŽYåñ•w‚̸_“IƒTƒ|[ƒg‚ɂ‚¢‚Ä. ¼“‡³”ŽC‹gŒ´ˆêiŽY•wj: Œú¶ÈSgáŠQŒ¤‹†u”DŽY•w‚ð‚Æ‚è‚Ü‚­”—vˆö‚Æ•êŽq‚ÌŒ’N‚ÉŠÖ‚·‚錤‹†v•½¬5”N“xŒ¤‹†•ñ‘, p.40`42, 1993.

2052. mŒ¤‹†•ñiŒú¶Èjn ‰Á—î‚É”º‚¤”DP‡•¹Ç‚ÉŠÖ‚·‚錤‹†. ²“¡ÍC‰F‰ê’¼Ž÷C¼“‡³”ŽiŽY•wjC—éXŒOC‰¬“cK—YCH“¡®•¶: •½¬5”N“xŒú¶ÈSgáŠQŒ¤‹†uƒnƒCƒŠƒXƒN”DP‚ÉŠÖ‚·‚錤‹†v, 1994.

2053. mÇ—á•ñn ƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^‚É‚æ‚镪•ØŽž‘ÙŽ™ŠÇ—‚ðs‚Á‚½æ“V«Š®‘S–[ŽºƒuƒƒbƒN‚Ì1—á. “V–슮C“¡¶—TŽqC‚¼ˆ¤C¼“‡³”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 46(5): 469`472, 1994.

2054. m‘àn •ª•ØŽž‚ÌŽq‹{Žûk, —r…ˆ³ƒ‚ƒjƒ^ƒŠƒ“ƒO. ‹gŒ´ˆêiŽY•wj: ƒyƒŠƒlƒCƒ‹ƒPƒA, 13(‰Ä‹G‘Š§): 79`90, 1994.

2055. m‘àn “ïŽY|¡“ú‚̘b‘è. “‡“cMGiŽY•wj: ŽüŽYŠúˆãŠw, 24(12): 1624`1626, 1994.

2056. m‘àn —r…ŒŸ¸‚̃XƒNƒŠ[ƒjƒ“ƒO‚Æ‚µ‚Ă̈Ӌ`. ‹gŒ´ˆêiŽY•wj: ŽüŽYŠúˆãŠw, 24(8): 1112`1116, 1994.

2057. m‘àn bó‘B‹@”\˜´iÇ. •{•s“ñ’jiŽY•wj: ŽüŽYŠúˆãŠw, 24(‘Š§): 193`195, 1994.

2058. m‘àn •ê‘ÌŽ¾Š³‚ÌŽüŽYŠúƒPƒA; bó‘B‰Š. ‹gŒ´ˆêiŽY•wj: ŽüŽYŠúˆãŠw, 24(‘Š§): 198`199, 1994.

2059. m‘àn ¡ŒŽ‚Ì—Õ°|•ª•Ø”­—ˆ‚Æ‚µ‚­‚Ý; 8. •ª•Ø—U”­¥ŠíŠB“IŒzŠÇŠg‘å‚Í—LŒø‚©. ’F‰pŽ÷iŽY•wj: —Õ°•wl‰ÈŽY‰È, 49(2): 176`178, 1995.

2060. muÀn (Œ¤Cˆã‚Ì‚½‚ß‚ÌuÀ)Šw‰ï”­•\‚̃Rƒc(1)ƒXƒ‰ƒCƒh‚Ìì‚è•û. “‡“cMGiŽY•wj: JOHNS, 10(10): 1495`1499, 1994.

2061. muÀn (Œ¤Cˆã‚Ì‚½‚ß‚ÌuÀ)Šw‰ï”­•\‚̃Rƒc(2)Šwpu‰‰‚ł̘b‚µ•û. “‡“cMGiŽY•wj: JOHNS, 10(11): 1619`1623, 1994.

2062. muÀn lH—r…•â[—Ö@(amnioinfusion). “V–슮iŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 43(6): 779`781, 1994.

2063. muÀn “ïŽY‚Æ‘ÙŽ™‰¼Ž€. “V–슮iŽY•wj: ŽüŽYŠúˆãŠw, 24(12): 1742`1746, 1994.

2064. muÀn ‘Ì“à”­ˆç’x‰„Ž™‚Ì•aˆö¥•a‘Ô. ¼“‡³”ŽC“V–슮CÄ“¡ŽiŽY•wj: ŽüŽYŠúˆãŠw, 24(4): 496`500, 1994.

2065. muÀn —r…•â[‚ÆŠÒ—¬. “V–슮iŽY•wj: ŽüŽYŠúˆãŠw, 24(7): 961`964, 1994.

2066. muÀn æ“V”~“Å. “‡“cMGiŽY•wj: ŽüŽYŠúˆãŠw, 25(2): 146`147, 1995.

2067. muÀn ”DP’†‚É‚æ‚­‚Ý‚ç‚ê‚éƒ}ƒCƒi[ƒgƒ‰ƒuƒ‹‚Ì–ò•¨—Ö@. “‡“cMGiŽY•wj: ŽüŽYŠúˆãŠw, 25(2): 223`226, 1995.

2068. muÀn œ”Ոʕª•Ø‚ÌŽY‰È–ƒŒ. “V–슮iŽY•wj: —Õ°•wl‰ÈŽY‰È, 48(5): 650`651, 1994.

2069. mŠwp‘i‰p•¶jn i•ª’SŽ·•Mj Hypoxische Gefahrdung des Fetus sub partu; Potential benefits of fetal pulse oximetry in the management of fetal arrhythmia, p.83`85, “V–슮C“¡¶—TŽqC‚¼ˆ¤C‘O“c@‘¥C¼“‡³”ŽiŽY•wj. •ÒW R. Knitza, SteinkopffCGermanyC94.00.00”­s.

2070. mŠwp‘n i•ª’SŽ·•Mj •W€ŽY‰È•wl‰ÈŠw; 29Í ŽY‰Èˆ’u, B.•ª•Ø—U”­¥‘£i C.–ƒŒ–@, p.356`359, ¼“‡³”ŽiŽY•wj. •ÒW –]ŒŽ^lCŒKŒ´Œc‹IC ˆãŠw‘‰@C“Œ‹žC94.04.01”­s.

2071. mŠwp‘n i•ÒWj ŽüŽYŠúˆã—Âɂ¨‚¯‚éƒyƒŠƒlƒCƒ^ƒ‹ƒ‚ƒjƒ^ƒŠƒ“ƒO; •ÒW “‡“cMGiŽY•wj, ƒƒfƒBƒJo”ÅC‘åãC94.06.01”­s.

2072. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj uŒŸ¸ƒŠƒXƒeƒBƒ“ƒOv•ÊûˆãŠw‚Ì‚ ‚ä‚Ý; STD|”~“Å, AIDS, p.366`372, –ì“c–FlC¼“‡³”ŽiŽY•wj. •ÒW ã“c‘Š°CX“OC ˆãŽ•–òo”ÅC“Œ‹žC94.04.05”­s.

2073. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ÅV‚ÌŽüŽYŠúŠÇ—; ‘ÙŽ™‰¼Ž€‚Ìf’f‚ÆŽ¡—à A.‹}«‘ÙŽ™‰¼Ž€, p.134`142, ¼“‡³”ŽiŽY•wj. ˆã‰ÈŠwo”ÅC“Œ‹žC94.05.25”­s.

2074. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ŽY•wl‰ÈŠO—ˆf—Ã; ŒŸ¸‚Æf’f C.ŽüŽYŠú 2.ƒJƒ‰[ƒhƒvƒ‰, p.204`208, ¼“‡³”ŽCA–ìM…iŽY•wj. •ÒW —é–ØH‰xCLˆä³•FC “ì]“°C“Œ‹žC94.11.10”­s.

2075. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj1995; •ª•Ø—U”­, ‘£i, ¼“‡³”ŽiŽY•wj. ˆãŠw‘‰@C“Œ‹žC95.03.15”­s.

2076. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Study on 312 cases of fetal distress in relation to neonatal prognosis. ¼“‡³”ŽC¯“c—²C‘O“c@“¿C•{•s“ñ’jC“V–슮C“‡“cMGiŽY•wj: 8th Asia-Oceania Congress of Perinatology i94.09.19j, Taipei.

2077. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Trend of Cesarean section rate and perinatal mortality rate. ¼“‡³”ŽC“V–슮C–ì“c–FlC¯“c—²C‘O“c@“¿C•{•s“ñ’jC‹gŒ´ˆêC“‡“cMGiŽY•wj: 14th World Congress of Gynecology and Obstetrics i94.09.26j, Montreal.

2078. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Oxygen saturation and fetal heart rate patterns. “V–슮C•{•s“ñ’jC¼“‡³”ŽiŽY•wj: ‘æ14‰ñ¢ŠEŽY•wl‰ÈŠw‰ï i94.09.28j, ƒ‚ƒ“ƒgƒŠƒI[ƒ‹.

2079. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Efficacies of antepartum amnioinfusion. •{•s“ñ’jC“V–슮C“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ14‰ñ¢ŠEŽY•wl‰ÈŠw‰ï i94.09.28j, ƒ‚ƒ“ƒgƒŠƒI[ƒ‹.

2080. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j •ª•Ø–ƒáƒ‚ÌŒ´ˆö‚Æ—\–h. “‡“cMGiŽY•wj: ‘æ5‰ñ“ú–{¬Ž™®Œ`ŠO‰ÈŠw‰ï i94.12.01j, “Œ‹ž.

2081. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^‚É‚æ‚é‘ÙŽ™Ž_‘f–O˜a“x‘ª’è‚ÉŠÖ‚·‚錟“¢. “V–슮C‘O“c@“¿C•{•s“ñ’jC“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ46‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï i94.04.09j, “Œ‹ž, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 46(Suppl.): 250, 1994.

2082. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •êb‚ÌoŒŒ‚ª‘ÙŽe‚É—^‚¦‚é‰e‹¿‚Æ‘ÙŽeŽ©g‚ÌoŒŒ‚É‚æ‚锽‰ž‚Ì”äŠr. ‹gŒ´ˆêCŒ¹“c’C—YCª–{‘‘ˆêC“‡“cMGC¼“‡³”ŽCóˆämŽiC‰–’Ép”VC²“¡ŠìˆêiŽY•wj: ‘æ46‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï i94.04.11j, “Œ‹ž.

2083. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘ÙŽ™“®–¬ŒŒŽ_‘f–O˜a“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚̈Ӌ`‚ɂ‚¢‚Ä. “V–슮C‘O“c@“¿C¼“‡³”ŽiŽY•wj: ‘æ30‰ñ“ú–{V¶Ž™Šw‰ï i94.07.19j, ɪ.

2084. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •êb‚ÌoŒŒ‚ª‘ÙŽe“®–¬ˆ³, S””‚É—^‚¦‚é‰e‹¿‚Æ‘ÙŽeŽ©g‚ÌoŒŒ‚É‚æ‚锽‰ž‚Ì”äŠr. ‹gŒ´ˆêC“V–슮C“‡“cMGC¼“‡³”ŽCŒ¹“c’C—YCª–{‘‘ˆêCóˆämŽiC‰–’Ép”VC²“¡ŠìˆêiŽY•wj: ‘æ17‰ñ“ú–{ŽY‰È•wl‰ÈME§˜b‰ï i94.07.30j, ‹{è.

2085. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘ÙŽ™•s®–¬‚Í’éØ‚Ì“K‰ž‚©? “V–슮C¼“‡³”ŽiŽY•wj: ‘æ6‰ñ“ú–{—Õ°ƒ‚ƒjƒ^[Šw‰ï‘‰ï i95.03.04j, “Œ‹ž.

2086. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j ˆÀ‘S‚È•ª•ØŠÇ—‚ð‚ß‚´‚µ‚Ä. ¼“‡³”ŽiŽY•wj: •½¬6”N“xŠò•ŒŒ§ŽY‰È•wl‰ÈŠw‰ïŽüŽYŠúŒ¤‹†‰ï i94.05.21j, Šò•Œ.

2087. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j ˆÀ‘S‚È•ª•ØŠÇ—‚ð‚ß‚´‚µ‚Ä. ¼“‡³”ŽiŽY•wj: ŽD–yŽsŽY•wl‰Èˆã‰ï i94.05.27j, ŽD–y.

2088. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j Ø”—‘ŽY‚Æ•ª•Ø‚ÌŠÇ—. ¼“‡³”ŽiŽY•wj: ²‰êŒ§“ú•ê“úŽY•w’è—ᑉï‘æ129‰ñŠwpŒ¤C‰ï i94.06.18j. ²‰ê.

2089. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘½‘Ù‚ð‚ß‚®‚é”–â‘è; ‘½‘Ù‚Å‚Ý‚ç‚ê‚é‘ÙŽ™ˆÙí. “V–슮iŽY•wj: ‘æ8‰ñ_“Þì•ê«‰q¶Šw‰ï i95.01.14j, ‰¡•l.

2090. mŠw‰ïi’n•ûjn iƒ[ƒNƒVƒ‡ƒbƒvj ‘ÙŽ™f’f‚Æ‚»‚ÌŽ¡—Ã. “V–슮C¼“‡³”ŽiŽY•wj: ‘æ300‰ñ“ú–{ŽY•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï i94.05.21j, ìè.

2091. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Cystic hygroma‚ÌŽY‰ÈŠÇ—‚ɂ‚¢‚Ä. “cŒû‰ë”VC‘O“c@“¿C¯“c—²C“V–슮C“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ87‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï i94.06.26j, “Œ‹ž.

2092. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j æ“V«Š®‘S–[ŽºƒuƒƒbƒN4—á‚ÌŒŸ“¢. ‹àˆä“”VC‘O“c@“¿C•{•s“ñ’jC“V–슮C“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ87‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï i94.06.26j, “Œ‹ž.

2093. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘Š–ÍŒ´’n‹æ‚É‚¨‚¯‚éƒqƒgƒpƒ‹ƒ{B19ƒEƒCƒ‹ƒXR‘Ì•Û—L—¦‚ÉŠÖ‚·‚錟“¢. ›”ŽˆûCÄ“¡ŽC’Jº”ŽC‹gŒ´ˆêC“V–슮C“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ301‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï i94.07.16j, ‘Š–ÍŒ´.

2094. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘ÙŽ™• …‚Ì—Õ°“IŒŸ“¢. •½–ì‘ŽqCVˆä³GC¯“c—²C“V–슮C“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ303‰ñ“úŽY•w_“Þì’n•û•”‰ï, ‘æ36‰ñ_“ÞìˆãŠw‰ï‘‰ï i94.11.19j, ‰¡•l.

2095. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”D•w‚̃AƒŒƒ‹ƒM[‚ɑ΂·‚éˆÓŽ¯’²¸. rì‚ЂëŽqC‹{Œ´‚©‚¸‚ÝCª–{—æŽqC‘å‰ÍŒ´‘C–]ŒŽˆ¤˜YC“à–ì’¼Ž÷iŽY•wj: _“Þ쌧•ê«‰q¶Šw‰ï i95.01.14j, ‰¡•l.

2096. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •ê‘Ì”À‘—•Ê‚Ì•ª•Ø—\Œã‚ÌŒŸ“¢. ª–{—æŽqC‘å‰ÍŒ´‘C–]ŒŽˆ¤˜YC“à–ì’¼Ž÷iŽY•wj: ‘æ306‰ñ“úŽY•w_“Þì’n•û•”‰ï i95.02.18j, ‰¡•l.

2097. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •ê‘ÌŽ€–S, ƒjƒAƒ~ƒX—á‚Ì—Õ°“IŒŸ“¢. ‘OŒ´‘å‰îC¯“c—²C“V–슮C“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ306‰ñ“úŽY•w_“Þì’n•û•”‰ï i95.02.18j, ‰¡•l.

2098. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Anorexia Nervosa‚Ì”DP—á. •ìOŽqC’Jº”ŽC“V–슮C“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ307‰ñ“úŽY•w_“Þì’n•û•”‰ï i95.03.18j, ‰¡•l.

2099. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j ƒAƒŒƒ‹ƒM[«“÷‰èŽî«ŒŒŠÇ‰Š‡•¹”DP‚Ì1—á. ‘O“c@“¿C—Ñ—æŽqC“¿]Šô˜Yi‘—§‘Š–ÍŒ´•a‰@jC’F‰pŽ÷iŽY•wj: ‘æ88‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï i94.10.23j, ¼–{.

2100. mŒ¤‹†‰ïi‘Ûjn iˆê”Êu‰‰j Potential benefits of fetal pulse oximetry in the management of fetal arrhythmia. “V–슮C“¡¶—TŽqC‚¼ˆ¤C‘O“c@‘¥C¼“‡³”ŽiŽY•wj: ‘æ2‰ñ‘Ûƒ[ƒNƒVƒ‡ƒbƒvgFetal 02-Monitoring sub partuh i94.08.22j, ƒ~ƒ…ƒ“ƒwƒ“.

2101. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j •ª•Ø–ƒáƒ‚Æœ”Ոʕª•Ø‚ÆŒ¨b“ïŽY. “‡“cMGiŽY•wj: SSƒZƒ~ƒi[ i95.01.07j, “Œ‹ž.

2102. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j –ƒŒ•ª•ØŽž‚Ì‘ÙŽ™ŠÇ—. “V–슮CÄ“¡ŽC¯“c—²C•{•s“ñ’jC’Jº”ŽC‹gŒ´ˆêC“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ88‰ñ•ª•Ø‚Æ–ƒŒŒ¤‹†‰ï i94.06.25j, “Œ‹ž.

2103. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j •ª•Ø–ƒáƒ‚ÌŒ´ˆö‚Æ—\–h. “‡“cMGiŽY•wj: ‘æ5‰ñ––½_ŒoŒ¤‹†‰ï i94.07.09j, “Œ‹ž.

2104. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j •ª•ØŽž‚Ì‘ÙŽ™“®–¬ŒŒŽ_‘f–O˜a“x‚ÆS””ŠŒ©‚Æ‚ÌŠÖŒW. “V–슮C¯“c—²C•{•s“ñ’jC¼“‡³”ŽiŽY•wj: ‘æ17‰ñ“ú–{ŽY‰È•wl‰ÈME§˜b‰ï i94.07.30j, ‹{è.

2105. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Å‹ß‚Ìg–³’É•ª•Øh‚ÌŒXŒü. •{•s“ñ’jC“V–슮C¼“‡³”ŽiŽY•wj: •ª•Ø‚Æ–ƒŒŒ¤‹†‰ï i94.12.17j, ‰¡•l.

2106. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j —r…‚ð‚݂‚߂Ă݂悤. “‡“cMGiŽY•wj: ‚¢‚í‚«ŽsŽY•wl‰È•”‰ï i94.11.02j, ‚¢‚í‚«.

2107. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j •ª•ØŽž‚Ì‘ÙŽ™“®–¬ŒŒŽ_‘f–O˜a“xƒ‚ƒjƒ^ƒŠƒ“ƒO. “V–슮iŽY•wj: ‘æ3‰ñ•ª•ØŠÄŽ‹Œ¤‹†‰ï i94.06.04j, “Œ‹ž.

2108. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‘ÙŽ™S””ƒ‚ƒjƒ^ƒŠƒ“ƒO‚ð‚ß‚®‚éŋ߂̘b‘è. “‡“cMGiŽY•wj: ‘æ7‰ñ–kŠC“¹ŽüŽYŠúƒZƒ~ƒi[ i94.07.02j, ŽD–y.

2109. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j •ª•Ø‘O‚Ì‘ÙŽ™ƒ‚ƒjƒ^ƒŠƒ“ƒO. “‡“cMGiŽY•wj: ‘æ7‰ñ–kŠC“¹ŽüŽYŠúƒZƒ~ƒi[ i94.07.03j, ŽD–y.

2110. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‚±‚ê‚©‚ç•êeŠw‹‰‚È‚Ç‚Å”D•w‚É‹³ˆç‚µ‚Ä‚Ù‚µ‚¢‚±‚Æ. “‡“cMGiŽY•wj: “Œ–kŽüŽYŠúƒZƒ~ƒi[ i94.07.30j, å‘ä.

2111. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”»“Ç‚É‹ê—¶‚µ‚½1—á. rˆä’‰ŽmCÄ“¡ŽC“V–슮C¼“‡³”ŽiŽY•wj: ‘æ3‰ñ•ª•ØŠÄŽ‹Œ¤‹†‰ï i94.06.04j, “Œ‹ž.

2112. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j •ª•ØŒo‰ß’†‚ÌŽq‹{”j—ô‚Ì1—á. ¼”—Œ[C¯“c—²C“V–슮C¼“‡³”ŽiŽY•wj: ‘æ4‰ñ•ª•ØŠÄŽ‹Œ¤‹†‰ï i94.11.05j, “Œ‹ž.

2113. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Žq‹{“àŠ´õ‚ªŒ´ˆö‚ÆŽv‚í‚ê‚é‘ÙŽ™‰¼Ž€. rˆä’‰ŽmCÄ“¡ŽC“V–슮C¼“‡³”ŽiŽY•wj: ‘æ4‰ñ•ª•ØŠÄŽ‹Œ¤‹†‰ï i94.11.05j, “Œ‹ž.

2114. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Žq‹{“àŠ´õ‚É‚æ‚é‚ÆŽv‚í‚ê‚é‘ÙŽ™‰¼Ž€‚Ì1—á. rˆä’‰ŽmC¯“c—²C’Jº”ŽC“V–슮C¼“‡³”ŽiŽY•wj: ‘æ37‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï i95.02.25j, ‰¡•l.

2115. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j œ”Ոʂƒ鉤؊J. rˆä’‰ŽmC“V–슮C“‡“cMGC¼“‡³”ŽiŽY•wj: ‘æ313‰ñŽl…‰ï i95.03.01j, “Œ‹ž.

2116. mŠw‰ïŽåÃi’n•û‰ïjn ‘æ306‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï(95.02.18), ‰¡•l, ¼“‡³”ŽiŽY•wj.


<<18 •wl‰ÈŠw>>

2117. mŒ´’˜n Isolation of an ascitic oncodevelopmental protein exhibiting high sequence homology with calcium-binding protein MRP8. ’†‹Œõ¶CÎì‰ëˆêiŽY•wjC•l“c—SŽqi¶‰»ŒnjCSachiko Sugano: Biol. Chem. Hoppe-Seyler, 375: 789`792, 1994.

2118. mŒ´’˜n •s³«ŠíoŒŒ‚ð”F‚ß‚È‚©‚Á‚½Žq‹{‘ÌŠàÇ—á‚ÌŒŸ“¢. ‹v“ˆ‘¥sCã–V•qŽqC‘å‰ÍŒ´‘C—§‰ª˜aOC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 43(5): 729`734, 1994.

2119. mŒ´’˜n ŠO‰A¥äT•a•Ï‚ɑ΂·‚郌[ƒU[Ž¡—Ã. ˜e“c–M•vC‘ –{”ŽsiŽY•wj: ‘æ14‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘å‰ï˜_•¶W, p.201`204, 1994.

2120. mŒ´’˜n ƒŒ[ƒU[‚É‚æ‚é• o‹¾‰ºŽèp. ˜e“c–M•vCŒãŒ«CŽR–{GŽÀCŠâ‰i‹v”üC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: “ú–{ƒŒ[ƒU[ˆãŠw‰ïŽ, 15(4): 31`37, 1994.

2121. mŒ´’˜n Žq‹{“à–Œ‘BÇ‚ÌŒo‰ßŠÏŽ@’†‚ÉŽq‹{‘ÌŠà‚ð”­Ç‚µ‚½7—á‚Ì—Õ°•a—Šw“IŒŸ“¢. ã–V•qŽqC‘å‰ÍŒ´‘C‘ –{”ŽsC¼“‡³”ŽiŽY•wj: “ú–{ŠàŽ¡—Êw‰ïŽ, 29(11): 1811`1818, 1994.

2122. mŒ´’˜n Žq‹{‘ÌŠà‚Ì‹Ø‘wZ‚ÉŠÖ‚·‚ép’†“÷Šáf’f‚Ì•]‰¿. ‘·’ìˆÔC–L˜¬‘iãŠC‘æˆêl–¯ˆã‰@jC‘ –{”ŽsiŽY•wj: “ú–{ŠàŽ¡—Êw‰ïŽ, 29(12): 1942`1947, 1994.

2123. mŒ´’˜n •wl‰Èˆ««Žîᇂɑ΂·‚éCarboplatin•ªŠ„“Š—^‚É‚æ‚é‚’PˆÊƒvƒ‰ƒ`ƒi—Ö@(CET—Ö@)‚̬Ñ. `GŽ÷C‘ –{”ŽsCŒË‰êè‹`–¾C’Òˆä“ÄC‹v“ˆ‘¥sC˜e“c–M•vCã–V•qŽqC¼“‡³”ŽiŽY•wj: “ú–{ŠàŽ¡—Êw‰ïŽ, 29(7): 1016`1023, 1994.

2124. mŒ´’˜n KTPƒŒ[ƒU[‚É‚æ‚éŽq‹{Œz•”ã”ç“àŽîᇂ̎¡—Ã|‚»‚ÌŠî‘b“I, —Õ°“IŒŸ“¢|. ò‹M•¶C˜e“c–M•vC‘ –{”ŽsiŽY•wj: “ú–{ŠàŽ¡—Êw‰ïŽ, 29(7): 990`1000, 1994.

2125. mŒ´’˜n œ”Õ“àƒŠƒ“ƒpߊs´Œã‚Ì•›áŠQ‚ɑ΂·‚é’áo—Í”¼“±‘̃Œ[ƒU[Ž¡—Â̎Ž‚Ý. Ä“¡ŽC˜e“c–M•vC¡ˆä‰ë•vC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 11(3): 303`307, 1994.

2126. mŒ´’˜n Žq‹{Œz•”Žîᇂɑ΂·‚郌[ƒU[—Ö@Œã‚Ì•›ì—p‚ÉŠÖ‚·‚錟“¢. ˜e“c–M•vC‘ –{”ŽsC²X–Ø‹I[Cò‹M•¶C¼“‡³”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 46(7): 597`604, 1994.

2127. mŒ´’˜n •wl‰È‹Ù‹}Ž¾Š³‚ɑ΂·‚é• o‹¾‰ºŽèp‚Ì—L—p«‚ɂ‚¢‚Ä. ”Ñ–ì÷“ñCì“à”ŽlCΈ䑸—YC’†‹Œõ¶iŽY•wj: “ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ïŽGŽ, 10(1): 67`70, 1994.

2128. mŒ´’˜n —‘‘ƒè÷—±–Œ×–EŽî‚Ì—Õ°“I¥•a—Šw“IŒŸ“¢. ã–V•qŽqCã•Ð•½º“ñCŠâ’JO–¾C²“¡—Ï–çC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: “ú–{•wl‰È•a—¥ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ïŽGŽ, 12(2): 179`186, 1994.

2129. mÇ—á•ñn f’f‚ª¢“ï‚Å‚ ‚Á‚½Œ‹Šj«• –Œ‰Š‚Ì2Ç—á. ã–V•qŽqCŒãŒ«C—§‰ª˜aOCŠâ’JO–¾C‘ –{”ŽsC¼“‡³”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 31(2): 168`171, 1995.

2130. mÇ—á•ñn ‹}Œƒ‚È• …‚ð‚«‚½‚µŒ´”­•s–¾‚Å‚ ‚Á‚½‘BŠà‚Ì1—á(–k—¢‘åŠw•a‰@CPC‘æ191‰ñ). ‘ –{”ŽsC²“¡—Ï–çiŽY•wjCŠ“cç”ü”Ti•a—j: –k—¢ˆãŠw, 24(6): 590`593, 1994.

2131. m‘àn —‘‘ƒ‹@”\ˆÙíÇ. ’†‹Œõ¶iŽY•wj: ˆãŠw‚Æ–òŠw, 32(5): 919`926, 1994.

2132. m‘àn Žq‹{‘ÌŠà“à•ª”å—Ö@‚ÌŠî‘b“IŒŸ“¢. `GŽ÷C‘ –{”ŽsiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jCŒË‰êè‹`–¾C’Òˆä“ÄCã–V•qŽqC¼“‡³”ŽC¼“c³lCˆÀ¼Œ·iŽY•wjCE. GurpideiMount Sinai Sch. Med.j: ŽY‰È‚Æ•wl‰È, 61(9): 1253`1259, 1994.

2133. m‘àn Žq‹{‘ÌŠà‚ɑ΂·‚éƒzƒ‹ƒ‚ƒ“—Ö@‚Ì“W–]. ‘ –{”ŽsCã–V•qŽqC`GŽ÷C‰Á“¡—ÇŽ÷iŽY•wj: ŽY‰È‚Æ•wl‰È, 61(9): 1269`1274, 1994.

2134. m‘àn Žq‹{‘ÌŠà‚ɑ΂·‚é”D›s”\‰·‘¶—Ö@. ‘ –{”ŽsC`GŽ÷C—§‰ª˜aOiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 43(5): 659`663, 1994.

2135. m‘àn ƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚ÆŽèp—Ö@; ‘ŠúŽq‹{‘ÌŠà. ‘ –{”ŽsC—§‰ª˜aOCã–V•qŽqiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 43(9): 1205`1209, 1994.

2136. m‘àn ŒŽŒoˆÙí‚̃zƒ‹ƒ‚ƒ“—Ö@|–³ŒŽŒo‚ÌŽ¡—Ã. ’†‹Œõ¶iŽY•wj: ŽY•wl‰ÈŽ¡—Ã, 62(2): 139`143, 1994.

2137. m‘àn • o‹¾Žèp‚É‚¨‚¯‚郌[ƒU[ƒƒX‚Ì—˜—p|“d‹CƒƒX‚Æ‚Ì”äŠr. ì“à”ŽliŽY•wj: “ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ïŽGŽ, 10(1): 7`9, 1994.

2138. m‘àn Žq‹{“à–Œ×–Ef‚É‚æ‚é‘ÌŠà‚Ì‘Šú”­Œ©. ‘ –{”ŽsiŽY•wjC‘å–ì‰pŽ¡i•a‰@•a—j: “ú–{—Õ°×–EŠw‰ï‘啪Œ§Žx•”‰ïŽ, 4: 3`6, 1994.

2139. m‘àn Žq‹{“à–ŒŠà¥‘BÇ‚Ì×–Ef. ‘ –{”ŽsiŽY•wjC‘å–ì‰pŽ¡C‰¡ŽR‘åi•a‰@•a—j: “ú–{—Õ°×–EŠw‰ï–kŠC“¹‰ï•ñ, 3(3): 1`4, 1994.

2140. m‘àn ”|—{×–E‚Ì×–Ef‚ւ̉ž—p|”|—{Žq‹{“à–ŒŠà×–E‚ð—á‚É|. ‘ –{”ŽsC`GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“j: •a—‚Æ—Õ°, 12(10): 1103`1106, 1994.

2141. m‘àn ¡ŒŽ‚Ì—Õ°|“«‡•¹Ç‚ðf‚é|ŽY‰È; ŽY•wl‰È‡•¹ÇCIN. ˜e“c–M•vC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: —Õ°•wl‰ÈŽY‰È, 48(11): 1326`1327, 1994.

2142. m‘àn ‘ŠúŠà|f—ÃXƒgƒ‰ƒeƒW|; Žq‹{‘ÌŠà|f’f; “à–Œ×–Ef. ‘ –{”ŽsiŽY•wj: —Õ°•wl‰ÈŽY‰È, 48(6): 752`753, 1994.

2143. mŠwp‘n i•ª’SŽ·•Mj ŽY•wl‰ÈŠO—ˆf—Ã; Žq‹{‘ÌŠà, p.53`58, ‘ –{”ŽsiŽY•wj. •ÒW —é–ØH‰xiŒc‘åjCLˆä³•FiŽRŒ`‘åj, “ì]“°C“Œ‹žC94.11.10”­s.

2144. mŠwp‘n i•ª’SŽ·•Mj ŽY•wl‰ÈŠO—ˆf—Ã; –³ŒŽŒo, p.154`163, ’†‹Œõ¶iŽY•wj. •ÒW —é–ØH‰xiŒc‘åjCLˆä³•FiŽRŒ`‘åj, “ì]“°C“Œ‹žC94.11.10”­s.

2145. mŠwp‘n i•ª’SŽ·•Mj ŽY•wl‰ÈŠO—ˆf—Ã; —‘ŠÇ‹@”\ŒŸ¸, p.164`170, ì“à”ŽliŽY•wj. •ÒW —é–ØH‰xiŒc‘åjCLˆä³•FiŽRŒ`‘åj, “ì]“°C“Œ‹žC94.11.10”­s.

2146. mŠwp‘n i•ª’SŽ·•Mj ŽY•wl‰ÈŠO—ˆf—Ã; •wl‰ÈƒŒ[ƒU[Ž¡—Ö@, p.246`251, ‘ –{”ŽsiŽY•wj. •ÒW —é–ØH‰xiŒc‘åjCLˆä³•FiŽRŒ`‘åj, “ì]“°C“Œ‹žC94.11.10”­s.

2147. mŠwp‘n i•ª’SŽ·•Mj }àŽY•wl‰ÈVIEW-10Žîá‡; —\ŒãˆöŽq‚©‚ç‚Ý‚½Ž¡—Ö@‚Ì‘I‘ð|Žq‹{‘ÌŠà, p.50`61, ‘ –{”ŽsiŽY•wj. •ÒW –òŽtŽ›“¹–¾i‹v—¯•Ä‘åjCŽ›“‡–F‹PiŽœŒb‘åj, ƒƒWƒJƒ‹ƒrƒ…[C“Œ‹žC94.11.10”­s.

2148. mŠwp‘n i•ª’SŽ·•Mj ŽY•wl‰Èf—à Q & A; ‚Ñ‚ç‚ñƒŒ[ƒU[—Ö@‚ÌŽ¡–ü‰ß’ö, p.1259‚Ì2`3, ‘ –{”ŽsiŽY•wj. ˜Z–@o”ÅC‹ž“sC94.12.12”­s.

2149. mŠwp‘n i•ª’SŽ·•Mj ŽY•wl‰Èf—à Q & A; ‰~Øœ, p.1378`1379, ‘ –{”ŽsiŽY•wj. ˜Z–@o”ÅC‹ž“sC94.12.12”­s.

2150. mŠwp‘n i•ª’SŽ·•Mj ŽY•wl‰Èf—à Q & A; Žq‹{Œz•”‰~ØœŒã‚Ì”DP, p.1382`1385, ‘ –{”ŽsiŽY•wj. ˜Z–@o”ÅC‹ž“sC94.12.12”­s.

2151. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Lymphadenectomy in the treatment of endometrial carcinoma. ‘ –{”ŽsiŽY•wj: Symposium on Endometrial Carcinoma i94.04.14j, ƒ[ƒ}.

2152. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Modified radical and radical histerectomy for endometrial carcinoma. ‘ –{”ŽsiŽY•wj: Symposium on Endometrial Carcinoma i94.04.14j, ƒ[ƒ}.

2153. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Intrauterine applications of the resectoscope. ˜e“c–M•vC“y‹Š²C›”ŽˆûC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: 4th World Congress of Endoscopic Surgery i94.06.18j, ‹ž“s, Surg. Endosc., 8(5): 460, 1994.

2154. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The autocrine regulations of endometrial adenocarcinoma cells by estrogen induced TGF-ƒ¿. `GŽ÷CŒË‰êè‹`–¾C’Òˆä“ÄC‘ –{”ŽsiŽY•wj: ‘æ14‰ñ¢ŠEŽY•wl‰ÈŠw‰ï i94.09.27j, ƒ‚ƒ“ƒgƒŠƒI[ƒ‹, Int. J. Gynecol. Obstet., 46(Suppl.1): 60, 1994.

2155. mŠw‰ïi‘S‘jn ih‘è•ñj Žq‹{‘ÌŠà‚ɑ΂·‚éƒzƒ‹ƒ‚ƒ“‘½Ü•¹—p‰»Šw—Ö@‚ÌŠm—§(•½¬5”N“xŒÂ•ÊŒ¤‹†•ñ). `GŽ÷iŽY•wj: ‘æ7‰ñ“ú–{•wl‰Èˆ««Žîᇉ»Šw—Ö@Šw‰ïŠwpW‰ï i94.11.26j, “Œ‹ž, ´˜^W, p.21, 1994.

2156. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Žq‹{‘Ì•”ƒ~ƒ…[ƒ‰[ŠÇ¬‡ŽîᇂÌ×–E‘œ|ƒ[ƒNƒVƒ‡ƒbƒv‡VuŽq‹{‘Ì•”ŽîᇂÌ×–Ef(”ñã”ç«ŽîᇂàŠÜ‚Þ)v. ò‹M•¶C‰º“c—²•vC—Ñ—æŽqCã–V•qŽqC‘ –{”ŽsiŽY•wjC‘å–ì‰pŽ¡i•a‰@•a—jCŒ¹“c’C—YiŽY•wjC¡ˆä’‰˜Ni–k—¢ƒƒfƒBƒJƒ‹j: ‘æ35‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï i94.06.03j, ¼], “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(2): 190, 1994.

2157. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Žq‹{“à–Œ×–Ef‚Å‹^—z«‚ð’悵‚½‹@”\«oŒŒ—á‚ÌÄŒŸ“¢. —Ñ—æŽqCã–V•qŽqC`GŽ÷C‘ –{”ŽsiŽY•wjC‘å–ì‰pŽ¡i•a‰@•a—j: ‘æ35‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï i94.06.04j, ¼], “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(2): 183, 1994.

2158. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒpƒlƒ‹|ŽY•wl‰È—̈æ‚ÌÅ‹ß‚Ì”|—{×–EŠ”: —‘‘ƒŸ÷‰t«”X–E‘BŠà”|—{×–EŠ”(Ikeda)‚ÌŽ÷—§‚Æ”«Ši. ”Ñ“c’q”Ži¹ƒ}ƒŠ‘åjC‘ –{”ŽsC‰º“c—²•viŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷iŽY•wjC—^“ß—ä‹žŽqC—јa•Fi¹ƒ}ƒŠ‘åj: ‘æ12‰ñ“ú–{ƒqƒg×–EŠw‰ï‘å‰ï i94.08.25j, “Œ‹ž, Human Cell, 7(2): 48, 1994.

2159. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒpƒlƒ‹|ŽY•wl‰È—̈æ‚ÌÅ‹ß‚Ì”|—{×–EŠ”: —‘‘ƒŸ÷‰t«”X–E‘BŠà”|—{×–EŠ”(Chikamatsu)‚ÌŽ÷—§‚Æ”«Ši. •l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷CŒË‰êè‹`–¾C’Òˆä“ÄC•ìOŽqC‘ –{”ŽsiŽY•wj: ‘æ12‰ñ“ú–{ƒqƒg×–EŠw‰ï‘å‰ï i94.08.25j, “Œ‹ž, Human Cell, 7(2): 49, 1994.

2160. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒpƒlƒ‹|ŽY•wl‰È—̈æ‚ÌÅ‹ß‚Ì”|—{×–EŠ”: —‘ŠÇ“û“ªó‘BŠà”|—{×–EŠ”‚ÌŽ÷—§‚Æ”«Ši. •l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷CŒË‰êè‹`–¾C’Òˆä“ÄC•ìOŽqC‘ –{”ŽsiŽY•wj: ‘æ12‰ñ“ú–{ƒqƒg×–EŠw‰ï‘å‰ï i94.08.25j, “Œ‹ž, Human Cell, 7(2): 50, 1994.

2161. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒpƒlƒ‹|ŽY•wl‰È—̈æ‚ÌÅ‹ß‚Ì”|—{×–EŠ”: Žq‹{‘Ì•”’†•ª‰»‘BŠà”|—{×–EŠ”(HEC-151)‚ÌŽ÷—§‚Æ”«Ši. •l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷CŒË‰êè‹`–¾C’Òˆä“ÄC•ìOŽqC‘ –{”ŽsiŽY•wj: ‘æ12‰ñ“ú–{ƒqƒg×–EŠw‰ï‘å‰ï i94.08.25j, “Œ‹ž, Human Cell, 7(2): 51, 1994.

2162. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j •wl‰È—̈æ‚É‚¨‚¯‚é• o‹¾‰ºƒŒ[ƒU[Ž¡—Ã: ƒVƒ“ƒ|ƒWƒEƒ€(2)‘Ìo‹¾‰ºƒŒ[ƒU[Ž¡—Â̌»ó‚Æ«—ˆ‡T. ˜e“c–M•vCŒãŒ«CŽR–{GŽÀCŠâ‰i‹v”üC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ15‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘å‰ï i94.10.13j, Ž­Ž™“‡, ´˜^W, p.44, 1994.

2163. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj • o‹¾‰ºŽèp‹@Ší‚Ì–â‘è“_: ƒŒ[ƒU[ƒƒX vs “d‹CƒƒX. ì“à”ŽliŽY•wj: ‘æ34‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ï i94.08.05j, “Œ‹ž.

2164. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj Žq‹{‘ÌŠà‚̉»Šw—Ö@. ã–V•qŽqC²“¡—Ï–çCŠâ’JO–¾C—§‰ª˜aOC`GŽ÷C‘ –{”ŽsC‘å‰ÍŒ´‘iŽY•wj: ‘æ7‰ñ“ú–{•wl‰Èˆ««Žîᇉ»Šw—Ö@Šw‰ïŠwpW‰ï i94.11.26j, “Œ‹ž, ´˜^W, p.28, 1994.

2165. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–E‚̃GƒXƒgƒƒQƒ“—U“±«‘BˆöŽq‚Æc-erbB-2Šàˆâ“`Žq”­Œ». `GŽ÷C‘ –{”ŽsiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC“n•Óƒi•a—jCŒË‰êè‹`–¾C’Òˆä“ÄC¼“‡³”ŽiŽY•wj: ‘æ46‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï i94.04.11j, “Œ‹ž, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 46(Suppl.): 147, 1994.

2166. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{“à–Œ‘BÇ‚Ì’·Šúfollow-up¬Ñ. ã–V•qŽqC‘å‰ÍŒ´‘C—§‰ª˜aOC“cŒû‰ë”VC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ46‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï i94.04.12j, “Œ‹ž, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 46(Suppl.): 266, 1994.

2167. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒJƒ‹ƒVƒEƒ€Œ‹‡’`”’MRP8‚ÆN-––’[ƒAƒ~ƒmŽ_”z—ñ‚Ì‚‚¢‘Š“¯«‚ðŽ¦‚·‚ª‚ñ• …’`”’‚Ì’P—£‚Æ‚»‚Ì“Á«‰ðÍ. ’†‹Œõ¶CÎì‰ëˆêiŽY•wj: ‘æ46‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï i94.04.12j, “Œ‹ž, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 46(Suppl.): 272, 1994.

2168. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–E‚̃GƒXƒgƒƒQƒ“—U“±«‘BˆöŽq‚È‚ç‚Ñ‚Éc-erbB-2Šàˆâ“`Žq”­Œ». `GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jCŒË‰êè‹`–¾C’Òˆä“ÄC•ìOŽqC‘ –{”ŽsiŽY•wj: ‘æ67‰ñ“ú–{‘gD”|—{Šw‰ï‘å‰ï i94.04.22j, ‰ªŽR, ‘gD”|—{Œ¤‹†, 13(1): 62, 1994.

2169. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{‘ÌŠà‚Ìp’†• …¥• oôò×–Ef|‘½XoŒ»‚·‚é”ñŠà«‘B×–E‚̈Ӌ`. ‘å–ì‰pŽ¡C‰¡ŽR‘åC•ž•”ŠwC‚ŽR–¾ŽqC–L‰i^Ÿi•a‰@•a—jCŠâŸºŒ[ˆêi•a—jC‘ –{”ŽsiŽY•wjC‹T’J“Oi•a—j: ‘æ35‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï i94.06.03j, ¼], “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(2): 205, 1994.

2170. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆ««• –Œ’†”çŽî3Ç—á‚Ì—Õ°“I¥×–E•a—Šw“IŒŸ“¢. ²“¡—Ï–çCã–V•qŽqC—§‰ª˜aOCŠâ’JO–¾C‘ –{”ŽsC¼“‡³”ŽiŽY•wjC•ž•”Šwi•a‰@•a—jC“n•Ó´Ž¡C‹T’J“Oi•a—j: ‘æ35‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï i94.06.03j, ¼], “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(2): 275, 1994.

2171. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽYåñ3TŠÔ‚Å• …’™—¯‚ð‰”­Çó‚É”­Ç‚µ‚½ˆ««ƒŠƒ“ƒpŽî‚Ì1—á. ŒãŒ«Cã–V•qŽqC‘å‰ÍŒ´‘C˜e“c–M•vC‘ –{”ŽsiŽY•wjCŠâŸºŒ[ˆêi•a—jC‘å–ì‰pŽ¡i•a‰@•a—j: ‘æ35‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï i94.06.03j, ¼], “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(2): 279, 1994.

2172. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒzƒ‹ƒ‚ƒ“•â[—Ö@‚É‚¨‚¯‚éŽq‹{“à–Œ×–EfŠŒ©. —§‰ª˜aOCã–V•qŽqC—Ñ—æŽqC‹v“ˆ‘¥sC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ35‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï i94.06.04j, ¼], “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(2): 337, 1994.

2173. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ã”竈««—‘‘ƒŽîá‡IaŠú‚Ì•a—Šw“IŒŸ“¢. Šâ’JO–¾Cã–V•qŽqC—§‰ª˜aOCΈ䑸—YC‚¼ˆ¤C‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ23‰ñ“ú–{•wl‰È•a—ƒRƒ‹ƒ|Šw‰ï i94.07.29j, ‹v—¯•Ä, “ú–{•wl‰È•a—¥ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ïŽGŽ, 12(1): 37`38, 1994.

2174. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{Œz•”‘ŠúŠà‚ɑ΂·‚é•Û‘¶—Ö@‚Æ‚µ‚Ä‚ÌŠeŽíƒŒ[ƒU[—Ö@. ˜e“c–M•vC‘ –{”ŽsC›”ŽˆûC¼“‡³”ŽiŽY•wj: ‘æ23‰ñ“ú–{•wl‰È•a—ƒRƒ‹ƒ|Šw‰ï i94.07.29j, ‹v—¯•Ä, “ú–{•wl‰È•a—¥ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ïŽGŽ, 12(1): 42, 1994.

2175. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ³íŽq‹{“à–Œ, Žq‹{“à–ŒŠà‚É‚¨‚¯‚éŠî’ê–Œ\¬’`”’‚¨‚æ‚ÑCathepsin-D‚ɑ΂·‚é–Ɖu‘gDŠw“IŒŸ“¢. ŒË‰êè‹`–¾C`GŽ÷C’Òˆä“ÄiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC•ìOŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ23‰ñ“ú–{•wl‰È•a—ƒRƒ‹ƒ|Šw‰ï i94.07.29j, ‹v—¯•Ä, “ú–{•wl‰È•a—¥ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ïŽGŽ, 12(1): 51`52, 1994.

2176. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆ««• –Œ’†”çŽî3Ç—á‚Ì—Õ°“I¥•a—Šw“IŒŸ“¢. ²“¡—Ï–çCã–V•qŽqC—§‰ª˜aOCŒãŒ«CŠÛŽR—TŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ23‰ñ“ú–{•wl‰È•a—ƒRƒ‹ƒ|Šw‰ï i94.07.29j, ‹v—¯•Ä, “ú–{•wl‰È•a—¥ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ïŽGŽ, 12(1): 59, 1994.

2177. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{“à–ŒŠàÇ—á‚É‚Ý‚ç‚ꂽ—‘‘ƒ‚Ì‘BŠà‚ÉŠÖ‚·‚錟“¢. ã•Ð•½º“ñCã–V•qŽqCŠp“cV•½C‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ23‰ñ“ú–{•wl‰È•a—ƒRƒ‹ƒ|Šw‰ï i94.07.29j, ‹v—¯•Ä, “ú–{•wl‰È•a—¥ƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ïŽGŽ, 12(1): 61, 1994.

2178. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —‘ŠÇ”DP‚ɑ΂·‚é”D›s«‰·‘¶Ž¡—Â̬Ñ. çÝŽ–«Cì“à”ŽlCΈ䑸—YC”Ñ–ì÷“ñC’†‹Œõ¶iŽY•wj: ‘æ34‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ï i94.08.04j, “Œ‹ž.

2179. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —‘ŠÇ”DP‚ɑ΂·‚é• o‹¾‰º—‘ŠÇØŠJp. ì“à”ŽlC”Ñ–ì÷“ñCΈ䑸—YCçÝŽ–«C’†‹Œõ¶iŽY•wj: ‘æ34‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ï i94.08.04j, “Œ‹ž.

2180. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •wl‰È‹Ù‹}Ž¾Š³‚ɑ΂·‚é• o‹¾‰ºŽèp‚Ì—L—p«‚ɂ‚¢‚Ä. ”Ñ–ì÷“ñCì“à”ŽlCΈ䑸—YCçÝŽ–«C’†‹Œõ¶iŽY•wj: ‘æ34‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ï i94.08.04j, “Œ‹ž.

2181. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éFitu-Hugh-CurtisÇŒóŒQ12—á‚ÌŒŸ“¢. Έ䑸—YCì“à”ŽlC“y‹Š²CŠâ‰i‹v”üCçÝŽ–«C”Ñ–ì÷“ñC’†‹Œõ¶iŽY•wj: ‘æ34‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ï i94.08.04j, “Œ‹ž.

2182. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Topel endoscopic cyst aspirator‚ð—p‚¢‚½• o‹¾‰º—‘‘ƒ”XŽîŽèp. Έ䑸—YCì“à”ŽlCçÝŽ–«C”Ñ–ì÷“ñC˜e“c–M•vC’†‹Œõ¶iŽY•wj: ‘æ34‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ï i94.08.05j, “Œ‹ž.

2183. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{Œz•”Žîᇂɑ΂·‚éŠO—ˆ, ƒRƒ‹ƒ|ƒXƒR[ƒvŠÄŽ‹‰º‚ł̃Œ[ƒU[—Ö@(ƒrƒfƒIƒZƒbƒVƒ‡ƒ“). ˜e“c–M•vC‘ –{”ŽsC“y‹Š²C›”ŽˆûC¼“‡³”ŽiŽY•wj: ‘æ34‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ï i94.08.05j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.70, 1994.

2184. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘Α¤—‘ŠÇ’[X•«‡pŒã‚É”DP‚ɬŒ÷‚µ‚½’PŠpŽq‹{‚Ì1—á. ì“à”ŽlC‹gŒ´ˆêC”Ñ–ì÷“ñCΈ䑸—YCçÝŽ–«C’†‹Œõ¶C¼“‡³”ŽiŽY•wj: ‘æ17‰ñŽY•wl‰Èƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ï i94.08.06j, “Œ‹ž.

2185. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j CA125’l‚É‚æ‚éis—‘‘ƒŠàŽ¡—ÃŒø‰Ê‚Ì”»’è. —§‰ª˜aOCã–V•qŽqC›”ŽˆûCŽR–{GŽÀC‘ –{”ŽsiŽY•wj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.05j, ‰ªŽR, “ú–{ŠàŽ¡—Êw‰ïŽ, 29(8): 1236, 1994, J. Jpn. Soc. Cancer Ther., 30(2): 238, 1995.

2186. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •wl‰Èˆ««Žîᇉ»Šw—Ö@‚É‚¨‚¯‚ét‹@”\•]‰¿‚ÉŠî‚¢‚½‚’PˆÊƒvƒ‰ƒ`ƒi—Ö@‚ÌŒŸ“¢. `GŽ÷C‘ –{”ŽsCŒË‰êè‹`–¾C‹v“ˆ‘¥sC˜e“c–M•vCã–V•qŽqiŽY•wj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.06j, ‰ªŽR, “ú–{ŠàŽ¡—Êw‰ïŽ, 29(8): 1268, 1994, J. Jpn. Soc. Cancer Ther., 30(2): 268, 1995.

2187. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —‘‘ƒãó×–EŽîᇂ̗հ“IŒŸ“¢. ‚¼ˆ¤CŠâ’JO–¾C²“¡—Ï–çC˜e“c–M•vCã–V•qŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.06j, ‰ªŽR, “ú–{ŠàŽ¡—Êw‰ïŽ, 29(8): 1268, 1994, J. Jpn. Soc. Cancer Ther., 30(2): 268, 1995.

2188. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{ŒzŠÇã”ç“à‘BŠà‚ÆŽq‹{Œz•”—\”õ×–EˆÙŒ^‘BÇ|—¼•a•Ï‚Ì×–E, ‘gDŠw“IŒŸ“¢‚ÆDNA ploidy‚̉ðÍ|. ó”ö•ŽmCŽR“c–«CŠÝì‰xŽqi‘—§‘Š–ÍŒ´•a‰@jC—Ñ—æŽqiŽY•wjC‘å’Ëd‘¥C“c’†¸i‘ŠŒÝ¶•¨ˆãŠwŒ¤‹†Šj: ‘æ33‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïŠwpW‰ï i94.11.18j, å‘ä.

2189. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •ÂŒoŒã—‘‘ƒŽîᇊ³ŽÒ‚É‚¨‚¯‚éŽq‹{äT•”ŽC‰ß×–Ef‚Ì×–E¬n“xŽw”(M.I.)‚ÌŒŸ“¢. Šâ‰i‹v”üCã–V•qŽqCŠâ’JO–¾C—§‰ª˜aOC²“¡—Ï–çC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ33‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïŠwpW‰ï i94.11.18j, å‘ä, “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(5): 928, 1994.

2190. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒzƒ‹ƒ‚ƒ“•â[—Ö@‚É‚¨‚¯‚éŽq‹{“à–Œ×–EfŠŒ©. —§‰ª˜aOCã–V•qŽqC—Ñ—æŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ9‰ñ“ú–{X”NŠúˆãŠw‰ï i94.11.26j, “Œ‹ž, “ú–{X”NŠúˆãŠw‰ïŽ, 2(Suppl.): 68, 1994.

2191. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒgˆ««’†”çŽî• …’†‚©‚縻‚µ‚½V‚µ‚¢u‚ª‚ñ”­¶’`”’v‚Ì28 kD’`”’•ªŽqŽí‚ð”FŽ¯‚·‚é’PƒNƒ[ƒ“R‘Ì‚Ìì». Îì‰ëˆêC’†‹Œõ¶iŽY•wj: ‘æ46‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï i94.04.11j, “Œ‹ž, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 46(Suppl.): 445, 1994.

2192. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Immunohistochemical study for the structural proteins of membrane and cathepsin-D in normal and neoplastic endometrium (International Session). ŒË‰êè‹`–¾C’Òˆä“ÄC`GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC“n•Óƒi•a—jC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ46‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï i94.04.12j, “Œ‹ž, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 46(Suppl.): 513, 1994.

2193. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Immunohistochemical study for EGFR, IGF-IR, c-erbB-2 and p53 in normal and neoplastic endometrium (International Session). ’Òˆä“ÄC`GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jCŒË‰êè‹`–¾iŽY•wjC“n•Óƒi•a—jC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ46‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï i94.04.12j, “Œ‹ž, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 46(Suppl.): 513, 1994.

2194. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ”xŠàpŒã‚ÉäT“]ˆÚ‚ð”F‚ßf’f‚É‹ê—¶‚µ‚½1—á. ‚¼ˆ¤CŠâ’JO–¾Cã–V•qŽqCÄ“¡ŽC‘ –{”ŽsC¼“‡³”ŽiŽY•wjC‘å–ì‰pŽ¡i•a‰@•a—j: ‘æ35‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï i94.06.03j, ¼], “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(2): 334, 1994.

2195. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žá”N—‘‘ƒˆ««Žîᇂ̗հ“IŒŸ“¢. Šâ’JO–¾Cã–V•qŽqCΈ䑸—YCŠÛŽR—TŽqC`GŽ÷C‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.06j, ‰ªŽR, “ú–{ŠàŽ¡—Êw‰ïŽ, 29(8): 1455, 1994, J. Jpn. Soc. Cancer Ther., 30(2): 443, 1995.

2196. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j —‘‘ƒˆ««Žîᇂ̉»Šw—Ö@’†Ž~Œˆ’è‚É‚¨‚¯‚éSecond look operation‚̈Ӌ`‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ŒãŒ«Cã–V•qŽqCVˆä³GC˜e“c–M•vC`GŽ÷CŠp“cV•½CŠâ’JO–¾C‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.06j, ‰ªŽR, “ú–{ŠàŽ¡—Êw‰ïŽ, 29(8): 1455, 1994, J. Jpn. Soc. Cancer Ther., 30(2): 443, 1995.

2197. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žq‹{‘ÌŠà×–E‚̃GƒXƒgƒƒQƒ“—U“±«‘BˆöŽq‚È‚ç‚Ñ‚Éc-erbB-2Šàˆâ“`Žq”­Œ». `GŽ÷C‘ –{”ŽsiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jCŒË‰êè‹`–¾C’Òˆä“ÄiŽY•wjC“n•Óƒi•a—j: ‘æ53‰ñ“ú–{ŠàŠw‰ï‘‰ï i94.10.20j, –¼ŒÃ‰®, “ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.251, 1994.

2198. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹K‘¥«”r—‘«ŒŽŒo‚ðŽ¦‚·•wl‚É‚¨‚¯‚é”A’†ƒeƒXƒgƒXƒeƒƒ“‘ª’è‚ɂ‚¢‚Ä. çÝŽ–«Cì“à”ŽlC”Ñ–ì÷“ñCΈ䑸—YC’†‹Œõ¶iŽY•wj: ‘æ39‰ñ“ú–{•s”DŠw‰ï i94.10.27j, •xŽR, “ú–{•s”DŠw‰ïŽGŽ, 39(4): 257, 1994.

2199. mŠw‰ïi’n•ûjn iƒ[ƒNƒVƒ‡ƒbƒvj ƒpƒlƒ‹|Žq‹{‹ØŽî: ƒGƒXƒgƒƒQƒ“ˆË‘¶«‘B. `GŽ÷CŒË‰êè‹`–¾C’Òˆä“ÄC•ìOŽqC—§‰ª˜aOC‘ –{”ŽsC¼“‡³”ŽiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‘å–ì‰pŽ¡i•a‰@•a—j: ‘æ302‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï i94.09.17j, ìè.

2200. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •ÂŒoŒã‚Ì‘ÌŠàÇ—á‚ÌŒŸ“¢. —§‰ª˜aOCã–V•qŽqC‘å‰ÍŒ´‘C‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ310‰ñŽl…‰ï i94.05.18j, “Œ‹ž.

2201. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “€Œ‹—Ö@Œã‚Ì‚—îŽÒŽq‹{Œz•”G•½ã”ç“àŠà‚Ì1—á. ‹v“ˆ‘¥sCò‹M•¶CŒ¹“c’C—YiŽY•wj: é‹ÊŒ§ŽY‰È•wl‰ÈŠw‰ï’n•û•”‰ï‘OŠúŠwpW‰ï i94.05.29j, ‰Y˜a.

2202. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Žq‹{ŒzŠà, Žq‹{‘ÌŠà, ‚¨‚æ‚Ñ—‘‘ƒŠà‚ªd•¡‚µ‚½ŽOd‘ŠúŠà‚Ì1—á. Vˆä³GCŠâ’JO–¾C‹v“ˆ‘¥sC˜e“c–M•vCã–V•qŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wjC¬”örˆêiŠÖ“Œ’üM•a‰@j: ‘æ87‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï i94.06.26j, “Œ‹ž, “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 31(2): 219, 1994.

2203. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Žq‹{“à–Œ×–Ef‚É‚æ‚é«ŽüŠú”»’è‚ÌŒŸ“¢. –L‰i^ŸC‘å–ì‰pŽ¡C‰¡ŽR‘åC•ž•”ŠwC‚ŽR–¾Žqi•a‰@•a—jCŠâŸºŒ[ˆêi•a—jC‘ –{”ŽsiŽY•wjC‹T’J“Oi•a—j: ‘æ8‰ñ“ú–{—Õ°×–EŠw‰ïŠÖ“Œ˜A‡‰ïŠwpW‰ï i94.09.10j, …ŒË, ´˜^W, p.10, 1994.

2204. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰‰ñŽ¡—©‚ç16”N‚̉ߒö‚ÅÄ”­‚ðŒJ‚è•Ô‚µ‚½—‘‘ƒŠà‚Ì‚P—á. ¼”—Œ[Cã–V•qŽqC²“¡—Ï–çCŠâ“cŒ›–¾C‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ88‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï i94.10.23j, ¼–{, “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 31(4): 496, 1994.

2205. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j CBDA‚ðŠÜ‚ÞRˆ««Žîá‡Ü‚É‚æ‚鈫S¥šq“f‚ɑ΂·‚éGranisetron‚Ì—Õ°Œø‰Ê. •ìOŽqC—§‰ª˜aOCŠâ’JO–¾C˜e“c–M•vC`GŽ÷Cã–V•qŽqC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ88‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï i94.10.23j, ¼–{, “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 31(4): 498, 1994.

2206. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j p’†v‘¬×–Ef¥‘gDf‚Åf’f‚É‹ê—¶‚µ‚½krukenbergŽîᇂÌ1—á. ‹v“ˆ‘¥sCò‹M•¶CŒ¹“c’C—YiŽY•wj: é‹ÊŒ§ŽY‰È•wl‰ÈŠw‰ï’n•û•”‰ïŒãŠúŠwpW‰ï i94.11.26j, ‰Y˜a.

2207. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰È‰Æ‘°Œv‰æŠO—ˆ‚É‚¨‚¯‚é”DP—á‚ÌŒŸ“¢. Έ䑸—YCì“à”ŽlCçÝŽ–«C”Ñ–ì÷“ñC’†‹Œõ¶C¼“‡³”ŽiŽY•wj: ‘æ111‰ñ“ú–{•s”DŠw‰ïŠÖ“Œ’n•û•”‰ï i95.01.28j, “Œ‹ž.

2208. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰æ‘œf’f‚ª¢“ï‚Å‚ ‚Á‚½•wl‰ÈŽîᇂÌ3—á. Šâ‰i‹v”üCã–V•qŽqCŠÖ–{—»•½C›”ŽˆûCŒãŒ«C—§‰ª˜aOC‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ306‰ñ“úŽY•w_“Þì’n•û•”‰ï i95.02.18j, ‰¡•l.

2209. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j isŒzŠà‚ɑ΂·‚éFT-207äT¿–ò‚Æ•úŽËü•¹—p—Ö@‚ÌŽŽ‚Ý. ò‹M•¶C‹v“ˆ‘¥sCŒ¹“c’C—YiŽY•wj: ‘æ32‰ñé‹ÊŒ§ˆãŠw‰ï‘‰ï i95.02.26j, ‰Y˜a.

2210. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j œ”Õ“à‹‘åŽîᎂðŒ`¬‚µ‚½_ŒoâŽî‚Ì1—á. ¼”—Œ[C—§‰ª˜aOCã–V•qŽqCŒãŒ«C‘ –{”ŽsC¼“‡³”ŽiŽY•wj: ‘æ307‰ñ“úŽY•w_“Þì’n•û•”‰ï i95.03.18j, ‰¡•l.

2211. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j • o‹¾‰º‚Ɉ’u‚µ“¾‚½—‘ŠÇ…ŽîŒs”P“]‚Ì2—á. “y‹Š²Cì“à”ŽlCŠÛŽR—TŽqCΈ䑸—YC”Ñ–ì÷“ñCçÝŽ–«C’†‹Œõ¶iŽY•wj: ‘æ88‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï i94.10.23j, ’·–ì, “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 31(4): 529, 1994.

2212. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j Žq‹{‘ÌŠà‚ɑ΂·‚éStaging Laparotomy‚̈Ӌ`. ‘ –{”ŽsiŽY•wj: ‘æ34‰ñŽq‹{ŠàŒ¤‹†‰ï i94.12.10j, •Ÿ‰ª, ´˜^W, p.16`17.

2213. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ”D•w‚ÌŽq‹{ŠàŒŸf‚ÆŽq‹{ŒzŠà‘Šú—á‚̃Œ[ƒU[Ž¡—¨‚æ‚Ñ‚»‚ÌŒã‚Ì”DP, •ª•Ø. ˜e“c–M•viŽY•wj: ‘æ3‰ñŽüŽYŠúˆã—ÃŒ¤CƒZƒ~ƒi[ i94.10.30j, “Œ‹ž, ƒeƒLƒXƒg, p.37`50, 1994.

2214. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j —‘‘ƒŠà‚É‚¨‚¯‚鎡—ÃŒø‰Ê‚ÆCA125’l‚Ì„ˆÚ‚ɂ‚¢‚Ä‚ÌŒŸ“¢. —§‰ª˜aOCã–V•qŽqCŠâ’JO–¾C²“¡—Ï–çC`GŽ÷C˜e“c–M•vC‘ –{”ŽsiŽY•wj: ‘æ11‰ñ“úŽY•wŽîᇃ}[ƒJ[Œ¤‹†‰ï i95.02.09j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€, p.40, 1995.

2215. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj Žq‹{“à–Œ‚Ì×–Ef. ‘ –{”ŽsiŽY•wj: ‘æ96‰ñ“ú–{—Õ°×–EŠw‰ïƒXƒNƒŠ[ƒi[—{¬uK‰ï i94.07.05j, “Œ‹ž.

2216. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj Žq‹{‘Ì•”. ‘ –{”ŽsiŽY•wj: ‘æ97‰ñ“ú–{—Õ°×–EŠw‰ïƒXƒNƒŠ[ƒi[—{¬uK‰ï i94.07.26j, “Œ‹ž.

2217. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj ‘Ì•”‘BŠà. ‘ –{”ŽsiŽY•wj: ‘æ19‰ñ×–Ef’fŠwƒZƒ~ƒi[ i94.08.08j, “Œ‹ž.

2218. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj Žq‹{‘ÌŠà‚ɑ΂·‚é”D›s«‰·‘¶—Ö@. ‘ –{”ŽsiŽY•wj: ƒ‰ƒWƒI‚½‚ñ‚Ïu“ú•ê¥ŽY•wl‰ÈƒAƒ[v i94.10.17j, “Œ‹ž.

2219. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj •wl‰È×–Ef|Œz•”, ‘Ì•”‘BŠà. ‘ –{”ŽsiŽY•wj: •½¬6”N“xŒú¶È‚ª‚ñ—\–h‹ZpEˆõŒ¤C‰ï—Õ°ŒŸ¸‹ZŽt(’†‹‰) i94.10.19j, “Œ‹ž.

2220. mŒ¤‹†‰ïi’n•ûjn ih‘è•ñj Žq‹{‹ØŽî‚ð‚ß‚®‚é”–â‘è; ƒzƒ‹ƒ‚ƒ“‚ÆŽq‹{‹ØŽî. `GŽ÷C¼“‡³”ŽiŽY•wj: ‘æ312‰ñŽl…‰ï i94.12.14j, “Œ‹ž.

2221. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Žq‹{‘ÌŠà‚̃zƒ‹ƒ‚ƒ“—Ö@|Šî‘b‚©‚ç—Õ°‚Ö|. ‘ –{”ŽsiŽY•wj: ‘æ2‰ñŽñ“sŒ—ŽY•wl‰Èˆã§˜b‰ï i94.06.07j, “Œ‹ž.

2222. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Žq‹{‘ÌŠà‚̃zƒ‹ƒ‚ƒ“—Ö@|Šî‘b“IŒ¤‹†‚©‚ç‚̈ꎄŒ©|. ‘ –{”ŽsiŽY•wj: ‘æ1‰ñŽîá‡‚Æ“à•ª”姘b‰ï i94.11.18j, ‹ž“s.

2223. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Šà‰»Šw—Ö@‚É‚æ‚霑—}§‚ɑ΂·‚éG-CSFŽ‘±”牺’–@. —§‰ª˜aOCŠâ’JO–¾C²“¡—Ï–çC`GŽ÷C˜e“c–M•vCã–V•qŽqC‘ –{”ŽsiŽY•wj: ‘æ18‰ñŠàŽ¡—ç˜b‰ï i95.03.11j, ‰¡•l.

2224. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj Žq‹{“à–Œ‚Ì×–Ef(Žq‹{“à–Œ‰ßŒ`¬‚¨‚æ‚ÑGI“à–ŒŠá‚ÌŠÓ•Ê‚ð’†S‚É). ‘ –{”ŽsiŽY•wj: ˆÇ—Ñ‘åŠw×–EŒŸ¸Žm—{¬‰Û’öu‹` i94.06.13j, ”ª‰¤Žq.

2225. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj Žq‹{‘Ì‚ª‚ñŒŸf‚ÌŒ»ó‚Æ¡Œã‚̉ۑè. ‘ –{”ŽsiŽY•wj: •½¬6”N“x‘æ1‰ñ“Œ‹ž“s¬l•aŒŸf]Ž–ŽÒuK‰ï i94.07.06j, “Œ‹ž.

2226. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj Žq‹{‚ª‚ñŽÔŒŸf‚É‚¨‚¯‚é–âfWŒv‚ÆŽq‹{‚ª‚ñŒŸfÅ‹ß‚Ì“®Œü. ‘ –{”ŽsiŽY•wj: ‘æ18‰ñ‚ª‚ñW’cŒŸfŒ¤C‰ï i94.08.23j, ˆÉ¨Œ´.

2227. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj Žq‹{‘Ì‚ª‚ñŒŸf‚ɂ‚¢‚Ä. ‘ –{”ŽsiŽY•wj: ‘Š–ÍŒ´ŽsŽY•wl‰Èˆã‰ï i95.02.08j, ‘Š–ÍŒ´.

2228. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj Žq‹{“à–Œ‚Ì×–Ef. ‘ –{”ŽsiŽY•wj: ‘ŠŒÝ¶•¨ˆãŠwŒ¤‹†Š, •a—¥×–EfƒZƒ“ƒ^[(PCL)Œ¤C‰ï i95.03.06j, “Œ‹ž.


<<19 ®Œ`ŠO‰ÈŠw>>

2229. mŒ´’˜n Surgery for bilateral carpal tunnel syndrome; Endoscopic and open release compared in 10 patients. “ñŒ©r˜Yi®ŠOj: Acta Orthop. Scand., 66(2): 153`155, 1995.

2230. mŒ´’˜n Effects of cyclosporin on serum hyaluronan levels in collagen arthritis. ‚ŠÝŒ›“ñCŽ…–ž·Œ›i®ŠOjCŒÜäzsMi¶‰»jCŒK”ö’èmi•a—jCMiyahara, H.i‹ã‘åjCKaibara, N.: Inflamm. Res., 44: 79`82, 1995.

2231. mŒ´’˜n The effect additive hyaluronic acid on animal joints with experimentally reduced lubricating ability. ”nŸº´Ž‘iˆã—Éq¶Šw•”jC’Ë–{s’ji®ŠOjC¬Œ´Œ’’jCŽRŒû•q“ñ˜YiŽ‘¶“°Œ¤‹†Šj: J. Biomed. Mater. Res., 28: 865`870, 1994.

2232. mŒ´’˜n Isolated paralysis of the infraspinatus muscle. ‚ŠÝŒ›“ñCÄ“¡º•FC—˜ªì‰ëri®ŠOjC’r“crºi•újCŽ…–ž·Œ›i®ŠOj: J. Bone Joint Surg., 4: 584`587, 1994.

2233. mŒ´’˜n Cubital tunnel syndrome: Surgical treatment utilizing a local fat flap and tendon transfers. “ñŒ©r˜YC“‡Kˆè•vC“¡“c³C–ذ•FC’Ë–{s’ji®ŠOj: J. Orthop. Surg., 2(1): 81`86, 1994.

2234. mŒ´’˜n Values of moving and static 2-point discrimination at the fingertips of the hand in normal individuals. “ñŒ©r˜YC–ذ•Fi®ŠOj: J. Orthop. Surg., 2(2): 9`11, 1994.

2235. mŒ´’˜n Immediate internal fixation for open fractures of the long bones of the upper and lower extremities. ‰¡ŽRˆê•Fi®ŠOjCV“¡³‹Pi‹~–½jCŽ…–ž·Œ›CŽR–{^Cù–{Œ›’ji®ŠOj: J. Trauma, 37(2): 230`236, 1994.

2236. mŒ´’˜n PLäF‹…‘}“ü‚É‚æ‚éTFCC‹@”\ÄŒš‚ÌŽŽ‚Ý. “ñŒ©r˜YCŽÂŒ´OsC–ذ•FC’Ë–{’B˜YC˜e“c—²ŽiC’r“c‹M‰pC¬—Ñ–¾³i®ŠOj: Joint, 9(3): 63`68, 1994.

2237. mŒ´’˜n –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚ÌlHŠÖß’uŠ·p‚É‚¨‚¯‚é’™ŒŒŽ®Ž©ŒÈ—AŒŒ–@‚Å‚ÌRecombinant Human Erythropoietin(KRN5702)”牺“Š—^‚Ì—Õ°¬Ñ|‘½Ž{Ý‹¤“¯‚É‚æ‚éŒãŠú‘æ‚Q‘ŠŽŽŒ±|. ÒìŒMC™‰ª—mˆêC˜Å•£F•vC“›ˆäGŽ÷Cˆî—tèñˆêC‚ŠÝŒ›“ñi®ŠOjCŠâ“c‹vC‘¼9–¼: ƒŠƒEƒ}ƒ`, 34: 583`593, 1994.

2238. mŒ´’˜n ŽOŽŸŒ³CT‚Ì—LŒø«‚ɑ΂·‚錟“¢. ŽÂŒ´OsC“ñŒ©r˜YC¬—Ñ–¾³C–ذ•FC’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 26(1): 1`7, 1995.

2239. mŒ´’˜n äF”Â’f—ôpŒã‚ÌMRI. ‚ŠÝŒ›“ñCÄ“¡º•FC‰¤‹žŽqC—˜ªì‰ërC¼‘º–¾lC‰Ô“ˆ”ü“ÞŽqCŽ…–ž·Œ›i®ŠOj: Œ¨ŠÖß, 18(2): 261`264, 1994.

2240. mŒ´’˜n ã˜r“ñ“ª‹Ø’·“ªäFäFâ‚Ì’áƒGƒR[—̈æ. ¬“‡—²ŽjC‚ŠÝŒ›“ñC‰¤‹žŽqCÄ“¡º•FCŽ…–ž·Œ›i®ŠOj: Œ¨ŠÖß, 18(2): 318`321, 1994.

2241. mŒ´’˜n ˆêŽŸ“I“àŒÅ’èp‚Ì“K‰ž‚ƬÑ|Žå‚É‘“à“BŒÅ’èp‚ɂ‚¢‚Ä|. ‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOj: “ú–{ЊQˆãŠw‰ï‰ïŽ, 42(6): 460`463, 1994.

2242. mŒ´’˜n Š°œ‰PœÜ‚ÌŽ¡—ÂƋ@”\“I—\Œã. Ž…–ž·Œ›C“n•Ó“NÆC•½“c_ŽqC“ì‘òˆç—Yi®ŠOj: “ú–{ЊQˆãŠw‰ï‰ïŽ, 42(7): 524`530, 1994.

2243. mŒ´’˜n Long-term results of abduction-opposition wedge osteotomy for trapezio-metacarpal arthrosis. “ñŒ©r˜YCŽÂŒ´OsC–ذ•FC˜e“c—²ŽiCŽR‰®’qNi®ŠOj: “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(1): 48`51, 1994.

2244. mŒ´’˜n Lateral humeral epicondylitis; Results of conservative and surgical treatments. “ñŒ©r˜YCŽÂŒ´OsC’Ë–{s’ji®ŠOj: –k—¢ˆãŠw, 24(5): 342`347, 1994.

2245. mŒ´’˜n ”|—{“îœ×–E‚É‚¨‚æ‚Ú‚·ƒTƒCƒgƒJƒCƒ“‚̉e‹¿. ¼‘º–¾lC‚ŠÝŒ›“ñC‰Ô“ˆ”ü“ÞŽqC‚•½®LCŽ…–ž·Œ›i®ŠOj: –k—¢ˆãŠw, 25(1): 36`45, 1995.

2246. mŒ´’˜n ‚•ªŽqƒqƒAƒ‹ƒƒ“Ž_ƒiƒgƒŠƒEƒ€(NRD101)‚Ì•ÏŒ`«•GŠÖßǂɑ΂·‚é—Õ°Œø‰Ê‚ÆŠÖ߉t•ªÍ. ’Ë–{s’jC—L”n—mmi®ŠOj: —Õ°ƒŠƒEƒ}ƒ`, 6(1): 18`32, 1994.

2247. m€Œ´’˜i‰p•¶jn Allograft reconstruction of acetabular bone defect in revision THR. ŠÖŒû¹˜aCŽ…–ž·Œ›C‘OŒ´G•vC“n•Ó“NÆCH—t—i®ŠOj: 8th International Conference on Biomedical Engineering, p.309`311, 1994.

2248. m€Œ´’˜i‰p•¶jn Repair of bone defect with rhBMP-2 experimental study in rabbit ulnar bone defect model. ‘OŒ´G•vCŽ…–ž·Œ›CŠÖŒû¹˜aC“ß{–ìG“ñi®ŠOj: 8th International Conference on Biomedical Engineering, p.315`317, 1994.

2249. m€Œ´’˜n ’·Šú“§Í—á‚É”­¶‚µ‚½ŽèªŠÇÇŒóŒQ‚ÌpŒã¬Ñ. ¬—Ñ–¾³C“ñŒ©r˜YC–ذ•FC’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 26(1): 53`55, 1995.

2250. m€Œ´’˜n ‰~“›Œ^‘“à“B‚Ë‚¶‰¡Ž~‚ß–@‚É‚æ‚éã˜rœœŠ²•”œÜ‚ÌŽ¡—ÃŒoŒ±. ù“‡Œ³‘¥C¬—Ñ–¾³C“n•Ó“NÆC“ì‘òˆç—YCŽ…–ž·Œ›C’Ë–{s’ji®ŠOj: œÜ, 16(1): 176`180, 1994.

2251. m€Œ´’˜n ƒŠ[ƒ~ƒ“ƒO‚È‚µ‚Å‘“à“B‚Ë‚¶‰¡Ž~‚ß–@‚ÅŽ¡—µ‚½‘å‘ÚœœŠ²•”œÜ—á‚ÌŒŸ“¢. ¬—Ñ–¾³C“ì‘òˆç—YC‘å–ìŽiCV“¡³‹PCù“‡Œ³‘¥C–q–ìk•¶CŽ…–ž·Œ›i®ŠOjCŽR–{^i‹ãB˜JЕa‰@j: œÜ, 16(2): 442`444, 1994.

2252. m€Œ´’˜n ‘å‘Úœè÷ãœÜ‚ÌŽ¡—ìÑ. ¬‹{Gˆê˜YC“ì‘òˆç—YC¬—Ñ–¾³C‘å–ìŽiC’†‘º‘–¾C“茴G”VCŽ…–ž·Œ›i®ŠOj: _“Þ쮌`ЊQŠO‰Èˆã‰ïŽGŽ, 7(1): 33`36, 1994.

2253. m€Œ´’˜n “–‰È‚É‚¨‚¯‚é‘å‘ÚœŠJ•úœÜ‚ÌŒŸ“¢. ‰¡ŽRˆê•FCb”ãGŽÀC¬—Ñ–¾³CŽ…–ž·Œ›i®ŠOj: ’†•”“ú®ÐŠO‰ïŽ, 37(1): 169`170, 1994.

2254. m€Œ´’˜n •I•”ŠÇÇŒóŒQ‚ÌŽ¡—Ã|—LŒsŽ‰–b•Ù‚ð—p‚¢‚½ŽÚœ_Œo”牺‘O•ûˆÚsp‹y‚ÑNeviaser–@‚ð’†S‚É|. ‚•½®LC“ñŒ©r˜YC“y‰®“ÖC”ª–؉pŒ›C–{•”ƒŽqC’Ë–{s’ji®ŠOj: “Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ïŽGŽ, 6(2): 175`178, 1994.

2255. m€Œ´’˜n ãøœè÷•”œÜ‚ÌŽ¡—ìÑ. ŽR“c—F‹vC–k’ÜLmC‘O”V‰€‘½KC‘OŒ´G•vC•“cŒo—mC’Ë–{s’ji®ŠOj: “Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ïŽGŽ, 6(3): 466`470, 1994.

2256. m€Œ´’˜n ŽèªŠÇÇŒóŒQ‚ɑ΂·‚鋾Ž‹‰ºŽèªŠÇŠJ•úp‚ÌŒŸ“¢|]—ˆ–@‚Æ‚Ì”äŠr|. “ñŒ©r˜YC–ذ•FC“¡“c³C¬—Ñ–¾³C’Ë–{s’ji®ŠOj: “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(3): 427`430, 1994.

2257. m€Œ´’˜n ’·Šú“§Í—á‚É‚¨‚¯‚éŽèªŠÇÇŒóŒQÄ”­—á‚ÌŒŸ“¢. ¬—Ñ–¾³C“ñŒ©r˜YC–ذ•FC’Ë–{s’jCŽ…–ž·Œ›i®ŠOj: “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(3): 44`46, 1994.

2258. m€Œ´’˜n ‰Æ“eŒãŽˆÄŠÁ—¬ƒ‚ƒfƒ‹‚É‚¨‚¯‚éÔŒŒ‹…—R—ˆŠˆ«Ž_‘f‚̈Ӌ`‚ɂ‚¢‚Ä. –Ø‘º³“C‰¡ŽRˆê•FC“ñŒ©r˜YCŽ…–ž·Œ›i®ŠOjC’†‘º‘‰qi•ª¶j: “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(3): 690`694, 1994.

2259. m€Œ´’˜n ‰~“›Œ^‘“à“B‚Ë‚¶‰¡Ž~‚ß–@‚É‚æ‚é‘«ŠÖߌŒèp‚̬Ñ. ‘•ªˆê³C“ì‘òˆç—YC¬—Ñ–¾³C‘å–ìŽiC–k’ÜLmC–q–ìk•¶C’Ë–{s’jCŽ…–ž·Œ›i®ŠOj: “ú–{‘«‚ÌŠO‰ÈŠw‰ïŽGŽ, 15: 22`26, 1994.

2260. m€Œ´’˜n ƒJƒjƒNƒCƒUƒ‹‚Ì•I“à‘¤‘¤•›x‘Ñ‚ÌŒ`‘ÔŠÏŽ@|ƒqƒg‚Æ‚Ì”äŠr‚É‚¨‚¢‚Ä|. –ذ•FC“ñŒ©r˜YC¬—Ñ–¾³C“¡“c³C–{•”ƒŽqC’Ë–{s’ji®ŠOj: “ú–{•IŠÖߌ¤‹†‰ïŽGŽ, 1(1): 39`40, 1994.

2261. m€Œ´’˜n V‘NžôœŒz•”œÜ‚ɑ΂·‚éŒo”ç“I®•œ–@‚ÌŽŽ‚Ý. “ñŒ©r˜YC“¡“c³C–ذ•FC¬—Ñ–¾³C’Ë–{s’jCŽ…–ž·Œ›i®ŠOj: “ú–{•IŠÖߌ¤‹†‰ïŽGŽ, 1(1): 79`80, 1994.

2262. m€Œ´’˜n ”ñÚGŒ^•ÏˆÊŒv‘ª‘•’u‚ð—p‚¢‚½•IŠÖ߉^“®‰ðÍ. “¡“c³C“ñŒ©r˜YC–ذ•FC’†‘ºˆêmC’Ë–{s’ji®ŠOjC“¡]—T“¹i¶‘ÌHj: “ú–{—Õ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ïŽ, 15: 435`440, 1994.

2263. mŒ¤‹†•ñiŒú¶Èjn “Á”­«‘å‘Úœ“ª‰óŽ€Ç‚ɑ΂·‚錌ŠÇ•¿•t‚«ŽxŽœ’ŒˆÚAp‚ɂ‚¢‚Ä. Ž…–ž·Œ›C¬—Ñ–¾³C“ì‘òˆç—YC’Ë–{’B˜Yi®ŠOjCŽR–{^i‹ãB˜JÐj: “Á”­«‘å‘Úœ“ª‰óŽ€’²¸Œ¤‹†”Ç•½¬5”N“xŒ¤‹†•ñ‘, p.59`68, 1994.

2264. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Bone banking in Japan and Kitasato University Bone Bank activity. Ž…–ž·Œ›C“ì‘òˆç—YC‘OŒ´G•vCŠÖŒû¹˜aC“n•Ó“NÆi®ŠOj: Radiation Sterilization of Tissue Grafts, Annex 18(‘ÛŒ´Žq—Í‹@\).

2265. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn •ÏŒ`«ŒÒŠÖßÇ‚É‚¨‚¯‚éŠÖß•\–Ê‚ÌC•œ‘gD‚ÉŠÖ‚·‚錟“¢. Ž…–ž·Œ›C“ß{–ìG“ñi®ŠOj: “ú–{ŒÒŠÖߌ¤‹†U‹»à’c‘æ11‰ñŒÒŠÖߌ¤‹†ƒZƒ~ƒi[‹L˜^W, p.65`70, 1994.

2266. mÇ—á•ñn ‘å‘ÚœŒz•”‚É‹‘å”XŽîó•Ï‰»‚ð”F‚ß‚½–«ŠÖ߃ŠƒEƒ}ƒ`‚Ì1—á. ‘å‚•¶“TC“y‰®“ÖC”ª–؉pŒ›CŽÂŒ´OsCˆÀ’BŒöC–k’ÜLmC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: Joint, 9(3): 77`82, 1994.

2267. mÇ—á•ñn ŽèªŠÇÇŒóŒQ‚𔺂Á‚½‹ŽwÇ‚Ì1—á. ”’{ˆê–çCŽR“¿‹`˜YC¬—Ñ–¾³C“ñŒ©r˜YC–q–ìk•¶C‘å–ìŽiCŽ…–ž·Œ›i®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(2): 121`124, 1994.

2268. mÇ—á•ñn ŒŒŠÇ‰Š‚É‚æ‚é”畆Çó‚𔺂¤ŒÒŠÖß, ‘«ŠÖß‚¨‚æ‚Ñ‘«•”‹­’¼‚Ì1—á. H—t—C“ì‘òˆç—YC“n•Ó“NÆC¬—Ñ–¾³CŽ…–ž·Œ›i®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(2): 164`168, 1994.

2269. mÇ—á•ñn GaleazziœÜ‚É•IŠÖß’E‰P‚𔺂Á‚½1—á. —L”n—mmCŽR“¿‹`˜YC“à–ì³—²C‘å–ìŽiC—L•xŠ°CŽ…–ž·Œ›C’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(3): 225`228, 1994.

2270. mÇ—á•ñn ACLŽÀŽ¿•”’f—ô‚Ɉꎟ–D‡‚ðs‚Á‚½‚TÎŽ™—á‚ÌŒoŒ±. ŒKŒ´­’jC“ì‘òˆç—YC‘å–ìŽiC¬—Ñ–¾³C–Ø‘º³“CH—t—CŽ…–ž·Œ›C’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(3): 242`246, 1994.

2271. mÇ—á•ñn ƒSƒ‹ƒtƒ@[‚ɶ‚¶‚½’e”­•êæä‚Ì1—á. ’†‘º‘–¾C‚ŠÝŒ›“ñCù“‡Œ³‘¥C˜e“c—²ŽiC“n•Ó“NÆC¬—Ñ–¾³CŽ…–ž·Œ›i®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(4): 436`438, 1994.

2272. mÇ—á•ñn Carpometacarpal boss‚Ì2—á. H—t—C“ñŒ©r˜YC“‡Kˆè•vC’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(5): 481`484, 1994.

2273. mÇ—á•ñn ŒÒŠÖß‚É”­¶‚µ‚½synovial chondromatosis‚Ì3—á. ŽR“c—F‹vC¬—Ñ–¾³C‘å–ìŽiC–kŒ©Œ\ŽiCŽ…–ž·Œ›CŽR–{^i®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(5): 550`554, 1994.

2274. mÇ—á•ñn ’´‰¹”gŒŸ¸‚ª—L—p‚Å‚ ‚Á‚½‰»”^«Œ¨ŠÖ߉Š‚Ì1—á. “茴G”VC‚ŠÝŒ›“ñC¬‹{Gˆê˜YC’†‘º‘–¾C“ì‘òˆç—YCŽ…–ž·Œ›i®ŠOj: ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(6): 651`653, 1994.

2275. mÇ—á•ñn ŠJ•ú«d“xFloating Knee‚Ì2—á. ‰¡ŽRˆê•FCŽ…–ž·Œ›C˜e“c—²ŽiCb”ãGŽÀi®ŠOjCV“¡³‹Pi‹~–½j: œÜ, 16(2): 463`468, 1994.

2276. mÇ—á•ñn •GŠÖߊŠ–ŒŒŒŠÇŽî‚Ì1—á. ŽR“c—F‹vi®ŠOjC‹g“cviÓ쒆‰›•a‰@jC¡–ì~i®ŠOjCªŠÝÆ—YiŒú¶’†‰›•a‰@jC¡ˆädMiÓ쒆‰›•a‰@j: _“Þ쮌`ЊQŠO‰Èˆã‰ïŽGŽ, 7(1): 11`14, 1994.

2277. mÇ—á•ñn •sK‚È“]‹A‚ð‚Æ‚Á‚½ˆ««ŠÖ߃ŠƒEƒ}ƒ`‚Ì1—á. “à–ì³—²C“y‰®“ÖCŽR“c—F‹vC•½“c_ŽqC–k’ÜLmC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: _“Þ쮌`ЊQŠO‰Èˆã‰ïŽGŽ, 7(1): 53`57, 1994.

2278. mÇ—á•ñn Ž©‘RÁŽ¸‚µ‚½‹¹’Å•”‹}«d–ŒŠOŒŒŽî‚Ì1—á. ŽÂŒ´OsCˆÀ’BŒöC“n•Ó®C•‚“c–L•FC“ñŒ©r˜YC’Ë–{s’jC¡–ì~i®ŠOj: _“Þ쮌`ЊQŠO‰Èˆã‰ïŽGŽ, 7(1): 65`67, 1994.

2279. m‘àn ŽèªŠÇÇŒóŒQ‚ÌŽèp—Ö@|‹¾Ž‹‰ºŽèªŠÇŠJ•úp. “ñŒ©r˜Yi®ŠOj: M.B. Orthop., 8(1): 61`66, 1995.

2280. m‘àn ‚—îŽÒ‚Ì•GŠÖߎü•Ó•”œÜ. “ì‘òˆç—YCŽ…–ž·Œ›i®ŠOj: OS NOW, (16): 180`185, 1994.

2281. m‘àn Œ¨½ŠÖß’E‰P|Vargas•Ï–@|. ‚ŠÝŒ›“ñi®ŠOj: OS NOW, 15: 74`77, 1994.

2282. m‘àn Œ¨ŠÖߎ¾Š³‚É‚¨‚¯‚éMRI. ‚ŠÝŒ›“ñi®ŠOjC’r“crºi•új: Orthopaedics, 7(11): 242`246, 1994.

2283. m‘àn “¯Ží•Û‘¶œˆÚA‚ÌŒ»‹µ|—v‹‚³‚ê‚éðŒ‚Æœ‹âs‚ÌŠˆ“®‚ð’†S‚Æ‚µ‚Ä|. “ì‘òˆç—YCŽ…–ž·Œ›C¬—Ñ–¾³i®ŠOj: Orthopaedics, 7(9): 125`128, 1994.

2284. m‘àn œ‘eé Ç. ‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOj: ƒAƒCƒr[, 5(3): 13`18, 1994.

2285. m‘àn ®Œ`ŠO‰È‚É‚¨‚¯‚铯ŽíˆÚA. Ž…–ž·Œ›i®ŠOj: ƒ}ƒ‹ƒz®Œ`ŠO‰ÈƒZƒ~ƒi[¥•ú‘—“à—eW(‘æ107W): 4`6, 1994.

2286. m‘àn œ‹âs‚ÌŒ»ó‚Æ«—ˆ‚Ì“W–]. ¬—Ñ–¾³CŽ…–ž·Œ›i®ŠOj: ƒŠƒEƒ}ƒ`‰È, 12(6): 413`420, 1994.

2287. m‘àn Œ¨ŠÖß. ‚ŠÝŒ›“ñi®ŠOjC’r“crºi•új: ŠÖߊO‰È, 13(9): 101`106, 1994.

2288. m‘àn ãøœè÷•”œÜ‚ɑ΂·‚é•Û‘¶—Ö@‚ÌŒÀŠE. ‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOj: œ¥ŠÖߥx‘Ñ, 7(11): 1207`1214, 1994.

2289. m‘àn ŠO”½‹ü‹ÈœØ‚èpŒã‚ÌŠÖß–ÊC•œ‘gD‚̳í‚Æ‚»‚Ì‹NŒ¹. Ž…–ž·Œ›CŠÖŒû¹˜aC“ß{–ìG“ñC‘OŒ´G•vi®ŠOj: ®Œ`ŠO‰È, 45(8): 763`768, 1994.

2290. m‘àn ŠO”½‹ü‹ÈœØ‚èp. Ž…–ž·Œ›CŠÖŒû¹˜aC“ß{–ìG“ñC‘OŒ´G•vi®ŠOj: ®Œ`ŠO‰È, 45(8): 901`906, 1994.

2291. m‘àn “¯Ží•Û‘¶œˆÚA|“¯Ží•Û‘¶œ(œ‹âs)‚É—v‹‚³‚ê‚éðŒ‚Æœ‹âs‚ÌŒ»ó, –â‘è“_, ˆÀ‘S‘Îô|. “ì‘òˆç—YCŽ…–ž·Œ›i®ŠOj: ®Œ`ŠO‰È, 46(3): 365`369, 1995.

2292. m‘àn ã˜r“ñ“ª‹Ø’·“ªäF‰Š. ‚ŠÝŒ›“ñi®ŠOj: ®Œ`¥ÐŠQŠO‰È, 37(8): 879`883, 1994.

2293. m‘àn ŒÜ\Œ¨‚̉摜f’f. ‚ŠÝŒ›“ñi®ŠOj: ®Œ`¥ÐŠQŠO‰È, 37: 1555`1560, 1994.

2294. m‘àn “¯ŽíœˆÚA. Ž…–ž·Œ›i®ŠOj: “ú–{ˆãŽ–V•ñ, 3697: 43`46, 1995.

2295. m‘àn “«ã˜rœŠO‘¤ãè÷‰Š‚ÌŽ¡—Ã(BoydŽèp). “ñŒ©r˜Yi®ŠOj: •Êû®Œ`ŠO‰È, 26: 251`254, 1994.

2296. m‘àn Bone banking in Japan and Kitasato University Bone Bank activity. Ž…–ž·Œ›C“ì‘òˆç—YC‘OŒ´G•vCŠÖŒû¹˜aC“n•Ó“NÆi®ŠOj: –k—¢ˆãŠw, 24(3): 157`167, 1994.

2297. m‘àn Œ¨‚±‚è|Œ´ˆö‚ÆŠÓ•Êf’f|. ’Ë–{s’ji®ŠOj: —Õ°‚ÆŒ¤‹†, 71(7): 86`90, 1994.

2298. m‘àn œÜ‚Æ’E‰P. ŠÖŒû¹˜aC“ì‘òˆç—YCŽ…–ž·Œ›i®ŠOj: —Õ°ŠÅŒì, 20(10): 1501`1507, 1994.

2299. m‹³‰È‘n i•ª’SŽ·•Mj Textbook of Operative Orthopeadics (‘æ3Šª) Œ¨¥•I‚ÌŽèp; 3A. ŠÖß, ‡T. Œ¨ŠÖß, ‡X. ŽèpŽè‹Z; D.lHŒ¨ŠÖß’uŠ·p, p.108`116, ‚ŠÝŒ›“ñi®ŠOj. •ÒW •½ˆä˜aÆC“ñ‹{ß•v, ’†ŽR‘“XC“Œ‹žC94.09.30”­s.

2300. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ®Œ`ŠO‰ÈŽèp(‘æ2Šª) B.ŠO‡U|Ò’Å: ¬Ž™; ‘æ‡VÍ‹UŠÖß‚¨‚æ‚Ñ‘J‰„Ž¡–ü, •ÏŒ`Ž¡–ü, Ž…–ž·Œ›i®ŠOj. •ÒW •ì‚Gi“Œ‘åjCŒ´“cªsiO‘O‘åjCŽç’JG”Éiç—t‘åj, ’†ŽR‘“XC“Œ‹žC94.06.30”­s.

2301. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ®Œ`ŠO‰ÈŽèp(‘æ2Šª) A.ŠO‡T|‰ºŽˆœÜ‚¨‚æ‚Ñ’E‰P: ‘å‘Úœ‹ßˆÊ•”; 1.‘å‘ÚœŒz•”œÜ, p.102`129, “ì‘òˆç—Yi®ŠOj. ’†ŽR‘“XC“Œ‹žC94.05.09”­s.

2302. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj —Õ°®Œ`ŠO‰ÈŽèp‘S‘(‘æ3Šª) ‰ŠÇ‚ɑ΂·‚éŽèp; ‘æ1ÍŠÖ߃ŠƒEƒ}ƒ`, 1. ŠŠ–ŒØœp, A.ŠŠ–ŒØœp‚Ì——R‚ƪ‹’, p.119`123, ŽR–{^C‚ŠÝŒ›“ñi®ŠOj. •ÒW ŽR–{^i‹ãB˜JЕa‰@jC‰Í˜H“niˆÇ—Ñ‘åj, ‹àŒ´o”ÅC“Œ‹žC94.07.29”­s.

2303. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj —Õ°®Œ`ŠO‰ÈŽèp‘S‘(‘æ3Šª) ‰ŠÇ‚ɑ΂·‚éŽèp; ‘æ1ÍŠÖ߃ŠƒEƒ}ƒ`, 1. ŠŠ–ŒØœp, C.ŠŠ–ŒØœp‚Ì•û–@(2`7), p.136`146, ‚ŠÝŒ›“ñi®ŠOj. •ÒW ŽR–{^i‹ãB˜JЕa‰@jC‰Í˜H“niˆÇ—Ñ‘åj, ‹àŒ´o”ÅC“Œ‹žC94.07.29”­s.

2304. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj —Õ°®Œ`ŠO‰ÈŽèp‘S‘(‘æ3Šª) ‰ŠÇ‚ɑ΂·‚éŽèp; ‘æ2Í •ÏŒ`«ŠÖßÇ, 1. Ž¾Š³ŠT”O‚¨‚æ‚ÑŽèp“K‰ž, A.•ÏŒ`«ŠÖßÇ‚ÌŠT”O, B.Žèp“K‰ž, p.205`211, Ž…–ž·Œ›i®ŠOj. •ÒW ŽR–{^i‹ãB˜JЕa‰@jC‰Í˜H“niˆÇ—Ñ‘åj, ‹àŒ´o”ÅC“Œ‹žC94.07.29”­s.

2305. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj —Õ°®Œ`ŠO‰ÈŽèp‘S‘(‘æ3Šª) ‰ŠÇ‚ɑ΂·‚éŽèp; ‘æ2Í •ÏŒ`«ŠÖßÇ, 5. •I, p.255`268, “ñŒ©r˜Yi®ŠOj. •ÒW ŽR–{^i‹ãB˜JЕa‰@jC‰Í˜H“niˆÇ—Ñ‘åj, ‹àŒ´o”ÅC“Œ‹žC94.07.29”­s.

2306. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj —Õ°®Œ`ŠO‰ÈŽèp‘S‘(‘æ3Šª) ‰ŠÇ‚ɑ΂·‚éŽèp; ‘æ5Í ‚»‚Ì‘¼‚ÌŠÖߎ¾Š³, p.285`308, ’Ë–{s’ji®ŠOj. •ÒW ŽR–{^i‹ãB˜JЕa‰@jC‰Í˜H“niˆÇ—Ñ‘åj, ‹àŒ´o”ÅC“Œ‹žC94.07.29”­s.

2307. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj —Õ°®Œ`ŠO‰ÈŽèp‘S‘(‘æ2Šª) ŠO‚ÌŠî–{“IŽèpŽè‹Z; ‘æ3Í ‹UŠÖ߂̜ڇp, A. —V—£œˆÚAp, p.223`240, Ž…–ž·Œ›i®ŠOj. •ÒW å“cŠìŽO˜YCœA’J”¹l, ‹àŒ´o”ÅC“Œ‹žC95.01.20”­s.

2308. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ®Œ`¥Œ`¬ŠO‰Èf—à Q & A; p.118`119, “ñŒ©r˜Yi®ŠOj. •ÒW ˆäã“N˜Yi•l¼ˆã‘åj, ˜Z–@o”ÅC–¼ŒÃ‰®C94.11.30”­s.

2309. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj V}à—Õ°®Œ`ŠO‰ÈuÀ|Œ¨¥ã˜r¥•I; ã˜rœŠOãè÷‰Š, p.226`229, “ñŒ©r˜YCŽÂŒ´Osi®ŠOj. •ÒW •½‘ò‘׉îi‹ž“s•{—§‘åj, ƒƒWƒJƒ‹ƒrƒ…[ŽÐC“Œ‹žC94.06.01”­s.

2310. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj V}à—Õ°®Œ`ŠO‰ÈuÀ|Œ¨¥ã˜r¥•I; ¬Ž™‚Ì•I“àá p.222`225, “ñŒ©r˜YC’Ë–{s’ji®ŠOj. •ÒW •½‘ò‘׉îi‹ž“s•{—§‘åj, ƒƒWƒJƒ‹ƒrƒ…[ŽÐC“Œ‹žC94.06.01”­s.

2311. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ®Œ`ŠO‰ÈŽ«“T; p.46, 56, 157, 228`229, 248, 299, 335, “ñŒ©r˜Yi®ŠOj. •ÒW “Œ”Ž•F, ‹àŒ´o”ÅC“Œ‹žC94.00.00”­s.

2312. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj V}à—Õ°®Œ`ŠO‰ÈuÀ|ŒÒŠÖß; Protrusio acetabuli, p.214`215, ’Ë–{s’ji®ŠOj. •ÒW ¼èº•v, ƒƒWƒJƒ‹ƒrƒ…[ŽÐC“Œ‹žC94.09.20”­s.

2313. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj V}à—Õ°®Œ`ŠO‰ÈuÀ(‘æ14Šª) ƒXƒ|[ƒc®Œ`ŠO‰È; (‘æ2Í Še˜_ 2.㎈‘Ñ, ã˜r); Œ¨ŠÖß’E‰P, p.78`83, ‚ŠÝŒ›“ñi®ŠOj. •ÒW —Ñ_ˆê˜Y, ƒƒWƒJƒ‹ƒrƒ…[ŽÐC“Œ‹žC94.05.20”­s.

2314. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj V}à—Õ°®Œ`ŠO‰ÈuÀ(‘æ5Šª) Œ¨¥ã˜r¥•I (‘æ1Í, Œ¨:‡U.Ž¾Š³); Œ¨b‘Ñ‚Ìæ“VˆÙí, p.46`49, ‚ŠÝŒ›“ñi®ŠOj. •ÒW •½‘ò‘׉î, ƒƒWƒJƒ‹ƒrƒ…[ŽÐC“Œ‹žC94.06.10”­s.

2315. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚̈•û, ‰ü’ù(‘æ2”Å); ‰^“®ŠíŽ¾Š³, p.531`548, ŽR–{^C‚ŠÝŒ›“ñi®ŠOj. •ÒW ‚‹vŽj–C…“‡—T, “ì]“°C“Œ‹žC94.10.15”­s.

2316. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj —Õ°®Œ`ŠO‰ÈŽèp‘S‘(‘æ12™É) ¬lŒÒŠÖß; ‘æ2Í. ‘å‘Úœ“ª‰óŽ€; œˆÚAp [(A).—V—£œˆÚA, (B).ŒŒŠÇ•¿•t‚«œˆÚA], p.5`23, Ž…–ž·Œ›CŽR–{^i®ŠOj. •ÒW “c’†´‰îC™‰ª—mˆê, ‹àŒ´o”ÅC“Œ‹žC95.02.27”­s.

2317. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚Ì®Œ`ŠO‰ÈŽ¡—ÃŽwj(‘æ3”Å); œˆÚA‚Æœ‹âs, p.35, ¬—Ñ–¾³i®ŠOj. •ÒW ŽR“à—T—Yi‡‘åjC^ŠpºŒái‘啪ˆã‘åjC’Ò—z—Yi•xŽRˆã–ò‘åjC÷ˆäŽÀi“Œ–k‘åjC ˆãŠw‘‰@C“Œ‹žC95.03.15”­s.

2318. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚Ì®Œ`ŠO‰ÈŽ¡—ÃŽwj(‘æ3”Å); ‘J‰„Ž¡–ü, ‹UŠÖß, p.68`69, ¬—Ñ–¾³i®ŠOj. •ÒW ŽR“à—T—Yi‡‘åjC^ŠpºŒái‘啪ˆã‘åjC’Ò—z—Yi•xŽRˆã–ò‘åjC÷ˆäŽÀi“Œ–k‘åjC ˆãŠw‘‰@C“Œ‹žC95.03.15”­s.

2319. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚Ì®Œ`ŠO‰ÈŽ¡—ÃŽwj(‘æ3”Å); Œ¨‚̒ɂ݂̂Ƃ炦•û, p.324`325, ‚ŠÝŒ›“ñi®ŠOj. •ÒW ŽR“à—T—Yi‡‘åjC^ŠpºŒái‘啪ˆã‘åjC’Ò—z—Yi•xŽRˆã–ò‘åjC÷ˆäŽÀi“Œ–k‘åjC ˆãŠw‘‰@C“Œ‹žC95.03.15”­s.

2320. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚Ì®Œ`ŠO‰ÈŽ¡—ÃŽwj(‘æ3”Å); Œ¨ŠÖ߉摜f’f, p.325`327, ‚ŠÝŒ›“ñi®ŠOj. •ÒW ŽR“à—T—Yi‡‘åjC^ŠpºŒái‘啪ˆã‘åjC’Ò—z—Yi•xŽRˆã–ò‘åjC÷ˆäŽÀi“Œ–k‘åjC ˆãŠw‘‰@C“Œ‹žC95.03.15”­s.

2321. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚Ì®Œ`ŠO‰ÈŽ¡—ÃŽwj(‘æ3”Å); ¬Ž™‚Ì‘å‘ÚœœÜ, p.651`652, Ž…–ž·Œ›i®ŠOj. •ÒW ŽR“à—T—Yi‡‘åjC^ŠpºŒái‘啪ˆã‘åjC’Ò—z—Yi•xŽRˆã–ò‘åjC÷ˆäŽÀi“Œ–k‘åjC ˆãŠw‘‰@C“Œ‹žC95.03.15”­s.

2322. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚Ì®Œ`ŠO‰ÈŽ¡—ÃŽwj(‘æ3”Å); ‘å‘Úœ‰“ˆÊ’[‚ÌœÜ, p.653`654, Ž…–ž·Œ›i®ŠOj. •ÒW ŽR“à—T—Yi‡‘åjC^ŠpºŒái‘啪ˆã‘åjC’Ò—z—Yi•xŽRˆã–ò‘åjC÷ˆäŽÀi“Œ–k‘åjC ˆãŠw‘‰@C“Œ‹žC95.03.15”­s.

2323. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj •a‹C‚ÆŽ¡—ÂƃNƒXƒŠ; ŒÜ\Œ¨, p.192`193, ‚ŠÝŒ›“ñi®ŠOj. ƒ\ƒVƒ€C“Œ‹žC95.03.31”­s.

2324. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj •a‹C‚ÆŽ¡—ÂƃNƒXƒŠ; ˜’É, p.194`195, Ž…–ž·Œ›i®ŠOj. ƒ\ƒVƒ€C“Œ‹žC95.03.31”­s.

2325. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj •a‹C‚ÆŽ¡—ÂƃNƒXƒŠ; •ÏŒ`«•GŠÖßÇ, p.196`197, Ž…–ž·Œ›i®ŠOj. ƒ\ƒVƒ€C“Œ‹žC95.03.31”­s.

2326. m‚»‚Ì‘¼‚Ì’˜‘i‰p•¶jn i•ª’SŽ·•Mj Year Book of Hand Surgery; Natural history of the carpal tunnel syndrome, p.127`128, “ñŒ©r˜YC¬—Ñ–¾³CŽá—ÑL”VC•Ä–{ŒõˆêC’†‘ºˆêmi®ŠOj. •ÒW Amadio, P.C.CHeutz, V.R.C MosbyCSt. LouisC94.00.00”­s.

2327. m‚»‚Ì‘¼‚Ì’˜‘i‰p•¶jn i•ª’SŽ·•Mj Year Book of Hand Surgery; Rotation osteotomy for dislocation of the radial head, p.250`251, “ñŒ©r˜YC’Ë–{s’jC“¡“c³i®ŠOj. •ÒW Amadio, P.C.CHeutz, V.R.C MosbyCSt. LouisC94.00.00”­s.

2328. m‚»‚Ì‘¼‚Ì’˜‘i‰p•¶jn i•ª’SŽ·•Mj Year Book of Hand Surgery; Osteotomy for trapezio-metacarpal arthrosis, p.281`282, “ñŒ©r˜Yi®ŠOj. •ÒW Amadio, P.C.CHeutz, V.R.C MosbyCSt. LouisC94.00.00”­s.

2329. mŠw‰ïi‘Ûjn i“Á•Êu‰‰j Influence of mechanical factors on fracture healing. Ž…–ž·Œ›i®ŠOj: 4th Conference of the International Society for Fracture Repair i94.09.27`10.01j, _ŒË.

2330. mŠw‰ïi‘Ûjn i“Á•Êu‰‰j Basics and clinical aspects of the bone graft. Lane, J.M.iUSAjCŽ…–ž·Œ›i®ŠOj: 4th Conference of the International Society for Fracture Repair i94.09.27`10.01j, _ŒË.

2331. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Activity and renewed facility of KUBB (Kitasato University Bone Bank). Ž…–ž·Œ›C“ì‘òˆç—YCŠÖŒû¹˜aC‘OŒ´G•vC“n•Ó“NÆCã“cºŒái®ŠOj: 18th Annual Meeting American Association of Tissue Banks i94.08.20`24j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

2332. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j The isolated paralysis of the infraspinatus muscle. ‚ŠÝŒ›“ñCÄ“¡º•FC—˜ªì‰ërC‚•½®LCŽ…–ž·Œ›i®ŠOj: 1st Asian Orthopedic Sports Symposium i94.09.26j, L“‡, ƒvƒƒOƒ‰ƒ€, p.38.

2333. mŠw‰ïi‘Ûjn iƒ[ƒNƒVƒ‡ƒbƒvj Allograft reconstruction of acetabular bone defects in revision total hip arthroplasty. Ž…–ž·Œ›CŠÖŒû¹˜ai®ŠOj: Symposium on Allografts in Orthopaedic Practice i94.10.07`08j, ƒEƒB[ƒ“.

2334. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Low echogenic space in the biceps sheath. ‚ŠÝŒ›“ñC–q–ìk•¶CÄ“¡º•FC‰¤‹žŽqCŽ…–ž·Œ›i®ŠOj: 3rd Meeting of International Society for the Locomotor Apparatus i94.04.14`16j, ‹ž“s.

2335. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Allograft reconstruction of acetabular bone defects encoutered in revision THR. Ž…–ž·Œ›CŠÖŒû¹˜ai®ŠOj: Protek Hip and Knee Meeting i94.04.24`27j, Interlarken.

2336. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Experimental study on healing of bone defects with recombinant human BMP-2; Radiological examination. ‘OŒ´G•vCŽ…–ž·Œ›CŠÖŒû¹˜aC“ß{–ìG“ñi®ŠOj: 5th Meeting of Asia-Pacific Association of Surgical Tissue Banking i94.06.15`17j, Suzhou, China, ´˜^W, p.12`13, 1995.

2337. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Activities of Kitasato University Bone Bank; Making for the regional bone bank. “ì‘òˆç—YCŽ…–ž·Œ›C‘OŒ´G•vCŠÖŒû¹˜aC¬—Ñ–¾³C“n•Ó“NÆi®ŠOj: 5th Meeting of Asia-Pacific Association of Surgical Tissue Banking i94.06.15`17j, Suzhou China, ´˜^W, p.5, 1995.

2338. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Limb salvage procedure using osteoarticular allografts for extensive bone defects. “n•Ó“NÆCŽ…–ž·Œ›C‘å–ìŽiC“ì‘òˆç—YCŠÖŒû¹˜aC‰¡ŽRˆê•FC‘OŒ´G•vCH—t—C‚•½®Li®ŠOj: 3rd European Conference on Tissue Banking and Clinical Application on Graft i94.10.04`07j, ƒEƒB[ƒ“, ƒvƒƒOƒ‰ƒ€, p.101.

2339. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Kitasato bone bank activity: Experiences of bone allografting in orthopedic practice. “ì‘òˆç—YCŽ…–ž·Œ›C“n•Ó“NÆCŠÖŒû¹˜aC‘OŒ´G•vC¬—Ñ–¾³i®ŠOj: 3rd European Conference on Tissue Banking and Clinical Application on Graft i94.10.04`07j, ƒEƒB[ƒ“, ƒvƒƒOƒ‰ƒ€, p.16.

2340. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Instrumented robotics system for measuring stiffness of knee joint ligament. ’Ë–{s’ji®ŠOjC“¡]—T“¹i¶‘ÌHjC“n•Ó®C‹g–ìŽõ˜YC–k’ÜLmi®ŠOj: 3rd International Meeting of Orthopaedic Research i94.10.27`30j, ƒ{ƒXƒgƒ“, ´˜^W, p.109.

2341. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Allograft reconstruction of acetabular bone defects in revision THR. ŠÖŒû¹˜aCŽ…–ž·Œ›C‘OŒ´G•vC“n•Ó“NÆCH—t—i®ŠOj: 8th International Conference on Biomedical Engneering i94.11.07`10j, ƒVƒ“ƒKƒ|[ƒ‹.

2342. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Repair of bone defect with rh BMP-2 experimental study in rabbit ulnar bone defect model. ‘OŒ´G•vCŽ…–ž·Œ›CŠÖŒû¹˜aC“ß{–ìG“ñi®ŠOj: 8th International Conference on Biomedical Engneering i94.11.07`10j, ƒVƒ“ƒKƒ|[ƒ‹.

2343. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Sonography for diagnosis of rotator cuff tear. ‚ŠÝŒ›“ñC–q–ìk•¶CÄ“¡º•FCŽ…–ž·Œ›i®ŠOj: 1st Academic Congress of the Asian Shoulder Association i94.11.16`19j, ‘ä˜p, Abstracts, p.22, 1994.

2344. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Acetabular roof reinforcement ring: role in revision THR. Ž…–ž·Œ›CŠÖŒû¹˜ai®ŠOj: Hip Meeting i95.03.19`22j, ƒAƒƒŠƒJ.

2345. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical experience of percutaneous nucleotomy in the treatment of lumbar disc herniation|comparative study between the results and magnetic resonance imaging|. ˆÀ’BŒöCŽO—Ö´ŽuC“n•Ó®CŽR“c—F‹vC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: Spine Across the Sea i94.04.08`21j, ƒnƒƒC.

2346. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Experimental study on incorporation of allogeneic bone and sydroxyapatite in rabbits. ã“cºŒáCŽ…–ž·Œ›i®ŠOj: 18th Annual Meeting American Association of Tissue Banks i94.08.20`24j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

2347. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Comminuted fractures of the femoral shaft treated by interlocking cylinder nailing. ¬—Ñ–¾³CŽ…–ž·Œ›C‰¡ŠÖ~C“ì‘òˆç—YC‘å–ìŽii®ŠOj: 4th Conference of the International Society for Fracture Repair i94.09.27`10.01j, _ŒË, Abstracts, p.126.

2348. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Retrospective study on open tibial fractures: Special reference on infection rate and fracture healing prosess. b”ãGŽÀC‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOj: 4th Conference of the International Society for Fracture Repair i94.09.27`10.01j, _ŒË, Abstracts, p.135.

2349. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Intramedullary correction osteotomy for the deformity of the lower extremity. “ì‘òˆç—YCŽ…–ž·Œ›C¬—Ñ–¾³C‘å–ìŽiC“c’†Œ[Ži‚aC–q–ìk•¶i®ŠOj: 4th Conference of the International Society for Fracture Repair i94.09.27`10.01j, _ŒË, Abstracts, p.142.

2350. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j œˆÚA‚̉摜. Ž…–ž·Œ›i®ŠOj: ‘æ14‰ñ“ú–{‰æ‘œˆãŠw‰ï i94.02.02`04j, –¼ŒÃ‰®, “ú–{‰æ‘œˆãŠwŽGŽ, 13(5): 342, 1994.

2351. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Condylo-cephalic interlocking nailing for the treatment of trochanteric and subtrochanteric fractures. “ì‘òˆç—YCŽ…–ž·Œ›C¬—Ñ–¾³C‘å–ìŽiC“ß{–ìG“ñCŽR–{^i®ŠOj: ‘æ67‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i94.05.12`14j, å‘ä.

2352. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘½”­ŠO‚É‚¨‚¯‚éŽlŽˆŠO‚ÌŽ¡—Ã. Ž…–ž·Œ›C‰¡ŽRˆê•FCb”ãGŽÀCV“¡³‹Pi®ŠOj: ‘æ67‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i94.05.12`14j, å‘ä, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(2): 35, 1994.

2353. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŒÜ\Œ¨‚̉摜f’f. ‚ŠÝŒ›“ñi®ŠOj: ‘æ67‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i94.05.12`14j, å‘ä, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(2): 7, 1994.

2354. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j V‘NƒAƒLƒŒƒXäF”牺’f—ô‚ɑ΂·‚éŒo”ç“I–D‡–@‚ÌŽ¡—ìÑ. H—t—C“ì‘òˆç—YC¬—Ñ–¾³CŽ…–ž·Œ›i®ŠOj: ‘æ19‰ñ“ú–{‘«‚ÌŠO‰ÈŠw‰ï i94.07.01`02j, “Œ‹ž, ´˜^W, p.47, 1994.

2355. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘å‘ÚœœŠ²•”•²ÓœÜ‚ɑ΂·‚é‰~“›“B‚Ë‚¶‰¡Ž~‚ß–@‚ÌŒŸ“¢. ¬—Ñ–¾³CŽ…–ž·Œ›C‰¡ŠÖ~C“ì‘òˆç—YC‘å–ìŽiCù–{Œ›’ji®ŠOjCŽR–{^i‹ãB˜JÐj: ‘æ20‰ñ“ú–{œÜŽ¡—Êw‰ï i94.07.08`09j, ŒF–{, ´˜^W, p.44, 1994.

2356. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘å‘ÚœŒz•”“à‘¤œÜ‚ɑ΂·‚鎄‚½‚¿‚̜ڇp‚Ì“K‰ž. “ì‘òˆç—YCŽ…–ž·Œ›i®ŠOjCŽR–{^i‹ãB˜JÐj: ‘æ20‰ñ“ú–{œÜŽ¡—Êw‰ï i94.07.08`09j, ŒF–{, ´˜^W, p.53, 1994.

2357. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ¬Ž™‰ºŽˆœÜ–ü‡Œã‚̃Šƒ‚ƒfƒŠƒ“ƒO‚ɂ‚¢‚Ä. b”ãGŽÀCŽ…–ž·Œ›Cå‚Œ´—L’ji®ŠOj: ‘æ5‰ñ“ú–{¬Ž™®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i94.12.01`02j, “Œ‹ž, ´˜^W, p.42, 1994.

2358. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”|—{“e¬’·˜]“îœ×–EŠOŠî‚Ì”j‰ó‚É‹y‚Ú‚·ƒTƒCƒgƒJƒCƒ“‚̉e‹¿. —˜ªì‰ërC‚ŠÝŒ›“ñi®ŠOjCÔ¯“§i“àjCŒÜäzsMi¶‰»jC¼‘º–¾lCŽ…–ž·Œ›i®ŠOj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž, ƒŠƒEƒ}ƒ`, 34(2): 452, 1994.

2359. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚¢‚í‚ä‚éŒÜ\Œ¨‚ɑ΂·‚éŠÖß“à’“ü‚ÌŒŸ“¢. ‚ŠÝŒ›“ñC‰¤‹žŽqCÄ“¡º•FCŽ…–ž·Œ›i®ŠOj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž, ƒŠƒEƒ}ƒ`, 34(2): 477, 1994.

2360. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‹y‚Ñ•ÏŒ`«•GŠÖßÇŠ³ŽÒ‚ÌŠÖ߉t’†ƒPƒ‰ƒ^ƒ“—°Ž_’l. ‰Ô“ˆ”ü“ÞŽqC‚ŠÝŒ›“ñC‘O“cŒ’“ñC¼‘º–¾lC—˜ªì‰ëri®ŠOjCŒÜäzsMi¶‰»jCŽ…–ž·Œ›i®ŠOj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž, ƒŠƒEƒ}ƒ`, 34(2): 482, 1994.

2361. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œ¨ÎŠD’¾’…«äF‰Š‚Ì’¾’…•¨Ž¿‚Ì•ªÍ. Ä“¡º•FC‚ŠÝŒ›“ñi®ŠOjC¼–ìVŽmi‰»jCŽ…–ž·Œ›i®ŠOj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.27`29j, “Œ‹ž, ƒŠƒEƒ}ƒ`, 34(2): 554, 1994.

2362. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •Â½«‘“àœØ‚èp‚É‚æ‚鉺Žˆ•ÏŒ`‚Ì‹¸³(ƒrƒfƒI). “ì‘òˆç—YCŽ…–ž·Œ›C‘å–ìŽiC¬—Ñ–¾³C–q–ìk•¶C“n•Ó“NÆCŽR“¿‹`˜Yi®ŠOj: ‘æ67‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i94.05.12`14j, å‘ä, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(2): 129, 1994.

2363. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒL[ƒ“ƒxƒbƒN•a‚ɑ΂·‚éStrut bone graftŽèp(ƒrƒfƒI). “ñŒ©r˜YC’Ë–{s’jCŽ…–ž·Œ›i®ŠOjCŽR–{^i‹ãB˜JÐj: ‘æ67‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i94.05.12`14j, å‘ä, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(2): 130, 1994.

2364. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽèªŠÇÇŒóŒQ‚ɑ΂·‚鋾Ž‹‰ºŽèªŠÇŠJ•úp. “ñŒ©r˜YC’Ë–{s’jC–ذ•FC“y‰®“ÖC–k’ÜLmCˆÀ’BŒöi®ŠOj: ‘æ67‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i94.05.12`14j, å‘ä, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(2): 131, 1994.

2365. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`Š³ŽÒ‚ÌŒC. “c“‡‹KŽqi®ŠOj: ‘æ67‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i94.05.12`14j, å‘ä, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(2): 142, 1994.

2366. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •êŽwCMŠÖß•ÏŒ`«ŠÖßǂɑ΂·‚éŠO“]‘Η§ž¶óœØ‚èp‚Ì’·Šú¬Ñ. “ñŒ©r˜YCŽá—ÑL”VC•Ä–{ŒõˆêC’†‘ºˆêmC“‡Kˆè•vi®ŠOj: ‘æ37‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï i94.05.19`21j, L“‡, “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(†ŠO): 128, 1994.

2367. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽèªŠÇÇŒóŒQ‚ɑ΂·‚鋾Ž‹‰ºŽèªŠÇŠJ•úp‚ÌŒŸ“¢|]—ˆ–@‚Æ‚Ì”äŠr. “ñŒ©r˜YC–ذ•FC“¡“c³C¬—Ñ–¾³C’Ë–{s’ji®ŠOj: ‘æ37‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï i94.05.19`21j, L“‡, “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(†ŠO): 165, 1994.

2368. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`ŽèŠÖß‚ÌŽ©‘RŒo‰ß‚ÆŠÖߌ`¬p‚̈Ӌ`. •Ä–{ŒõˆêCˆäã˜a•FCÄ“¡¹“ñi“Œ—ˆã‘åjC—L•xŠ°i‚Ý‚ª‚È‚¬ŒÜ”½“c•a‰@jC“ñŒ©r˜Yi®ŠOj: ‘æ37‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï i94.05.19`21j, L“‡, “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(†ŠO): 182, 1994.

2369. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽèŠÖß3ŽŸŒ³‰^“®‰ðÍ‚Ö‚Ì”ñÚGŒ^•ÏˆÊŒv‘ª‘•’u‚̉ž—p. ’†‘ºˆêmC“ñŒ©r˜YC“¡“c³C“‡Kˆè•vC’Ë–{s’ji®ŠOj: ‘æ37‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï i94.05.19`21j, L“‡, “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(†ŠO): 207, 1994.

2370. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’·Šú“§Í—á‚É‚¨‚¯‚éŽèªŠÇÇŒóŒQÄ”­—á‚ÌŒŸ“¢. ¬—Ñ–¾³C“ñŒ©r˜YC–ذ•FC‘å–ìŽiCŽ…–ž·Œ›i®ŠOj: ‘æ37‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï i94.05.19`21j, L“‡, “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(†ŠO): 219, 1994.

2371. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰Æ“eŒãŽˆÄŠÁ—¬ƒ‚ƒfƒ‹‚É‚¨‚¯‚éÔŒŒ‹…—R—ˆŠˆ«Ž_‘f‚̈Ӌ`‚ɂ‚¢‚Ä. –Ø‘º³“C‰¡ŽRˆê•Fi®ŠOjC’†‘º‘‰qi•ª¶jC“ñŒ©r˜YCŽ…–ž·Œ›i®ŠOj: ‘æ37‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï i94.05.19`21j, L“‡, “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(†ŠO): 224, 1994.

2372. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˜’ŒŊԔƒwƒ‹ƒjƒA•Û‘¶—Ö@‚Ì’†Šú¬Ñ|MRI‰æ‘œf’f‚ð’†S‚É|. ŽR“c—F‹vCˆÀ’BŒöCŽO—Ö´ŽuC“n•Ó®C‚•½®LC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ23‰ñ“ú–{Ò’ÅŠO‰ÈŠw‰ï i94.06.03`04j, ’·è, “ú–{Ò’ÅŠO‰ÈŠw‰ïŽGŽ, 5(1): 238, 1994.

2373. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˜’ŒŊԔƒwƒ‹ƒjƒA•Û‘¶—Ö@‚ƃXƒ|[ƒc•œ‹A|MRI‰æ‘œf’f‚ð’†S‚É|. ŽR“c—F‹vCˆÀ’BŒöCŽO—Ö´ŽuC“n•Ó®C‚•½®LC”ª–؉pŒ›C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ20‰ñ“ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ïŠwpW‰ï i94.06.16`17j, O‘O, “ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ïŽGŽ, 14(2): 157, 1994.

2374. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”½•œ«Œ¨ŠÖß’E‰P‚ɑ΂·‚émodified inferior capsular shift–@. ‚ŠÝŒ›“ñC“n•Ó“NÆCÄ“¡º•FC‰Ô“ˆ”ü“ÞŽqC‚•½®LCŽ…–ž·Œ›i®ŠOj: ‘æ20‰ñ“ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ïŠwpW‰ï i94.06.16`17j, O‘O, “ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ïŽGŽ, 14(2): 189, 1994.

2375. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ãøœè÷•”œÜ‚ÌŽ¡—ÃŒoŒ±. “n•Ó®C–k’ÜLmCŽR“c—F‹vC‘•ªˆê³C‘å‚•¶“TC‰““¡‘¾“’jCˆÀ’BŒöC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ20‰ñ“ú–{œÜŽ¡—Êw‰ï i94.07.08`09j, ŒF–{, ´˜^W, p.45, 1994.

2376. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ãøœè÷ŠÔ—²‹NœÜ‚ɑ΂·‚éŠÖß‹¾Ž‹‰ºŽèp. –k’ÜLmC“n•Ó®C‹g–ìŽõ˜YC‘O”V‰€‘½KC‹àˆä“¿²CˆÀ’BŒöC“y‰®“ÖC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ20‰ñ“ú–{œÜŽ¡—Êw‰ï i94.07.08`09j, ŒF–{, ´˜^W, p.89, 1994.

2377. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j lHŠÖß “®•”Þ‚Ì•s“®‘Ô–Œ”j‰ó‚ÆŒ`¬. ’†‘ºL”Vi®ŠOjCX“c^Žji¶‘ÌHjC’Ë–{s’ji®ŠOjCù“c’¼iç—tH‘åj: ‘æ38‰ñ“ú–{Šwp‰ï‹cÞ—¿Œ¤‹†˜A‡u‰‰‰ï i94.09.12`13j, ‹ž“s, —\eW, p.139`140, 1994.

2378. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j PMMAœƒZƒƒ“ƒg‚̉tó•Û‘¶‚ɂ‚¢‚Ä. ’¹‰zrŽ|i®ŠOjCX“c^Žji¶‘ÌHjC’Ë–{s’ji®ŠOj: ‘æ38‰ñ“ú–{Šwp‰ï‹cÞ—¿Œ¤‹†˜A‡u‰‰‰ï i94.09.12`13j, ‹ž“s, —\eW, p.139`140, 1994.

2379. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ti‡‹à(64AT)‚Ì‘Ì“à•…H|•…H‰t‚Ì”rŸ•‚ÆŽc—¯‚Ì‘ª’è|. ŽR“c—F‹vi®ŠOjCX“c^Žji¶‘ÌHjCˆäã—tŽqi—\–hˆãŠwŒnjC–{“cKŽ¡i‰q¶jCù“c’¼iç—tH‘åjC’Ë–{s’ji®ŠOj: ‘æ16‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï‘å‰ï i94.10.00j, b•{.

2380. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j lHŠÖß “®Þ‚Ì•s“®‘Ô–ŒŒ`¬”\‚Ì‘ª’è. ’†‘ºL”Vi®ŠOjCX“c^Žji¶‘ÌHjCù“c’¼iç—tH‘åjC’Ë–{s’ji®ŠOj: ‘æ9‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.10.07`08j, _ŒË, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(8): 1203, 1994.

2381. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “àŠO”½ƒ‚[ƒƒ“ƒg‚Ìãøœ‰ñù‰^“®‚É‹y‚Ú‚·‰e‹¿|ƒƒ{ƒeƒBƒNƒX‚ð‰ž—p‚µ‚Ä|. “n•Ó®i®ŠOjC“¡]—T“¹i¶‘ÌHjC’Ë–{s’jC–k’ÜLmi®ŠOjC”nŸº´Ž‘iˆã—Éq¶Šw•”jCŽ…–ž·Œ›i®ŠOj: ‘æ9‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.10.07`08j, _ŒË, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(8): 1312, 1994.

2382. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Recombinant human BMP-2‚ð—p‚¢‚½œŒ‡‘¹•”C•œ‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†|‚wüŠw“I‹y‚Ñ‘gDŠw“IŒŸ“¢|. ‘OŒ´G•vCŽ…–ž·Œ›CŠÖŒû¹˜aC“ß{–ìG“ñi®ŠOjC‚‹´_ˆê˜YiŽR”V“à»–òj: ‘æ9‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.10.07`08j, _ŒË, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(8): 1336, 1994.

2383. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰Æ“eŒãŽˆ‰·‹•ŒŒŒãÄŠÁ—¬Žž‚É‚¨‚¯‚銈«Ž_‘f”­¶—Ê‚ÌŒoŽž“I•Ï‰». –Ø‘º³“C‰¡ŽRˆê•Fi®ŠOjC’†‘º‘‰qi•ª¶jCŽ…–ž·Œ›i®ŠOj: ‘æ9‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.10.07`08j, _ŒË, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(8): 1516, 1994.

2384. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äF”Â’f—ôŽèp—á‚ɑ΂·‚é’´‰¹”gŒŸ¸–@‚ÌŒŸ“¢. ‚ŠÝŒ›“ñC–q–ìk•¶CÄ“¡º•FC‰¤‹žŽqC—˜ªì‰ërC¼‘º–¾lC‰Ô“ˆ”ü“ÞŽqCŽ…–ž·Œ›i®ŠOj: ‘æ21‰ñ“ú–{Œ¨ŠÖߊw‰ï i94.10.14`15j, ŽR—œ, ´˜^W, p.105, 1994.

2385. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Successful osteotomyŒã‚ÌŠÖßC•œ‘gD‚ÉŠÖ‚·‚é‘gDŠw“IŒŸ“¢. “ß{–ìG“ñCŽ…–ž·Œ›Cb”ãGŽÀi®ŠOj: ‘æ21‰ñ“ú–{ŒÒŠÖߊw‰ï i94.10.27`28j, ’·è, ´˜^W, p.41, 1994.

2386. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ––Šú•ÏŒ`«ŒÒŠÖßÇ‘å‘Úœ“ª•\–Ê‚Ì•a—‘gDŠw“IŒŸ“¢. b”ãGŽÀCŽ…–ž·Œ›C“ß{–ìG“ñi®ŠOj: ‘æ21‰ñ“ú–{ŒÒŠÖߊw‰ï i94.10.27`28j, ’·è, ´˜^W, p.41, 1994.

2387. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’´‰¹”g‚ð—˜—p‚µ‚½‘“à“BœÜŽèpŽx‰‡ƒVƒXƒeƒ€. –q–ìk•¶C‚ŠÝŒ›“ñCŽ…–ž·Œ›i®ŠOjCŠÝ–{FŽiC‘å‹´‰p”VCHŽR‚¢‚í‚«iÓìH‘åj: “ú–{‰¹‹¿Šw‰ï(•½¬6”N“xH‹GŒ¤‹†”­•\‰ï) i94.10.31`11.02j, ŒF–{, ƒvƒƒOƒ‰ƒ€, p.1031, 1994.

2388. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰º‘ÚœŠJ•ú«œÜŽ¡—Ö@‚ÌŒŸ“¢. b”ãGŽÀCŽ…–ž·Œ›Cã“cºŒáC‰¡ŽRˆê•Fi®ŠOjCV“¡³‹Pi‹~–½j: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï i94.11.03`04j, “Œ‹ž, “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 5: 500, 1994.

2389. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “¯ŽíäCœ‚ð—p‚¢‚½ãøœƒvƒ‰ƒg[œÜ‚ÌŽ¡—ÃŒoŒ±. ”’{ˆê–çCŽ…–ž·Œ›CŠÖŒû¹˜aC“ì‘òˆç—YCŽu‘ºKFi®ŠOj: ‘æ42‰ñ“ú–{ЊQˆãŠw‰ï i94.11.18`19j, ‹à‘ò, “ú–{ЊQˆãŠw‰ï‰ïŽ, 42(—Õ‘): 148, 1994.

2390. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬lã˜rœ‰“ˆÊ’[œÜ‚ÌŽ¡—ÃŒoŒ±|AO•ª—Þ, B,CŒ^‚ɂ‚¢‚Ä|. ’Ë–{’B˜YCŠÖŒû¹˜aC‘å–ìŽiC“n•Ó“NÆC¬‹{Gˆê˜YC’Ë–{s’jCŽ…–ž·Œ›i®ŠOj: ‘æ42‰ñ“ú–{ЊQˆãŠw‰ï i94.11.18`19j, ‹à‘ò, “ú–{ЊQˆãŠw‰ï‰ïŽ, 42(—Õ‘): 92, 1994.

2391. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Massive segmental bone allografts‚Ì’·ŠúŒŸ“¢. “ß{–ìG“ñCŽ…–ž·Œ›CŠÖŒû¹˜aCb”ãGŽÀi®ŠOj: ‘æ30‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i94.11.24`25j, L“‡, ˆÚA, 29(´˜^†): 269, 1994.

2392. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “e”|—{“îœ×–E‚É‚¨‚æ‚Ú‚·MCAF‚¨‚æ‚ÑIL-8‚̉e‹¿. ¼‘º–¾lC‚ŠÝŒ›“ñC—˜ªì‰ërC‰Ô“ˆ”ü“ÞŽqC‚•½®Li®ŠOjCÔ¯“§C‰““¡•½mi“àjCŽ…–ž·Œ›i®ŠOj: ‘æ8‰ñ“ú–{“ãŽÓŠw‰ï i95.03.03`04j, “Œ‹ž.

2393. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j •I•”ŠÇÇŒóŒQ‚ɑ΂·‚鎦ŽwŠO“]‹@”\ÄŒšp. “ñŒ©r˜YCŽá—ÑL”VC“‡Kˆè•vC“¡“c³C’†‘ºˆêmC–ذ•FC’Ë–{s’ji®ŠOjC•Ä–{Œõˆêi“Œ—ˆã‘åj: ‘æ67‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï i94.05.12`14j, å‘ä, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(2): 446, 1994.

2394. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Žèªœœ—À\‘¢‹y‚Ñœ‘ÌÏ–§“x‚©‚ç‚Ý‚½—Í‚Ì“`’BŒn‚ÉŠÖ‚·‚錤‹†. “‡Kˆè•vC“ñŒ©r˜YC’†‘ºˆêmC“¡“c³C’Ë–{s’ji®ŠOj: ‘æ37‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ïŠwpW‰ï i94.05.19`21j, L“‡, “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(†ŠO): 206, 1994.

2395. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ¿-TCPœƒZƒƒ“ƒg‚Ɣ玿œŠE–Ê‚É‚¨‚¯‚éŒoŽž“I‘gDŠw“I•Ï‰»‚ɂ‚¢‚Ä. å‚Œ´—L’jCŽ…–ž·Œ›i®ŠOjCX“c^Žji¶‘ÌHj: ‘æ9‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.10.07`08j, _ŒË, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(8): 1610, 1994.

2396. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j lHŠÖß‹à‘®Þ—¿‚Ì‹à‘®ƒCƒIƒ“‚ÌŽc—¯‚Æ”rŸ•. ŽR“c—F‹vC’Ë–{s’ji®ŠOjCX“c^Žji¶‘ÌHjC”nŸº´Ž‘iˆã—Éq¶Šw•”jCˆäã—tŽqi—\–hˆãŠwŒnjCù“c’¼iç—tH‘åj: ‘æ9‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.10.07`08j, _ŒË, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(8): 1621, 1994.

2397. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰tó•Û‘¶‚ð‰Â”\‚É‚µ‚½PMMAœƒZƒƒ“ƒg‚ÌŠJ”­. ’¹‰zrŽ|i®ŠOjCX“c^Žji¶‘ÌHjC’Ë–{s’ji®ŠOj: ‘æ9‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.10.07`08j, _ŒË, “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽ, 68(8): 1622, 1994.

2398. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j —¼‘¤½œ‰“ˆÊ’[ü—£ŠJ‚Ì1—á. ‰Ô“ˆ”ü“ÞŽqC‚ŠÝŒ›“ñCŽ…–ž·Œ›i®ŠOj: ‘æ21‰ñ“ú–{Œ¨ŠÖߊw‰ï i94.10.14`15j, ŽR—œ, ´˜^W, p.21, 1994.

2399. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “e¬’·˜]“îœ×–EŠOŠîŽ¿‚̃qƒAƒ‹ƒƒ“Ž_‘ãŽÓ‚É‹y‚Ú‚·IL-1, 6‚¨‚æ‚Ñ8‚̉e‹¿. —˜ªì‰ërC‚ŠÝŒ›“ñi®ŠOjCŒÜäzsMi¶‰»jCÔ¯“§i“àjC¼‘º–¾lC‚•½®LCŽ…–ž·Œ›i®ŠOj: ‘æ8‰ñ“ú–{“ãŽÓŠw‰ï i95.03.03`04j, “Œ‹ž.

2400. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j “¯‘¤‰ºŽˆ•¡‡œÜ‚ÌŽ¡—Ö@. ã“cºŒáCV“¡³‹PCb”ãGŽÀi‹~–½jCŽ…–ž·Œ›C‰¡ŽRˆê•FC“ì‘òˆç—Yi®ŠOj: ‘æ43‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï i94.09.21`22j, •xŽm‹g“c, “Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ïŽGŽ, 6(4): 551, 1994.

2401. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Žr‘Ì•I‚É‚¨‚¯‚éŠO‘¤x‘Ñ\‘¢‚ÌŠÏŽ@. –ذ•FC“ñŒ©r˜YC“¡“c³CŠÖ”EC“ŒŒvC’Ë–{s’ji®ŠOj: ‘æ28‰ñŠÖ“Œ®Œ`ŠO‰ÈŠw‰ï i94.05.28j, “Œ‹ž, ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(—Õ‘): 104, 1994.

2402. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ã˜rœœŠ²•”‘J‰„œ–ü‡‚ÌŽ¡—ÃŒoŒ±. “y‰®“ÖC“ñŒ©r˜YCˆÀ’BŒöC–k’ÜLmCù“‡Œ³‘¥C’Ë–{s’ji®ŠOj: ‘æ28‰ñŠÖ“Œ®Œ`ŠO‰ÈŠw‰ï i94.05.28j, “Œ‹ž, ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(—Õ‘): 106, 1994.

2403. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˜’ŒŊԔƒwƒ‹ƒjƒA•Û‘¶—Ö@‚Ì’†Šú¬Ñ|MRI‰æ‘œf’f‚ð’†S‚É|. ŽR“c—F‹vCˆÀ’BŒöCŽO—Ö´ŽuC“n•Ó®C‘å‚•¶“TC–{•”ƒŽqC“à–ì³—²CŽÂŒ´OsC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ28‰ñŠÖ“Œ®Œ`ŠO‰ÈŠw‰ï i94.05.28j, “Œ‹ž, ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(—Õ‘): 74, 1994.

2404. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j 3DCT‚Ì—LŒø«‚ɑ΂·‚錟“¢. ŽÂŒ´OsC“ñŒ©r˜YC¬—Ñ–¾³C–ذ•FC‰““¡‘¾“’jCŠÖ”EC’Ë–{s’ji®ŠOj: ‘æ28‰ñŠÖ“Œ®Œ`ŠO‰ÈŠw‰ï i94.05.28j, “Œ‹ž, ŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŽGŽ, 25(—Õ‘): 86, 1994.

2405. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j L”͈͔畆Œ‡‘¹‚𔺂¤‰ºŽˆŠJ•ú«œÜ, ’E‰P‚Ì”ç•ÙŒ`¬p‚ɂ‚¢‚Ä. ‰¡ŽRˆê•FCb”ãGŽÀi®ŠOjCV“¡³‹Pi‹~–½jCŽ…–ž·Œ›i®ŠOj: ‘æ87‰ñ¼“ú–{®Œ`¥ÐŠQŠO‰ÈŠw‰ï i94.06.10`11j, •Ÿ‰ª, ´˜^W, p.107, 1994.

2406. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒ‰ƒbƒgŒãŽˆ‚ð—p‚¢‚½•¡‡‘gD•Û‘¶‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†|Euro-Collins‰t‚ÆUW‰t‚Ì”äŠr|. ‰¡ŽRˆê•FC–Ø‘º³“C–ذ•FC“ñŒ©r˜YCŽ…–ž·Œ›i®ŠOj: ‘æ87‰ñ¼“ú–{®Œ`¥ÐŠQŠO‰ÈŠw‰ï i94.06.10`11j, •Ÿ‰ª, ´˜^W, p.162, 1994.

2407. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŽÚœplus variance‚É”º‚¤L‹ØäF’f—ô‚Ì1—á. •‚“c–L•FC“ñŒ©r˜YC¬—Ñ–¾³C–k’ÜLmC“à–ì³—²C’Ë–{’B˜YC’r“c‹M‰pC’Ë–{s’ji®ŠOj: ‘æ91‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i94.07.16j, ‰¡•l, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.15, 1994.

2408. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ÄŒšÞ—¿‚É”j‘¹‚𗈂µ‚½‘å‘Úœ•a“IœÜ‚Ì1—á. ‰Í“àr“ñC‘å–ìŽiC‰¡ŽRˆê•FC¬—Ñ–¾³C–k’ÜLmC“c’†Œ[Ži‚aC’†‘º‘–¾CŽ…–ž·Œ›i®ŠOj: ‘æ91‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i94.07.16j, ‰¡•l, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.31, 1994.

2409. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`Œ¨‚ɑ΂·‚éŽèp—Ö@‚̬ŒoŒ±. ‚•½®LC‚ŠÝŒ›“ñC¼‘º–¾lC—˜ªì‰ërC‰Ô“ˆ”ü“ÞŽqCŽ…–ž·Œ›i®ŠOj: ‘æ91‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i94.07.16j, ‰¡•l, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.34, 1994.

2410. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Mutilating type RA—Ö@‚Ì–â‘è“_‚ɂ‚¢‚Ä. ’r“c‹M‰pC’Ë–{s’jC¬—Ñ–¾³C–k’ÜLmCˆÀ’BŒöC‘å‚•¶“TCŽR‰®’qNC“茴G”Vi®ŠOj: ‘æ91‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i94.07.16j, ‰¡•l, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.39, 1994.

2411. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •Û‘¶“I‚ɉÁ—µ‚½ŒŽóœVertical Fracture‚Ì1—á. “àŽRŸ•¶C“ñŒ©r˜YC’Ë–{’B˜YC“茴G”VC•‚“c–L•FCŽÂŒ´OsC’r“c‹M‰pC¬—Ñ–¾³C’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ŠO‰ÈŠw‰ïŒŽ—á‰ï, ‘æ559‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï i94.07.30j, “Œ‹ž.

2412. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j d“x‰º‘ÚœŠJ•úœÜ‚Ì3Ž¡Œ±ŒoŒ±. “c’†Œ[Ži‚aC‰¡ŽRˆê•FC‰Í“àr“ñCŽ…–ž·Œ›i®ŠOjCV“¡³‹PCb”ãGŽÀi‹~–½j: ŠÖ“Œ®Œ`ŠO‰ÈŠw‰ïŒŽ—á‰ï, ‘æ559‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï i94.07.30j, “Œ‹ž.

2413. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒGƒ`ƒŒƒ“ƒIƒLƒTƒCƒhƒKƒX–Å‹Ûœ‚̃Gƒ`ƒŒƒ“ƒIƒLƒTƒCƒhŽc—¯ƒKƒX”Z“x‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†. ‘OŒ´G•vCŽ…–ž·Œ›C“ì‘òˆç—YCŠÖŒû¹˜ai®ŠOjC–å˜e•”ŽC•Ð‹Ë—TŽjiŠÅŒìŠw•”j: ‘æ43‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï i94.09.21`22j, •xŽm‹g“c, “Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ïŽGŽ, 6(4): 526, 1994.

2414. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j lHŒÒŠÖßÄ’uŠ·p‚ÌŠ°œ‰PÄŒš‚É—p‚¢‚½“¯Žíœ‚̉^–½. ŠÖŒû¹˜aCŽ…–ž·Œ›C‘OŒ´G•vCŽu‘ºKFi®ŠOj: ‘æ43‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï i94.09.21`22j, •xŽm‹g“c, “Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ïŽGŽ, 6(4): 540, 1994.

2415. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j f’f‚É“ïa‚µ‚½‹¹‘‚­‚à–Œ”XŽî‚Ì2—á. “à–ì³—²CˆÀ’BŒöCå‚Œ´—L’jC“n•Ó®C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ43‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï i94.09.21`22j, •xŽm‹g“c, “Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ïŽGŽ, 6(4): 615, 1994.

2416. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j äF”Â’f—ô‚ɑ΂·‚é’´‰¹”gŒŸ¸–@. –q–ìk•¶C‚ŠÝŒ›“ñCÄ“¡º•FC£ì‹žŽqCŽ…–ž·Œ›i®ŠOj: ‘æ43‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï i94.09.21`22j, •xŽm‹g“c, “Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ïŽGŽ, 6(4): 621, 1994.

2417. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œ¨ÎŠD’¾’…«äF‰Š‚Ì’¾’…•¨Ž¿‚ÌVˆ—–@‚É‚æ‚錋»Šw“IŒŸ“¢. Ä“¡º•FC‚ŠÝŒ›“ñi®ŠOjC¼–ìVŽmi‰»jCŽ…–ž·Œ›i®ŠOj: ‘æ43‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï i94.09.21`22j, •xŽm‹g“c, “Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ïŽGŽ, 6(4): 622, 1994.

2418. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œ–@—ûK’†‚ɶ‚¶‚½ŽwL‹ØäF’E‰P‚ɑ΂·‚鎡—ÃŒoŒ±. ’Ë–{’B˜YC“ñŒ©r˜YCŽÂŒ´OsC’r“c‹M‰pC“àŽRŸ•¶C’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ŠO‰ÈŠw‰ïŒŽ—á‰ï, ‘æ560‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï i94.09.24j, “Œ‹ž.

2419. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j –k—¢‘åŠwœƒoƒ“ƒN‚Ì‚±‚ê‚Ü‚Å‚Æ‚±‚ê‚©‚ç|ƒŠƒjƒ…[ƒAƒ‹ƒXƒ^[ƒg‚ð‹@‚É|. “ì‘òˆç—YCŽ…–ž·Œ›CŠÖŒû¹˜aC‘OŒ´G•vC“n•Ó“NÆC¬—Ñ–¾³C“ß{–ìG“ñi®ŠOj: ‘æ20‰ñ–k—¢ˆãŠw‰ï‘‰ï i94.10.15j, ‘Š–ÍŒ´, –k—¢ˆãŠw, 24(6): 598, 1994.

2420. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”ñÚGŒ^3ŽŸŒ³•ÏˆÊ‘ª’è‘•’u‚ð—p‚¢‚½•IŠÖ߉^“®‰ðÍ. “¡“c³CŽÂŒ´OsC–ذ•FC“‡Kˆè•vC’†‘ºˆêmC“ñŒ©r˜YC’Ë–{s’ji®ŠOjC“¡]—T“¹i¶‘ÌHj: ‘æ20‰ñ–k—¢ˆãŠw‰ï‘‰ï i94.10.15j, ‘Š–ÍŒ´. –k—¢ˆãŠw, 24(6): 599, 1994.

2421. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ®Œ`ŠO‰È—̈æ‚É‚¨‚¯‚é3ŽŸŒ³CT‚̉ž—p. ŽÂŒ´OsC“ñŒ©r˜YC’Ë–{s’ji®ŠOjCˆé•”‹`Œ›i•újC–Ø‘ºŒ³ˆêi•úŽËü•”j: ‘æ20‰ñ–k—¢ˆãŠw‰ï‘‰ï i94.10.15j, ‘Š–ÍŒ´. –k—¢ˆãŠw, 24(6): 599, 1994.

2422. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰»Šw—Ö@‚ª’˜Œø‚µ‚½¬×–Eœ“÷Žî‚Ì1—á. ‘弑¾C‘å–ìŽiC’†‘º‘–¾C“c’†Œ[Ži‚aCŽ…–ž·Œ›i®ŠOj: ŠÖ“Œ®Œ`ŠO‰ÈŠw‰ïŒŽ—á‰ï, ‘æ561‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï i94.10.29j, “Œ‹ž.

2423. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚·‚Ý‚â‚©‚ÉÇó‚ÌŒy‰õ‚ð‚Ý‚½Œ¨bã_ŒoáŠQ‚Ì1—á. ’爨ŽÀC‚ŠÝŒ›“ñCŠÖŒû¹˜aC–q–ìk•¶C¬“‡—²ŽjCŽ…–ž·Œ›i®ŠOj: ‘æ92‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i94.11.12j, ‰¡•l.

2424. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Cup and socket arthroplasty‚©‚ç20”NŒo‰ß‚µ‚½1—á. ŽR‰®’qNC¬—Ñ–¾³C•‚“c–L•FC’Ë–{’B˜YC–k’ÜLmC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ92‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i94.11.12j, ‰¡•l.

2425. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹¾Ž‹‰ºŽèpŒã‚ÉÄ”­‚ð‚«‚½‚µ‚½ŽèªŠÇÇŒóŒQ‚Ì1—á. Ä“cN”VC¬—Ñ–¾³CŽÂŒ´OsC‘å‚•¶“TC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ92‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i94.11.12j, ‰¡•l.

2426. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “¯ŽíäCœ‚ð—p‚¢‚½ãøœƒvƒ‰ƒg[œÜ‚ÌŽ¡—ÃŒoŒ±. ”’{ˆê–çCŽ…–ž·Œ›CŠÖŒû¹˜aC“ì‘òˆç—YCŽu‘ºKFi®ŠOj: ‘æ29‰ñŠÖ“Œ®Œ`ŠO‰ÈŠw‰ï i94.11.26j, “Œ‹ž, ´˜^W, p.106, 1994.

2427. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰Á‰·–Å‹Ûœ‚Ì”÷¶•¨Šw“I, —ÍŠw“IŒŸ“¢. ŠÖŒû¹˜aCŽ…–ž·Œ›C“ì‘òˆç—YC‘OŒ´G•vC“n•Ó“NÆi®ŠOjCX“c^Žji¶‘ÌHj: ‘æ29‰ñŠÖ“Œ®Œ`ŠO‰ÈŠw‰ï i94.11.26j, “Œ‹ž, ´˜^W, p.107, 1994.

2428. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Recombinant human BMP-2‚ð—p‚¢‚½œŒ‡‘¹•”C•œ‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†(‘æ2•ñ)|‚wüŠw“I‹y‚Ñ‘gDŠw“IŒŸ“¢|. ‘OŒ´G•vCŽ…–ž·Œ›CŠÖŒû¹˜aC“ß{–ìG“ñC“n•Ó“NÆi®ŠOjC‚‹´_ˆê˜YiŽR”V“à»–òj: ‘æ29‰ñŠÖ“Œ®Œ`ŠO‰ÈŠw‰ï i94.11.26j, “Œ‹ž, ´˜^W, p.108, 1994.

2429. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j äF”¼ŒŽ”‚̌ŒŠÇ•ª•z. –k’ÜLmC‘å‚•¶“TC’r“c‹M‰pC‘•ªˆê³C‹g–ìŽõ˜YC“n•Ó®C“茴G”VC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ29‰ñŠÖ“Œ®Œ`ŠO‰ÈŠw‰ï i94.11.26j, “Œ‹ž, ´˜^W, p.54, 1994.

2430. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é•G”¼ŒŽ”ÂC•œp‚̬Ñ. ‘•ªˆê³C–k’ÜLmC‘O”V‰€‘½KC’Ë–{s’ji®ŠOjC‹v•ÛŽ›‘å–çi‹v•ÛŽ›®Œ`ŠO‰Èj: ‘æ29‰ñŠÖ“Œ®Œ`ŠO‰ÈŠw‰ï i94.11.26j, “Œ‹ž, ´˜^W, p.55, 1994.

2431. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠÏŒŒ“IŽ¡—Âðs‚Á‚½ŽèªŠÇÇŒóŒQ’j«—á‚ÌŒŸ“¢. ¬—Ñ–¾³C“ñŒ©r˜YCŽÂŒ´OsC–ذ•FC“茴G”VC’Ë–{s’ji®ŠOj: ‘æ29‰ñŠÖ“Œ®Œ`ŠO‰ÈŠw‰ï i94.11.26j, “Œ‹ž, ´˜^W, p.79, 1994.

2432. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œ¨ÎŠD’¾’…«äF‰Š‚É‚¨‚¯‚é•Û‘¶“IŽ¡—Â̌Ÿ“¢(‘æ2•ñ). Ä“¡º•FC‚ŠÝŒ›“ñCŽ…–ž·Œ›i®ŠOj: ‘æ29‰ñŠÖ“Œ®Œ`ŠO‰ÈŠw‰ï i94.11.26j, “Œ‹ž, ´˜^W, p.81, 1994.

2433. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œ¨½ŠÖ߉Š‚É‚¨‚¯‚齜‰“ˆÊ’[Øœp. —˜ªì‰ërC‚ŠÝŒ›“ñC¼‘º–¾lC‰Ô“ˆ”ü“ÞŽqC‚•½®LC–q–ìk•¶CŽ…–ž·Œ›i®ŠOj: ‘æ5‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ïŠÖ“Œ’n•û‰ï i94.12.10j, ç—t, ƒvƒƒOƒ‰ƒ€, p.21, 1994.

2434. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒAƒ~ƒƒCƒh’¾’…‚É‚æ‚é‘å‘ÚœŒz•”•a“IœÜ‚Ì1—á. •y‰irsC‘å–ìŽiCŠÖŒû¹˜aC¬“‡—²ŽjCŠ}ˆäŒª˜aCŽ…–ž·Œ›i®ŠOj: ŠÖ“Œ®Œ`ŠO‰ÈŠw‰ïŒŽ—á‰ï¥‘æ563‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï i95.01.28j, “Œ‹ž.

2435. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠÖß’“ü‚É‚æ‚鉻”^«Œ¨ŠÖ߉Š‚Ɉø‚«‘±‚«‰»”^«Ò’ʼnŠ‚𶂶‚½1—á. ‰Í“àr“ñCˆÀ’BŒöC“ñŒ©r˜YC¬—Ñ–¾³C“茴G”VC’Ë–{s’ji®ŠOj: ‘æ93‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i95.02.04j, ‰¡•l, _“Þ쮌`ЊQŠO‰Èˆã‰ïŽGŽ, 7(2): 134, 1995.

2436. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¬n‰Æ“e‘å‘Úœ‚̃ÁüÆŽË‚É‚æ‚é—ÍŠw“I‰e‹¿. “n•Ó“NÆCŽ…–ž·Œ›C“ì‘òˆç—YCŠÖŒû¹˜aC‘OŒ´G•vi®ŠOjCX“c^Žji¶‘ÌHjCˆÉ“¡‹Ïi“ú–{Œ´Žq—ÍŒ¤j: ‘æ93‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï i95.02.04j, ‰¡•l, _“Þ쮌`ЊQŠO‰Èˆã‰ïŽGŽ, 7(2): 137, 1995.

2437. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éãøœ‘e–ʈړ®pŒã‚̬Ñ. ‹g–ìŽõ˜YC–k’ÜLmC“茴G”VC“àŽRŸ•¶C’Ë–{s’ji®ŠOj: ‘æ16‰ñ“Œ‹ž•GŠÖߊw‰ï i95.02.18j, “Œ‹ž, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.27, 1995.

2438. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹ØŒ´«“÷Žî‚Ì“]ˆÚ‚ ‚é‚¢‚ÍZ‚É‚æ‚é‘æ4˜’Å•a“IœÜ‚Ì1—á. •Ð‹Ë’•¶C–k’ÜLmCŽR‰®’qNC’r“c‹M‰pC¬£NŽ¡C‹{‰ºŒªˆêC“àŽRŸ•¶C’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ŠO‰ÈŠw‰ïŒŽ—á‰ï¥‘æ564‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï i95.02.25j, “Œ‹ž.

2439. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Multiple epiphyseal dysplasia‚ÉŠÖß“à—V—£‘̂𶂶‚½1—á. ”ª‘ã”EC–k’ÜLmC‘O”V‰€‘½KC‘•ªˆê³C•Ð‹Ë’•¶C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ŠÖ“Œ®Œ`ŠO‰ÈŠw‰ïŒŽ—á‰ï¥‘æ565‰ñ®Œ`ŠO‰ÈW’k‰ï“Œ‹ž’n•û‰ï i95.03.25j, “Œ‹ž.

2440. mŒ¤‹†‰ïi‘Ûjn iˆê”Êu‰‰j Bone transplantation, bone banking and sterilization of bone allograft. “ì‘òˆç—Yi®ŠOj: UNDP/IAEA/RCA’nˆæŒP—ûƒR[ƒX(‘ÛŒ´Žq—Í‹@\ŽåÃ)u•úŽËü‹Zp‚Ìæ’[“I—˜—p|¶•¨ˆãŠw—˜—pvuK‰ï i95.03.03j, ‚è.

2441. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j Malunion and correction. Ž…–ž·Œ›i®ŠOj: 7th AO-Course in Kobe-Japan i94.11.01`03j, _ŒË.

2442. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ”ñÚGŒ^ŽOŽŸŒ³•ÏˆÊ‘ª’è‘•’u‚ð—p‚¢‚½•IŠÖ߉^“®‰ðÍ. “¡“c³CŽÂŒ´OsC’†‘ºˆêmC“ñŒ©r˜YC’Ë–{s’ji®ŠOjC“¡]—T“¹i¶‘ÌHj: ‘æ7‰ñ“ú–{•IŠÖߌ¤‹†‰ï i95.02.18j, L“‡, ´˜^W, p.36, 1995.

2443. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‰Æ“e‰·‹•ŒŒŒãÄŠÁ—¬Žž‚É‚¨‚¯‚銈«Ž_‘f”­¶—Ê‚ÌŒoŽž“I•Ï‰». –Ø‘º³“C‰¡ŽRˆê•Fi®ŠOjC’†‘º‘‰qi•ª¶jCŽ…–ž·Œ›i®ŠOj: ‘æ13‰ñ“ú–{œ¥ŠÖߥ“î•”‘gDˆÚAŒ¤‹†‰ï i94.11.24`25j, L“‡, ´˜^W, p.23, 1994.

2444. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j BMP‚ð—p‚¢‚½ŠÖß“îœC•œ‚̉”\«. “ß{–ìG“ñCŽ…–ž·Œ›C“n•ÓX‹vC‘OŒ´G•vCb”ãGŽÀCŠÖŒû¹˜ai®ŠOjC‚‹´_ˆê˜YiŽR”V“à»–òj: ‘æ13‰ñ“ú–{œ¥ŠÖߥ“î•”‘gDˆÚAŒ¤‹†‰ï i94.11.24`25j, L“‡, ´˜^W, p.45, 1994.

2445. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Recombinant human BMP-2‚ð—p‚¢‚½œŒ‡‘¹•”C•œ‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†|‚wüŠw“I‹y‚Ñ‘gDŠw“IŒŸ“¢|. ‘OŒ´G•vCŽ…–ž·Œ›CŠÖŒû¹˜aC“ß{–ìG“ñCi®ŠOjC‚‹´_ˆê˜YiŽR”V“à»–òj: ‘æ13‰ñ“ú–{œ¥ŠÖߥ“î•”‘gDˆÚAŒ¤‹†‰ï i94.11.24`25j, L“‡, ´˜^W, p.46, 1994.

2446. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‰Á‰·–Å‹Û‘•’u(Lobator sd-1)‚ÌŽg—pŒoŒ±. ŠÖŒû¹˜aCŽ…–ž·Œ›C“ì‘òˆç—YC‘OŒ´G•vC“n•Ó“NÆi®ŠOj: ‘æ13‰ñ“ú–{œ¥ŠÖߥ“î•”‘gDˆÚAŒ¤‹†‰ï i94.11.24`25j, L“‡, ´˜^W, p.56, 1994.

2447. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j –k—¢‘åŠwœƒoƒ“ƒN‚Ì‚±‚ê‚Ü‚Å‚Æ‚±‚ê‚©‚ç|ƒŠƒjƒ…[ƒAƒ‹ƒXƒ^[ƒg‚ð‹@‚É|. “ì‘òˆç—YCŽ…–ž·Œ›CŠÖŒû¹˜aC‘OŒ´G•vC“n•Ó“NÆC¬—Ñ–¾³C“ß{–ìG“ñi®ŠOj: ‘æ13‰ñ“ú–{œ¥ŠÖߥ“î•”‘gDˆÚAŒ¤‹†‰ï i94.11.24`25j, L“‡, ´˜^W, p.65, 1994.

2448. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‚RŽŸŒ³CT‚ªf’f, Ž¡—Ãã—L—p‚Å‚ ‚Á‚½•I•²ÓœÜ‚Ì1—á. ŽÂŒ´OsC“ñŒ©r˜YCÄ“cN”VC•Ð‹Ë’•¶C¬—Ñ–¾³C’Ë–{s’ji®ŠOj: ‘æ7‰ñ“ú–{•IŠÖߌ¤‹†‰ï i95.02.18j, L“‡, ´˜^W, p.19, 1995.

2449. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒg•I“àŠO‘¤‘¤•›x‘Ñ‚ÌŒ`‘ÔŠÏŽ@. –ذ•FC“ñŒ©r˜YC“¡“c³C¬—Ñ–¾³C’Ë–{s’ji®ŠOj: ‘æ7‰ñ“ú–{•IŠÖߌ¤‹†‰ï i95.02.18j, L“‡, ´˜^W, p.31, 1995.

2450. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “«ƒeƒjƒX•I‚ɑ΂·‚éBoydŽèp‚̬Ñ. “ñŒ©r˜YCŽÂŒ´OsC–ذ•FC“¡“c³C¬—Ñ–¾³C’Ë–{s’ji®ŠOj: ‘æ7‰ñ“ú–{•IŠÖߌ¤‹†‰ï i95.02.18j, L“‡, ´˜^W, p.48, 1995.

2451. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j œ¥“ÚA‚ɂ‚¢‚Ä. Ž…–ž·Œ›i®ŠOj: ‘æ11‰ñO‘O‘åŠwœ‚ðŒê‚é‰ï i94.04.01j, O‘O.

2452. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Œ¨‚̃Xƒ|[ƒcáŠQ‚ɑ΂·‚éf’f‚ÆŽ¡—Ã. ‚ŠÝŒ›“ñi®ŠOj: ‘æ6‰ñ‘Š–ÍŒ´ŽsˆãŽt‰ï®Œ`ŠO‰Èˆã‰ï i94.04.23j, ‘Š–ÍŒ´.

2453. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ’·ŠÇœ•²ÓœÜ‚ÌŽ¡—¨‚¯‚éInterlocking Nailing‚Ì–ðŠ„. Ž…–ž·Œ›i®ŠOj: ‘æ5‰ñç—tœÜ¥œ–ü‡Œ¤‹†‰ï i94.10.13j, ç—t.

2454. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ––ŠúŒÒŠÖßÇ‚ÌŠÖ߉·‘¶—Ö@|ŠO”½œØ‚èp‚Ìì—p‹@˜|. Ž…–ž·Œ›i®ŠOj: ‹ž“s®Œ`ŠO‰ÈŒ¤C‰ï i94.11.10j, ‹ž“s.

2455. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j œƒoƒ“ƒN|‚æ‚èˆÀ‘S‚Å—ÇŽ¿‚Ì‘gD‚ðˆÀ’è‹Ÿ‹‹‚·‚邽‚ß‚É|. Ž…–ž·Œ›i®ŠOj: ‘æ2‰ñ“¯Žíœ“î•”‘gDˆÚAƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.11.11j, –¼ŒÃ‰®.

2456. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ––ŠúŒÒŠÖßǂɑ΂·‚éŠÖ߉·‘¶Žèp. Ž…–ž·Œ›i®ŠOj: •Ÿ‰ª’n‹æƒCƒ“ƒtƒŠ[ƒ\ƒtƒgƒJƒvƒZƒ‹V”­”„‹L”Ou‰‰‰ï i95.01.23j, •Ÿ‰ª.

2457. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j •GŠÖß‚ÌŠO‚ƃXƒ|[ƒcŠO‚ɂ‚¢‚Ä. –k’ÜLmi®ŠOj: ɪŒ§Šwpu‰‰‰ï i95.02.25j, ɪ.

2458. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ‘“à“B‚Ì—Õ°‚Ɯ܎¡–ü‚É‹y‚Ú‚·—ÍŠw“IŽhŒƒ‚̉e‹¿. Ž…–ž·Œ›i®ŠOj: ‘æ13‰ñàÕ®‰ïŒöŠJŠwpu‰‰‰ï i95.03.08j, ‰F“s‹{.

2459. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ––ŠúŒÒŠÖßǂɑ΂·‚éŠO”½‹ü‹ÈœØ‚èp. Ž…–ž·Œ›i®ŠOj: ‘æ123‰ñVŠƒ®Œ`ŠO‰ÈŒ¤‹†‰ï i94.05.21j, VŠƒ.

2460. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ã˜rœè÷ãœÜ‚ɑ΂·‚é“kŽè®•œcross pinning–@. Ž…–ž·Œ›i®ŠOj: ‘æ9‰ñ_“Þ쮌`ŽèpŽè‹ZŒ¤‹†‰ï i94.12.08j, ‰¡•l.

2461. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j rhMBP-2‚ð—p‚¢‚½œŒ‡‘¹•”C•œ‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†|‚wüŠw“I‚¨‚æ‚Ñ‘gDŠw“IŒŸ“¢|. ‘OŒ´G•vCŽ…–ž·Œ›CŠÖŒû¹˜aC“ß{–ìG“ñi®ŠOj: rhBMP-2Šî‘bŒ¤‹†‰ï i94.10.08j, _ŒË.

2462. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘O\Žšx‘ÑØ—£‚É‚æ‚éŽÀŒ±“I•ÏŒ`«•GŠÖßÇ‚Ì–€ŽCŒW”‚ƃqƒAƒ‹ƒƒ“Ž_“Y‰Á‚ÌŠŠŒø‰Ê. ¬Œ´Œ’’jCâE‹MŽqCŽRŒû•q“ñ˜YiŽ‘¶“°Œ¤jC¬‹ÊiÓìH‘åjC’Ë–{s’ji®ŠOjC”nŸº´Ž‘iˆã—Éq¶j: ‘æ15‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ i95.03.04j, “Œ‹ž.

2463. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j äF”ÂC•œp‚É‚æ‚è…‰j‚ª‰Â”\‚É‚È‚Á‚½’†”N’j«‚Ì1—á. ŠÖ”EC‚ŠÝŒ›“ñCŠÖŒû¹˜aCŽu‘ºKFC”’{ˆê–çCŽ…–ž·Œ›i®ŠOj: ‘æ2‰ñ‚悱‚͂܃Xƒ|[ƒc®Œ`ŠO‰ÈƒtƒH[ƒ‰ƒ€ i94.06.11j, ‰¡•l.

2464. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ã˜rœ¬“ª‚ɉ”­œ‰óŽ€‘ƒ‚ð‚«‚½‚µ‚½SLE‚Ì1—á. ”\”ü®C‚ŠÝŒ›“ñC‰¡ŽRˆê•FCŠÖŒû¹˜aC“n•Ó“NÆC“c’†Œ[Ži‚aC’†‘º‘–¾CŽ…–ž·Œ›i®ŠOjC‰ª“cƒi“àj: ‘æ35‰ñŠÖ“ŒƒŠƒEƒ}ƒ`Œ¤‹†‰ï i94.07.02j, “Œ‹ž.

2465. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ãøœ“ºœ‚ÉœŒ‡‘¹‰A‰e‚𶂶‚½”¼ŒŽ””XŽî‚Ì1—á. ‘O”V‰€‘½KC–k’ÜLmC–kŒ©Œ\ŽiC‘•ªˆê³C’Ë–{s’ji®ŠOj: ‘æ21‰ñŠÖ“Œ•G‚ðŒê‚é‰ï i94.11.12j, “Œ‹ž.

2466. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ž™‰º‹Ø’P“Æ–ƒáƒ. ‚ŠÝŒ›“ñi®ŠOj: ‘æ84‰ñ‹ãB‘åŠw®Œ`ŠO‰ÈŠw‹³ŽºŠJu‹L”O‰ï, ‘æ21‰ñ_’†ƒƒ‚ƒŠƒAƒ‹¥ƒŒƒNƒ`ƒƒ[ i94.11.26`27j, •Ÿ‰ª.

2467. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ã˜rœ‹ßˆÊ’[œÜ‚Ì1—á. ‚•½®Li®ŠOj: ‘æ3‰ñŠÖ“ŒŒ¨‚ðŒê‚é‰ï i95.02.04`05j, _“Þì.

2468. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ã˜rœŠO‰ÈãøœÜŒã‚ɉº•û’E‰P‚ð’悵‚½1—á. Ä“¡º•Fi®ŠOj: ‘æ3‰ñŠÖ“ŒŒ¨‚ðŒê‚é‰ï i95.02.04`05j, _“Þì.

2469. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j —¼Œ¨½ŠÖß’É‚ð‘i‚¦‚½30Î’j«. —˜ªì‰ërC–q–ìk•¶i®ŠOj: ‘æ3‰ñŠÖ“ŒŒ¨‚ðŒê‚é‰ï i95.02.04`05j, _“Þì.

2470. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Žè‚ÌŠO‰È—̈æ‚É‚¨‚¯‚é3ŽŸŒ³CT‚Ì—LŒø«‚ÌŒŸ“¢. ŽÂŒ´OsC“ñŒ©r˜YC¬—Ñ–¾³C˜e“c—²ŽiC’†‘ºŒõLC’Ë–{s’ji®ŠOj: ‘æ9‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï i95.02.04j, ‰¡•l, ƒvƒƒOƒ‰ƒ€, p.117, 1995.

2471. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒeƒtƒƒ“ƒ`ƒ…[ƒu‚ð—˜—p‚µ‚½‹¾Ž‹‰ºŽèªŠÇ‰ð•úp. “ñŒ©r˜YC¬—Ñ–¾³CŽá—ÑL”VC’†‘ºˆêmC“‡Kˆè•vC“¡“c³C–ذ•FCŽÂŒ´Osi®ŠOj: ‘æ9‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï i95.02.04j, ‰¡•l, ƒvƒƒOƒ‰ƒ€, p.50, 1994.

2472. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŽwL‹ØäF’E‰P‚ÌŽ¡—ÃŒoŒ±. ’Ë–{’B˜YC“ñŒ©r˜YCŽÂŒ´OsC’r“c‹M‰pC“àŽRŸ•¶C’Ë–{s’ji®ŠOj: ‘æ9‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï i95.02.04j, ‰¡•l, ƒvƒƒOƒ‰ƒ€, p.68, 1995.

2473. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j œ•Ð“Eo‚ðs‚Á‚½—LçêœçêœÜ—á‚ÌŒŸ“¢. ¬—Ñ–¾³C“ñŒ©r˜YCŽÂŒ´OsC’Ë–{s’ji®ŠOj: ‘æ9‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï i95.02.04j, ‰¡•l, ´˜^W, p.84, 1995.

2474. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ¶ŒŸŒã‘noŒŒ‚ðŒJ‚è•Ô‚µ‚½‰E‘lŒa•”‹‘åŽîᎂÌ1—á. ’†‘º‘–¾i®ŠOj: ‘æ196‰ñ–k—¢‘åŠw•a‰@CPC i95.02.22j, ‘Š–ÍŒ´.

2475. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒAƒLƒŒƒXäF•t’…•”‚Éœ•Ï‰»‚ð”F‚ß‚½–«ŠÖ߃ŠƒEƒ}ƒ`‚ÆŽv‚í‚ê‚é2—á. ‚–Ø~C’Ë–{s’jC“ñŒ©r˜YC–k’ÜLmCŽÂŒ´OsC˜e“c—²ŽiCÄ“cN”Vi®ŠOj: ‘æ20‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï i95.03.11j, ‰¡•l.

2476. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘oŠg‘å—á‚ɑ΂·‚éƒZƒƒ“ƒgƒŒƒXƒXƒeƒ€ŒÅ’è‚̈êH•v|“¯Ží•Û‘¶œ‚ÌŽg‚¢•û|. ŠÖŒû¹˜aCŽ…–ž·Œ›C‘å–ìŽiCŒKŒ´­’ji®ŠOj: ‘æ20‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï i95.03.11j, ‰¡•l.

2477. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j SchanzœØ‚èpŒã‚ÌlHŠÖß’uŠ·p‚ÌŒoŒ±. ŠÖŒû¹˜aCŽ…–ž·Œ›C‘å–ìŽiC¬“‡—²ŽjC“c’†Œ[Ži‚aC•i“c®Fi®ŠOj: ‘æ20‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï i95.03.11j, ‰¡•l.

2478. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ã˜rœ“ª‰º•û’E‰P‚̈êˆö‚Æ‚µ‚ÄŒŒŽî‚àl‚¦‚ç‚ꂽã˜rœŠO‰ÈãøœÜ‚Ì1—á. –ØMˆêC‚ŠÝŒ›“ñCÄ“¡º•FC’†‘º‘–¾C“c’†Œ[Ži‚aC“ì‘òˆç—YCŽ…–ž·Œ›i®ŠOj: ‘æ20‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï i95.03.11j, ‰¡•l.

2479. mŠw‰ïŽåÃi‘“àŠw‰ïjn ‘æ15‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€(95.03.04), “Œ‹ž, Ž…–ž·Œ›i®ŠOj.

2480. mŠw‰ïŽåÃi’n•û‰ïjn ‘æ20‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï(95.03.11), ‰¡•l, Ž…–ž·Œ›i®ŠOj.


<<20 Œ`¬ŠO‰ÈŠw>>

2481. mŒ´’˜n AllevynR cavity wound dressing‚Ìåñጂɑ΂·‚é—Õ°ŽŽŒ±¬Ñ. ‘å’|®”VC‰–’JMKC’Ò–ìˆê˜YC’†–kMºCÎŒ´GˆêC—é–Ø•q•FCXìˆê•FC’†‘ºŒ³MCˆÀ•y‹`“NCˆÀ“¡³‰piŒ`ŠOj: ˆãŠw‚Æ–òŠw, 33(2): 467`481, 1995.

2482. mŒ´’˜n “¯Ží•¡‡”|—{^”ç‚ÆR‹ÛÜŠÜ—L‘n”í•¢Þ‚É‚æ‚é‘nŽ¡–ü‘£i—ÃŒø‰Ê: —Õ°•]‰¿. ŽR‰º—ŠGC‚‹´Œ³C‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 14(9): 554`564, 1994.

2483. mŒ´’˜n ŠpŽ¿‰»×–E‚ÆüˆÛ‰è×–E‚Ì•\”牻‘£iŒø‰Ê‚Ì”äŠr; “®•¨ŽÀŒ±•]‰¿. •“cŒ[C‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 15(2): 80`90, 1995.

2484. mŒ´’˜n ƒXƒ‹ƒtƒ@ƒWƒAƒWƒ“‹âŠÜ—L‘n”í•¢Þ‚Ì[’B«”M‚Ö‚Ì“K—p|—Õ°•]‰¿|. ’†‘ºŒ³MC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: “ú–{”MŠw‰ïŽ, 20(2): 53`63, 1994.

2485. mŒ´’˜n Neurofibromatosis‚Ì—Õ°ŒŸ“¢|–k—¢‘åŠw•a‰@Œ`¬ŠO‰È‚É‚¨‚¯‚é14”NŠÔ‚ÌŒoŒ±|. –î•”“TŽqi—Õ•a—jC“àÀ‰hŽ÷C‘å’|®”VC‰–’JMKiŒ`ŠOjC‘O“c“OiŠÅŒìŠw•”jC‘å’J‰pŽ÷i—Õ•a—j: —Õ°ˆâ“`Œ¤‹†, 15(3¥4): 63`71, 1994.

2486. m€Œ´’˜n “¯Ží•¡‡”|—{^”ç‚ÆR‹ÛÜŠÜ—L‘n”í•¢Þ‚Ì•¹—p‚É‚æ‚é‘nŽ¡–üŒø‰Ê. ŽR‰º—ŠGiŒ`ŠOj: Prog, Med., 14(9): 247`249, 1994.

2487. m€Œ´’˜n ŠO—ˆŽèpŒã‚̌Œè–@‚̈êH•v. ’†‘ºŒ³MCˆÉ“¡³ŽkC‰–’JMKiŒ`ŠOj: “ú–{”ü—eŠO‰ÈŠw‰ï‰ï•ñ, 16(2): 23`28, 1994.

2488. m’Z•ñ¥‘¬•ñn R‹ÛÜŠÜ—L‘n”í•¢Þ‚Ì“®•¨ŽÀŒ±•]‰¿; ƒfƒuƒŠ[ƒhƒ}ƒ“‚µ‚½”M–ʂ̔핢Œø‰Ê. ’†‘ºŒ³MiŒ`ŠOjC•–ö”\Œõi¶‘ÌHjC‰–’JMKiŒ`ŠOj: Prog, Med., 14(9): 249`250, 1994.

2489. mÇ—á•ñn Extraskeletal chondroma with bony destruction | A case report and review of literature|. “àÀ‰hŽ÷C–،Ҋ®mCŽR‰º—ŠGC‰–’JMKiŒ`ŠOj: Eur. J. Plast. Surg., 17: 159`160, 1994.

2490. mÇ—á•ñn ‰º‘ڔ畆“«’×ᇂ̎¡—×á. ŽR“c’¼lC“잊º—YC‘å’|®”VC•“cŒö—˜C‰–’JMKiŒ`ŠOj: é‹ÊŒ§ˆãŠw‰ïŽGŽ, 28(5): 647`649, 1994.

2491. mÇ—á•ñn ’Üb‰º—Lž™×–EŠà‚ÌŒŸ“¢. ŽR“c’¼lC“잊º—YC“àÀ‰hŽ÷C‰–’JMKiŒ`ŠOj: “ú–{Žè‚ÌŠO‰ÈŠw‰ïŽGŽ, 11(2): 301`304, 1994.

2492. m‘àn Ý‘î‚Å‚Ìåñጎ¡—ÂƃPƒA‚ð—LŒø‚És‚Á‚Ä: ˆãŽt‚Ì—§ê‚©‚çŠÅŒì•w‚Ì—§ê‚©‚ç. ’†‘ºŒ³MC‰–’JMKC•Ÿˆä‹v”üŽqC’†“c‚è‚ÂŽqiŒ`ŠOj: ƒi[ƒX¥ƒvƒ‰ƒXƒƒ“, 4(13): 3`7, 1994.

2493. m‘àn ‘nŽ¡–ü. ’–Œ´ß”V‰îC‰–’JMKiŒ`ŠOj: ŠO‰Èf—Ã, 36(4): 441`444, 1994.

2494. m‘àn ‚»‚Ì‘¼‚Ì•”•ªá°Žæ‚èp. ‘å’|®”VC‰–’JMKiŒ`ŠOj: Œ`¬ŠO‰È, 37(‘): 139`143, 1994.

2495. m‘àn •ïŒs. ‚‹´Œ³iŒ`ŠOj: Œ`¬ŠO‰È, 37(‘): 285`290, 1994.

2496. mŠwp‘n i•ª’SŽ·•Mj }àŠOŽ¡—ÃKƒCƒh; ”M‚Ì‹ÇŠ—Ö@, p.446`456, ‰FˆäŒª“ñiŒ`ŠOj. •ÒW ™–{Š¤iã‘åjC •¶Œõ“°C“Œ‹žC94.04.02”­s.

2497. mŠwp‘n i•ª’SŽ·•Mj Advances in Wound Dressing and Cultured Skin Substitute; Frozen skin viability in a common skin bank in the USA, and a simulation of overseas transportation for the intention to import foreign skin, p.202`214, ‘å’J’˱”ViŒ`ŠOjCT. TaddonioCW. GarnerCJ. RodrigueziUniv. of MichiganjC‰–’JMKiŒ`ŠOjCD. SmithiUniv. of Michiganj. •ÒW •–ö”\Œõi¶‘ÌHjC‰–’JMKiŒ`ŠOjC –k—¢‘åŠwˆãŠw•”C‘Š–ÍŒ´C94.10.00”­s.

2498. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The effects of fatty acids of epidermal cell growth. W. GarneriUniv. of MichiganjC‘å’J’˱”ViŒ`ŠOjCD. SmithCJ. RodriguezCC. MarceloiUniv. of Michiganj: 4th Annual Meeting of the Wound Healing Society i94.05.18`20j, San Francisco, Wound Repair and Regeneration, 2(1): 77, 1994.

2499. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Tetrazolium reductase assay for evaluation of frozen skin viability under simulation of overseas transportation. ‘å’J’˱”ViŒ`ŠOjCT. TaddonioCW. GarnerCJ. RodriguezCD. Smith, Jr.iUniv. of MichiganjC‰–’JMKiŒ`ŠOj: 9th Congress of the International Society of Burn Injuries i94.06.27`07.01j, Paris, —\eW, p.123, 1994.

2500. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Allogeneic cultured dermal substitute composed of fibroblasts combined within spongy collagen matrix; Fundamental evaluation in animal tests. ŽR“c’¼lC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: Advances in Wound Healing, Burn Care and Infection Control i95.03.06j, Maui, Hawaii.

2501. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Viability of banked skin: The efficacy of tetrazolium reductase assay. ‘å’J’˱”ViŒ`ŠOjCT. TaddonioCW. GarnerCC. ZuccaroCM. TaitCJ. RodriguezCD. SmithiUniv. of Michiganj: 26th Annual Meeting American Burn Association i94.04.20`23j, Orlando, USA, —\eW, p.243, 1994.

2502. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The interaction between bacteria, neutrophils and epidermal cell growth. ‘å’J’˱”ViŒ`ŠOjCT. TaddonioCD. Smith, Jr.CJ. RodriguezCW. GarneriUniv. of Michiganj: 39th Annual Meeting Plastic Surgery Research Council i94.06.04`07j, Ann Arbor, USA.

2503. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Wound management using hyaluronic acid spongy sheet in conjunction with a medicated covering material. ‰eŽRL”üiŒ`ŠOjC•–ö”\Œõi¶‘ÌHjC‰–’JMKiŒ`ŠOj: ‘æ‚X‰ñ‘Û”MŠw‰ï i94.06.28j, ƒpƒŠ, —\eW, p.190, 1994.

2504. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Assessment of refrigerated storage time before cryopreservation on skin viability. T. TaddonioiUniv. of MichiganjC‘å’J’˱”ViŒ`ŠOjCM. TaitCW. GarnerCJ. RodriguezCD. SmithiUniv. of Michiganj: 18th Annual Meeting American Association of Tissue Banks i94.08.20`24j, San Francisco, —\eW, p.29, 1994.

2505. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Wound management using allogeneic cultured dermal sheet in conjunction with medicated covering material. ŽR‰º—ŠGiŒ`ŠOjC•–ö”\Œõi¶‘ÌHjCŽR“c’¼lC‰–’JMKiŒ`ŠOj: 4th Annual Meeting of the European Tissue Repair Society i94.08.26j, Oxford.

2506. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Allogeneic cultured dermal substitute composed of fibroblasts combined with in spongy collagen matrix; Clinical evaluation. ŽR‰º—ŠGiŒ`ŠOjC•–ö”\Œõi¶‘ÌHjC‰–’JMKiŒ`ŠOj: Advances in Wound Healing, Burn Care and Infection Control i95.03.06j, Maui, Hawaii.

2507. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Efficacy of keratinocytes and fibroblasts in promoting epithelization; A comparative study in animal tests. •“cŒ[C“c’†³‰pC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: Advances in Wound Healing, Burn Care and Infection Control i95.03.06j, Maui, Hawaii, Abstracts, p.46, 1994.

2508. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰‰ñ—¼‘¤Š{—ô•Â½‚Æ[‚¢Œûo‘O’ëÄŒš‚ðs‚¤—¼‘¤ŒûO—ô‚ÌŽèp–@. ’¹Ž”ŸsC£èWˆê˜YiŒ§—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[jC‰–’JMKiŒ`ŠOj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.07j, “Œ‹ž, “ú–{Œ`¬ŠO‰ÈŠw‰ïŽ, 14(12): 846, 1994.

2509. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ÄŒšŠO‰È‚É‚¨‚¯‚éAesthetic Mind|‘˜_|. ‘å’|®”VC‰–’JMKiŒ`ŠOj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.09j, “Œ‹ž, ´˜^W, p.129, 1994.

2510. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j åñጂɂ¨‚¯‚éƒGƒAƒ}ƒbƒgŒø‰Ê‚ɂ‚¢‚Ä. ’†‘ºŒ³MC•Ÿ“c—ŠGŽqC“àÀ‰hŽ÷C‰–’JMKiŒ`ŠOj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.07j, “Œ‹ž.

2511. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –³’É“I‹ÇŠZ–ƒŒ. ‘O“c‰Ø˜YC¼ˆäŽqCå“c¹ŽqC‹àŽj‰pC•t¬‘²CŽá¼MŒái“Œ—ˆã‘åjC£èWˆê˜YiŒ§—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[jC²X–ØŒbˆêi‰¡•lŽs‘åj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.07j, “Œ‹ž, “ú–{Œ`¬ŠO‰ÈŠw‰ïŽ, 14(12): 853, 1994.

2512. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –j”S–Œ‹Ø•Ù–@‚É‚æ‚éŒûŠWŒ`¬p‚ÌpŒãŠ{”­ˆç(ãŠ{Ž•Œ^–ÍŒ^•ªÍ). ‘厜–í—T”Vi•Ÿ‰ª‘åjC‘O“c‰Ø˜Yi“Œ—ˆã‘åjC£èWˆê˜YC’¹Ž”Ÿsi_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[jC•½ì’CŽÄèDLiº˜a‘åj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.08j, “Œ‹ž, “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 14(12): 858, 1994.

2513. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —¼‘¤O—ô‚É‚¨‚¯‚é‘N–¾‚ÈCupid's bow‚Ìì»–@. ‘O“c‰Ø˜YC¼ˆäŽqCå“c¹ŽqC‹àŽj‰pC•t¬‘²CŽá¼MŒái“Œ—ˆã‘åjC£èWˆê˜YiŒ§—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[jC²X–ØŒbˆêi‰¡•lŽs‘åj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.08j, “Œ‹ž, “ú–{Œ`¬ŠO‰ÈŠw‰ïŽ, 14(12): 857, 1994.

2514. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒRƒ‰[ƒQƒ“‚ðƒ}ƒgƒŠƒbƒNƒX‚Æ‚µ‚½‘¼‰Æ•¡‡”|—{^”çƒV[ƒg‚Ì컂Ɨհ‰ž—p. ŽR‰º—ŠGC‚‹´Œ³C”’èËWC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ20‰ñ“ú–{”MŠw‰ï i94.05.27j, ‰¡•l, —\eW, p.95, 1994.

2515. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j üˆÛ‰è×–E‚ðƒRƒ‰[ƒQƒ“ƒ}ƒgƒŠƒbƒNƒX‚É‘g‚Ýž‚ñ‚¾‘¼‰Æ”|—{^”çƒV[ƒg‚ÌŠJ”­. ŽR‰º—ŠGC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ43‰ñ‚•ªŽqŠw‰ï i94.06.17j, “Œ‹ž.

2516. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Furlow–@‚Ì–â‘è“_‚Ɖü—Ç–@. ’¹Ž”ŸsC£èWˆê˜YiŒ§—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[jCŽRèˆÀ°C’†–kMºC‰–’JMKiŒ`ŠOjC—é–ØŒbŽqCŒ´—R‹NŽqC‰ª–{˜NŽqiŽ¨•@j: “ú–{ŒûŠW—ôŠw‰ï‘‰ï i94.07.01j, ‘åã, “ú–{ŒûŠW—ôŠw‰ïŽGŽ, 19(4): 316`317, 1994.

2517. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘ÙŽe”畆‚Ì‘n•Â½‚É”º‚¤ƒÀ-actin mRNA‚¨‚æ‚уAƒNƒ`ƒ“üˆÛ‚ÌÁ’·. ’–Œ´ß”V‰îiŒ`ŠOjC–{—Ñ—R”üŽqi¶•¨‰»ŠwŒnj: ‘æ65‰ñ“ú–{“®•¨Šw‰ï‘å‰ï i94.10.05j, –¼ŒÃ‰®, —\eW, p.50, 1994.

2518. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •@¥–j•”–Ñ׌ŒŠÇŠg’£Ç‚ÌF‘fƒŒ[ƒU[“™‚É‚æ‚鎡—ÃŒoŒ±. ‚‹´Œ³CŽR‰º—ŠGCˆÉ“¡³ŽkC…–ìŽõŽqC‰–’JMKiŒ`ŠOj: ‘æ15‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘å‰ï i94.10.13j, Ž­Ž™“‡, ´˜^W, p.85, 1994.

2519. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒsƒAƒXŽ{sŽž‚ÌŽ¨‚‚̶‰E·‚ɂ‚¢‚Ä|‘æ2•ñ|. ’†‘ºŒ³MiŒ`ŠOjC’r“c•qŽqi‰ðjCˆÉ“¡³ŽkC‰–’JMKiŒ`ŠOj: ‘æ17‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï i94.10.15j, “Œ‹ž.

2520. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚Z¶‚É‚¨‚¯‚éƒsƒAƒX‚É‚æ‚é‹à‘®ƒAƒŒƒ‹ƒM[‚ɑ΂·‚éˆÓŽ¯: _“Þ쌧‰º 3981l‚Ì’²¸‚æ‚è. ‚‹´Œ³C’†‘ºŒ’‚aCˆÉ“¡³ŽkC‰–’JMKiŒ`ŠOj: ‘æ61‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï i94.10.15j, “Œ‹ž.

2521. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž¨‰îŒ`‘ÔˆÙ펡—ÃŽx‰‡ƒVƒXƒeƒ€i–„–vŽ¨—p‹¸³‹ïŒ`ó‚ÌŽ©“®¶¬). ‰Ô–[º•FCŠÖŒûs—YCˆé‘ºPCŠ_–{‰fiE‹Æ”\—ÍŠJ”­‘åjC‚‹´Œ³iŒ`ŠOj: ‘æ‚R‰ñƒRƒ“ƒsƒ…[ƒ^ŠO‰ÈŠw‰ï i94.10.16j, “Œ‹ž.

2522. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒCƒIƒ“ƒgƒtƒIƒŒ[ƒVƒX–ƒŒ–@‚É‚¨‚¯‚é¬H•v. ‚‹´Œ³C’†‘ºŒ’‚aCˆÉ“¡³ŽkC‰–’JMKiŒ`ŠOj: ‘æ11‰ñ“ú–{—Õ°”畆ŠO‰ÈŠw‰ï i94.10.23j, ‹ž“s.

2523. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘¼‰Æ•¡‡”|—{^”çƒV[ƒg‚ÌŠJ”­; —Õ°•]‰¿. ŽR‰º—ŠGC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ16‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï i94.11.04j, b•{.

2524. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‡V“x”MÄáoØœ‘n–ʂ̔핢ނ̓K—p; “®•¨ŽÀŒ±•]‰¿. ’†‘ºŒ³MC“c’†³‰piŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ3‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.11.18j, ‰¡•l, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.36, 1994.

2525. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠpŽ¿‰»×–E‚È‚ç‚Ñ‚ÉüˆÛ‰è×–E‚Ì•\”牻‘£iŒø‰Ê; “®•¨ŽÀŒ±•]‰¿. •“cŒ[C‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ3‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.11.18j, ‰¡•l, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.45, 1994.

2526. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •\”çŒnŠ´õ‘nƒ‚ƒfƒ‹‚É‚¨‚¯‚é׋ۂ¨‚æ‚Ñ”’ŒŒ‹…‚Ì‘nŽ¡–ü‚ւ̉e‹¿. ‘å’J’˱”VC‰–’JMKiŒ`ŠOj: ‘æ3‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.11.18`19j, ‰¡•l, —\eW, p.53, 1994.

2527. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “¯Ží”|—{^”ç‚Ì‘nŽ¡–ü‘£iŒø‰Ê‚Ì•]‰¿. ŽR“c’¼liŒ`ŠOjC•–ö”\Œõi¶‘ÌHjC‰–’JMKiŒ`ŠOj: ‘æ3‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.11.19j, ‰¡•l, —\eW, p.51, 1994.

2528. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒzƒ‹ƒ‚ƒ“—Ö@‚ÆlHáΊێèp‚ðs‚Á‚½–³áΊÛÇŠ³ŽÒ‚ÌŽ¡—ÃŒoŒ±. ‚‹´Œ³CŽR‰º—ŠGiŒ`ŠOjC‰¡“csŽjiŽ™jC”’èËWC•“cŒ[C–،Ҋ®mCŽðˆä’¼•FC—јaOCˆÉ“¡³ŽkC‰–’JMKiŒ`ŠOj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.07j, “Œ‹ž.

2529. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠO, pŒã‘n•”‚ÌF’²‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ’†‘ºŒ³MC•Ÿ“c—ŠGŽqC“àÀ‰hŽ÷CˆÉ“¡³ŽkC‰–’JMKiŒ`ŠOj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.08j, “Œ‹ž.

2530. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j —L–Ñ«F‘f«•ê”Á‚ɑ΂·‚éregrat‚̉“Šu¬Ñ. ‘O“c‰Ø˜YC¼ˆäŽqCå“c¹ŽqC‹àŽj‰pC•t¬‘²CŽá¼MŒái“Œ—ˆã‘åjC£èWˆê˜YiŒ§—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[jC²X–ØŒbˆêi‰¡•lŽs‘åj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.08j, “Œ‹ž, “ú–{Œ`¬ŠO‰ÈŠw‰ïŽ, 14(12): 862, 1994.

2531. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j œ‚¨‚æ‚ÑäF•t‚«—V—£‘O˜r”ç•Ù‚É‚æ‚éŒûŠW‘SŒ‡‘¹‚ÌÄŒš. ŽÄ“c—T’BCÎŒ´GˆêC‘哇•àC‹g쎠i‰¡•l“실ϕa‰@jC’†–kMºC—é–Ø•q•FC‰–’JMKiŒ`ŠOj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.09j, “Œ‹ž.

2532. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j CrouzonÇŒóŒQ‚Ì1‰ÆŒn. £èWˆê˜YC’¹Ž”ŸsCŽRŒû˜a˜YCŠÖŒËŒªˆêCŽüâÙ‚CÄ“cW•FiŒ§—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[jC´…’²i‰¡•lŽs‘åjC_‘ò•qiŒ`ŠOj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.09j, “Œ‹ž, “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 14(12): 872, 1994.

2533. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j •Ð‘¤ Dismasking Flap‚ð‰ž—p‚µ‚½’†“ªŠW’ê, —ƒŒûŠWâ|‚Ö‚ÌV‚µ‚¢ƒAƒvƒ[ƒ`. ’¹Ž”ŸsC£èWˆê˜YCŠÖŒËŒªˆêC•ž•”‹±‹vCÄ“cW•FC¬‰ÍŒ´¸C‚¼ˆê˜YiŒ§—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[jC—é–Ø•q•Fi‰¡•lŽs–¯•a‰@jC‘º‘òÍŽqi‰¡•lŽs ‘åj: ‘æ37‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i94.04.09j, “Œ‹ž, “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 14(12): 872, 1994.

2534. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ž¨‰îŒ`‘ÔˆÙ펡—ÃŽx‰‡ƒVƒXƒeƒ€iŽ¨‰î‰æ‘œƒf[ƒ^[ƒx[ƒX‚Ì\’zŽx‰‡). ‰Ô–[º•FCŠÖŒûs—YCˆé‘ºPCŠ_–{‰fiE‹Æ”\—ÍŠJ”­‘åjC‚‹´Œ³iŒ`ŠOjC“y”쌒ƒi“Œ‘åj: ‘æ10‰ñƒGƒ‹ƒGƒXƒeƒBŠw‰ïi‚ç‚¢‚ÓƒTƒ|[ƒgƒeƒNƒmƒƒW[j i94.10.02j, Ô•ä, —\eW, p.59, 1994.

2535. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒg‘ÙŽe”畆ŠíŠ¯”|—{Œn‚É‚¨‚¯‚錰”÷‹¾“IŠÏŽ@. –،Ҋ®mC£èWˆê˜YC’–Œ´ß”V‰îC‰–’JMKiŒ`ŠOj: ‘æ3‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.11.18j, ‰¡•l.

2536. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ù‰ñ”|—{–@‚ð—p‚¢‚½–Ñ•ï‚ÌÄ\’z‚ƈÚAŽŽŒ±. •“cŒ[C’†‘ºŒ’‚aC‰–’JMKiŒ`ŠOj: ‘æ3‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.11.18j, ‰¡•l, ƒvƒƒOƒ‰ƒ€¥´˜^W, p.77, 1994.

2537. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ž¨‰îŒ`‘ÔˆÙ펡—ÃŽx‰‡ƒVƒXƒeƒ€‚ÌŒ¤‹†. ‚‹´Œ³C’†‘ºŒ’‚aCˆÉ“¡³ŽkC‰–’JMKiŒ`ŠOjC‰Ô–[º•FCŠÖŒûs—YCˆé‘ºPCŠ_–{‰fiE‹Æ”\—ÍŠJ”­‘åjC“y”쌒ƒi“Œ‘åjC“茴O”Vi–k‘åj: ‘æ‚R‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.11.18`19j, ´˜^W, p.85, 1994.

2538. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Š´õ‘n‚É‚¨‚¯‚é’´Ž_‰»…‚ÌŽE‹ÛŒø‰Ê|“®•¨ŽÀŒ±•]‰¿|. ’†‘ºŒ³MiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ3‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï i94.11.19j, ‰¡•l, —\eW, p.82, 1994.

2539. mŠw‰ïi’n•ûjn iƒ[ƒNƒVƒ‡ƒbƒvj Ζûƒ^ƒ“ƒN‰Šã‚É‚æ‚é”MŽ–—á|’j«(52Î)‚ÌŽ¡—ÃŒo‰ß. ‘å’J’˱”VC‰ª“c–M•FC‘º‰ºˆêWiŒ`ŠOj: ‘æ8‰ñ“ú–{”MŠw‰ïMB’n•û‰ï i95.03.04j, z–K.

2540. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “û–[•”Œ´”­Amelarotic malignant melanoma‚Ì1—á. ŽR‰º—ŠGC‚‹´Œ³C“àÀ‰hŽ÷CˆÉ“¡³ŽkC‰–’JMKiŒ`ŠOj: “ú–{Œ`¬ŠO‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.05.01j, “Œ‹ž.

2541. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “–‹³Žº‚É‚¨‚¯‚é“û—cŽ™V‘N”M‚Ì10”NŠÔ‚Ì“Œv. ²“¡–¾’jC…–ìŽõŽqCª–{[C“àÀ‰hŽ÷CˆÉ“¡³ŽkC‰–’JMKiŒ`ŠOj: “ú–{Œ`¬ŠO‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.05.07j, “Œ‹ž.

2542. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒGƒmƒLƒ^ƒPÍ”|‚É‚æ‚éŠO‚ɂ‚¢‚Ä. ‚£ÅCˆêŽr¢i–kM‘‡•a‰@jCƒvƒŠƒ“ƒ„EƒsƒpƒbƒVƒ…ƒLƒƒƒbƒgCˆÀ•y‹`“NC•“cŒö—˜iŒ`ŠOj: ‘æ51‰ñ’·–쌧”_‘ºˆãŠw‰ï‘‰ï i94.07.03j, ’·–ì.

2543. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘½”­ŠO‚ÌŽ¨‰î“¹‚ɑ΂·‚鎡—Õû–@‚ÌH•v. ‘º‰ºˆêWC–،Ҋ®mCˆÀ“¡³‰piŒ`ŠOj: ‘æ51‰ñ’·–쌧”_‘ºˆãŠw‰ï‘‰ï i94.07.03j, ’·–ì.

2544. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j bó‘BŠà‹CŠÇ‡•¹ØœŒã‚Ì‹CŠÇÄŒšp‚ðs‚Á‚½‚P—á. ¼‰º‰À‘ãiŒ`ŠOjCŒy•”G–¾Cˆ¢•”K—mC瓇—R˜NC²“¡DMC–ì˜C¹–¤i‘Š–ÍŒ´‹¦“¯•a‰@jC‚‹´Œ³iŒ`ŠOjC“cŠ‰qi‘Š–ÍŒ´‹¦“¯•a‰@jC—é–Ø–M•vi“ú ‘åj: ‘æ35‰ñxŠO‰ïŠwp‘å‰ï i94.12.03j, “Œ‹ž. ƒvƒƒOƒ‰ƒ€W, p.5, 1994.

2545. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j f’f‚É‹ê—¶‚µ‚Ä‚¢‚é•@•”ŽîᇂÌ1—á. ²“¡–¾’jC…–ìŽõŽqC¼ˆäŒ‰CŽO“c–ƒ’ÃŽqC’†–kMºC‰–’JMKiŒ`ŠOj: “ú–{Œ`¬ŠO‰ÈŠw‰ï_“ÞìǗጟ“¢‰ï i94.12.10j, ìè.

2546. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒsƒAƒXŽ{sŽž‚ÌŽ¨‚‚̶‰E·‚ɂ‚¢‚Ä|‘æ3•ñ|. ’†‘ºŒ³MiŒ`ŠOjC’r“c•qŽqi‰ðjCˆÉ“¡³ŽkiŒ`ŠOj: ‘æ62‰ñ”ü—eŠO‰ÈŠwpW‰ï i95.01.14j, “Œ‹ž.

2547. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¶‰ºŠááÙ•””畆‚É”­¶‚µ‚½pleomorphic adenoma‚Ì1—á. ’r–{”ÉOCŽÄ“c—T’BCÎŒ´GˆêC–k‘º‘ni‰¡•l“실ϕa‰@jC‰–’JMKiŒ`ŠOj: ‘æ107‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠÖ“ŒŽx•”“Œ‹ž’n•û‰ï—á‰ï i95.03.04j, “Œ‹ž.

2548. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j á­Sk‚ð—\–h‚µ“¾‚½Œz•””M‚Ì1Ç—á‚ɂ‚¢‚Ä. ˆêŽr¢CƒvƒŠƒ“ƒ„EƒsƒpƒbƒVƒ…ƒLƒƒƒbƒgCˆÀ•y‹`“NiŒ`ŠOj: ‘æ8‰ñ“ú–{”MŠw‰ïMB’n•û‰ï i95.03.04j, z–K.

2549. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j ƒƒ‹ƒPƒ‹×–EŠà‚Ì‚P—á. X“c½C’ô—DŽqC“¿‹´ŽŠCŽR‰º—ŠGC‚‹´Œ³iŒ`ŠOjC‰Í–ì½C“cŠ‰qCŒE“c‘וvCaŒû¹Žq: ‘æ58‰ñ“ú–{”畆‰ÈŠw‰ï“Œ•”Žx•”ŠwpW‰ï i94.09.10j, “È–Ø.

2550. mŒ¤‹†‰ïi‘Ûjn i‹L”Ou‰‰j Investigation of relationship between characteristics of microcapsules containing bone morphogenetic protein (BMP) and osteo-inductive activity. M. Isobei“ŒˆãŽ•‘åjCŽRèˆÀ°iŒ`ŠOjCK. IshiharaCN. NakabayashiCT. Amagasai“ŒˆãŽ•‘åj: International Conference on Bone Morphogenetic Proteins i94.06.10j, Baltimore.

2551. mŒ¤‹†‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Wound closure in fetal rat skin. ’–Œ´ß”V‰îiŒ`ŠOjC–{—Ñ—R”üŽqi¶•¨‰»ŠwŒnj: International Symposium on Wound Healing and Tissue Regeneration i95.02.23j, L“‡, —\eW, p.53, 1995.

2552. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™Šç–ÊŠO‚ÌŒŸ“¢. ’†‘ºŒ³MC’Ï‹MŽqC•Ÿ“c—ŠGŽqC“àÀ‰hŽ÷C‰–’JMKiŒ`ŠOj: ‘æ8‰ñ“ú–{ŠOŒ¤‹†‰ï i94.05.19j, ‘q•~, “ú–{ŠOŒ¤‹†‰ïŽ, 18(2): 79, 1994.

2553. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ŒûOŒûŠW—ô‚ÌŽ¡—Âƃ`[ƒ€ƒAƒvƒ[ƒ`. ’†–kMºiŒ`ŠOj: ‘æ43‰ñ‘Š•Ž¨•@‰ÈŒ¤‹†‰ï i94.06.25j, ‘Š–ÍŒ´.

2554. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “¯Ží•¡‡”|—{^”çƒV[ƒg‚Ì—Õ°•]‰¿. ŽR‰º—ŠGC‚‹´Œ³C‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ2‰ñ–k—¢Œ`¬ŠO‰ÈŒ¤‹†‰ï i94.10.08j, ‰¡•l.

2555. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘n‚É‚¨‚¯‚é‹ÇŠôò‚ÌŒø‰Ê‚ɂ‚¢‚Ä. ’†‘ºŒ³MCŽðˆä’¼•FCŽODGC“c’†³‰piŒ`ŠOj: ‘æ2‰ñ–k—¢Œ`¬ŠO‰ÈŒ¤‹†‰ï i94.10.08j, ‰¡•l.

2556. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”x«S‚É‚æ‚éS•s‘S‚ð‡•¹‚µ‚½”M‚Ì1Ž¡Œ±—á. Žðˆä’¼•FC“c’†³‰pCŽODGC’†‘ºŒ³MiŒ`ŠOjC‘“c‘ìC‘å˜a“c—²i‹~–½j: ‘æ2‰ñŽlŽ{Ý”MŒ¤‹†‰ïiBurn Forum in Sinjukuj i94.10.14j, “Œ‹ž.

2557. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŽO“ª‹ØäF”牺’f—ô‚Ì1—á. ‘哇•àiŒ`ŠOjC‹v‰ä“N–çCŽðˆäº“TC‘åΗz‰îC”nꌫŽ¡C—é–ØŸŒÈiŽY‹Æˆã‘åj: –k‹ãBŽè‚ÌŠO‰ÈŒ¤‹†‰ï i95.02.04j, •Ÿ‰ª.

2558. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰È‚ÅŒoŒ±‚µ‚½”畆ˆ««Žîᇂɂ‚¢‚Ä‚ÌlŽ@. ‚‹´Žk–¾C’Ò–ìˆê˜YiŒ`ŠOj: é‹ÊŒ§ˆãŽt‰ï i95.02.26j, ‰Y˜a.

2559. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj Œ`¬ŠO‰È‚Æ‚Í‚ð‚«‚ê‚¢‚ÉŽ¡‚·‚É‚Í. ŽR‰º—ŠGiŒ`ŠOj: Ó슙‘q•a‰@ŒöŠJuÀ i94.03.18j, ‘å‘D.


<<21 ”畆‰ÈŠw>>

2560. mŒ´’˜n ”畆׋ۊ´õÇ. “V–ì—²•¶Cì–¼½Žii”çj: JIM, 4(10): 878`879, 1994.

2561. mŒ´’˜n F‘f«áy]|“–‰È23—á‚ÌWŒv‚Æ•a—‘gD‹y‚іƉu‘gDŠwŒŸ“¢|. “¡“c—T‰îCŸ‰ªŒ›¶Crˆä—ºCŠâè‰ëi”çj: ¼“ú–{”畆‰È, 56: 749`757, 1994.

2562. mŒ´’˜n ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á•a‚É‚¨‚¯‚é—n˜A‹ÛRŒ´‚ÌŒŸo. ‹´–{–¾•FC“¡‘º‹¿’jC‘‘òŠ²’jC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽ, 104(12): 1421`1426, 1994.

2563. mŒ´’˜n ˆ««•FŽî×–EŠ”‚É‚¨‚¯‚éMTS1/CDK4Iˆâ“`Žq‚ÌŒ‡Ž¸‚Æ“_“Ë‘R•ÏˆÙ. óˆäŽõŽqi”çjC˜a“c’m‰vi—Õ•a—jC•ÄŒ³N‘ C‰q“¡ŒõC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽ, 104(14): 1715`1720, 1994.

2564. mŒ´’˜n Exfoliative toxinŽY¶MRSA‚ª‘ˆ«ˆöŽq‚Æl‚¦‚ç‚ꂽ¬lƒAƒgƒs[«”畆‰Š. ‹´–{–¾•FC’؈äL”üCŽðˆä’qŒbCŠÖª“ÖŽqC“¡‘º‹¿’ji”çj: “ú–{”畆‰ÈŠw‰ïŽGŽ, 104(6): 799`802, 1994.

2565. mŒ´’˜n ƒGƒNƒŠƒ“Š¾ŠíŠ¯Šà‚Ì1—á. ‰H‹àdŠìC“¡‰ª²Cóˆär–íC‰q“¡Œõi”çjC”’èËWCŒÃŽR“o—²iŒ`ŠOjCó’J‰ë•¶CŠâè‰ëi”çj: ”畆‰È‚Ì—Õ°, 37(4): 561`564, 1995.

2566. mŒ´’˜n ƒTƒ‰ƒ]ƒsƒŠƒ“‚É‚æ‚é–ò]. ‚–ìWC•ÄŒ³N‘ i”çj: ”畆‰È‚Ì—Õ°, 37: 239`242, 1995.

2567. mŒ´’˜n ‘Sg‚É’˜‚µ‚¢F‘f’¾’…‚ð‚«‚½‚µ‚½”畆‹Ø‰Š. •ÄŒ³N‘ CóˆäŽõŽqCŽðˆä’qŒbi”çj: ”畆•af—Ã, 16(5): 393`396, 1994.

2568. mŒ´’˜n Addison•a. “c•Ó˜a”üC•ÄŒ³N‘ C“”I^—CÄ“¡ºi”çj: ”畆•af—Ã, 16(5): 413`416, 1994.

2569. m€Œ´’˜n ”畆•a•Ï‚©‚ç‚Ý‚½Å‹ß‚ÌäPŒ´•a. ‰q“¡Œõi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽ, 104: 1613`1615, 1994.

2570. m€Œ´’˜n ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX. ‰q“¡ŒõCVˆätŽ}i”çj: ”畆•af—Ã, 16: 517`521, 1994.

2571. m€Œ´’˜n äPŒ´•a‚ÌŽ¡—Ã|‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX. ‰q“¡Œõi”çj: ”畆•af—Ã, 16: 848`850, 1994.

2572. mŒ¤‹†•ñiŒú¶Èjn D’†‹…‚É‚æ‚é”畆”÷¬ŒŒŠÇ“à”ç×–E”—£áŠQ. ‘‘òŠ²’jC“V–ì—²•¶C“¡‘º‹¿’jC¼ŽR–Εvi”çj: Œú¶È“«ŒŒŠÇ‰Š’²¸Œ¤‹†”Ç1993”N“xŒ¤‹†•ñ‘, p.139`143, 1994.

2573. mŒ¤‹†•ñiŒú¶Èjn ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á‚Ì3—á(¬Ž™—á, ˜Vl—á, ŠÌŽ¾Š³‚É”º‚¤—á). “V–ì—²•¶C‹´–{–¾•FC‘‘òŠ²’jC¼ŽR–Εvi”çj: Œú¶È“«ŒŒŠÇ‰Š’²¸Œ¤‹†”Ç1993”N“xŒ¤‹†•ñ‘, p.215`216, 1994.

2574. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ‚ç‚¢‹ÛŠ´õƒ}ƒEƒX‚Ì‘«’ê•”‚¨‚æ‚ÑäB‘Ÿ‚É”­Œ»‚·‚éƒTƒCƒgƒJƒCƒ“ˆâ“`Žq. äo‹Vƒ„ƒXŽqC–ìŠÔŒû”ŽŽqCâ–{–FŠ²C¼‰ª³“Ti‘—§‘½–€Œ¤jC“¡‘º‹¿’ji”çjC“à‘ºtŽ÷i•ºŒÉˆã‘åjC“ú’u‹±ŽiCÄ“¡@’jC–쑺’BŽŸiŽÀ’†Œ¤j: ‘—§‘½–€Œ¤‹†Š”N•ñ, (39): 45`50, 1995.

2575. mÇ—á•ñn ƒeƒ‹ƒrƒiƒtƒBƒ“‚ª‘tŒø‚µ‚½ƒŠƒ“ƒpŠÇŒ^ƒXƒ|ƒƒgƒŠƒR[ƒVƒX. óˆäŽõŽqC“cÀO”VCó’J‰ë•¶i”çjCˆ¢•””ü’mŽqi—ÕŒŸj: ¼“ú–{”畆‰È, 56(4): 780`783, 1994.

2576. mÇ—á•ñn •úŽËüÆŽËŒã‚ɶ‚¶‚½‘½”­«Šî’ê×–Eã”çŽî. ‰H‹àdŠìC•‘ºr”VCrˆä—ºCŽR–{’B—Yi”çj: ”畆•af—Ã, 16(2): 133`136, 1994.

2577. mÇ—á•ñn Papillomatose confluente et reticulee. ’ËŒ´“NÆCóˆär–íCŸ‰ªŒ›¶i”çj: ”畆•af—Ã, 17(3): 265`268, 1995.

2578. mÇ—á•ñn Dyskeratosis-congenita (Cole-EngmanÇŒóŒQ). Vˆä’BC‘åìŽii”çj: ”畆•af—Ã, 17(3): 273`276, 1995.

2579. mÇ—á•ñn ƒŠƒ“ƒpŠÇ“à”ç×–E—R—ˆ‚ÆŽv‚í‚ꂽ“ª•”–¬ŠÇ“÷Žî‚Ì1—á. ‘‘òŠ²’jCŒü–ì“Ni”çjCŒK”ö’èmi•a—j: –k—¢ˆãŠw, 24: 315`317, 1994.

2580. m—Õ°Ž¡Œ±n ƒAƒgƒs[«”畆‰ŠŠ³ŽÒ‚ð‘ÎÛ‚Æ‚µ‚½DPC Specific IgE Kit (AlasTAT)‚É‚æ‚é“ÁˆÙ“IIgER‘Ì‘ª’è‚Ì—L—p«‚ÌŒŸ“¢. –ìŒûr•FC‰H‹àdŠìC“¡‰ª²CŒüˆäGŽ÷C¼ŽR–ΕvCŠâ“c‹žŽqi”çj: ¼“ú–{”畆‰È, 55: 118`122, 1993.

2581. m—Õ°Ž¡Œ±n ŠeŽí”畆Ž¾Š³‚ɑ΂·‚郃Tƒfƒ‹ƒ€(0.1% Dexamethasone 17,21-Dipropionate)“îpŠÜ—L¬‡Ü‚Ì—Õ°”äŠr. •ÄŒ³N‘ C¼ŽR–ΕvC‰q“¡ŒõCì–ìMŽqC‹àŠÛ“NŽRCŸ‰ªŒ›¶CŒüˆäGŽ÷i”çj: ¼“ú–{”畆‰È, 56: 327`334, 1994.

2582. m‘àn ”畆‚̖Ɖu‚ÆtáŠQ. ‰q“¡Œõi”çj: Modern Urinalysis, 36: 24`27, 1994.

2583. m‘àn Š£á‚ɑ΂·‚é1ƒ¿,24R-(OH)2D3‚Ì—Õ°‰ž—p. ‰q“¡ŒõC¼ŽR–Εvi”çj: The Bone, 9(1): 129`134, 1995.

2584. m‘àn Á‰»ŠÇƒ|ƒŠƒ|[ƒVƒX‚Ɣ畆•a•Ï. •ÄŒ³N‘ i”çj: f’f‚ÆŽ¡—Ã, 83(2): 331`334, 1995.

2585. m‘àn •\”ç×–E‚Æ“]ŽÊ§ŒäˆöŽq. óˆär–íi”çjC”‘qŒhˆëiCity of Hopej: ”畆•af—Ã, 17(1): 173`176, 1995.

2586. m‘àn zŠÂŠQ|“œ”A•a«’×á‡, “®–¬d‰»«’×á‡|. ‘‘òŠ²’ji”çj: ˜V‰»‚ÆŽ¾Š³, 8(1): 4`10, 1995.

2587. muÀn ”畆‰È—̈æ‚ÆtŽ¾Š³. ¼ŽR–Εvi”çjCŽðˆä‹Ši”åj: Modern Urinalysis, 10(2): 2`8, 1994.

2588. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒrƒ^ƒ~ƒ“‚c3“îp‚ÌŠ£á‚Ö‚Ì—Õ°‰ž—p‚ÌŽÀÛ. ‰q“¡Œõi”çj: ‘æ93‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i94.04.23j, •Ÿ‰ª.

2589. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj SLE‚Ì•aŒ^•ª—Þ. ‰q“¡Œõi”çj: ‘æ38‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i94.04.29j, “Œ‹ž, ƒŠƒEƒ}ƒ`, 34: 367, 1994.

2590. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒCƒ“ƒ^[ƒƒCƒLƒ“‚Q—Ö@|“ª•”–¬ŠÇ“÷Žî‚ɑ΂·‚é—Õ°‰ž—p‚ÆŽ¡—Õûj|. ‘‘òŠ²’ji”çj: ‘æ10‰ñ“ú–{”畆ˆ««Žîᇊw‰ïŠwp‘å‰ï i94.06.25j, “Œ‹ž.

2591. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —D«‰h—{áŠQŒ^•\”ç…ávÇ‚Ì•ê–º—á. Žðˆä’qŒbCŠÖª“ÖŽqC•ÄŒ³N‘ C‘‘òŠ²’ji”çj: ‘æ93‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i94.04.21`23j, •Ÿ‰ª, “ú–{”畆‰ÈŠw‰ïŽGŽ, 104(3): 384, 1994.

2592. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “ª•”ŒŒŠÇ“÷Žî‚É‚æ‚éSCIDƒ}ƒEƒX“à”ç×–EŒ`Ž¿“]Š·. ‘‘òŠ²’jC“¡‘º‹¿’ji”çjC÷ˆä”ü“TCŽ›“c‰pŽii—Šw•”jC¼ŽR–Εvi”çjC‰Á“¡GŽ÷iŽÀ’†Œ¤j: ‘æ93‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i94.04.21`23j, •Ÿ‰ª, “ú–{”畆‰ÈŠw‰ïŽGŽ, 104(3): 402, 1994.

2593. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”畆•\Ý«^‹ÛŠ´õÇ‹ÇŠ‚É‚¨‚¯‚éIFN-ƒÁmRNA‚Ì”­Œ». ‹{“c‘ŽqC“¡‘º‹¿’jC‘‘òŠ²’jC¼ŽR–Εvi”çj: ‘æ93‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i94.04.21`23j, •Ÿ‰ª, “ú–{”畆‰ÈŠw‰ïŽGŽ, 104(3): 446, 1994.

2594. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒTƒCƒgƒJƒCƒ“‚ðŽw•W‚Æ‚µ‚½”畆ƒAƒŒƒ‹ƒM[”½‰ž‚̃XƒNƒŠ[ƒjƒ“ƒO‚ɂ‚¢‚Ä. ŽRèr‰îCŒKŒ´—TŽjCŠ`“‡”ŽiƒJƒlƒ{ƒEjCŽ›“c‰pŽii—Šw•”jC“¡‘º‹¿’jC‘‘òŠ²’ji”çj: ‘æ93‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i94.04.21`23j, •Ÿ‰ª, “ú–{”畆‰ÈŠw‰ïŽGŽ, 104(3): 456, 1994.

2595. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –û—n«ŠÃ‘’Šo•¨‚É‚æ‚éŠÌ”Á‚ÌŽ¡—Ã. Œ´–{òi¹ƒ}ƒŠˆã‘åjC¼ŽR–ΕvC•ÄŒ³N‘ i”çjC“ú–쎡ŽqiŠÖ“Œ’†‰›•a‰@jC‘¼: ‘æ93‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i94.04.22j, •Ÿ‰ª.

2596. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘Ñóáv]Š´õŽž‚É‚¨‚¯‚é’x‰„Œ^‰ß•q”½‰ž—}§‹@\‚̉ðÍ. “¡“c—T‰îC•“cŽüìC“¡‘º‹¿’jC‘‘òŠ²’jC¼ŽR–Εvi”çj: ‘æ93‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i94.04.22j, •Ÿ‰ª, “ú–{”畆‰ÈŠw‰ïŽGŽ, 104: 422, 1994.

2597. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žá”N«—Þ“VáváŒ. Ä“¡“T[C’ËŒ´“NÆC‹´–{–¾•FC‘‘òŠ²’ji”çj: ‘æ18‰ñ“ú–{¬Ž™”畆‰ÈŠw‰ï i94.06.12j, “Œ‹ž.

2598. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j …áv«—Þ“Vávጂ̔ç]•”‚É‚¨‚¯‚écytokine profile. ò–¾Ž…C‹´–{–¾•FC“¡‘º‹¿’jC‘‘òŠ²’jC¼ŽR–Εvi”çj: ‘æ19‰ñ“ú–{Œ¤‹†”畆‰ÈŠw‰ï i94.08.31j, ‘åã.

2599. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Thl type CD4+ lymphocytes predominantly in lichen planus. ‹{“c‘ŽqC“¡‘º‹¿’jC‘‘òŠ²’jC¼ŽR–Εvi”çj: 19th Annual Meeting of the Japanese Society for Investigative Dermatology i94.08.31j, ‘åã, J. Dermatol. Sci., 8(1): 65, 1994.

2600. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “ª•”ŒŒŠÇ“÷Žî—R—ˆƒqƒg“à”ç×–E”|—{Š”Ž÷—§. ‘‘òŠ²’jC“¡‘º‹¿’jC¼ŽR–Εvi”çj: ‘æ19‰ñ“ú–{Œ¤‹†”畆‰ÈŠw‰ïŠwp‘å‰ï i94.09.01j, ‘åã, J. Dermatol. Sci., 8(1): 77, 1994.

2601. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Usefulness of anti-human endothelial cell monoclonal antibody AO28 for histological diagnosis of angiosarcoma. “¡“c—T‰îC‘‘òŠ²’jC“¡‘º‹¿’jC¼ŽR–Εvi”çj: 19th Annual Meeting of the Japanese Society for Investigative Dermatology i94.09.01j, ‘åã, Program, p.70, 1994.

2602. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«“—áŒó‘Ûáóâáf]. _èrˆêC’؈äL”üC‹´–{–¾•FCŸ‰ªŒ›¶i”çjC—é–Ø—§riŽ¨•@j: ‘æ45‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”‘‰ï i94.10.29`30j, ‹ž“s.

2603. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒRƒŒƒXƒeƒ[ƒ‹ÇðÇ‚Ì1—á. ‰H‹àdŠìC‹´–{–¾•FCóˆär–íC¼ŽR–Εvi”çj: ‘æ46‰ñ“ú–{”畆‰ÈŠw‰ï¼•”Žx•”‘‰ï i94.11.12j, ‰F•”.

2604. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Angiolymphoid hyperplasia with eosinophilia. ’؈äL”üC‹´–{–¾•FC•ÄŒ³N‘ C‘‘òŠ²’jCŸ‰ªŒ›¶i”çjC”\”ü®C“c’†Œ[Ži‚ai®ŠOj: ‘æ46‰ñ“ú–{”畆‰ÈŠw‰ï¼•”Žx•”‘‰ï i94.11.12j, ‰F•”.

2605. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –ò]Š³ŽÒ”ç]•”Z‚s×–E‚̉ðÍ. ŽRŒû“TŽqC“¡‘º‹¿’jC‹´–{–¾•FC‘‘òŠ²’jC¼ŽR–Εvi”çj: ‘æ24‰ñ“ú–{–ƉuŠw‰ï i94.11.29`12.01j, ‹ž“s, ŠwpW‰ï‹L˜^, (24): 372, 1994.

2606. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒAƒgƒs[«”畆‰ŠŠ³ŽÒ‚Ì”ç]•”‚É‚¨‚¯‚éCD4+ T×–EƒTƒuƒZƒbƒg(Th1, Th2)‚Ì•Ï“®(‡U)|…“—RŒ´‚É‚æ‚éSwitching|. ŽR—œ—˜C“¡‘º‹¿’jC“¡“c—T‰îC‘‘òŠ²’jC¼ŽR–Εvi”çj: ‘æ24‰ñ“ú–{–ƉuŠw‰ï i94.11.29`12.01j, ‹ž“s, ŠwpW‰ï‹L˜^, (24): 373, 1994.

2607. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚ç‚¢‹ÛŠ´õƒ}ƒEƒX‚É”­Œ»‚·‚éƒTƒCƒgƒJƒCƒ“mRNA‚ÌŒŸ“¢. äo‹Vƒ„ƒXŽqC–ìŠÔŒû”ŽŽqC¼‰ª³“Ti‘—§‘½–€Œ¤jC“¡‘º‹¿’ji”çjC‰ª‘ºtŽ÷i•ºŒÉˆã‘åj: ‘æ24‰ñ“ú–{–ƉuŠw‰ï i94.11.29`12.01j, ‹ž“s, ŠwpW‰ï‹L˜^, (24): 554, 1994.

2608. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒhŽ‡”Á‚Ì’·Šú—\Œã. óˆär–íC‹´–{–¾•FC‘‘òŠ²’jC¼ŽR–Εvi”çj: ‘æ18‰ñ”畆–¬ŠÇ§˜b‰ï i95.01.26j, “Œ‹ž.

2609. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j glandular involvement‚ð”F‚ß‚½ã‰º‚Ìsquamous cell carcinoma. “yˆäŠó•¶Cóˆär–íC•ÄŒ³N‘ i”çj: ‘æ58‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï i95.02.18j, ‰¡•l.

2610. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —Õ°“I¥‘gDŠw“I‚É‘½”­«ŒÅ’è]‚ð’悵‚½2—á. óˆär–íCŽíˆä—Ç“ñCŠÖª“ÖŽqi”çj: ‘æ58‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”‘‰ï i95.02.19j, ‰¡•l.

2611. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰Æ‘°«”畆ƒAƒ~ƒƒCƒh[ƒVƒX. Vˆä’Bi”çjC‰Í–ìŒoŽqC‰¹ŽR˜aéC‰Á“¡ˆê˜YCŒüˆäGŽ÷i‰¡•l˜JÐj: ‘æ220‰ñ“ú–{”畆‰ÈŠw‰ïŽ­Ž™“‡’n•û‰ï i95.03.12j, •Ÿ‰ª.

2612. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚ç‚¢‹Û‘‘åŠú‚ÌŠ´õ‘«‘gD’†‚É”­Œ»‚·‚éƒTƒCƒgƒJƒCƒ“ˆâ“`Žq. äo‹Vƒ„ƒXŽqC–ìŠÔŒû”ŽŽqi‘—§‘½–€Œ¤jC“¡‘º‹¿’ji”çjC¼‰ª³“TC‰ª‘ºtŽ÷i•ºŒÉˆã‘åj: ‘æ68‰ñ“ú–{׋ۊw‰ï‘‰ï i95.03.25`27j, ‹ž“s, “ú–{׋ۊwŽGŽ, 50(1): 332, 1995.

2613. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ€ƒ`ƒ“’¾’…‚𔺂¤‰©FŽî«•a•Ï‚ð”F‚ß‚½SLE. óˆäŽõŽqCVˆätŽ}C‹´–{–¾•FC•ÄŒ³N‘ C‰q“¡ŒõC¼ŽR–Εvi”çj: ‘æ45‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”‘‰ïŠwp‘å‰ï i94.10.29j, ‹ž“s.

2614. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j ƒGƒCƒY‚Æ‚Í. ‰q“¡Œõi”çj: _“Þ쌧”畆‰Èˆã‰ï i94.07.10j, ‰¡•l.

2615. mŠw‰ïi’n•ûjn iƒ[ƒNƒVƒ‡ƒbƒvj “«”畆Ž¾Š³‚ÌdÇ“x‚ÆŽ¡—Â̑I‘ð|ƒGƒŠƒeƒ}ƒg[ƒfƒX|. ‰q“¡Œõi”çj: ‘æ45‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”‘‰ï i94.10.29j, ‹ž“s.

2616. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘O—§‘BŠà‚𔺂Á‚½g”çÇ. ‰H‹àdŠìC“¡‰ª²C‹´–{–¾•FCóˆär–íi”çjC‘åì–ƒŽqCŒÃ”¨½”Vi”åj: ‘æ702‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.06.18j, “¡‘ò.

2617. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Žá”N”­Ç‚ÌPSS‚Ì1—á. Œü–ì“NC‰H‹àdŠìC’ËŒ´“NÆC‹´–{–¾•Fi”çj: ‘æ702‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.06.18j, “¡‘ò.

2618. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¶–[”S‰tŽîpŒã‚ÉoŒ»‚µ‚½ŽèŽw––’[‚Ì—L’É«”“®•a•Ï. ‹àŽq‘C‘‘òŠ²’ji”çjCª–{EiŠOjC‘b—DŽqi‘Š–ÍŒ´‹¦“¯j: “ú–{”畆‰ÈŠw‰ï‘æ704‰ñ“Œ‹ž’n•û‰ï i94.09.17j, ‰¡•l.

2619. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’܉º‚ɶ‚¶‚½atypical blue nevns. Vˆä’BC•ÄŒ³N‘ C¼ŽR–Εvi”çj: ‘æ704‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.09.17j, ‰¡•l.

2620. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j L”͈͂ɔç]‚ª¶‚¶‚½DŽ_‹…«”^áv«–Ñ”X‰Š(‘¾“¡•a). VŽRŽj˜NC’؈äL”üC‹´–{–¾•FC“¡‘º‹¿’jCŸ‰ªŒ›¶i”çj: ‘æ704‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.09.17j, ‰¡•l.

2621. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j –Ø–Úó‚ÉŠg‘å‚·‚ég”Á‚Ì1—á. ´–ì‚Ý‚«C’؈äL”üC’ËŒ´“NÆC‹´–{–¾•FCŸ‰ªŒ›¶i”çj: ‘æ705‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.10.15j, ‰¡•l.

2622. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “]ˆÚ«”]ŽîᇂŎ€–S‚µ‚½‘½”­«ƒ{[ƒGƒ“•a’·ŠúŠÏŽ@—á. A¼“TŽqC‘‘òŠ²’ji”çjC‚–ìN—Yi•a—j: ‘æ705‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.10.15j, ‰¡•l.

2623. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Chilblain lupus—l—Õ°‚ð’悵‚½lichen planus. ’؈äL”üC•½¼³_C‹´–{–¾•FCŸ‰ªŒ›¶i”çj: ‘æ705‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.10.15j, ‰¡•l.

2624. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j …ávŒ`¬‚𔺂¢ˆÝŠà‚̇•¹‚ð‚Ý‚½”畆‹Ø‰Š‚Ì1—á. Œ´®“¹C’؈äL”üCVˆä’BCóˆär–íC•ÄŒ³N‘ i”çjC–Ø‘º“OiŠOj: ‘æ45‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”‘‰ïŠwp‘å‰ï i94.10.30j, ‹ž“s.

2625. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Pachyonichia congenita‚Ì1—á. ‹ÀêLìCŸ‰ªŒ›¶i”çj: ‘æ706‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.11.18j, _“Þì.

2626. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”畆B cell lymphoma‚Ì1—á. “¡“c—T‰îC’ËŒ´“NÆC‰H‹àdŠìC‹´–{–¾•FC‘‘òŠ²’ji”çjC‰–’J–Îi“àj: ‘æ706‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.11.19j, ìè.

2627. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j DLE‚Ì’E–Ñ‚Ì1—á. Vˆä’BCŸ‰ªŒ›¶i”çj: ‘æ706‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.11.19j, “¡‘ò.

2628. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j …áv«—Þ“VáváŒH Vˆä’BC‹àŽq‘C’؈äL”üC‹´–{–¾•Fi”çj: ‘æ706‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.11.19j, “¡‘ò.

2629. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒ}ƒEƒXŒŒŠÇ“÷Žî×–EŠ”(ISOB-1)‚ÌLAKŠ´Žó«‚ɂ‚¢‚Ä. ’Ø슲•FC‘‘òŠ²’ji”çjC•l“c—SŽqi¶‰»ŒnjC“¡‘º‹¿’jC¼ŽR–Εvi”çjCŽ›“c‰pŽii—Šw•”j: ‘æ707‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.12.17j, “Œ‹ž.

2630. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒŠƒ“ƒpŠÇ“÷Žî×–EŠ”(MO: LAS)‚ÌŽ÷—§‚Æin vitro LAKŠQ«‚ÌŒŸ“¢. ‘‘òŠ²’ji”çjC•l“c—SŽqi¶‰»ŒnjCrìLŽqC—§“c”ü“ÞŽqC“¡‘º‹¿’jC¼ŽR–Εvi”çj: ‘æ707‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.12.17j, “Œ‹ž.

2631. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒqƒg–¬ŠÇ“÷Žî×–EŠ”‚ɑ΂·‚éRŠàÜ(CYVADIC)Š´Žó«‚ÌŒŸ“¢. ‰H‹àdŠìC‘‘òŠ²’jC¼ŽR–Εvi”çjC`GŽ÷iŽY•wj: ‘æ707‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.12.17j, “Œ‹ž.

2632. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ˆŸ‰”Œ‡–RÇ‚Ì1—á. _èrˆêC“¡“c—T‰îC‹´–{–¾•FCóˆär–íi”çj: ‘æ108‰ñ“ú–{”畆‰ÈŠw‰ïŽ­Ž™“‡’n•û‰ï i95.01.15j, Ž­Ž™“‡.

2633. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Bowen•a‚ɑ΂·‚é’´‰¹”gƒƒXŽ¡—Â̎ÀŒ±“IŽŽ‚Ý. ‹ÀêLìi”çjC‘å’JŒª‘¾CˆÉ“¡–FŒ›iº˜a‘åj: ‘æ108‰ñ“ú–{”畆‰ÈŠw‰ïŽ­Ž™“‡’n•û‰ï i95.01.15j, Ž­Ž™“‡.

2634. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”畆õk‚æ‚è“ûŠà‚Æf’f‚µ‚½1—á. VŽRŽj˜NC“V–ì—²•¶C“¡“c—T‰îC‹´–{–¾•FCóˆär–íi”çj: ‘æ108‰ñ“ú–{”畆‰ÈŠw‰ïŽ­Ž™“‡’n•û‰ï i95.01.15j, Ž­Ž™“‡.

2635. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰Æ‘°«‚ɶ‚¶‚½Ž‰˜R«Šp‰»Ç‚ƃ{[ƒGƒ“•a‘½”­—á. ‹´–{–¾•FC‹{“c‘ŽqC’ËŒ´“NÆi”çj: ‘æ708‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i95.01.21j, “¡‘ò.

2636. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’˜–¾‚ÈDŽ_‹…Z‚𔺂Á‚½–ѕ遲€ƒ`ƒ“’¾’…Ç‚Ì1—á. Œ´®“¹CŸ‰ªŒ›¶i”çj: ‘æ708‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i95.01.21j, “¡‘ò.

2637. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒXƒ‹ƒtƒ@ƒ‚ƒmƒƒgƒLƒVƒ“(ƒ_ƒCƒƒgƒ“R)‚É‚æ‚éŒÅ’è–ò]‚Ì1—á. Œ´®“¹CA¼“TŽqC’؈äL”üC‹´–{–¾•FC“¡‘º‹¿’jCóˆär–íi”çj: ‘æ708‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i95.01.21j, “¡‘ò.

2638. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —Z‡«×–Ôó“û“ªŽîÇ‚Ì3—á. ’ËŒ´“NÆCóˆär–íCŸ‰ªŒ›¶i”çj: ‘æ708‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i95.01.21j, “¡‘ò.

2639. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¬Ž™”畆‹Ø‰Š‚Ì1—á. “¡“c—T‰îC“V–ì—²•¶C’ËŒ´“NÆCóˆär–íC‰q“¡Œõi”çj: ‘æ292‰ñ“ú–{”畆‰ÈŠw‰ï•Ÿ‰ª’n•û‰ï i95.03.12j, •Ÿ‰ª.

2640. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰~Œ`’E–ÑÇŠ³ŽÒ•a•Ï•””畆‚ÌSCID nude mouse‚ւ̈ÚA. ’؈äL”üCŸ‰ªŒ›¶C‹g‘ò³_Cò–¾Ž…C“¡‘º‹¿’jC¼ŽR–Εvi”çj: ‘æ709‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i95.03.18j, “Œ‹ž.

2641. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”|—{ƒqƒgƒƒ‰ƒm[ƒ}×–E‚É‚¨‚¯‚éribozyme(catalytic RNA)‚ÌRŽîᇌø‰Ê‚ɂ‚¢‚Ä. ‘¾“cK‘¥i”çjCK. J. ScanloniCity of Hopej: ‘æ709‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i95.03.18j, “Œ‹ž.

2642. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Šñ¶’ŽŠ´õÇ‚ÌŒƒŒ¸‚ƃAƒgƒs[«”畆‰Š(A.D.)Š³ŽÒ‚Ì’˜‘‚Ì‘ŠŠÖ«‚ɂ‚¢‚Ä. “¡‰ª²CŒü–ì“NC‚{”ŽC‰H‹àdŠìi”çjC•l“c—SŽqi¶‰»ŒnjC¼ŽR–Εvi”çjC’†‘ºŒ’iŠñjC‘¼: ‘æ709‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i95.03.18j, “Œ‹ž.

2643. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j •²áŽ‚æ‚趂¶‚½—Lž™×–EŠà. “V–ì—²•¶Cì–¼½ŽiC’¾‘—Yi”çjCA‘—˜Œöi¹˜H‰Áj: ‘æ45‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”‘‰ïŠwp‘å‰ï i94.10.30j, ‹ž“s.

2644. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘å‘Ú‚ÌŒŒŠÇ“÷Žî|—Õ°“I¥‘gDŠw“If’f‚É‹ê—¶‚µ‚½1—á|. Œ´®“¹CA¼“TŽqC“¡“c—T‰îC²“¡’¼ÆC‘‘òŠ²’ji”çjCVˆätŽ}i‘å˜aŽs—§j: ‘æ18‰ñ”畆–¬ŠÇ§˜b‰ï i95.01.26j, “Œ‹ž.

2645. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒg–¬ŠÇ“÷Žî×–EŠ”‚ɑ΂·‚éRŠàÜ(CYVADIC)Š´Žó«‚ÌŒŸ“¢. ‰H‹àdŠìC‘‘òŠ²’jC¼ŽR–Εvi”çjC`GŽ÷iŽY•wj: ‘æ18‰ñ”畆–¬ŠÇ§˜b‰ï i95.01.26j, “Œ‹ž.

2646. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ƒ}ƒEƒXŒŒŠÇ“÷Žîƒ‚ƒfƒ‹. ‘‘òŠ²’jC’Ø슲•Fi”çjC•l“c—SŽqi¶‰»ŒnjC“¡‘º‹¿’jC¼ŽR–Εvi”çjCŽ›“c‰pŽii—Šw•”j: ‘æ18‰ñ”畆–¬ŠÇ§˜b‰ï i95.01.26j, “Œ‹ž.

2647. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j SLEŠ³ŽÒ‚É”F‚ß‚½‰©F”畆‹Ç–Ê. Vˆä’BCóˆäŽõŽqCŠÖª“ÖŽqC‰H‹àdŠìC‰q“¡ŒõCVˆätŽ}i”çj: ‘æ9‰ñäPŒ´•aŒ¤‹†‰ï i95.01.27j, “Œ‹ž.

2648. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™ƒAƒiƒtƒBƒ‰ƒNƒgƒCƒh«Ž‡”Á•a‚Ì’·Šú—\Œã. óˆär–íC‹´–{–¾•FC‘‘òŠ²’jC¼ŽR–Εvi”çj: Œú¶È“«ŒŒŠÇ‰Š’²¸Œ¤‹†”Ç•½¬6”N“x‘æ2‰ñ‘‰ï i95.01.27j, “Œ‹ž.

2649. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ׋۬•ª‚ªŠÖ—^‚µ‚½D’†‹…‚É‚æ‚é”÷¬ŒŒŠÇ“à”ç×–EŠQ. ‘‘òŠ²’jC‹´–{–¾•FC“¡‘º‹¿’ji”çjC•l“c—SŽqi¶‰»ŒnjC¼ŽR–Εvi”çj: Œú¶È“«ŒŒŠÇ‰Š’²¸Œ¤‹†”Ç•½¬6”N“x‘æ2‰ñ‘‰ï i95.01.27j, “Œ‹ž.

2650. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‹­”çÇ‚ÌADCC‚É‚æ‚é”÷¬ŒŒŠÇ“à”ç×–EŠQ‚ɂ‚¢‚Ä. ‘‘òŠ²’ji”çjC•l“c—SŽqi¶‰»ŒnjC’ËŒ´“NÆC“¡‘º‹¿’jC‰q“¡ŒõC¼ŽR–Εvi”çj: Œú¶È‹­”çÇ’²¸Œ¤‹†”Ç•½¬6”N“x‘æ2‰ñ”ljï‹c i95.02.08j, “Œ‹ž.

2651. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ^‹ÛŠ´õ‚É‚¨‚¯‚éDTH(Delayed type hypersensitivity)‚Ì–ðŠ„. “¡‘º‹¿’ji”çj: ‘æ37‰ñ_“Þìˆã^‹Û’k˜b‰ï i95.01.28j, ‰¡•l.

2652. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j • •”‚ɶ‚¶‚½”’á‹Û«“÷‰èŽî‚Ì1—á. ‰H‹àdŠìCì–ìMŽqC“cÀO”VC¼ŽR–Εvi”çj: ‘æ37‰ñ_“Þìˆã^‹Û’k˜b‰ï i95.01.28j, ‰¡•l.


<<22 ”å”AŠí‰ÈŠw>>

2653. mŒ´’˜n Detection of extracapsular extension prior radical prostatectomy. ‘å–x—C‰oìWCŽÂŒ´Žli”åjCWheeler, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: Br. J. Urol., 74: 72`79, 1994.

2654. mŒ´’˜n Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma. “à“c–Lºi”åjC˜a“c’m‰vi—Õ•a—jC‰¤tŠìC‰oìWi”åjC‘å’J‰pŽ÷i—Õ•a—jC¬ŽÄŒ’i”åj: Cancer Res., 54: 3682`3685, 1994.

2655. mŒ´’˜n The new TNM classification of prostate cancer: Pathologic features of cancers detected by PSA alone(Tlc). ‘å–x—i”åjCWheeler, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: Cancer, 73: 104`114, 1994.

2656. mŒ´’˜n Neodymium: Yag laser ablatin of the prostate gland-acute perioperative morbidity and short-term outcome. ‰oìWC“à“c–LºCìã’B‰›C‰¡ŽR‰p“ñC¬ŽÄŒ’i”åj: Int. J. Urol., 1(3): 246`251, 1994.

2657. mŒ´’˜n Immuroreactive parathyroide hormone-related Is present in human seminal plasma and Is of prostate origin. Šâ‘º³Žki”åjCAbrahamsson, P.A.CSchon, S.CCockett, A.T.K.CDeftos, L.J.iƒƒ`ƒFƒXƒ^[ˆã‰È‘åj: J. Andol., 15(5): 410`414, 1994.

2658. mŒ´’˜n Androgen receptor immunostaining and its tissue distribution in formalin-fixed, paraffin-embedded sections after microwave treatment. Šâ‘º³Žki”åjCAbrahamsson, P.A.CBenning, C.M.CCockett, A.T.K.Cdi Sant'Agnese, P.A.iƒƒ`ƒFƒXƒ^[‘åj: J. Histochem. Cytochem., 42(6): 783`788, 1994.

2659. mŒ´’˜n Pathologic features and prognosis of prostate cancers detectable with current diagnostic tests. ‘å–x—i”åjCWheeler, T.M.CDunn, J.K.CStamey, T.A.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: J. Urol., 152: 1714`1720, 1994.

2660. mŒ´’˜n Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? ‘å–x—i”åjCGoad, J.R.CWheeler, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: J. Urol., 152: 1843`1849, 1994.

2661. mŒ´’˜n p53 mutations and prognosis in bladder tumors. “à“c–Lºi”åjC˜a“c’m‰vi—Õ•a—jCΓc—T‘¥CWang, C.C‰oìWC‰¡ŽR‰p“ñi”åjC‹T’J“Oi•a—jC¬ŽÄŒ’i”åj: J. Urol., 153: 1097`1104, 1994.

2662. mŒ´’˜n Indication for oral 1,25-dihydroxyvitamin D3 pulse therapy in patients with renal osteodystrophy at hemodialysis induction. •º“¡“§CŒF–ì˜a—YCX—²Žii”åjC‰–GC‹g–ì•Ûsi’¹Žæ‘åjCŽðˆä‹Ši”åj: Nephron, 67: 379`380, 1994.

2663. mŒ´’˜n Measurement of calcaneus bone mineral density using the osteoanalyzer model SPXHA 110 in patients receiving hemodialysis. •º“¡“§i”åjC’†‘º’B•Fi¼]Žs–¯•a‰@jC‹{쪒ji’¹Žæ‘åj: Nephron, 68: 153`154, 1994.

2664. mŒ´’˜n Diagnostic revolution of microhematuria by real-time confocal scanning laser microscope [hyodo-lino-Miyagawa (HIM) Method]. •º“¡“§i”åjC‹{쪒jC‰Ô–{éºC‹g–ì•ÛsC‰–Gi’¹Žæ‘åjC‰œ’JW–¾C‘åoF”ŽC”Ñ–ìWŒ[: Nephron, 68: 401`402, 1994.

2665. mŒ´’˜n Alterations of microsatellite repeats in bladder cancer. “à“c–Lºi”åjC˜a“c’m‰vi—Õ•a—jCΓc—T‘¥C‰oìWC‰¡ŽR‰p“ñi”åjC‹T’J“Oi•a—jC‘å’J‰pŽ÷i—Õ•a—jC¬ŽÄŒ’i”åj: Oncology Reports, 1: 967`970, 1994.

2666. mŒ´’˜n Microsatellite instability in prostate cancer. “à“c–LºC‰oìWi”åj: Proceedings of 5th Prostate Cancer Workshop, p.36`39, 1994.

2667. mŒ´’˜n Effect of non-invasive vibration on mass transfer rate in peritoneal dialysis. Yamashita, A.CTojo, K.i‹ã‘åjCŒF–ì˜a—YCŽðˆä‹Ši”åjCMoncrief, J.W.CPoporich, R.P.iAcorn Research Laboratoryj: Taipei-Kyusyu Joint Symposium on Chemical Engineering, p.71`76, 1994.

2668. mŒ´’˜n Plasma endothelin level following kidney transplantation. ŒF–ì˜a—YC‘ˆä‘¥ºC‘v¬_C^‰ºß•vC‰““¡’‰—Yi”åj: Transplant. Proc., 26(4): 2114`2116, 1994.

2669. mŒ´’˜n Serum erythropoientin levels after renal transplantation. ‘v¬_CŒF–ì˜a—YC‰F“s‹{‘ñŽ¡C^‰ºß•vC‰““¡’‰—Yi”åj: Transplant. Proc., 26(4): 2154`2156, 1994.

2670. mŒ´’˜n Roles of solution impermeants during cold kidney storage. ŒF–ì˜a—YC‰¤tŠìi”åjC^è‹`•FiŽÀ“®ŒnjC‰““¡’‰—Yi”åj: Transplant. Proc., 26(4): 2410`2412, 1994.

2671. mŒ´’˜n Effects of a new solution for cold kidney preservation studied on isolated perfused rat kidney. ^è‹`•FiŽÀ“®ŒnjCŒF–ì˜a—YC‰““¡’‰—YC¬ŽÄŒ’i”åj: Transplant. Proc., 26: 2045`2046, 1994.

2672. mŒ´’˜n Roles of endothelin in FK506-induced renal hypoperfusion in rats. ŒF–ì˜a—Yi”åjCChen, J.CHe, M.C‰““¡’‰—Yi”åjC^è‹`•FiŽÀ“®Œnj: Transplant. Proc., 27: 550`553, 1995.

2673. mŒ´’˜n Nodules resembling nodular hyperplasia in the peripheral zone of the prostate gland. ‘å–x—C‰oìWi”åjCWheeler, T.M.iƒxƒCƒ‰[ˆã‰È‘åj: Urologic Pathology, 2: 223`233, 1994.

2674. mŒ´’˜n Heterogeneity of prostate cancer in radical prostatectomy specimens. ‘ŠŒ´³Oi”åjCWheeler, T.M.iƒxƒCƒ‰[ˆã‰È‘åjC‘å–x—i”åjCScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: Urology, 43(1): 60`67, 1994.

2675. mŒ´’˜n Parathyroid hormone-related protein is expressed by prostatic neuroendocrine cells. Šâ‘º³Žki”åjCdi Sant'Agness, P.A.CWu, G.CCockett, A.T.K.CAbrahamsson, P.A.CDeftos, L.J.iƒƒ`ƒFƒXƒ^[‘åj: Urology, 43(5): 667`674, 1994.

2676. mŒ´’˜n Parathyroid hormone-related protein: A potential autocrine growth regulator in human prostate cancer cell lines. Šâ‘º³Žki”åjCWu, G.CAbrahamsson, P.A.CCockett, A.T.K.CFoss, K.A.CDeftos, L.J.: Urology, 43(5): 675`679, 1994.

2677. mŒ´’˜n Overexpression of human epidermal growth factor receptor and c-erbB-2 by neuroendocrine cells in normal prostatic tissue. Šâ‘º³Žki”åjCBenning, C.M.Cdi Sant'Agnese, P.A.CCockett, A.T.K.CWu, G.CGershagen, S.iƒƒ`ƒFƒXƒ^[‘åj: Urology, 43(6): 838`843, 1994.

2678. mŒ´’˜n V‚µ‚¢t•Û‘¶‰t‚Ì‘g¬‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†. ^è‹`•FiŽÀ“®ŒnjCŒF–ì˜a—YC‰““¡’‰—YC¬ŽÄŒ’i”åj: ¡“ú‚̈ÚA, 7(2): 171`173, 1994.

2679. mŒ´’˜n f’f‚É“ïa‚µ‚½ã•””A˜HŽîᇂÌ2—á. Žu‘º“NC‰Á“¡–«C•ìƒi”åj: é‹ÊŒ§ˆãŠw‰ïŽGŽ, 28(4): 448`451, 1994.

2680. mŒ´’˜n Extracorporeal pulsatile peritoneal dialysis (EPPD) ‚ÌŽÀŒ±“IŒ¤‹†. ŒF–ì˜a—Yi”åjCŽR‰º–¾‘×i‹ãH‘åjCŽðˆä‹Ši”åj: lH‘ŸŠí, 23(2): 367`370, 1994.

2681. mŒ´’˜n “ÁW t”A˜HŽ¾Š³‚Ì‹~‹}ˆã—Ã|”A˜HŒ‹Î|. ^‰ºß•vi”åj: t‚Æ“§Í, 36(5): 916`919, 1994.

2682. mŒ´’˜n tˆÚAŒã‚ÌŒŒ´ƒGƒŠƒXƒƒ|ƒGƒ`ƒ“’l‚Ì•Ï“®‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‘v¬_CŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—YC¬ŽÄŒ’i”åj: tˆÚA¥ŒŒŠÇŠO‰È, 6(1): 42`45, 1994.

2683. mŒ´’˜n “àƒVƒƒƒ“ƒg컢“ï—á‚É‚¨‚¯‚é˜rŽÚ‘¤Ã–¬‚ð—p‚¢‚½blood access‚ÌŒŸ“¢. ‰F“s‹{‘ñŽ¡CŒF–ì˜a—YC‰““¡’‰—YC‚–Ø—Ti”åjCç—t“N’ji‘Pm‰ï‰¡•l‘æˆê•a‰@j: tˆÚA¥ŒŒŠÇŠO‰È, 6(1): 47`50, 1994.

2684. mŒ´’˜n ¸õ֬ᎂɑ΂·‚épŽ®‚ÌŒŸ“¢|ŠJ• Žèp‚Æ• o‹¾‰ºŽèp‚Æ‚Ì”äŠr|. ‹PºC‰““¡’‰—YC‘º–{«rCˆÉ“¡Œ[ˆêC“à“c–LºC‰¡ŽR‰p“ñC^‰ºß•vC¬ŽÄŒ’i”åj: ¼“ú–{”å”AŠí‰È, 56(11): 1319`1323, 1994.

2685. mŒ´’˜n t‚Ì’Pƒ•\–Ê—â‹p•Û‘¶‚É‚¨‚¯‚é•Û‘¶‰t‚ÌZ“§ˆ³•Ï‰»‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†. ^è‹`•FiŽÀ“®ŒnjCŒF–ì˜a—YC‰““¡’‰—Yi”åjC‰Á‰ê’J”£i–òÜjCŒK”ö’èmi•a—jC¬ŽÄŒ’i”åj: ’ቷˆãŠw, 20(3): 73`79, 1994.

2686. mŒ´’˜n • •”‘ÌŠOU“®‚É‚æ‚郉ƒbƒg• –Œ“§‰ß”\‹y‚уŠƒ“ƒp‹zŽû‚ւ̉e‹¿. ‰F“s‹{‘ñŽ¡CŒF–ì˜a—YCŽðˆä‹Ši”åjCŽR‰º–¾‘×i‹ãH‘åj: “ú–{t‘ŸŠw‰ïŽ, 37(1): 24`28, 1995.

2687. mŒ´’˜n Automated urinary sediment analyzer(‘SŽ©“®”A’¾ŸÔ‘ª’è‘•’u)‚ð—p‚¢‚½tŽ…‹…‘Ì—R—ˆ‚Æ”ñtŽ…‹…‘Ì—R—ˆ”A’†ÔŒŒ‹…‚ÌŠÓ•Ê–@‚Ìì¬. •º“¡“§CŒF–ì˜a—YC–F‰ê½CŽðˆä‹Ši”åj: “ú–{t‘ŸŠw‰ïŽ, 37(1): 35`43, 1995.

2688. mŒ´’˜n ƒ‰ƒbƒg• –Œ“§Í‚É‚¨‚¯‚éŠeŽíŒŒŠÇŠg’£Ü‚Ì• –Œ“§‰ß”\‚¨‚æ‚Ñ• o“àƒŠƒ“ƒp‹zŽû‚É‹y‚Ú‚·‰e‹¿. ŒàŠ²ƒCŒF–ì˜a—YCŽðˆä‹Ši”åj: “ú–{“§Íˆã‰ïŽGŽ, 27(11): 1373`1378, 1994.

2689. mŒ´’˜n ‘O—§‘BŠàŒŸo‚É‚¨‚¯‚éŠeŽíŽîᇃ}[ƒJ[‚Æ‚»‚Ì‘O—§‘B‘ÌÏ”ä‚Ì—L—p«‚ÌŒŸ“¢. ‰oìWC‘å–x—C‘v¬_Cìã’B‰›C‰F“c씎•¶C“à“c–LºC‰¡ŽR‰p“ñC¬ŽÄŒ’i”åj: “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 85(10): 1543`1551, 1994.

2690. mŒ´’˜n tˆÚAŒã‘Šú‚É‚¨‚¯‚錌’†ƒGƒ“ƒhƒZƒŠƒ““®‘Ô. ‘ˆä‘¥ºCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åj: “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 85(11): 1622`1628, 1994.

2691. mŒ´’˜n äNã÷Šà‚É‚¨‚¯‚éŠeŽí”A˜H•ÏXp‚ÆQCL‚ÉŠÖ‚·‚錟“¢. ‹PºC‰¡ŽR‰p“ñC“à“c–LºCŒüˆäLÆC‰F“s‹{‘ñŽ¡C‘«—§Œ÷ˆêC“¡–ì’WlC¬ŽÄŒ’i”åj: “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 85(4): 616`625, 1994.

2692. mŒ´’˜n ‘O—§‘BŠà•aŠúf’f‚É‚¨‚¯‚é’¼’°f‚¨‚æ‚ÑŠeŽí‰æ‘œf’f–@‚Ì—L—p«‚ÆŒÀŠE. ‰oìWCìã’B‰›i”åjC¼Šª”Ži•újCŒK”ö’èmi•a—jC“à“c–LºC‰¡ŽR‰p“ñC^‰ºß•vC¬ŽÄŒ’i”åj: “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 85(5): 792`801, 1994.

2693. mŒ´’˜n ƒ‰ƒbƒg’P—£ŠÁ—¬t‚ð—p‚¢‚½t—â‹p•Û‘¶‰t‚É‚¨‚¯‚éZ“§ˆ³•¨Ž¿‚ÌŒŸ“¢. ŒF–ì˜a—YC‰¤ˆÌ‰ØC‰““¡’‰—Yi”åj: “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 85(6): 925`931, 1994.

2694. mŒ´’˜n “ÁW ‘O—§‘B”ì‘åÇ‚É‚¨‚¯‚郌[ƒU[Ž¡—Ã, ‘O—§‘B”ì‘åǂɑ΂·‚éVisual laser ablation of the prostate(VLAP)—Ö@. “à“c–LºC¬ŽÄŒ’i”åj: ”å”AŠíŠO‰È, 7(5): 453`457, 1994.

2695. mŒ´’˜n ŽY•wl‰È“I”å”AŠíŽ¾Š³‚ÌŽæ‚舵‚¢; äNã÷áŽ. ‰¡ŽR‰p“ñC“à“c–LºC΋´Wi”åj: ”å”AŠíŠO‰È, 7(8): 763`768, 1994.

2696. mŒ´’˜n Œ£tˆÚA‚É‚¨‚¯‚é–Ɖu—}§—Ö@. ‰““¡’‰—YCŒF–ì˜a—Yi”åj: ”å”AŠíŠO‰È, 7: 117`124, 1994.

2697. mŒ´’˜n ‘O—§‘B‚ɑ΂·‚éÅ“_Ž®‚ƒGƒlƒ‹ƒM[’´‰¹”g—Ö@‚ÌŠî‘b“I¥—Õ°“IŒŸ“¢. ‘«—§Œ÷ˆêC‹PºC“à“c–Lºi”åj: –k—¢ˆãŠw, 24(4): 277`283, 1994.

2698. mŒ´’˜n ”A˜H«ŠíŠà(äNã÷Šà, ‘O—§‘BŠà, t×–EŠà, áΊێîá‡)‚ɂ‚¢‚Ä. “à“c–Lºi”åj: –k—¢‘åŠw•a‰@‚É‚¨‚¯‚éŠàf—Ã, p.28`30, 1994.

2699. mŒ´’˜n ‘O—§‘B”ì‘åǂɑ΂·‚銿•û–ò‚Ì“K—p. ΋´Wi”åj: –ò‹Ç, 45(6): 41`45, 1994.

2700. mŒ´’˜n ƒŠƒAƒ‹ƒ^ƒCƒ€ƒŒ[ƒU[Œ°”÷‹¾‚É‚æ‚錌”A‰æ‘œ‚Ì‘N–¾“x. •º“¡“§i”åjC‹{쪒jC”Ñ–ìWŒ[i’¹Žæ‘åj: —Õ°”å”AŠí‰È, 48(6): 399`402, 1994.

2701. mŒ¤‹†•ñn “§Í‚ƃGƒ“ƒhƒgƒLƒVƒ“. ‰¡“c^“ñCŒF–ì˜a—YCŽðˆä‹Ši”åj: Infection Control, 4(1): 16`20, 1995.

2702. mŒ¤‹†•ñi•¶•”Èjn ƒŠƒAƒ‹ƒ^ƒCƒ€‹¤Å“_Œ^ƒŒ[ƒU[Œ°”÷‹¾‚É‚æ‚錌”A‚ÌŠÓ•Ê. •º“¡“§i”åj: •¶•”ȉȊwŒ¤‹†”‹†•ñ‘, 1994.

2703. mŒ¤‹†•ñiŒú¶Èjn ŠwZŒŸ”A‚É‚æ‚é’·Šú—\Œã’ÇÕ‚ÌŒ»ó‚Æ–â‘è“_‚ÉŠÖ‚·‚錤‹†. Žðˆä‹Ši”åjC‘qŽR‰pºi‘—§—×{Šç—t“Œ•a‰@jC‚‹´¹—¢iɪŒ§—§‚±‚Ç‚à•a‰@jC•x‘òCˆêi‘—§—×{ŠVŠƒ•a‰@jC“茴—Di“ú‘åjCŽO‘ºM‰piŒÕ‚Ì–å •a‰@j: •½¬5”N“xŒú¶‰ÈŠwŒ¤‹†”ï•â•‹àt•s‘Sˆã—ÃŒ¤‹†Ž–‹ÆŒ¤‹†•ñ‘, p.170`171, 1994.

2704. mŒ¤‹†•ñiŒú¶Èjn ¬Ž™ŠúIgAtÇ‚É‚¨‚¯‚éƒLƒƒƒŠ[ƒI[ƒo[‚ÌŒŸ“¢. Žðˆä‹ŠC‰º“c‰vOi”åjC”Ñ‚Šì‹v—YC‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èiŽ™jCŽO‘ºM‰piŒÕ‚Ì–å•a‰@j: •½¬5”N“xŒú¶‰ÈŠwŒ¤‹†”ï•â•‹àt•s‘Sˆã—ÃŒ¤‹†Ž–‹ÆŒ¤‹†•ñ‘, p.172`175, 1994.

2705. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn _“Þ쌧‚É‚¨‚¯‚éŠwZ¥tŒŸfƒVƒXƒeƒ€‚Ì‹OÕ. Žðˆä‹Ši”åj: _“Þ쌧ŠwZ¥tŽ¾Š³ŠÇ—Œ¤‹†‰ï‹L”OŽu20”N‚Ì‚ ‚ä‚Ýv, p.25`33, 1994.

2706. mÇ—á•ñn Nodular hyperplasia in the peripheral zone of the prostate gland. ‰oìWC‘å–x—C“à“c–LºC^‰ºß•vi”åjCŒK”ö’èmi•a—j: Br. J. Urol., 74: 520`521, 1994.

2707. mÇ—á•ñn Emphysematous pyelonephritis, ureteritis, and cystitis in a diabetic patient. ‰oìWC‰F“s‹{‘ñŽ¡C“à“c–LºC^‰ºß•vC¬ŽÄŒ’i”åj: Urol. Int., 52: 176`178, 1994.

2708. mÇ—á•ñn ’·ŠúŒo‰ß’†‚Ét•s‘S‚ɊׂÁ‚½HBtÇ‚ÆŽv‚í‚ê‚é1—á. ’©’·C’†‘ºM–çC–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YiŽ™jC‰º“c‰vOCŽðˆä‹Ši”åj: ¬Ž™t•s‘SŒ¤‹†‰ïŽ, (14): 29`33, 1994.

2709. mÇ—á•ñn ƒRƒ“ƒvƒ‰ƒCƒAƒ“ƒX‚̈ێ‚ªd—v‚ÆŽv‚í‚ꂽIgAtǃLƒƒƒŠ[ƒI[ƒo[‚Ì1—á. ‰º“c‰vOi”åjC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŒK”ö’èmi•a—jCŽðˆä‹Ši”åj: ¬Ž™t•s‘SŒ¤‹†‰ïŽ, (14): 45`47, 1994.

2710. mÇ—á•ñn Enalapril“Š—^‚É‚Ä‹}«t•s‘S‚ð’悵ˆÚAt“®–¬‹·ó‚ªf’f‚³‚ê, ƒoƒCƒpƒXpŒã‚É•«‡•”––½‚É’ZŠúŠÔ‚ÅÄ‹·ó‚ð‚«‚½‚µ‚½1—á. •º“¡“§CŒF–ì˜a—YC‰F“s‹{‘ñŽ¡C^‰ºß•vC‰““¡’‰—Yi”åj: tˆÚA¥ŒŒŠÇŠO‰È, 6(1): 55`59, 1994.

2711. mÇ—á•ñn tŒŒŠÇ«‚ŒŒˆ³Ç‚ɑ΂·‚鎩‰ÆtˆÚA‚É‚æ‚鎡—Ã. ‰““¡’‰—YCŒF–ì˜a—YC¬ŽÄŒ’i”åj: tˆÚA¥ŒŒŠÇŠO‰È, 6: 117`120, 1994.

2712. mÇ—á•ñn ƒŠƒ“ƒp‹zŽû‘‰Á‚Æ• –Œ“§‰ß«˜´i‚Ì‚½‚ß’˜‚µ‚­ŒÀŠOàh‰ß”\‚ª‘rŽ¸‚µ‚½• –Œ“§Í‚Ì1—á. {ŽRˆê•äCŒF–ì˜a—YCŒàŠ²ƒCŽðˆä‹Ši”åj: “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 85(4): 664`667, 1994.

2713. mÇ—á•ñn tOncocytoma‚Ì1—á. ‘º–{«rC“à“c–LºC‹y”\‹v—²CΓc—T‘¥C‰F“s‹{‘ñŽ¡C‰oìWC^‰ºß•vC¬ŽÄŒ’i”åj: ”å”AŠí‰È‹I—v, 40: 47`50, 1994.

2714. mÇ—á•ñn MEP—Ö@(Methotrexate, Etopside, Cisplatin)‚ɂĈꎞ“IŠ°‰ð‚Ì‚¦‚ç‚ꂽ‘O—§‘B•½ŠŠ‹Ø“÷Žî‚Ì1—á. ‘v¬_C“à“c–LºCŒüˆäLÆC˜ZŠpŽüC¬ŽÄŒ’i”åj: ”å”AŠí‰È‹I—v, 40: 83`85, 1994.

2715. mÇ—á•ñn MEP—Ö@‚ɂĈꎞ“IŠ°‰ð‚Ì“¾‚ç‚ꂽ‘O—§‘B“÷Žî‚Ì1—á. “à“c–LºCX—²ŽiCŒÃ”¨½”Vi”åjC“n•Ó´Ž¡CŠ}ˆäŒ‰i•a—j: –k—¢ˆãŠw, 24: 220`222, 1994.

2716. m—Õ°Ž¡Œ±n CAPDŠ³ŽÒ‚É‚¨‚¯‚éƒGƒ|ƒGƒ`ƒ“ƒx[ƒ^(EPOCH’)”牺“Š—^–@‚ÌŒŸ“¢|‰Šú“Š—^‚©‚çˆÛŽ“Š—^‚Ö|. Žðˆä‹ŠCŒF–ì˜a—Yi”åj: —Õ°“§Í, 10(12): 1849`1864, 1994.

2717. m‘àn Cyclosporin trial in nephrotic syndrome. Žðˆä‹Ši”åj: Current Concepts in Pediatrics, p.409`413, 1994.

2718. m‘àn ‚—îŽÒ”AŽ¸‹Ö‚Ì‘Îô; ƒRƒ‰[ƒQƒ“’“ü—Ö@. ‰¡ŽR‰p“ñC“à“c–Lºi”åj: Gerontology, 6: 64`69, 1994.

2719. m‘àn ”A˜HŒ‹Î‚ÉV‚µ‚¢Ž¡—Ö@‚ª‚ ‚é‚Æ•·‚«‚Ü‚µ‚½, ‹³‚¦‚Ä‚­‚¾‚³‚¢. ¬ŽÄŒ’i”åj: NHKo”Å, ‚ ‚È‚½‚̃z[ƒ€ƒhƒNƒ^[; “Ç‚Þ‘‡•a‰@‡C‚¨”NŠñ‚è•Ò, p.230, 1995.

2720. m‘àn •Ð•û‚ÌáΊۂª‘å‚«‚¢‚Ì‚Í, ‚ª‚ñ‚Å‚µ‚傤‚©. ΋´Wi”åj: NHKo”Å, ‚ ‚È‚½‚̃z[ƒ€ƒhƒNƒ^[; “Ç‚Þ‘‡•a‰@‡C‚¨”NŠñ‚è•Ò, p.224, 1995.

2721. m‘àn ¸‰t‚ÉŒŒ‚ª¬‚¶‚é‚Ì‚ªS”z‚Å‚·. ΋´Wi”åj: NHKo”Å, ‚ ‚È‚½‚̃z[ƒ€ƒhƒNƒ^[; “Ç‚Þ‘‡•a‰@‡C‚¨”NŠñ‚è•Ò, p.222, 1995.

2722. m‘àn Љ‚‚ß‚é‘åŠw•a‰@‚Ì‹ºˆÐ. ΋´Wi”åj: Nikkei Healthcare, 12: 70`73, 1994.

2723. m‘àn Early detection of prostate cancer: The nature of cancers detected with current diagnostic tests. ‘å–x—i”åjCScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: Seminars in Oncology, 21(5): 522`526, 1994.

2724. m‘àn ‚È‚º‘‚¦‚È‚¢“ú–{‚ÌŽ€‘ÌtˆÚA. ‰““¡’‰—Yi”åj: Sontara Medical News, 17: 3`4, 1994.

2725. m‘àn “Á’è‹@”\•a‰@‚ª‚ŽŸ‹@”\‚ð’S‚¢Š³ŽÒ–{ˆÊ‚̈ã—ØAŒg‚ð. ΋´Wi”åj: ƒtƒFƒCƒY‚R, 11: 32`35, 1994.

2726. m‘àn “Á’è‹@”\•a‰@‚Ì«—ˆ‘œ|’ñŒ¾: Œ»ó‚Æ«—ˆ—\‘ª|ˆê”Ê•a°‚ðƒZƒ~ƒI[ƒvƒ“‰»‚µ’nˆæŠJ‹Æˆã‚Ì‹³ˆç‚É‚àvŒ£. ΋´Wi”åj: ƒtƒFƒCƒY‚R, 9: 24`25, 1994.

2727. m‘àn ‡•¹Ç‚̉摜f’f, ”AŠÇ¥äNã÷‘¹. “à“c–Lºi”åj: ŠO‰È, 56: 1434`1440, 1994.

2728. m‘àn ´S˜@Žqˆù‡AŠî‘b. ΋´Wi”åj: Š¿•û»Ü‚Ì’mŽ¯, 12: 4`7, 1994.

2729. m‘àn Š¿•ûŽ¡—Ã: ”r”AˆÙí. ΋´Wi”åj: ¡“ú‚ÌŒ’N, 10: 28`31, 1994.

2730. m‘àn Š¿•ûŽ¡—à Q & A. ΋´Wi”åj: ¡“ú‚ÌŒ’N, 10: 32, 1994.

2731. m‘àn “­‚«·‚è‚Ì Q & A: ‘O—§‘B”ì‘åÇ‚ÌŽèp‚ð‚µ‚Ü‚µ‚½‚ª”A˜R‚ê‚Æ«Œð•s‘S‚ª‚ ‚è‚Ü‚·. ΋´Wi”åj: ¡“ú‚ÌŒ’N, 3: 150, 1994.

2732. m‘àn ‚r󌋒°ØœŒã, ŽË¸‚µ‚È‚­‚È‚è‚Ü‚µ‚½. ΋´Wi”åj: ¡“ú‚ÌŒ’N, 9: 145, 1994.

2733. m‘àn ‚±‚ê‚©‚ç‚̬Ž™‰ÈŠO—ˆf—Ã; tˆÚAŠ³Ž™. ‰º“c‰vOCŽðˆä‹Ši”åj: ¬Ž™‰È, 35(7): 867`872, 1994.

2734. m‘àn Å“_: ”AŽ¸‹Ö‚Ì•a‘Ô‚ÆŽ¡—Ö@. ‰¡ŽR‰p“ñi”åj: î•ñ, 27: 2`8, 1994.

2735. m‘àn ŽŠ“K“§Í‚ÌŽw•W‚Æ‚»‚Ì•]‰¿. ŒF–ì˜a—YC‚–Ø—Ti”åj: f’f‚ÆŽ¡—Ã, 83(3): 449`454, 1995.

2736. m‘àn Q & A: ‘Ìd10kgˆÈ‰º‚Ì’á‘ÌdŽ™‚É‚¨‚¯‚étˆÚA‚ÌŽèpŽè‹Z. ‰““¡’‰—Yi”åj: t‚Æ“§Í, 37: 1140`1141, 1994.

2737. m‘àn “Á’è‹@”\•a‰@‚Ì”–â‘è; ˜A—‹¦‹c‰ï’Ê‚¶‚Ä—v–]. ΋´Wi”åj: “ú–{ˆãŽ–V•ñ, 3660: 110`111, 1994.

2738. m‘àn “Á’è‹@”\•a‰@‚Ì“_”; ‘¼•a‰@‚æ‚è—DˆÊŽ¦‚·. ΋´Wi”åj: “ú–{ˆãŽ–V•ñ, 3662: 110, 1994.

2739. m‘àn Š³ŽÒ’†S‚̈ã—Ã. ΋´Wi”åj: “ú–{ˆãŽ–V•ñ, 3666: 18, 1994.

2740. m‘àn ŠwZŒŸ”A|§“x”­‘«21”N|’·Šú—\Œã’ÇÕ‚ÌŒ»ó‚Æ–â‘è“_. Žðˆä‹Ši”åj: –k—¢ˆãŠw, 25(1): 1`7, 1995.

2741. m‘àn ‚“xæiˆã—Â̎ÀÛ; ‘O—§‘B”ì‘åǂɑ΂·‚éŒo”A“¹“IƒŒ[ƒU[‘O—§‘BØœp. “à“c–LºC΋´WC¬ŽÄŒ’i”åj: –òŽ–V•ñ, 1837: 9`15, 1995.

2742. m‘àn –«t•s‘S¬Ž™Š³ŽÒ‚ÆQOL. Žðˆä‹Ši”åj: —Õ°“§Í, (5ŒŽ•Êû): 150`155, 1994.

2743. m‘àn “§Í“±“üŒã‚ÌQOL(”N’·Ž™)|ˆãŽt‚Ì—§ê‚©‚ç. –kžŠ‚Ý‚Ç‚èiŽ™j: —Õ°“§Í, (5ŒŽ•Êû): 165`167, 1994.

2744. m‘àn ¬Ž™‚Ìblood access‚Æperitoneal access. ‰º“c‰vOi”åj: —Õ°“§Í, (5ŒŽ•Êû): 181`187, 1994.

2745. m‘àn ŒŒ‰tò‰»‹Zp‚ͬŽ™t•s‘SŠ³ŽÒ‚ðK‚¹‚É‚µ‚½‚©. Žðˆä‹Ši”åj: —Õ°“§Í, (5ŒŽ•Êû): 221`223, 1994.

2746. m‘àn t•s‘Sˆã—Â̫—ˆ‚ÉŽv‚¤. Žðˆä‹Ši”åj: —Õ°“§Í, (5ŒŽ•Êû): 224`225, 1994.

2747. m‘àn CAPD‚É‚¨‚¯‚éŽw•W. ŒF–ì˜a—Yi”åj: —Õ°“§Í, 10(11): 1641`1649, 1994.

2748. muÀn ”A˜HŠ´õÇ|äNã÷‰Š‚ÌÇó‚Æ—\–h¥Ž¡—Âɂ‚¢‚Ä. Žðˆä‹Ši”åj: ‚³‚©‚¦, 34(5): 25, 1994.

2749. muÀn tŽ¾Š³‚ÌŽÀ‘H“I•ÛŒ’Žw“±, “O’ê Q & A. Žðˆä‹Ši”åj: ¶Šˆ‹³ˆç, 38(8): 40`45, 1994.

2750. muÀn ŠwZŒŸ”A. Žðˆä‹Ši”åj: –ˆ“úƒ‰ƒCƒt, 25(9): 92`96, 1994.

2751. mŠwp‘n i•ª’SŽ·•Mj –«Ž¾Š³‚Ɖ^“®; –«tŽ¾Š³Š³ŽÒ‚̉^“®, p.158`167, ŒF–ì˜a—Yi”åj. •ÒW ŽR茳iŒc‘åj, •¶Œõ“°C94.00.00”­s.

2752. mŠwp‘i‰p•¶jn i•ª’SŽ·•Mj Asian Nephrology; Erythropoientin, p.533`537, Žðˆä‹Ši”åj. •ÒW K.S. Chughiƒ`ƒƒƒ“ƒfƒBƒK‘åj, Oxford University PressC94.05.00”­s.

2753. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj1994; tˆÚAŠ³ŽÒ‚̃PƒA, p.801`802, ‰““¡’‰—Yi”åj. ˆãŠw‘‰@C“Œ‹žC94.02.15”­s.

2754. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¬ŠO‰Èƒ}ƒjƒ…ƒAƒ‹; ¸ŠÇŒ‹ãF, p.172`175, ΋´Wi”åj. “ú–{ˆãŽt‰ïC94.06.15”­s.

2755. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¬ŠO‰Èƒ}ƒjƒ…ƒAƒ‹; “±”A–@, p.300`306, ^‰ºß•vi”åj. “ú–{ˆãŽt‰ïC94.06.15”­s.

2756. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj }à—Õ°ŠÅŒìˆãŠw17: lH‘ŸŠí‚Æ‘ŸŠíˆÚA; 2Í|‘ŸŠíˆÚA(3)‘ãŽÓŒn|tˆÚA, p.230`237, ‰““¡’‰—YC¬ŽÄŒ’i”åj. “¯•üŽÉo”ÅC94.10.31”­s.

2757. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj —Õ°ˆã‚Ì‚½‚ß‚ÌŠ¿•ûŽ¡—Ã, t¥”å”AŠíŽ¾Š³•Ò; ”AŽ¸‹Ö, ΋´Wi”åj. ƒcƒ€ƒ‰C94.11.18”­s.

2758. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj •W€ŠÅŒìŠwuÀ, ¬lŠÅŒìŠw|t¥”å”AŠíŒn|; ‘æ4Í|ŒŸ¸‚ÆŠÅŒì, A.Žå‚ÈŒŸ¸, p.44`70, ΋´Wi”åj. ‹àŒ´o”ÅC94.00.00”­s.

2759. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj V•Ò|ƒpƒp‚ƃ}ƒ}‚̈玙•S‰È|‚Í‚¶‚ß‚Ä‚ÌÔ‚¿‚á‚ñ; t‘Ÿ¥”å”AŠí‚Ì•a‹C, p.514`518, Žðˆä‹Ši”åj. •ÒW —é–ØKŽqiŽå•w‚Ì—FŽÐj, Žå•w‚Ì—FŽÐC“Œ‹ž, 94.04.10”­s.

2760. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Role of TGF-ƒÀ in mesothelial cell growth & regeneration. ŒF–ì˜a—Yi”åj: 15th Annual Conference on Peritoneal Dialysis i95.02.11j, Baltimore, USA.

2761. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The new TNM classifications of prostate cancer: Clinicopathologic correlations. ‘å–x—i”åjCWheeler, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: 47th Annual Meeting of the Society of Surgical Oncology i94.03.18j, Houston.

2762. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? ‘å–x—i”åjCGoad, J.R.CWheeler, T.M.CDunn, J.K.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: 3rd Methodist Oncology Conference i94.04.12j, Houston.

2763. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The incidence of BPH in Japanese men. ¬ŽÄŒ’C‰oìWC‰¡ŽR‰p“ñC“à“c–Lºi”åj: International BPH Conference i94.05.14j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

2764. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Visual laser ablation of prostatectomy in Japan. “à“c–Lºi”åj: ‘æ89‰ñ•Ä‘”å”AŠí‰ÈŠw‰ï‘‰ï i94.05.15j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

2765. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Microsatellite instability, RFLP and PCR-SSCP analysis on chromosome 17 and p53 gene in 58 urothelial tumors. “à“c–LºCÝŠy•q–çCΓc—T‘¥C‰oìWC¬ŽÄŒ’i”åj: ‘æ89‰ñ•Ä‘”å”AŠí‰ÈŠw‰ï‘‰ï i94.05.17j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

2766. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Prognostic significance of prostate cancer in the apex of the gland. Lerner, S.iƒxƒCƒ‰[ˆã‰È‘åjC‘å–x—i”åjCGoad, J.R.CWheeler, T.M.iƒxƒCƒ‰[ˆã‰È‘åj: Annual Meeting of the American Urological Association i94.05.17`20j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

2767. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? ‘å–x—i”åjCGoad, J.R.CWheeler, T.M.CDunn, J.K.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: Annual Meeting of the American Urological Association i94.05.17`20j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

2768. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Pathologic features and prognosis of prostate cancers detectable with current diagnostic tests. ‘å–x—i”åjCWheeler, T.M.CDunn, J.K.CStamey, T.A.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: Annual Meeting of the American Urological Association i94.05.17`20j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

2769. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Prognosis of positive margins without extra-capsular extension in radical prostatectomy specimens. Œã“¡NŽ÷C‘å–x—i”åjCWheeler, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: Annual Meeting of the American Urological Association i94.05.17`20j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

2770. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Distinguishing clinically important from unimportant prostate cancers before treatment: preliminary report. Œã“¡NŽ÷C‘å–x—i”åjCArakawa, A.CWheeler, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: Annual Meeting of the American Urological Association i94.05.17`20j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

2771. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Incontinence after radical prostatectomy in 315 patients: the outcome and risk factors. Goad, J.R.CRogers, E.iƒxƒCƒ‰[ˆã‰È‘åjC‘å–x—i”åjCKassabian, V.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: Annual Meeting of the American Urological Association i94.05.17`20j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR.

2772. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Clinical outcome of endoscopic laser ablation of benign prostatic bypertrophy. ¬ŽÄŒ’C“à“c–LºC‰oìWC‹PºC‰¡ŽR‰p“ñi”åj: 4th World Congress of Endoscopic surgery i94.06.19j, ‹ž“s.

2773. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The new TNM classification of prostatic cancer: Clinicopathologic correlations. ‘å–x—i”åj: 2nd Seminar for the International Cooperative Study of Diagnostic Ultrasound in Prostatic Cancer i94.07.14j, ‹ž“s.

2774. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j The ability of transrectal ultrasonography to detect residural carcinoma after radical prostatectomy. ‰oìWCìã’B‰›C‘v¬_C“à“c–LºC΋´WC¬ŽÄŒ’i”åj: 2nd Seminar for the International Cooperative Study of Diagnostic Ultrasound in Prostatic Cancer i94.07.14`15j, ‹ž“s.

2775. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Role of endothelin in FK506-induced renal hypoperfusion in rats. ŒF–ì˜a—Yi”åjCJ. ChenCM. HeC‰““¡’‰—Yi”åjC^è‹`•FiŽÀ“®Œnj: 15th World Congress of the Transplantation Society i94.08.28`09.02j, ‹ž“s.

2776. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Microsatellite instability and p53 mutation in transitional cell carcinoma of the urinary tract. “à“c–LºC‰¤tŠìC‘å–x—CŠâ‘º³ŽkC‰oìWC‰¡ŽR‰p“ñC¬ŽÄŒ’i”åj: 11th Japan-Korea Urological Congress i94.09.10j, “Þ—Ç.

2777. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Pathologic features and prognosis of prostate cancers detctable with current diagnostic tests. ‘å–x—C“à“c–Lºi”åjCWheeler, T.M.CDunn, J.K.CStamey, T.A.iƒxƒCƒ‰[ˆã‰È‘åjC¬ŽÄŒ’i”åjCScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: 11th Japan-Korea Urological Congress i94.09.10j, “Þ—Ç.

2778. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Genetic instability of microsatellite in bladder cancer. “à“c–LºCÝŠy•q–çCΓc—T‘¥C‰oìWC‰¡ŽR‰p“ñC^‰ºß•vC‰““¡’‰—YC΋´WC¬ŽÄŒ’i”åj: 23rd World Congress Societe Internationale D'Urologie i94.09.20j, Sydney.

2779. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Clinical experience with visual laser ablation of prostate for relief of bladder outlet obstruction. “à“c–LºC‰oìWC‹PºC‰¡ŽR‰p“ñC‰““¡’‰—YC΋´WC¬ŽÄŒ’i”åj: 23rd World Congress Societe Internationale D'Urologie i94.09.20j, Sydney.

2780. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j A device in surgical suspension of bladder neck in female anti-incontinence operation. “c’†‹•½CHori, N.COgawa, H.C‰¡ŽR‰p“ñC^‰ºß•vC¬ŽÄŒ’i”åj: 23rd World Congress Societe Internationale D'Urologie i94.09.20j, Sydney.

2781. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Treatment of end stage renal disease (ESRD)|update registry data in Japan|. Žðˆä‹Ši”åj: 5th Asian Congress of Pediatric Nephrology i94.12.02j, ƒCƒ“ƒh, ƒjƒ…[ƒfƒŠ[.

2782. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Inhibition of peritoneal mesothelial cell growth by glycosylated albumin. ŒF–ì˜a—YCManalaysay, M.T.C•º“¡“§CŽðˆä‹Ši”åj: 15th Annual Conference on Peritoneal Dialysis i95.02.12j, Baltimore, USA.

2783. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Effect of heparin on mesothelial cell growth and protein synthesis. ŒF–ì˜a—YCManalaysay, M.T.C•º“¡“§CŽðˆä‹Ši”åj: 15th Annual Conference on Peritoneal Dialysis i95.02.12j, Baltimore, USA.

2784. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Distribution and androgen receptor status of neuroendocrine cells in the prostate. Šâ‘º³Žki”åjCGershagen, S.CWu, G.CCockett, A.T.K.Cdi Sant Agneseiƒƒ`ƒFƒXƒ^[‘åj: ‘æ89‰ñ•Ä‘”å”AŠí‰ÈŠw‰ï‘‰ï i94.05.15`17j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR, J. Urol., 151: 296, 1994.

2785. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Prostatic neuroendocrine cell products in human seminal plasma. Šâ‘º³Žki”åjCSchwarts, B.CSchoen, S.CGershagen, S.CCockett, A.T.K.CAbrahamsson, P.-A.CDeftos, L.J.iƒƒ`ƒFƒXƒ^[‘åj: ‘æ89‰ñ•Ä‘”å”AŠí‰ÈŠw‰ï‘‰ï i94.05.15`17j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR, J. Urol., 151: 299, 1994.

2786. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Prostatic neuroendocrine cells overexpress the human epidermal growth factor receptor (HER) family. Šâ‘º³Žki”åjCdi Sant'Agness, P.A.CWu, G.CMcCall, C.CBenning, C.CCockett, A.T.K.CGershagen, S.iƒƒ`ƒFƒXƒ^[‘åj: ‘æ89‰ñ•Ä‘”å”AŠí‰ÈŠw‰ï‘‰ï i94.05.15`17j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR, J. Urol., 151: 368, 1994.

2787. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effects of substance P on human prostate cancer cell growth in vitro. Šâ‘º³Žki”åjCSchwartz, B.CPackman, K.CCockett, A.T.K.CGershagen, S.iƒƒ`ƒFƒXƒ^[‘åj: ‘æ89‰ñ•Ä‘”å”AŠí‰ÈŠw‰ï‘‰ï i94.05.15`17j, ƒTƒ“ƒtƒ‰ƒ“ƒVƒXƒR, J. Urol., 151: 460, 1994.

2788. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Effects of advanced glycation end product of albumin on cell proliferation and protein synthesis in rat peritoneal mesothelial cells. ŒF–ì˜a—Yi”åjCManalaysay, M.T.C•º“¡“§CŽðˆä‹Ši”åj: 27th Annual Meeting of American Society of Nephrology i94.10.26`29j, Orlando, Florida.

2789. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j TGF-ƒÀ suppresses peritoneal mesothelial cell growth and enhances fibronectin gene expression. ŒF–ì˜a—YC‰º“c‰vOC•º“¡“§CŽðˆä‹Ši”åjCSchiller, B.iRush Presbyterian Medical CenterjCMoran, J.E.iBaxter HealthcarejCHjelle, J.T.iUniv. Illinoisj: 27th Annual Meeting of American Society of Nephrology i94.10.26`29j, Orlando, Florida.

2790. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Endothelin receptor antagonist partially reverses FK506 induced nephrotoxicity in rat. ŒF–ì˜a—YCChen, J.CHe, M.C‰““¡’‰—Yi”åj: 27th Annual Meeting of American Society of Nephrology i94.10.26`29j, Orlando, Florida.

2791. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Visual laser ablation of the prostate (VLAP). “à“c–Lºi”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.07j, •Ÿ‰ª.

2792. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ”å”AŠí‰È‚ÆŠ¿•û. ΋´Wi”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.09j, •Ÿ‰ª.

2793. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘O—§‘B”ì‘åǂɑ΂·‚éUrolase‚ð—p‚¢‚½Visual Laser Ablation of the Prostate (VLAP)—Ö@. “à“c–Lºi”åj: ‘æ15‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘å‰ï‘æ8‰ñ‘ÛYAGƒŒ[ƒU[ƒVƒ“ƒ|ƒWƒEƒ€ i94.10.12j, Ž­Ž™“‡.

2794. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰æ‘œ‰ðÍ‘•’u‚ð—p‚¢‚½äNã÷ƒJƒe[ƒeƒ‹”A‚Ì×–EŠw“IŒŸ“¢: “Á‚É—Ç«Ž¾Š³‚ÆG1ˆÚsã”çŠà‚ÌŠÓ•ÊŠŒ©‚ɂ‚¢‚Ä. “à“c–Lºi”åj: ‘æ33‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ï i94.11.17j.

2795. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Clinical experience with visual laser ablation of the prostate for benign prostatic hyperplasia. “à“c–Lºi”åj: ‘æ8‰ñ“ú–{Endourology¥ESWLŠw‰ï‘‰ï i94.11.18j, ‹ž“s.

2796. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘O—§‘B”ì‘åǂɑ΂·‚éVLAP—Ö@. “à“c–Lºi”åj: ‘æ11‰ñ“ú–{EEŠw‰ï i94.11.19j, “Þ—Ç.

2797. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘ŸŠíˆÚA‚Ì‚½‚߂̉摜f’f|tˆÚA‚É‚¨‚¯‚éƒAƒCƒ\ƒg[ƒvf’f|. ‰oìWi”åj: ‘æ14‰ñ“ú–{‰æ‘œˆãŠw‰ï i95.02.02j, –¼ŒÃ‰®.

2798. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj “§Í“±“üŠ³ŽÒ‚Ì•Û‘¶Šú‚É‚¨‚¯‚éƒ`[ƒ€ˆã—Â̕K—v«. ‹à“cKiC—é–Ø‚½‚©ŽqC’|“cFŽ}itƒZƒ“ƒ^[j: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.01`03j, ‘åã.

2799. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒg‘O—§‘B‚É“ÁˆÙ“I‚È“œ’`”’‚ðŽY¶‚·‚éƒk[ƒhƒ}ƒEƒX‰ÂˆÚA«‘O—§‘BŽîᇂ̌Ÿ“¢. ‹y”\‹v—²C“¡–ì’WlC‘º–{«rC’|쟎¡CŽu‘º“Ni”åjCò”Žˆêi“ú—§ŒË’ËjC¬–““ñ–çi•xŽmŒú¶ƒNƒŠƒjƒbƒNjC“à“c–LºC΋´Wi”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.07j, •Ÿ‰ª.

2800. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 125I•WŽ¯RƒÁ-seminoproteinƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚ð—p‚¢‚½‘O—§‘BŠà‚ɑ΂·‚é–ƉuƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚ÌŠî‘b“IŒŸ“¢. “¡–ì’WlCŒÃ”¨½”VCÝŠy•q–çC‰““¡’‰—YC΋´WC¬ŽÄŒ’C‘º–{«rC˜ZŠpŽüC–{“c’¼Ni”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.07j, •Ÿ‰ª.

2801. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘B”ì‘åÇ‚¨‚æ‚Ñ‘O—§‘BŠà‚ɑ΂·‚éUrolase‚ð—p‚¢‚½VLAP (Visual Laser Ablation Prostatectomy) —Ö@‚ÌŒŸ“¢. ‹PºC“à“c–LºC²X–Ø–M–¾C¬—ѹ“ñCÝŠy•q–çCãð‹PsC“¡–ì’WlC‰¡ŽR‰p“ñC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.08j, •Ÿ‰ª.

2802. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘B”ì‘åǂɑ΂·‚éHigh internsity focused ultrasound (HIFU) —Ö@. “à“c–LºCÝŠy•q–çCŽOžŠN“TC‹PºC“¡–ì’WlC‰¡ŽR‰p“ñC^‰ºß•vC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.08j, •Ÿ‰ª.

2803. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BŠàŒŸo‚É‚¨‚¯‚éŠeŽíŽîᇃ}[ƒJ[‚Æ‚»‚Ì‘O—§‘B‘ÌÏ”ä‚Ì—L—p«‚ÌŒŸ“¢. ìã’B‰›C‰oìWC’†žŠO—²C‘ˆä‘¥ºi”åjC•ìƒi–kŒ¤ƒƒfƒBƒJƒ‹jCŽÄ“c—Y“ñC¼‘º´ŽuC‘åì–ƒŽqC¬ŽÄŒ’i”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.08j, •Ÿ‰ª.

2804. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž€‘Ì“à‰ŠúŠÁ—¬ðŒ‚Ìt‚É‹y‚Ú‚·‰e‹¿|ƒ‰ƒbƒgt‚É‚¨‚¯‚éŠÁ—¬ˆ³‹y‚щ·“x‚ÌŒŸ“¢|. ŒF–ì˜a—YC’‰Ƒ¶i”åjC^è‹`•FiŽÀ“®ŒnjCŒàŠ²ƒC‰F“s‹{‘ñŽ¡C•º“¡“§C‰¡“c^“ñCŠÛ“T•vCX—²ŽiCŠ‹¼ŒMC‰““¡’‰—Yi”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.08j, •Ÿ‰ª.

2805. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”A˜Hˆ««Žîᇂɑ΂·‚éMicrosatellite instability‰ðÍ. “à“c–LºCŒÃ”¨½”VC‹y”\‹v—²CΓc—T‘¥CÝŠy•q–çCŒüˆäLÆC‰oìWi”åjC˜a“c’m‰vi—Õ•a—jC¬ŽÄŒ’i”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.08j, •Ÿ‰ª.

2806. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’Sƒqƒg‘O—§‘B”ì‘åÇ‘gDƒk[ƒhƒ}ƒEƒX‚É‚¨‚¯‚é125‚h•WŽ¯RƒÁ-Smƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚Ì‘Ì“à“®‘Ô. ’|쟎¡C“¡–ì’WlC‹y”\‹v—²C‰F“s‹{‘ñŽ¡CŠ‹¼ŒMC‹PºC’r“cŽ C^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.08j, •Ÿ‰ª.

2807. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Stage BO(T2)Šà‚ɑ΂·‚é_Œo•Û‘¶ªŽ¡“I‘O—§‘B‘S“Eœp. ‰oìWC‘v¬_Cìã’B‰›C{ŽRˆê•äC‰–ì‰pŽjC{ŽRo•äC¬ŽÄŒ’i”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.08j, •Ÿ‰ª.

2808. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’¼’°fã‚̈Ù튌©‚𔺂í‚È‚¢‘O—§‘BŠà(stage BoŠà)‚Ì•a—Šw“IŒŸ“¢. ‰oìWCìã’B‰›C‘v¬_C‘ºŽR‰ëˆêi”åjCŒK”ö’èmi•a—jCŽu‘º“NC˜ZŠpŽüC¬ŽÄŒ’i”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.08j, •Ÿ‰ª.

2809. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘ÌŠOÕŒ‚”g‚É‚æ‚ét‹@”\‚ւ̉e‹¿|Endothelin (ET-1)‚ÌŒŒ’†“®‘Ô‚ð’†S‚É|. ‘ˆä‘¥ºi”åjC•ìƒi–kŒ¤ƒƒfƒBƒJƒ‹jCŒF–ì˜a—YC¬ŽÄŒ’i”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.09j, •Ÿ‰ª.

2810. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒ¸‰tÇ, •s”DÇŠ³ŽÒ‚É‚¨‚¯‚鸔X‘B, ‘O—§‘B‚ÌŒ`‘Ô“I•Ï‰»‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‘v¬_C‰oìWCìã’B‰›CˆÉ“¡Œ[ˆêC‘ºŽR‰ëˆêC¼‘º´ŽuC¬ŽÄŒ’i”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.09j, •Ÿ‰ª.

2811. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘B”ì‘åǂɑ΂·‚éHigh Intensity Focused Ultrasound (HIFU)—Ö@. “à“c–LºCÝŠy•q–çCŽOžŠN“TC‹PºC“¡–ì’WlC‰¡ŽR‰p“ñC^‰ºß•vC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ82‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï i94.04.09j, •Ÿ‰ª.

2812. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • •”‘ÌŠOU“®‚̃‰ƒbƒg• –Œ“§‰ß”\‹y‚уŠƒ“ƒp‹zŽû‚ւ̉e‹¿. ‰F“s‹{‘ñŽ¡CŒF–ì˜a—YCŽðˆä‹Ši”åjCŽR‰º–¾‘×i‹ãBH‘åj: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.02j, ‘åã.

2813. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j CAPDŠ³ŽÒ‚É‚¨‚¯‚霑ãŽÓ‚ÌŒŸ“¢. •º“¡“§CŒF–ì˜a—YC‰¡“c^“ñCŽðˆä‹Ši”åjC‰–GC‹g–ì•Û”Vi’¹ŽæŒ§—§’†‰›•a‰@j: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.02j, ‘åã.

2814. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒAƒ“ƒWƒIƒeƒ“ƒVƒ“ˆË‘¶«‚ŒŒˆ³ƒ‰ƒbƒg‚Ì• –Œ‹@”\‹y‚Ñ• o“àƒŠƒ“ƒp‹zŽû”\‚ÌŒŸ“¢. ŒàŠ²ƒi”åjC´…’C—YCŽRŒ`—zié‹Ê‹¦“¯jCŒF–ì˜a—YCŽðˆä‹Ši”åj: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.02j, ‘åã.

2815. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒnƒCƒpƒtƒH[ƒ}ƒ“ƒX–Œ(PMMA)‚ÌŒ¨ŠÖߒɉü‘PŒø‰Ê‚ÉŠÖ‚·‚錟“¢. ‚–Ø—TCŒF–ì˜a—Yi”åjC¬o½C“ì•”³lC‘Š CˆêitƒZƒ“ƒ^[jCŽðˆä‹Ši”åjCH“c‹v’¼C‘Šì’å•vi‰q¶Šw•”jC÷ˆäŒ’“ñi‹´–{ƒNƒŠƒjƒbƒNjC“ú‘ä ‰p—Y—zi‰¡•l‘æˆêj: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.02j, ‘åã.

2816. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘¢‰eÜ‚É‚æ‚ét‹@”\áŠQ‚ðŒŒ‰t“§Í‚É‚æ‚è‰ñ”ð‚Å‚«‚é‚©”Û‚©H “ŒŒ«ˆêC“ì•”³lC–ìì—²ˆê˜YC´…”ÍŽqC¬ŽR½C‘Š ‚èCˆêitƒZƒ“ƒ^[jCŒF–ì˜a—YCŽðˆä‹Ši”åj: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.02j, ‘åã.

2817. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • –Œ“§‰ß”\(PP)˜´iƒ‚ƒfƒ‹‚É‚¨‚¯‚é• –Œ“§‰ß”\˜´i—}§•¨Ž¿‚ÌŒŸõ. {ŽRˆê•äCŒF–ì˜a—YCŽðˆä‹Ši”åj: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.03j, ‘åã.

2818. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Automated PD (APD)Š³ŽÒ‚ÌŽŠ“K“§Í‚ÉŠÖ‚·‚錟“¢. X—²ŽiC‚–Ø—TC•º“¡“§C‰¡“c^“ñCŒF–ì˜a—YCŽðˆä‹Ši”åj: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.03j, ‘åã.

2819. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’SLNCaPŽîᇃk[ƒhƒ}ƒEƒX‚É‚¨‚¯‚é131‚h•WŽ¯RƒÁ-seminoproteinƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚¨‚æ‚Ñ67Ga-citrate‚ð—p‚¢‚½ŽîᇃC ƒ[ƒWƒ“ƒO. “¡–ì’WlC’|쟎¡C‹y”\‹v—²C΋´Wi”åjCˆË“cˆêdC’†‘òŒ\Ž¡CΈ䟌Èi•új: ‘æ34‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï i94.09.29j, ŽD–y, ŠjˆãŠw, 31(7): 780, 1994.

2820. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’SLNCaPŽîᇃk[ƒhƒ}ƒEƒX‚É‚¨‚¯‚é125‚h•WŽ¯RProstatic Acid Phosphataseƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚Ì‘Ì“à“®‘Ԃɂ‚¢‚Ä. “¡–ì’WlC‹y”\‹v—²C’|쟎¡C΋´Wi”åjCˆË“cˆêdC’†‘òŒ\Ž¡CΈ䟌Èi•új: ‘æ34‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï i94.09.29j, ŽD–y, ŠjˆãŠw, 31(7): 780, 1994.

2821. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘B”ì‘åÇp‘O•]‰¿–@‚Æ‚µ‚Ä‚Ì‘ÌŒn“Iƒ‰ƒ“ƒ_ƒ€¶ŒŸp‚̈Ӌ`. “à“c–LºC‰oìWCìã’B‰›C‘v¬_C¬ŽÄŒ’i”åj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.05j, ‰ªŽR.

2822. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’¼’°f‚Å‚ÍG’m‚Å‚«‚È‚¢‘O—§‘BŠà(BO or Tlc-T2Šà)‚Ì—Õ°•a—Šw“IŒŸ“¢. ‰oìWCìã’B‰›C‘v¬_C“à“c–LºC¬ŽÄŒ’i”åj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.05j, ‰ªŽR.

2823. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BŠàŒŸo‚É‚¨‚¯‚éŠeŽíŽîᇃ}[ƒJ[‚Æ‚»‚Ì‘O—§‘B‘ÌÏ”ä‚Ì—L—p«‚ÌŒŸ“¢. ìã’B‰›C‰oìWC‘v¬_C“à“c–LºC‰¡ŽR‰p“ñC¬ŽÄŒ’i”åj: ‘æ32‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i94.10.05j, ‰ªŽR.

2824. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒg• –Œ“§Í‚Å‚ÌŽíX‚ÌðŒ‰º‚É‚¨‚¯‚鉡Šu–Œ‰ºƒŠƒ“ƒp‹zŽû‚¨‚æ‚уŠƒ“ƒp‚ð‰î‚³‚È‚¢• o“à‹zŽû‚ÌŠÖ—^. ŒF–ì˜a—YCŒàŠ²ƒC‰½”JCŽðˆä‹Ši”åj: ‘æ32‰ñ“ú–{lH‘ŸŠíŠw‰ï i94.10.12j, “Œ‹ž.

2825. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j • –Œ“§ÍŽÀŒ±‚É‚¨‚¯‚éŽÀŒ±“®•¨‚ÌŽí·. ŽR‰º–¾‘×i‹ãBH‘åjCŒF–ì˜a—YCŽðˆä‹Ši”åjC’†¼ŒõiòHˆã‰ÈjCMoncrief, J.W.iAustin Diagnostic Clinic FoundationjCPopovich, R.P.iUniv. Texasj: ‘æ32‰ñ“ú–{lH‘ŸŠíŠw‰ï i94.10.12j, “Œ‹ž.

2826. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒgt×–EŠà‚ɑ΂·‚éDNA Instability‚¨‚æ‚Ñp53ˆâ“`Žq‰ðÍ. “à“c–Lºi”åjC˜a“c’m‰vi—Õ•a—jC¬–““ñ–çi•xŽmŒú¶ƒNƒŠƒjƒbƒNjC‰oìWC¬ŽÄŒ’i”åj: ‘æ53‰ñ“ú–{ŠàŠw‰ï‘‰ï i94.10.19j, –¼ŒÃ‰®.

2827. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒg• –Œ’†”ç×–E(HMC)‚ɑ΂·‚éZ“§ˆ³•¨Ž¿‚Ì×–E‘B”\‚É‹y‚Ú‚·‰e‹¿. •º“¡“§CŒF–ì˜a—YCŽðˆä‹ŠC‰¡ŽR‰p“ñC¬ŽÄŒ’i”åj: ‘æ46‰ñ“ú–{”å”AŠí‰ÈŠw‰ï¼“ú–{‘‰ï i94.10.21j, •ÄŽq.

2828. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Automated urinary sediment analyzer(‘SŽ©“®”A’¾ŸÔ‘ª’è‘•’u)‚ð—p‚¢‚½tŽ…‹…‘Ì—R—ˆ‚Æ”ñtŽ…‹…‘Ì—R—ˆ”A’†ÔŒŒ‹…‚ÌŠÓ•Ê–@‚Ìì¬. •º“¡“§CŒF–ì˜a—YC–F‰ê½CŽðˆä‹Ši”åj: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª.

2829. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ESWLŒã‚̃Jƒ‹ƒVƒEƒ€Œ‹Î‚É‚¨‚¯‚éÄ”­—á‚ÌŒŸ“¢. ’†žŠO—²C‘º–{«rCˆÉ“¡Œ[ˆêC^‰ºß•vC¬ŽÄŒ’i”åjCrìFC‹v•Û¯ˆêi‘Š–Í‘äj: ‘æ8‰ñ“ú–{Endourology¥ESWLŠw‰ï‘‰ï i94.11.18j, ‹ž“s.

2830. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒŒ—F•aŠ³ŽÒ‚Ì”AŠÇŽîᇂɑ΂·‚éLaparoscopy Assisted Nephroureterectomy. ’·‘q˜a•FC‰F“s‹{‘ñŽ¡i”åjCŽR“¡­•vi¼ŒEjC”nêŽu˜YiŒc‰žj: ‘æ8‰ñ“ú–{Endourology¥ESWLŠw‰ï‘‰ï i94.11.18j, ‹ž“s.

2831. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ‰ƒbƒgt‘jŒŒ‚ƃ~ƒgƒRƒ“ƒhƒŠƒA‚̌ċz”\. Š‹¼ŒMCŒF–ì˜a—YC‰½”JC^‰ºß•vC‰““¡’‰—YC¬ŽÄŒ’i”åjC“n•Ó“”ü”Ti¶‰»j: ‘æ30‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i94.11.25j, L“‡.

2832. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j FK506‚É‚æ‚étŒŒ—¬’ቺ‚ւ̃Gƒ“ƒhƒZƒŠƒ“(ET)‚¨‚æ‚Ñ×–E“àƒJƒ‹ƒVƒEƒ€‘ãŽÓˆÙí‚ÌŠÖ—^. ‰½”JC’‰Ƒ¶CŒF–ì˜a—YCŒÃ”¨½”VC‰““¡’‰—Yi”åjC^è‹`•FiŽÀ“®Œnj: ‘æ30‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i94.11.25j, L“‡.

2833. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÚAƒ‚ƒfƒ‹‚Æin vitroƒ‚ƒfƒ‹‚Å‚Ìt•Û‘¶Œø‰Ê‚Ì·ˆÙ‚ɂ‚¢‚Ä. ^è‹`•FiŽÀ“®ŒnjCŒF–ì˜a—YC‰½”JC‰““¡’‰—YC¬ŽÄŒ’i”åjC‰¡“c˜a•FiJR“Œ‹ž‘‡•a‰@j: ‘æ30‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i94.11.25j, L“‡.

2834. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒg• –Œ’†”ç×–E(HMC)‚ɑ΂·‚éZ“§ˆ³•¨Ž¿‚Ì’`”’‡¬”\‹y‚Ñ×–E‘B”\‚É‹y‚Ú‚·‰e‹¿. •º“¡“§CŒF–ì˜a—YC‰º“c‰vOCŽðˆä‹Ši”åj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï i94.12.16`18j, ç—t.

2835. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j VƒCƒkƒŠƒ“‘ª’èŒn‚É‚æ‚éGFR‘ª’è. ‰º“c‰vOCŽðˆä‹Ši”åjCV“c“Œ—m•FC‹e’r’CŽŸC›–ìŽOŠì’jCŠâ“cŒõ•viŒà‰H‰»Šw¶•¨ˆãŠwŒ¤‹†Šj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï i94.12.16`18j, ç—t.

2836. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Ž©—§‚ւ̃Aƒvƒ[ƒ`. ’|“cFŽ}C—é–Ø‚½‚©ŽqCÔâ—DŽqC‹àŽRŒhŽqC‹à“cKiitƒZƒ“ƒ^[j: ‘æ39‰ñ“ú–{“§ÍˆãŠw‰ï‘‰ï i94.07.01`03j, ‘åã.

2837. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ‰ƒbƒg• –Œ’†”ç×–E(RMC)‚Ìfibronectin (FN), monocyte chemoattractant protein(MCP-1) gene expression‚¨‚æ‚Ñ’`”’‡¬”\. ŒF–ì˜a—YC•º“¡“§C‰º“c‰vOCŽðˆä‹Ši”åj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï i94.12.16`18j, ç—t.

2838. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠeŽíZ“§ˆ³•¨Ž¿‚ÆZ“§ˆ³‚ªƒ‰ƒbƒg”|—{• –Œ’†”ç×–E‚É—^‚¦‚é‰e‹¿. ‰º“c‰vOC•º“¡“§CŒF–ì˜a—YCŽðˆä‹Ši”åj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï i94.12.16`18j, ç—t.

2839. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Inhibition of peritoneal mesothelial cells by heparin. M.T. ManalaysayCŒF–ì˜a—YC•º“¡“§CŽðˆä‹Ši”åj: ‘æ37‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï i94.12.16`18j, ç—t.

2840. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j ŠwZŒŸ”A‚É‚æ‚茩‚¢o‚³‚ꂽ¬Ž™ŠútŽ¾Š³‚Ì’·Šú—\Œã‚ÌŒ»ó‚Æ–â‘è“_. Žðˆä‹Ši”åj: ‘æ158‰ñ“ú–{¬Ž™‰ÈŠw‰ïVŠƒ’n•û‰ï i94.08.20j, VŠƒ.

2841. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j TURP‚̃Rƒc‚ÆV‚µ‚¢Ž¡—Ö@‚ɂ‚¢‚Ä. ¬ŽÄŒ’i”åj: ‘æ222‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‰ªŽR’n•û‰ï i94.12.11j, ‰ªŽR.

2842. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”AŠÇŽq‹{“à–ŒÇ‚Ì1—á. ŠÛ“T•vCŠÑˆä•¶•FC“¡–ì’Wli”åjC‰i“cŠ²’jC‰ª–{dâXC•Ÿˆä€”V•i¹˜H‰ÁjCŽÄ“c—Y“ñi”åj: ‘æ500‰ñ‹L”O“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.09.08j, “Œ‹ž.

2843. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œã• –Œo‚É”F‚ß‚ç‚ꂽ‹‘å_ŒoãˆßŽî‚Ì1—á. Ä“¡‹BC{ŽRo•äC•º“¡“§C‹PºC“à“c–LºC΋´WC¬ŽÄŒ’i”åj: ‘æ10‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i94.09.08j, ‰¡•l.

2844. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹‘åΊD‰»“à‚É”F‚ß‚½t×–EŠà‚Ì1—á. ²“¡ˆÐ•¶C“¿ŽRŽüŽiCŒÃ”¨½”VC‰¡ŽR‰p“ñC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ10‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i94.09.08j, ‰¡•l.

2845. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j äNã÷Œã–Ê‚É”­¶‚µ‚½‹‘å_ŒoâŽî‚Ì1—á. ŽÄ“c—Y“ñC{ŽRˆê•äC‘åì–ƒŽqC‰oìWC“à“c–LºC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ10‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i94.09.08j, ‰¡•l.

2846. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘O—§‘Bperipheral zone‚É”­Œ©‚³‚ꂽBPH nodule‚Ì‘gDŠw“IŒŸ“¢. ‘å–x—C“à“c–LºC‰oìWC¬ŽÄŒ’i”åjCWheeler, T.M.iƒxƒCƒ‰[ˆã‰È‘åj: ‘æ10‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i94.09.08j, ‰¡•l.

2847. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œã• –Œo‚É”F‚ß‚ç‚ꂽ‹‘å_ŒoãˆßŽî‚Ì1—á. Ä“¡‹BC{ŽRo•äC•º“¡“§C‹PºC“à“c–LºC΋´WC¬ŽÄŒ’i”åj: ‘æ10‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i94.09.08j, ‰¡•l.

2848. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”A˜H•ÏXpŒã‚É”­¶‚µ‚½”A˜HŒ‹Î‚ɑ΂·‚錋ΔjÓŽ¡—Â̌oŒ±. rìFCˆÉ“¡Œ[ˆêCŒ´–ì—TŽiC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ59‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i94.11.05j, ‰F“s‹{.

2849. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒVƒ‹ƒo[ƒ‰ƒCƒ“Žg—p‚É‚æ‚éŒo”A“¹“I‘O—§‘BØœp‚É‚¨‚¯‚épŒãŠ´õ—\–h‚ÌŒø‰Ê. ŒÃ”¨½”VC“à“c–LºC‰F“s‹{‘ñŽ¡C¬—ѹ“ñC²X–Ø–M–¾C{ŽRˆê•äCŒ´–ì—TŽiC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ59‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i94.11.05j, ‰F“s‹{.

2850. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —«‚Ì• ˆ³«”AŽ¸‹Ö‚ɑ΂·‚霔Ւê‹ØƒgƒŒ[ƒjƒ“ƒO‚ÌŒø‰Ê”­Œ»ŽžŠú‚ÆŒÀŠE. ‘åì–ƒŽqC΋´WC‹y”\‹v—²i”åjC¬–““ñ–çi•xŽmŒú¶ƒNƒŠƒjƒbƒNjC¼‘º‚©‚¨‚éiƒRƒ“ƒ`ƒ“ƒX‹¦‰ïjC^‰ºß•vC‰¡ŽR‰p“ñi”åj: ‘æ59‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i94.11.05j, ‰F“s‹{.

2851. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œ´”­«‚Æl‚¦‚ç‚ê‚铧͗á‚Å‚Ì•›bó‘B‹@”\˜´iÇ4—á. ‚–Ø—TCX—²Žii”åj: ‘æ59‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i94.11.05j, ‰F“s‹{.

2852. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘O—§‘B”ì‘åǂɑ΂·‚éProrase‡UR‚ð—p‚¢‚½non-contact+contact–@‚É‚æ‚éVLAP—Ö@(ƒrƒfƒI). “à“c–LºC‹PºCãð‹PsC‰““¡’‰—YCÝŠy•q–çC{ŽRˆê•äCŒÃ”¨½”VC‰¡ŽR‰p“ñC¬ŽÄŒ’i”åj: ‘æ59‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i94.11.05j, ‰F“s‹{.

2853. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘O—§‘B”ì‘åǂɑ΂·‚éProrase‡UR‚ð—p‚¢‚½non-contact+contact–@‚É‚æ‚éVLAP—Ö@. “à“c–LºC‹PºC‰““¡’‰—YCÝŠy•q–çCŽÄ“c—Y“ñCa’J@‘¥C“¿ŽRŽüŽiCÄ“¡‹BC²“¡ˆÐ•¶CŒÃ”¨½”VC¬ŽÄŒ’i”åj: ‘æ59‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i94.11.05j, ‰F“s‹{.

2854. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒk[ƒhƒ}ƒEƒX‰ÂˆÚA«LNCaPŽîᇂɑ΂·‚邃Gƒlƒ‹ƒM[“dŽqüƎ˂ɂ‚¢‚Ä‚ÌŠî‘b“IŒŸ“¢. “¡–ì’WlC‹y”\‹v—²CŠÛ“T•vC¬ŽÄŒ’i”åj: ‘æ59‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i94.11.05j, ‰F“s‹{.

2855. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”A“¹ˆÚsã”çŠà‚Ì1—á. ŠÛ“T•vC“¡–ì’Wli”åj: ‘æ59‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i94.11.05j, ‰F“s‹{.

2856. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¼ŒE•a‰@‚É‚¨‚¯‚éPNLŽ¡—Â̌oŒ±. ‰F“s‹{‘ñŽ¡i”åj: ‘æ59‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i94.11.05j, ‰F“s‹{.

2857. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j The use of the serum PSA to distinguish clinically important from unimportant cancers detected by TURP. ‘å–x—C“à“c–LºC¬ŽÄŒ’i”åj: ‘æ59‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i94.11.05j, ‰F“s‹{.

2858. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒuƒŒƒIƒ}ƒCƒVƒ“”xüˆÛÇ‚É‚æ‚莀–S‚µ‚½¸‘ƒŠà‚Ì1—á. “ü]Œ[C–å˜e˜abC—›Š¿‰hi”åj: ‘æ59‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï i94.11.05j, ‰F“s‹{.

2859. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j äNã÷ƒwƒ‹ƒjƒA‚Ì1—á. ŠÛ“T•vi”åjCŠÑˆä•¶•Fi¹˜H‰ÁjC“¡–ì’Wli”åjC‰i“cŠ²•vC‰ª–{dâXC•Ÿˆä€”V•i¹˜H‰Áj: ‘æ501‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï i94.12.01j, “Œ‹ž.

2860. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒXƒeƒƒCƒh«“œ”A•a‚ɇ•¹‚µ‚½renal gas abscess‚Ì1—á. ˆÉ“¡Œ[ˆêC‘å–x—C^‰ºß•vC“à“c–LºC{ŽRo•äC¬ŽÄŒ’i”åj: ‘æ11‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i95.02.09j, ‰¡•l.

2861. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰º‘åÖ¬Œã”AŠÇ‚É”­¶‚µ‚½”÷¬ZˆÚsã”çŠà‚Ì1—á. ²X–Ø–M–¾C“à“c–LºC²“¡ˆÐ•¶CÄ“¡‹BC¬ŽÄŒ’i”åjC‰¡“c^“ñi‘Š–Í‘ä•a‰@j: ‘æ11‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i95.02.09j, ‰¡•l.

2862. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¬Ž™rhabdomyosarcoma‚Ì1—á. ‘åì–ƒŽqC{ŽRˆê•äCŠâ‘º³ŽkC‹PºC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ11‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï i95.02.09j, ‰¡•l.

2863. mŒ¤‹†‰ïi‘Ûjn i‹³ˆçu‰‰j Recent advance in management of chronic renal failure in children. Žðˆä‹Ši”åj: Annual Doctor's Meeting Cathay General Hospital i94.04.29j, Taiwan.

2864. mŒ¤‹†‰ïi‘Ûjn iˆê”Êu‰‰j Distinguishing clinically important from unimportant prostate cancers before treatment: preliminary report. Œã“¡NŽ÷iŠâŽèˆã‰È‘åjC‘å–x—i”åjCArakawa, A.CWheeler, T.M.CScardino, P.T.iƒxƒCƒ‰[ˆã‰È‘åj: 3rd Methodist Oncology Conference i94.04.12j, Houston.

2865. mŒ¤‹†‰ïi‘Ûjn iˆê”Êu‰‰j Frequency of apoptic bodies correlates with prognosis of grade 3+3 prostate cancer. ‘ŠŒ´³Oi”åjCScardino, P.T.CWheeler, T.M.CTroung, L.D.CDunn, J.K.iƒxƒCƒ‰[ˆã‰È‘åjC‘å–x—C‹g“cˆê¬i”åjCRogers, E.CŒã“¡NŽ÷iŠâŽèˆã‰È‘åjCThompson, T.C.iƒxƒCƒ‰[ˆã‰È‘åj: 3rd Methodist Oncology Conference i94.04.12j, Houston.

2866. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ŽÐ‰ïˆãŠw“IŽ‹–ì‚Å‚ÌCAPD—Ö@. Žðˆä‹Ši”åj: ‘æ1‰ñCAPDƒi[ƒXƒtƒH[ƒ‰ƒ€ i94.07.01j, ‘åã.

2867. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ŠwZŒŸ”A§’èŒã21”N|’·ŠúfollowŠ³ŽÒ‚ÌŽÀ‘Ô‚Æ–â‘è“_. Žðˆä‹Ši”åj: ‰ª“c•q•v‹³Žö‘ÞŠ¯‹L”Ou‰‰‰ï i95.02.25j, •xŽR.

2868. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j ŒŒ‰t“§Í’†‚ÌŽ–ŒÌ‚Æ‘Îô. Žðˆä‹Ši”åj: Œú¶È“§Íˆã—Ã]Ž–ŽÒŒ¤C‰ï i94.07.22j.

2869. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j CAPD‚ÌŠî‘b‚Æ—Õ°. ŒF–ì˜a—Yi”åj: ‘æ3‰ñƒoƒNƒXƒ^[MDƒJƒŒƒbƒW i94.07.30j, –‹’£.

2870. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j APD—Ö@. ŒF–ì˜a—Yi”åj: ‘æ3‰ñƒoƒNƒXƒ^[MDƒJƒŒƒbƒW i94.08.01j, –‹’£.

2871. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j ŽŠ“K“§Í‚ÆAPD—Ö@. ŒF–ì˜a—Yi”åj: CAPD Initiative Meeting i94.09.03j, –kŠC“¹.

2872. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j tŽ¾Š³‚̈ã—ÂƊwZ•ÛŒ’. Žðˆä‹Ši”åj: •½¬6”N“x‘—§“ÁŽê‹³ˆç‘‡Œ¤CŠ’ZŠúŒ¤C‰ï i94.10.05j, ‹v—¢•l.

2873. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j tŽ¾Š³‚ÌŽÀ‘H“I•ÛŒ’Žw“±‚Í‚±‚¤‚·‚é. Žðˆä‹Ši”åj: tŽ¾Š³¥“œ”A•a—\–h‚Ì‚½‚ß‚ÌŒ¤C‰ï i95.02.04j, ‚¼.

2874. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰ä‚ª‘‚É‚¨‚¯‚étˆÚAŠ³ŽÒ‚ÌQ.O.L.: tˆÚAŒã‚Ì”DP¥oŽY. ‰““¡’‰—YCŒF–ì˜a—Yi”åjC²“¡ŒõŽjiŠOjC¬ŽÄŒ’i”åj: ‘æ28‰ñ“ú–{tˆÚA—Õ°Œ¤‹†‰ï i95.01.26j, ” ª.

2875. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‚킪‘‚É‚¨‚¯‚étˆÚAŠ³ŽÒ‚ÌQOL. ¬ŽÄŒ’i”åjC‰ª—²Gi‹ž“s•{—§‘åj: ‘æ28‰ñ“ú–{tˆÚA—Õ°Œ¤‹†‰ï i95.01.27j, ” ª, —\eW, p.40`45, 1995.

2876. mŒ¤‹†‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‘O—§‘B‚ª‚ñ‚Ìmicrosatellite instability. ‰oìWC“à“c–Lºi”åj: ‘æ5‰ñ‘O—§‘B‚ª‚ñƒ[ƒNƒVƒ‡ƒbƒv i94.09.09j, “Œ‹ž.

2877. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘B“ÁˆÙRŒ´‚É‚æ‚é‘O—§‘BŠàƒXƒNƒŠ[ƒjƒ“ƒO‚Ì—L—p«. ‰oìWC‘v¬_Cìã’B‰›C‰¡ŽR‰p“ñC“à“c–LºC¬ŽÄŒ’i”åjC•½–콈ê˜YCL–åˆêFiƒwƒ‹ƒXƒTƒCƒGƒ“ƒXj: ‘æ3‰ñ“ú–{t”å”AŠíŽ¾Š³—\–hˆãŠwŒ¤‹†‰ï i94.06.08j, ‹ž“s.

2878. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™t•s‘S‚É”º‚¤‚ŒŒˆ³‚ɑ΂·‚éƒjƒtƒFƒWƒsƒ“ŽŒø«×—±Ü(ƒZƒpƒ~ƒbƒg-R)‚Ì“Š—^—Ê‚ÌŒŸ“¢. •x‘òCˆêi‘—§—×{ŠVŠƒ•a‰@jC“àŽR¹iVŠƒ‘åjC‘qŽR‰pºi‘—§—×{Šç—t“Œ•a‰@jC‚‹´¹—¢iɪŒ§—§‚±‚Ç‚à•a‰@jC²Œ´—Di“ú‘åjC–å˜eƒˆêi‘ —§—×{Š¼ŽD–y•a‰@jCŽðˆä‹Ši”åj: ‘æ1‰ñ¬Ž™‚ŒŒˆ³Œ¤‹†‰ï i94.08.21j, VŠƒ.

2879. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŽvtŠú‚ÉtˆÚA‚ðs‚¢‚»‚ÌŒãƒrƒ^ƒ~ƒ“D3ƒpƒ‹ƒX—Ö@Ž{s‚µ•›bó‘B—R—ˆ‚ÌŒz•”Žîá‡‚ð‚«‚½‚µ‚½Ä“§Í—á. •º“¡“§CŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—YCŽðˆä‹Ši”åj: ‘æ16‰ñ¬Ž™t•s‘SŒ¤‹†‰ï i94.09.08`09j, •ó’Ë.

2880. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “§Í“±“üŽžƒrƒ^ƒ~ƒ“D3ŒoŒûƒpƒ‹ƒX—Ö@‚ÌŒoŒ±. •º“¡“§CŒF–ì˜a—YC‚–Ø—TC‰¡“c^“ñCŽðˆä‹Ši”åj: ‘æ13‰ñt‚Æœ‘ãŽÓŒ¤‹†‰ï i94.10.01j, “Œ‹ž.

2881. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ¶‘ÌtˆÚAŒã‘Sg‘~áyŠ´‚𔺂¤ƒwƒ‚ƒOƒƒrƒ“”A‚ð‚«‚½‚µ‚½1—á. •º“¡“§CŒF–ì˜a—YC‰““¡’‰—YC^‰ºß•vCŽðˆä‹ŠC¬ŽÄŒ’i”åj: ‘æ10‰ñtˆÚA¥ŒŒŠÇŠO‰ÈŒ¤‹†‰ï i94.11.10j, ‘åã.

2882. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ”DPŒãŠú‚É’˜–¾‚È”DP’†“ÅÇ‚ð’悵‚½tˆÚAŠ³ŽÒ‚Ì1—á. {ŽRo•äCŒÃ”¨½”VC•º“¡“§i”åjC•½–ì“N•viŽs—§ŽD–y•a‰@jCŒF–ì˜a—YC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ28‰ñ“ú–{tˆÚA—Õ°Œ¤‹†‰ï i95.01.26j, ” ª.

2883. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ŠwZŒŸ”A‚É‚æ‚é’·Šú—\Œã’ÇÕ‚ÌŒ»ó‚Æ–â‘è“_‚ÉŠÖ‚·‚錤‹†. Žðˆä‹Ši”åjC‘qŽR‰pºi‘—§—×{Šç—t“Œ•a‰@jC²Œ´—Di“ú‘åjC•x‘òCˆêi‘—§—×{ŠVŠƒ•a‰@jC‚‹´¹—¢iɪŒ§—§‚±‚Ç‚à•a‰@jC“àŽR¹iVŠƒ ‘åj: Œú¶‰ÈŠwŒ¤‹†”ï•â•‹àut•s‘Sˆã—ÃŒ¤‹†Ž–‹Æv•½¬6”N“xŒ¤‹†‹ÆÑ•ñ‰ï i95.02.24j, “Œ‹ž.

2884. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j TURP‚ÌŽè‹Z‚ÆV‚µ‚¢Ž¡—Ö@. ¬ŽÄŒ’i”åj: ‘æ86‰ñɪŒ§”å”AŠí‰Èˆã‰ï i94.06.04j, •l¼.

2885. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ŠwZŒŸ”A‚Å”­Œ©‚³‚ꂽ¬Ž™tŽ¾Š³’·ŠúŠÇ—‚Ì”–â‘è. Žðˆä‹Ši”åj: Š‹ü‹æˆãŽt‰ïŠwpŒ¤C‰ï i94.06.06j, “u.

2886. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j CAPDŠ³ŽÒ‚ÌtˆÚA. ŒF–ì˜a—Yi”åj: ŽR—œCAPDŒ¤‹†‰ï i94.06.08j, b•{.

2887. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ŠwZŒŸ”A‚Å”­Œ©‚³‚ꂽ¬Ž™tŽ¾Š³’·ŠúŠÇ—‚Ì”–â‘è. Žðˆä‹Ši”åj: ‘æ16‰ñ_“Þ쌧ŠwZ¥tŽ¾Š³ŠÇ—Œ¤‹†‰ïˆãŽt•”‰ïŒ¤‹†‰ï i94.06.25j, ‰¡•l.

2888. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j • –Œ‹@”\. ŒF–ì˜a—Yi”åj: ‘æ10‰ñ‹ãB• –Œ“§ÍŒ¤‹†‰ï i94.09.16j, ‰«“ê.

2889. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j –«t•s‘S|Ž¡—ÂÌi•à; •Û‘¶—Ö@Šú‚©‚çtˆÚA‚Ü‚Å|. Žðˆä‹Ši”åj: ‘æ55‰ñ’†Žl‘“§ÍŒ¤‹†§˜b‰ï i94.09.17j, L“‡.

2890. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ”å”AŠí‰È—̈æ‚ÌŠ¿•û—Ö@. ΋´Wi”åj: Š™‘qˆãŽt‰ï i94.09.26j, Š™‘q.

2891. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “ú–{l‚ÌŽ€¶ŠÏ. ΋´Wi”åj: ˆã—Éq¶Šw•”“Á•Êu‹` i94.10.12j.

2892. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j tˆÚA(Ž©‰ÆtˆÚA, ex vivo surgery‚ðŠÜ‚Þ)‚Ì—Õ°. ‰““¡’‰—Yi”åj: ‘æ17‰ñ“Œ‹ž”å”AŠí‰È§˜b‰ï i94.10.13j, “Œ‹ž.

2893. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ŠwZŒŸ”A‚É‚æ‚茩‚¢o‚³‚ꂽ¬Ž™tŽ¾Š³‚Ì’·ŠúŠÇ—‚Ì–â‘è“_. Žðˆä‹Ši”åj: ‘æ4‰ñ–kŠC“¹¬Ž™t‘Ÿ•aŒ¤‹†‰ï i94.10.29j, ŽD–y.

2894. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j V‚µ‚¢tƒCƒ[ƒWƒ“ƒOÜ99mTc MAG3‚ɂ‚¢‚Ä. ΋´Wi”åj: ƒeƒNƒlMAG3‹L”Ou‰‰‰ï i94.11.05j.

2895. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ƒuƒ‰ƒbƒhƒAƒNƒZƒX. ŒF–ì˜a—Yi”åj: ‘æ3‰ñ‘ŠB“§Í‹ZŽm§˜b‰ï i94.11.20j, ’¬“c.

2896. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ŠwZŒŸ”A“™‚Å”­Œ©‚³‚ꂽ¬Ž™tŽ¾Š³’·ŠúŠÇ—‚Ì”–â‘è‚ÌŒŸ“¢. Žðˆä‹Ši”åj: ‰¡•lŽsˆãŽt‰ïŠwZˆãŒ¤C‰ï i94.11.29j, ‰¡•l.

2897. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “§Í—Ö@‚É‚¨‚¯‚érisk management‚ɂ‚¢‚Ä. Žðˆä‹Ši”åj: ‘æ19‰ñé‹ÊŒ§t•s‘S§˜b‰ïŒ¤‹†”­•\‰ï i94.12.06j, ‘å‹{.

2898. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “ú–{‚̈ã—ÃŒoÏ. ΋´Wi”åj: ˆã—Éq¶Šw•”“Á•Êu‹` i94.12.14j.

2899. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “û—cŽ™‚Ì”A˜HŠ´õÇ. Žðˆä‹Ši”åj: é“ŒˆãŽt‰ïŒã‰‡‰ï i95.01.30j, “Œ‹ž.

2900. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j f’f‚©‚爕û‚Ü‚Å(‡U). ΋´Wi”åj: ì芿•û“¯D‰ï i95.02.10j, ìè.

2901. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j tˆÚA. ‰““¡’‰—Yi”åj: '94‚©‚È‚ª‚ít‘Ÿ•a‚ðl‚¦‚é‰ï i94.10.15j, ‘Š–ÍŒ´.

2902. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ”å”AŠí‰È‚ÆŠ¿•û. ΋´Wi”åj: ‘æ41‰ñ‹³ˆçuÀ i94.10.15j, “Œ‹ž.

2903. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j f’f‚©‚爕û‚Ü‚Å(‡T)‚Ç‚¤‚â‚Á‚Ä“KØ‚ÈŠ¿•û–ò‚ð‘I‚Ô‚©. ΋´Wi”åj: ì芿•û“¯D‰ï i94.11.11j, ìè.

2904. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ”å”AŠí‰È‚Ì•a‹C‚Æ—\–h. ΋´Wi”åj: ‘ãX–Ø’†Œ´‹³‰ïŒã‰‡‰ï i94.12.04j, ‘ãX–Ø.

2905. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j APD—Ö@. ŒF–ì˜a—Yi”åj: ‘æ4‰ñCAPDuÀ i95.02.05j, •Ÿ‰ª.

2906. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j tŽ¾Š³‚ÌŽÀ‘H“I•ÛŒ’Žw“±‚Í‚±‚¤‚·‚é. Žðˆä‹Ši”åj: tŽ¾Š³¥“œ”A•a—\–h‚Ì‚½‚ß‚ÌŒ¤C‰ï i95.03.04j, ‚è.

2907. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j tŽ¾Š³‚ÌŽÀ‘H“I•ÛŒ’Žw“±‚Í‚±‚¤‚·‚é. Žðˆä‹Ši”åj: tŽ¾Š³¥“œ”A•a—\–h‚Ì‚½‚ß‚ÌŒ¤C‰ï i95.03.11j, ŽçŽR.

2908. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j tŽ¾Š³‚ÌŽÀ‘H“I•ÛŒ’Žw“±‚Í‚±‚¤‚·‚é. Žðˆä‹Ši”åj: tŽ¾Š³¥“œ”A•a—\–h‚Ì‚½‚ß‚ÌŒ¤C‰ï i95.03.18j, ·‰ª.

2909. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j UFT‚ÆCimetidine“Š—^‚É‚æ‚è’˜Œø‚ðŽ¦‚µ‚½is«tŠà‚Ì1—á. ‘åì–ƒŽqCŒÃ”¨½”VC{ŽRo•äCŽÄ“c—Y“ñC^‰ºß•vC‰¡ŽR‰p“ñC“à“c–Lºi”åj: ‘æ46‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï i94.06.25j, ‰¡•l.

2910. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j tŠà‚ɑ΂·‚éGenomic instability‚Æp53ˆâ“`Žq‰ðÍ. “à“c–LºC‰¤tŠìC{ŽRˆê•äC‰oìWC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ46‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï i94.06.25j, ‰¡•l.

2911. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j S“d}ã‚Ì‹•ŒŒ«•Ï‰»‚ÆŒŒ´P’l‚ÌŒŸ“¢: Preliminary Report. ‘ºã“ÖC“ñ‘ò½C“c’†G—ÇMCŠÖ–{’B•vC‘å–[Š]CiŽmŒ’C—é–ØO”üC‚‹´¼‘¾˜YC‚‹´Ž‘ŽqC—é–Ø•¶ŽqCŠâè‘•cC•º“¡“§C‰i“c‰ë•viˆÉ“¤‰º“c•a‰@jCŽðˆä ‹Ši”åj: ‘æ9‰ñɪŒ§“Œ•”’n‹æ“§Í•×‹­‰ï i94.11.15j, À’Ã.

2912. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “«CAPDoŒû•”/ƒgƒ“ƒlƒ‹Š´õǂɑ΂·‚éoŒû•”•ÏXp‚Ì—L—p«. ŒÃ”¨½”VCŒF–ì˜a—YC‰¡“c^“ñCŽðˆä‹Ši”åj: ‘æ48‰ñ_“ÞìtŒ¤‹†‰ï‡“¯Œ¤‹†‰ï i94.11.27j, ‰¡•l.

2913. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘SŽ©“®”A’¾ŸÔ‘ª’è‘•’u‚ð—p‚¢‚½tŽ…‹…‘Ì—R—ˆ‚Æ”ñtŽ…‹…‘Ì—R—ˆ”A’†ÔŒŒ‹…‚ÌŠÓ•Ê–@‚Ìì¬. •º“¡“§CŒF–ì˜a—YC–F‰ê½CŽðˆä‹Ši”åj: ‘æ48‰ñ_“ÞìtŒ¤‹†‰ï‡“¯Œ¤‹†‰ï i94.11.27j, ‰¡•l.

2914. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j æ“V«‰AŒsœ^‹ÈÇ‚Ì1—á. ²“¡ˆÐ•¶C‘å–x—C{ŽRo•äC“à“c–LºC‹PºC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ47‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï i94.12.03j, ‰¡•l.

2915. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œ´”­‘ƒG’m•s–¾—Ä‚Å‚ ‚Á‚½Stage‡VB2¸‘ƒ‘ÙŽ™«Šà‚Ì1—á. Ä“¡‹BCŠâ‘º³ŽkC‰¡ŽR‰p“ñC‰““¡’‰—YC¬ŽÄŒ’i”åjC‰¡“c^“ñi‘Š–Í‘äj: ‘æ47‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï i94.12.03j, ‰¡•l.

2916. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Experiences with VLAP and a strategy for better clinical outcome. “à“c–LºC‰oìWC‘å–x—C‹PºC‰¡ŽR‰p“ñC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ3‰ñ”å”AŠí‰ÈŒ¤‹†ŽÒ‰«“êƒtƒH[ƒ‰ƒ€ i95.01.21j, ‰«“ê.

2917. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j t×–EŠà‚Ì“ª”ç“]ˆÚ‚Ì1—á. ‘º–{«rCŠâ‘º³ŽkC{ŽRo•äC‰oìWC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ9‰ñ_“Þ쌧”A˜H«ŠíŠà“]ˆÚŒ¤‹†‰ï i95.02.24j, ‰¡•l.

2918. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ’ጌˆ³‚ÆÔŒŒ‹…‘‘½‚ð’æ‚·‚éCAPDÇ—á‚ÌŒŸ“¢. ‰¡“c^“ñC{ŽRo•äCŒF–ì˜a—YCŽðˆä‹Ši”åj: ‘æ9‰ñ_“Þ쌧CAPDŒ¤‹†‰ï i95.03.18j, ‰¡•l.

2919. mŠwpÜi‘ÛÜjn Presidential Citation Award, American Urological Association (94.05.17), •Ä‘”å”AŠí‰ÈŠw‰ï‰ï’·Ü, ¬ŽÄŒ’i”åj.


<<23 Šá‰ÈŠw>>

2920. mŒ´’˜n Melatonin as a free radical scavenger: theoretical implication for neurodegenerative disorders in the aged. Reiter, R.J.Cˆ¢•”[ŽuiŠájCet al.: Acta Gerontologica, 24: 1994.

2921. mŒ´’˜n Sudden visual loss. Žá‘q‰ë“oCÎì“NiŠáj: Asian Med. J., 37(6): 317`324, 1994.

2922. mŒ´’˜n Sensitivity of nasal and temporal hemiretinas in latent nystagmus and strabismus evaluated using the light reflex. ŠÖ’JŽ¡‹vC’·’JìKŽqCŒü–ì˜a—YCÎì“NiŠáj: Br. J. Ophthalmol., 78: 327`331, 1994.

2923. mŒ´’˜n Vestibulo-ocular reflex abnormality in Vogt-Koyanagi-Harada syndrome. ‰œ‰pOi‘åãˆã‘åjCÎì“NiŠáj: Br. J. Opthalmol., 78: 912`916, 1994.

2924. mŒ´’˜n ”÷—ÊŒ³‘f‚Æ_ŒoŽ¾Š³. ‹{“cŠ²•vCˆ¢•”[ŽuC’Ò‘ò‰F•FiŠáj: Clin. Neurosci., 12: 200`202, 1994.

2925. mŒ´’˜n Neuro-ophthalmic aspects of vascular disease. Žá‘q‰ë“oCÎì“NiŠáj: Cur. Opin. Ophthalmol., 5(6): 18`22, 1994.

2926. mŒ´’˜n Morphological study on glucocorticoid-induced cataract in developing chick embryo. ‰F‰ê–ÎŽOiŠájCHideo Nishigorii’é‹ž‘åjCÎì“NiŠáj: Graefe's Arch. Clin. Exp. Ophthalmol., 232: 415`420, 1994.

2927. mŒ´’˜n Inhibitory effect of melatonin on cataract formation in new born rats: evidenence for an antioxidative role for melatonin. ˆ¢•”[ŽuiŠájCReiter, R.J., et al.: J. Pineal Res., 17: 94`100, 1994.

2928. mŒ´’˜n Response of mouse lens to central needle injury. ‰F‰ê–ÎŽOCQing WanC”µ–ì’·•¶CÎì“NiŠáj: Ophthalmic Res., 26: 181`188, 1994.

2929. mŒ´’˜n Histopathological study of anterior segments of the eye with the intraocular lens in the posterior chamber. ”µ–ì’·•¶Ct–ìŒ÷C¼–{_”VC”’ìTŽ¢C‰F‰ê–ÎŽOCÎì“NiŠáj: Ophthalmologica, 208: 298`303, 1994.

2930. mŒ´’˜n Morphological study on cataractous lens of senescence accelerated mouse (SAM). ¼–{_”VC‰F‰ê–ÎŽOC‹{“cŠ²•vCÎì“NiŠájCKanae YamashitaišŽR—Šw‰@‰@‘åj: Tje SAM Model of Senescence, Elsevier Science B.V. Allrights Reserved., p.251`254,1994.

2931. mŒ´’˜n Cytosolic calcium transient increase through the AMPA/kainate receptor in culured Muller cells. Žá‘q‰ë“oiŠájCŽR–{¸iŠÅŒìŠw•”j: Vision Res., 34(9): 1105`1109, 1994.

2932. mŒ´’˜n ƒXƒ|[ƒc‘IŽè‚É‚¨‚¯‚éuŠÔ’ñŽ¦Žw•W‚ÌŽ‹”F”\—Í. Ž}ìGC–]ŒŽ½ŽqCΊ_®’jiŠáj: ‚ ‚½‚炵‚¢Šá‰È, 11(9): 1994.

2933. mŒ´’˜n Šáâ|“àŽîᇂðp’†k¬‰»‚·‚éH•v. –Ø‘º^–çCŽá‘q‰ë“oCŒü–ì˜a—YiŠáj: Šá‰ÈŽèp, 8(1): 165`169, 1994.

2934. mŒ´’˜n ƒqƒg“µEŠ‡–ñ‹Ø‚É‚¨‚¯‚éƒAƒhƒŒƒiƒŠƒ“Žó—e‘Ì‚Ì‘¶Ý‚ɂ‚¢‚Ä. ‹g•xŒ’ŽuiŠáj: Ž©—¥_Œo, 31(1): 33`37, 1994.

2935. mŒ´’˜n ‰ä‚ª‘‚É‚¨‚¯‚鎋_Œo‰Š‚Ì•p“x‚ÆŽ¡—Â̌»‹µ‚ɂ‚¢‚Ä. Žá‘q‰ë“oCÎì“NiŠájC‘å–ìVŽ¡i²‰êˆã‘åjC“c•£º—Yiìèˆã‘åjC‰ÂŽ™ˆêFiŽ ‰êˆã‘åjC“càV–LiŠâŽèˆã‘åjC’†”ö—YŽOi‹ß‹E‘åjC´àVŒ¹Oi“Œˆã Ž•‘åjC‰Í‡ˆêdiŽœŒb‘åjC‘啽–¾•Fi“Œ‘åjCˆ¾‰®”Ei–¼‘åjCŒÜ\—’•Û’jiŽD–yˆã‘åjC‘O“cCŽiiO‘O‘åjC‰ª–ì’q•¶iL‘åjC™“c–«i“Œ–M‘åj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 99(1): 93`97, 1995.

2936. mŒ´’˜n ŠÂ‹«’†—L‹@‰–‘f‰»‡•¨‚ÌŽÀŒ±“IƒAƒŒƒ‹ƒM[«Œ‹–Œ‰Š‚ւ̉e‹¿. —›‹ÎC‰Ôˆä‹`“¹i‰¡‘‘åjC‹{“cŠ²•vCÎì“NiŠáj: “ú–{Šá‰È‹I—v, 45(5): 475`480, 1994.

2937. mŒ´’˜n –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é–Ô–Œ”—£Š³ŽÒ‚Ì•Ï‘J|10”N‘O‚Æ‚Ì”äŠr|. –Ø‘º^–çC”’ìTŽ¢C•Ÿ“c•q‰ëCª–{“OCÎì“NiŠáj: “ú–{Šá‰È‹I—v, 45: 680`683, 1994.

2938. mŒ´’˜n ƒx[ƒ`ƒFƒbƒg•a‚É‚¨‚¯‚éhŽå‘¤ˆöŽq‚Ɗ‹«ˆöŽq‚ɂ‚¢‚Ä. ‰œ˜eŒ«ˆêiŠáj: —Õ°ŠÂ‹«ˆãŠw, 2(2): 1994.

2939. m€Œ´’˜n Šáâ|Žèp‚É•K—v‚ȉ摜f’f. Œ´’¼lCŽá‘q‰ë“oiŠáj: Šá‰ÈŽèp, 7: 193`200, 1994.

2940. m’Z•ñE‘¬•ñn ƒqƒg“àŠá‹Ø‚ɑ΂·‚éƒGƒ“ƒhƒZƒŠƒ“‚Ìì—p. Îì‹ÏC‹g•xŒ’ŽuCÎì“NiŠáj: _ŒoŠá‰È, 11: 71`75, 1994.

2941. mŒ¤‹†•ñiŒú¶Èjn ”|—{–Ô–ŒF‘fã”ç×–E‚̃XƒgƒŒƒX‰ž“š‚ɂ‚¢‚Ä. Žá‘q‰ë“oiŠáj: Œú¶È“Á’莾Š³¢–Ô–Œ–¬—–ŒˆÞkÇ’²¸Œ¤‹†”Ç£•½¬5”N“xŒ¤‹†•ñ‘, p.22`24, 1994.

2942. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Ž‡ŠOü‚ÆŒ‹–Œ¥Šp–Œ. ‹{“cŠ²•vC´…Œhˆê˜YC“ï”g—´lCˆ¢•”[ŽuiŠáj: ‘¾—zŽ‡ŠOü–hŒäŒ¤‹†ˆÏˆõ‰ïŠwp•ñ, 4: 37`46, 1994.

2943. mÇ—á•ñn ’E‰P…»‘Ì‚É“_ó¬‘÷‚ª‘½””F‚ß‚ç‚ꂽ‚P—á. ”–ØLÆCŒÃ–ì‹v”üŽqiŠájC’¹ŠC‚µ‚Ì‚Ôi’¹ŠCŠá‰ÈjC‰F‰ê–ÎŽOCÎì“NiŠáj: ‚ ‚½‚炵‚¢Šá‰È, 11: 109`112, 1994.

2944. mÇ—á•ñn PCR–@‚É‚ÄÉŽq‘Ì‚æ‚è…“—¥‘Ñóáv]ƒEƒBƒ‹ƒX‚ªŒŸo‚Å‚«‚½‹Ë‘òŒ^‚Ô‚Ç‚¤–Œ‰Š‚Ì‚P—á. ”µ–ì’·•¶C¯ŽiŽ¡‘ãC”’ìTŽ¢iŠáj: Šá‰È, 36: 1655`1658, 1994.

2945. mÇ—á•ñn ‘å‚«‚È–Ô–ŒF‘fã”ç—ôE‚ƌ㕔‹­–Œ‰Š‚ð’悵‚½‹­”çÇŠ³ŽÒ‚Ì‚P—á. ²“¡”üØŽqC¡“c–LC‰œ˜eŒ«ˆêC‹{“cŠ²•viŠáj: “ú–{Šá‰È‹I—v, 45: 762`765, 1994.

2946. m‘àn “àŠá‹Ø–ƒáƒ|•a‘Ô‹@˜¥ŒŸ¸–@¥ŠÖ˜AŽ¾Š³|. “y‰®–M•FC”’ìTŽ¢iŠáj: Brain and Nerve, 46(11): 1021`1028, 1994.

2947. m‘àn ƒgƒƒsƒJƒ~ƒh; ƒAƒ‹ƒcƒnƒCƒ}[•a‚Ìf’f‚É—LŒø‚©H Žá‘q‰ë“oC’Ò‘ò‰F•FiŠáj: Mebio, 12(4): 90`93, 1995.

2948. m‘àn ƒeƒNƒmƒXƒgƒŒƒXŠáǂɂ‚¢‚Ä. Îì“NC–ؔÉiŠáj: Pharma Medica, 12(6): 13`16, 1994.

2949. m‘àn ‹ßŽ‹‚ƃAƒŒƒ‹ƒM[‚É‚æ‚é–Ú‚Ì•a‹C. “ï”g—´liŠáj: ‰ä‚ªŽq‚Í’†Šw¶, (184): 26`31, 1994.

2950. m‘àn Ž‹_ŒoŽ¾Š³‚ÌÅ‹ß‚ÌŽ¡—Ö@|The current management for optic neuropathy|. Žá‘q‰ë“oiŠáj: Šá‰È, 37(2): 153`158, 1995.

2951. m‘àn –Ñ—l‘Ì‹Ø‚Ì–ò—Šw“I«Ž¿. ‹g•xŒ’ŽuiŠáj: Ž©—¥_Œo, 31(1): 5`7, 1994.

2952. m‘àn –Ô–Œ_Œo‹Ø×–E|˜˜_|. Žá‘q‰ë“oiŠáj: _ŒoŠá‰È, 11(3): 257`262, 1994.

2953. m‘àn Šª“ªŒ¾. Îì“NiŠáj: _ŒoŠá‰È, 11: 1`2, 1994.

2954. m‘àn ‹U”]Žîá‡; Pseudotumor cerebri (John B.Selhorst–ó). Vˆä“cF—TiŠáj: _ŒoŠá‰È, 11: 47`51, 1994.

2955. m‘àn Ž¿‹^‰ž“š: Œã“V«ŠáUŽ‘±—á‚Ì“®—hŽ‹‚Ì—}§–@‚ɂ‚¢‚Ä. Îì“NiŠáj: _ŒoŠá‰È, 11: 92, 1994.

2956. m‘àn ŠááÙ‰º‚‚Ì—Õ°. Œü–ì˜a—Yiˆã—Éq¶Šw•”j: “ú–{‚ÌŠá‰È, 65(7): 741`746, 1994.

2957. m‘àn ƒVƒ“ƒ|ƒWƒEƒ€; _ŒoŠá‰ÈŠw“I—§ê‚©‚ç|Šááق̉ð–U‚ƶ—, ‰º‚‚Ìf’f|. Œü–ì˜a—YiŠáj: “ú–{Šá‰È‹I—v, 45(6): 585`589, 1994.

2958. mŠwp‘n i•ª’SŽ·•Mj Šá‰Èf—Ãvƒ‰ƒNƒeƒBƒX11; ‘M‹PˆÃ“_‚ƕГª’É, p.224`225, Žá‘q‰ë“oiŠáj. •¶Œõ“°, “Œ‹ž, 94.04.25”­s.

2959. mŠwp‘n i•ª’SŽ·•Mj Šá‰Èf—Ãvƒ‰ƒNƒeƒBƒX11; –ò•¨‚É‚æ‚é–Ô–ŒáŠQ, p.186`189, ‹{“cŠ²•viŠáj. •¶Œõ“°, “Œ‹ž, 94.04.25”­s.

2960. mŠwp‘n i•ª’SŽ·•Mj Šá‰Èf—Ãvƒ‰ƒNƒeƒBƒX11; ‹Ø–³—ÍÇiŠá‹ØŒ^), p.232`234, Œü–ì˜a—Yiˆã—Éq¶Šw•”j. •¶Œõ“°, “Œ‹ž, 94.04.25”­s.

2961. mŠwp‘n i•ª’SŽ·•Mj Šá‰È New Insight 1 Ž‹Šoî•ñˆ—; 1. Ž‹Šoî•ñ‚Ì—¬‚êi—Õ°“I”–â‘è‚Ì—‰ð‚ð[‚߂邽‚ß‚É), Žá‘q‰ë“oiŠáj.

2962. mŠwp‘n i•ª’SŽ·•Mj Šá‰Èf—Ãvƒ‰ƒNƒeƒBƒX; ‚₳‚µ‚¢_ŒoŠá‰È|ŒõŽ‹Ç¥‘M‹PˆÃ“_, p.140`143, Žá‘q‰ë“oiŠáj. •¶Œõ“°, 94.11.17”­s.

2963. mŠwp‘n i•ª’SŽ·•Mj Šá‰Èf—Ãvƒ‰ƒNƒeƒBƒX; ‘¤“ª“®–¬‰Š, p.66`67, Žá‘q‰ë“oiŠáj. •¶Œõ“°, 94.11.07”­s.

2964. mŠwp‘n i•ª’SŽ·•Mj Šá‰Èf—Ãvƒ‰ƒNƒeƒBƒX; •úŽËü–Ô–ŒÇ, p.232`233, Žá‘q‰ë“oiŠáj. •¶Œõ“°, 94.11.07”­s.

2965. mŠwp‘n i•ª’SŽ·•Mj Šá‰Èf—Ãvƒ‰ƒNƒeƒBƒX; Šá‹Ø–ƒáƒ, p.272`273, Žá‘q‰ë“oiŠáj. 94.11.07”­s.

2966. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈƒNƒ‹ƒYƒX; Šá‹…‰^“®, A: Šá‹…‰^“®‚Ì‹@˜‚ÆŒŸ¸i\‘¢, _ŒoŽx”z, çtçs, EMG‚ðŠÜ‚Þ), p.598`606, Žá‘q‰ë“oiŠáj. 94.11.07”­s.

2967. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈƒNƒ‹ƒYƒX; Šá‹…‰^“®AB: Šjã«Šá‹…‰^“®áŠQ, p.607`610, Žá‘q‰ë“oiŠáj. 94.11.07”­s.

2968. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈƒNƒ‹ƒYƒX; Šá‹…‰^“®, C: ŠjŠÔ«Šá‹…‰^“®áŠQ, p.611, Žá‘q‰ë“oiŠáj. 94.11.07”­s.

2969. mŠwp‘n i•ª’SŽ·•Mj Šá‰Èf—à Q & A; ‘æ15†, ‹}«“Á”­«Ž‹_Œo‰Š‚Ì”­Ç‚ÆŽ¡—ÂÌó‹µ, p.104`105, Žá‘q‰ë“oiŠáj. ˜Z–@o”ÅŽÐ, “Œ‹ž, 94.12.19”­s.

2970. mŠwp‘n i•ª’SŽ·•Mj Šá‰Èf—Ãvƒ‰ƒNƒeƒBƒX; Ž‹–쌇‘¹, p.15`19, Žá‘q‰ë“oiŠáj. •¶Œõ“°, 95.01.01”­s.

2971. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈŒŸ¸–@ƒnƒ“ƒhƒuƒbƒN(‘æ2”Å); ‘¼Šo’²ßŒŸ¸, p.72`74, ‰LŽ”ˆê•FiŠáj. 95.01.15”­s.

2972. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈŒŸ¸–@ƒnƒ“ƒhƒuƒbƒN(‘æ2”Å); ƒXƒNƒŠ[ƒjƒ“ƒOŽ‹–ìŒviOKP), p.137`140, Žá‘q‰ë“oiŠáj. 95.01.15”­s.

2973. mŠwp‘n i•ª’SŽ·•Mj Šá‰È New Insight 1, Ž‹Šoî•ñˆ—; “µE (pupillography), p.137`141, ”’ìTŽ¢iŠáj.

2974. mŠwp‘n i•ª’SŽ·•Mj Šá‰ÈŠw‘åŒn10|‰Á—î‚ÆŠá; ‰Á—î‚Æ“µE, p.163`166, ”’ìTŽ¢iŠáj. 95.03.00”­s.

2975. mŠwp‘n i•ª’SŽ·•Mj Šá‰È New Insight 1 Ž‹Šoî•ñˆ—; ‡U Ž‹Šoî•ñˆ—‰ß’öiŽ‹˜H‚É‚¨‚¯‚éƒOƒ‹ƒ^ƒ~ƒ“Ž_Žó—e‘Ì‚Æ‚»‚Ì–ðŠ„), Žá‘q‰ë“oiŠáj.

2976. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j –Ô–Œ_Œoß×–E‚ÌŠî‘b. Žá‘q‰ë“oiŠáj: ‰¡•l‘Û•½˜a‰ï‹c i94.08.00j, ‰¡•l.

2977. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Abnormalities of the autonomic nervous system seen in patients who have silicon breast implants. ”óŒû—T•FCÎì“NiŠájCRea, W.J.: 12th Annual International Symposium on Man and His Environment in Health and Disease i94.00.00j, ƒ_ƒ‰ƒX.

2978. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j AndersonŽèp‚Ìæ“VŠáU‚ÌÇ—á|“Á‚É–³Œø—á‚ÉŠÖ‚·‚錟“¢|. ”g˜C‰hŽqC¼–ìÊŽqC–ؔÉCÎì“NiŠáj: ‘æ19‰ñ“ú–{¬Ž™Šá‰ÈŠw‰ï i94.04.01`02j, ‘q•~.

2979. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Mechanism of experimental corneal graft rejection in the rat. •ÐŒ©—¤•viŠáj: Cambridge Ophthalmic Symposium i94.09.15j, ƒCƒMƒŠƒX.

2980. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Nicotinic acetylcholine receptors in cultured retinal neurons. Žá‘q‰ë“oCìè‚¢‚ÂÝiŠáj: JERMOV (Joint European Research Meetings in Ophthalomogy and Vision) i94.11.15`19j, France.

2981. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Possible role of the ampal ka receptor in cultured Muller cells. ìè‚¢‚ÂÝCŽá‘q‰ë“oiŠájCŽR–{¸iŠÅŒìŠw•”j: JERMOV (Joint European Research Meetings in Ophthalomogy and Vision) i94.11.15`19j, France.

2982. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Frequency of mitochondrial DNA mutations in Leber's hereditary optic neuropathy (LHON). Yamada, K.CMashima, Y.CHida, Y.CŽá‘q‰ë“oiŠájCOguchi, Y.: JERMOV (Joint European Research Meetings in Ophthalomogy and Vision) i94.11.15`19j, France.

2983. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Aldose reductase inhibitor treatment for diabetic ophthalmoparesis. ¯ŽiŽ¡‘ãCŽá‘q‰ë“oCÎì“NiŠáj: JERMOV (Joint European Research Meetings in Ophthalomogy and Vision) i94.11.15`19j, France.

2984. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Accommodative function in partial Horner syndrome. –Ø‘º^–çC{“¡‚¢‚æ‚èiŠáj: JERMOV (Joint European Research Meetings in Ophthalomogy and Vision) i94.11.15`19j, France.

2985. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Accommodative and pupilliary after effects following near vision in subjects with and without eyestrain. “y‰®–M•FC‰LŽ”ˆê•FC‹g•xŒ’ŽuC‘å’Ë‹I‰ÀC•ŸŒ´‰ë”VCÎì“NiŠáj: Annual Meeting of Association for Research in Vision and Ophthalmology i94.05.01`06j, ƒTƒ‰ƒ\ƒ^.

2986. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Adrenergic receptors affect accommodation by modulating cholinergic activity. ‘å’Ë‹I‰ÀC“y‰®–M•FC‰LŽ”ˆê•FC‹g•xŒ’ŽuCÎì“NiŠáj: Annual Meeting of Association for Research in Vision and Ophthalmology i94.05.01`06j, ƒTƒ‰ƒ\ƒ^.

2987. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Component estimation of pupillary light reflex. •ŸŒ´‰ë”VC‰LŽ”ˆê•FC‹g•xŒ’ŽuC“y‰®–M•FC‘å’Ë‹I‰ÀC¬’¬—SŽqiŠáj: Annual Meeting of Association for Research in Vision and Ophthalmology i94.05.01`06j, ƒTƒ‰ƒ\ƒ^.

2988. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Different actions of substance P and histamine on IRIS sphincter muscles of rabbit and human. ‹g•xŒ’ŽuCÎì‹ÏCt–ìŒ÷CÎì“NiŠáj: Annual Meeding of Association for Research in Vision and Ophthalmology i94.05.01`06j, ƒTƒ‰ƒ\ƒ^.

2989. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical features of Japanese Leber's herediary optic neuropathy with the 11778 mutation. Y. HottaCF. AraCK. FujikiCA. NakajimaCA. KanaiCY. MashimaCY. HiidaCK. ShinodaCK. YamadaCY. OguchiCŽá‘q‰ë“oCÎì“NiŠájCM. NakamuraCJ. SakaiCM. YamamotoCT. HayashiCI. MitaniCS. MiyazakiCM. ShimookuCJ. ImachiCY. IsashikiCN. OhbaCN. KuniyoshiCS. Nagataki: ARVO i94.05.01`06j, ƒTƒ‰ƒ\ƒ^, Investigative Ophthalmology & Visual Science, 35(4), 1994.

2990. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Optic neuritis treatment by intravenous administration of ascorbic acid (AC): A comparative study with corticosteroids and methylcobalamin. Îì“NCŽs•Ó‹`ÍCŽs•ÓO”üCŒü–ì˜a—YiŠáj: INOS i94.06.06j, ƒhƒCƒc.

2991. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Evidence for only subtle afferent pupillary defect in Leber's hereditary optic neuropathy. Žá‘q‰ë“oC‰¡]~ŽqiŠáj: INOS i94.06.09j, ƒhƒCƒc.

2992. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j A case of spasm of convergence and accommodation with pupil sparing. ¬ì‘דTCÎì“NC“y‰®–M•FCÎì“NiŠáj: INOS i94.06.09j, ƒhƒCƒc.

2993. mŠw‰ïi‘S‘jn i“Á•Êu‰‰j ’†“Å«Šá‹…‰^“®ˆÙíiŽå‚É—L‹@—ÓÜ). Îì“NiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.18j, ‘åã.

2994. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j VDTŠá¸”æ˜JŠ³ŽÒ‚ÌŽ©—¥_Œo–òÜ‚ð’†S‚Æ‚µ‚½Ž¡—Ã. Îì“NiŠáj: “ú–{Ž©—¥_ŒoŠw‰ï‘‰ï i94.00.00j,

2995. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹üÜ, ’²ß. “ï”g—´liŠáj: ‘æ60‰ñ“ú–{’†•”Šá‰ÈŠw‰ï i94.10.01j, _ŒË.

2996. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Šá‹…‰^“®. Œü–ì˜a—Yiˆã—Éq¶Šw•”j: ‘æ60‰ñ“ú–{’†•”Šá‰ÈŠw‰ï i94.10.01j, _ŒË.

2997. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “ªŒz•”Ž©—¥_Œo‚Ì‹@”\‚Æ•a‘Ô. Îì“NiŠájC‹v•Û•iŽ¨•@j: ‘æ47‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï i94.10.20j, ‘åã.

2998. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “µE‘ÎŒõ”½‰ž‚ÆŽ©—¥_Œo‹@”\. ”’ìTŽ¢iŠáj: ‘æ47‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï i94.10.20j, ‘åã, Ž©—¥_Œo, 32(3), 1995.

2999. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ž‹—͂ƃXƒ|[ƒc; ƒXƒ|[ƒc‚ðs‚¤ã‚Å“ü—ÍŒn‚Æ‚µ‚Ä‚ÌŠá‚Ìd—v«‚ɂ‚¢‚Ä. Ž}ìGiŠáj: ‘æ21‰ñ“ú–{ƒXƒ|[ƒcS—Šw‰ï i94.11.17`18j, Žl“úŽs.

3000. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”|—{‰Æ“eƒ~ƒ…[ƒ‰[×–E‚É‚¨‚¯‚é_Œo“Å«ƒAƒ~ƒmŽ_‚̉e‹¿. ìè‚¢‚ÂÝCŽá‘q‰ë“oiŠájCŽR–{¸iŠÅŒìŠw•”j: ‘æ98‰ñ“ú–{Šá‰ÈŠw‰ï i94.04.21j, ‰¡•l.

3001. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒŒ[ƒxƒ‹•aŽ‹_ŒoÇ‚É‚¨‚¯‚éƒ~ƒgƒRƒ“ƒhƒŠƒA DNA•ÏˆÙ‚̈â“`ŽqŒ^‚̉ðÍ. ^“‡s•FC”ê“c–FŽ÷C²‰ê³“¹C¬Œû–F‹viŒc‘åjCŽá‘q‰ë“oiŠájC‹C‰ê‘òˆê‹PCìè•×C´‘òŒ¹O: ‘æ98‰ñ“ú–{Šá‰ÈŠw‰ï i94.04.21j, ‰¡•l.

3002. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚wü”’“àá‚Ì”­¶‹@˜‚ÉŠÖ‚·‚éŒ`‘ÔŠw“IŒ¤‹†. ‰F‰ê–ÎŽOiˆã—Éq¶Šw•”jC¬Œ´Šì—²iàÕ‹¦ˆã‘åjC’|•@áÁi‹¤—§–ò‘åjC¼•”G•vi’é‹ž‘åjC•D“cŒõŽjCp¶Š°”ViŽQ“V»–òj: ‘æ98‰ñ“ú–{Šá‰ÈŠw‰ï i94.04.22j, ‰¡•l.

3003. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒŒ[ƒxƒ‹Ž‹_ŒoÇ‚É‚¨‚¯‚é•ÏˆÙŒ^ƒ~ƒgƒRƒ“ƒhƒŠƒA DNA‚Ì SSCP–@‚É‚æ‚éƒwƒeƒƒvƒ‰ƒXƒ~[‚Ì’è—Ê“I‰ðÍ. ²‰ê³“¹C^“‡s•FC”ê“c–FŽ÷C¬Œû–F‹vCH“¡ƒC´…M‹`iŒc‘åjCŽá‘q‰ë“oC‹g‰i½ŽqiŠáj: ‘æ98‰ñ“ú–{Šá‰ÈŠw‰ï i94.04.22j, ‰¡•l.

3004. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ}ƒEƒXŠO«”’“àá‚Ì”­¶‹@˜. ”µ–ì’·•¶C‰F‰ê–ÎŽOCÎì“NiŠáj: ‘æ98‰ñ“ú–{Šá‰ÈŠw‰ï i94.04.22j, ‰¡•l.

3005. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ºŽÎ‹Ø‰ß“®Ç‚ɑ΂·‚éŽèpŒø‰Ê. ¯Ži—ÏŽqCA¼iŽqC“¡ŽR—R‹IŽqC–ؔÉCÎì“NiŠáj: ‘æ50‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘‰ï i94.09.17j, “Œ‹ž.

3006. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ÉŽq‘ÌŽèp’¼Œã‚É”­Ç‚µ‚½‹•ŒŒ«Ž‹_ŒoÇ‚Ì‚PÇ—á. ’†—¢éKC”’ìTŽ¢C–{ŠÔŒ[‘ CÎì“NiŠáj: ‘æ60‰ñ“ú–{’†•”Šá‰ÈŠw‰ï i94.09.30j, _ŒË.

3007. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –¬—–ŒŽîᇂª‹^‚í‚ꂽ•úü‹Û‚É‚æ‚é–¬—–Œ‰º”^ᇂ̂P—á. ‰Ô—ÖŽç•FC²“¡”üØŽqC‰œ˜eŒ«ˆêC¡“c–LC‹{“cŠ²•viŠáj: ‘æ60‰ñ“ú–{’†•”Šá‰ÈŠw‰ï i94.09.30j, _ŒË.

3008. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ~ƒgƒRƒ“ƒhƒŠƒAˆâ“`Žq‚Ì11778”Ô‰–Šî‘ΈÙí‚ð‚à‚ƒŒ[ƒxƒ‹•a‚Ì—Õ°‘œ. –x“cŠì—TC“¡–ØŒcŽqC‘ì‚Þ‚ÂŽqC’†“‡ÍC‹àˆä~C^“‡s•FC”ê“c–FŽ÷CŽÂ“cŒ[CŽR“cŒbŽqC¬Œû–F‹vCΓc‚Ý‚³ŽqCâÊ“‡ŒªŽŸCŽá‘q‰ë“oCÎì“NiŠájC’† ‘º½Câˆä÷CŽR–{ßC—ÑŒöŽqCŽO’JˆêŽOC‹{è–ΗYC‰º‰œmCˆäŠX÷CˆÉ²•~–õC‘å’ë‹I—YC‘‹g’¼”üC’·‘ëd’q: ‘æ48‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i94.11.04j, –‹’£.

3009. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰QÖ¬‚©‚ç‚ÌŒŒs«“]ˆÚ‚É‚æ‚Á‚½Šáâ|“à‚Ì‹‘å‚Ȉ««•FŽî. ŽO‘î²CŽá‘q‰ë“oCÎì“NiŠájC‹T’J“Oi•a—j: ‘æ48‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i94.11.04j, –‹’£.

3010. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 14484‚Ì“_“Ë‘R•ÏˆÙ‚ð—L‚µ‚½ƒŒ[ƒxƒ‹•a‚Ì‚P—á. Žs•Ó‹`ÍCŽá‘q‰ë“oCÎì“NiŠájC^“‡s•FiŒc‘åj: ‘æ48‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i94.11.04j, –‹’£.

3011. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬“û“ª‚ðŽ¦‚µ‚½Ž‹‹@”\‰ñ•œ•s—Ç‚ÈŽ‹_ŒoÇ. ”ä‰Ã—˜¹ŽqC‘å–ìWŽiCŽá‘q‰ë“oC¡“c–LCÎì“NiŠáj: ‘æ48‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i94.11.04j, –‹’£.

3012. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŽÀŒ±“IƒAƒŒƒ‹ƒM[«Œ‹–Œ‰Š‚Ö‚Ì“dŽ¥”g‚̉e‹¿. –x“à_ŽjC“ï”g—´lC‹{“cŠ²•vCÎì“NiŠáj: ‘æ48‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i94.11.04j, –‹’£.

3013. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “µEŽ‹–ìŒviPupil Perimetryj‚ÌŽŽì. ‹g•xŒ’ŽuC“¡“c“NC¼ˆäFŽqC’·]®”üCŒü–ì˜a—YCÎì“NiŠáj: ‘æ48‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï‘‰ï i94.11.05j, –‹’£.

3014. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒXƒeƒƒCƒhˆË‘¶«‚Ì‹­‚©‚Á‚½‰EŠáâ|ë’[ÇŒóŒQ, ¶Ž‹_ŒoÇ‚Ì‚P—á. ŽO‘î²CŽá‘q‰ë“oCŽs•Ó‹`ÍCÎì“NiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.17j, ‘åã.

3015. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Scanning laser polarimeter‚ð—p‚¢‚½ nerve fiber layer‚ÌŒú‚Ý‚ÉŠÖ‚·‚é’è—Ê“IŒŸ“¢; (1) ‚»‚ÌŒ´—‚ÌŠT—ª‚ƳíŽÒ‚̉Á—î•Ï‰». ŽR–{–¾ŽqCŽá‘q‰ë“oC‘å–ìWŽiC”ä‰Ã—˜¹ŽqCÎì“NiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.17j, ‘åã.

3016. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Scanning laser polarimeter‚ð—p‚¢‚½ nerve fiber layer‚ÌŒú‚Ý‚ÉŠÖ‚·‚é’è—Ê“IŒŸ“¢; (2)‹üÜ’l‚É‚æ‚é·ˆÙ‚Æ“û“ªŒa‚Ì•ªÍ. ‘å–ìWŽiCŽá‘q‰ë“oCŽR–{–¾ŽqC”ä‰Ã—˜¹ŽqCÎì“NiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.17j, ‘åã.

3017. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘å”]«FŠoˆÙí‚ð‹^‚Á‚½‚P—á. ’†‘ò³”ŽCª–{“OC‹g“cŠ°iŠájC”“cr¬i“s—§_Œo•a‰@j: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.18j, ‘åã.

3018. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÓ•ÐŠáŠá‹…‰^“®‚É‚¨‚¯‚éƒo[ƒWƒFƒ“ƒX‚ƃTƒbƒP[ƒh‚Ì‘ŠŒÝì—p. A¼iŽqCŽR“c“OlC‰LŽ”ˆê•FiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.18j, ‘åã.

3019. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œ´ˆö•s–¾‚Ì…•½« slow saccades‚Ì‚P—á. Œ´’¼lCŽs•Ó‹`ÍCVˆä“cF—TCŒü–ì˜a—YCÎì“NiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.18j, ‘åã.

3020. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ÉŽ_ƒƒ`ƒ‹ƒAƒgƒƒsƒ“Ã’‚ª—LŒø‚Å‚ ‚Á‚½‹ßŒ©”½‰žáz¹‚Ì‚PÇ—á. —é–Ø–í¶C–{ŠÔŒ[‘ C“ï”g—´lCÎì“NiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.18j, ‘åã.

3021. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “µEŽ‹–ìŒvipupil perimetryj‚É‚æ‚铯–¼”¼–ÓŠ³ŽÒ‚ÌŽ‹–쑪’è‚ÌŽŽ‚Ý. “¡“c“NC‹g•xŒ’ŽuC¼ˆäFŽqC’·]®”üCŒü–ì˜a—YCVˆä“cF—TCÎì“NiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.19j, ‘åã.

3022. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “µE‘ÎŒõ”½‰ž‚Ìk“µ‘Š‚É‚¨‚¯‚éŒðŠ´_Œo‚̉e‹¿|cŠuŽîá‡pŒã Horner ÇŒóŒQ‚ÌÇ—á‚É‚æ‚錟“¢|. ”’ìTŽ¢C’Ò‘ò‰F•FC“ï”g—´liŠájC•i“cƒi‹¹ŠOj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.19j, ‘åã.

3023. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¯ó_Œo߃uƒƒbƒN‚Ì‹üÜ‹y‚Ñ’²ß‚É‹y‚Ú‚·‰e‹¿. {“¡‚¢‚æ‚èC–Ø‘º^–çC”Ñ“c“ÖŽqC–؉º•×C“y‰®–M•FC‹g•xŒ’ŽuC‰LŽ”ˆê•FiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.19j, ‘åã.

3024. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j SPECT‹y‚Ñ GaƒVƒ“ƒ`‚Å•a‘ƒ‚ª„’è‚Å‚«‚½ŠJŽU–ƒáƒ, ‚’¼Šá‹…‰^“®áŠQ‚̬Ž™—á. ’†¼L‰hCŒ´’¼lC•y‰ª•q–çCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.19j, ‘åã.

3025. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚Ɗዾ•¹—p‚É‚æ‚é oscillopsia‚Ì—}§–@. ŠCã‹v”üŽqCVˆä“cF—TC‰LŽ”ˆê•FCÎì“NiŠáj: ‘æ32‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï i94.11.19j, ‘åã.

3026. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —Ü‘B‘½Œ^«‘BŽîÄ”­‚Å‚R‰ñ–Ú‚ÌŽîᇓEop‚ðs‚Á‚½Ç—á. ‰Ô—ÖŽç•FCŽá‘q‰ë“oiŠáj: ‘æ9‰ñŠáâ|Ž¾Š³ƒVƒ“ƒ|ƒWƒEƒ€ i94.11.25`26j, “Œ‹ž.

3027. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •s“¯Ž‹ŽãŽ‹‚É‚¨‚¯‚鎋ŠoŠ´“x‚ÌŒŸ“¢. ’·]®”üCVˆä“cF—TCÎì“NiŠáj: ‘æ35‰ñ“ú–{Ž‹”\‹¸³Šw‰ï i94.11.27j, “Œ‹ž.

3028. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒŒnƒ‰ƒbƒg‚ÌŠp–ŒˆÚA‹‘┽‰ž‚É‚¨‚¯‚éŠp–ŒŒa‚Ì‘å‚«‚³‚ƈÚA‚³‚ê‚é•”ˆÊ‚Ìd—v«. •ÐŒ©–r•viŠáj: ‘æ11‰ñ“ú–{Šp–ŒˆÚAŠw‰ï i95.02.10j, ‹ž“s.

3029. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j —L‹@ƒQƒ‹ƒ}ƒjƒEƒ€‰»‡•¨‚ÌŠá“àˆÚs‚ɂ‚¢‚Ä. ¼–{_”VC‰F‰ê–ÎŽOC‹{“cŠ²•vCÎì“NiŠájCŠ`–{‹I”ŽióˆäƒQƒ‹ƒ}ƒjƒEƒ€Œ¤j: ‘æ98‰ñ“ú–{Šá‰ÈŠw‰ï i94.04.21j, ‰¡•l.

3030. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚wü”’“àá‚Ì”­Ç‚ƃ^ƒ“ƒpƒNŽ¿‚̕ω». ’|•@áÁi‹¤—§–ò‰ÈjC¼•”G•vi’é‹ž‘åjC‰F‰ê–ÎŽOiŠájC¬Œ´Šì—²C•D“cŒõŽj: ‘æ98‰ñ“ú–{Šá‰ÈŠw‰ï i94.04.21j, ‰¡•l.

3031. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j —L‹@—Ó”_–ò Fenitrothin‚̉Ɠe‘gD“àŽc—¯. –{ŠÔŒ[‘ C’†—¢éKC‹{“cŠ²•vCÎì“NiŠáj: ‘æ98‰ñ“ú–{Šá‰ÈŠw‰ï i94.04.22j, ‰¡•l.

3032. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j H•iF‘f‚É‚æ‚éŽÀŒ±“IƒXƒM‰Ô•²ƒAƒŒƒ‹ƒM[«Œ‹–Œ‰Š. ’†ŽR‰F•Fi–kŒ¤jC“ï”g—´lC‹{“cŠ²•vCÎì“NiŠáj: ‘æ98‰ñ“ú–{Šá‰ÈŠw‰ï i94.04.22j, ‰¡•l.

3033. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j Ž‹_Œo‰Š‚Ì—Õ°. Žá‘q‰ë“oiŠáj: ç‘ã“cŠá‰Èˆã‰ï3ŒŽ—á‰ï i95.03.10j, “Œ‹ž.

3034. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j —Γàá‚Æ‚»‚Ì—ÞŽ—Ž¾Š³. Žá‘q‰ë“oiŠáj: ÓìŠá‰Èˆã‰ï i94.09.20j, ‰¡{‰ê.

3035. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Treatment of congenital nystagmus by biofeedback and acupuncture. Îì“NC¬‘òŽ¡•vC“¡ŽR—R‹IŽqiŠáj: ‘æ45‰ñ“ú–{“Œ—mˆãŠw‰ïŠwp‘‰ï i94.05.13`15j, _ŒË.

3036. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Leber's idiopathic stellate neuroretinitis‚ÆŽv‚í‚ꂽ‚P—á. ¡“c–LC‰œ˜eŒ«ˆêC²“¡”üØŽqCŽá‘q‰ë“oiŠáj: ŠÖ“ŒŠá‰ÈŠw‰ï i94.06.11j, “Œ‹ž.

3037. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ž‹_Œo‰Š‚Ìf’f‚ÆŽ¡—Ã. Îì“NiŠáj: ŠÖ“ŒbM‰zŠá‰ÈŠw‰ï i94.11.13j, ‰¡•l.

3038. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j –Ô–ŒF‘f•Ï«Ç‚É‚¨‚¯‚錌’†”÷—ÊŒ³‘f‚̃Œƒxƒ‹‚ɂ‚¢‚Ä. ŽR–{–¾ŽqC”óŒû—T•FCŽá‘q‰ë“oiŠáj: –Ô–Œ–¬—–ŒˆÞkÇ’²¸Œ¤‹†”Ç i95.01.20`21j, ‹ž“s.

3039. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ”|—{‰Æ“eƒ~ƒ…[ƒ‰[×–E‚É‚¨‚¯‚é AMPAŽó—e‘Ì‚Ì–ðŠ„‚Ì„’è. ìè‚¢‚ÂÝiŠájCŽR–{¸iŠÅŒìŠw•”jCŽá‘q‰ë“oiŠáj: –Ô–Œ–¬—–ŒˆÞkÇ’²¸Œ¤‹†”Ç i95.01.20`21j, ‹ž“s.

3040. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j _ŒoŠá‰È‚©‚ç‚Ý‚½—Γàá. Žá‘q‰ë“oiŠáj: ‘æ23‰ñ“Œ‹ž—Γàá’k˜b‰ï i94.07.09j, “Œ‹ž.

3041. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j Ž‹_Œo“û“ª‚ÉŠÜ‚Ü‚ê‚é–L•x‚Èî•ñ. Žá‘q‰ë“oiŠáj: ‘æ64‰ñ_“Þ쌧Šá‰ÈW’k‰ïi_“ÞìˆãŠw‰ï‘‰ïŠá‰È•ª‰È‰ïj i94.10.23j, ‰¡•l.

3042. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j “û“ªŠŒ©‚Ìf’f“IˆÓ‹`. Žá‘q‰ë“oiŠáj: ‘æ11‰ñ‘啪ˆã‰È‘åŠwŠá‰ÈŒ¤‹†‰ï i95.02.04j, ‘啪.

3043. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒ}ƒEƒX…»‘ÌÃ’u”|—{–@, ƒRƒ“ƒgƒ[ƒ‹Œn‚ÌŠm—§‚ɂ‚¢‚Ä. •Ÿ“‡ˆêÆiŠáj: ‘æ7‰ñƒQƒ‹ƒ}ƒjƒEƒ€Œ¤‹†‰ï i94.00.00j, _“Þì.

3044. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘O–[…úŽh×–Ef‚ÅŠm”F‚³‚ꂽ‘Sgˆ««ƒŠƒ“ƒpŽî‚É‚æ‚é‚Ô‚Ç‚¤–Œ‰Š. ”ä‰Ã—˜¹ŽqC¡“c–LCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ63‰ñ_“Þ쌧Šá‰ÈW’k‰ï i94.09.01j, ‰¡•l.

3045. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Š´õ«S“à–Œ‰Š‚É”º‚Á‚½–Ô–ŒŒŒŠÇ‰Š‚Ì‚P—á. ”µ–ì’·•¶CŽá‘q‰ë“oiŠájCŒÜ–ì—R‰À—C‰ª“cƒi“àj: ‘æ22‰ñ–k—¢‘åŠw¥_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.12.08j, _“Þì.

3046. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘½”‚ÌŒuŒõ˜Ro“_‚ð”F‚ß‚½’†S«Ÿ÷‰t«–Ô–Œ—–ŒÇ‚Ì‚P—á. •y‰ª•q–çCŽá‘q‰ë“oiŠáj: ‘æ22‰ñ–k—¢‘åŠw¥_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.12.08j, _“Þì.

3047. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹´–{•a, dÇ‹Ø–³—Íǂɇ•¹‚µ‚½—¼‘¤Ž‹_ŒoÇ. —é–Ø–í¶C“ï”g—´lCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ22‰ñ–k—¢‘åŠw¥_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.12.08j, _“Þì.

3048. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “Á”­«Ž‹_Œo‰Š‚ðŒ_‹@‚ɃŒ[ƒxƒ‹•a‚ð”­Ç‚µ‚½‚ÆŽv‚í‚ꂽ‚PÇ—á. –Ζؒ©ŽqCŽá‘q‰ë“oCŽs•Ó‹`ÍCŒ´’¼lCÎì“NiŠáj: ‘æ22‰ñ–k—¢‘åŠw¥_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.12.08j, _“Þì.

3049. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒƒ‰ƒgƒjƒ“‚̃‰ƒbƒg”’“àჂƒfƒ‹‚ɑ΂·‚é—}ˆ³Œø‰Ê; ¼‰Ê‘̃zƒ‹ƒ‚ƒ“, ƒƒ‰ƒgƒjƒ“‚ÌRŽ_‰»ì—p‚ɂ‚¢‚Ä. ˆ¢•”[ŽuiŠáj: ‘æ22‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.12.08j, _“Þì.


<<24 Ž¨•@ˆôA‰ÈŠw>>

3050. mŒ´’˜n Sudden deafness accompanied by asymptomatic mumps. ‰ª–{–qlCÝŠy“N–çC’†ŽR–¾miŽ¨•@jC‚‹{t’ji—ÕŒŸjC¼ŽRkˆê˜YC¬–ì—YˆêC²–씣iŽ¨•@j: Acta Otolaryngol. Suppl. (Stockh.), 514: 45`48, 1994.

3051. mŒ´’˜n A study of distribution of hearing level in idiopathic bilateral sensorineural hearing loss. •½ŽR•ûrCÝŠy“N–çC‰ª–{–qlC²–씣iŽ¨•@j: Acta Otolaryngol. Suppl. (Stockh.), 514: 73`77, 1994.

3052. mŒ´’˜n Transient deafness with iopamidol following angiography. ¼‰ª–¾—TCÝŠy“N–çC‰ª–{–qlC²–씣iŽ¨•@j: Acta Otolaryngol. Suppl. (Stockh.), 514: 78`80, 1994.

3053. mŒ´’˜n Myringoplasty in the outpatient clinic. ’·À‰p–¾C‰ª–{–qlCÝŠy“N–çC“¿‘Œú“ñiŽ¨•@j: Acta Otorhinolaryngol. Belg., 48: 59`65, 1994.

3054. mŒ´’˜n Vestibular training for benign pareoxysmal positional vertigo. “¡–ì–¾lC“¿‘Œú“ñC‹g”ö’mC’·À‰p–¾iŽ¨•@jC•Ä“c•qi¶•¨•¨—ŒnjC’†‘ºŒ«iˆã—ÎЉïŠwj: Arch. Otolaryngol. Head Neck Surg., (120): 497`504, 1994.

3055. mŒ´’˜n ’ቹáŠQŒ^Š´‰¹“ï’®’·ŠúŠÏŽ@—á‚ÌŒŸ“¢. •½ŽR•ûrCÝŠy“N–çC‰ª–{–qlC²–씣C¼‰ª–¾—TiŽ¨•@j: Audiol. Jpn., 37: 142`149, 1994.

3056. mŒ´’˜n Epstein-Barr virus in patients with polymorphic reticulosis (Lethal midline granuloma) from China and Japan. K. MishimaCK. Horiuchii“ޗLjã‘åjCS. Kojyai—®‹…‘åjC‚‹´LbiŽ¨•@jCM. OhsawaCK. Aozasaiã‘åj: Cancer, 73(12): 3041`3046, 1994.

3057. mŒ´’˜n ƒƒjƒG[ƒ‹•a‚Ì‚ß‚Ü‚¢¥“ï’®‚Ì—\Œã‚ɂ‚¢‚Ä. “¿‘Œú“ñC“¡–ì–¾lC‹g”ö’mC¯–ìŒ÷iŽ¨•@jC•Ä“c•qi¶•¨•¨—Œnj: Equilibrium Res, (Suppl.10): 112`116, 1994.

3058. mŒ´’˜n ’®—Í•ª•z‚©‚猩‚½“Ë”­«“ï’®‚Ì•a‘Ô. ‰ª–{–qliŽ¨•@j: Otol. Jpn., 4: 117`124, 1994.

3059. mŒ´’˜n Vestibular exercise for older laborers in the 5th decade of life. “¿‘Œú“ñC“¡–ì–¾liŽ¨•@jCŠ¡•”‚ЂƂÝi‰qj: Vestibular and Neuralfront, p.247`250, 1994.

3060. mŒ´’˜n •ÂÇ«‡–°Žž–³ŒÄ‹zÇŒóŒQ‚É‚¨‚¯‚éƒZƒtƒ@ƒƒƒgƒŠ[‚ÌŒŸ“¢(‘æ‚Q•ñ). –]ŒŽ‚sC‰ª–{–qliŽ¨•@jC“¡“cŽj˜NiOakland Otology & Aprea ClinicjC²–씣C’·À‰p–¾iŽ¨•@j: Œûo¥ˆô“ª‰È, 69(2): 143`150, 1994.

3061. mŒ´’˜n šb‘§Š³ŽÒ‚É‚¨‚¯‚é•@•a•Ï‚ÉŠÖ‚·‚錤‹†. Έä–L‘¾iŽ¨•@j: ‘—§‘Š–ÍŒ´•a‰@Ž, p.35`78, 1994.

3062. mŒ´’˜n ƒsƒAƒX‚É‚æ‚鎨‚‚̃PƒƒCƒhÇ—á‚ɂ‚¢‚Ä. Έä–L‘¾C¼ŽRkˆê˜YiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 60(1): 6`7, 1994.

3063. mŒ´’˜n Galvanic Body Sway Test|ŽhŒƒ•û–@‚ɂ‚¢‚Ä‚ÌŒŸ“¢|. –ìŒû_’jiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 66(5): 403`407, 1994.

3064. mŒ´’˜n ˜Vl«“ï’®‚ÆŽ¨–Â. ”ª–عlCì’[ŒÜ\—éC²“¡P³C’¹ŽR–«CŽR‰ºŒöˆêC–q“ˆ˜aŒ©C‘ºˆä˜a•vCŒ´“c—E•FC‰ª–{–qliŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 66(5): 415`418, 1994.

3065. mŒ´’˜n ŠOŽ¨“¹‘½Œ`‘BŽî‚Ì1—á. ˆäŒû–F–¾C‚‹´LbiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 66(5): 426`428, 1994.

3066. mŒ´’˜n ˆ««‰»‚µ‚½•@•›•@o“û“ªŽî‚Ì1—á. ˆäŒû–F–¾C’†‘º—vC¯–ìŒ÷C¬ìŽ“ñCŽÄè½C–]ŒŽ‚sCŠ™“c—˜•FiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 66(9): 821`824, 1994.

3067. mŒ´’˜n •ÂÇ«‡–°Žž–³ŒÄ‹zÇŒóŒQ‚É‚¨‚¯‚é’†ˆô“ªŒv‘ª‚ÌŒŸ“¢. –]ŒŽ‚sC‰ª–{–qlC²–씣C’·À‰p–¾CÝŠy“N–çiŽ¨•@j: “ªŒz•”ŠO‰È, 4(2): 133`140, 1994.

3068. mŒ´’˜n ‹}«A“ªŠW‰Š‚Ì—Õ°“IŒŸ“¢|‹C“¹Šm•Û‚ð•K—v‚Æ‚µ‚½Ç—á‚ɂ‚¢‚Ä|. ˆäŒû–F–¾CÝŠy“N–çC‚‹´LbC”ª”ö˜a—YCŒÃì_ŽOCΈä–L‘¾Cˆî–ØŸ‰piŽ¨•@j: “ú–{‹CŠÇH“¹‰ÈŠw‰ï‰ï•ñ, 45(1): 1`7, 1994.

3069. mŒ´’˜n º‘Ñ–ü’…Ç‚Ì—Õ°“IŒŸ“¢. •½ŽR•ûrCÝŠy“N–çCL£”£C‚‹´LbC‰ª–{–qlC”ª”ö˜a—YCˆî–ØŸ‰pC¼‰ª–¾—TC¼ŽRkˆê˜YC”n‰z’q_CŒÃì_ŽOiŽ¨•@j: “ú–{‹CŠÇH“¹‰ÈŠw‰ï‰ï•ñ, 45(4): 318`322, 1994.

3070. mŒ´’˜n ƒAƒŒƒ‹ƒM[«•@‰Š‚É‚¨‚¯‚é•@`’†‘gDƒJƒŠƒNƒŒƒCƒ“Šˆ«‚¨‚æ‚уLƒjƒ“‚Ì‘‘å‚Æ—}§. ¼ŽRkˆê˜YiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 97(8): 1512`1522, 1994.

3071. m€Œ´’˜i‰p•¶jn Chemosurgery with trichloroacetic acid in allergic rhinitis. ”ª”ö˜a—YCÝŠy“N–çC¼ŽRkˆê˜YCˆäŒû–F–¾CŽR–{ˆê”ŽiŽ¨•@j: Am. J. Rhinol., 8(5): 378`379, 1994.

3072. m€Œ´’˜i‰p•¶jn Cholesteatoma in children: sex defferences. ¼‰ª–¾—TCÝŠy“N–çC‰ª–{–qlC²–씣iŽ¨•@j: Cholesteatoma and Mastoid Surgery(4th International Conference), p.259`262, 1993.

3073. m€Œ´’˜i‰p•¶jn Immunological aspects on inflammatory middle ear diseases in children: sex differences. ¼‰ª–¾—TCÝŠy“N–çC‰ª–{–qlC²–씣iŽ¨•@j: Recent Advances in Otitis Media, p.141`145, 1994.

3074. m€Œ´’˜i‰p•¶jn Sterilization of temporal fascia homograft in myringoplasty. ’·À‰p–¾CÝŠy“N–çC‰ª–{–qlC“¿‘Œú“ñiŽ¨•@jC‘å’J‰pŽ÷i—Õ•a—jC‚‹{t’ji—ÕŒŸj: Recent Advances in Otitis Media, p.829`835, 1994.

3075. m€Œ´’˜n “–‰@‚É‚¨‚¯‚éBlowoutœÜÇ—á‚ÌŽèpŽ¡—Â̌Ÿ“¢. –ö‘iŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‰ï•ñ, 8(1): 28`29, 1994.

3076. mŒ¤‹†•ñiŒú¶Èjn “Ë”­«“ï’®•a“ú‹æ•ª‚ÌŒŸ“¢. ‰ª–{–qlC’†ŽR–¾mC¬–ì—YˆêiŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬5”N“xŒ¤‹†‹ÆÑ•ñ‘, p.67`69, 1994.

3077. mŒ¤‹†•ñiŒú¶Èjn “Ë”­«“ï’®‘ŠúŽófŽÒ‚Ì’®—͉ñ•œ‚ÌŒŸ“¢. ÝŠy“N–çC²–씣C‰ª–{–qlC•½ŽR•ûriŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬5”N“xŒ¤‹†‹ÆÑ•ñ‘, p.71`72, 1994.

3078. mŒ¤‹†•ñiŒú¶Èjn “Ë”­«“ï’®‚ÌŽóf•a“ú•Ê’®—Í‘œ‚ÌŒŸ“¢. ÝŠy“N–çC²–씣C‰ª–{–qlC•½ŽR•ûriŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬5”N“xŒ¤‹†‹ÆÑ•ñ‘, p.77`78, 1994.

3079. mŒ¤‹†•ñiŒú¶Èjn “Á”­«—¼‘¤«Š´‰¹“ï’®‚ÌŒŸ“¢. ÝŠy“N–çC•½ŽR•ûrC‰ª–{–qlC²–씣iŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬5”N“xŒ¤‹†‹ÆÑ•ñ‘, p.145`147, 1994.

3080. mŒ¤‹†•ñiŒú¶Èjn “Á”­«—¼‘¤«Š´‰¹“ï’®‚ÌŒŸ“¢|Žá”NŒ^‚ƬlŒ^‚Ì”äŠr. ÝŠy“N–çC•½ŽR•ûrC‰ª–{–qlC²–씣iŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬5”N“xŒ¤‹†‹ÆÑ•ñ‘, p.149`151, 1994.

3081. mŒ¤‹†•ñiŒú¶Èjn ƒXƒM“´Žv쎡—Âɂ¨‚¯‚éRŒ´“ÁˆÙ“I–ƉuƒOƒƒuƒŠƒ“‚̕ω». Έä–L‘¾iŽ¨•@jCˆÀŽ}_CM‘¾—²•vi‘—§‘Š–ÍŒ´•a‰@j: Œ¤‹†•ñ‘, 1994.

3082. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ‚ß‚Ü‚¢‚ɑ΂·‚鎡—ÃŒø‰Ê”»’è‚̊Ä(ƒƒjƒG[ƒ‹•a‚ð’†S‚É)|1993”N‚ß‚Ü‚¢‚ɑ΂·‚鎡—ÃŒø‰Ê”»’èŠî€‰»ˆÏˆõ‰ï“š\|. …‰z“S—C“n•Ós—YC«Ï“úo•vi•xŽRˆã–ò‘åjC¼‰i‹ªi“ޗLjã‘åjC“¿‘Œú“ñiŽ¨•@j: Equilibrium Res, (Suppl.10): 117`122, 1994.

3083. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ¬Ž™‚Æ‚—îŽÒ‚Ì•½t‹@”\Œ¤‹†•ñ‘. “¿‘Œú“ñiŽ¨•@j: Equilibrium Res, 53(2): 315`319, 1994.

3084. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ‚”N—î˜J“­ŽÒ‚Ì•½t‹@”\‚Æg‚Ì‚±‚È‚µ”\—Í‚ÉŠÖ‚·‚é•ñ‘. “¿‘Œú“ñiŽ¨•@j: ‚”N—îŒÙ—pŠJ”­‹¦‰ï•½¬5”N“x•ñ‘, p.1`76, 1994.

3085. mÇ—á•ñn ‰Ì•‘Šêƒ[ƒLƒƒƒbƒvÇŒóŒQ‚Ì1Ç—á. ”n‰z’q_C“¿‘Œú“ñC–àŽRˆÀOCŽR’†‚C—é–Ø—§riŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 66(4): 330`333, 1994.

3086. m—Õ°Ž¡Œ±n ‚ß‚Ü‚¢Ç—á‚ɑ΂·‚鉖Ž_ƒrƒtƒFƒƒ‰ƒ“(ƒZƒŒƒ|[ƒgR)‚Ì—Õ°Œø‰Ê‚ɂ‚¢‚Ä. …‰z“S—i•xŽRˆã–ò‘åjC¼‰i‹ªi“ޗLjã‘åjC“¿‘Œú“ñiŽ¨•@jC¬’r‹g˜YC‹àŽR—ºŽ¡C–Ø‘º—miŽRŒ`‘åjC‹Tˆä–¯—YC¼è[’jiŒQ”n‘åjC‹g”ö’miŽ¨ •@jC_èmC•ˆä‘וFiŒc‘åjC’|ŽR—EC‰Á“¡Œ÷C‰ª“c’qKC‰¬–ì’å—Yi¹ƒ}ƒŠˆã‘åjC¬¼è“ÄC‘º‰ªGŽ÷i“Œ‹žˆãŽ•‘åjC–ì––“¹•FCÎè‹v‹`Cóˆä”ü —mC•õ“cŽüKi•l¼ˆã‘åjC‹{‰ºOiÄ’ÃŽs—§‘‡•a‰@jC–{ŠÔ–Fli“¡Ž}Žs—§Žu‘¾‘‡•a‰@jCX“c_Žji´…Œú¶•a‰@jC‹{“c‰p—YCˆÉ“¡”ªŽŸC‰Á“¡‰ë–çC ¬“‡rŒÈiŠò•Œ‘åjC“n•Ós—Yi•xŽRˆã–ò‘åjCˆÀ“cŒ’“ñiŽs—§áè”g‘‡•a‰@jC‘åˆäGÆiVŠƒ˜JЕa‰@jC¼‰i‹œC•“cŒ›ºC“c–î’¼ŽOC¼’r‹G—²i‘åã ‘åjC“¡“cMÆCŽR’†•q²i“ޗLjã‘åjCŒ´“cN•vC—é–؉qiL“‡‘åjC¼•½CC‹gì–ÎŽ÷i‹ã‘åjC㑺‘ì–çi²‰êˆã‘åj: Ž¨•@ˆôA‰È“W–], 37(5): 584`603, 1994.

3087. m‘àn ”­¶‚Æ‚»‚ÌáŠQ. L£”£iŽ¨•@j: Brain Medical, 6(1): 29`32, 1994.

3088. m‘àn ŒÛ–ŒŒ`¬p‚̈êH•v|ˆ—“¯Ží‹Ø–Œ‚ð—p‚¢‚½ŠO—ˆŒÛ–ŒŒ`¬p|. ’·À‰p–¾CL£”£C‰ª–{–qlCÝŠy“N–çiŽ¨•@j: JOHNS, 11(1): 54`58, 1995.

3089. m‘àn ƒXƒ|[ƒcŠO‚É‚¨‚¯‚鎨•@ˆôA‰È—̈æ‚ÌáŠQ. ‰ª–{–qlCÝŠy“N–çiŽ¨•@j: M.B. Orthop., 7(4): 75`83, 1994.

3090. m‘àn ‰Ô•²ÇŠ³ŽÒ‚Ì—\–h¶ŠˆŽw“±‚ÌŽÀÛ. Έä–L‘¾iŽ¨•@j: Medical Practice, 11: 254`256, 1994.

3091. m‘àn isA“ªŠà‚ɑ΂·‚é•úŽËü¥RŠàÜ•¹—p—Ö@. ‚‹´LbiŽ¨•@j: ŠÅŒì‹Zp, 40(7): 26`28, 1994.

3092. m‘àn Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰ÈŽîᇂÌf’f; Žî’¯‚ð‚«‚½‚·Ž¾Š³‚Æ”N—î. ‚‹´LbiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 66(11‘Š§): 156`162, 1994.

3093. m‘àn ‡–°Žž–³ŒÄ‹zÇŒóŒQ‚É‚¨‚¯‚éUPPPŽèp–@. ‰ª–{–qliŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 66(6): 494`495, 1994.

3094. m‘àn –ƒáƒ«\‰¹áŠQ. L£”£iŽ¨•@j: Ž¸ŒêÇŒ¤‹†, 14(2): 121`128, 1994.

3095. m‘àn ‰¹º‹@”\áŠQ. L£”£iŽ¨•@j: áŠQŽÒ‚Ì•ŸŽƒ, 7: 40`43, 1994.

3096. m‘àn u˜b‚·v‚Æ‚Í‚Ç‚ñ‚È‚±‚Æ‚©. L£”£iŽ¨•@j: •Êû‹³ˆç‹Zp, 94(6): 102`119, 1994.

3097. muÀn A“ªŠài“W—á(T3, T4)‚Ì•Û‘¶Ž¡—Ã. ‚‹´LbiŽ¨•@j: Ž¨•@—Õ°, 87(10): 1309`1319, 1994.

3098. muÀn ŠŒ©‚Ì­‚È‚¢‚ß‚Ü‚¢Ž¾Š³‚ɂ‚¢‚Ä. “¿‘Œú“ñiŽ¨•@j: Ž¨•@—Õ°, 87(5): 732`733, 1994.

3099. muÀn ‚—îŽÒ‚Ì“ï’®‚Æ‚»‚̑Ήž. ‰ª–{–qliŽ¨•@j: –òŽ–“ú•ñ, (8395): 16, 1994.

3100. m‹³‰È‘n i‹¤’˜j º‚ÌŒŸ¸–@¥Šî‘b•Ò; ”­¶‚̶—Cº‚Ì”N—î“I•Ï‰», p.19`42, p.183`202, L£”£iŽ¨•@j. •ÒW “ú–{‰¹ºŒ¾ŒêˆãŠw‰ï, ˆãŽ•–òo”ÅC“Œ‹ž, 94.00.00”­s.

3101. m‹³‰È‘n i‹¤’˜j º‚ÌŒŸ¸–@¥—Õ°•Ò; A“ª‚Ì‹Ø“d}ŒŸ¸, p.221`234, L£”£iŽ¨•@j. •ÒW “ú–{‰¹ºŒ¾ŒêˆãŠw‰ï, ˆãŽ•–òo”ÅC“Œ‹ž, 94.00.00”­s.

3102. m‹³‰È‘i‰p•¶jn i•ª’SŽ·•Mj ; Dysarthria, acquired and speech: Neuromuscular aspects, p.1077`1080, 4183`4186, L£”£iŽ¨•@j. •ÒW R. E. Asher, Pergamon PressC94.00.00”­s.

3103. m‹³‰È‘n i•ª’SŽ·•Mj ÅV“à‰ÈŠw‘åŒn79. ˜V”N‚Ìf—Ã; Ž¨•@ˆôAŒûoŽ¾Š³ŠÖ˜A—̈æ3, 79: 288`296, ÝŠy“N–çC‰ª–{–qliŽ¨•@j. •ÒW ˆä‘º—T•vC”öŒ`‰x˜YC‚‹vŽj–C‚ˆä´ˆê˜Y, ’†ŽR‘“XC“Œ‹ž, 95.01.31”­s.

3104. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“21¢‹I‚Ì–k—¢‘åŠw•a‰@‚ð–Íõ‚·‚é; Ž¨•@ˆôA‰È‚Ìê‡, p.19`27, ‰ª–{–qliŽ¨•@j. •ÒW –k—¢‘åŠwˆãŠw•”Ž¨•@ˆôA‰ÈC –k—¢‘åŠw•a‰@‹³ˆçˆÏˆõ‰ïC94.00.00”­s.

3105. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj áŠQŽÒ‚Æ‹¤‚ɶ‚«‚é|Ž¸‚í‚ꂽŒ¾Œê‚ðŽæ‚è–ß‚µ‚Ä; ˜b‚µŒ¾—t‚ÌáŠQ‚ð‚ß‚®‚Á‚Ä, p.56`66, L£”£iŽ¨•@j. •ÒW ŽRè‹žŽqCŽO—Ö‡N, ‚â‚Ç‚©‚èo”ÅCé‹Ê, 94.00.00”­s.

3106. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj “à‰ÈŽ¡—ÃKƒCƒh'94; ‚ß‚Ü‚¢, p.155`161, “¿‘Œú“ñiŽ¨•@j. •ÒW ˜a“cUC‘¼C •¶Œõ“°C94.00.00”­s.

3107. mŠw‰ïi‘Ûjn i“Á•Êu‰‰j The role of the larynx in speech production. L£”£iŽ¨•@j: 57th Annual Meeting of the Otolaryngological Society of Republic of China i94.11.05j, Taichung, Taiwan, Proceeding, p.93, 1994.

3108. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Teflon injection; Complications and management. ’†ŽR–¾miŽ¨•@jCC.N. FordiUniv. of Wisconsinj: 3rd International symposium on Phonosurgery i94.06.26`28j, ‹ž“s.

3109. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Protein in pituita from patients with allergic rhinitis (2nd report). ˆäŒû–F–¾CÝŠy“N–çC”ª”ö˜a—YC¼ŽRkˆê˜YCŽR–{ˆê”ŽiŽ¨•@jCŽ­ŽæMi–ò—j: 13th International Symposium Infection and Allergy of Nose i94.06.19`23j, ƒRƒyƒ“ƒn[ƒQƒ“.

3110. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Vestibular exercise for older laborers in the 5th decade of life. “¿‘Œú“ñC“¡–ì–¾liŽ¨•@jCŠ¡•”‚ЂƂÝi‰qj: 12th International Symposium on Posture and Gait i94.10.04j, ¼–{.

3111. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Sinonasal polyposis with atypical stromal cells; Immunohistochemical evaluation as an aid in defining histogenesis. ’†ŽR–¾miŽ¨•@jCB.M. WenigCD.K. Heffner: The American Laryngological Rhinological and Otological Society Western Section Meeting i95.01.08j, ƒTƒ“ƒfƒBƒGƒS.

3112. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Characteristic distribution of pure-tone thresholds in sudden deafness. ‰ª–{–qlC²–씣CÝŠy“N–çC•½ŽR•ûriŽ¨•@j: 22nd International Congress of Audiology i94.07.05j, Halifax, Canada.

3113. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Cephalometric analysis patients with obstructive sleep apnea syndrome. –]ŒŽ‚sC‰ª–{–qlC’·À‰p–¾iŽ¨•@j: 4th World Congress of Sleep Apnea i94.10.01`04j, San Francisco, Abstract Book, p.547, 1994.

3114. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Mutual relations among physical conditions, findings in endoscopy, cephalometry and sleep study. ’·À‰p–¾CB.T. WoodsonC‰ª–{–qlC–]ŒŽ‚siŽ¨•@j: 4th World Congress of Sleep Apnea i94.10.02j, San Francisco, Abstract Book, p.358, 1994.

3115. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Re-evaluation of uvulopalatopharyngoplasty from the viewpoint of mesopharyngometry. ‰ª–{–qlC–]ŒŽ‚sC’·À‰p–¾iŽ¨•@j: 4th World Congress of Sleep Apnea i94.10.04j, San Francisco.

3116. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‰Á—î‚ÆŒûoŠà. ’†ŽR–¾mCÝŠy“N–çC‚‹´LbC‰ª–{–qlC”ª”ö˜a—YCˆî–ØŸ‰pC”n‰z’q_iŽ¨•@j: ‘æ7‰ñ“ú–{Œûo¥ˆô“ª‰ÈŠw‰ï i94.09.22j, –¼ŒÃ‰®.

3117. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’®—͉ü‘P¢“ï‚È’†Ž¨‰Š‚ÌŽèp;ƒRƒŒƒXƒeƒŠƒ““÷‰èŽîÇ‚ÌŽ¡—Õûj. ‰ª–{–qliŽ¨•@j: ‘æ4‰ñ“ú–{Ž¨‰ÈŠw‰ï i94.11.12j, ‘åã.

3118. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‚—îŽÒ‚Ì‘Ì•½t(’¼—§‚Æ‘«“¥). “¿‘Œú“ñiŽ¨•@j: ‘æ53‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i94.11.25j, ¼], —\eW, p.75, 1994.

3119. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰Ô•²Ç‚Ì’nˆæ“Á«ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“|ƒuƒ^ƒNƒT, ƒJƒiƒ€ƒOƒ‰‚ɂ‚¢‚Ä. Έä–L‘¾iŽ¨•@jCÎè”ü’qŽqCM‘¾—²•vi‘—§‘Š–ÍŒ´•a‰@j: ‘æ6‰ñƒAƒŒƒ‹ƒM[Šw‰ï i94.04.14`16j, ŒF–{.

3120. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j A“ª‚É”­¶‚µ‚½ŒŒŠÇ•½ŠŠ‹ØŽî‚Ì1—á. Š™“c—˜•FC¬ìŽ“ñCˆäŒû–F–¾C’†‘º—vC–]ŒŽ‚siŽ¨•@j: ‘æ56‰ñŽ¨•@ˆôA‰È—Õ°Šw‰ï i94.04.26j, Ž­Ž™“‡.

3121. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”¼‹KŠÇ_Œo‹y‚щ„‘–Ô—l‘ÌŠO‘¤•”“d‹CŽhŒƒ‚É‚æ‚éˆÝ“àˆ³‚ƌċz•Ï‰». ¯–ìŒ÷C“¿‘Œú“ñC“¡–ì–¾liŽ¨•@j: ‘æ95‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï‘‰ï i94.05.19j, VŠƒŽs, “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 97(10): 1787, 1994.

3122. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒAƒŒƒ‹ƒM[«•@‰Š‚É‚¨‚¯‚é•@`’†’`”’Ž¿¬•ª‚ÌŒŸ“¢. ˆäŒû–F–¾C¬ìŽ“ñi‰¡{‰êŽs—§Žs–¯•a‰@jCÝŠy“N–çC”ª”ö˜a—YC¼ŽRkˆê˜YCŽR–{ˆê”ŽiŽ¨•@jCŽ­ŽæMi–ò—j: ‘æ95‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï‘‰ï i94.05.19j, VŠƒŽs, “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 97(10): 1848, 1994.

3123. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j A“ª‚Ì‘gDŒ`‘ÔŠw“IŠÏŽ@(‘æ2•ñ). –ö‘CÝŠy“N–çCL£”£C‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC•½ŽR•ûriŽ¨•@j: ‘æ95‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï‘‰ï i94.05.20j, VŠƒŽs.

3124. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ºˆô“ªŒz•”H“¹Šà‚ÌŽ¡—ìÑ|Žèp‚ðŠî–{‚Æ‚·‚鎡—ÂƕúŽËü‚ðŠî–{‚Æ‚·‚鎡—Ö@‚Ì”äŠrŒŸ“¢|. ‰ª–{–qlC‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰piŽ¨•@jC¼—Ñ—²i•új: ‘æ18‰ñ“ú–{“ªŒz•”Žîᇊw‰ï i94.06.22j, ŽD–y.

3125. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j A“ªŠàT3, T4Ç—á‚Ì•Û‘¶Ž¡—ÂɊւ·‚錟“¢. ‚‹´LbC‰ª–{–qlC”ª”ö˜a—YCˆî–ØŸ‰pC’†ŽR–¾miŽ¨•@jC¼—Ñ—²i•új: ‘æ18‰ñ“ú–{“ªŒz•”Žîᇊw‰ï i94.06.24j, ŽD–y.

3126. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚éFurlow•Ï–@‚ÌŒ¾Œê¬Ñ. —é–ØŒbŽqC‰ª–{˜NŽqCŒ´—R‹IiŽ¨•@jCV”ü¬“ñi“Œ‘åjC–xŒû—˜”Viº˜a•a‰@jC’¹Ž”ŸsC’†–kMºCŽRèˆÀ°iŒ`ŠOjCŒ´“c´i“Œ‹žˆãŽ•‘åj: ‘æ18‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïŠwpW‰ï i94.06.30j, “c, “ú–{ŒûŠW—ôŠw‰ïŽGŽ, 19(4): 298, 1994.

3127. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŋߌoŒ±‚µ‚½ƒ€ƒ“ƒvƒX“ï’®‚ɂ‚¢‚Ä. —é–Ø—§rCÄ“¡‘åC‰ª–{–qlCÝŠy“N–çC²–씣C•½ŽR•ûrC¬–ì—YˆêiŽ¨•@jCŒÃ‘òTˆêi‘—§‘Š–ÍŒ´•a‰@jC¼ŽRkˆê˜Yi‰¡•lÔ\Žš•a‰@jCˆÉ“¡”\¬i“¡ ‘òŽs–¯•a‰@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬6”N“x‘æ1‰ñ‘‰ï i94.08.26j, “Œ‹ž.

3128. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •@ƒAƒŒƒ‹ƒM[‚É‚¨‚¯‚é•@`’†‘gDƒJƒŠƒNƒŒƒCƒ“‚ÌŠÖ—^. ¼ŽRkˆê˜YCÝŠy“N–çC”ª”ö˜a—YCˆäŒû–F–¾CŽR–{ˆê”ŽiŽ¨•@jCŽ­ŽæMi–ò—j: ‘æ33‰ñ“ú–{•@‰ÈŠw‰ïŠwpu‰‰‰ï i94.09.08j, L“‡, “ú–{•@‰ÈŠw‰ï‰ïŽ, 33(1): 211, 1994.

3129. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ãŠ{œFibrous dysplasia‚Ì2—á. ¼ŽRkˆê˜YC”óŒû²GCV“cŒ’‘¾˜YiŽ¨•@j: ‘æ30‰ñ“ú–{Ô\ŽšŽÐˆãŠw‰ï‘‰ï i94.09.13j, ŽD–y, “úÔˆãŠw, 46(2): 105, 1994.

3130. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j bó“̌`‘ÔˆÙí‚Ì1—á. ˆäŒû–F–¾C¬ìŽ“ñC¯–ìŒ÷C’†‘º—vCŠ™“c—˜•FC–]ŒŽ‚siŽ¨•@j: ‘æ7‰ñ“ú–{Œûo¥ˆô“ª‰ÈŠw‰ï i94.09.22j, –¼ŒÃ‰®, Œûo¥ˆô“ª‰È, 7(1): 35, 1994.

3131. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒûŠW‚“îŒûŠWˆô“ªŒ`¬p‚ÌŠÇ—‚Ì–â‘è“_. –]ŒŽ‚sC‰ª–{–qlC²–씣C’·À‰p–¾CÝŠy“N–çiŽ¨•@j: ‘æ7‰ñ“ú–{Œûo¥ˆô“ª‰ÈŠw‰ï i94.09.22j, –¼ŒÃ‰®, Œûo¥ˆô“ª‰È, 7(1): 56, 1994.

3132. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Œûo‚ÌŽîᎫŽ¾Š³|”N—î‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä|. ‚‹´LbCˆî–ØŸ‰pC’†ŽR–¾miŽ¨•@j: ‘æ7‰ñ“ú–{Œûo¥ˆô“ª‰ÈŠw‰ï i94.09.23j, –¼ŒÃ‰®.

3133. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j lHA“ª‚ð—p‚¢‚½‰¹ºƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‰ª–{˜NŽqCŒ´—R‹IiŽ¨•@jC¬’rŽO“ÞŽqiƒŠƒn•”jC¬—є͎qiˆã—Éq¶jCΖєü‘ãŽqi“Œ‘åj: ‘æ39‰ñ“ú–{‰¹ºŒ¾ŒêˆãŠw‰ï i94.10.07j, ‹à‘ò, —\eW, p.78, 1994.

3134. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j A“ª‘gDŒ`‘ÔŠw“IŠÏŽ@(‘æ3•ñ). –ö‘CÝŠy“N–çCL£”£C‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC•½ŽR•ûriŽ¨•@j: ‘æ46‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ï i94.10.21j, ‰F“s‹{.

3135. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒˆƒ‚ƒMƒAƒŒƒ‹ƒM[‚ª•aˆö‚̃NƒCƒ“ƒ`•‚Žî‚Ì1—á. Έä–L‘¾CŒÃ‘òTˆêC‹v–쌒ŽuiŽ¨•@j: ‘æ46‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ï i94.10.21j, ‰F“s‹{.

3136. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j A“ªè÷—±×–EŽî‚Ì1—á. •½ŽR•ûrCÝŠy“N–çCL£”£C‚‹´LbC”ª”ö˜a—YC–ö‘CL“‡‰®FiŽ¨•@j: ‘æ46‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ï i94.10.21j, ‰F“s‹{, —\eW, p.89, 1994.

3137. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “Á”­«—¼‘¤«Š´‰¹“ï’®‚ÌŒŸ“¢. •½ŽR•ûrCÝŠy“N–çC‰ª–{–qlC²–씣iŽ¨•@j: ‘æ39‰ñ“ú–{’®ŠoˆãŠw‰ï i94.10.29j, ’}”g, Audiol. Jpn., 37(5): 469`470, 1994.

3138. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •—]Œã‚É”­Ç‚µ‚½“Ë”­“ï’®—á. ¼ŽRkˆê˜YCÝŠy“N–çC‰ª–{–qlC”óŒû²GCV“cŒ’‘¾˜YiŽ¨•@j: ‘æ4‰ñ“ú–{Ž¨‰ÈŠw‰ï i94.11.11j, ‘åã, Otol. Jpn., 4(4): 494, 1994.

3139. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘½Ê‚ȈÙíŠá‹…‰^“®‚ð‚Ý‚½”]‰Š‚Ì1Ç—á. ¯–ìŒ÷C“¿‘Œú“ñC“¡–ì–¾lCVˆäŠî—mC’†‘º—vCŽR’†‚iŽ¨•@j: ‘æ53‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i94.11.24j, ¼].

3140. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j OKAN‚Ì—Õ°“IŒ¤‹†|Œ’íŽÒ‚ÌOKAN‚ɂ‚¢‚Ä|. VˆäŠî—mC“¿‘Œú“ñiŽ¨•@jCˆ¢•”—EŸi—ÕŒŸj: ‘æ53‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i94.11.24j, ¼], —\eW, p.115, 1994.

3141. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Galvanic body sway test; ÄŒ»«‚ɂ‚¢‚Ä‚ÌŒŸ“¢. –ìŒû_’jCVˆäŠî—mC¯–ìŒ÷CV“cŒ’‘¾˜YC“¡–ì–¾lC“¿‘Œú“ñiŽ¨•@j: ‘æ53‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i94.11.25j, ¼].

3142. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚ß‚Ü‚¢‚ðŽå‘i‚Æ‚µ‚½‹‘å’Åœ“®–¬áŽ‚Ì1—á. ŽR’†‚C“¿‘Œú“ñC“¡–ì–¾lC•½ŽR•ûrC–ìŒû_’jC¯–ìŒ÷CVˆäŠî—miŽ¨•@j: ‘æ53‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i94.11.25j, ¼].

3143. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’®ŠoƒtƒB[ƒhƒoƒbƒN•t‚«ƒoƒ‰ƒ“ƒXƒ{[ƒh‚É‚æ‚镽tŒP—û. “¡–ì–¾lC“¿‘Œú“ñiŽ¨•@jC•Ä“c•qi¶•¨•¨—Œnj: ‘æ53‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i94.11.25j, ¼].

3144. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j A“ª‚Ì‘gDŒ`‘ÔŠw“IŠÏŽ@(‘æ4•ñ). –ö‘CÝŠy“N–çCL£”£C‚‹´LbC”ª”ö˜a—YCˆî–ØŸ‰pC’†ŽR–¾mC•½ŽR•ûrC‹àŽqŒ÷iŽ¨•@j: ‘æ7‰ñ“ú–{A“ª‰ÈŠw‰ï i95.03.10j, ‹ž“s.

3145. mŠw‰ïi’n•ûjn i“Á•Êu‰‰j ¬Ž™‚̉¹ºŒ¾ŒêáŠQ‚ɂ‚¢‚Ä. L£”£iŽ¨•@j: ‘Š–ÍŒ´ˆãŽt‰ï¬Ž™‰Èˆã‰ï, Ž¨•@ˆôA‰Èˆã‰ï‡“¯u‰‰‰ï i94.07.22j, ‘Š–ÍŒ´.

3146. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŠO«Ž¾Š³‚Ì‚ ‚ꂱ‚꥕@•›•@o—̈æ, ‚»‚Ìf’f‚ÆŽ¡—Ã. –ö‘iŽ¨•@j: ‘æ88‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.06.04j, ìè.

3147. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Œz“®–¬¬‘ÌŽîᇂ̂P—á. ŽR’†‚C‚‹´LbC‰ª–{–qlC”ª”ö˜a—YCˆî–ØŸ‰pC¬–ì—YˆêiŽ¨•@jCª–{EiŠOj: ‘æ88‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.06.04j, ìè.

3148. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‚—ǃƒjƒG[ƒ‹•a‚Ì1Ç—á. –]ŒŽ‚sC“¿‘Œú“ñC–ìŒû_’jCVˆäŠî—miŽ¨•@j: ‘æ89‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.09.03j, ‰¡•l.

3149. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •@o“àMRSA•Û‹Û󋵂̌Ÿ“¢. —é–Ø—§rC”ª”ö˜a—YCˆî–ØŸ‰piŽ¨•@jC“‡“àçŒbŽqCˆä㼋vi”÷j: ‘æ89‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.09.03j, ‰¡•l.

3150. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “Á”­«ŒŒ¬”ÂŒ¸­«Ž‡”Á•a‚ɇ•¹‚µ‚½ˆ««ƒŠƒ“ƒpŽî‚Ì1—á. ¬–ì—YˆêC”n‰z’q_C–]ŒŽ‚sC’†ŽR–¾mC”ª”ö˜a—YC‰ª–{–qlC‚‹´LbiŽ¨•@j: ‘æ89‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.09.03j, ‰¡•l.

3151. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j •@΂ɂæ‚趂¶‚½‚ÆŽv‚í‚ê‚éãŠ{“´^‹ÛÇ‚Ì1—á. ¯–ìŒ÷C¬ìŽ“ñCˆäŒû–F–¾C’†‘º—viŽ¨•@j: ‘æ89‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.09.03j, ‰¡•l.

3152. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‹}«ŽUÝ«”]Ò‘–Œ‰ŠŒãˆâÇ‚Ì‚ß‚Ü‚¢Ç—á. —Ñ”J“NC“¿‘Œú“ñC‰ª–{–qlC²–씣C•½ŽR•ûrC–ìŒû_’jCVˆäŠî—mC¬–ì—YˆêCŽR–{ˆê”ŽiŽ¨•@j: ‘æ90‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.12.03j, ‰¡•l.

3153. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “Á”­«cŠu‹CŽî‚Ì1—á. ‰z–ìŽ÷“TCL£”£C”ª”ö˜a—YC•½ŽR•ûrC–ö‘CŽR–{ˆê”ŽiŽ¨•@jCL“‡‰®Fi‘—§‰¡•l•a‰@j: ‘æ90‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.12.03j, ‰¡•l.

3154. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j qí«“Vávጂɇ•¹‚µ‚½A“ªŠà‚Ì1Ç—á. ŽRèŒö‹`C‚‹´LbC‰ª–{–qlC”ª”ö˜a—YC’†ŽR–¾mC•½ŽR•ûrC¼ŽRkˆê˜YC”n‰z’q_C–ö‘CŽR–{ˆê”ŽiŽ¨•@jCΈä–L‘¾CŒÃ‘òTˆêC‹v–쌒Žui‘—§‘Š –ÍŒ´•a‰@j: ‘æ90‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.12.03j, ‰¡•l.

3155. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j G“Œ‹Šj‚Ì1—á. èc“cW‹vC‚‹´LbC‰ª–{–qlC”ª”ö˜a—YC’†ŽR–¾mC¼ŽRkˆê˜YC”n‰z’q_C–ö‘CŽR–{ˆê”ŽiŽ¨•@j: ‘æ90‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.12.03j, ‰¡•l.

3156. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŠOŽ¨“¹Žîᇂð‹^‚Á‚½‘B—lŽ‰‘B‘BÇ‚Ì1—á. ˆÉ“¡”\¬CŠ™“c—˜•FC–àŽRˆÀOiŽ¨•@j: ‘æ90‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.12.03j, ‰¡•l.

3157. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒ‰ƒ~ƒiƒŠƒA‚ð—p‚¢‚½H“¹‹·ó‚ÌŽ¡—ÃŒoŒ±. ˆäŒû–F–¾C’†‘º—vC¯–ìŒ÷C¬ìŽ“ñiŽ¨•@j: ‘æ90‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï i94.12.03j, ‰¡•l.

3158. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ‚ß‚Ü‚¢¥•½táŠQ‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. “¿‘Œú“ñiŽ¨•@j: ‘æ3‰ñŽ¨•@ˆôA‰ÈƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Œ¤‹†‰ï i94.04.10j, “Œ‹ž.

3159. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j Voice quality in patients with neurological disorders. L£”£iŽ¨•@j: 8th Vocal Fold Physiology Conference i94.04.08j, ‹v—¯•Ä.

3160. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‰Á—î‚É‚æ‚é’®—͈«‰»‘¬“x‚ÌŒŸ“¢. ¬–ì—YˆêC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: Œú¶È’·Žõ‰ÈŠw‚—îŽÒ‚Ì’®ŠoáŠQ‚ÉŠÖ‚·‚錤‹†”ljï‹c i94.01.08j, –¼ŒÃ‰®.

3161. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j Œ’íŽÒ‚ÌOKAN‚ɂ‚¢‚Ä. VˆäŠî—mC“¿‘Œú“ñiŽ¨•@j: ‘æ4‰ñŒãŠáUŒ¤‹†‰ï i94.04.09j, ‚è.

3162. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‚—îŽÒ‚̉^“®KŠµ‚Æ“úí¶Šˆ“®ì‚ɂ‚¢‚Ä. “¿‘Œú“ñC“¡–ì–¾liŽ¨•@j: ‘æ2‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ïƒXƒ|[ƒcˆãŠwŒ¤‹†‰ï i94.06.26j, “Œ‹ž.

3163. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‰Á—î‚É‚æ‚é¬l’®—͂̈«‰»‚Ì‹}‘¬‘Š‚ÌŒŸ“¢. ¬–ì—YˆêC‰ª–{–qlC²–씣C•½ŽR•ûriŽ¨•@j: ‘æ5‰ñŽ¨•@ˆôA‰È‚ƘV‰»‚ÌŒ¤‹†‰ï i94.07.22j, “Œ‹ž.

3164. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “Ë”­«“ï’®Ž¡—ÃŒŸ“¢ƒgƒ‰ƒCƒAƒ‹‚ÉÛ‚µ‚ẴCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg—pŽ†‚Ìì¬. ‰ª–{–qlC²–씣CÝŠy“N–çC•½ŽR•ûrCÄ“¡‘åC¬–ì—YˆêiŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬6”N“x‘æ1‰ñ‘‰ï i94.08.26j, “Œ‹ž.

3165. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ¬l’®—͂̉Á—î•Ï‰»‚É‚¨‚¯‚鈫‰»‚ÌŒŸ“¢|“Á”­«“ï’®‚ɂ‚¢‚Ä|. ¬–ì—YˆêC‰ª–{–qlC•½ŽR•ûrC²–씣CÄ“¡‘åCÝŠy“N–çiŽ¨•@j: Œú¶È’·Žõ‰ÈŠw‚—îŽÒ‚Ì’®ŠoáŠQ‚ÉŠÖ‚·‚錤‹†”ljï‹c i94.11.18j, –¼ŒÃ‰®.

3166. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ’®—͈«‰»‚Ì‹}‘¬‘Š‚ÌŒŸ“¢. ¬–ì—YˆêC‰ª–{–qliŽ¨•@j: Œú¶È’·Žõ‰ÈŠw”ÇŒ¤‹† i95.01.08j, –¼ŒÃ‰®.

3167. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj ‘O’ëÒ‘”½ŽË, ‚ß‚Ü‚¢¥•½táŠQ‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. “¿‘Œú“ñiŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ïˆãŽtuK‰ï i94.07.01`02j, ’·è, uK‰ïƒeƒLƒXƒg.

3168. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj l‚̈궂Ǝ¨•@ˆôA‰Èˆã‚Ì–ðŠ„; Žîᇎ¾Š³‚Æ”N—î. ‚‹´LbiŽ¨•@j: ‘æ8‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ïê–åˆãuK‰ï i94.11.20j, •Ÿ‰ª.

3169. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j •ÂÇ«‡–°Žž–³ŒÄ‹zÇŒóŒQ‚É‚¨‚¯‚éƒZƒtƒ@ƒƒƒgƒŠ[‚ÌŒŸ“¢. –]ŒŽ‚sC²–씣C‰ª–{–qliŽ¨•@j: ‘æ43‰ñ‘Š•Ž¨•@ˆôA‰ÈŒ¤‹†‰ï i94.06.25j, ‘Š–ÍŒ´.

3170. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “–‰È‚ÅŒoŒ±‚µ‚½Œy’†“™“x“ï’®Ž™‚ɂ‚¢‚Ä. ‰ª–{˜NŽqC—é–ØŒbŽqCŒ´—R‹IiŽ¨•@j: ‘æ43‰ñ‘Š•Ž¨•@ˆôA‰ÈŒ¤‹†‰ï i94.06.25j, ‘Š–ÍŒ´.

3171. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j –k—¢‘åŠw‚É‚¨‚¯‚éA“ª‘S“E. ’†ŽR–¾miŽ¨•@j: ‘æ4‰ñ_“Þ쌧Ž¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŽèpŽè‹ZŒ¤‹†‰ï i94.12.09j, ‰¡•l.

3172. mŠw‰ïŽåÃi‚»‚Ì‘¼jn Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬6”N“x‘æ1‰ñ‘‰ïi94.08.26`27j, “Œ‹ž, ÝŠy“N–çiŽ¨•@j.

3173. mŠw‰ïŽåÃi‚»‚Ì‘¼jn Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬5”N“x‘æ2‰ñ‘‰ïi94.02.18`19j“Œ‹ž, ÝŠy“N–çiŽ¨•@j.


<<25 ¸_‰ÈŠw>>

3174. mŒ´’˜n Pilot study of plasma concentrations of mosapramine, a new iminodibenzyl antipsychotic agent, after multiple oral administration in schizophrenic patients. ΋½‰ªƒC‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”jCShibata M.,Takamatsu R.: Curr. Ther. Res., 55: 331`342, 1994.

3175. mŒ´’˜n Œ’í‚—îŽÒ‚Ì”F’m‹@”\‚É‹y‚Ú‚·ƒTƒCƒNƒƒZƒŠƒ“‚ÌŒø‰Ê‚ɂ‚¢‚Ä;|Cognitive research test‚ð—p‚¢‚½ŒŸ“¢. ‘å’J‹`•vC—é–Ø–q•FCìŒû‹BC“àŠCŒõ’©CŒÃ’m‹MŒbŽqC‘ºèŒõ–Mi¸j: Neurosciences, 20(Suppl.): 19`20, 1994.

3176. mŒ´’˜n Effects of nitrazepam and rilmazafone hydrochloride combinded with ethanol on human@memory. —é–Ø–q•FC“àŠCŒõ’©C΋½‰ªƒi¸jC’|“எqi–òÜjC¬—Ñ”ü•cC‘º‰ª‰p—YC‘ºèŒõ–Mi¸j: Neurosciences, 20: 43`56, 1994.

3177. mŒ´’˜n ¶•¨ŽžŒv‚ƃqƒg‚ÌŠT“úƒŠƒYƒ€. “‡–{¹˜ai¸jC’·’J쌚Ž¡i¶—jC’†“‡ß•vi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: Ö°ŠwŒ¤‹†, 38(2): 23`32, 1994.

3178. mŒ´’˜n Ž‘±Ã–°CŽ©—¥ŒP—û–@‚̶‘̃ŠƒYƒ€‚É‹y‚Ú‚·‰e‹¿. ’†“‡ß•vC“‡–{¹˜ai¸j: Ö°ŠwŒ¤‹†, 38(2): 33`40, 1994.

3179. mŒ´’˜n ‘½“®«áŠQŽ™‚Ìs“®“Á’¥‚ɂ‚¢‚Ä|‹CŽ¿Ž¿–⎆–@‚ð—p‚¢‚½Œ¤‹†|. ˆÉ“¡ˆèŽqC—é–Ø–q•Fi¸j: ¬Ž™‚̸_‚Æ_Œo, 34: 137`148, 1994.

3180. mŒ´’˜n BenzodiazepineŽó—e‘Ìì“®«V‹K‡–°–ò L-846‚Ì‘æ‡T‘ŠŽŽŒ±|’P‰ñ“Š—^¥”½•œ“Š—^ŽŽŒ±|. “àŠCŒõ’©C™ŽRŒ’ŽuC—é–Ø–q•FC‘ºèŒõ–Mi¸j: _Œo¸_–ò—, 17(3): 185`202, l995.

3181. mŒ´’˜n ˜Vl‚Ì‘å—Ê•ž–ò‚ɂ‚¢‚Ä|Ž©Œ±—á‚ÌŒŸ“¢|. “‡“c‰hŽqC‰ª“cGrCÎì³”ŽC‘å’J‹`•vi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: _“Þì¸_–ò—, (6): 1`8, 1994.

3182. mŒ´’˜n ƒfƒCƒPƒA‚Ì—LŒø«‚ÉŠÖ‚·‚錟“¢|Ä“ü‰@—¦‚ðŽw•W‚Æ‚µ‚Ä|. ’ËŒ´•q³i‹î–Ø–ì•a‰@jC‰Á“¡Œ³ˆê˜Yi“ŒŽ•‘åjC‚–ì‰À–çC—é–Ø“§i‹î–Ø–ì•a‰@jCŠ}Œ´—FKi`–ì•a‰@j: ¸_‰ÈŽ¡—Êw, 9(12): 1371`1377, 1994.

3183. mŒ´’˜n V‚µ‚¢R‚¤‚–ò‚Ì—Õ°. ‘ºèŒõ–Mi¸j: ‘æ‚Q‰ñ” ª¸_–ò—ƒVƒ“ƒ|ƒWƒEƒ€, 2: 79`91, 1994.

3184. mŒ´’˜n V‚µ‚¢R•sˆÀ–ò Sc-48274‚Ì‘æ‚P‘ŠŽŽŒ±. ‚‹´–¾”äŒÃCŠ}Œ´—FKC‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: –ò—‚ÆŽ¡—Ã, 22(7): 3095`3141, 1994.

3185. mŒ´’˜n DM-9384iƒlƒtƒBƒ‰ƒZƒ^ƒ€)‚Ì‘æ1‘ŠŽŽŒ±. ‘ºèŒõ–MCˆîŒ©ˆòºC΋½‰ªƒCŽá“c•””Ž•¶C“àŠCŒõ’©C¼–{‡³C•ŸŽR‰Ãji¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”jC—§àV°’jC{“¡Œ«ˆêC“¡Šª‚䂤Žq: –ò—‚ÆŽ¡—Ã, 22: 3539`3587, 1994.

3186. mŒ´’˜n Remuxipride‚Ì‘æˆê‘ŠŽŽŒ±. ìŒû‹BC‹ž–ì“N•vC‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: —Õ°•]‰¿, 22: 141`174, 1994.

3187. m€Œ´’˜n Ö°‰º‚̈ӎ¯‘ÌŒ±. ’†“‡ß•vi¸j: Ö°ŠwŒ¤‹†, 38(1): 33`37, 1994.

3188. mŒ¤‹†•ñiŒú¶Èjn ¸_‰È‹~‹}ˆã—ÃVƒXƒeƒ€‚ÉŠÖ‚·‚錤‹†. ŽRè•q—YiŽRè•a‰@jC‹TˆäŒ[•ãi‹î–Ø–ì•a‰@jC•–Øé•vi“Œ–M‘岑q•a‰@jC•‘ò®i“úˆã‘åjCŒvŒ©ˆê—Yiç—tŒ§¸_‰Èˆã—ÃZƒ“ƒ^[jCŽ÷_Šwi‚±‚¾‚Ü ƒzƒXƒsƒ^ƒ‹jC{“¡_ˆê˜Yi“y²•a‰@jC’Ëv]ˆê˜Yi£–ìì•a‰@jC’†“‡ß•vi¸jC¼“c“¹OiŽ©Ž¡ÈÁ–h’¡jC¼ŽR‘Fi“Œ‹ž“s—§¸_ˆãŠwŒ¤‹†ŠjC•½“c –L–¾iç—tŒ§¸_‰Èˆã—ÃZƒ“ƒ^[jCŽç‰®—T•¶i“s—§L”ö•a‰@jC˜a‹C—²ŽOiV¶‰ï•a‰@j: Œú¶‰ÈŠwŒ¤‹†Œ¤‹†•ñ‘, 1994.

3189. mŒ¤‹†•ñiŒú¶Èjn ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•¨‚Ì—Õ°—p—ʈˑ¶‚ɂ‚¢‚Ä|‚»‚Ì‚P: ‰f‚©‚ç’·ŠúŽg—p‚ÉŽŠ‚éŒo‰ß‚ɂ‚¢‚Ä|. ‘ºèŒõ–MCˆä‘òŽu–¼–ìC™ŽRŒ’ŽuC—é–Ø–q•Fi¸jC’|“எqi–òÜ•”j: Œú¶Èu¸_¥_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ïv¸_ì—p•¨Ž¿«¸_áŠQ‚Ìf’f‚ÆŽ¡—ÂɊւ·‚錤‹†,•½¬5”N“xŒ¤‹†¬‰Ê•ñ‘, p.85`90, 1994.

3190. mŒ¤‹†•ñiŒú¶Èjn Diazepam‚Æ Lorazepam‚Ì–°‹C‚¨‚æ‚Ѹ_‰^“®‹@”\‚ɑ΂·‚é‰e‹¿. ΋½‰ªƒC™ŽRŒ’ŽuC‰i‘ò‹IŽqC“àŠCŒõ’©C—é–Ø–q•FC‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: Œú¶È¢¸_¥_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”–°áŠQ‚Ìf’f¥Ž¡—¨‚æ‚щuŠw‚ÉŠÖ‚·‚錤‹†, •½¬‚T”N“x•ñ‘, p.37`42, 1994.

3191. mŒ¤‹†•ñiŒú¶Èjn ¸_‰È‹~‹}ˆã—ÃVƒXƒeƒ€‚ÉŠÖ‚·‚錤‹†. ¼ŽR‘Fi“Œ‹ž“s—§¸_ˆãŠwŒ¤‹†ŠjCŠâèNFi“úˆã‘åjC‹TˆäŒ[•ãi‹î–Ø–ì•a‰@jCŒvŒ©ˆê—Yiç—tŒ§¸_‰Èˆã—ÃZƒ“ƒ^[jCŽðˆä³—Yi‹Ú•a‰@jCàV‰· i‚³‚í•a‰@jC{“¡_ˆê˜Yi“y²•a‰@jCŠÖ‰pˆêiŒú¶È•ÛŒ’ˆã—ËÇjC’†“‡ß•vi¸jC—Ñ’¼Ž÷i¼‘ò•a‰@jC•½“c–L–¾iç—tŒ§¸_‰Èˆã—ÃZƒ“ƒ^[jCX³ Oi’†‹{•a‰@jCŽRè•q—YiŽRè•a‰@jC˜a“cŒcŽ¡i’†‹{•a‰@j: ‘‡Œ¤‹†•ñ‘i•½¬4¥5”N“xŒú¶‰ÈŠwŒ¤‹†), 1994.

3192. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ƒXƒgƒŒƒX•]‰¿–@“™‚ÉŠÖ‚·‚錤‹†. ‹e’r’·“¿i“Œ—ˆã‘åjCŒá‹½W_i‘—§¸E_ƒZƒ“ƒ^[jC’†“‡ß•vi¸jC™]ªiã‰z‹³ˆç‘åŠwj: ì‹ÆŠÖ˜AŽ¾Š³‘ÎôŒ¤‹†¬‰Ê•ñ‘i˜J“­Èj, 1994.

3193. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•¨‚ÌŠî‘b‚ÆŽg—p–@. ‘ºèŒõ–Mi¸j: ¸_•ÛŒ’Œ¤‹†Š‘æ7‰ñi•½¬5”N“xj–ò•¨ˆË‘¶—Õ°ˆãŽtŒ¤C‰ï•ñ‘, p.79`107, 1994.

3194. mÇ—á•ñn ”]Ž€Š³ŽÒ‰Æ‘°‚ւ̑Ήž. –쑺’mŽqCŽR‰ê–MŽqC•ŸŽR‰Ãji‘‡‘Š’kjC’ç–M•Fi¸jC‘å˜a“c—²i‹~–½j: ‹~‹}ˆãŠw, 18(13): 1848`1851, l994.

3195. mÇ—á•ñn ‘å—ʃJƒ‹ƒoƒ}ƒ[ƒsƒ“’†“Å‚Ì‚P—á. ÷ˆäO”TC’ç–M•Fi¸jC–ؑ¥–¾C‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~–½‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 15: 360`362, l994.

3196. m—Õ°Ž¡Œ±n Phase 1 study of viga batrin. ‚‹´–¾”äŒÃC—é–Ø–q•FCŽá“c•””Ž•¶C΋½‰ªƒCˆîŒ©ˆòºC‘ºèŒõ–Mi¸j: Jpn. J. Psychiat. Neurol., 48(2): 340`341, l994.

3197. m‘àn R•sˆÀ–ò. ‘ºèŒõ–Mi¸j: Clin. Neurosci., 12: 897`900, 1994.

3198. m‘àn ‹~‹}—̈æ‚ł̃ƒ“ƒ^ƒ‹ƒPƒA(8) ”í‹s‘ÒŽ™ÇŒóŒQ‚̉Ƒ°‚ւ̑Ήž. X“c¶‹IŽqC’ç–M•Fi¸jC‘å“c„•äiŽ™j: Emergency Nursing, 7: 118`124, 1994.

3199. m‘àn ‡–°–òˆ•û‚ÌŒ»ó‚ƈÀ‘S‚ÈŽg—p–@‚ð‚ß‚®‚Á‚Ä|–ò—Šw“I“Á’¥‚Æ QOL‰ü‘P‚ðl—¶‚µ‚½Žg—p–@‚ÌŽÀÛ|. ‘ºèŒõ–Mi¸j: Ther. Res., 15: 4198`4206, 1994.

3200. m‘àn ŠÄ–ó: ƒvƒ‰ƒCƒ}ƒŠ¥ƒPƒA‚É‚¨‚¯‚邤‚•a‚Ì”­Œ©, f’f, Ž¡—Ã|—Õ°ˆã‚Ì‚½‚߂̃NƒCƒbƒN¥ƒŠƒtƒ@ƒŒƒ“ƒXƒKƒCƒh|i•Ä‘j. ‘ºèŒõ–Mi¸j: Ther. Res., 15: 763`782, 1994.

3201. m‘àn ‡–°áŠQi•s–°Çj‚Ì–ò•¨—Ö@. ‘ºèŒõ–Mi¸j: ŠÅŒì‹Zp, 41: 19`24, 1994.

3202. m‘àn ¸_•ª—ô•a‚Ì‘Šú”­Œ©. ‘ºèŒõ–Mi¸j: ¡“ú‚ÌŒ’N, 12: 86`89, 1994.

3203. m‘àn u¶‘̃ŠƒYƒ€‚ÆÖ°v“ÁW‚ɂ‚¢‚Ä. ’†“‡ß•vi¸j: Ö°ŠwŒ¤‹†, 38(2): 21`22, 1994.

3204. m‘àn ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“‚Æí—p—ʈˑ¶. ΋½‰ªƒi¸j: Ž¡—Êw, 28: 1005`1008, 1994.

3205. m‘àn Ach-M1Žó—e‘Ìì“®–ò(M1ƒAƒSƒjƒXƒgj‚Æ Ach•úo‘£i–ò. ‘å’J‹`•vi¸j: _Œo¸_–ò—, 16(12): 739`745, 1994.

3206. m‘àn Œü¸_–ò‚ÌŒ»ó‚Æ«—ˆ. ‘ºèŒõ–Mi¸j: æ’[ˆã—Ã, 6: 28`30, 1994.

3207. m‘àn ‚—îŽÒ‚Ì•s–°Ç‚Æ‚»‚ÌŽ¡—Ã. ‘ºèŒõ–Mi¸j: “Œ‹ž“sˆãŽt‰ïŽGŽ, 47: 1005`1013, 1994.

3208. m‘àn ƒAƒ‹ƒR[ƒ‹‚Æ‚Ä‚ñ‚©‚ñ. ‚‹´–¾”äŒÃi¸j: “ú–{ƒAƒ‹ƒR[ƒ‹¸_ˆãŠwŽGŽ, 1(1): 49`54, 1994.

3209. m‘àn ‹}«Ž¾Š³‚ÌŽ¡—Ãí—ª|¸__Œo‰È—̈æ|. ‘ºèŒõ–Mi¸j: “ú–{ˆãŽ–V•ñ, (3678): 32`46, 1994.

3210. m‘àn ‘åŠw‚É‚¨‚¯‚é¸_‰È‘²Œã‹³ˆç‚Ì‚P‚‚̎Ž‚Ý|–k—¢‘åŠw‚ÌŒoŒ±‚©‚ç|. ’†“‡ß•vi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: “ú–{¸_•a‰@‹¦‰ïŽGŽ, 13(4): 25`33, 1994.

3211. m‘àn çN‚¤‚•a‚ÌŽ¡—Ã: –ò•¨—Ö@. ‘ºèŒõ–Mi¸j: “ú–{—Õ°, 52: 1213`1220, 1994.

3212. m‘àn Šw‰ïˆóÛ‹L: ‘æ1‰ñƒAƒWƒA‡–°Šw‰ï‚¨‚æ‚Ñ‘æ19‰ñ“ú–{‡–°Šw‰ï‹¤“¯‰ï‹c‚È‚ç‚Ñ‚É‘æ4‰ñ‘Ûƒiƒ‹ƒRƒŒƒvƒV[ƒVƒ“ƒ|ƒWƒEƒ€. ‘ºèŒõ–Mi¸j: —Õ°¸_ˆãŠw, 23: 1713`1715, 1994.

3213. m‘àn ƒqƒg‹L‰¯‹@”\‚ɑ΂·‚é—Õ°–ò—Šw“IŒ¤‹†. ΋½‰ªƒi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: ˜V”NŠú’s•ð, 8: 215`222, 1994.

3214. m‘àn –ò•¨‚É‚æ‚é’†“Å«”]Ç. ΋½‰ªƒi¸j: ˜V”N¸_ˆãŠw, 5: 413`419, 1994.

3215. muÀn ƒXƒgƒŒƒXƒR[ƒsƒ“ƒO‚Æ‚µ‚Ä‚ÌŽ©—¥ŒP—û–@i‚Q). •ŸŽR‰ÃjCŒÜäzi‘‡‘Š’kjC’ç–M•Fi‹~–½jC’†“‡ß•vi¸j: Emergency Nursing, 7(8): 683`689, 1994.

3216. muÀn Sˆö«Œ’–Y|–Y‚ꂽ‚¢Œ»ŽÀ‚ð‚ǂ̂悤‚ÉŽæ‚è–ß‚³‚¹‚é‚©|. ’†“‡ß•vi¸j: ‹~‹}ˆãŠw, 18(13): 1811`1815, 1994.

3217. muÀn ¶‘̃ŠƒYƒ€‚©‚ç‚Ý‚½ì‹ÆŠÖ˜AEƒ‰ƒCƒtƒXƒ^ƒCƒ‹•a. ’†“‡ß•vi¸j: “ú–{ˆãŽt‰ïŽGŽ, 111(11): 1844`1848, 1994.

3218. muÀn ¸_Çó‚ð‚¨‚±‚µ‚â‚·‚¢g‘Ì•a. ’†“‡ß•vi¸j: “ú–{ˆãŽt‰ïŽGŽ, 112(10): 1378`1384, 1994.

3219. mŠwp‘n i•ª’SŽ·•Mj ‹­”—«áŠQi¶•¨Šw“I¸_ˆãŠw Vol.7); ”F’m‹@”\‚©‚猩‚½‹­”—‚Ì“ÁˆÙ«, p.21`41, Ží“c^»—Yi¸j. •ÒW ’†‘òPKi’·’Jì•a‰@jC’†“ˆÆ•vi‹ž“s•{—§ˆã‘åjC ‹àŒ´o”Å, “Œ‹ž, 94.08.20”­s.

3220. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ˆ•û‚ÌŽÀÛ; ‚¤‚•ai‹C•ªáŠQ), ˆîŒ©ˆòºi¸j. •ÒW “à“¡ŽüKi’é‹ž‘åjC –ò‹ÆŽž•ñŽÐ, “Œ‹ž, 94.09.30”­s.

3221. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ŽÀ‘Hî•ñ’ÊM; Žq‚Ç‚à‚Æ—F’B|Ž™“¶Šú‚Ì—FlŠÖŒW‚Æ•s“K‰žs“®|; ‹³ˆç‘Š’k‚ÌŒ»ê‚©‚ç, p.4`6, X“c¶‹IŽqi¸j. •ÒW Šâ“c‘׎qi_“Þ쌧—§Žq‚Ç‚àˆã—ÃZƒ“ƒ^[jC¼–{N˜YiˆÀ“c¶–½ŽÐ‰ïŽ–‹Æ’cjC ˆÀ“c¶–½ŽÐ‰ïŽ–‹Æ’c, “Œ‹ž, 94.12.15”­s.

3222. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Hypnotic uses for insomnia |from the results of a questionnaire invesigation. ‘ºèŒõ–Mi¸j: Founding Congress of the Asian Sleep Research Society in association with 19th Annual Meeting of the Japanese Society of Sleep Research i94.06.15`16j, “Œ‹ž.

3223. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Amnesia induced by hypnotics; Symposium|Insomnia and hypnotics. ΋½‰ªƒi¸j: Founding Congress of the Asian Sleep Research Society i94.06.15j, “Œ‹ž.

3224. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Clinical efficacy of azapirones in anxiety disorders: An overview. ‘ºèŒõ–Mi¸j: ‘æ19‰ñ‘Û_Œo¸_–ò—Šw‰ï i94.06.27`07.01j, Washington, D.C., Neuropsychopharmacology, 10(Part 1): 614, 1994.

3225. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Pharmaco-kinetics and pharmacodynamics in phase 1 clinical trials. ‚‹´–¾”äŒÃC΋½‰ªƒC™ŽRŒ’ŽuC“àŠCŒõ’©C‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: ‘æ19‰ñ‘Û_Œo¸_–ò—Šw‰ï i94.06.27`07.01j, Washington, D.C., Neuropsychopharmacology, 10(Part 1): 651, 1994.

3226. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Dual 5HT and NE reuptake inhibitors: Biology and early clinical experience pharmacokinetics and pharmacodynamics in phase 1 clinical trials. ‚‹´–¾”äŒÃC΋½‰ªƒC™ŽRŒ’ŽuC“àŠCŒõ’©C‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: 19th Collegium Internationale Neuro-Psychopharmacologicum Congress i94.06.30j, Washington, D.C., Neuropsychopharmacology, 10(3S): 651, 1994.

3227. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Drug therapy against negative symptoms of schizophrenia. ‘ºèŒõ–Mi¸j: Psyche '94 International Symposium on Body-Mind Problem i94.10.07j, ‘åã.

3228. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j New prospects for psychotropic drug development in Japan. ‘ºèŒõ–Mi¸j: International Academy for Biomedical and Drug Research i94.11.01j, “Œ‹ž.

3229. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j The current situation surrounding the development of psychopharmaceuticals in Japan. ‘ºèŒõ–Mi¸j: 1995 Japan-United States Visiting Medical Scientist Award i95.03.20j, Philadelphia, USA.

3230. mŠw‰ïi‘Ûjn iƒ[ƒNƒVƒ‡ƒbƒvj Depressive patients in group music therapy. Makiko Kubotai“Œ•a‰@jC•B“cŒ\ˆê˜Yi¸_‰ÈjCToyoko Morishitai“Œ•a‰@jCMieko Yamashitai“Œ•a‰@jC’†“‡ß•vi¸_‰Èj: International Congress of Art Therapy i94.10.09j, ‹ž“s.

3231. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Effects of single oral dose of diazepam and lorazepam on daytime sleepiness and psychomotor functions. ™ŽRŒ’ŽuC‰i‘ò‹IŽqC“àŠCŒõ’©C—é–Ø–q•FC΋½‰ªƒC‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: 19th Collegium Internationale Neuro-Psychopharmacologicum Congress i94.06.29j, Washington, D.C., Neuropsychopharmacology, 10(3S): 111, 1994.

3232. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Phase 1 study of Y-23684, a novel benzodiazepine receptor partial agonist activity. ‘ºèŒõ–MC‚‹´–¾”äŒÃCˆîŒ©ˆòºi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: 19th Collegium Internationale Neuro-Psychopharmacologicum Congress i94.06.29j, Washington, D.C., Neuropsychopharmacology, 10(3S): 171, 1994.

3233. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Phase 1 clinical study of AD-5423, a new antipsychotic drug with D2 and S2 antagonist activity. Žá“c•””Ž•¶C—Ž‡ˆê‹vC‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: 19th Collegium Internationale Neuro-Psychopharmacologicum Congress i94.06.30j, Washington, D.C., Neuropsychopharmacology, 10(3S): 192, 1994.

3234. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Sigma antagonists in the treatment of schizophremia; Recent advances in novel antipsychotic drug treatment. ΋½‰ªƒi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: 19th Collegium Internationale Neuro-Psychopharmacologicum Congress i94.07.01j, Washington, D.C., Neuropsychopharmacology, 10(3S): 806, 1994.

3235. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Serum ƒ¿1-antichymotrypsin concentrations in Alzheimer type- and vascular dementia. ‹g“c–FŽqC‘å’J‹`•vCìŒû‹BC‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: International Conference on Alzheimers Disease i94.08.01j, Minesota, USA.

3236. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Broad clinical spectrum of a new atypical neuroleptic, SM-9018 on positive and negative symptoms, and anxiety-depression in patients with schizophrenia. ‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”jCKudo Y.: Schizophrenia 1994: Exploring the Spectrum of Psychosis Third International Conference i94.08.21`24j, Vancouver, Canada, Abstracts, p.11, 1994.

3237. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j The effect of sertindole in normal subjects: Its safety, plasma concentration, and effects on psychomotor functions. ΋½‰ªƒC’ËŒ´•q³C—é–Ø–q•FC•ŸŽR‰ÃjC‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: 19th Collegium Internationale Neuro-Psychopharmacologicum Congress i94.06.28j, Washington, D.C., Neuropsychopharmacology, 10(3S): 139, 1994.

3238. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Serotonin uptake inhibition in platelets of duloxetine-treated subjects. ΋½‰ªƒi¸jC‰i“c‰xŽqi“Œ•a‰@Œ¤‹†ŒnjC‚‹´–¾”äŒÃC™ŽRŒ’ŽuC‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: 19th Collegium Internationale Neuro-Psychopharmacologicum Congress i94.06.30j, Washington, D.C., Neuropsychopharmacology, 10(3S): 218, 1994.

3239. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j A phase 1 study in healthy volunteers of ICI 204636, a novel neuroleptic agent. “‡“c‰hŽqC‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”jC’å‘‘¾ŽuC‹g–{Âi¸j: 12th International Congress of Pharmacology i94.07.25j, Montreal, Canada.

3240. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Safety and pharmacokinetics of cycloserine in normal healthy elderlys. ‘å’J‹`•vC—é–Ø–q•FC‹g“c–FŽqCìŒû‹BC“àŠCŒõ’©CŒÃ’m‹MŒbŽqC‘ºèŒõ–Mi¸j: 12th International Congress of Pharmacology i94.07.29j, Montreal, Canada, Can. J. Physiol. Pharmacol., 72(Suppl.1): 461, 1994.

3241. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j R•sˆÀ–ò‚Ì—Õ°—p—ʈˑ¶. ‘ºèŒõ–Mi¸j: ‘æ29‰ñ“ú–{ƒAƒ‹ƒR[ƒ‹ˆãŠw‰ï i94.09.30j, ‰¡•l.

3242. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹L‰¯‚ÌŽ©ŒÈ•]‰¿‚Æ‹­”—“I«ŠiŒXŒü. à’z—TŽqC¬—ÑË‘×CˆÀ•”˜a”üC¬o”ŽŒÈCƒg•”_˜aCŽRŒûC•½i“‡ªˆã‘åjCŽí“c^»—Yi¸j: ‘æ18‰ñ“ú–{Ž¸ŒêÇŠw‰ï i94.11.18j, –¼ŒÃ‰®. —\eW, p.15, 1994.

3243. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j SSRI‚Æ‚¤‚•a. ‘ºèŒõ–Mi¸j: ‘æ17‰ñ“ú–{¶•¨Šw“I¸_ˆãŠw‰ï i95.03.31j, ŽRŒ`Žs.

3244. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —tŽR’¬‹³ˆçˆÏˆõ‰ï‚É‚¨‚¯‚é•s“oZŽ™‚Ö‚ÌŠÖ‚í‚è|ê”C‹³ˆõ‚Ì—§ê‚©‚ç|. ‚‹´Œõ—YC¡ˆä—˜“Ti—tŽR’¬‹³ˆçˆÏˆõ‰ïjCŠâ–{°‘ãiŽO‰Y‚µ‚ç‚Ƃ艀jCX“c¶‹IŽqi¸j: ‘æ34‰ñ“ú–{Ž™“¶Â”N¸_ˆãŠw‰ï‘‰ï i93.10.22j, VŠƒ, Ž™“¶Â”N¸_ˆãŠw‚Æ‚»‚Ì‹ßڗ̈æ, 35(1): 23`24, 1994.

3245. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —tŽR’¬‹³ˆçˆÏˆõ‰ï‚É‚¨‚¯‚é•s“oZŽ™‚Ö‚ÌŠÖ‚í‚è|¸_‰Èˆã‚Ì—§ê‚©‚ç|. X“c¶‹IŽqi¸jCŠâ–{°‘ãiŽO‰Y‚µ‚ç‚Ƃ艀jC‚‹´Œõ—YC¡ˆä—˜“Ti—tŽR’¬‹³ˆçˆÏˆõ‰ïj: ‘æ34‰ñ“ú–{Ž™“¶Â”N¸_ˆãŠw‰ï‘‰ï i93.10.22j, VŠƒ, Ž™“¶Â”N¸_ˆãŠw‚Æ‚»‚Ì‹ßڗ̈æ, 35(1): 24`25, 1994.

3246. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘åŠw•a‰@‚É‚¨‚¯‚éƒfƒCEƒPƒA‰Æ‘°‰ï‚ɂ‚¢‚Ä. ŽR–{–¾”üC”’–ØŒ´ŽsŽŸCŠâ–{‘€CA¼”ü”¿i“ŒƒŠƒn•”jC’†“‡ß•vi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: ‘æ90‰ñ“ú–{¸__ŒoŠw‰ï i94.05.25j, ¼ŽR.

3247. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«Œü¸_–ò’†“ÅŠ³ŽÒ‚Æ‚Ý‚ç‚ꂽRhobdomyolysis|Œü¸_–ò‚ð‘å—Ê•ž—piŽ©ŽEŠé}j‚µ‚½Š³ŽÒ‚©‚ç‚ÌŒŸ“¢|. X“c¶‹IŽqC’ç–M•Fi¸jC¬Œû“OiŠÅŒìŠw•”jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”jC“yˆä˜a”üi¶•¨•¨—Œnj: ‘æ90‰ñ“ú–{¸__ŒoŠw‰ï‘‰ï i94.05.25j, ¼ŽR, —\eW, p.97, 1994.

3248. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˜V”NŠú‚¤‚•a‚ÌCT‚¨‚æ‚ÑMRIŠŒ©‚ɂ‚¢‚Ä. ‹g“c–FŽqC‘å’J‹`•vCìŒû‹BC‘ºèŒõ–Mi¸j: ‘æ7‰ñ“ú–{˜V”N¸_ˆãŠw‰ï i94.06.18j, “Œ‹ž.

3249. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Bromocriptine‚ª—LŒø‚Å‚ ‚Á‚½¨–Àó‘Ԃ𔺂¤ Wernicke-Korsakoff syndrome‚Ì‚P—á. “n•Ó”Ci¸jC‰Á“¡Œ³ˆê˜Yi“ŒŽ•‰È‘åjC‹g–ì‘Š‰pC‹g‰v°•vC‹TˆäŒ[•ãi‹î–Ø–ì•a‰@j: ‘æ6‰ñ“ú–{ƒAƒ‹ƒR[ƒ‹¸_ˆãŠw‰ï i94.07.29j, ‘åã, “ú–{ƒAƒ‹ƒR[ƒ‹¸_ˆãŠw, 1(2): 179`180, 1994.

3250. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ’ZöŽžVEP‚Ì—Õ°‰ž—p. ‹g–{gŽqC—é–Ø~Žqi—ÕŒŸjC•Ÿ“c—Ï–çC”¨—²Žui“àjCŽí“c^»—Yi¸j: ‘æ24‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ï i94.10.26j, å‘ä.

3251. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹~‹}ˆã—Âɂ¨‚¯‚éƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn’ŽË–ò‚ÌŽg—pó‹µ. ÷ˆäO”TC’ç–M•FC—§‘òŒ«FC㞊‹glC¬Œû“Oi¸j: ‘æ‚V‰ñ“ú–{‘‡•a‰@¸_ˆãŠw‰ï‘‰ï i94.11.11j, ·‰ª.

3252. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –D‚¢j‚Å‚ÌŽ©sˆ×‚©‚çS–ŒØŠJŒãÇŒóŒQ—l•a‘Ô‚ð’悵, Sƒ^ƒ“ƒ|ƒi[ƒf‚𗈂µ‚½‚P—á. “sŠÛ‹`˜YC‘“c‘ìC㞊‹glC¼ŽRÄ‹vC—é–Ø—EˆêC•‘ò—˜˜Yi‹~–½jC’†“‡ß•vi¸j: ‘æ7‰ñ“ú–{‘‡•a‰@¸_ˆãŠw‰ï i94.11.11j, ·‰ª.

3253. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«Œü¸_–ò’†“ÅŠ³ŽÒ‚É‚Ý‚ç‚ꂽ Rhabdomyolysis|Œü¸_–ò‚É‚æ‚鎩ŽEŠé}Š³ŽÒ‚©‚ç‚ÌŒŸ“¢|. X“c¶‹IŽqC’ç–M•Fi¸jC¬Œû“OiŠÅŒìŠw•”jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”jC“yˆä˜a”üi¶•¨•¨—ŒnjC’ß“c—z˜aiˆã—pîj: ‘æ‚V‰ñ“ú–{‘‡•a‰@¸_ˆãŠw‰ï‘‰ï i94.11.11j, ·‰ª, ‘‡•a‰@¸_ˆãŠw, 6: 79, 1994.

3254. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˜V”NŠú‚¤‚•a‚ÌMRIŠŒ©‚Æ—Õ°Œo‰ß‹y‚Ñ–ò•¨—Ö@‚ÌŒø‰Ê. ‹g“c–FŽqC‘å’J‹`•vC‹Êé‰Ã˜aCìŒû‹BCˆä‘òŽu–¼–ìC‘ºèŒõ–Mi¸j: ‘æ‚S‰ñ—Õ°¸__Œo–ò—Šw‰ï i94.11.18j, ‹ž“s.

3255. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«ö—ó‘Ô‚ð’悵‚½ƒƒVƒA’“ݤŽÐˆõ‚Ì‚P—á. •B“cŒ\ˆê˜YCŽá“c•””Ž•¶C’†“‡ß•vi¸j: ‘æ2‰ñ“ú–{ŽY‹ÆƒXƒgƒŒƒXŠw‰ï i94.11.26j, “Œ‹ž.

3256. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒfƒCƒPƒA’ÊŠŽÒ‚̸_Çó‚̉ü‘P. ‚–ì‰À–çC’ËŒ´•q³C—é–Ø“§CŒ´íŸC’¬“c—²Ž¡C‹Ê–؉ê’ÃŽ}C‰¬Œ´“¹ŽqC–ìŒû‚Ȃ‚«i‹î–Ø–ì•a‰@jCŠ}Œ´—FKC‰Á“¡Œ³ˆê˜Yi¸j: ‘æ15‰ñ“ú–{ŽÐ‰ï¸_ˆãŠw‰ï i95.03.16j, ‚‚­‚ÎŽs.

3257. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒfƒCƒPƒA‚Ì—LŒø«‚ÉŠÖ‚·‚錟“¢|‚T”NŠÔ‚ÌÄ“ü‰@‚ðŽw•W‚Æ‚µ‚Ä|. ’ËŒ´•q³C‚–ì‰À–çCŒIŒ´–«”VCŒ´íŸC‰Á“¡Œ³ˆê˜Yi‹î–Ø–ì•a‰@jCŠ}Œ´—FKi¸j: ‘æ15‰ñ“ú–{ŽÐ‰ï¸_ˆãŠw‰ï i95.03.16j, ‚‚­‚ÎŽs.

3258. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒfƒCƒPƒAƒvƒƒOƒ‰ƒ€‚̈Ⴂ‚Í’ÊŠŽÒ‚Ì—Õ°Çó‚ɉe‹¿‚ð—^‚¦‚é‚©. Š}Œ´—FKi`–ì•a‰@jC”’–ØŒ´ŽsŽŸC’Ø“c—R”üCŽR–{–¾”üCŠâ–{‘€C—é–؃ŒbCA¼”ü”¿C¼˜e~i“Œ•a‰@jC’†“‡ß•vi¸jC’ËŒ´•q³C‚–ì‰À–çi‹î–Ø–ì•a ‰@jC‰Á“¡Œ³ˆê˜Yi“ŒŽ•‘åj: ‘æ15‰ñ“ú–{ŽÐ‰ï¸_ˆãŠw‰ï i95.03.16j, ’}”g.

3259. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒfƒCƒPƒA’ÊŠŽÒ‚̗̑͂Ƹ_Çó. ”’–ØŒ´ŽsŽŸC’Ø“c—R”üCŽR–{–¾”üCA¼”ü”¿C—é–؃ŒbCŠâ–{‘€C”’–ØŒ´—tŽqCK“c‚é‚ÝŽqC¼˜e~i“Œ•a‰@jC’†“‡ß•vi¸jC“yàVŒ’ˆêiˆã—Éq¶Šw•”jC Š}Œ´—FKi`–ì•a‰@j: ‘æ15‰ñ“ú–{ŽÐ‰ï¸_ˆãŠw‰ï i95.03.16j, ’}”g.

3260. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒfƒCƒPƒA’ÊŠ’†‚̸_•ª—ô•aŠ³ŽÒ‚̉^“®‘OŒã‚Ìg‘Ì’mŠo‚̕ω»|‚Q|. K“c‚é‚ÝŽqC”’–ØŒ´ŽsŽŸC’Ø“c—R”üi“Œ•a‰@jC—é–Ø–q•Fi¸jC•ŸŽR‰ÃjC¼˜e~i“Œ•a‰@jCŠ}Œ´—FKi`–ì•a‰@jC’†“‡ß•vi¸jCŽO‰Y’å‘¥iˆã—Éq¶ Šw•”j: ‘æ15‰ñ“ú–{ŽÐ‰ï¸_ˆãŠw‰ï i95.03.17j, ’}”g.

3261. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‹~‹}ˆã—Âɂ¨‚¯‚éƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn’ŽË–ò‚ÌŽg—pó‹µ. ÷ˆäO”TC’ç–M•FC㞊‹glCŽR–{aˆê˜YC–ؑ¥–¾C“sŠÛ‹`˜Yi¸jC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i94.11.04j, “Œ‹ž.

3262. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ¸_áŠQ‚ð—L‚·‚é•wl‚Ì”DP¥•ª•Ø‚ÌŠÇ—|¸_‰Èˆã‚Ì—§ê‚©‚ç|. X“c¶‹IŽqi¸j: ‘æ‚V‰ñ_“Þì•ê«‰q¶Šw‰ï‘‰ï i95.02.05j, ‰¡•l, —\eW, p.11`12, 1994.

3263. mŠw‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j “«‚¤‚•a‚ɑ΂·‚éƒTƒtƒ‰ƒWƒ“‚ÌŽg—pŒoŒ±‚ÆMAO‘jŠQ–ò•œŠˆ‚̉”\«. Žá“c•””Ž•¶i¸j: ‘æ‚Q‰ñ_“Þì¸_–ò—Šw‰ï i95.03.09j, ‰¡•l.

3264. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¸_Çó‚ð’悵‚½”畆‹Ø‰Š‚Ì‚PÇ—á. •B“cŒ\ˆê˜YC—é–Øç•äC’†–ì’qmC‹g“c³ÆC΋½‰ªƒC‘ºèŒõ–Mi¸j: _“Þ쌧¸_ˆãŠw‰ï i94.07.16j, _“Þì.

3265. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’x”­«ƒWƒXƒgƒjƒA‚ɂ‚¢‚Ä|Ž©Œ±—á‚ÌŒŸ“¢‚©‚ç|. Žá“c•””Ž•¶C²“¡Ž‹vC“ï”g—ŽuC‹g‰ª³ÆC‘å’J‹`•vi¸j: ‘æ‚R‰ñ_“Þ쌧¸_–ò—Šw‰ï i94.09.29j, ‰¡•l.

3266. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘½Ê‚ȸ_Ç󉺂ɂт܂ñ«ˆÙí”]”g‚ð”F‚ß‚½‚P—á. ‹g–{ÂCŠ}Œ´—FKC‚‹´–¾”äŒÃC‚‹´KŽ}i¸j: _“Þì¸_ˆãŠw‰ï i94.11.06j, ‰¡•l.

3267. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‘å—ʃJƒ‹ƒoƒ}ƒ[ƒsƒ“’†“Å‚Ì‚PÇ—á. ÷ˆäO”TC’ç–M•FC㞊‹glCŽá—Ñ–õ‹vCó—˜–õC‹ß“¡•x”üŽqC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ36‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i95.02.05j, “Œ‹ž.

3268. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ž©ŽEŠé}‚É‚Ü‚ÅŽŠ‚Á‚½Œã‘å”]“®–¬—̈æ[Ç‚Ì‚P—á. Vˆä~Žqi¸jCHŽR‹v®C‚‹´’õlC—§‘òŒ«FC•½“cŒõ”ŽC’ç–M•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i95.02.25j, “Œ‹ž.

3269. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “¯Žž‚ɶ‘æ‚Tæä‚ðØ’f‚µ‚½¸_•ª—ô•a‚ÆŠ´‰ž¸_•a‚ÌŒZ’í—á. ‰“æGŽ÷C™ŽRŒ’ŽuC“c’†•üŽqC΋½‰ªƒC‘ºèŒõ–Mi¸j: ‘æ116‰ñ_“Þ쌧¸_ˆãŠw‰ï i95.03.18j, ‰¡•l.

3270. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒCƒ“ƒ^[ƒtƒFƒƒ““Š—^‚É‚æ‚è‚“xˆÓŽ¯áŠQ‚ð’悵‚½‚PÇ—á. 㑺—²C—é–Øç•äC™ŽRŒ’ŽuC‹g“c–FŽqC΋½‰ªƒC‘ºèŒõ–Mi¸j: ‘æ116‰ñ_“Þ쌧¸_ˆãŠw‰ï i95.03.18j, ‰¡•l.

3271. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ˜V”NŽÒ‚̇–°áŠQ|‡–°–ò‚ÌŽg‚¢•û|. ‘ºèŒõ–Mi¸j: “ú–{ˆãŽt‰ï¶ŠU‹³ˆçuÀ¥’©“úV•·ˆã—ÃZƒ~ƒi[ i94.06.18j, “Œ‹ž.

3272. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚é¸_‰È‹Ù‹}ˆã—Â̌»ó‚Æ–â‘è“_. ˆîŒ©ˆòºCŽá“c•””Ž•¶C’†“‡ß•vC‘ºèŒõ–Mi¸jCŽO‰Y’å‘¥iˆã—Éq¶Šw•”j: ‘æ2‰ñ¸_‰È‹~‹}Œ¤‹†‰ï i94.07.02j, ‰¡•l.

3273. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‡–°–ò‚ÆQŽð‚ÉŠÖ‚·‚é’²¸i‚»‚Ì‚Q). ’·’Jì‹g¶C‘º‰ª‰p—YC”’싳lC—é–Ø–q•Fi¸jC…’J—R”üŽqC¼â—˜”VC‘ºèŒõ–Mi¸j: •s–°ÇŒ¤‹†‰ï i94.11.26j, “Œ‹ž.

3274. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ‡–°–ò‚Ì’·Šú•ž—p‚ɂ‚¢‚Ä|¶–½•\‰ðÍ‚ð—p‚¢‚½ˆ•ûâ³’²¸|. ΋½‰ªƒC™ŽRŒ’ŽuCˆä‘òŽu–¼–ìC‘ºèŒõ–MC’|“எqi¸j: Œú¶È¢¸_¥_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”–°áŠQ‚Ìf’f¥Ž¡—¨‚æ‚щuŠw‚ÉŠÖ‚·‚錤‹†•½¬‚U”N“xŒ¤‹†•ñ‰ï i94.12.09j, “Œ‹ž.

3275. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j •s–°Ç. ‘ºèŒõ–Mi¸j: ‘æ19‰ñ“쑽–€Žx•”‹L”Ou‰‰ i94.05.17j, ‘½–€Žs.

3276. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ”F’mƒvƒƒZƒX|‚¤‚•a‚ð’†S‚É|. Ží“c^»—Yi¸j: ‘æ32‰ñL“‡Œ§‚¤‚•aŒ¤‹†‰ï i94.11.22j, L“‡.

3277. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ¸_•ª—ô•a‚É‚¨‚¯‚é–ò•¨—Ö@‚̈Ӌ`. ΋½‰ªƒi¸j: ƒ„ƒ“ƒZƒ“‹¦˜aŠ”Ž®‰ïŽÐŒ¤‹†‰ï i94.04.07j, “Œ‹ž.

3278. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ¸_•ª—ô•a‚Ì–ò•¨—Ö@|—Õ°“IŠÏ“_‚©‚ç|. ΋½‰ªƒi¸j: Œo‰cŠJ”­ƒZƒ“ƒ^[ƒZƒ~ƒi[ i94.05.26j, “Œ‹ž.

3279. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ¸_‰È‚©‚猩‚½X”NŠúáŠQ. ‹g“c–FŽqi¸j: ‘æ‚U‰ñ‘Š–ÍŒ´ŽsŽY•wl‰Èˆã‰ï i94.09.26j, ‘Š–ÍŒ´, ƒVƒmƒvƒX, p.94`96, 1994.

3280. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‘‡•a‰@‚É‚¨‚¯‚é¸_‰È•a“‚Ì‚ ‚è•û‚ð‚ß‚®‚Á‚Ä. ’†“‡ß•vi¸j: ‘æ22‰ñGeneral Hospital PsychiatryŒ¤‹†‰ï i94.06.18j, “Œ‹ž.

3281. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j •s–°Ç‚ÌŽ¡—Ã. ‘ºèŒõ–Mi¸j: •½¬‚U”N“x‘åã•{E•ºŒÉŒ§¸_‰Èf—ÊO—ˆu‰‰‰ï i94.10.15j, _ŒË.

3282. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•¨‚ÌŠî‘b‚Æ—Õ°. ‘ºèŒõ–Mi¸j: ‘æ8‰ñ–ò•¨ˆË‘¶—Õ°ˆãŽtŒ¤C‰ï i94.10.24j, ‘—§¸_•ÛŒ’Œ¤‹†Š.

3283. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j _“ÞìƒGƒ~ƒŒ[ƒXŒ¤‹†‰ï•ñ. ‹g“c–FŽqi¸j: _“ÞìƒGƒ~ƒŒ[ƒXŒ¤‹†‰ï i94.07.15j, ‰¡•l.

3284. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‘O“ª—t‚Ä‚ñ‚©‚ñ‚Ì‚Q—á. ‚‹´–¾”äŒÃC•B“cŒ\ˆê˜YC‹g‘º•¶CˆîŒ©ˆòºC‘ºèŒõ–Mi¸j: _“Þì‚Ä‚ñ‚©‚ñ§˜b‰ï i94.07.23j, ‰¡•l.

3285. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ¸_•ª—ô•a‚Ì–ò•¨—Ö@. ‚‹´–¾”äŒÃi¸j: “ú–{¸_‰ÈŠÅŒì‹ZpŒ¤‹†‰ï i94.11.29j, ‰¡•l.

3286. mŒ¤‹†‰ïi’n•ûjn iŒöŠJuÀj ¸_•ª—ô•a|ŋ߂̘b‘è|. ˆîŒ©ˆòºi¸j: ¸_áŠQŽÒ‰Æ‘°‰ïŒöŠJuÀ i95.02.09j, ”Ñ”\.


<<26 •úŽËü‰ÈŠw>>

3287. mŒ´’˜n Double-contrast barium enema study with computed radiography: Assessment in detection of colorectal polyps. ‰ª“c‹g—²C‘–쳈êC‰““¡‚i•új: Journal of Digital Imaging, 17(3): 154`159, 1994.

3288. mŒ´’˜n “Ý“I• •”ŠO‚É‚æ‚é\“ñŽw’°‘¹‚ÌCT‘œ‚ÌŒŸ“¢. ¼Šª”ŽC–x’rdŽ¡i•újCó—˜–õC™–{Ÿ•FC‘꓇í‰ëCV“¡³‹PC‘å˜a“c—²i‹~–½jC‘Oì˜a•Fi“Œ‘åj: “ú–{ŠOŒ¤‹†‰ïŽ, 8(4): 337`344, 1994.

3289. m€Œ´’˜n Šà‚Ìf’f‚ÆŽ¡—ÂÌi•à|ŒÀŠE‚Æ“W–]|ƒAƒCƒ\ƒg[ƒvŒŸ¸‚ÅŠàf’f‚Í‚Ç‚±‚܂ʼn”\‚©. Έ䟌Èi•új: —Õ°¬l•a, 24(8): 1003`1013, 1994.

3290. mŒ¤‹†•ñiŒú¶Èjn Ž¥‹C‹¤–‰摜–@‚É‚æ‚邪‚ñf’f”\‚ÌŒüã‹y‚ÑŽ¡—Âւ̊ñ—^. ’©‘q‰p’ji‘—§‘Š–ÍŒ´•a‰@jCr–Ø—Íi“Œ‘åjC¬–ìŒö“ñi‹ž‘åjC›Mˆêi•újC“’ó—S“ñiŒc‘åjCå“cG•½i‘—§–¼ŒÃ‰®•a‰@jC–{ŠÔ‹v“oi‘—§ŽD–y•a ‰@jC“¡ˆä‹±ˆêi‘—§•a‰@ˆã—ÃZƒ“ƒ^[jCX–{kŽ¡i‘—§‘åã•a‰@jC‹g–{Œ«—²iŠàŒ¤jC‘OŒ´N‰„iŒQ”nŒ§—§‚ª‚ñƒZƒ“ƒ^[j: Œú¶È‚ª‚ñŒ¤‹†•¬‹à‚É‚æ‚é•ñW•½¬4”N“x, p.436`441, 1992.

3291. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn y‘f•ªŽq‚ɑ΂·‚é’áü—Ê•úŽËüÆŽË‚Ì‹@”\˜´iŒø‰Ê. ‘¾“cŒ°¬C¼—Ñ—²i•új: Œ´Œ¤Ž{Ý—˜—p‹¤“¯Œ¤‹†¬‰Ê•ñ‘•½¬5”N“x(“Œ‹ž‘åŠwŒ´Žq—ÍŒ¤‹†‘‡ƒZƒ“ƒ^[), p.8`9, 1994.

3292. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn •a—‘gD‚Ì•úŽË‰»•ªÍ. ‘¾“cŒ°¬C¼—Ñ—²i•új: —§‹³‘åŠwŒ´Žq˜F—˜—p‹¤“¯Œ¤‹†¬‰Ê•ñ‘•½¬5”N“x(“Œ‹ž‘åŠwŒ´Žq—ÍŒ¤‹†‘‡ƒZƒ“ƒ^[), p.33`34, 1994.

3293. mÇ—á•ñn ‘½”­«ŠÌŒÀ‹Ç«Œ‹ß«‰ßŒ`¬‚Ì1—á. ‰““¡‚Cˆé•”‹`Œ›i•újC²“¡³Ž÷i“àjC¼Šª”ŽC¼—Ñ—²i•újC‚“c‰ë”ŽC™–{­’¼i“àjCò‰Æ‹v’¼C‹g“c@‹IiŠOjCŽO•xO”VC’†‰p’ji•a—j: “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 91(12): 2244`2251, 1994.

3294. mÇ—á•ñn äBinflammatory pseudotumor‚ÌCT¥MRIŠŒ©|Ž©Œ±—á1—Ⴈ‚æ‚Ñ•¶Œ£“IŒŸ“¢|. •Ð‹Ë‰ÈŽqC¼Šª”ŽC’r“crºCˆé•”‹`Œ›C¼—Ñ—²i•újCŒY•”“ŒŽ¡iŠOjCŠâŸºŒ[ˆêi•a—j: —Õ°•úŽËü, 39(12): 1635`1638, 1994.

3295. m‘àn –å–¬ˆ³˜´iǂɑ΂·‚éIVR (2)•Â½p4)ƒoƒ‹[ƒ“‰º‹ts«Ã–¬Çðp. ‰““¡‚Cˆé•”‹`Œ›i•újC‰““c÷i“Œ‹ž—ˆã‘åjC¼Šª”ŽC¼‰iŒh“ñCŽR–{aˆê˜Yi•újC‘•ª–ΔŽC‘ºã‹§lC¼“c–€–çi“àjC¼—Ñ—²i•új: IVR, 9(3): 273`278, 1994.

3296. m‘àn Šî–{“I‚ȉ摜f’f|“K‰ž‚ÆŒÀŠE|• •”ŒŒŠÇ‘¢‰e. ˆé•”‹`Œ›i•új: Medicina, 32(1): 42`49, 1995.

3297. m‘àn CTƒKƒCƒh‚É‚æ‚éintervention. ˆé•”‹`Œ›C¼Šª”ŽC‰““¡‚C¼‰iŒh“ñi•újCã–ìŒbŽqC‹g“còi“Œ‹ž—ˆã‘åj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 12(4): 41`47, 1994.

3298. m‘àn äX«áu’ɂɑ΂·‚鎡—Ã: CT‰º_ŒoƒuƒƒbƒN. ã–ìŒbŽqi“Œ‹ž—ˆã‘åjCˆé•”‹`Œ›i•új: ƒNƒŠƒjƒJ, 21(5): 64`70, 1994.

3299. m‘àn ŠjˆãŠwŒŸ¸‚ÌŽÀ‘H–@: ŒŸ¸‚Ìi‚ß•û‚Æf’f‚̃|ƒCƒ“ƒg, ŠÌƒVƒ“ƒ`ƒOƒ‰ƒtƒB: 99mTc-GSAŒŸ¸‚ÌŽÀ‘H. ¼Šª”ŽC¼‰iŒh“ñC‰““¡‚Cˆé•”‹`Œ›C’†‘òŒ\Ž¡CΈ䟌ÈC¼—Ñ—²i•új: ‰f‘œî•ñƒƒfƒBƒJƒ‹, 26(20): 1214`1220, 1994.

3300. m‘àn d–ŒŠO•a•Ï. ›Mˆêi•új: —Õ°‰æ‘œ, 10(10): 150`158, 1994.

3301. muÀn Arteriovenous Malformation‚ɑ΂·‚é“®–¬Çð—Ö@. –x’rdŽ¡i•újCŒ´—TŽqC—ÑšôCΓcŽ¡—Yi´£¬Ž™•a‰@j: ¬Ž™ŠO‰È, 26(6): 723`726, 1994.

3302. m‹³‰È‘n i•ª’SŽ·•Mj _ŒoŽ¾Š³‚ÌMRI; “®Ã–¬ŠïŒ`, p.479`493, ›Mˆêi•új. •ÒW ‚‹´–r³iŒF–{‘åjC “ì]“°C“Œ‹žC94.09.01”­s.

3303. m‹³‰È‘n i•ª’SŽ·•Mj _ŒoŽ¾Š³‚ÌMRI; “®–¬áŽ, ‚»‚Ì‘¼, p.494`510, ›Mˆêi•új. •ÒW ‚‹´–r³iŒF–{‘åjC “ì]“°C“Œ‹žC94.09.01”­s.

3304. m‹³‰È‘n i•ª’SŽ·•Mj ˆê‹Ø“ê‚Å‚¢‚©‚È‚©‚Á‚½’†•_ŒoŒn‚̉摜f’f; ”]Žîá‡H, p.43`46, ›Mˆêi•új. •ÒW ˆÉ“¡Žõ‰îiVŠƒ‘åjC ˆãŠw‘‰@C“Œ‹žC95.02.01”­s.

3305. m‹³‰È‘n i•ª’SŽ·•Mj ˆê‹Ø“ê‚Å‚¢‚©‚È‚©‚Á‚½’†•_ŒoŒn‚̉摜f’f; ŠC–È󌌊ǎîH, p.113`115, ›Mˆêi•új. •ÒW ˆÉ“¡Žõ‰îiVŠƒ‘åjC ˆãŠw‘‰@C“Œ‹žC95.02.01”­s.

3306. m‹³‰È‘n i•ª’SŽ·•Mj ˆê‹Ø“ê‚Å‚¢‚©‚È‚©‚Á‚½’†•_ŒoŒn‚̉摜f’f; ”]ŽîᇓàoŒŒ‚Æ•‚ŽîH, p.187`188, ›Mˆêi•új. •ÒW ˆÉ“¡Žõ‰îiVŠƒ‘åjC ˆãŠw‘‰@C“Œ‹žC95.02.01”­s.

3307. m‹³‰È‘n i•ª’SŽ·•Mj ˆê‹Ø“ê‚Å‚¢‚©‚È‚©‚Á‚½’†•_ŒoŒn‚̉摜f’f; _ŒoâŽîH, p.252`253, ›Mˆêi•új. •ÒW ˆÉ“¡Žõ‰îiVŠƒ‘åjC ˆãŠw‘‰@C“Œ‹žC95.02.01”­s.

3308. m‹³‰È‘n i•ª’SŽ·•Mj ‰æ‘œŒŸ¸‚ÌŠî–{‚ÆŽÀÛ|Ž¸”s‚µ‚È‚¢ŽB‚è•û¥“Ç‚Ý•û; ”]¥“ªŠWŒŒŠÇ‘¢‰e, p.19`23, ›Mˆêi•új. •ÒW ‰iˆäƒiŽ©Ž¡ˆã‘åjC ƒƒWƒJƒ‹ƒrƒ…[ŽÐC95.03.15”­s.

3309. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Balloon occluded retrograde transvenous obliteration of gastric varices (B-RTO). ˆé•”‹`Œ›C‰““¡‚C¼Šª”Ži•újC‘•ª–ΔŽC^‹ÊŽõ”ü¶i“àjC‰““c÷Cã–ìŒbŽqi“Œ—ˆã‘åj: ƒˆ[ƒƒbƒpIVRŠw‰ï i94.06.05`09j, ƒMƒŠƒVƒƒ.

3310. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Brain and spinal MR imaging in patients with systemic lupus erythematosus. ›MˆêC’r“crºC•Ð‹Ë‰ÈŽqC¼ŽR³ŒáC¼—Ñ—²i•újC‰ª“cƒi“àj: 15th Symposium Neuroradiologicum i94.09.29j, ŒF–{.

3311. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Balloon occluded retrograde transvenous obliteration (B-RTO) for gastric varices. ‰““¡‚Cˆé•”‹`Œ›i•újC‰““c÷i“Œ—ˆã‘åjC¼Šª”ŽC¼‰iŒh“ñC‹g“c’¨Œ³C¼—Ñ—²i•újCOno Y.CNaritaka, Y.i“Œ—ˆã‘åj: 5th International Symposium on Interventional Radiology and New Vascular Imaging i94.05.00j, ‹ž“s, Cardiovascular and Interventional Radiology, 17: 124, 1994.

3312. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Clinical evaluation of Tc-99m-GSA liver SPECT: Comparison with SPECT and CT. ¼Šª”ŽCˆé•”‹`Œ›CΈ䟌ÈC¼‰iŒh“ñC–k–ì‰ëŽjC‹g“c’¨Œ³C•Ð‹Ë‰ÈŽqC‰““¡‚C’†‘òŒ\Ž¡C¼—Ñ—²i•újCa’J–¾—²C‘•ª–ΔŽi“àjC‹g“c@‹IiŠOj: 6th World Congress of Nuclear Medicine and Biology i94.10.23`28j, Sydney, Eur. J. Nucl. Med., 21(10): 233, 1994.

3313. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Measurements of regional lung blood volume and regional alpha value by SPECT. ’†‘òŒ\Ž¡CΈ䟌ÈC¼Šª”Ži•újCâˆä•¶•Fi“àjC¼ŽR³ŒáC•Ð‹Ë‰ÈŽqC‹g“c’¨Œ³C–k–ì‰ëŽjCˆË“cˆêdC¼—Ñ—²i•új: 6th World Congress of Nuclear Medicine and Biology i94.10.27j, Sydney, Eur. J. Nucl. Med., 21(10): 237, 1994.

3314. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j “dŽqüƎ˂ɑ΂·‚éLDH‚ÌŠˆ«áŠQ‚ÌIsozymeŽ¯•Ê. ‘¾“cŒ°¬C¼—Ñ—²i•újC—«‹Å—’i”’‹‰¶ˆã‘åjC‘ëàV‘Pti“ú–{Œ´Œ¤j: ‘æ6‰ñ“ú’†•úŽËü‰»ŠwƒVƒ“ƒ|ƒWƒEƒ€ i94.11.06j, “Œ‹ž, ´˜^W, p.85, 1994.

3315. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j æ“VŠïŒ`|Ò‘‹ó“´Ç. ›Mˆêi•új: ‘æ14‰ñ“ú–{‰æ‘œˆãŠw‰ï i95.02.03j, –¼ŒÃ‰®, “ú–{‰æ‘œˆãŠw‰ïŽGŽ, 13(5): 377, 1994.

3316. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j LDH IsozymeŒ^‚É‚æ‚é•úŽËüŠ´Žó«‚ÌŽ¯•Ê. ‘¾“cŒ°¬C¼—Ñ—²i•újC‘]ª—R”üŽqC‚ŽR‹v”üŽqi¶•¨‰»ŠwŒnj: ‘æ36‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï¶•¨•”‰ï i94.04.06j, _ŒË, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 53(12): 1471, 1994.

3317. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 99mTc-GSAŠÌSPECT‚É‚æ‚éŠÌ—\”õ”\•]‰¿‚ÌŽŽ‚Ý. ¼Šª”ŽCâE•”‹`Œ›CΈ䟌ÈC‹g“c’¨Œ³C–k–ì‰ëŽjC¼‰iŒh“ñC•Ð‹Ë‰ÈŽqC‰““¡‚C’†‘òŒ\Ž¡C¼—Ñ—²i•újCŽÄ“c‹v—Yi“àj: ‘æ53‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠwp”­•\‰ï i94.04.07`09j, _ŒË, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 54(3): 170, 1994.

3318. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BŠà‹ÇŠZ“xf’f‚É‚¨‚¯‚éMRI‚Ì—L—p«‚ÌÄŒŸ“¢. ‹g“c’¨Œ³C¼Šª”ŽC‰““¡˜aŽqC–k–ì‰ëŽjC¼‰iŒh“ñC•Ð‹Ë‰ÈŽqC¼ŽR³ŒáC‰““¡‚C’r“crºCˆé•”‹`Œ›C›MˆêC¼—Ñ—²i•újC‰oìWi”åj: ‘æ53‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠwp”­•\‰ï i94.04.08j, _ŒË, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 54(3): 170, 1994.

3319. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j HCC”j—ôÇ—á‚É‚¨‚¯‚éTAE‚Æ•Û‘¶—Ö@‚Ì”äŠrŒŸ“¢. ¼‰iŒh“ñCˆé•”‹`Œ›C¼Šª”ŽC‰““¡‚C‹g“c’¨Œ³C¼—Ñ—²i•új: ‘æ53‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠwp”­•\‰ï i94.04.09j, _ŒË, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 54(3): 274, 1994.

3320. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‘O—§‘BŠàp’†ÆŽË‚ÌŒŸ“¢. ¼ŽR³ŒáC¼—Ñ—²C¼Šª”ŽCŠâ”g–ÎCΈ䟌Èi•újC“¡–ì’Wli”åjC¼‘òŽ“TiŠOjC“cŠŽŒÈi•új: ‘æ53‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠwp”­•\‰ï i94.04.09j, _ŒË, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 54(3): 320, 1994.

3321. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¶‘Ì•”•ªŠÌˆÚAŠ³Ž™‚ÌL/S‚È‚ç‚Ñ‚É’_`—¬o”\‚Ì„ˆÚ‚É‚æ‚ép‘O•]‰¿. Ÿº–{NŽjCΓcŽ¡—YC—Ñšôi´£¬Ž™•a‰@jCΈ䟌Èi•új: ‘æ31‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i94.06.01j, ‚¼, “ú–{¬Ž™ŠO‰ÈŠw‰ïŽ, 30(3): 514, 1994.

3322. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠjˆãŠw“IŽè–@‚É‚æ‚é‹ÇŠäBŒŒ‰t—Ê‹y‚Ñ‹ÇŠƒ¿’l‚Ì‘ª’è. ’†‘òŒ\Ž¡CΈ䟌ÈC¼—Ñ—²i•új: ‘æ13‰ñ“ú–{ˆã—p‰æ‘œHŠw‰ï i94.07.07j, “Œ‹ž, Medical Imaging Technology, 12(4): 497`498, 1994.

3323. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 99mTc-GSA SPECT‚Ì‹ÇŠŠÌ‹@”\•]‰¿‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ¼‰iŒh“ñC¼Šª”ŽCˆé•”‹`Œ›CΈ䟌ÈC‰““¡‚C¼—Ñ—²CŒ´MNC_‹{ŽiŒö“ñC‹e’rŒhCˆË“cˆêdi•új: ‘æ34‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï i94.09.28j, ŽD–y, ŠjˆãŠw, 31(7): 699, 1994.

3324. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j äNã÷”AŠÇ‹t—¬Ç‚ɑ΂·‚ét‘ŸŠjˆãŠwŒŸ¸‚É‚æ‚錟“¢. Έ䟌ÈC¼Šª”ŽC‹g“c’¨Œ³C–k–ì‰ëŽjC’†‘òŒ\Ž¡CˆË“cˆêdC_‹{ŽiŒö“ñC¼—Ñ—²i•új: ‘æ34‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï i94.09.28j, ŽD–y, ŠjˆãŠw, 31(7): 729, 1994.

3325. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j TAEÇ—á‚É‚¨‚¯‚é99mTc-GSAŠÌSPECT‚Ì—Õ°“I•]‰¿. ¼Šª”ŽCˆé•”‹`Œ›CΈ䟌ÈC¼‰iŒh“ñC•Ð‹Ë‰ÈŽqC‰““¡‚C¼—Ñ—²CŒ´LNi•újCa’J–¾—²C‘•ª–ΔŽi“àj: ‘æ34‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï i94.09.28`30j, ŽD–y, ŠjˆãŠw, 31(7): 774, 1994.

3326. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˆÊ‘Š‰ðÍ‚É‚æ‚éASD¥VSDp‘O¥pŒã‚Ì”x––½ŒŒ—¬“®‘Ô‚Ì•]‰¿. ’†‘òŒ\Ž¡CΈ䟌ÈC¼Šª”ŽC¼ŽR³ŒáC’r“crºC•Ð‹Ë‰ÈŽqC‹g“c’¨Œ³C–k–ì‰ëŽjC‹e’rŒhCˆË“cˆêdC¼—Ñ—²i•új: ‘æ34‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï i94.09.29j, ŽD–y, ŠjˆãŠw, 31(7): 767, 1994.

3327. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™¶‘̊̈ÚAŠ³Ž™‚ÌŠÌ×–E‹@”\•]‰¿‚É‚¨‚¯‚é99mTc-GSA‚ɂ‚¢‚Ä. ΓcŽ¡—YC—ÑšôCŠ™Œ`³ˆê˜Yi´£¬Ž™•a‰@jCΈ䟌ÈC–x’rdŽ¡i•új: ‘æ34‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï i94.09.29j, ŽD–y, ŠjˆãŠw, 31(7): 774, 1994.

3328. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¬Ž™ŠÌŽ¾Š³‚ÌŠÌ‹@”\•]‰¿‚É‚¨‚¯‚é99mTc-GSA‚Æ99mTc-PMT‚ɂ‚¢‚Ä. …ãȈêCŒ´—TŽqCΓcŽ¡—YC‘¼i´£¬Ž™•a‰@jCΈ䟌ÈC–x’rdŽ¡i•új: ‘æ34‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï i94.09.29j, ŽD–y, ŠjˆãŠw, 31(7): 774, 1994.

3329. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 201Tl SPECT‘œ‚É‚æ‚é”]Ž¾Š³f’f‚̈ãŽtŠÔ•Ï“®. –{“cŒ›‹ÆC’¬“cŠì‹v—YCˆäã—D‰îié‹Êˆã‘åjC¼–{“OC”ÑÀ•i•úˆãŒ¤jCΈ䟌ÈC¼Šª”Ži•újC‘º“cŒ[iŒÕƒm–å•a‰@jC‘¼: ‘æ34‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï i94.09.30j, ŽD–y, ŠjˆãŠw, 31(7): 806, 1994.

3330. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹¹•”¥• •”H“¹ŠàpŒãÆŽË‚É‚¨‚¯‚élong TÆŽË–ì‚ÌŒŸ“¢. ‰““¡‚C¼—Ñ—²i•újCŽOd–슰ŠìiŠOjCã‘O•ôŽqC‚Œ´Äi•új: ‘æ7‰ñ“ú–{•úŽËüŽîᇊw‰ï‘å‰ï i94.10.00j, –¼ŒÃ‰®, “ú–{•úŽËüŽîᇊw‰ïŽGŽ, 6: 87, 1994.

3331. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌPseudolymphoma‚Ì1—á. ‰““¡‚C¼Šª”ŽCˆé•”‹`Œ›C–k–ì‰ëŽjC¼‰iŒh“ñCŽR–{aˆê˜YC¼—Ñ—²i•újC‹g“c@‹IiŠOjC’†‰p’ji•a—j: ‘æ30‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Õ°‘å‰ï i94.11.00j, ‹{è, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 54: 552, 1994.

3332. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠjˆãŠw“IŽè–@‚É‚æ‚é‹ÇŠŠÌŒŒ‰t—Ê‹y‚Ñ‹ÇŠƒ¿’l‚Ì‘ª’è. ’†‘òŒ\Ž¡CΈ䟌Èi•új: ‘æ31‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï i94.11.17j, ‘åã, “ú–{—Õ°¶—Šw‰ïŽGŽ, 24(suppl.): 76, 1994.

3333. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 0.5ƒeƒXƒ‰MRI‚É‚¨‚¯‚é‘O—§‘BŠà‚ÌŒŸ“¢|‹U—z«—á‚ÌŒŸ“¢|. ‹g“c’¨Œ³C¼Šª”ŽC‰““¡˜aŽqC–k–ì‰ëŽjC¼‰iŒh“ñC•Ð‹Ë‰ÈŽqC‰““¡‚C¼ŽR³ŒáCˆé•”‹`Œ›C›Mˆêi•újC‰oìWi”åjCŒK”ö’èmi•a—j: ‘æ14‰ñ“ú–{‰æ‘œˆãŠw‰ï i95.02.02j, –¼ŒÃ‰®, “ú–{‰æ‘œˆãŠw‰ïŽGŽ, 13(5): 388, 1994.

3334. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j MELAS‚Ì2—á|99mTc-ECD SPECT‚ÆMRI‚ð’†S‚É|. •Ð‹Ë‰ÈŽqC¼Šª”ŽCΈ䟌ÈC‰““¡˜aŽqC–k–ì‰ëŽjC‹g“c’¨Œ³C¼‰iŒh“ñC‰““¡‚C’r“crºCˆé•”‹`Œ›C›Mˆêi•újCâˆä•¶•Fi“àj: ‘æ14‰ñ“ú–{‰æ‘œˆãŠw‰ï i95.02.02j, –¼ŒÃ‰®, “ú–{‰æ‘œˆãŠw‰ïŽGŽ, 13(5): 394, 1994.

3335. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j H“¹ŠàŽèpÇ—á‚É‚¨‚¯‚é•úŽËü•¹—pŒø‰Ê‚ÌŒŸ“¢. ‰““¡‚C¼—Ñ—²C¼Šª”ŽC¼‰iŒh“ñC‹g“c’¨Œ³CâE•”‹`Œ›i•új: ‘æ53‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠwp”­•\‰ï i94.04.07`09j, _ŒË, “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 54: 320, 1994.

3336. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Fricke, MB, ‚¨‚æ‚ÑIP‰»Šwü—ÊŒv‚Ì‘ª’芴“x. ‘¾“cŒ°¬C¼—Ñ—²i•újC—«‹Å—’i”’‹‰¶ˆã‘åj: ‘æ37‰ñ•úŽËü‰»Šw“¢˜_‰ï i94.09.26`28j, ŽD–y, ´˜^W, p.27, 1994.

3337. mŠw‰ïi‘S‘jn iŒöŠJuÀj ‰æ‘œf’f. –x’rdŽ¡i•új: “ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï¬Ž™ŒÄ‹zŠíƒZƒ~ƒi[ i94.04.00j, ŽD–y, “ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ïŽGŽ, 5(2): 55`59, 1994.

3338. mŠw‰ïi’n•ûjn i‹³ˆçu‰‰j Interventional Radiology‚ÌÅ‹ß‚ÌŒ»‹µ. ˆé•”‹`Œ›i•új: ŠÖ“Œ’n•û‰ï i95.02.18j, “Œ‹ž.

3339. mŠw‰ïi’n•ûjn iƒ|ƒXƒ^[u‰‰j ”x‰èŽî‚Ì1—á. ‘êì­˜aC¼ŽR³ŒáC‰““¡˜aŽqC–k–ì‰ëŽjC‹g“c’¨Œ³C•Ð‹Ë‰ÈŽqC’r“crºCΈ䟌ÈC¼—Ñ—²i•új: ‘æ406‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠÖ“Œ’n•û‰ï i94.12.17j, “Œ‹ž.

3340. mŒ¤‹†‰ïi‘Ûjn iˆê”Êu‰‰j ¶‘Ì“î•”‘gDParticle-Induced X-ray Emission‘ª’莎—¿‚Ì’²». ‘¾“cŒ°¬C¼—Ñ—²i•újC—«‹Å—’i”’‹‰¶ˆã‘åjC¢—Çkˆê˜YC“ñ‚ÂìW“ñiRI‹¦‰ïm‰È‹L”OƒTƒCƒNƒƒgƒƒ“ƒZƒ“ƒ^[j: ‘æ12‰ñParticle-Induced X-ray EmissionƒVƒ“ƒ|ƒWƒEƒ€ i94.10.19j, ‘åã, ´˜^W, p.13, 1994.

3341. mŒ¤‹†‰ïi’n•ûjn i“Á•Êu‰‰j ”]ŒŒ—¬ƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚Ì—Õ°“I—L—p«‚ɂ‚¢‚Ä. Έ䟌Èi•új: ‹{èRIƒJƒ“ƒtƒ@ƒŒƒ“ƒX i94.09.17j, ‹{è.

3342. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j Machintosh‚É‚æ‚é CT/MR‰æ‘œ‚̉ðÍ‹y‚ÑŠˆ—p. ‰““¡¹Fi”]ŠOj: ˆã—ÃŽx‰‡ƒVƒXƒeƒ€uK‰ï i94.06.26j, “Œ‹ž.

3343. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‚ ‚È‚½‚È‚ç‚Ç‚¤Ž¡—·‚é‚©. ˆé•”‹`Œ›i•új: ŠÖ“ŒIVRŒ¤‹†‰ï i94.07.08j.

3344. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ¬×–EŠà‚ɑ΂·‚鈟‹æˆæ“I“®¥–å–¬ÇðpŒã‚Ì1Øœ—á. ¼‰iŒh“ñCˆé•”‹`Œ›C¼Šª”ŽC‰““¡‚i•újCŽR–{aˆê˜Yi‹~–½j: ‘æ6‰ñŠÖ“ŒIVRŒ¤‹†‰ï i94.05.12j, “Œ‹ž.

3345. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŠÌŒÀ‹Ç«Œ‹ß«‰ßŒ`¬(FNH)‚Ì2—á|99mTc-GSA SPECTŠŒ©‚ð’†S‚É|. –k–ì‰ëŽjC¼Šª”ŽCˆé•”‹`Œ›CΈ䟌ÈC¼‰iŒh“ñC‹g“c’¨Œ³C•Ð‹Ë‰ÈŽqC‰““¡˜aŽqC’†‘òŒ\Ž¡C¼—Ñ—²i•új: ‘æ41‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.07.02j, “Œ‹ž.

3346. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j MELAS‚Ì1Ç—á|99mTc-ECD SPECTŠŒ©‚ð’†S‚É|. •Ð‹Ë‰ÈŽqC¼Šª”ŽCΈ䟌ÈC‹g“c’¨Œ³C–k–ì‰ëŽjC¼ŽR³ŒáC’r“crºCˆé•”‹`Œ›C›MˆêC¼—Ñ—²i•újCâˆä•¶•Fi“àj: ‘æ42‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i95.01.21j, “Œ‹ž.


<<27 –ƒŒ‰ÈŠw>>

3347. mŒ´’˜n Autogenous production of hydroxyl radicals from thiopental. ‰œ•xr”Vi–ƒjC–쌳‚¯‚¢Žqi¶‰»ŒnjC’†‘º‘‰qi•ª¶jCŒã“¡•¶•vi–ƒj: Acta Anaesthesiol. Scand., 39: 338`342, 1995.

3348. mŒ´’˜n Power spectral analysis in heart rate and blood pressure valiability during lumbar epidural anaesthesia. rì^”VCŒã“¡•¶•vi–ƒj: Can. J. Anaesth., 41(8): 680`687, 1994.

3349. mŒ´’˜n _ŒoáŠQ‚É”º‚¤Šà«áu’É‚ÆR‚¤‚–ò, Ráz¹–ò‚ÌŒø‰Ê. “IꌳOCŒã“¡•¶•vi–ƒj: Pain Research, 9: 99`107, 1994.

3350. mŒ´’˜n ƒZƒ{ƒtƒ‹ƒŒƒ“–ƒŒ‰º‚É‚¨‚¯‚éPGE1‚Ìt‚ւ̉e‹¿. ŒÜ\—’Š°i•xŽm‹{Žs—§•a‰@jC‰œ•xr”Vi–ƒjC‘“c–M’jC—é–Ø–¾i•xŽm‹{Žs—§•a‰@jC”’΋`liɪŒ§—§‘‡•a‰@j: Œ»‘ãˆã—Ã, 26(‘4): 3645`3649, 1994.

3351. mŒ´’˜n –ƒŒ‚ƈêŽ_‰»’‚‘f. ‰œ•xr”VCŒã“¡•¶•vi–ƒj: –ƒŒ, 43(‘): 216`222, 1994.

3352. m’Z•ñ¥‘¬•ñn Š¥“®–¬ƒoƒCƒpƒXp‚É‚¨‚¯‚é‰EŽº‹ìo—¦‘ª’è‚Ì—L—p«. –ÎŽè–Ø—R—¢C‰iˆäˆê¬C”’ˆä³rCŒã“¡•¶•vi–ƒj: “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(6): 50`52, 1994.

3353. mÇ—á•ñn Unilateral hypoglossal nerve paralysis following the use of the laryngeal mask airway. ‰iˆäˆê¬C÷–{çŒbŽqCŒã“¡•¶•vi–ƒj: Anaesthesia, 49(7): 603`604, 1994.

3354. mÇ—á•ñn ‹ßÔŠOŒõ‚É‚æ‚éoŒŒ«ƒVƒ‡ƒbƒNÇ—á‚Ì”]Ž_‘f–O˜a“xƒ‚ƒjƒ^[. Vˆä³NC‰œ•xr”VC’|’†’qºC”’ˆä³rC‰Á“¡´ŽiC“n•Ó•qCŒã“¡•¶•vi–ƒj: —Õ°ƒ‚ƒjƒ^[, 5: 100`101, 1994.

3355. m‘àn ŒŸØ¥ƒ^[ƒ~ƒiƒ‹ƒPƒA. “IꌳOi–ƒj: Nurse Eye, 7: 6`11, 1994.

3356. m‘àn ŽüŽYŠú‚Ìáu’É‚É‚æ‚鶑̂̔½‰ž. ‰œ•xr”VCŒã“¡•¶•vi–ƒj: Perinatal Care, 13(7): 565`568, 1994.

3357. m‘àn šb‘§‚Æ–ƒŒ. ‰iˆäˆê¬C–ÎŽè–Ø—R—¢i–ƒj: ƒAƒŒƒ‹ƒM[‚Ì—Õ°, 14(11): 897`902, 1994.

3358. m‘àn ˆÙ•¨(‹CŠÇ¥H“¹)‚Ì–ƒŒ. ‰iˆäˆê¬C–ÎŽè–Ø—R—¢i–ƒj: ‹~‹}ˆãŠw, 18(8): 981`984, 1994.

3359. m‘àn ‰ß•q«‹C“¹‚Æ–ƒŒ. ‰iˆäˆê¬i–ƒj: –k—¢ˆãŠw, 24(4): 257`263, 1994.

3360. mŠwp‘n i•ª’SŽ·•Mj Œ¤Cˆã‚Ì‚½‚ß‚Ì–ƒŒ‰È—̈æ–òÜ‚ÌŽg‚¢•û; t•s‘SŠ³ŽÒ‚ɑ΂·‚é–ò‚ÌŽg‚¢•û, 4: 294`306, Œã“¡•¶•vi–ƒj. •ÒW ¬ì—´i“ú–{ˆã‰È‘åjC Ž½“°o”ÅC“Œ‹žC95.03.00”­s.

3361. m‹³‰È‘n i•ª’SŽ·•Mj –ƒŒ‰Èƒjƒ…[ƒ}ƒjƒ…ƒAƒ‹; ƒVƒ‡ƒbƒN, p.233`242, ‰Á“¡´ŽiCŒã“¡•¶•vi–ƒj. •ÒW ‚܉v•Fiìèˆã‘åjC‹|í–Е¶iL“‡‘åjC ‹àŒ´o”ÅC“Œ‹žC95.02.28”­s.

3362. m‹³‰È‘n i•ª’SŽ·•Mj –ƒŒ‰Èƒjƒ…[ƒ}ƒjƒ…ƒAƒ‹; ’ጌˆ³–ƒŒ–@, p.247`252, Œã“¡•¶•vi–ƒj. •ÒW ‚܉v•Fiìèˆã‘åjC‹|í–Е¶iL“‡‘åjC ‹àŒ´o”ÅC“Œ‹žC95.02.28”­s.

3363. m‹³‰È‘n i•ª’SŽ·•Mj –ƒŒ‰Èƒjƒ…[ƒ}ƒjƒ…ƒAƒ‹; ’á‘̉·–ƒŒ, p.252`257, Œã“¡•¶•vi–ƒj. •ÒW ‚܉v•Fiìèˆã‘åjC‹|í–Е¶iL“‡‘åjC ‹àŒ´o”ÅC“Œ‹žC95.02.28”­s.

3364. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Á‰»ŠíŠO‰ÈŽèp‚É‚¨‚¯‚釕¹ÇŠÇ—‚Ì‚·‚ׂÄ; d–ŒŠO–ƒŒ‚ÉŠÖ˜A‚µ‚½‡•¹Ç, Á‰»ŠíŠO‰È, 17(5): 700`701, ˆÀ—¢•¶—YCŒã“¡•¶•vi–ƒj. ‚Ö‚é‚·o”ÅC“Œ‹žC94.04.20”­s.

3365. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Recently developing monitors to be used in anesthesia. Œã“¡•¶•vCVˆä³NCrì^”Vi–ƒj: ‘æ3‰ñ“ú•Ä–ƒŒ‰ï‹c i94.11.14j, ‘啪.

3366. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Pain character and analgesic efficacy of antidepressant and anticonvulsant. “IꌳOCŒã“¡•¶•vi–ƒj: American Pain Society 13th Annual Scientific Meeting i94.11.11j, Florida, U.S.A.

3367. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Motor paralysis induced by epidural alcohol injection in rabbits. ˆÀ—¢•¶—Yi–ƒj: ‘æ20‰ñ•Ä‘‹ÇŠ–ƒŒŠw‰ï i95.03.31j, ƒtƒƒŠƒ_.

3368. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒZƒ{ƒtƒ‹ƒŒƒ“–ƒŒ‰º‚É‚¨‚¯‚éPGE1‚Ìt‚ւ̉e‹¿. ŒÜ\—’Š°i•xŽm‹{Žs—§•a‰@jC‰œ•xr”Vi–ƒjC‘“c–M’jC—é–Ø–¾i•xŽm‹{Žs—§•a‰@j: ‘æ41‰ñ“ú–{–ƒŒŠw‰ï‘‰ïƒTƒeƒ‰ƒCƒgƒVƒ“ƒ|ƒWƒEƒ€ i94.04.12j, “Œ‹ž.

3369. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j –ƒŒ‚ƈêŽ_‰»’‚‘f. ‰œ•xr”VCŒã“¡•¶•vi–ƒj: ‘æ41‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i94.04.14j, “Œ‹ž, J. Anesth., 8(Suppl.): 14, 1994.

3370. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Šàˆã—Â̓]Š·“_|‰„–½Ž¡—©‚çƒzƒXƒsƒXƒPƒA[‚Ö. “IꌳOi–ƒj: ‘æ8‰ñ“ú–{ƒTƒCƒRƒIƒ“ƒRƒƒW[Šw‰ïƒCƒuƒjƒ“ƒOƒZƒ~ƒi[ i94.10.01j, ˆ®ì.

3371. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ¿2Žó—e‘Ìì“®–ò‚Æpentobarbital‚Ì‘ŠŒÝì—p. ‰Á“¡´Žii–ƒjC—«—°•Ÿi”’‹‰¶ˆã‘åjC”tg–…iãŠCˆã‘åjC¬ŽÄŒ’ˆê˜YCŒã“¡•¶•vi–ƒj: ‘æ41‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i94.04.14j, “Œ‹ž.

3372. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒuƒ^“¯Š«“¯ŽíŠÌˆÚAp‚É‚¨‚¯‚ézŠÂ“®‘Ԃ̕ω». ’|’†’qºCŒã“¡•¶•vi–ƒjC¼‘òŽ“TC²“¡ŒõŽjCŠ`“cÍiŠOj: ‘æ41‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i94.04.14j, “Œ‹ž.

3373. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒpƒ[ƒXƒyƒNƒgƒ‹‰ðÍ‚ð—p‚¢‚½˜•”d–ŒŠO–ƒŒŽž‚ÌŽ©—¥_ŒoŠˆ“®‚̕ω». rì^”VCŠÛŽRGC‹ß“¡½CÎŽRIC”¼êŽ‡–ƒŽqCŒã“¡•¶•vi–ƒj: ‘æ41‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i94.04.14j, “Œ‹ž, J. Anesth., 8(Suppl.): 520, 1994.

3374. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Šà«áu’É‚Ì«ó‚É‚æ‚éŽOŠÂŒnR‚¤‚–ò‚ÆRáz¹–ò‚ÌŒø‰Ê. “IꌳOCŠÛŽRGC–ÎŽè–Ø—R—¢C–î“c_C’|’†’qºCŒã“¡•¶•vi–ƒj: ‘æ41‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i94.04.15j, “Œ‹ž.

3375. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠJSp‚É‚¨‚¯‚éˆÝ”S–ŒpH(pHi)‚̕ω», ‘å—ʃtƒFƒ“ƒ^ƒj[ƒ‹–@‚Æd–ŒŠO–ƒŒ–@‚Ì”äŠr. Vˆä³NC’|’†’qºC’|˜Q–¯]C”’ˆä³rC‰Á“¡´ŽiCŒã“¡•¶•vi–ƒj: ‘æ15‰ñ“ú–{zŠÂ§ŒäˆãŠw‰ï‘‰ï i94.05.21j, ‘å‹{, zŠÂ§Œä, 15(Suppl.): 55, 1994.

3376. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹ßÔŠOŒõ‚É‚æ‚éoŒŒ«ƒVƒ‡ƒbƒNÇ—á‚Ì”]Ž_‘f–O˜a“xƒ‚ƒjƒ^[. Vˆä³NC‰œ•xr”VC’|’†’qºC”’ˆä³rC‰Á“¡´ŽiCŒã“¡•¶•vi–ƒj: “ú–{—Õ°ƒ‚ƒjƒ^[Šw‰ï‘‰ï i94.06.04j, ŽD–y.

3377. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “–Ž{Ý‚É‚¨‚¯‚éS’âŽ~16—á‚ÌŒŸ“¢. ’|˜Q–¯]CŒã“¡•¶•vC‰Á“¡´ŽiCVˆä³Ni–ƒj: ‘æ13‰ñ‘h¶Šw‰ï i94.10.21j, O‘O.

3378. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŒûŠW‚“îŒûŠWˆô“ªŒ`¬p(VPPP)Ç—á‚Ì‘}ŠÇ¢“ï‚Ì—\‘ª. ¯–ì^—¢ŽqC—^“ß”eÄC‰Á“¡´ŽiCŒã“¡•¶•vi–ƒj: ‘æ14‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i94.11.17j, ‘啪, “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(8): 122, 1994.

3379. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌ‘ŸŽèpŽž‚ÌŠÌÖ¬Ž_‘f–O˜a“x‚Ì•Ï“®‚ÆpŒãŠÌ‹@”\‚Ì‘ŠŠÖ‚ɂ‚¢‚Ä. ’|’†’qºC“IꌳOC–î“c_C“n•Ó•qCŒã“¡•¶•vi–ƒj: ‘æ14‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i94.11.17j, ‘啪, “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(8): 129, 1994.

3380. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –å–¬‚©‚ç‚Ì‘å—ÊoŒŒ‚ÉŠÌÖ¬ŒŒŽ_‘f–O˜a“xƒ‚ƒjƒ^[‚ª—L—p‚Å‚ ‚Á‚½‚P—á. –î“c_C’|’†’qºCÎŽRICŒã“¡•¶•vi–ƒj: ‘æ14‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i94.11.17j, ‘啪, “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(8): 130, 1994.

3381. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ]—ˆ‚ÌTUR-P‚ÆV‚½‚ÈpŽ®‚Å‚ ‚éVLAP‚É‚¨‚¯‚ép’†, pŒã‚Ì—A‰t—Ê‚Æ“d‰ðŽ¿‚Ì”äŠr. ‹ß“¡½C‰iˆäˆê¬C‰Á“¡´ŽiCŒã“¡•¶•vi–ƒj: ‘æ14‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i94.11.17j, ‘啪, “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(8): 160, 1994.

3382. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠÌØœp’†‚ÉÖ¬‹ó‹CÇðÇ‚ð”­¶‚µ‚½3Ç—á. ‰J‹{”ÍKC¯–ì^—¢ŽqC—^“ß”eÄCˆÀ—¢•¶—YCŒã“¡•¶•vi–ƒj: ‘æ14‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i94.11.18j, ‘啪, “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(8): 194, 1994.

3383. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •Ð‘¤Œz“®–¬ŽÕ’f‚Æ‹ÇŠ”]Ž_‘f–O˜a“x‚ÌŠÖ˜A. Vˆä³NC‰Á“¡´ŽiCŒã“¡•¶•vi–ƒj: ‘æ22‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï i95.02.03j, ‘åã, “ú–{W’†Ž¡—ÈãŠw‰ïŽ, 2(Suppl.): 463, 1995.

3384. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒqƒg Brain natriuretic peptide(BNP)‚ÌŒ¢t‘Ÿ‚É‚¨‚¯‚éì—p. Vˆä³NCŒã“¡•¶•vi–ƒj: ‘æ41‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i94.04.14j, “Œ‹ž, J. Anesth., 8: 492, 1994.

3385. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Œƒ’É”­ì‚𔺂¢Ž©sˆ×‚ðŒJ‚è•Ô‚µ‚½pŒãŽO³_Œo’É‚ÌÇ—á. “IꌳOC¯–ì^—¢Žqi–ƒjCâE–{–¾•Fi¸jCŒã“¡•¶•vi–ƒj: ‘æ28‰ñ“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘‰ï i94.07.15j, Žl“úŽs.

3386. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒEƒTƒMd–ŒŠOoƒAƒ‹ƒR[ƒ‹’“ü–@‚É‚æ‚é‰^“®–ƒáƒ‚ÌŒŸ“¢. ˆÀ—¢•¶—Yi–ƒj: ‘æ28‰ñ“ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘‰ï i94.07.16j, Žl“úŽs, “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ, 1(2): 326, 1994.

3387. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j • o‹¾‰º’_”X“Eop‚Ì–ƒŒ300—á‚ÌŒŸ“¢. ¬ŽÄŒ’ˆê˜YC”¼êŽ‡–ƒŽqC‰J‹{”ÍKCˆÀ—¢•¶—YC‰Á“¡´ŽiCŒã“¡•¶•vi–ƒj: ‘æ14‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i94.11.17j, ‘啪, “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(8): 273, 1994.

3388. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘å“®–¬—£’fǂŇ•¹‚µ‚½‘“®–¬Š²Ç‚Ì–ƒŒŒoŒ±. ŠÛŽRGC[’ÃCi”ª‰¤Žq¬Ž™•a‰@jCrì^”VCŒã“¡•¶•vi–ƒj: ‘æ14‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i94.11.17j, ‘啪, “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(8): 312, 1994.

3389. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Š®‘S‘匌ŠÇ“]ˆÊLJVŒ^‚ɑ΂·‚éNikaidohŽèp‚Ì–ƒŒŒoŒ±. –ÎŽè–Ø—R—¢C–î“c_C‰Á“¡´ŽiCŒã“¡•¶•vi–ƒj: ‘æ14‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i94.11.17j, ‘啪, “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(8): 315, 1994.

3390. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j KniestÇŒóŒQ‚Ì–ƒŒŒoŒ±. ÎŽRIC‹àˆäº•¶C’|˜Q–¯]C‰Á“¡´ŽiCŒã“¡•¶•vi–ƒj: ‘æ14‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i94.11.18j, ‘啪, “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(8): 318, 1994.

3391. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^‚É‚æ‚é‰Î‚ÆŽ–ŒÌ–hŽ~‘Îô. —^“ß”eÄC‰iˆäˆê¬C‰Á“¡´ŽiCŒã“¡•¶•vi–ƒj: ‘æ14‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i94.11.18j, ‘啪, “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(8): 383, 1994.

3392. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˜r_Œo‘pƒuƒƒbƒNŽw“±‚̬Œ÷—¦. ˆÀ—¢•¶—YC‰J‹{”ÍKC¬ŽÄŒ’ˆê˜YC–î“c_CŒã“¡•¶•vi–ƒj: ‘æ14‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï i94.11.19j, ‘啪, “ú–{—Õ°–ƒŒŠw‰ïŽ, 14(8): 421, 1994.

3393. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒCƒ“ƒ^[ƒtƒFƒƒ“‚É‚æ‚é–«äX‰Š‚ªƒNƒ‚–Œ‰ºƒtƒFƒm[ƒ‹ƒuƒƒbƒN‚É‚æ‚葈«‚µ‚½Ç—á‚ÌŽ¡—ÃŒoŒ±. ¯–ì^—¢ŽqCŠÛŽRGCˆÀ—¢•¶—YC“IꌳOCŒã“¡•¶•vi–ƒj: ‘æ34‰ñ“ú–{–ƒŒŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i94.09.10j, “Œ‹ž.

3394. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Ý‘îŠàŽ¡—Âւ̃Aƒvƒ[ƒ`uáu’ɗÖ@v. “IꌳOi–ƒj: ‘æ5‰ñÝ‘îŠàŽ¡—ÃŒ¤‹†‰ï i94.07.16j, “Œ‹ž, Šà‚Ɖ»Šw—Ö@, 21: 571`575, 1994.

3395. mŒ¤‹†‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj d–ŒŠO–ƒŒ‚É•¹—p‚·‚é‘Sg–ƒŒ–ò‚ÌzŠÂ—}§‚É‹y‚Ú‚·‰e‹¿. ÷–{çŒbŽqC“IꌳOC’|’†’qºCŒã“¡•¶•vi–ƒj: ‘æ1‰ñd–ŒŠO–ƒŒƒ[ƒNƒVƒ‡ƒbƒv i95.00.00j, ‹{è.

3396. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Š³ŽÒ‚Í•s“KØ‚Æl‚¦‚Ä‚¢‚éŠà«áu’ɂ̉Šú•]‰¿. “IꌳOi–ƒjCâE–{–¾•Fi¸jC–û’J˜aŽqiŠÅŒì•”j: ‘æ18‰ñ“ú–{Ž€‚Ì—Õ°Œ¤‹†‰ï i94.11.05j, ’·‰ª, Ž€‚Ì—Õ°24, 17(2): 169, 1994.

3397. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j Šà«áu’ɂ̃Rƒ“ƒgƒ[ƒ‹. “IꌳOi–ƒj: _“Þ쌧ŠÅŒì‹¦‰ï•½¬6”N“x‹³ˆçŒ¤C‰ï i94.06.21j, “¡‘ò.

3398. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ƒyƒCƒ“ƒNƒŠƒjƒbƒN‚Æ–«’É‚ÌŽ¡—Ã. Œã“¡•¶•vi–ƒj: •½’ËŽsˆãŽt‰ï®Œ`ŠO‰È i94.10.27j, •½’Ë.

3399. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j Šà«áu’ÉŽ¡—Â̎ÀÛ. “IꌳOi–ƒj: “Œ‹ž“s‰q¶‹Ç, ŽÐ’c–@l“Œ‹ž“sˆãŽt‰ïÝ‘îƒ^[ƒ~ƒiƒ‹¥ƒPƒAˆãŽtŒ¤C‰ï i94.12.08j, “Œ‹ž.

3400. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j pŒã––½_ŒoáŠQ‚ð”F‚ß‚½2Ç—á‚ÌŒŸ“¢. ¬ì^—R”üC‰Á“¡´ŽiCŒã“¡•¶•vC‹àˆäº•¶i–ƒj: _“Þìê–åˆã‰ï i94.02.25j, ‰¡•l.

3401. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ‹»–¡‚ ‚銌F×–EŽî‚Ì‚P—á. ŠÛŽRGi–ƒjC[’ÃCC–kŒ´—DŽqi”ª‰¤Žq¬Ž™•a‰@j: ‘æ6‰ñŽO‘½–€–ƒŒ§˜b‰ï i95.02.25j, ¬•½.


<<28 —Õ°•a—Šw>>

3402. mŒ´’˜n Benzodiazepine concentrations in sera determined by radioreceptor assay for therapeutic-dose recipients. ¼ì—²i—Õ•a—jC—é–Ø‘”üi¶‰»ŒnjC‘å’J‰pŽ÷i—Õ•a—jC‰i‘ò‹IŽqC™ŽRŒ’ŽuCìŒû‹BCŽO‰Y’å‘¥i¸j: Am. J. Clin. Pathol., 102(6): 605`610, 1994.

3403. mŒ´’˜n Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia. ˜a“c’m‰vi—Õ•a—jC‰–’J–ÎC“¡–ì—R”üC“¿O‰p¶CÔ¯“§i“àjC“à“c–Lºi”åjC‘å’J‰pŽ÷i—Õ•a—j: Blood, 83(12): 3449`3456, 1994.

3404. mŒ´’˜n Reversible isomerization of rapamycin demonstrated by liquid chromatography. ¼ì—²i—Õ•a—jC—é–Ø‘”üi¶‰»ŒnjC‘å’J‰pŽ÷i—Õ•a—j: J. Antibiot., 47(12): 1554`1556, 1994.

3405. mŒ´’˜n ƒjƒRƒvƒ‰ƒXƒ`ƒ“‚É‚¨‚¯‚錌Ÿ÷ƒvƒƒgƒƒ“ƒrƒ“ŽžŠÔ‘ª’è‚ÌŠî‘b“IŒŸ“¢. ‘O“c’‰LC–؉º•¶ŽqC“y‰®‰ÀŽqC—]ŒÎ‹v”üŽqC”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—jC‰œŽR––ŽqC™‘º–F•¶iŽOŒõƒ–òj: ˆãŠw‚Æ–òŠw, 32(2): 371`376, 1994.

3406. mŒ´’˜n Nested PCR–@‚É‚æ‚é Candida albicans‚ÌŒŸo. ‘º¼GŽ÷i—Õ•a—j: Š´õÇŠwŽGŽ, 68(12): 1465`1471, 1994.

3407. mŒ´’˜n ƒgƒ‰ƒ“ƒXƒRƒoƒ‰ƒ~ƒ“Œ‡–RÇ. “àŽRKMi—Õ•a—j: ¶•¨•¨—‰»Šw, 38(6): 403`410, 1994.

3408. mŒ´’˜n PCR-ƒ}ƒCƒNƒƒTƒeƒ‰ƒCƒg•sˆÀ’èƒAƒbƒZƒC(MIA)‚ð—p‚¢‚½–«œ‘«”’ŒŒ•a‚Ì‹}«“]‰»‚É‚¨‚¯‚éˆâ“`Žq‚Ì•sˆÀ’諂̉ðÍ. ˜a“c’m‰vi—Õ•a—jC‰–’J–Îi“àjC“à“c–Lºi”åjC‘å’J‰pŽ÷i—Õ•a—j: ¶•¨•¨—‰»Šw, 39(1): 19`24, 1995.

3409. mŒ´’˜n CRP‚Ì”÷—Ê’è—Ê‚ÉŠÖ‚·‚éŠî‘b“I‚¨‚æ‚Ñ—Õ°“IŒ¤‹†|‘æ‚P•ñ ”÷—Ê’è—Ê–@ (Latex Immunoassay)‚ÌŠî‘b“IŒŸ“¢‚È‚ç‚тɬl³í’l‚ÌÝ’è|. Y’J’¼li—Õ•a—jC”«‘º˜a’ji—ÕŒŸjC¼“c—zC‘å’J‰pŽ÷i—Õ•a—j: –k—¢ˆãŠw, 24(2): 97`103, 1994.

3410. mŒ´’˜n PCR–@‚É‚æ‚é Candida albicans‚ÌŒŸo‚ÉŠÖ‚·‚錟“¢. ‘º¼GŽ÷C˜a“c’m‰vi—Õ•a—jC‹v•ÄŒõi•a—jC‘å’J‰pŽ÷i—Õ•a—j: —Õ°•a—, 42(9): 961`965, 1994.

3411. m€Œ´’˜i‰p•¶jn Clinical significance of serum CRP quantitation by latex immunoassay with high sensitivity. Y’J’¼li—Õ•a—jCŽsìŒbŽqi‘‡—Õ°ŒnjC”«‘º˜a’ji—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—j: 17th World Congress of Anatomic and Clinical Pathology, p.157`163, 1994.

3412. m€Œ´’˜n PCR‚ð‰ž—p‚µ‚½”’ŒŒ•a‚̕ψوâ“`Žq‚̉ðÍ. ˜a“c’m‰vi—Õ•a—j: ¶•¨•¨—‰»Šw, 38(6): 355`360, 1994.

3413. m€Œ´’˜n Šà‚É‚¨‚¯‚郿2ƒ}ƒNƒƒOƒƒuƒŠƒ“Œ‡–Rǂ̬ˆö‚ɂ‚¢‚Ä. Žë–ì—LìC‘å’J‰pŽ÷i—Õ•a—j: ¶•¨•¨—‰»Šw, 38(6): 391`396, 1994.

3414. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn ŒŒ´Šw“IŒŸ¸ƒRƒ“ƒgƒ[ƒ‹ƒT[ƒxƒC•ñ. “àŽRKMi—Õ•a—jC÷ˆäŒc‘¢C–F“cvi—ÕŒŸjC‹g“cŸ•Fiº˜a‘å“¡‚ª‹u•a‰@j: _“Þ쌧‰q¶•”•½¬‚U”N“x¸“xŠÇ—’²¸W, p.60`74, 1995.

3415. m—Õ°Ž¡Œ±n HBsR‘Ì’è—Ê–@‚É‚æ‚郃Nƒ`ƒ“ÚŽíR‘Ì‚ÌŒŸo. ‚‹{t’jCŽR•Ó°”üi—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—j: —Õ°ŒŸ¸‹@Ší¥ŽŽ–ò, 17(3): 655`659, 1994.

3416. m‘àn ÔŒŒ‹…‚̈Ùíi‚»‚Ì‘¼‚Ì•nŒŒ). “àŽRKMC‘å’JTˆêCŽë–ì—Lìi—Õ•a—j: ŒŸ¸ŒŒ‰tŠw, (97): 156`159, 1994.

3417. m‘àn ƒÀ-tubulin‚ð•W“I‚Æ‚µ‚½ PCR–@‚É‚æ‚é“à‘ŸƒJƒ“ƒWƒ_ǂ̈â“`Žqf’f. ‘º¼GŽ÷i—Õ•a—jC‹v•ÄŒõi•a—jC˜a“c’m‰vi—Õ•a—jCŽRè•q˜ai•a—jC‘å’J‰pŽ÷i—Õ•a—j: “ú–{ˆã^‹ÛŠw‰ïŽGŽ, 35(2): 151`154, 1994.

3418. m‘àn ƒ¿2ƒ}ƒNƒƒOƒƒuƒŠƒ“Œ‡–RÇ. Žë–ì—LìC‘å’J‰pŽ÷i—Õ•a—j: —Õ°ŒŸ¸, 38(13): 1437`1440, 1994.

3419. muÀn —Õ°ŒŸ¸i—Õ°•a—jŒ¤Cˆã‚Ì‘²Œã‹³ˆç‚ɂ‚¢‚Ä|–k—¢‘åŠw•a‰@‚É‚¨‚¯‚鉊ú—Õ°Œ¤C‚ð’†S‚Æ‚µ‚Ä|. Y’J’¼li—Õ•a—j: Lab. Clin. Pract., 12(1): 58`62, 1994.

3420. muÀn ƒNƒŠƒIƒOƒƒuƒŠƒ“. ‘å’J‰pŽ÷i—Õ•a—j: Medicina, 31(11): 507`509, 1994.

3421. muÀn ƒpƒCƒƒOƒƒuƒŠƒ“. ‘å’J‰pŽ÷i—Õ•a—j: Medicina, 31(11): 510`511, 1994.

3422. muÀn “à‘Ÿ^‹Ûǂ̈â“`Žqf’f‚ÌŒ»ó. ‘º¼GŽ÷i—Õ•a—jC‹v•ÄŒõi•a—j: Molecular Medicine, 31(5): 571, 1994.

3423. muÀn –Ɖu•s‘SÇ|AIDS. ‘å’J‰pŽ÷i—Õ•a—j: ˆãŠw‚Ì‚ ‚ä‚Ý, (•Êû): 314`322, 1994.

3424. muÀn ^‹ÛŠ´õÇi[Ý«). ˆ¢•””ü’mŽqi—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—jC‹v•ÄŒõi•a—j: ŒŸ¸‚Æ‹Zp, 22(5): 308`311, 1994.

3425. muÀn –ƉuŠw“I‘ª’è–@: ’¾~”½‰ž|–ƉuŠgŽU–@¥–Ɖu“d‹C‰j“®–@¥–ƉuŒÅ’è–@. ‘å’J‰pŽ÷i—Õ•a—j: ŒŸ¸‚Æ‹Zp, 22(5): 35`37, 1994.

3426. muÀn ƒ¿2ƒ}ƒNƒƒOƒƒuƒŠƒ“iƒ¿2M). ‘å’J‰pŽ÷i—Õ•a—j: “ú–{—Õ°, —Õ‘(683): 210`212, 1995.

3427. muÀn ‚b”½‰ž«’`”’iCRP). ‘å’J‰pŽ÷i—Õ•a—j: “ú–{—Õ°, —Õ‘(683): 233`236, 1995.

3428. m•ÒWŽÒ‚ւ̎莆i‰p•¶jn Microsatellite instability in myeloid leukemias. ˜a“c’m‰vi—Õ•a—j: Blood, 84(9): 3236`3237, 1994.

3429. mŠwp‘n i•ª’SŽ·•Mj —Õ°•a— (“ÁW‘æ97†)ŒŸ¸ŒŒ‰tŠw; ŒŸ¸f’f–@, ‡T. ÔŒŒ‹…‚̈Ùí, 6.‚»‚Ì‘¼‚Ì•nŒŒ, p.156`159, “àŽRKMi—Õ•a—j. •ÒW “ú–{—Õ°•a—Šw‰ï, —Õ°•a—Š§s‰ï, “Œ‹ž, 94.07.30”­s.

3430. mŠwp‘n i•ª’SŽ·•Mj }ॗհŠÅŒìˆãŠw(‘æ‚SŠª)ŒŒ‰t¥‘¢ŒŒŠí; ‘æ‚RÍ; f’fã•K—v‚ÈŒŸ¸|ÌŒŒ–@‚ÆR‹ÃŒÅÜ, p.98`99, “àŽRKMi—Õ•a—j. •ÒW ‰ªˆÀ‘åmi“ú‘åjCŽRŒûŠo‘¾˜Yiç—t‘åj, “¯•üŽÉo”Å, ‹ž“s, 94.10.31”­s.

3431. mŠwp‘n i•ª’SŽ·•Mj }ॗհŠÅŒìˆãŠw(‘æ‚SŠª)ŒŒ‰t¥‘¢ŒŒŠí; ‘æ‚RÍ; f’fã•K—v‚ÈŒŸ¸|ŒŒ‹…ŒvŽZCŒŒ‹…•ª—Þ, p.100`103, “àŽRKMi—Õ•a—j. •ÒW ‰ªˆÀ‘åmi“ú‘åjCŽRŒûŠo‘¾˜Yiç—t‘åj, “¯•üŽÉo”Å, ‹ž“s, 94.10.31”­s.

3432. mŠwp‘n i•ª’SŽ·•Mj “ú–{—Õ°¥L”͈͌Œ‰t¥”A‰»ŠwŒŸ¸C–ƉuŠw“IŒŸ¸|‚»‚Ì”’l‚ð‚Ç‚¤“Ç‚Þ‚©|; (‡U)¶‰»Šw“IŒŸ¸|ƒrƒ^ƒ~ƒ“ŠÖŒW|, ƒrƒ^ƒ~ƒ“B12, p.704`708, “àŽRKMi—Õ•a—j. •ÒW ‰Í‡’‰iŽ©Ž¡ˆã‘åj, “ú–{—Õ°ŽÐ, ‘åã, 95.02.28”­s.

3433. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj —Õ°ŒŸ¸‚ÌABC; ƒnƒvƒgƒOƒƒrƒ“CƒtƒFƒŠƒ`ƒ“CƒVƒAƒ‹Ž_Cƒ¿1ƒAƒ“ƒ`ƒgƒŠƒvƒVƒ“CƒZƒ‹ƒƒvƒ‰ƒXƒ~ƒ“CƒvƒŒƒAƒ‹ƒuƒ~ƒ“, p.149`156, ‘å’J‰pŽ÷i—Õ•a—j. •ÒW ‰Í‡’‰iŽ©Ž¡ˆã‘åjC‹´–{M–çiŽœŒbˆã‘åj, “ú–{ˆãŽt‰ï, “Œ‹ž, 94.09.10”­s.

3434. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ³í’l‚ƈÙí’l‚ÌŠÔ|‚»‚Ì”»’è‚Æ‘Îô|; ƒvƒŒƒAƒ‹ƒuƒ~ƒ“, p.450`451; ƒ¿1ƒAƒ“ƒ`ƒgƒŠƒvƒVƒ“, p.452`453; ƒ¿1Ž_«“œ’`”’, p.454`455; ƒ¿2ƒ}ƒNƒƒOƒƒuƒŠƒ“, p.459`460; ƒnƒvƒgƒOƒƒrƒ“, p.461`462; ƒZƒ‹ƒƒvƒ‰ƒXƒ~ƒ“, p.463`464, ‘å’J‰pŽ÷i—Õ•a—j. •ÒW ‰Í‡’‰iŽ©Ž¡ˆã‘åj, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 95.03.01”­s.

3435. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j Šà‚É‚¨‚¯‚郿2ƒ}ƒNƒƒOƒƒuƒŠƒ“Œ‡–Rǂ̬ˆö‚ɂ‚¢‚Ä. Žë–ì—Lìi—Õ•a—j: ‘æ44‰ñ“ú–{“d‹C‰j“®Šw‰ït‹G‘å‰ï i94.06.03`04j, “Œ‹ž.

3436. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŒŒŸ÷’`”’Œ‡–RÇ‚Æ‚»‚Ì—Õ°; ƒgƒ‰ƒ“ƒXƒRƒoƒ‰ƒ~ƒ“Œ‡–RÇ. “àŽRKMi—Õ•a—j: ‘æ44‰ñ“ú–{“d‹C‰j“®Šw‰ït‹G‘å‰ï i94.06.04j, “Œ‹ž, ¶•¨•¨—‰»Šw, 38(2): 68, 1994.

3437. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ˆâ“`Žq‰ðÍ‚É‚¨‚¯‚é“d‹C‰j“®: PCR‚ð‰ž—p‚µ‚½”’ŒŒ•a‚̕ψوâ“`Žq‚̉ðÍ. ˜a“c’m‰vi—Õ•a—j: ‘æ44‰ñ“ú–{“d‹C‰j“®Šw‰ït‹G‘å‰ï i94.06.03`04j, “Œ‹ž.

3438. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž©ŒÈŒŒ—R—ˆƒtƒBƒuƒƒlƒNƒ`ƒ““_Ž¨–ò‚̸». ˆ¾–앶„C”ª–ؘa¢C•—ŠÔ‚ ‚«‚ÝCH“¡”g—¯”üC¬–{”ü“ÞC’|“à—Li—ÕŒŸjC¼“c—zi—Õ•a—jC•y‰i½ˆêi‹¹ŠOj: ‘æ42‰ñ“ú–{—AŒŒŠw‰ï i94.05.31j, “Œ‹ž, ‘æ42‰ñ“ú–{—AŒŒŠw‰ï‘‰ï†, 40(2): 371, 1994.

3439. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”A’†—V—£‚k½‘ª’è–@‚ÌŠî‘b“IŒŸ“¢. ‘å’JTˆêi—Õ•a—jCŽsìŒbŽqi‘‡—Õ°ŒnjC–L‰ª—TŽqi—ÕŒŸjCŒE“cMKCãèLˆê˜YiŠwŒ¤‰»Šw¶•¨‰»ŠwŒ¤‹†ŠjC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ44‰ñ“ú–{“d‹C‰j“®Šw‰ït‹G‘å‰ï i94.06.03j, “Œ‹ž, ¶•¨•¨—‰»Šw, 38(2): 18, 1994.

3440. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j HPLCƒJƒ‰ƒ€“àˆÙ«‰»”½‰ž‚̉ðÍ: “œ—Þ, ƒvƒƒŠƒ“ƒyƒvƒ`ƒhC–Ɖu—}§Ü‚ɂ‚¢‚Ä. ¼ì—²i—Õ•a—jC—é–Ø‘”üi¶‰»ŒnjC‘å’J‰pŽ÷i—Õ•a—j: ‘æ43‰ñ“ú–{•ªÍ‰»Šw‰ï”N‰ï i94.10.00j, •Ÿ‰ª.

3441. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j V‚½‚ȃƒ`ƒ‹ƒ}ƒƒ“Ž_ŒŒÇ‚Ì‚P‰ÆŒn‚̈â“`Žq‰ðÍ. ˜a“c’m‰vi—Õ•a—jC‘åŠÑ—TŽqi¶•¨‰»ŠwŒnjC‘å’J‰pŽ÷i—Õ•a—jC‚“cŽj’jiŽ™jC–L‰ª—TŽqC‘å–쓹Žqi—ÕŒŸjC‚ŽR‹g‰iCìã³–çi•ª¶j: ‘æ45‰ñ“ú–{“d‹C‰j“®Šw‰ï‘‰ï i94.10.08j, ŽD–y, ¶•¨•¨—‰»Šw, 38(5): 30, 1994.

3442. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –«œ‘«”’ŒŒ•a‚Ì‹}«“]‰»‚É‚¨‚¯‚éƒ}ƒCƒNƒƒTƒeƒ‰ƒCƒg‚Ì•sˆÀ’è«. ˜a“c’m‰vi—Õ•a—jC‰–’J–Îi“àjC“à“c–Lºi”åjC‘å’J‰pŽ÷i—Õ•a—j: ‘æ53‰ñ“ú–{ŠàŠw‰ï‘‰ï i94.10.19j, –¼ŒÃ‰®, “ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.157, 1994.

3443. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•¨‚̃ŠƒZƒvƒ^[ƒAƒbƒZƒC‚Ì—Õ°‰ž—p: hR–òƒtƒ‹ƒ}ƒ[ƒjƒ‹‚ÌŒŒ’†”Z“x. ¼ì—²i—Õ•a—jC—é–Ø‘”üi¶•¨‰»ŠwŒnjC㞊‹gli‹~–½jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª, —Õ°•a—, 42(•âû): 146, 1994.

3444. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹É¬–¢nŽ™‚É‚¨‚¯‚é CRP‚Ìo¶ŒãŒoŽž“I•Ï“®‚ɂ‚¢‚Ä. ¼“c—zC‘å’J‰pŽ÷i—Õ•a—jC”«‘º˜a’ji—ÕŒŸjC¬ŒûO‹BC–ì“n³•FC²“¡‰ë•FiŽ™j: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª, —Õ°•a—, 42(•âû): 203, 1994.

3445. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Latex immunoassay‚É‚æ‚é”A’† Free light chain‚Ì‘ª’è–@‚ɂ‚¢‚Äi‘æ2•ñ). ‘å’JTˆêi—Õ•a—jCŽsìŒbŽqi‘‡—Õ°ŒnjC–L‰ª—TŽqi—ÕŒŸjC¼ì—²C“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª, —Õ°•a—, 42(•âû): 207, 1994.

3446. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j EIA‚É‚æ‚é PBP2'v‘¬ŒŸo‚ÌŒŸ“¢. ”©ŽR–õŽqiç—t‘åjCˆ¢•””ü’mŽqi—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—jC‘¼‚U–¼: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª, —Õ°•a—, 42(•âû): 281, 1994.

3447. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Žq‹{‹ØŽîŠ³ŽÒ‚É‚Ý‚ç‚ꂽRCwR‘̂ɂ‚¢‚Ä. ‰|–{”ü‰ÀŽqC”ö‘ò³”Vi–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[jCŒ¹“c’C—YiŽY•wjC‰|–{—²sC”¼ŒËŒ[ˆêC•ž•”—’jié‹ÊˆÉ“ÞÔ\ŽšŒŒ‰tƒZƒ“ƒ^[jC“àì½i“ú–{Ô\Žš ŽÐj: ‘æ43‰ñ“ú–{—AŒŒŠw‰ï‘‰ï i95.03.24j.

3448. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“’†“ÅŠ³ŽÒ‚É“Š—^‚³‚ꂽhR–òƒtƒ‹ƒ}ƒ[ƒjƒ‹‚ÌŒŒ’†”Z“x‚ÆŒø‰Ê. ¼ì—²i—Õ•a—jC—é–Ø‘”üi¶‰»ŒnjC‹ß“¡—¯”üŽqi–òÜ•”jC㞊‹gli‹~–½jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.29j, å‘ä.

3449. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j y‘fõF–@‚¨‚æ‚Ñ“§‰ßŒõ–@‚É‚æ‚é•ú’u‘SŒŒ’†‚Ì”’ŒŒ‹…Œ`‘ԕω»‚ɂ‚¢‚Ä. ‘O“c’‰LC–؉º•¶ŽqC“y‰®‰ÀŽqC—]ŒÎ‹v”üŽqC”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—j: ‘æ43‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï‘‰ï i94.05.12j, ¼ŽR, ˆãŠwŒŸ¸, 43(3): 333, 1994.

3450. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j CA5000‚É‚æ‚éƒI[ƒ\‚sƒeƒXƒg¥ƒI[ƒ\‚gƒeƒXƒg‚ÌŠî‘b“IŒŸ“¢. –؉º•¶ŽqC“y‰®‰ÀŽqC—]ŒÎ‹v”üŽqC‘O“c’‰LC”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—j: ‘æ43‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï‘‰ï i94.05.13j, ¼ŽR, ˆãŠwŒŸ¸, 43(3): 517, 1994.

3451. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚—îŽÒ‚É‚¨‚¯‚éƒJƒ“ƒWƒ_R‘Ì‘ª’è‚Ì—Õ°“IˆÓ‹`. ‘º¼GŽ÷i—Õ•a—jC‹v•ÄŒõi•a—jC‘å’J‰pŽ÷i—Õ•a—jCˆäŽè—zŽqC‚–ìŠì‹v—Yi‘ò•a‰@j: ‘æ38‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï i94.10.14j, ¼–{, “ú–{ˆã^‹ÛŠw‰ïŽGŽ, 35(‘1): 133, 1994.

3452. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‚—îŽÒ‚É‚¨‚¯‚éƒJƒ“ƒWƒ_R‘Ì‘ª’è‚Ì—Õ°“IˆÓ‹`. ‘º¼GŽ÷i—Õ•a—jC‹v•ÄŒõi•a—jC‘å’J‰pŽ÷i—Õ•a—jCˆäŽè—zŽqC‚–ìŠì‹v—Yi‘ò•a‰@j: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ŠâŽè, —Õ°•a—, 42(•âû): 191, 1994.

3453. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j CRP’á’l—á‚É‚¨‚¯‚é IL-6‚¨‚æ‚Ñ‹}«‘Š”½‰ž’`”’‚Ì•Ï“®‚ɂ‚¢‚Ä. Y’J’¼li—Õ•a—jCŽsìŒbŽqi‘‡—Õ°ŒnjC”«‘º˜a’ji—ÕŒŸjCΓc—™iZ—F‹à‘®ƒoƒCƒIƒTƒCƒGƒ“ƒXjC_•Û’qC‰vŽq‹MbC“àŽRKMC‘å’J‰pŽ÷i—Õ•a —j: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª, —Õ°•a—, 42(•âû): 202, 1994.

3454. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ŠeŽíŽ¾Š³‚É‚¨‚¯‚év‘¬Ô’¾’l‚È‚ç‚Ñ‚ÉŠeŽí‰ŠÇƒ}[ƒJ[‚Ì•Ï“®. ‰ª“c—R‹IC–³‘¾˜YC•½ˆä½Cõ’J—mŽqC”«‘º˜a’jCŒÃ–ؗʈê˜YC‘O“c’‰LC—]ŒÎ‹v”üŽqi—ÕŒŸjC‰vŽq‹MbC“c’†P”CC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª, —Õ°•a—, 42(•âû): 203, 1994.

3455. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j HCVŠ´õÇ‚É‚¨‚¯‚éƒNƒŠƒIƒOƒƒuƒŠƒ“‚ÆŠeŽíŽ©ŒÈR‘Ì‚ÌŒŸo‚ɂ‚¢‚Ä. ÷ˆäŒc‘¢C”ª–؈ê•vC”·—EŽŠi—ÕŒŸjC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª, —Õ°•a—, 42(•âû): 209, 1994.

3456. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Šà‚É‚¨‚¯‚郿2 MacroglobulinŒ‡‘¹Ç‚̬ˆö‚ɂ‚¢‚Ä. Žë–ì—LìC˜a“c’m‰vi—Õ•a—jCŽsìŒbŽqi‘‡—Õ°ŒnjC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª, —Õ°•a—, 42(•âû): 210, 1994.

3457. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Enzyme immunoassay‚ð—p‚¢‚½ŒŒ´ƒlƒIƒvƒeƒŠƒ“’è—Ê–@‚ÌŒŸ“¢. “àŽRKMCŽë–ì—LìC‘å’JTˆêCY’J’¼lC“c’†P”CC‰vŽq‹MbC_•Û’qC‘å’J‰pŽ÷i—Õ•a—jC÷ˆäŒc‘¢C‘O“c’‰LC”ª–؈ê•vC‰““¡—mi—ÕŒŸj: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª, —Õ°•a—, 42(•âû): 220, 1994.

3458. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒCƒ€ƒmƒNƒƒ}ƒgƒOƒ‰ƒt–@‚É‚æ‚é–ƉuŠw“I•ÖöŒŒ”½‰ž‚ÌŠî‘b“I‚¨‚æ‚Ñ—Õ°“IŒŸ“¢. ”ª–؈ê•vC÷ˆäŒc‘¢C”·—EŽŠi—ÕŒŸjCŽë–ì—LìC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª, —Õ°•a—, 42(•âû): 227, 1994.

3459. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ATRA—U“±—Ö@‚É‚¨‚¢‚Ä”’ŒŒ‹…•ª—Þƒpƒ^[ƒ“‚ɈÙ킪Œ©‚ç‚ꂽ APL‚Ì‚PÇ—á. •½ˆä½C㑺çqC‰ª“c—R‹ICŒÃ–ؗʈê˜YC—]ŒÎ‹v”üŽqC‘O“c’‰Li—ÕŒŸjC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.27j, ·‰ª, —Õ°•a—, 42(•âû): 266, 1994.

3460. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j PCR-MIA (microsatellite instability assay)‚ð—p‚¢‚½–«œ‘«”’ŒŒ•a‚Ì‹}«“]‰»‚É‚¨‚¯‚éˆâ“`Žq‚Ì•sˆÀ’諂̉ðÍ. ˜a“c’m‰vi—Õ•a—jC‰–’J–Îi“àjC“à“c–Lºi”åjC‘åŠÑ—TŽqi¶•¨‰»ŠwŒnjC–L‰ª—TŽqi—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—j: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.28j, ·‰ª, —Õ°•a—, 42(•âû): 274, 1994.

3461. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’´‰¹”g’f‘w–@‚É‚æ‚éŒz“®–¬d‰»‚Ì•]‰¿. “c’†P”CC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—jC’ß–ì˜a‘¥C‰FŽ¡‹´‘PŸCŽR•Ó‚³‚ð‚èC‰®‹X­ŽqC•½–{ƒ}ƒŠŽqi—ÕŒŸj: ‘æ41‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï i94.10.28j, ·‰ª, —Õ°•a—, 42(•âû): 371, 1994.

3462. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “–‰@‚É‚¨‚¯‚é“–’¼Žž—AŒŒŒŸ¸‚Ì–â‘è“_‚Æ‚»‚Ì‘Îô. ‰““¡—mC”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—j: ‘æ43‰ñ“ú–{—AŒŒŠw‰ï‘‰ï i95.03.22j, –¼ŒÃ‰®, “ú–{—AŒŒŠw‰ïŽGŽ, 40(6): 1014, 1994.

3463. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j • –Œ“§Í‰t’†‚̃NƒŒƒAƒ`ƒjƒ“’è—Ê‚É‚¨‚¯‚郄ƒbƒtƒF–@‚Æy‘f–@‚Ì”äŠr: • –Œ•½t‹@”\ŒŸ¸ (PET)‚É‚¨‚¯‚éy‘f–@‚Ì—L—p«‚ɂ‚¢‚Ä. ¼“c—zC¼ì—²C‘å’J‰pŽ÷i—Õ•a—jC’†‘ºM–çC’©‰iC–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YiŽ™j: ‘æ‚S‰ñ“ú–{—Õ°‰»Šw‰ïŠÖ“ŒŽx•”Šwp‘‰ï i94.05.00j, “Œ‹ž.

3464. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ô’¾v‘¬–@‚ÆŠeŽí‰ŠÇƒ}[ƒJ[‚ÌŠÖ˜A‚ɂ‚¢‚Ä. –³‘¾˜YC‰ª“c—R‹IC•½ˆä½Cõ’J—mŽqC”«‘º˜a’jCŒÃ–ؗʈê˜Yi—ÕŒŸjC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ31‰ñŠÖ“ŒbM’n‹æ—Õ°‰q¶ŒŸ¸Šw‰ï‘‰ï i94.09.10j, ‰¡•l, u‰‰W, p.121, 1994.

3465. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’˜–¾‚ÈäXŽî‘å‚ð’悵äXŠà‚Æ‚ÌŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½–«äX‰Š‚Ì‚PÇ—á. –öŒ´”ü’qŽqCâ–{˜a‘ãCŒFâLC“¡“c’‰˜aC”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—jC‘•ª–ΔŽi“àj: ‘æ31‰ñŠÖ“ŒbM’n‹æ—Õ°‰q¶ŒŸ¸Šw‰ï‘‰ï i94.09.11j, ‰¡•l, u‰‰W, p.103, 1994.

3466. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ”]Ò‘‰t’†‚Ɉ««×–E‚ªoŒ»‚µ‚½‚PÇ—á. ”ª–؈ê•vC¬—Ñ^”üC÷ˆäŒc‘¢C”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—j: ‘æ31‰ñŠÖ“ŒbM’n‹æ—Õ°‰q¶ŒŸ¸Šw‰ï‘‰ï i94.09.11j, ‰¡•l, u‰‰W, p.215, 1994.

3467. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Šà‚É‚¨‚¯‚郿2 MacroglobulinŒ‡‘¹Ç‚̬ˆö‚ɂ‚¢‚Ä. Žë–ì—LìC˜a“c’m‰vC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—jCŽsìŒbŽqi‘‡—Õ°Œnj: ‘æ20‰ñ–k—¢ˆãŠw‰ï‘‰ï i94.10.15j, ‘Š–ÍŒ´, –k—¢ˆãŠw, 24(6): 600`601, 1994.

3468. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j —¬ŒŒ’†ƒJƒ“ƒWƒ_R‘Ì‚Ì‘¶Ý‚Æ—Õ°“IˆÓ‹`. ‘º¼GŽ÷i—Õ•a—jC‹v•ÄŒõi•a—j: ‘æ37‰ñ_“Þìˆã^‹Û’k˜b‰ï i95.01.28j, ‰¡•l.

3469. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Šà‚É‚¨‚¯‚郿2 macroglobulinŒ‡–RÇ‚Ì”­Ç‹@˜‚ɂ‚¢‚Ä. Žë–ì—LìC˜a“c’m‰vC¼ì—²C‘º¼GŽ÷CY’J’¼lC_•Û’qi—Õ•a—jCŽsìŒbŽqi‘‡—Õ°ŒnjC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ‚T‰ñ_“Þ쌧—Õ°ŒŸ¸ˆãŠwŒ¤‹†‰ï i94.06.11j, “Œ‹ž, —\eW, p.3, 1994.

3470. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ”A’†—V—£‚k½‘ª’è–@‚ÌŠî‘b“IŒŸ“¢. ‘å’JTˆêC¼“c—zC‚‹´‰fŽqC“c’†P”CC‰vŽq‹MbC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ‚T‰ñ_“Þ쌧—Õ°ŒŸ¸ˆãŠwŒ¤‹†‰ï i94.06.11j, “Œ‹ž, —\eW, p.5, 1994.

3471. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŠjŽ_‘•‚É‚æ‚錋Šj‹Û’¼ÚŒŸo–@‚ÌŒŸ“¢. “¡ŽR—S‹GŽqC¬”¦iC‘ºãŽuDC–ì‘ò»ŽqCªŠÝ–ƒ‹|C¬“cØ”ü‹IC––O‡ŽqC‹TˆäçLCˆäã]C‚–Øç’ßC’†èM•FCˆ¢•””ü’mŽqC“à“cˆêOC•½“c‘×—Ç i—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—jC‘Š”nˆêˆåi‹~–½jCˆä㼋vi”÷jC΋´Wi”åj: ‘æ36‰ñ_“Þ슴õÇŒ¤‹†‰ï i94.08.27j, ‰¡•l.

3472. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ƒuƒhƒE‹…‹Û‘®‚Ì mecA‚ÆPBP-2'‚ÌŒŸo‚ɂ‚¢‚Ä. ‹TˆäçLC¬”¦iC‘ºãŽuDC–ì‘ò»ŽqCªŠÝ–ƒ‹|C¬“cØ”ü‹IC––O‡ŽqC“¡ŽR—S‹GŽqCˆäã]C‚–Øç’ßC’†èM•FCˆ¢•””ü’mŽqC“à“cˆêOC•½“c‘×—Ç i—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—jC‘Š”nˆêˆåi‹~–½jCˆä㼋vi”÷jC΋´Wi”åj: ‘æ36‰ñ_“Þ슴õÇŒ¤‹†‰ï i94.08.27j, ‰¡•l.

3473. mŠw‰ïŽåÃi‘“àjn ‘æ44‰ñ“ú–{“d‹C‰j“®Šw‰ïtŠú‘å‰ïi“Œ‹žj, ‘å’J‰pŽ÷i—Õ•a—j.


<<29 ‹~–½‹~‹}ˆãŠw>>

3474. mŒ´’˜n The role of angiography in the assessment of blunt liver injury. ™–{Ÿ•FC–x’rdŽ¡C•½“cŒõ”ŽC‘å˜a“c—²i‹~–½jC‘Oì˜a•Fi“Œ‘åj: Injury, 25(5): 283`287, 1994.

3475. mŒ´’˜n Mechanically assisted intraoperative peritoneal lavage for genaralized peritonitis as a result of perforated of the upper part of the gastrointestinal tract. ™–{Ÿ•FC•½“cŒõ”Ži‹~–½jC‘꓇í‰ëiŠOjC‘å˜a“c—²i‹~–½jC“‡’÷ˆêCŠ`“cÍiŠOj: J. Am. Coll. Surgeons, 179: 443`448, 1994.

3476. mŒ´’˜n ŒÄ‹zŠÇ—‚Æ—Õ°HŠw‹ZŽm. ‘Š”nˆêˆåi‹~–½j: ˆã‰ÈŠíŠBŠw, 64: 513`515, 1994.

3477. mŒ´’˜n ŽlŽˆŒŒŠÇ‘¹‚ɑ΂·‚étemporary shunt tube (ƒAƒ“ƒXƒƒ“ƒ`ƒ…[ƒu)‚ÌŽg—pŒoŒ±. V“¡³‹PC™–{Ÿ•FC‘å˜a“c—²i‹~–½jC‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOjC–،Ҋ®mC‰FˆäŒª“ñiŒ`ŠOj: œÜ, 16(1): 139`144, 1994.

3478. mŒ´’˜n “ª•”ŠO‚ð‡•¹‚µ‚½ŽlŽˆœÜ‚ÌŽ¡—ÂƖâ‘è“_. V“¡³‹PC–kŒ´F—YC™–{Ÿ•FC‘å˜a“c—²i‹~–½jC‰¡ŽRˆê•FCŽ…–ž·Œ›i®ŠOj: œÜ, 16(1): 64`68, 1994.

3479. mŒ´’˜n ŠJ•ú«œ”՜܂̎¡—ÂƖâ‘è“_. V“¡³‹PC™–{Ÿ•FC–x’rdŽ¡C‘å˜a“c—²i‹~–½jCŽ…–ž·Œ›i®ŠOjC‘Oì˜a•Fi“Œ‘åj: “ú–{ŠOŠw‰ïŽGŽ, 8(4): 345`350, 1994.

3480. mŒ´’˜n ƒNƒ‚–Œ‰ºoŒŒ‹}«Šú‚É‚¨‚¯‚鶎º•Ç‰^“®ˆÙí‚̬ˆö‚Æ•a‘Ô. ‘“c‘ìi‹~–½jC’r“c‘׎qi“àjC·“ø–¾C–kŒ´F—YC”’J‹`GC“y‰®’¼—²C‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 5(3): 251`260, 1994.

3481. mŒ´’˜n –³Ž_‘f”]Ç‚É‚¨‚¯‚é“àˆö«ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn•¨Ž¿‚Ì‘¶Ý‚ÉŠÖ‚·‚錟“¢. 㞊‹glC‘“c‘ìC’ç–M•Fi‹~–½jC‹ß“¡—¯”üŽqi–òÜjC¼ì—²i—Õ•a—jCŽO‰Y’å‘¥i¸jC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 5(4): 344`352, 1994.

3482. mŒ´’˜n ƒ~ƒ_ƒ]ƒ‰ƒ€’ÁÃŽž‚ÌSzŠÂ“®‘ԂƃXƒgƒŒƒX”½‰ž‚ɑ΂·‚éƒtƒ‹ƒ}ƒ[ƒjƒ‹‚̉e‹¿. 㞊‹glC‘“c‘ìC’ç–M•Fi‹~–½jC¼ì—²i—Õ•a—jC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 6(1): 33`42, 1995.

3483. mŒ´’˜n dÇŠ³ŽÒ‚ɑ΂·‚é‘ŠúƒOƒ‹ƒ^ƒ~ƒ“‰ÁŒo’°‰h—{‚Ì—L—p«‚ÉŠÖ‚·‚é—Õ°“IŒ¤‹†. •Ð‰ª—SˆêC™–{Ÿ•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 6: 16`24, 1995.

3484. m€Œ´’˜n “M…‚ɑ΂µPCPS‚ðŽg—p‚µ‚½1‹~–½—á. 㞊‹glC¡ˆäŠ°C‘“c‘ìC•Ð‰ª—SˆêC•‘ò—˜˜YC™–{Ÿ•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 15: 316`317, 1994.

3485. mŒ¤‹†•ñiŒú¶Èjn •½¬5”N“x‹~‹}¥ÐŠQˆã—ч‰ÈŠwŒ¤‹†|”]‹•ŒŒ‚ɑ΂·‚éf—ËZp‚ÉŠÖ‚·‚錤‹†. ¬à_Œ[ŽŸiìèˆã‘åjC‘å˜a“c—²i‹~–½j: •ñ‘, 1994.

3486. mŒ¤‹†•ñiŒú¶Èjn •½¬5”N“xŒ¤‹†Ž–‹ÆƒvƒŒƒzƒXƒsƒ^ƒ‹¥ƒPƒA‚É‚¨‚¯‚é‹~‹}ˆã—Ë@ŠÖ‚̘AŒg‚ÉŠÖ‚·‚錤‹†. –kì’茪i‘—§ˆã—Õa‰@jC‘å˜a“c—²i‹~–½j: •ñ‘, 1994.

3487. mŒ¤‹†•ñiŒú¶Èjn u‘ŸŠíˆÚA‚̎Љï“I–â‘è‚ÉŠÖ‚·‚錤‹†”Ç(‚a”Ç)‘‡•ñ‰ïv•ñ‘. ‰¡“c—Tsi“úˆã‘åjC‘å˜a“c—²i‹~–½j: •ñ‘, p.133`148, 1993.

3488. mÇ—á•ñn –D‚¢j‚É‚æ‚鎩sˆ×‚É‚æ‚èS–ŒØŠJŒãÇŒóŒQ—l•a‘Ô‚ð’悵‚½1Ç—á. “sŠÛ‹`˜YC‘“c‘ìC’ç–M•FC•‘ò—˜˜YCŽá—Ñ–õ‹vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 15(2): 134`135, 1994.

3489. mÇ—á•ñn ‹Ù‹}ŠJ‹¹Žèp‚ð—v‚µ‚½Stanford-AŒ^‰ð—£«‘å“®–¬áŽ‚Ì1‹~–½—á. ŽR–{aˆê˜YC¼ŒûŽ•FC•Ð‰ª—SˆêC–ؑ¥–¾C‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 15: 282`283, 1994.

3490. mÇ—á•ñn h-HGF‚É‚ÄŒo‰ßŠÏŽ@‚µ“¾‚½‹}«”DP«Ž‰–bŠÌ‚Ì1—á. ŽR–{aˆê˜YC•Ð‰ª—SˆêC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 15: 668`669, 1994.

3491. mÇ—á•ñn Descending necrotizing mediastinitis‚Ì1—á. –ؑ¥–¾C•½“cŒõ”ŽC–x’rdŽ¡C™–{Ÿ•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ, 15: 672`673, 1994.

3492. m—Õ°Ž¡Œ±n ŠeŽíƒVƒ‡ƒbƒN‚ɑ΂·‚éFUT-175‚Ì—Õ°“IŒŸ“¢. ‘å’Ë•q•¶i“úˆã‘åjC‘å˜a“c—²i‹~–½j: —Õ°ˆã–ò, 9(12): 113`129, 1993.

3493. m‘àn Š³ŽÒ‚ª‰Ÿ‚µŠñ‚¹‚é‘å“sŽs‹ßxŒ^V݈ã‘å•a‰@. ‘å˜a“c—²i‹~–½j: Detailman, 22: 59`61, 1994.

3494. m‘àn Ò‘‘¹|Ž¸‚Á‚½‹@”\‚ð‚¢‚ÂA‚ǂ̂悤‚É’m‚·‚é‚©. 㞊‹gli‹~–½j: ‹~‹}ˆãŠw, 18: 1787`1789, 1994.

3495. m‘àn ‹~‹}Ž¡—ÃŽè‹Z|֬؊J|. ™–{Ÿ•Fi‹~–½j: Ž¡—Ã, 77(2): 712`721, 1995.

3496. m‘àn dÇ”]‘¹Š³ŽÒ‚É‚¨‚¯‚鶑̔½‰ž‚Ɖh—{ŠÇ—. ™–{Ÿ•Fi‹~–½j: W’†Ž¡—Ã, 7(3): 277`286, 1995.

3497. m‘àn dÇ”]‘¹Š³ŽÒ‚̶‘Ì”½‰ž‚ÆŠ´õÇ. ‰““¡¹Fi”]ŠOjC‘å˜a“c—²i‹~–½j: W’†Ž¡—Ã, 7(3): 299`306, 1995.

3498. m‘àn “Ë‘RŽ€‚É”º‚¤‹~‹}ˆ’u. ‘å’Ë•q•¶C‰vŽq–M—mi“úˆã‘åjCã¼£Ÿ’ji“ú‘åjC‘å˜a“c—²i‹~–½jC‘å—ÑŠ®“ñi‘å—Ñ“à‰Èˆã‰@j: zŠÂ‰ÈŠw, 14(12): 1196`1208, 1994.

3499. m‘àn ŒÄ‹zŠÇ—. ‘Š”nˆêˆåi‹~–½j: “à‰Èê–åˆã‰ïŽ, 6(3): 207`213, 1994.

3500. m‘àn ŒÄ‹zŠí‹~‹}‚Í‚Ç‚¤‚ ‚é‚ׂ«‚©. ‘Š”nˆêˆåi‹~–½j: “ú–{‹¹•”—Õ°, 54(2): 102`105, 1995.

3501. muÀn Ž¾Š³•Ê‹~‹}ŒŸ¸‚ÌŽÀÛ; ‹}«ŒÄ‹z•s‘S. ‘Š”nˆêˆåi‹~–½j: Innervision, 10: 46`53, 1994.

3502. muÀn …¥“d‰ðŽ¿¥Ž_‰–Šî•½tˆÙ튳ŽÒ‚ÌŽ¡—Ã. ‘Š”nˆêˆåi‹~–½j: JJNƒXƒyƒVƒƒƒ‹, 42: 122`138, 1994.

3503. muÀn ‹C“¹Šm•Û‚Ì•û–@. ‘Š”nˆêˆåi‹~–½j: Practitioners, 2(12): 1618`1622, 1994.

3504. muÀn ƒRƒ“ƒp[ƒgƒƒ“ƒg“àˆ³‘ª’è. V“¡³‹Pi‹~–½j: ‹~‹}ˆãŠw, 18(4): 499`503, 1994.

3505. muÀn –Ú‚ÅŒ©‚é‹~‹}ˆã—Â̎ÀÛ; ”xÇðÇ. ‘Š”nˆêˆåi‹~–½j: Ž¡—Ã, 77(2): 458`462, 1995.

3506. muÀn ‹CŠÇŽxšb‘§”­ì‚É”º‚¤•s®–¬. ‘Š”nˆêˆåi‹~–½j: “ú–{ˆãŽ–V•ñ, (3681): 133`134, 1994.

3507. muÀn W’†Ž¡—Âɂ¨‚¯‚郂ƒjƒ^ƒŠƒ“ƒO; y‘fŒn‚̃‚ƒjƒ^ƒŠƒ“ƒO. ‘Š”nˆêˆåi‹~–½j: —Õ°ƒ‚ƒjƒ^[, 5(2): 139`148, 1994.

3508. muÀn ‹~‹}ˆã—Âɂ¨‚¯‚éy‘fŠw“Iƒ‚ƒjƒ^ƒŠƒ“ƒO. ‘Š”nˆêˆåi‹~–½j: —Õ°ƒ‚ƒjƒ^[, 5: 37`39, 1994.

3509. mŠwp‘n i•ª’SŽ·•Mj V}à—Õ°®Œ`ŠO‰ÈuÀ (7)ŒÒŠÖß; œ”ÕœÜ, p.236`263, V“¡³‹Pi‹~–½jCŽ…–ž·Œ›i®ŠOj. •ÒW ¼èº•vi•Ÿ‰ª‘åjC ƒƒWƒJƒ‹ƒrƒ…[ŽÐC“Œ‹žC94.09.01”­s.

3510. mŠwp‘n i•ª’SŽ·•Mj }‰ðŠOŽ¡—ÃKƒCƒh; ”]ŽºúŽh, ƒhƒŒƒi[ƒW, p.101`102, –kŒ´F—Yi‹~–½j. •ÒW ™–{Š¤C •¶Œõ“°C“Œ‹žC94.00.00”­s.

3511. mŠwp‘n i•ª’SŽ·•Mj ¡“ú‚Ì_ŒoŽ¾Š³Ž¡—ÃŽwj; ”]‘h¶‚Éd“_‚ð‚¨‚¢‚½‘SgŠÇ—, p.147`149, –kŒ´F—Yi‹~–½j. •ÒW ‹TŽR³–MC‚‘qŒö–¾C ˆãŠw‘‰@C“Œ‹žC94.00.00”­s.

3512. m‹³‰È‘n i•ª’SŽ·•Mj ‹~‹}‹~–½Žm•W€ƒeƒLƒXƒg; _Œo, p.284`297, ‘å˜a“c—²i‹~–½j. ‚Ö‚é‚·o”ÅC“Œ‹žC94.03.28”­s.

3513. m‹³‰È‘n i•ª’SŽ·•Mj ‹~‹}‹~–½Žm•W€ƒeƒLƒXƒg; ˆÓŽ¯áŠQ, p.392`404, ‘å˜a“c—²i‹~–½j. ‚Ö‚é‚·o”ÅC“Œ‹žC94.03.28”­s.

3514. m‹³‰È‘n i•ª’SŽ·•Mj ‹~‹}”F’èˆã‚Ì‚½‚ß‚Ìf—ÃŽwj; Ò’ÅÒ‘‘¹, p.349`354, ‘å˜a“c—²i‹~–½j. •ÒW ‘å˜a“c—²i‹~–½jC ‚Ö‚é‚·o”ÅC“Œ‹žC94.10.01”­s.

3515. m‹³‰È‘n i•ª’SŽ·•Mj Ò’Å, Ò‘‘¹‚ÌŽ¡—Ã; ‘SgŠÇ—, p.77`102, ‘å˜a“c—²i‹~–½j. •ÒW ˆäŒ`‚–¾Cˆ¢•”OC Œ»‘ãˆã—ÃŽÐC“Œ‹žC94.10.03”­s.

3516. m‹³‰È‘n i•ª’SŽ·•Mj –ƒŒ‰Èƒjƒ…[ƒ}ƒjƒ…ƒAƒ‹; ‹~‹}ˆã—Ã|ŠO|, p.426`432, ™–{Ÿ•Fi‹~–½jCŒã“¡•¶•vi–ƒj. •ÒW ‚܉v•Fiìèˆã‘åjC‹|í–Е¶iL“‡‘åjC ‹àŒ´o”ÅC“Œ‹žC95.02.28”­s.

3517. m‹³‰È‘n i•ª’SŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; “ª•”ŠO, ‘å˜a“c—²i‹~–½j. ˆãŠw‘‰@C“Œ‹žC94.00.00”­s.

3518. m‹³‰È‘n i•ª’SŽ·•Mj –ƒŒ‰Èƒjƒ…[ƒ}ƒjƒ…ƒAƒ‹; 16. ‹~‹}ˆã—Ã, 1. ‘h¶Šw a.S”x‘h¶–@, b.‹}«’†“ł̉ŠúŽ¡—Ã, p.419`425, ó—˜–õi‹~–½j. •ÒW ‚܉v•Fiìèˆã‘åjC‹|í–Е¶iL“‡‘åjC ‹àŒ´o”ÅC“Œ‹žC95.02.28”­s.

3519. m‹³‰È‘n i•ÒWj ‹~‹}”F’èˆã‚Ì‚½‚ß‚Ìf—ÃŽwj; •ÒW ‘å˜a“c—²i‹~–½jC ‚Ö‚é‚·o”ÅC“Œ‹žC94.10.01”­s.

3520. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚Ì®Œ`ŠO‰ÈŽ¡—ÃŽwj(‘æ3”Å); ‘Å–o, Á–Å, ”PÁ, p.39`40, V“¡³‹Pi‹~–½j. •ÒW ŽR“à—T—Yi‡‘åjC^ŠpºŒái‘啪ˆã‘åjC’Ò—z—Yi•xŽRˆã–ò‘åjC÷ˆäŽÀi“Œ–k‘åjC ˆãŠw‘‰@C“Œ‹žC95.03.15”­s.

3521. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚Ì®Œ`ŠO‰ÈŽ¡—ÃŽwj(‘æ3”Å); ‰˜õ¥Á–Å‘n‚̃vƒ‰ƒCƒ}ƒŠƒPƒA, p.40`41, V“¡³‹Pi‹~–½j. •ÒW ŽR“à—T—Yi‡‘åjC^ŠpºŒái‘啪ˆã‘åjC’Ò—z—Yi•xŽRˆã–ò‘åjC÷ˆäŽÀi“Œ–k‘åjC ˆãŠw‘‰@C“Œ‹žC95.03.15”­s.

3522. m‚»‚Ì‘¼‚Ì’˜‘n i•ª’SŽ·•Mj ¡“ú‚Ì®Œ`ŠO‰ÈŽ¡—ÃŽwj(‘æ3”Å); ŠOŽˆØ’f‚Ì“K‰žŠî€, p.50, V“¡³‹Pi‹~–½j. •ÒW ŽR“à—T—Yi‡‘åjC^ŠpºŒái‘啪ˆã‘åjC’Ò—z—Yi•xŽRˆã–ò‘åjC÷ˆäŽÀi“Œ–k‘åjC ˆãŠw‘‰@C“Œ‹žC95.03.15”­s.

3523. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Œ¤Cˆãƒm[ƒg‰”Å; Ý‘îŽ_‘f—Ö@, p.400`402, ‚“cM˜aC‘Š”nˆêˆåi‹~–½j. •ÒW ‰iˆä—ÇŽOC f’f‚ÆŽ¡—ÃŽÐC94.03.15”­s.

3524. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Management of open pelvic fractures. V“¡³‹PC™–{Ÿ•FC–x’rdŽ¡C‘å˜a“c—²i‹~–½jC‘Oì˜a•Fi“Œ‘åj: Korean Emergency Medicine Congress i94.04.29j, Wonjun, Korea.

3525. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Non-operative management of blunt liver injury in Japan. ™–{Ÿ•FC–x’rdŽ¡C‘å˜a“c—²i‹~–½jC‘Oì˜a•Fi“Œ‘åj: Korean Emergency Medicine Congress i94.04.29j, Wonjun, Korea.

3526. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Transcatheter arterial embolization in patients with blunt splenic injury. –x’rdŽ¡i•újC™–{Ÿ•FCV“¡³‹PC‘å˜a“c—²i‹~–½jC‘Oì˜a•Fi“Œ‘åj: ŠØ‘‹~‹}ˆãŠw‰ï‘æ5‰ñt‹G‘å‰ï i94.04.29j, ŠØ‘.

3527. mŠw‰ïi‘S‘jn i‹³ˆçu‰‰j ‹~‹}ˆã—Âɂ¨‚¯‚éy‘fŠw“Iƒ‚ƒjƒ^ƒŠƒ“ƒO. ‘Š”nˆêˆåi‹~–½j: ‘æ5‰ñ“ú–{—Õ°ƒ‚ƒjƒ^[Šw‰ï‘‰ï i94.06.03j, ŽD–y.

3528. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‹~‹}ˆã—Âɂ¨‚¯‚é”]_ŒoŠO‰Èˆã‚Ì–ðŠ„|–k—¢‘åŠw‚̃VƒXƒeƒ€‚Ì“Á’¥|. –kŒ´F—YC‘å˜a“c—²i‹~–½jC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ‘æ14‰ñ“ú–{”]_ŒoŠO‰ÈƒRƒ“ƒOƒŒƒX i94.05.27`29j, å‘ä.

3529. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ”MŠ³ŽÒ‚Ì—A‰tŠÇ—‚É‚¨‚¯‚éƒXƒƒ“¥ƒKƒ“ƒcƒJƒe[ƒeƒ‹‚Ì•K—v‚ɂ‚¢‚Ä. ‘“c‘ìC–ؑ¥–¾C¼ŽRÄ‹vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ5‰ñ“ú–{—Õ°ƒ‚ƒjƒ^[Šw‰ï‘‰ï i94.06.03`05j, ŽD–y, ´˜^W, p.47, 1994.

3530. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “ÁˆÙ“I‰ð“ÅÜ‚ÌŒ»ó‚Æ–â‘è“_; ‹~‹}ˆã‚Ì—§ê‚©‚ç. ó—˜–õC‹ß“¡—¯”üŽqC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ16‰ñ“ú–{’†“ÅŠw‰ï i94.07.15j, ‘åã, ’†“ÅŒ¤‹†, 8: 19`44, 1995.

3531. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ŠÖ“Œ’n‹æ‚É‚¨‚¯‚é‹~‹}ˆã—ÃTƒCƒh‚©‚猩‚½”]Ž€ˆÚA. ‰¡“c—TsC‰Á“¡ˆê—ÇC‘å’Ë•qŽqi“úˆã‘åjC—L‰ê“Oiº˜a‘åjC‘å˜a“c—²i‹~–½jC²“¡Íiç—tŒ§‹~‹}ˆã—ÃZƒ“ƒ^[jCÀŠÔKŽqiŒÕƒm–å•a‰@jC—Ѭ”Vi“ú ‘åj: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i94.11.03`05j, “Œ‹ž.

3532. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ŒÄ‹zŠÇ—‚Æ—Õ°HŠw‹ZŽt. ‘Š”nˆêˆåi‹~–½j: ‘æ69‰ñ“ú–{ˆã‰ÈŠíŠBŠw‰ï‘å‰ï i94.05.19`21j, “Œ‹ž.

3533. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¸_áŠQŽÒ‚ªŠ×‚è‚â‚·‚¢g‘ÌŽ¾Š³|‹ô”­«’á‘̉·Ç‚Ƹ_•ª—ô•a|. 㞊‹gli‹~–½jC’ç–M•FC÷ˆäO”Ti¸j: ‘æ90‰ñ“ú–{¸_E_ŒoŠw‰ï‘‰ï i94.05.27j, ¼ŽR.

3534. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j S”x‘h¶Œã‚É‚¨‚¯‚éŠeŽíŒŒ´y‘f‚ÌŽžŠÔ“I„ˆÚ‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ŽR–{aˆê˜YC–ؑ¥–¾C‘Š”nˆêˆåC‘“c‘ìC‘å˜a“c—²i‹~–½j: ‘æ5‰ñ“ú–{—Õ°ƒ‚ƒjƒ^[Šw‰ï‘‰ï i94.06.04j, ŽD–y.

3535. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”M’†Ç‚Ìy‘fƒ‚ƒjƒ^ƒŠƒ“ƒO‚É‚æ‚é—\Œã„’è‚ÉŠÖ‚·‚élŽ@. –ؑ¥–¾C‘Š”nˆêˆåC‘“c‘ìCŽR–{aˆê˜YC‘å˜a“c—²i‹~–½j: ‘æ5‰ñ“ú–{—Õ°ƒ‚ƒjƒ^[Šw‰ï‘‰ï i94.06.04j, ŽD–y.

3536. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j SIRS-MOFŠ³ŽÒ‚ÉCHF‚ðŽ{s‚µ‚½Û‚̃TƒCƒgƒJƒCƒ“àh‰ßŒø—¦‚ÌŒŸ“¢. 㞊‹glCŽá—Ñ–õ‹vi‹~–½jC–xˆäºi“àjCŽðˆä‹Ši”åjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ39‰ñ“ú–{“§Í—Ö@Šw‰ï‘‰ï i94.07.01j, ‘åã.

3537. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “œ”A•a«ƒPƒgƒAƒVƒh[ƒVƒX‚É‚æ‚éS’âŽ~Ç—á‚ɑ΂µPCPS‚ðŽ{s‚µ‚½1—á. “sŠÛ‹`˜YC¡ˆäŠ°C‘“c‘ìC”’èŒh“ñC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ9‰ñ“ú–{‹~–½ˆã—ÃŒ¤‹†‰ï i94.09.17j, ‘åã.

3538. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”]“®–¬áŽ‹}«ŠúÄ”j—ô‚ÉŠÖ‚·‚錟“¢. –kŒ´F—YC‰““¡¹FC‹g“cF—FC‘å˜a“c—²i‹~–½jC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i94.10.03`05j, “Œ‹ž.

3539. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚—îŽÒ”j—ô“®–¬áŽ‚ÌŽ¡—Õûj. –kŒ´F—YC‹g“cF—FC‰““¡¹FC‘å˜a“c—²i‹~–½jC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.26`28j, “¿“‡, Neurol. Med. Chir., (´˜^W): 57, 1993.

3540. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰ä‚ª‘‚É‚¨‚¯‚é‚­‚à–Œ‰ºoŒŒŠ³ŽÒ‚ÌŽ¡—Â̎Àî|ê–åˆãŒP—ûŽ{Ý‚`€•a‰@‚̃Aƒ“ƒP[ƒg’²¸‚ÌŒ‹‰Ê‚©‚ç|. Žs—ˆ›½Œ‰C—L‰ê“OC‰Í£•kC–kŒ´F—Yi‹~–½jC²–ìŒörC‰€•”^C’†‘º–FŽ÷: ‘æ53‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï i94.10.26`28j, “¿“‡, Neurol. Med. Chir., (´˜^W): 73, 1993.

3541. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‹}«’†“ÅŠ³ŽÒ‚ÌŽ€–SÇ—á‚ÌŒŸ“¢. ó—˜–õC•Ð‰ª—SˆêC•½“cŒõ”ŽC’ç–M•FCŽá—Ñ–õ‹vi‹~–½jC‹ß“¡—¯”üŽqi–òÜjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i94.11.03`05j, “Œ‹ž.

3542. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Swan-GanzƒJƒe[ƒeƒ‹‚É‚æ‚Á‚ÄzŠÂŠÇ—‚ð—v‚µ‚½L”͈͔MŠ³ŽÒ‚Ì”wŒiˆöŽq‚ÌŒŸ“¢. ¼ŽRÄ‹vC‘“c‘ìC–ؑ¥–¾C“Œ‰ªG–¾C’†‘ºŒ³MC“c’†³‰pCŽR–{aˆê˜YC•½“cŒõ”ŽC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i94.11.03`05j, “Œ‹ž, J. Jpn. Assoc. Acute Med., 5(5): 522, 1994.

3543. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒNƒ‚–Œ‰ºoŒŒ(SAH)‹}«Šú‚É”F‚ß‚ç‚ê‚éS“d}ˆÙí‚Æ’†•«‚¨‚æ‚Ñ––½«ƒmƒ‹ƒAƒhƒŒƒiƒŠƒ“Šˆ“®‚Æ‚ÌŠÖŒW. ŽR–{aˆê˜YC‘“c‘ìC–kŒ´F—YC¼ŽRÄ‹vC“sŠÛ‹`˜YC“Œ‰ªG–¾C‹g“cF—FC¼ŽR‹v®C‰““¡¹FC•‘ò—˜˜YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i94.11.03`05j, “Œ‹ž, J. Jpn. Assoc. Acute Med., 5(5): 546, 1994.

3544. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ~ƒ_ƒ]ƒ‰ƒ€’ÁÃŽž‚ÌSzŠÂ“®‘ԂƃXƒgƒŒƒX”½‰ž‚ɑ΂·‚éƒtƒ‹ƒ}ƒ[ƒj[ƒ‹‚̉e‹¿. ‘“c‘ìC㞊‹glC’ç–M•Fi‹~–½jC‹ß“¡—¯”üŽqi–òÜjCŽR–{aˆê˜YC–ؑ¥–¾C•Ð‰ª—SˆêC¼ŽRÄ‹vC“sŠÛ‹`˜YC•‘ò—˜˜YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i94.11.03`05j, “Œ‹ž, J. Jpn. Assoc. Acute Med., 5(5): 556, 1994.

3545. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –³Ž_‘f”]Ç‚É‚¨‚¯‚é“àˆö«ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn•¨Ž¿‚Ì‘¶Ý‚ÉŠÖ‚·‚錟“¢. 㞊‹glC‘“c‘ìC’ç–M•Fi‹~–½jC‹ß“¡—¯”üŽqi–òÜjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i94.11.03`05j, “Œ‹ž, “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 5: 535, 1994.

3546. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Á‰»ŠÇúE‚É‚æ‚é”Ä”­«• –Œ‰Š‚ɑ΂·‚é‘å—Êp’†• oôò‚ÌŒŸ“¢. ™–{Ÿ•FC•½“cŒõ”ŽC‘꓇í‰ëC‘å˜a“c—²i‹~–½jCŠ`“cÍiŠOj: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i94.11.03`05j, “Œ‹ž, “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 5: 583, 1994.

3547. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”’ŒŒ•aŠ³ŽÒ‚É‚¨‚¯‚éoŒŒ«”]ŒŒŠÇáŠQ—á‚ɂ‚¢‚Ä‚ÌŒŸ“¢. HŽR‹v®C–kˆä‘¥•vi“àjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i94.11.04j, “Œ‹ž, “ú–{‹~‹}ˆãŠw‰ïŽGŽ, 5(5): 548, 1994.

3548. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒ~ƒ_ƒ]ƒ‰ƒ€’ÁÃŽž‚ÌSzŠÂ“®‘ԂƃXƒgƒŒƒX”½‰ž‚ɑ΂·‚éƒtƒ‹ƒ}ƒ[ƒjƒ‹‚̉e‹¿. 㞊‹glC‘“c‘ìC’ç–M•FC“sŠÛ‹`˜YC“c’†³‰pi‹~–½j: ‘æ7‰ñ“ú–{‘‡•a‰@¸_ˆãŠw‰ï‘‰ï i94.11.23j, ·‰ª, ‘‡•a‰@¸_ˆãŠw, 6: 52, 1994.

3549. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j SIRS‚É‘±”­‚µ‚½MOF-ARF‚ɑ΂·‚ézŠÂƒTƒCƒgƒJƒCƒ“œ‹ŽŽ¡—ÃŒø‰Ê. 㞊‹glCŽá—Ñ–õ‹vC‘å˜a“c—²i‹~–½j: ‘æ37‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï i94.12.08j, –‹’£, Jpn. J. Nephrol., 36: 162, 1994.

3550. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“’ÁÃŽž‚Ì‘gDŽ_‘f‘ãŽÓ‚ƃXƒgƒŒƒX”½‰ž‚ÌŒŸ“¢. 㞊‹glC‘“c‘ìC’ç–M•FC¼ŽRÄ‹vCŽR–{aˆê˜YC–ؑ¥–¾C‹e–ì—²–¾C‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï i95.02.01`03j, ‘åã, “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 2(Suppl.): 166, 1995.

3551. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒtƒ‹ƒ}ƒ[ƒjƒ‹•‰‰×‚É‚æ‚éƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“’ÁÃŽž‚ÌSzŠÂ“®‘Ô‚ÌŒŸ“¢. ‘“c‘ìC㞊‹glC’ç–M•FC¼ŽRÄ‹vCŽR–{aˆê˜YC‹e–ì—²–¾C‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï i95.02.01`03j, ‘åã, “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 2(Suppl.): 167, 1995.

3552. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž‰–bÇðÇ”­Ç‹@˜‚ÉŠÖ‚·‚é—Õ°“IŒ¤‹†. –ؑ¥–¾C•½“cŒõ”ŽCHŽR‹v®C‘“c‘ìC•‘ò—˜˜YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC‹v•Û“cŸC•y“c—FKi“àj: ‘æ22‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï i95.02.01j, ‘åã, “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ, 2(Suppl.): 203, 1995.

3553. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ”]ŒŒŠÇáŠQ‚É‚æ‚éDOA(—ˆ‰@ŽžS”x’âŽ~)Ç—á‚ÌŒŸ“¢. –kŒ´F—YC‘“c‘ìC‰““¡¹FCHŽR‹v®C‘å˜a“c—²i‹~–½jC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ‘æ20‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i95.03.03j, ‰¡•l.

3554. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “Ý“It‘¹‚Ì—Õ°“IŒŸ“¢. •½“cŒõ”ŽC–x’rdŽ¡C¼ŽRÄ‹vC“Œ‰ªG–¾C‘꓇í‰ëCV“¡³‹PC™–{Ÿ•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ22‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï i94.11.03`05j, “Œ‹ž.

3555. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Descending necrotizing mediastinitis‚Ì1—á. –ؑ¥–¾C¡ˆäŠ°C•½“cŒõ”ŽC–x’rdŽ¡C™–{Ÿ•FC‘꓇í‰ëC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ37‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i94.06.25j, ‘åˆé.

3556. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j h-HGF‚É‚ÄŒo‰ßŠÏŽ@‚µ‚¦‚½‹}«”DP«Ž‰–bŠÌ‚Ì1—á. ŽR–{aˆê˜YC•Ð‰ª—SˆêC‹ß“¡ˆê‰pC”’èŒh“ñC‘å“c„•äC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ37‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i94.06.25j, ‘åˆé.

3557. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j –D‚¢j‚É‚æ‚鎩sˆ×‚É‚æ‚èS–ŒØŠJŒãÇŒóŒQ—l•a‘Ô‚ð’悵‚½1Ç—á. “sŠÛ‹`˜YC‘“c‘ìC’ç–M•FC•‘ò—˜˜YCŽá—Ñ–õ‹vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ37‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i94.06.26j, ‘åˆé.

3558. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j d“x“]—ŽŠO‚ð‚Æ‚à‚È‚Á‚½“dŒ‚‚Ì‚P—á. “c’†³‰pCŽðˆä’¼•FCŽODGC’†‘ºŒ³MC‘å˜a“c—²i‹~–½jC‰–’JMKiŒ`ŠOj: ‘æ186‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠÖ“ŒŽx•”’n•û‰ï i95.02.04j, “Œ‹ž.

3559. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j Ž©ŽEŠé}‚É‚Ü‚ÅŽŠ‚Á‚½Œã‘å”]“®–¬—̈æ[Ç‚Ì‚P—á. Vˆä~ŽqCHŽR‹v®C‚‹´’õlC—§‘òŒ«FC•½“cŒõ”ŽC’ç–M•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i95.02.25j, “Œ‹ž.

3560. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰¡Šu–Œƒwƒ‹ƒjƒA‚Ìæi•”ˆÝ’×á‡úE‚É”º‚¤”^‹¹‚Ì1—á. “Œ‰ªG–¾C¼ŽRÄ‹vC–ؑ¥–¾C”’èŒh“ñC‘꓇í‰ëC¡ˆäŠ°C•‘ò—˜˜YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i95.02.25j, “Œ‹ž.

3561. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ’°˜‹Ø”^ᇂ̂P—á. “ŒŒvCV“¡³‹PCã“cºŒáCb”ãG”üC•½“cŒõ”ŽC™–{Ÿ•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i95.02.25j, “Œ‹ž.

3562. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŽèŽw, ‘«æ䑹‚ɑ΂·‚éƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“E1»Ü‚ÌŽg—pŒoŒ±. “c’†³‰pC’†‘ºŒ³MCŽODGCŽðˆä’¼•FC•½“cŒõ”ŽC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC‰–’JMKiŒ`ŠOj: ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i95.02.25j, “Œ‹ž.

3563. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j —nŒŒ«˜A½‹…‹Û‚É‚æ‚éŽlŽˆ‰óŽ€«‹Ø–Œ‰Š‚Ì2—á. •~“‡NŽjiŽ™jCV“¡³‹PCb”ãGŽÀCã“cºŒáC•½“cŒõ”ŽCŽá—Ñ–õ‹vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï i95.02.25j, “Œ‹ž.

3564. mŒ¤‹†‰ïi‘S‘jn i‰ï“ªi‰ï’·ju‰‰j ƒNƒ‚–Œ‰ºoŒŒ‚É‚¨‚¯‚éS”x‡•¹Ç‚Ì•a‘Ô‚Æ‹}Ž€‚Ì‹@˜‚ÉŠÖ‚·‚錟“¢. ‘å˜a“c—²i‹~–½j: ‘æ7‰ñ”]Ž€”]‘h¶Œ¤‹†‰ï i94.06.17j, ‰¡•l.

3565. mŒ¤‹†‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‚­‚à–Œ‰ºoŒŒ‚É‚æ‚é’´‘ŠúS”x’âŽ~‚̃ƒJƒjƒYƒ€. –kŒ´F—YC‘“c‘ìC‰““¡¹FCHŽR‹v®C‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ‘æ24‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï i95.03.01j, “Œ‹ž.

3566. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j CHF‚É‚æ‚è—ÇD‚ÈŒo‰ß‚ð‚½‚Ç‚Á‚½dÇäX‰Š‚Ì1—á. 㞊‹glCŽá—Ñ–õ‹vC“à“¡CC¬–ìO“ñC‹ß“¡ˆê‰pC”’èŒh“ñC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ6‰ñ‹}«ŒŒ‰tò‰»Œ¤‹†‰ï i94.09.30j, ‹v—¯•Ä.

3567. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j “ª•”ŠO‚𔺂¤ŽlŽˆœÜÇ—á‚ÌŒŸ“¢. V“¡³‹PC–kŒ´F—YCã“cºŒáCb”ãGŽÀC‘Š”nˆêˆåi‹~–½jCŽ…–ž·Œ›i®ŠOj: ‘æ1‰ñ‹~‹}®Œ`ŠOƒZƒ~ƒi[ i95.01.20j, ŽD–y.

3568. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‹~‹}—̈æ‚É‚¨‚¯‚é‹CŠÇŽx‹¾ŒŸ¸‚Ì—L—p«. ‘Š”nˆêˆåi‹~–½j: ŽD–y’n‹æMRC‚̉ï i94.07.08j, ŽD–y.

3569. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j • o“àoŒŒ‚É‚æ‚莀–S‚µ‚½ƒEƒFƒWƒi[“÷‰èŽî‚Ì1—á. –ؑ¥–¾C㞊‹glC•‘ò—˜˜YC‘“c‘ìCŽá—Ñ–õ‹vC”’èŒh“ñC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ36‰ñ_“Þ슴õÇŒ¤‹†‰ï i94.08.27j, ‰¡•l.

3570. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Descending necrotizing mediastinitis‚Ì1—á. –ؑ¥–¾C¡ˆäŠ°C‘꓇í‰ëC“Œ]—ǺC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ36‰ñ_“Þ슴õÇŒ¤‹†‰ï i94.08.27j, ‰¡•l.

3571. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j ŽèŽwŠO‚É‚¨‚¯‚é PGE1‚ÌŽg—pŒoŒ±. “c’†³‰pCŽðˆä’¼•FCŽODGC’†‘ºŒ³Mi‹~–½j: ‘æ2‰ñ–k—¢Œ`¬ŠO‰ÈŒ¤‹†‰ï i94.10.08j, ‰¡•l.

3572. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j Œz’Å‘¹‚Ý‚Ì‚ª‚µÇ—á. V“¡³‹Pi‹~–½j: ŠOǗጟ“¢‰ï i94.12.03j, “Œ‹ž.

3573. mŒ¤‹†‰ïi’n•ûjn iˆê”Êu‰‰j “œ”A•aƒPƒgƒAƒ`ƒh[ƒVƒX‚É‚æ‚éS’âŽ~Ç—á‚ɑ΂µPCPS‚ðŽ{s‚µ‚½1‹~–½—á. ŽR–{aˆê˜YC‘“c‘ìC¡ˆäŠ°C¼ŽRÄ‹vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ10‰ñ_“Þì‹}«zŠÂ•s‘SŒ¤‹†‰ï i95.01.26j, ‰¡•l.

3574. mŠw‰ïŽåÃi‘“àŠw‰ïjn ‘æ6‰ñ“ú–{_Œo‹~‹}Œ¤‹†‰ï, ‘ã•\¢˜bl, ‘å˜a“c—²i‹~–½j.

3575. mŠw‰ïŽåÃi‘“àŠw‰ïjn ‘æ7‰ñ”]Ž€¥”]‘h¶Œ¤‹†‰ï, Šw‰ï’·, ‘å˜a“c—²i‹~–½j.


<<30 ¶‘ÌHŠw>>

3576. mŒ´’˜n Progression of osteoporosis in cancellous bone depending on trabecular structure. X“c^Žji¶‘ÌHjCå‚Œ´—L’jCŽ…–ž·Œ›i®ŠOjCù“c’¼iç—tH‘åj: Ann. Biomed. Eng., 22: 532`539, 1994.

3577. mŒ´’˜n The use of a universal force-moment sensor to determine in-situ forces in ligaments: A new methodology. “¡]—T“¹i¶‘ÌHjCG.A. LivesayCS.L-Y. WooC”ŒûV“ñCG. Blonstromiƒsƒbƒcƒo[ƒO‘åj: J. Biomech. Eng., 117(1): 1`7, 1995.

3578. mŒ´’˜n Materials preparation and artificial skin graft. •–ö”\Œõi¶‘ÌHj: Materials Science and Engineering, C1: 133`137, 1994.

3579. mŒ´’˜n Development of new wound dressing with antimicrobial delivery capability. •–ö”\Œõi¶‘ÌHjC”’λ•FC”’èËWC’†–kMºCˆÀ•y‹`“NiŒ`ŠOjC‚–ìN—Yi•a—jC‰–’JMKiŒ`ŠOj: Wound Repair Regeneration, 2: 122`129, 1994.

3580. mŒ´’˜n ”|—{”畆ƒ‚ƒfƒ‹‚ð—p‚¢‚½×–E“Å«ŽŽŒ±. ”’èËWiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ¶‘ÌÞ—¿, 12: 217`224, 1994.

3581. mŒ´’˜n ”|—{”畆‚É“K‚µ‚½ˆÚA°‚ÌŒ`¬: “®•¨ŽÀŒ±•]‰¿. ”’èËWiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ¶‘ÌÞ—¿, 12: 265`273, 1994.

3582. mŒ´’˜n •GŠÖß“®—h«ŽŽŒ±(LachmanƒeƒXƒg)ŽÀsŽž‚ɶ‚¶‚é‘O\Žšx‘Ñ“à’£—Í‚Ì‘å‚«‚³‚Æ•ª•z. “¡]—T“¹i¶‘ÌHjC”ŒûV“ñCG.A. LivesayCS.L-Y. Wooiƒsƒbƒcƒo[ƒO‘åj: “ú–{‹@ŠBŠw‰ï˜_•¶W, 60(578): 291`295, 1994.

3583. mŒ´’˜n ƒqƒg‘O\Žšx‘Ñ‚ÆŒã\Žšx‘Ñ‚ÌŒ`‘ÔŠw“I”äŠr(New Ligament Substitute‚Ì’Tõ‚ׂ̈É). ”ŒûV“ñCG.A. LivesayC“¡]—T“¹i¶‘ÌHjCC.D. HarnerCS.L-Y. WooCF.H. Fuiƒsƒbƒcƒo[ƒO‘åj: “ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ïŽGŽ, 14(1): 23`30, 1994.

3584. mŒ´’˜n •GŠÖß‚Ì‚UŽ©—R“x‚ɶ‚¶‚é—͂ƃ‚[ƒƒ“ƒg‚ÌŒv‘ª. “¡]—T“¹i¶‘ÌHjC”nŸº´Ž‘iˆã—Éq¶Šw•”jC’Ë–{s’ji®ŠOjCG.A. LivesayCS.L-Y. Wooiƒsƒbƒcƒo[ƒO‘åjCù“c’¼iç—tH‘åj: “ú–{—Õ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ïŽ, 15: 345`349, 1994.

3585. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Šm—¦˜_“IFEMƒ‚ƒfƒ‹‚É‚æ‚霂̔j‰ó“`”d‹@\‚̉𖾂Ƒå‘ÚœŒz•”œÜ”­¶‹@˜‚ÌŒŸ“¢. X“c^Žji¶‘ÌHjC“ì‘òˆç—Yi®ŠOj: Biomechanics(‘æ7‰ñŒöŠJƒZƒ~ƒi[—vŽ|), No.14, p.18, 1994.

3586. m‘àn ŠC–Èœ‚Ì—ÍŠw“Á«. X“c^Žji¶‘ÌHj: The Bone, 8(3): 61`69, 1994.

3587. mŠwp‘i‰p•¶jn i•ª’SŽ·•Mj Clinical Biomechanics and Related Research; Application of robotics to studies of joint biomechanics, p.81`95, “¡]—T“¹i¶‘ÌHjCS.L-Y. WooCG.A. Livesayiƒsƒbƒcƒo[ƒO‘åjC”nŸº´Ž‘iˆã—Éq¶Šw•”j. •ÒW •½‘ò‘׉îi‹ž“s•{—§ˆã‘åjCC.B. Sledgeiƒn[ƒo[ƒh‘åjCS.L-Y. Wooiƒsƒbƒcƒo[ƒO‘åj, Springer-VerlagC“Œ‹žC94.00.00”­s.

3588. mŠwp‘i‰p•¶jn i•ª’SŽ·•Mj Clinical Biomechanics and Related Research; Anatomy and biomechanics of the human posterior cruciate ligament, p.200`216, G.A. LivesayCC.D. HarnerCJ.W. XerogeanesCG.J. CarlinC‘ŽR‹Biƒsƒbƒcƒo[ƒO‘åjC“¡]—T“¹i¶‘ÌHjC”ŒûV“ñCS.L-Y. Wooiƒsƒbƒcƒo[ƒO‘åj. •ÒW •½‘ò‘׉îi‹ž“s•{—§ˆã‘åjCC.B. Sledgeiƒn[ƒo[ƒh‘åjCS.L-Y. Wooiƒsƒbƒcƒo[ƒO‘åj, Springer-VerlagC“Œ‹žC94.00.00”­s.

3589. mŠwp‘n i•ª’SŽ·•Mj ŠÅŒì‹Zp; lH”畆, 40: 628`632, •–ö”\Œõi¶‘ÌHj. ƒƒaƒJƒ‹ƒtƒŒƒ“ƒhŽÐC“Œ‹žC94.04.00”­s.

3590. mŠwp‘n i•ª’SŽ·•Mj ”M|ÅV‚Ì—˜_‚ÆŽÀÛ; ”|—{”畆, p.309`316, •–ö”\Œõi¶‘ÌHj. Ž½“°C“Œ‹žC94.12.20”­s.

3591. mŠwp‘n i•ª’SŽ·•Mj ƒhƒŒƒbƒVƒ“ƒO|V‚µ‚¢‘nŠÇ—; ¶‘̃hƒŒƒbƒVƒ“ƒO, p.60`67, •–ö”\Œõi¶‘ÌHj. ‚Ö‚é‚·o”ÅC“Œ‹žC95.02.05”­s.

3592. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ƒoƒCƒIƒGƒ“ƒWƒjƒAƒŠƒ“ƒO•”–å•ñ; ”|—{”畆‚Ì—ðŽj, 18: 3`6, •–ö”\Œõi¶‘ÌHj. “ú–{‹@ŠBŠw‰ïC94.05.00”­s.

3593. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ª’SŽ·•Mj ƒgƒ‰ƒCƒ{ƒƒW[Ž«“T; ƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒW[ŠÖ˜A, X“c^Žji¶‘ÌHj. •ÒW –Ø‘ºDŽŸC‘¼(15–¼), —{Œ«“°C“Œ‹žC95.03.00”­s.

3594. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ÒWj ƒgƒ‰ƒCƒ{ƒƒW[Ž«“T; ƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒW[ŠÖ˜A, •ÒW –Ø‘ºDŽŸCX“c^Žji¶‘ÌHjC‘¼(15–¼), —{Œ«“°C“Œ‹žC95.03.00”­s.

3595. mŠw‰ïi‘Ûjn i‹³ˆçu‰‰j Application of antimicrobial agent and biologically active substance into wound dressing. •–ö”\Œõi¶‘ÌHjC‰eŽRL”üC‰–’JMKiŒ`ŠOj: ‘nŽ¡—ÂɊւ·‚é‘ÛƒVƒ“ƒ|ƒWƒEƒ€ i95.03.10j, ƒ}ƒEƒC.

3596. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Wound management using allogeneic cultured dermal sheet in conjunction with medicated covering material. •–ö”\Œõi¶‘ÌHjCŽR‰º—ŠGC”’èËWC•“cŒ[C‚‹´Œ³C‰–’JMKiŒ`ŠOj: ‘æ9‰ñ‘Û”MŠw‰ï i94.06.28j, ƒpƒŠ, —\eW, p.189, 1994.

3597. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Application of a robotics system for the study of joint biomechanics. “¡]—T“¹i¶‘ÌHjC”nŸº´Ž‘iˆã—Éq¶Šw•”jC’Ë–{s’ji®ŠOjCG.A. Livesayiƒsƒbƒcƒo[ƒO‘åjCù“c’¼iç—tH‘åj: 2nd World Congress of Biomechanics i94.07.10`15j, ƒAƒ€ƒXƒeƒ‹ƒ_ƒ€, Abstracts, p.299, 1994.

3598. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j Formation of the non-union at the experimentally fractured rabbit tibia by the mechanical stimulation produced by a robot arm. ”nŸº´Ž‘iˆã—Éq¶Šw•”jC“¡]—T“¹i¶‘ÌHjCŽR“¿‹`˜YCŽR–{^CŽ…–ž·Œ›i®ŠOj: 4th Conference of the International Society for Fracture Repair i94.09.27`10.01j, _ŒË, Abstracts, p.61, 1994.

3599. mŠw‰ïi‘Ûjn iˆê”Êu‰‰j New hyaluronic acid spongy sheet wound dressing containing biologically active substances. •–ö”\Œõi¶‘ÌHj: ‘æ7‰ñ‘Û‘nŽ¡—ÃVƒ“ƒ|ƒWƒEƒ€ i94.10.09j, ƒVƒJƒS.

3600. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Quantitative cytotoxicity tests on antimicrobial agent using cultured skin substitutes in an iterface system. •–ö”\Œõi¶‘ÌHjC”’èËWC•“cŒ[C‰–’JMKiŒ`ŠOj: ‘æ9‰ñ‘Û”MŠw‰ï i94.06.28j, ƒpƒŠ, —\eW, p.191, 1994.

3601. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Wound management using allogeneic cultured dermal sheet in conjunction with medicated covering material. •–ö”\Œõi¶‘ÌHjCŽR‰º—ŠGC‰–’JMKiŒ`ŠOj: ‘æ4‰ñƒˆ[ƒƒbƒp‘nŽ¡–üŠw‰ï i94.08.26j, ƒIƒbƒNƒXƒtƒH[ƒh, —\eW, p.248, 1994.

3602. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Efficacy of hyaluronic acid spongy sheet containing antithrombin agent in conjunction with medicated covering material. •–ö”\Œõi¶‘ÌHjC‰eŽRL”üC‰–’JMKiŒ`ŠOj: ‘æ4‰ñƒˆ[ƒƒbƒp‘nŽ¡–üŠw‰ï i94.08.26j, ƒIƒbƒNƒXƒtƒH[ƒh, —\eW, p.249, 1994.

3603. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒƒ{ƒbƒg‚É‚æ‚é•GŠÖß•sˆÀ’è«‚Ì•]‰¿|Œ»‹µ‚Æ«—ˆ«|. “¡]—T“¹i¶‘ÌHj: ‘æ10‰ñ•GŠÖ߃tƒH[ƒ‰ƒ€ i93.06.05j, “Œ‹ž.

3604. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j üˆÛ‰è×–E‚ðƒRƒ‰[ƒQƒ“ƒ}ƒgƒŠƒbƒNƒX‚É‘g‚Ýž‚ñ‚¾‘¼‰Æ”|—{^”çƒV[ƒg‚ÌŠJ”­: —Õ°•]‰¿. •–ö”\Œõi¶‘ÌHjCŽR‰º—ŠGC‚‹´Œ³C”’èËWC‰–’JMKiŒ`ŠOj: ‘æ23‰ñˆã—p‚•ªŽqƒVƒ“ƒ|ƒWƒEƒ€ i94.06.17j, “Œ‹ž, —\eW, p.77`78, 1994.

3605. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒqƒAƒ‹ƒƒ“Ž_ƒXƒ|ƒ“ƒW‚ÆR‹ÛÜŠÜ—L”í•¢Þ‚Ì•¹—p‚É‚æ‚é‘nŽ¡–ü‘£iŒø‰Ê: “®•¨ŽÀŒ±•]‰¿. •–ö”\Œõi¶‘ÌHjC‰eŽRL”üC‰–’JMKiŒ`ŠOj: ‘æ23‰ñˆã—p‚•ªŽqƒVƒ“ƒ|ƒWƒEƒ€ i94.06.17j, “Œ‹ž, —\eW, p.79`80, 1994.

3606. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒqƒAƒ‹ƒƒ“Ž_ƒXƒ|ƒ“ƒW‚ÆR‹ÛÜŠÜ—L”í•¢Þ‚Ì•¹—p‚É‚æ‚é‘nŽ¡–ü‘£iŒø‰Ê: “®•¨ŽÀŒ±•]‰¿. •–ö”\Œõi¶‘ÌHjC‰eŽRL”üC‰–’JMKiŒ`ŠOj: ‘æ11‰ñ¶‘Ì‘@ˆÛ‚ƶˆãŠwÞ—¿‚ÉŠÖ‚·‚éƒVƒ“ƒ|ƒWƒEƒ€ i94.07.05j, “Œ‹ž, —\eW, p.12, 1994.

3607. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒRƒ‰[ƒQƒ“‚ðŠîÞ‚Æ‚·‚鑼‰Æ•¡‡”|—{”畆‚Ì컂Ɨհ•]‰¿. •–ö”\Œõi¶‘ÌHjCŽR‰º—ŠGC‚‹´Œ³C‰–’JMKiŒ`ŠOj: ‘æ11‰ñ¶‘Ì‘@ˆÛ‚ƶˆãŠwÞ—¿‚ÉŠÖ‚·‚éƒVƒ“ƒ|ƒWƒEƒ€ i94.07.05j, “Œ‹ž, —\eW, p.27, 1994.

3608. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ¶‘ÌŠÖß‚ÌÖ€ŽC‚Æ“®–€ŽC. ”nŸº´Ž‘iˆã—Éq¶Šw•”jC“¡]—T“¹i¶‘ÌHjC¬‹ÊCHŽR‚¢‚í‚«iÓìH‘åjCù“c’¼iç—tH‘åjCŽ…–ž·Œ›i®ŠOj: ‘æ15‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ i95.03.04j, “Œ‹ž, —\eW, p.4, 1995.

3609. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Anatomy and biomechanics of the human posterior cruciate ligament. G.A. LivesayCC.D. HarnerC‘ŽR‹BCG.J. CarlinCJ.W. Xerogeanesiƒsƒbƒcƒo[ƒO‘åjC“¡]—T“¹i¶‘ÌHjC”ŒûV“ñCS.L-Y. Wooiƒsƒbƒcƒo[ƒO‘åj: ‘æ20‰ñ“ú–{—Õ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ï i93.11.05`06j, ‹ž“s, Abstracts, p.122, 1993.

3610. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒqƒAƒ‹ƒƒ“Ž_ƒXƒ|ƒ“ƒW‚ÆR‹ÛÜŠÜ—L”í•¢Þ‚Ì•¹—p‚É‚æ‚é‘nŽ¡–ü‘£iŒø‰Ê‚ÌŒŸ“¢. ‰eŽRL”üC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ20‰ñ“ú–{”MŠw‰ï i94.05.26j, ‰¡•l.

3611. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j —ÍŠo§Œäƒƒ{ƒbƒgƒA[ƒ€‚É‚æ‚éƒEƒTƒM•GŠÖß‚Ì–€ŽC‘ª’è. ”nŸº´Ž‘iˆã—Éq¶Šw•”jC“¡]—T“¹i¶‘ÌHjC¬Œ´Œ’’jCŽRŒû•q“ñ˜YiŽ‘¶“°jC’Ë–{s’jCŽ…–ž·Œ›i®ŠOj: ‘æ6‰ñƒoƒCƒIƒGƒ“ƒWƒjƒAƒŠƒ“ƒOŠwpu‰‰‰ï i94.08.05`06j, ˆÉ“¤’·‰ª, —\eW, p.37`39.

3612. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •GŠÖß‚Ì‚RŽŸŒ³“®—h«|“àŠO”½ƒ‚[ƒƒ“ƒg‚̉e‹¿|. “¡]—T“¹i¶‘ÌHjC‹ß“¡Œ÷ˆêiÓìH‘åjC”nŸº´Ž‘iˆã—Éq¶Šw•”jC’Ë–{s’ji®ŠOjC²“¡bˆ¨iÓìH‘åj: ‘æ6‰ñƒoƒCƒIƒGƒ“ƒWƒjƒAƒŠƒ“ƒOŠwpu‰‰‰ï i94.08.05`06j, ˆÉ“¤’·‰ª, —\eW, p.51`53.

3613. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒtƒBƒuƒƒlƒNƒ`ƒ“ƒtƒ‰ƒOƒƒ“ƒgŠÜ—LƒqƒAƒ‹ƒƒ“Ž_ƒXƒ|ƒ“ƒW‚Ì‘nŽ¡–ü‘£iŒø‰Ê‚Ì•]‰¿. •–ö”\Œõi¶‘ÌHjC‰eŽRL”üCŽR“c’¼liŒ`ŠOj: ‘æ16‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï i94.10.16j, ŽR—œ.

3614. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j •Gx‘тɶ‚¶‚é’£—Í‚Ì•ª•z|‘OŒã•û—͂̉e‹¿|. “¡]—T“¹i¶‘ÌHjC”nŸº´Ž‘iˆã—Éq¶Šw•”jC“n•Ó®C–k’ÜLmC’Ë–{s’ji®ŠOjC‘ºÎ–¾•FCù“c’¼iç—tH‘åj: ‘æ21‰ñ“ú–{—Õ°ƒoƒCƒIƒƒJƒjƒNƒXŠw‰ï i94.10.21`22j, VŠƒ, —\eW, p.88, 1994.

3615. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒ`ƒ^ƒ“‡‹à•…H‰t• o“à“Š—^‚É‚¨‚¯‚éŽå—v‹à‘®‚Ì‘ÌŠO”rŸ•‚ÆŽc—¯‚ɂ‚¢‚Ä. X“c^Žji¶‘ÌHjCŽR“c—F‹vC’Ë–{s’ji®ŠOjCˆäã—tŽqi—\–hˆãŠwŒnjC–{“cKŽ¡Cù“c’¼iç—t‘åj: ‘æ15‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ i95.03.03j, “Œ‹ž, —\eW, p.1, 1994.

3616. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ˆâ“`Žq‘gŠ·ƒqƒgƒtƒBƒuƒƒlƒNƒ`ƒ“ƒtƒ‰ƒOƒƒ“ƒg‚Ì‘nŽ¡–ü‘£iŒø‰Ê. •–ö”\Œõi¶‘ÌHjC‰eŽRL”üCŽR“c’¼lC‰–’JMKiŒ`ŠOj: ‘æ24‰ñ‘nŽ¡–üŒ¤‹†‰ï i94.11.12j, ç—t, —\eW, p.22, 1994.

3617. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j œ‚ÌDamage—ÝÏ‘¬“x‚Ì„’è‚Æ‘å‘ÚœŒz•”œÜ—\’mƒ\ƒtƒgƒEƒGƒA‚ÌŠJ”­. X“c^Žji¶‘ÌHj: •¶•”Èd“_—̈æƒoƒCƒIƒƒJƒjƒNƒX”ljï‹c i95.01.27j, “Œ‹ž.

3618. mŒ¤‹†‰ïi‘S‘jn iŒöŠJuÀj Šm—¦˜_“IFEMƒ‚ƒfƒ‹‚É‚æ‚霂̔j‰ó“`”d‹@\‚̉𖾂Ƒå‘ÚœŒz•”œÜ”­¶‹@˜‚ÌŒŸ“¢. X“c^Žji¶‘ÌHj: •¶•”ȉȌ¤”ïd“_—̈挤‹†‘æ7‰ñŒöŠJƒZƒ~ƒi[ i95.05.24j, –¼ŒÃ‰®.

3619. mŠwpÜi‘“àÜjn ‘æ7‰ñ–k—¢ŽÄŽO˜Y‹L”OÜ; lH”畆‚ÌŠJ”­‚Æ—Õ°‰ž—p, •–ö”\Œõi¶‘ÌHj.


<<31 —Õ°–ò—ŠwE–òÜŠw>>

3620. mŒ´’˜n Sustained release of phenytoin following the oral administration of phenytoin sodium/etylcellulose microcapsules in human subjects and rabbits. ŽPˆèŽqi¶‰»jC”ª–Ø’¼”üCŽÄ“c‚ß‚®‚ÝCçÝŽ°”üCŠÖì•jC‚“c¹•Fi–kŠC“¹ˆã—Ñåj: Biol. Pharm. Bull., 17(3): 432`436, 1994.

3621. mŒ´’˜n R¶•¨Ž¿ƒLƒbƒg»Ü(—n‰ð‰t•t‚«ŒÅŒ`’ŽËÜ)‚Ì—L—p«‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†. •½ŽR•ŽiC“‡“cŽœ•Fi–òÜj: JJPEN, 16(6): 595`601, 1994.

3622. mŒ´’˜n Utility and sterility of TAB injection, an amino acid solution with carbohydrates and electrolytes for total parenteral nutrition, packaged in a dual-chambered plastic bag. “‡“cŽœ•FC’|“எqC•½ŽR•Žii–òÜj: Nutrition, 10(5): 510`514, 1994.

3623. mŒ´’˜n Chronotoxicity of glufosinate ammonium in mice. ‹gŽR—F“ñi–òŠw•”jC¬—Ñ‹P–¾C‹ß“¡—¯”üŽqC’©’·•¶–íi–òÜjC‘å˜a“c—²i‹~–½j: Vet. Hum. Toxicol., 37(1): 22`23, 1995.

3624. mŒ´’˜n V‹K’´‰¹”gƒlƒuƒ‰ƒCƒU[‚É‚¨‚¯‚é‹CŠÇŽxŠg’£Ü, ƒCƒmƒŠƒ“‰t‚̈À’è«. Œú“cKˆê˜YCÀ—¢—F‹IC‘º£¨’ÃŽqC’©’·•¶–íi–òÜjC‹gŽR—F“ñi–òŠw•”j: ŒÄ‹z, 13(7): 691`694, 1994.

3625. mŒ´’˜n ˜V”NŽÒ‚É‚¨‚¯‚éŒoŒû—pƒZƒtƒFƒ€ŒnR¶•¨Ž¿‚Ì’`”’Œ‹‡‚ÉŠÖ‚·‚錤‹†. •ŽR­ˆêC–{‹´–ÎC“‡“cŽœ•Fi–òÜjC‘ºèŒõ–Mi¸j: “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 42(12): 1355`1360, 1994.

3626. mŒ´’˜n —n‰ð‰t•t‚«’ŽË—pŒÅŒ`R¶•¨Ž¿ƒLƒbƒg»Ü‚̃Lƒbƒg—L—p«‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†|‚Æ‚­‚É—˜•Ö«, —n‰ð’²»ŽžŠÔ, •ÛŠÇ—eςɂ‚¢‚Ä|. “‡“cŽœ•FC•½ŽR•Žii–òÜj: “ú–{•ï‘•Šw‰ïŽ, 4(1): 48`63, 1995.

3627. mŒ´’˜n Synthesis and antimicrobial properties of amphiphilic sugar derivatives containing sulfur and nitrogen. –îŒã˜a•vi–òÜjC‘Vº”V•i–òŠw•”jC‰Í“c˜a—Yi—Šw•”jC“à–x‹BiŽR–ì”ü—e’Z‘åjCK. AsakuraC¼‘ºGˆêiŒc‘åj: –h‹Û–hꀎ, 22(4): 213`216, 1994.

3628. mŒ´’˜n ƒGƒ^ƒm[ƒ‹‚É‚æ‚郉ƒbƒg‹}«ˆÝ”S–Œ•a•Ï‚ɑ΂·‚éƒmƒ‹ƒAƒhƒŒƒiƒŠƒ“`ŒðŠ´_ŒoŒn‚̈Ӌ`. Œú“cKˆê˜Yi–òÜj: –k—¢ˆãŠw, 24(3): 203`209, 1994.

3629. m€Œ´’˜n ”÷—ÊŒ³‘f’ŽËÜ‚Ì”z‡•Ï‰»‚ÉŠÖ‚·‚錟“¢. –îŒã˜a•vC²‹vŠÔ­•FC¼Œ´”£C”ö’¹Ÿ–çC¬—Ñ‹P–¾C’©’·•¶–íC“‡“cŽœ•Fi–òÜj: JJPEN, 16(5): 511`514, 1994.

3630. m’Z•ñ¥‘¬•ñn ‘æ16‰ñ“ú–{—Õ°‰h—{Šw‰ï”­•\•ñu“ú–{‚É‚¨‚¯‚éNST‚ÌŒ»óvHPN‚É‚¨‚¯‚éƒ`[ƒ€ˆã—Ã|–òÜŽt‚Ì—§ê‚©‚ç. ¬ìK—Yi–òÜj: _“Þ쌧•a‰@–òÜŽt‰ï‰ïŽ, (78): 7`10, 1995.

3631. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Ý‘îˆã—ÖòÜ‹Ÿ‹‹„iƒ‚ƒfƒ‹Ž–‹Æ’†ŠÔ•ñ. “‡“cŽœ•Fi–òÜjCŽ½”¨–«iɪŒ§–òÜŽt‰ïjC‰Á‰êä¿•vi“ú–{ˆãŽt‰ïjC쑺²˜aŽqi“Œ‹žˆãŽ•‘åjC’†¼•q•vi“ú–{–òÜŽt‰ïjC¼ŽO˜Yiˆ¤’m‚Ý‚¸‚Ù‘åj: •ñ‘, 1994.

3632. m‘àn —Õ°‰h—{–@‚ɉʂ½‚·–òÜ•”‚Ì–ðŠ„. ¬ìK—YC“‡“cŽœ•Fi–òÜj: JJPEN, 16(10): 963`967, 1994.

3633. m‘àn ŠÅŒì‹Æ–±‚ƈã–ò•iî•ñ|ˆã–ò•i“Y•t•¶‘‚ÌŠˆ—p–@‚ð’†S‚Æ‚µ‚Ä. –]ŒŽ^‹|C¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: ƒn[ƒgƒi[ƒVƒ“ƒO, 7(4): 18`24, 1994.

3634. m‘àn —Õ°–òÜ‹Æ–±‚ÌŒ»ó. –]ŒŽ^‹|i–òÜj: ƒtƒ@ƒ‹ƒ}ƒVƒA, 30(10): 1160`1163, 1994.

3635. m‘àn ˆã–ò•ª‹Æ‚É‚¨‚¯‚é–òŠw‹³ˆç‚ÌÝ‚è•û. –]ŒŽ^‹|i–òÜjC”óŒûxi‹ã‘åjC’·”ö‘ñi“Œ‘åjCì“Y–Li–¼Žs‘åjC›‰Æ•áŽqi•ŸŽR‘åjC‘ºã‘׋»i“Œ–M‘åj: ƒtƒ@ƒ‹ƒ}ƒVƒA, 30(4): 351`356, 1994.

3636. m‘àn •ž–òŽw“±‚É‚¨‚¯‚éî•ñ‚ÌŠÇ—. –]ŒŽ^‹|i–òÜj: ˆã–òƒWƒƒ[ƒiƒ‹, 30(7): 105`110, 1994.

3637. m‘àn ƒAƒ‹ƒR[ƒ‹»Ü‚ÌŽE‹Ûì—p. •ŽR­ˆêC“‡“cŽœ•Fi–òÜj: Š´õ‚ÆÁ“Å, 1(1): 32`35, 1994.

3638. m‘àn –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚éÝ‘îˆã—Ã; ‘‡‘Š’k•”‚¨‚æ‚Ñ–òÜŽt‚ÌŠˆ“®. ¬ìK—YC“‡“cŽœ•Fi–òÜjCŽR–{ŒPŽqC‰““¡MŽqiŠÅŒì•”j: Ý‘îˆã—Ã, 1(1): 75`80, 1994.

3639. m‘àn Á“ÅÜ‚ÌŽí—Þ‚Æ“Á«. ¼Œ´”£C’©’·•¶–íi–òÜj: ¬Ž™“à‰È, 26(10): 1636`1640, 1994.

3640. m‘àn ‰ü—ǃZƒtƒ@ƒƒWƒ“’ŽË—pƒLƒbƒg•i‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. •½ŽR•ŽiC“‡“cŽœ•Fi–òÜj: V–ò‚Æ—Õ°, 43(11): 2440`2446, 1994.

3641. m‘àn —¼“ªj•t‚«¶—H‰–’(ƒn[ƒtƒLƒbƒg»•i)‚Ì—L—p«‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†. •½ŽR•ŽiC“‡“cŽœ•Fi–òÜj: V–ò‚Æ—Õ°, 43(7): 1252`1264, 1994.

3642. m‘àn ùÜ¥ƒJƒvƒZƒ‹Ü‚Ì•²Ó¥ŠJ••[‡T]™•ú«»Ü‚Ì•²Ó¥ŠJ••‚É‚æ‚é‰e‹¿. ²ìŒ«ˆêCaŒû‘OC’©’·•¶–íi–òÜj: ’²Ü‚Æî•ñ, (‘nŠ§Ž–‘O†): 91`94, 1994.

3643. m‘àn R^‹Û–ò. ‘º£¨’ÃŽqi–òÜjC‹v•ÄŒõi•a—j: “ú–{—Õ°, (683‘): 1006`1009, 1995.

3644. m‘àn ¶‚«‚½ˆã–ò•iî•ñ‚Ì’ñ‹Ÿ. –]ŒŽ^‹|i–òÜj: –òŽ–, 36(12): 2731`2739, 1994.

3645. m‘àn ”\“®“Iˆã–ò•iî•ñ’ñ‹ŸŠˆ“®‚ƈ•ûÝŒvŽx‰‡|ˆã–ò•iî•ñ’ñ‹Ÿ‚̃mƒEƒnƒE|. •ŽR­ˆêC’|“எqC“‡“cŽœ•Fi–òÜj: –òŽ–, 36(12): 2801`2808, 1994.

3646. m‘àn Š³ŽÒŒü‚¯ˆã–ò•iî•ñ; “ú–{‚Æ”ŠO‘‚Ì”äŠr. –]ŒŽ^‹|i–òÜj: –òŽ–, 36(5): 1011`1018, 1994.

3647. m‘àn Š¿•ûƒGƒLƒXÜ‚Ì•ž–òŽw“±|Š¿•û–ò‚Ì—p–@¥•ž—pŠúŠÔ, •¹—p‚Ì–â‘è“_|. Ô£•üGC•ŽR­ˆêC–îŒã˜a•vC¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: –òŽ–, 36(5): 1115`1121, 1994.

3648. m‘àn Š³ŽÒ‚©‚ç‚Ìî•ñ‚̃tƒB[ƒhƒoƒbƒN. •ŽR­ˆêC–îŒã˜a•vi–òÜj: –òŽ–, 36(5): 979`984, 1994.

3649. m‘àn Š¿•ûƒGƒLƒXÜ‚Ì•ž–òŽw“±|•›ì—p¥”D•w‚ɑ΂·‚é’ˆÓ“_|. Ô£•üGC•ŽR­ˆêC–îŒã˜a•vC¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: –òŽ–, 36(7): 1647`1654, 1994.

3650. muÀn –òf. ’ràV‘P˜Yi‰¡•lŽs‘å•a‰@jC–]ŒŽ^‹|i–òÜj: 3Ž Plus One, 2(1): 4`11, 1995.

3651. muÀn Ý‘î’†SÖ¬‰h—{–@‚É‚¨‚¯‚é–òÜŽt‚Ì–ðŠ„. •½ŽR•ŽiC¬ìK—YC“‡“cŽœ•Fi–òÜj: Medical Pharmacy, 28(2): 46`50, 1994.

3652. muÀn DIŽÀ—áW(104). –]ŒŽ^‹|i–òÜj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 12(7): 216`219, 1994.

3653. muÀn Á‰»«’×ᇂƕž–òŽw“±. •½ŽR•Žii–òÜj: Š¿•û’²ÜŒ¤‹†, 2(4): 18`21, 1994.

3654. muÀn ˆã–ò•i‚Ì•\Ž¦¥•ï‘•¥—eŠí‚ÌŒ»ó‚Æ‚»‚Ì–â‘è“_[‡T]. •ŽR­ˆêC’©’·•¶–íi–òÜj: »Ü‚Æ‹@ŠB, (188): 6`8, 1994.

3655. muÀn ˆã–ò•i‚Ì•\Ž¦¥•ï‘•¥—eŠí‚ÌŒ»ó‚Æ‚»‚Ì–â‘è“_[‡U]. •ŽR­ˆêC’©’·•¶–íi–òÜj: »Ü‚Æ‹@ŠB, (189): 6`7, 1994.

3656. muÀn ˆã–ò•i‚Ì•\Ž¦¥•ï‘•¥—eŠí‚ÌŒ»ó‚Æ‚»‚Ì–â‘è“_[‡V]. •ŽR­ˆêC’©’·•¶–íi–òÜj: »Ü‚Æ‹@ŠB, (190): 5`6, 1994.

3657. muÀn ˆã–ò•i‚Ì•\Ž¦¥•ï‘•¥—eŠí‚ÌŒ»ó‚Æ‚»‚Ì–â‘è“_[‡W]. •ŽR­ˆêC’©’·•¶–íi–òÜj: »Ü‚Æ‹@ŠB, (191): 9`10, 1994.

3658. muÀn ˆã–ò•i‚Ì•\Ž¦¥•ï‘•¥—eŠí‚ÌŒ»ó‚Æ‚»‚Ì–â‘è“_[‡X]. •ŽR­ˆêC’©’·•¶–íi–òÜj: »Ü‚Æ‹@ŠB, (192): 12`13, 1994.

3659. muÀn ˆã–ò•i‚Ì•\Ž¦¥•ï‘•¥—eŠí‚ÌŒ»ó‚Æ‚»‚Ì–â‘è“_[‡Y]. •ŽR­ˆêC’©’·•¶–íi–òÜj: »Ü‚Æ‹@ŠB, (193): 6`7, 1994.

3660. muÀn ˆã–ò•i‚Ì•\Ž¦¥•ï‘•¥—eŠí‚ÌŒ»ó‚Æ‚»‚Ì–â‘è“_[‡Z]. •ŽR­ˆêC’©’·•¶–íi–òÜj: »Ü‚Æ‹@ŠB, (194): 6`7, 1994.

3661. muÀn –ò܉uŠw‚ÉŠÖ‚·‚é’²¸Œ¤‹†. ¬‘î³C‘¾“cLC–k‘òŽ®•¶C•ŽR­ˆêC‘Š—ljx˜YC‰º“°‰€Œ —mC­“cŠ²•vi–òÜj: •a‰@–òŠw, 20(2): 88`91, 1994.

3662. mŠwp‘n i‹¤’˜j ‰@“à‚É‚¨‚¯‚éÁ“ÅÜ‚ÌŽg—pŽwj‰ü’ù”Å; “‡“cŽœ•FC¬ìK—Yi–òÜjC”ö‰ÆdŽ¡iŽRŒû‘åjC÷ˆä³‘¾˜Yi”•a‰@jC”’γiŽRŒ`‘åjC–öì’‰“ñi¹ƒ}ƒŠ‘åj. •ÒW “ú–{•a‰@–òÜŽt‰ï, –òŽ–“ú•ñŽÐC94.08.26”­s.

3663. mŠwp‘n i•ª’SŽ·•Mj ‚±‚̈êû‚ňãŽÒ‚©‚ç‚à‚ç‚Á‚½–ò‚ª‚æ‚­‚í‚©‚é; 7. ƒzƒ‹ƒ‚ƒ“–ò, 8. ƒrƒ^ƒ~ƒ“–ò, p.253`275, ’©’·•¶–íC²ìŒ«ˆêCˆÉ“¡—msi–òÜj. •ÒW ²ìŒ«ˆêC’©’·•¶–íi–òÜj, ŽOŠ}‘–[C“Œ‹žC95.01.10”­s.

3664. m‹³‰È‘n i•ª’SŽ·•Mj ˆã–ò•i“K³Žg—p‚ÌŠî‘b‚ÆŽÀ‘H; Šef—ÉȂ̎ÀÛ(1)-“à‰È, p.280`287, (3)-”畆‰È, p.294`299, ‚‹´Œ«¬i–òÜj. •ÒW ’©’·•¶–íC¬—Ñ‹P–¾i–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.10”­s.

3665. m‹³‰È‘n i•ª’SŽ·•Mj ˆã–ò•i“K³Žg—p‚ÌŠî‘b‚ÆŽÀ‘H; f—Éȕʗհ–òÜ‹Æ–±‚ÌŽÀÛ-Ž¨•@ˆôA‰È, p.300`304, ’¬“c[i–òÜj. •ÒW ’©’·•¶–íC¬—Ñ‹P–¾i–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.10”­s.

3666. m‹³‰È‘n i•ª’SŽ·•Mj ˆã–ò•i“K³Žg—p‚ÌŠî‘b‚ÆŽÀ‘H; ‰h—{ŠÇ—, p.316`323, ‹ß“¡—¯”üŽqi–òÜj. •ÒW ’©’·•¶–íC¬—Ñ‹P–¾i–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.10”­s.

3667. m‹³‰È‘n i•ª’SŽ·•Mj ˆã–ò•i“K³Žg—p‚ÌŠî‘b‚ÆŽÀ‘H; ’†“Åî•ñ‚Ì’ñ‹Ÿ, p.344`353, ‹ß“¡—¯”üŽqi–òÜj. •ÒW ’©’·•¶–íC¬—Ñ‹P–¾i–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.10”­s.

3668. m‹³‰È‘n i•ÒWj ˆã–ò•i“K³Žg—p‚ÌŠî‘b‚ÆŽÀ‘H; •ÒW ’©’·•¶–íC¬—Ñ‹P–¾i–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.10”­s.

3669. m‹³‰È‘n iŠÄCj ˆã–ò•i“K³Žg—p‚ÌŠî‘b‚ÆŽÀ‘H; ŠÄC ’©’·•¶–íi–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.10”­s.

3670. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i‹¤’˜j ùÜ¥ƒJƒvƒZƒ‹Ü•²Óƒnƒ“ƒhƒuƒbƒN; ²ìŒ«ˆêCaŒû‘Oi–òÜj. •ÒW ²ìŒ«ˆêCaŒû‘Oi–òÜj, ŠÄC ’©’·•¶–íi–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.31”­s.

3671. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ‚±‚̈êû‚ňãŽÒ‚©‚ç‚à‚ç‚Á‚½–ò‚ª‚æ‚­‚í‚©‚é; 9. Š´õÇŽ¡—Öò, p.276`298, –{‹´–Îi–òÜj. •ÒW ²ìŒ«ˆêC’©’·•¶–íi–òÜj, ŽOŠ}‘–[C“Œ‹žC95.01.10”­s.

3672. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj –ƒ–ò‹y‚ÑŒü¸_–òƒnƒ“ƒhƒuƒbƒN; –ƒ–òŽ––±Žè‘±‚«‚ð‚·‚é•û‚Ö, –ƒ–ò‚ðŠÇ—‚·‚é•û‚Ö, p.1`17, •ŽR­ˆêi–òÜj. _“Þ쌧•a‰@–òÜŽt‰ïC_“ÞìC94.03.00”­s.

3673. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj –òÜŽt‚ÌÝ‘îˆã—Âւ̎Q‰ÁŽwj; “‡“cŽœ•Fi–òÜjCŽ½”¨–«iɪŒ§–òÜŽt‰ïjC‰Á‰êä¿•vi“ú–{ˆãŽt‰ïjC쑺²˜aŽqi“Œ‹žˆãŽ•‘åjC’†¼•q•vi“ú–{–òÜŽt‰ïjC¼ŽO˜Yiˆ¤’m‚Ý‚¸‚Ù‘åj. –òŽ–“ú•ñŽÐC94.09.20”­s.

3674. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ‚±‚Ì–ò‚Ì‘½Ü•¹—p•›ì—p; ƒJƒ‹ƒoƒ}ƒ[ƒsƒ“‚ƃGƒŠƒXƒƒ}ƒCƒVƒ“/ƒCƒ\ƒjƒAƒWƒh, p.36`39, ’|“எqi–òÜjCŽO‰Y’å‘¥i¸j. •ÒW ¼“cdŽOi’é‹ž‘åj, ˆãŽt–òo”ÅC“Œ‹žC94.10.20”­s.

3675. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj ‚±‚Ì–ò‚Ì‘½Ü•¹—p•›ì—p; ƒ`ƒAƒWƒhŒn»Ü‚Æ’YŽ_ƒŠƒ`ƒEƒ€, p.116`119, ’|“எqi–òÜjCŽO‰Y’å‘¥i¸j. •ÒW ¼“cdŽOi’é‹ž‘åj, ˆãŽt–òo”ÅC“Œ‹žC94.10.20”­s.

3676. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj •a‰@Š´õ–hŽ~Žwj; “‡“cŽœ•Fi–òÜj. •ÒW “ú–{ŠÂ‹«Š´õŠw‰ï•a‰@Š´õƒ}ƒjƒ…ƒAƒ‹ŒŸ“¢ˆÏˆõ‰ï, “ìŽR“°C95.02.16”­s.

3677. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŠÄCj ùÜ¥ƒJƒvƒZƒ‹Ü•²Óƒnƒ“ƒhƒuƒbƒN; •ÒW ²ìŒ«ˆêCaŒûš Oi–òÜj, ŠÄC ’©’·•¶–íi–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.31”­s.

3678. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj ‚±‚̈êû‚ňãŽÒ‚©‚ç‚à‚ç‚Á‚½–ò‚ª‚æ‚­‚í‚©‚é; zŠÂŠí(S‘Ÿ¥ŒŒŠÇ)Œn—p–ò; ‹­S–ò, ¸ˆ³–ò, •s®–¬Ž¡—Öò, ‹·SÇŽ¡—Öò, p.1`9, p.134`141, ²ìŒ«ˆêC²“¡“§CaŒû‘OC‰ªèŒ›‘ãC–Ø‘º—˜”üC‘•ªG–çCã‘q’qŽqCVˆä–œ—¢ŽqC’©’·•¶–íCŒú“cKˆê˜YC˜Iè_ŽqCˆÉ“¡—msC–{‹´–ÎC”ö’¹Ÿ–çC“ï”g º—YCM‰ª”ü»ŽqCÔ£•üGi–òÜj. •ÒW ²ìŒ«ˆêC’©’·•¶–íi–òÜj, ŽOŠ}‘–[C“Œ‹žC95.01.10”­s.

3679. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj •a‹C‚ÆŽ¡—ÂƃNƒXƒŠ; ‚±‚ñ‚È‚Æ‚«‚É‚ÍA‚±‚̉ȂŎóf‚ð|”M‚ªo‚½, ‚ß‚Ü‚¢‚ª‚·‚é, “ª‚ª’É‚¢, Œ¨‚ª‚±‚é, p.46`61, ‚‹´Œ«¬C²ìŒ«ˆêC²“¡“§i–òÜj. •ÒW ¬—Ñ‹P–¾C²ìŒ«ˆêi–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.31”­s.

3680. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ª’SŽ·•Mj •a‹C‚ÆŽ¡—ÂƃNƒXƒŠ; (‘æ‚SÍ)•é‚炵‚ÆŒ’N, p.232`253, ²ìŒ«ˆêC²“¡“§C‚‹´Œ«¬C•ŽR­ˆêi–òÜj. •ÒW ¬—Ñ‹P–¾C²ìŒ«ˆêi–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.31”­s.

3681. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ÒWj ‚±‚̈êû‚ňãŽÒ‚©‚ç‚à‚ç‚Á‚½–ò‚ª‚æ‚­‚í‚©‚é; •ÒW ²ìŒ«ˆêC’©’·•¶–íi–òÜj, ŽOŠ}‘–[C“Œ‹žC95.01.10”­s.

3682. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ÒWj •a‹C‚ÆŽ¡—ÂƃNƒXƒŠ; •ÒW ¬—Ñ‹P–¾C²ìŒ«ˆêi–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.31”­s.

3683. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn i•ª’SŽ·•Mj •a‹C‚ÆŽ¡—ÂƃNƒXƒŠ; Ž¾Š³ƒVƒŠ[ƒYŽå‚ÈŽ¡—Öòˆê——, p.68`231, •ŽR­ˆêi–òÜj. •ÒW ¬—Ñ‹P–¾C²ìŒ«ˆêi–òÜj, –ò‹ÆŽž•ñŽÐC“Œ‹žC95.03.31”­s.

3684. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Surface activities and antimicrobial properties of 3-O-alkyl and 3-O-haloalkyl-D-glucose. –îŒã˜a•vi–òÜjC‰Í“c˜a—Yi—Šw•”jC“à–x‹BiŽR–ì”ü—e’Z‘åjC‘Vº”V•i–òŠw•”jC’©’·•¶–íi–òÜj: 17th Internaitonal Carbohydrate Symposium i94.07.17`22j, Ottawa.

3685. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Inhibitory effect of noradrenaline on ethanol-induced acute gastric mucosal lesion in the rat. Œú“cKˆê˜YC’©’·•¶–íi–òÜjC‹gŽR—F“ñi–òŠw•”jCÎŒ´˜a•Fi‰»jCΈäŒö“¹C¼Œ³Ž›Ž—çi“àj: 10th World Congresses of Gastroenterology i94.10.06j, Los Angeles, Abstract ‡U, 1961, 1994.

3686. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Protective effects of noradrenaline on ethanol-induced gastric mucosal lesion in rats. Œú“cKˆê˜YC‹gŽR—F“ñC’©’·•¶–íi–òÜjCΈäŒö“¹C¼Œ³Ž›Ž—çi“àj: 8th International Conference on Ulcer Research i94.11.22j, ‹ž“s, Digestion, 55(Suppl. 2): 4, 1994.

3687. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j “ú–{‚É‚¨‚¯‚éNST‚ÌŒ»ó; HPN‚É‚¨‚¯‚éƒ`[ƒ€ˆã—Ã|–òÜŽt‚Ì—§ê‚©‚ç|. ¬ìK—YC“‡“cŽœ•Fi–òÜjCŸ–””º‰hi“àjC”äŠé”\Ž÷iŠOj: “ú–{—Õ°‰h—{Šw‰ï i94.10.28j, å‘ä.

3688. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j –ð‚É—§‚Âî•ñ‚ÌŽæ‚è•û‚Æ¡Œã‚̉ۑè. –]ŒŽ^‹|i–òÜj: ‘æ27‰ñ“ú–{–òÜŽt‰ïŠwp‘å‰ï i94.11.19`20j, ç—t.

3689. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j –ò܉uŠw‚ÉŠÖ‚·‚é’²¸Œ¤‹†. ¬‘î³C‘¾“cLC–k‘òŽ®•¶C•ŽR­ˆêC‘Š—ljx˜YC‰º“°‰’Œ —mC­“cŠ²•vC‹´–{‚Ђë”üi–òÜj: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.29`31j, å‘ä.

3690. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ’ŽËÜ‚ÌŠÇ—‚È‚ç‚тɬ‡‚ÌŽÀ‘Ô’²¸¥Œ¤‹†. “‡“cŽœ•FCŠ£Œ«ˆêC™Œ´³‘×C“ì•”’¼Ž÷C‹´–{‹­C¼—t˜a‹vC•ŽR­ˆêi–òÜj: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.29`31j, å‘ä.

3691. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ‹}«’†“Å‚É‚¨‚¯‚é–òÜŽt‚Ì–ðŠ„; —Õ°Œ»ê‚Å‚ÌŽÀ‘H|‘åŠw•a‰@‚Ì—§ê‚©‚ç|. ‹ß“¡—¯”üŽqi–òÜjC‘å˜a“c—²i‹~–½jC’©’·•¶–íi–òÜj: ‘æ16‰ñ“ú–{’†“ÅŠw‰ï‘‰ï i94.07.15j, ‘åã.

3692. mŠw‰ïi‘S‘jn iƒ[ƒNƒVƒ‡ƒbƒvj ƒAƒ][ƒ‹ŒnR^‹ÛÜ‚Ì•¹—p‚Í¥‚©”ñ‚©. –]ŒŽ^‹|C‘º£¨’ÃŽqC’©’·•¶–íi–òÜjC‘q“c_i“Œ‹žŒ°”÷‹¾‰@jCŽRè•q˜aC‹v•ÄŒõi•a—j: ‘æ38‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï i94.10.14j, ¼–{, —\eW, p.68, 1994.

3693. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒIƒŠƒS“œ‚ðŒ´—¿‚Æ‚µ‚½N-ƒAƒ‹ƒLƒ‹ƒOƒŠƒRƒVƒ‹ƒAƒ~ƒ“‚ÌR‹ÛŠˆ«. ‰Í“c˜a—Yi—Šw•”jC–îŒã˜a•vi–òÜjC¼‘ºGˆêiŒc‘åjC“à–x‹BiŽR–ì”ü—e’Z‘åj: “ú–{–h‹Û–hꀊw‰ï i94.05.30j, “Œ‹ž.

3694. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒNƒ‰ƒŠƒXƒƒ}ƒCƒVƒ“‚Ì‘Ì“à“®‘Ô‚É‹y‚Ú‚·“V‘RƒPƒCŽ_ƒAƒ‹ƒ~ƒjƒEƒ€•¹—p‚̉e‹¿. ‚‹´Œ«¬C•ŽR­ˆêC‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: ‘æ42‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i94.06.10j, •Ÿ‰ª, —vŽ|W, p.174, 1994.

3695. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ˜V”NŽÒ‚É‚¨‚¯‚éŒoŒû—pƒZƒtƒFƒ€ŒnR¶Ü‚Ì’`”’Œ‹‡‚ÉŠÖ‚·‚錤‹†. –{‹´–ÎC•ŽR­ˆêC‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: ‘æ42‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï i94.06.11j, •Ÿ‰ª, —vŽ|W, p.172, 1994.

3696. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j uŽ‰–b“ûÜ‚Æ‘¼‚Ì’ŽËÜ‚Æ‚Ì”z‡•Ï‰»‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒgvŒ‹‰Ê•ñ. “‡“cŽœ•FC’|“எqC•½ŽR•ŽiC¬ìK—Yi–òÜj: “ú–{ŠO‰È‘ãŽÓ‰h—{Šw‰ï i94.07.13j, ‘åã, —\eW, p.212, 1994.

3697. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒEƒC[ƒNƒŠ[ƒV[ƒg‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢. “ï”gº—YC–x‰z³lC“ŒŽRˆŸ‹IŽqC•ŽR­ˆêC–îŒã˜a•vC¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: ‘æ44‰ñ“ú–{•a‰@Šw‰ï i94.10.04j, ‰¡•l, —\eW, p.572`573, 1994.

3698. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ŠO—ˆ‚É‚¨‚¯‚éV‚µ‚¢–òÜ‹Æ–±‚Ì“WŠJ|”畆‰ÈŠ¿•ûŠO—ˆ‚Ö‚ÌoŒü|. Ô£•üGC–îŒã˜a•vC¬—Ñ‹P–¾C’©’·•¶–íC•ŽR­ˆêi–òÜjC“Œˆê‹Ii”çj: ‘æ44‰ñ“ú–{•a‰@Šw‰ï i94.10.04j, ‰¡•l, —\eW, p.584`585, 1994.

3699. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒAƒNƒAŽ_‰»…‚Ì•Û‘¶•û–@‚ÆÁ“ÅŒø‰Ê‚ÉŠÖ‚·‚錟“¢. ‘Š‘ò­–¾C–쓪‰h—¢ŽqC¬ìK—YC“‡“cŽœ•Fi–òÜjCŽO‰YNŽ¡i—ÕŒŸj: ‘æ10‰ñ“ú–{ŠÂ‹«Š´õŠw‰ï i95.02.19j, ‘q•~.

3700. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒÀ-ƒOƒ‹ƒJƒ“‚̶‘Ì“à‚Å‚Ì•sŠˆ‰». ŽO‰Y•qGC¬—Ñ‹P–¾C’©’·•¶–íi–òÜjC{“c¹GCŽO‰Y“TŽqC‘å–ì®mCh‘O—˜˜Yi“Œ‹ž–ò‰È‘åj: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.29j, å‘ä, —\eW, p.205, 1995.

3701. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Ž_‰»…‚Ì•Û‘¶•û–@‚ÉŠÖ‚·‚錟“¢. ‘Š‘ò­–¾C–쓪‰h—¢ŽqC¬ìK—YC“‡“cŽœ•Fi–òÜjCŽO‰YNŽ¡i—ÕŒŸj: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.31j, å‘ä.

3702. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒXƒsƒƒmƒ‰ƒNƒgƒ““îp‚Ì’è—Ê‚¨‚æ‚шÀ’è«. •xŠ~“ÖŽqC¼Œ´”£CˆÉ“¡—msCç—t”üçC‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.31j, å‘ä, —vŽ|W4, p.286, 1995.

3703. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Pilsicainide‚̃qƒgŒŒ´‹y‚Ñ‘Á‰t’†”Z“x‚Ì”äŠrŒ¤‹†. ²ìŒ«ˆêC¬—Ñ‹P–¾CÔ£•üGC‘•ªG–çC’©’·•¶–íi–òÜjC‘º¼€C–Øì“c—²ˆêi“àjC–Ñ—˜Œö‘¥C’©–ì–Úˆê‹@Cã™Fi–¾Ž¡–ò‰È‘åj: ‘æ11‰ñ“ú–{TDMŠw‰ï i94.06.03j, ŽD–y, —vŽ|W, p.92, 1994.

3704. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚éƒGƒŠƒXƒƒ|ƒGƒ`ƒ“»Ü‚Ì–òÜŽg—p•]‰¿(DUE). –]ŒŽ^‹|C‰Á‰ê’J”£C¬—Ñ‹P–¾C’©’·•¶–íi–òÜjC“y‰®_ŽuC“‡“c‰p¢i–òŠw•”j: ‘æ5‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ i94.06.24`25j, ¼–{, —\eW, p.230`231, 1994.

3705. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Rbó‘B܃ƒ`ƒ}ƒ][ƒ‹‚Ì‘Ì“à“®‘Ô(1). ‘º£¨’ÃŽqC–]ŒŽ^‹|C²“¡“§CŽR‘«—RC‘•ªG–çC¬—Ñ‹P–¾C’©’·•¶–íi–òÜjC‘åŽR‹XGiŽ™jCˆ¢•”D•¶i“ŒŠC‘åjCˆÉ“¡‘•FiˆÉ“¡•a‰@j: ‘æ5‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ i94.06.24j, ¼–{, —vŽ|W, p.152`153, 1994.

3706. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “œ”A•aŠ³ŽÒ‚ɑ΂·‚éƒtƒ@[ƒ}ƒVƒ…[ƒPƒBƒJƒ‹ƒPƒA[|“œ”A•a‹³Žº‚É‚¨‚¯‚銳ŽÒ‹³ˆç|. ’¬“c[CM‰ª”ü»ŽqCŒú“cKˆê˜YC¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: ‘æ5‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ i94.06.25j, ¼–{, —vŽ|W, p.166`167, 1994.

3707. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ’nˆæ¸_•a‰@–òÜŽtŒ¤‹†‰ï‚ÌŠˆ“®|¸_‰È—̈æ‚É‚¨‚¯‚é—Õ°–òÜŽt‚Ìstep up‚Ì‚½‚ß‚É|. ’|“எqi–òÜjCˆ¢•”GŽqi‰¶•û•a‰@jC•{ìKŽqi”ª‰¤ŽqŒbˆ¤•a‰@jC–،˔ü‘ãŽqi“¡‘ò•a‰@jC“c‘º—æŽqi‘å˜a•a‰@j: ‘æ5‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ i94.06.25j, ¼–{, —vŽ|W, p.206`207, 1994.

3708. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˜V”NŽÒ‚É‚¨‚¯‚éŒoŒû—pƒZƒtƒFƒ€ŒnR¶Ü‚Ì’`”’Œ‹‡‚ÉŠÖ‚·‚錤‹†. •ŽR­ˆêC–{‹´–ÎC‘º£¨’ÃŽqC“‡“cŽœ•Fi–òÜjC‹gŽR—F“ñi–òŠw•”jC‘ºèŒõ–Mi¸j: ‘æ4‰ñ“ú–{•a‰@–òŠw‰ï”N‰ï i94.09.24`25j, ‘åã, —\eW, p.116`117, 1994.

3709. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒCƒ“ƒ^[ƒtƒFƒƒ“»Ü‚É‚æ‚é—}‚¤‚‚Ɋւ·‚銳ŽÒƒAƒ“ƒP[ƒg’²¸. –ì’†”ü˜aC’|“எqC“‡“cŽœ•Fi–òÜjCa’J–¾—²C¼Œ³Ž›Ž—çi“àjC•ŸŽR‰Ãji‘‡‘Š’k•”j: ‘æ4‰ñ“ú–{•a‰@–òŠw‰ï”N‰ï i94.09.24`25j, ‘åã, —\eW, p.124`125, 1994.

3710. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Disopyramide‚̃qƒgŒŒŸ÷‹y‚Ñ‘Á‰t’†”Z“x‚Ì”äŠrŒ¤‹†. ²ìŒ«ˆêC–{‹´–ÎCÔ£•üGC‘•ªG–çC¬—Ñ‹P–¾C’©’·•¶–íi–òÜjC’·’J쉄LC‘º¼€i“àjC–Ñ—˜Œö‘¥C‰H’¹‹IŽqCã™Fi–¾Ž¡–ò‰È‘åj: ‘æ15‰ñ“ú–{—Õ°–ò—Šw‰ï i94.12.01j, •l¼, Program, p.108, 1994.

3711. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Rbó‘B܃ƒ`ƒ}ƒ][ƒ‹‚Ì“Š—^–@‚ÉŠÖ‚·‚錟“¢; 1“ú“–‚½‚è‚Ì“Š—^‰ñ”‚ɂ‚¢‚Ä. ‘º£¨’ÃŽqC–]ŒŽ^‹|C²“¡“§CŽR‘«—RC‘•ªG–çC¬—Ñ‹P–¾C’©’·•¶–íi–òÜjC‘åŽR‹XGiŽ™jCˆ¢•”D•¶i“ŒŠC‘åjCˆÉ“¡‘•FiˆÉ“¡•a‰@j: ‘æ15‰ñ“ú–{—Õ°–ò—Šw‰ï i94.12.01j, •l¼, Program, p.109, 1994.

3712. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒ}ƒNƒƒ‰ƒCƒhŒnR¶•¨Ž¿‚Ì‘Ì“à“®‘Ô‚É‹y‚Ú‚·§Ž_Ü•¹—p‚̉e‹¿. ‚‹´Œ«¬C•ŽR­ˆêC¬—Ñ‹P–¾C’©’·•¶–íi–òÜjC‹gŽR—F“ñi–òŠw•”j: ‘æ15‰ñ“ú–{—Õ°–ò—Šw‰ï i94.12.01j, •l¼, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ, 43(2): 297`298, 1995.

3713. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒQƒ“ƒ^ƒ}ƒCƒVƒ“‚ÌPopulation Pharmacokinetics. –Ø‘º—˜”üC‰Á‰ê’J”£C¬—Ñ‹P–¾C’©’·•¶–íC•ŽR­ˆêi–òÜjC‰iˆä®”üC•ûG‘×i–¾Ž¡–ò‰È‘åj: ‘æ15‰ñ“ú–{—Õ°–ò—Šw‰ï i94.12.01j, •l¼, —vŽ|W, p.111, 1994.

3714. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j —Õ°‘æ‡T‘ŠŽŽŒ±ŽQ‰Áƒ{ƒ‰ƒ“ƒeƒBƒA‚ð‘ÎÛ‚Æ‚µ‚½ƒrƒfƒI‚Ì쬂ƕ]‰¿. ‰¡“cTˆêCŽµžŠ‹v”üŽqCˆ¢•”—ÇdC–쑺´ŽqCâE•”‰hŽqC’‡ì–¾”üCŸè‰hŽiC‰z‘OGrC“àŠCŒõ’©C‘ºèŒõ–Mi—Õ°–ò—ŽŽŒ±•”jCHŽR‹P—YiAVƒZƒ“ ƒ^[jC‹gŽR—F“ñC“‡“cŽœ•Fi–òÜj: ‘æ15‰ñ“ú–{—Õ°–ò—Šw‰ï i94.12.02j, •l¼.

3715. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j •a‰@–òÜ•”‚É‚æ‚éPMS‚Ö‚ÌV‚µ‚¢ŽŽ‚Ý. ’|“எqi–òÜjC¬´…•q¹C’†ì—Œbi‡“V“°‘åjCˆ¢•””ü]Žqi“Œ‹žŒú¶”N‹à•a‰@jC‚‹´—˜Ki“Œ‹žˆã‘åjCâ“c³Ž÷i“ŒŠC‘åjCX^—R”üi“s˜Vlˆã —ÃZƒ“ƒ^[jC“‡“cŽœ•Fi–òÜj: ‘æ15‰ñ“ú–{—Õ°–ò—Šw‰ï i94.12.02j, •l¼, —Õ°–ò—, 26(1): 383`384, 1995.

3716. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “_ŠáÜ‚Ì׋ۉ˜õ‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†. r–Ø—TŽqC–x‰z³lC²“¡“§C–îŒã˜a•vC¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.29j, å‘ä.

3717. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j •a‰@ŽÀK‚Ì–òŠw¶‚̉¡Š„‚èƒeƒLƒXƒg쬂Ɋւ·‚éƒAƒ“ƒP[ƒg’²¸. ç—t”üçC–Ø‘º—˜”üC“n•ÓÛŽqC’r“c—R”üŽqCŽO‰Y•qGC‘•ªG–çC˜[Kˆê˜YC–x‰z³lCˆÉ“¡—ߎqC¼ì²Ž}C¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.29j, å‘ä, —vŽ|W, 258, 1995.

3718. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j •ž–òŽw“±Žº‚ð—˜—p‚µ‚½“œ”A•aŠO—ˆŠ³ŽÒ‹³ˆç|ê–å–òÜŽt‚ւ̃`ƒƒƒŒƒ“ƒW|. “ï”gº—YCŒú“cKˆê˜YCÀ—¢—F‹ICŽR‘«—RCˆÉ“¡—ߎqC‘ºã—S”üŽqC–îŒã˜a•vC¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.29j, å‘ä, —vŽ|W4, 238, 1995.

3719. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‘Á‰t’†Disopyramide”Z“x‘ª’è‚É‚æ‚éTDM‚ւ̉ž—p. ²ìŒ«ˆêC¬—Ñ‹P–¾C’©’·•¶–íi–òÜjC’·’J쉄LC‘º¼€i“àjC‰H’¹‹IŽqC–Ñ—˜Œö‘¥Cã™Fi–¾Ž¡–ò‰È‘åj: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.29j, å‘ä, —vŽ|W4, 253, 1995.

3720. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒp[ƒ\ƒiƒ‹ƒRƒ“ƒsƒ…[ƒ^‚ð—˜—p‚µ‚½•ž–òŽw“±ƒV[ƒg쬃VƒXƒeƒ€‚ɂ‚¢‚Ä‚ÌlŽ@. ‚‹´Œ«¬C’¬“c[C‰ªè”ü‘ãŽqC’r“c—R”üŽqCÔ£•üGC‰Á‰ê’J”£C¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.29j, å‘ä, —vŽ|W4, p.236, 1995.

3721. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰@“àƒg[ƒ^ƒ‹ƒVƒXƒeƒ€‚ð—˜—p‚µ‚½Ž¡Œ±ˆ•ûŠÇ—. ÷ˆäKŽqC’|“எqC–ì’†”ü˜aCŠ—¶²’mŽqC“‡“cŽœ•Fi–òÜjC¼–{½ŽŸCŒ´“c•¶—²C–öì‘iî•ñˆ—•”j: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.30j, å‘ä.

3722. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ICU‚É‚¨‚¯‚é–ò•¨Žg—pƒ}ƒjƒ…ƒAƒ‹‚ÌŒŸ“¢(‚»‚Ì‚P)ƒXƒgƒŒƒX’×ᇗ\–h‚ɑ΂·‚éƒtƒ@ƒ‚ƒ`ƒWƒ“‚ÌŽg—p•]‰¿ ‰H“¡•äC•Ÿ–{^—ŽqC“‡“c‰p¢i–òŠw•”jC‹ß“¡—¯”üŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.30j, å‘ä, —vŽ|W, p.247, 1995.

3723. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒXƒeƒƒCƒh‹z“ü—Ö@‚É‚¨‚¯‚ég‚Ó‚é‚¢Ž®h’´‰¹”gƒlƒuƒ‰ƒCƒU[(SUN)‚Ì—L—p«. –{‹´–ÎCŒú“cKˆê˜YCÀ—¢—F‹IC‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜjC‹gŽR—F“ñi–òŠw•”j: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.30j, å‘ä, —vŽ|W, p.269, 1995.

3724. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ‰@“à‚É‚¨‚¯‚éˆã–ò•iî•ñ‚ÌŠmŽÀ‚È“`’B•û–@‚ÉŠÖ‚·‚錟“¢|ƒXƒpƒ‹ƒtƒƒLƒTƒVƒ“‚ÌŒõü‰ß•qÇ‚ð—á‚É‚Æ‚Á‚Ä|. M‰ª”ü»ŽqC–]ŒŽ^‹|C–Ø‘º—˜”üC‰Á‰ê’J”£C¬—Ñ‹P–¾C’©’·•¶–íi–òÜj: ‘æ115‰ñ“ú–{–òŠw‰ï”N‰ï i95.03.30j, å‘ä, —vŽ|W4, p.272, 1995.

3725. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒAƒ‹ƒR[ƒ‹«ˆÝ”S–ŒáŠQ‚ɑ΂·‚éƒmƒ‹ƒAƒhƒŒƒiƒŠƒ“‚Ì—}§ì—p. Œú“cKˆê˜YC’©’·•¶–íi–òÜjCΈäŒö“¹C¼Œ³Ž›Ž—çi“àj: ‘æ90‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï i94.06.04j, ç—t, “ú–{–ò—ŠwŽGŽ, 104(4): 76, 1994.

3726. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j V‹K’´‰¹”gƒlƒuƒ‰ƒCƒU[‚É‚¨‚¯‚éƒCƒmƒŠƒ“‰t‚̈À’è«. À—¢—F‹ICŒú“cKˆê˜YC–{‹´–ÎC‘º£¨’ÃŽqC¬—Ñ‹P–¾C‹gŽR—F“ñC’©’·•¶–íi–òÜj: ‘æ24‰ñ“ú–{–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒNŠwp‘å‰ï i94.08.28j, ˆïé.

3727. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ¸__Œo‰È‚É‚¨‚¯‚éƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•¨‚Ì’·Šúˆ•û’²¸. Š—¶²˜aŽqC’|“எqC–ì’†”ü˜aC÷ˆäKŽqC“‡“cŽœ•Fi–òÜjCŽO‰Y’å‘¥C‘ºèŒõ–MCˆä‘òŽu–¼–ìi¸j: ‘æ24‰ñ“ú–{–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒNŠwp‘å‰ï i94.08.28j, …ŒË.

3728. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ƒAƒNƒAŽ_‰»…‚Ì•Û‘¶•û–@‚ÉŠÖ‚·‚錟“¢. –쓪‰h—¢ŽqC‘Š‘ò­–¾C¬ìK—YC“‡“cŽœ•Fi–òÜj: ‘æ15‰ñ_“Þ쌧•a‰@Šw‰ï i94.11.25j, ‰¡•l.

3729. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ‰@“àƒg[ƒ^ƒ‹ƒVƒXƒeƒ€‚ð—˜—p‚µ‚½Ž¡Œ±ˆ•ûŠÇ—. ÷ˆäKŽqC’|“எqC–ì’†”ü˜aCŠ—¶²’mŽqC“‡“cŽœ•Fi–òÜjC¼–{½ŽŸCŒ´“c•¶—²C–öì‘iî•ñˆ—•”j: ‘æ2‰ñ_“Þ쌧•a‰@–òÜŽt‰ïŠwp‘å‰ï i94.11.27j, ‰¡•l.

3730. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j ŽUÜ”‰—ʊĸ‹Æ–±‚ÌŒø—¦‰»¥“K³‰»‚ÉŠÖ‚·‚錟“¢|V‚µ‚¢ŽUÜ‘•’u•r‚ÌŽŽì|. ‘哇”ü˜aŽqC•ŽR­ˆêC“uLKC–ؔüçC‰¡ˆäMŽqCŽðˆäiŽqCŠ}Œ´—S“ñCŠ—¶²’mŽqC¬ìK—YCìŒûŽž•FC“‡“cŽœ•Fi–òÜj: ‘æ2‰ñ_“Þ쌧•a‰@–òÜŽt‰ïŠwp‘å‰ï i94.11.27j, ‰¡•l.

3731. mŒ¤‹†‰ïi‘S‘jn i‹³ˆçu‰‰j ‰h—{ŠÇ—‚ɉʂ½‚·–òÜŽt‚Ì–ðŠ„. ¬ìK—YC“‡“cŽœ•Fi–òÜj: “ú–{Ö¬¥Œo’°‰h—{Œ¤‹†‰ï‹³ˆçƒZƒ~ƒi[ i95.02.03j, ‘åã.

3732. mŒ¤‹†‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j –{–M‚É‚¨‚¯‚éÖ¬¥Œo’°‰h—{‚̃KƒCƒhƒ‰ƒCƒ“. “‡“cŽœ•FC’|“எqC•ŽR­ˆêC¬ìK—YC•½ŽR•Žii–òÜj: “ú–{Ö¬¥Œo’°‰h—{Œ¤‹†‰ï i95.02.02`03j, ‘åã, “ú–{Ö¬¥Œo’°‰h—{Œ¤‹†‰ïŽ, 10: 221`222, 1994.

3733. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j V‹K’´‰¹”gƒlƒuƒ‰ƒCƒU[‚É‚¨‚¯‚é‹CŠÇŽxŠg’£Ü‚̈À’è«. À—¢—F‹ICŒú“cKˆê˜YC–{‹´–ÎC‘º£¨’ÃŽqC¬—Ñ‹P–¾C‹gŽR—F“ñC’©’·•¶–íi–òÜj: ‘æ18‰ñ“ú–{ˆã—pƒGƒAƒƒ]ƒ‹Œ¤‹†‰ï i94.09.04j, “Œ‹ž, ´˜^W, p.5, 1994.

3734. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ’²Ü‹Æ–±‚É‚¨‚¯‚é–òÜ•”‚Ì–ðŠ„. “‡“cŽœ•Fi–òÜj: —Õ°‰h—{ƒVƒ“ƒ|ƒWƒEƒ€ i94.09.14j, “Œ‹ž.

3735. mŒ¤‹†‰ïi‘S‘jn iˆê”Êu‰‰j ˜Vl‚É‚Ó‚³‚킵‚¢ˆã—ÃT[ƒrƒX‚ÌŠJ”­‚Æ•]‰¿‚ÉŠÖ‚·‚錤‹†|‚—îŽÒ‚̉h—{ŠÇ—ƒ}ƒjƒ…ƒAƒ‹. ¼“c˜NC•“¡³Ž÷CŠ™“cƒPƒCƒRCŒ´³rC“V–{GC“‡“cŽœ•FC[‘òr’jC•l’¬‹±ˆêC”©ŽRŸ‹`C‰Á‰êä¿•vCˆäãC“ñC“s—¯³“WCˆæ’J“T•ÛC•ŽR­ˆêC‘å’|“oŽu ŽqC’†‘º’šŽŸCŽðˆä–õ•vC¬ŽRG•vi–òÜj: Œú¶È•½¬6”N“x˜Vl•ÛŒ’Œ’N‘i“™Ž–‹Æ‘æ2‰ñ”ljï‹c i95.03.04j.

3736. mŒ¤‹†‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ®Œ`ŠO‰È•a“‚É‚¨‚¯‚é–òÜŽt‹Æ–±. ¬›—L”üC™‘º–qŽqC‘哇”ü˜aŽqC¼ŽR—R”üŽqC—é–؉€ŽqC‘å‰Í“à‹M_C‰¡ˆäMŽqC•½ŽR•ŽiC“‡“cŽœ•Fi–òÜj: ‘æ5‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ i94.06.25j, ¼–{, —vŽ|W, p.104`105, 1994.

3737. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j Á“Å‚¨‚æ‚Ñ–Å‹Û‚ÌŠî‘b‚ÆŽÀÛ. “‡“cŽœ•Fi–òÜj: ‰@“àŠ´õ‘ÎôuK‰ï i94.09.26`27j, “Œ‹ž, —\eW, p.8.

3738. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j R¶•¨Ž¿»Ü‚Ì–ò—‚Æ•ž–òŽw“±. •ŽR­ˆêi–òÜj: ²‰êŒ§–òÜŽt‰ï¶ŠU‹³ˆçŒ¤C‰ï i94.11.20j, ²‰ê.


<<32 ˆã—ÎЉïŠwiˆãŠwŒ´˜_j>>

3739. m‘àn ‰Æ‘°‚ð‚ß‚®‚é­ô‚Æ–@. ‰Æ‰i“oiˆãŠwŒ´˜_j: •ŸŽƒ“W–], (18): 10`15, 1994.

3740. mŠwp‘n i•ª’SŽ·•Mj ‰Æ‘°‚ƈã—Ã|‚»‚Ì–@Šw“IlŽ@; áŠQV¶Ž™‚ÌŽ¡—Âð‚ß‚®‚ée‚ƈãŽt‚ÌŠÖŒW|ƒA[ƒT[ˆãŽtŽ–Œ‚ÌŒŸ“¢, p.145`169, ‰Æ‰i“oiˆãŠwŒ´˜_j. •ÒW ‰SFˆêi“s—§‘åjCÎì–«iã’q‘åj, O•¶“°C“Œ‹žC95.02.28”­s.

3741. mŠwp‘n i•ª’SŽ·•Mj ‰Æ‘°‚ƈã—Ã|‚»‚Ì–@Šw“IlŽ@; “ú–{‚É‚¨‚¯‚élHŽö¸‚Ìó‹µ, p.423`431, ‰Æ‰i“oiˆãŠwŒ´˜_j. •ÒW ‰SFˆêi“s—§‘åjCÎì–«iã’q‘åj, O•¶“°C“Œ‹žC95.02.28”­s.

3742. mŠwp‘n i•ª’SŽ·•Mj Intractable Neurological Disorders, Human Genome Research and Society; Legal aspects of treatment for disabled newborn babies, p.146`148, ‰Æ‰i“oiˆãŠwŒ´˜_j. •ÒW N. FujikiCD. Macer, Eubios Ethics InstituteC’}”gC94.00.00”­s.

3743. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ª’SŽ·•Mj Œ»‘ã“ú–{‚Ì–@“I˜_“_|‘ێЉï‚Ì’†‚Ål‚¦‚é; ¶–½‚Æ–@, p.1`37, ‰Æ‰i“oiˆãŠwŒ´˜_j. •ÒW ’çŒûN”ŽC‘å•lŒ[‹gC‹g“c–«i‘‘åj, ™¤‘‘–[C“Œ‹žC94.07.20”­s.

3744. mŒ¤‹†‰ïi’n•ûjn ih‘è•ñj ˆÙ•êŒZ‚Ö‚Ìœ‘’ñ‹Ÿ‚ð‹‚ß‚ç‚ꂽ‚RΔ¼‚ÌŽq‚Ì•ê‚Í, ‚»‚ꂪŽq‚̃xƒXƒg¥ƒCƒ“ƒ^ƒŒƒXƒg‚É‚©‚È‚¤ê‡‚É‚Ì‚Ý“¯ˆÓ‚ð—^‚¦‚邱‚Æ‚ª‚Å‚«‚é‚Æ‚µ‚½Ž–—á|Curren V. Bosze(ƒCƒŠƒmƒCB, 1990”N). ‰Æ‰i“oiˆãŠwŒ´˜_j: ‰p•Ä‰Æ‘°–@”»—ጤ‹†‰ï i94.04.23j, “Œ‹ž.


<<33 ˆã—pî•ñŠw>>

3745. muÀn “dŽq‹³‰È‘uQuick reference: ˆã‰È¶—Šwv. ’|“ດŽiˆã—pî•ñj: ˆã—ÂƃRƒ“ƒsƒ…[ƒ^, 7(1): 26`32, 1995.

3746. muÀn ‚±‚¤‚·‚ê‚΂ł«‚éŒø‰Ê“I‚ȃvƒŒƒ[ƒ“ƒe[ƒVƒ‡ƒ“. ’|“ດŽC“úŒü‚©‚¨‚éiˆã—pî•ñj: ˆã—ÂƃRƒ“ƒsƒ…[ƒ^, 7(1): 72`76, 1995.

3747. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Incidence of atopic diseases in infants and children related to family history in Japan. —L“c¹•Fiº˜a‘åjCŽO‰ÍtŽ÷iŠÖ¼“d—Í•a‰@jC”’‘é‘’jiˆã—pî•ñjC´…³lC‘àVG‹IiX‰i“û‹ÆŒ¤j: 15th International Congress of Allergology and Clinical Immunology i94.06.26j, Stockholm, Abstracts, p.475, 1994.

3748. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “ûŽ™Šú‚̃Aƒgƒs[«Ž¾Š³”­Ç‚̃ŠƒXƒNƒtƒ@ƒNƒ^[‚ɂ‚¢‚Ä. ‚‹´KˆêC‘àVG‹IC•x“cŽçiX‰i“û‹ÆŒ¤jC”’‘é‘’jiˆã—pî•ñjC‹{Œ´‰p•viˆã—Éq¶j: ‘æ22‰ñ“ú–{s“®Œv—ÊŠw‰ï‘å‰ï i94.00.00j, ’}”g, ´˜^W, p.238`239, 1994.

3749. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰uŠw’²¸‚É‚æ‚é“û—cŽ™‚̃Aƒgƒs[«Ž¾Š³”­Ç‚ƉƑ°‚̃Aƒgƒs[«Ž¾Š³Šù‰—ð‚Æ‚ÌŠÖŒW. —L“c¹•Fiº˜a‘åjCŽO‰ÍtŽ÷iŠÖ¼“d—Í•a‰@jC”’‘é‘’jiˆã—pî•ñjC´…³lC‚‹´KˆêC‘àVG‹IiX‰i“û‹ÆŒ¤j: ‘æ6‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G‘å‰ï i94.04.14j, ŒF–{, ƒAƒŒƒ‹ƒM[, 43(2-2): 380, 1994.

3750. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‹@”\‚ð‚à‚¶—Šw“dŽq‹³‰È‘‚Ìì¬. ’|“ດŽC”’‘é‘’jiˆã—pî•ñjC’r“cŒ›ºC‹{Œ´‰p•viˆã—Éq¶jC²“¡“oŽu˜Yi¶—j: “ú–{ƒGƒ€¥ƒC[Šw‰ï i94.05.13j, ‚¼, ˆã—p“dŽq‚ƶ‘ÌHŠw, 32(“Á•Ê): 139, 1994.

3751. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “û—cŽ™‚̃Aƒgƒs[«Ž¾Š³”­Ç‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸Œ‹‰Ê‚ɂ‚¢‚Ä. ”’‘é‘’jiˆã—pî•ñjC—L“c¹•Fiº˜a‘åjCŽO‰ÍtŽ÷iŠÖ¼“d—Í•a‰@jC´…³lC‚‹´KˆêC‘àVG‹IiX‰i“û‹ÆŒ¤j: ‘æ48‰ñ“ú–{‰h—{¥H—ÆŠw‰ï‘‰ï i94.05.13j, •Ÿ‰ª, ˜_•¶W, p.228, 1994.

3752. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‰h—{ÛŽæ—Ê‚©‚çÛŽæH•i\¬A‰ñ”‚ð‹‚ß‚éƒvƒƒOƒ‰ƒ€‚Ì•]‰¿|ŒÂl•Ê‰h—{’²¸‚̌݊·«‚ÌŒŸ“¢(‘æ25•ñ). Š–{‰ërCŠ‹–Ø‚Ý‚Ç‚èi‘—§ŒöO‰q¶‰@jC’†Œ´Ÿ’jiŒú¶ÈjC”’‘é‘’jC’ß“c—z˜aiˆã—pî•ñjC—é–Ø–­ŽqC²X–Ø“o‘ãŽqi‘—§ŒöO‰q¶‰@jC“c‘º{”üŽq i’Ëvˆä•ÛŒ’ŠjC“c’†O”ViéŽR’¬–ðêj: ‘æ41‰ñ“ú–{‰h—{‰ü‘PŠw‰ï i94.09.08j, _ŒË, u‰‰W, p.243, 1994.

3753. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “û—cŽ™‚̃Aƒgƒs[«Ž¾Š³”­Ç•p“x‚Æ‚»‚̉Ƒ°—ð‹y‚ÑŽ™‚Æ•êe‚ÌH¶Šˆ‚ÌŽÀ‘Ԃɂ‚¢‚Ä. ‚‹´KˆêC‘àVG‹IC•x“cŽçiX‰i“û‹ÆŒ¤jC”’‘é‘’jiˆã—pî•ñjC—L“c¹•Fiº˜a‘åj: ‘æ41‰ñ“ú–{‰h—{‰ü‘PŠw‰ï i94.09.08j, _ŒË, u‰‰W, p.380, 1994.

3754. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j OS/Z‚ðŽg—p‚µ‚½ŒŸ‘ÌŒŸ¸ƒVƒXƒeƒ€. ŠÖŒûŸ”üCˆÉ“¡­ŒåC‰eŽRDŒõC‰““¡’qCŽRX‘SCŽæˆê—EC¼ŠL‰hŽO˜Yi•a‰@î•ñˆ—‰ÛjC‹g‘º”Ž–Mi‹¹ŠOjC‘å˜a“c—²i‹~–½j: ‘æ14‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï i94.11.21`23j, _ŒË.

3755. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “Á’è‹@”\•a‰@‚Æ‚µ‚Ä‚Ì•af˜AŒgŽx‰‡ƒVƒXƒeƒ€. ¼–{r°CHŽRŒ¹•xCŽæˆê—EC¼ŠL‰hŽO˜Yi•a‰@î•ñˆ—‰ÛjC‹g‘º”Ž–Mi‹¹ŠOjC‘å˜a“c—²i‹~–½j: ‘æ14‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï i94.11.21`23j, _ŒË.

3756. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 08/2‚É‚æ‚é—AŒŒƒZƒ“ƒ^[ƒVƒXƒeƒ€‚ÌÄ\’z. ÀŠÔKŽŸC‘Š”nCŽ‰i—²sC‰eŽRDŒõC™è“¹•vCˆÉ“¡­ŒåCŽæˆê—EC¼ŠL‰hŽO˜Yi•a‰@î•ñˆ—‰ÛjC‹g‘º”Ž–Mi‹¹ŠOjC‘å˜a“c—²i‹~–½j: ‘æ14‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï i94.11.21`23j, _ŒË.

3757. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j –k—¢‘åŠwˆãŠw•”‚É‚¨‚¯‚錤‹†‹ÆÑ•]‰¿ƒVƒXƒeƒ€‚ÌŠJ”­. ’ß“c—z˜aiˆã—pî•ñjC’r“cŒ›ºiˆã—Éq¶jC–Øì“c—²ˆêi“àjC²“¡“oŽu˜Yi¶—j: ‘æ14‰ñ“ú–{ˆã—Ãî•ñŠw˜A‡‘å‰ï i94.11.21j, _ŒË, ‘æ14‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.333`336, 1994.

3758. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j “dŽq‹³‰È‘ƒVƒXƒeƒ€(¶—Šw)‚©‚ç‘̉t§ŒäƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚ðŽÀs‚·‚é. ’|“ດŽiˆã—pî•ñjC’r“cŒ›ºiˆã—Éq¶jC²“¡“oŽu˜Yi¶—j: ‘æ14‰ñ“ú–{ˆã—Ãî•ñŠw˜A‡‘å‰ï i94.11.22j, _ŒË, ‘æ14‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.559`562, 1994.

3759. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j S“d}•s®–¬ŠwKƒVƒXƒeƒ€‚Ìì¬. ’|“ດŽiˆã—pî•ñjC“ޗljÀ—mi¶•¨•¨—ŒnjC’r“cŒ›ºC‹{Œ´‰p•viˆã—Éq¶jC…ŒË•”G•vi⑇•a‰@j: ‘æ14‰ñ“ú–{ˆã—Ãî•ñŠw˜A‡‘å‰ï i94.11.22j, _ŒË, ‘æ14‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.563`566, 1994.

3760. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j “ûŽ™Šú‚É‚¨‚¯‚éƒAƒgƒs[«Ž¾Š³‚Ì”­Ç‚ƉƑ°‚̃Aƒgƒs[«Ž¾Š³Šù‰—ð‚Æ‚ÌŠÖŒW‚ÉŠÖ‚·‚é‰uŠw’²¸Œ‹‰Ê‚ɂ‚¢‚Ä. —L“c¹•Fiº˜a‘åjCŽO‰ÍtŽ÷iŠÖ¼“d—Í•a‰@jC”’‘é‘’jiˆã—pî•ñjC´…³lC‚‹´KˆêC‘àVG‹IiX‰i“û‹ÆŒ¤j: ‘æ97‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï i94.05.26j, ŽD–y, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 98(3): 754, 1994.

3761. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j “àŽ‹‹¾“IƒNƒŠƒbƒsƒ“ƒOp‚É‚æ‚莡—µ‚¦‚½ˆãŒ´«H“¹úE‚Ì‚P—á. •Ð‰ª—Sˆêi‹~–½jC‹{–{‰p—YC…–ì—F—TC‚£ÅC‰|–{‘ñ–ÎC¼–{–LC¬À”ŽC‰¡“c“™CVˆäLNC–å˜eŒ›C¼‘º”Žsi–kM‘‡•a‰@j: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïbM‰z’n•û‰ï i94.11.19j, ¼–{.

3762. mŠw‰ïi’n•ûjn iˆê”Êu‰‰j VAN‚ð—˜—p‚µ‚½ˆã–ò•i”­’‹Æ–±‚̉ü‘P. ‘•ªG–çC”ö’¹Ÿ–çCaŒû‘OC²ìŒ«ˆêC¬—Ñ‹P–¾C’©’·•¶–íi–òÜjCŽ‰i—²sC‹{“à–¾LC™è“¹•vCŽæˆê—EiŠé‰æŽºj: ‘æ2‰ñ_“Þ쌧•a‰@–òÜŽt‰ïŠwp‘å‰ï i94.11.29j, ‰¡•l, —vŽ|W, p.46`47, 1994.


<<35 •¨—Šw>>

3763. mŒ´’˜n New aspects of post-collision interaction profiles observed in Auger cascade following Ar-K-shell photoionization. T. HayaishiCE. MurakamiCY. MoriokaCE. ShigemasaCA. YagishitaC¬’r•¶”Ži•¨—j: J. Phys. B., 27: 115`121, 1994.

3764. mŒ´’˜n Ne valence correlation satellites in the photon energy region 80-220 eV. G. KutlukCT. TakakuCM. KannoCT. NagataCE. ShigemasaCA. YagishitaC¬’r•¶”Ži•¨—j: J. Phys. B., 27: 5637`5646, 1994.

3765. mŒ´’˜n Theory of inelastic scattering of low energy electrons by lanthanide and actinide atoms. ¬’r•¶”Ži•¨—j: Phys. Lett. A, 176: 439`442, 1993.

3766. mŒ´’˜n Many-electron effects in post-collision interaction spectra created by Auger cascade of atoms. ¬’r•¶”Ži•¨—j: Phys. Lett. A, 193: 173`178, 1994.

3767. mŒ´’˜n Alignment of atomic autoionizing states created by slow Na+ + He collisions. H.A. SakaueCT. NegishiCY. SekiCT. TakayanagiCK. WakiyaC¬’r•¶”Ži•¨—jCH. Suzuki: Z. Phys. D, 25: 157`160, 1993.

3768. mŒ¤‹†•ñi•¶•”Èjn ’´—ã‹Nó‘Ô‚ÌŠÖ—^‚·‚é“®“I‰ß’ö‚Ì—˜_“IŒ¤‹†. ‚–ØGˆêi•¨—j: •¶•”Èd“_—̈挤‹†u‰»Šw”½‰ž—˜_v•ñ‘, p.164`167, 1995.

3769. mŒ¤‹†•ñi‚»‚Ì‘¼Œö“I‚È•ñjn Œ´Žq¥•ªŽq¥ƒCƒIƒ“‚ÌÕ“Ë‚ÉŠÖ‚·‚é’²¸|“dŽq‚Æ…‘f•ªŽqƒCƒIƒ“‚ÌÕ“Ë. ‚–ØGˆêi•¨—j: “ú–{Œ´Žq—ÍŒ¤‹†Š(‰ÈŠw‹Zp’¡)‚É’ño‚µ‚½•ñ‘, p.1`212, 1995.

3770. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j 3d ‘JˆÚ‹à‘®Œ´Žq‚Ì 2p-3d ‹zŽûƒXƒyƒNƒgƒ‹‚̉ðÍ. ¬’r•¶”Ži•¨—j: ‘æ49‰ñ“ú–{•¨—Šw‰ï”N‰ï i94.03.28j, •Ÿ‰ª, Abstract, 28aF3, 1994.

3771. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j HD+-eÕ“Ë‚É‚¨‚¯‚é‰ð—£‰ß’ö‡U. ‚–ØGˆêi•¨—j: “ú–{•¨—Šw‰ï i94.09.02j, ɪ, ‘æ‚S•ªû, p.26, 1994.

3772. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ‚–§“xƒvƒ‰ƒYƒ}‚©‚ç‚Ì‚wüçtŽË‚ÉŠÖ—^‚·‚é‹à‘½‰¿ƒCƒIƒ“‚̃Gƒlƒ‹ƒM[€ˆÊ‚ÌŒvŽZ. ¬’r•¶”Ži•¨—j: “ú–{•¨—Šw‰ïH‚Ì•ª‰È‰ï i94.09.04j, ɪ, Abstract, 4aL7, 1994.

3773. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j Calculation of spectator satellite lines of niclel-like gold ions in high density thermonuclear plasma. ¬’r•¶”Ži•¨—j: 7th International Conference on the Physics of Highly Charged Ions i94.09.20j, ƒEƒB[ƒ“, Abstract, Tu69, 1994.

3774. mŒ¤‹†‰ïi’n•ûjn i‹³ˆçu‰‰j ‰ð—£«ÄŒ‹‡‰ß’ö‚ÌŒ»ó‚Æ–â‘è“_. ‚–ØGˆêi•¨—j: TARN‡UŒ´ŽqÕ“ËŽÀŒ±‚ÉŠÖ˜A‚·‚镨—‚Æ‹ZpŒ¤‹†‰ï i95.03.17j, “Œ‘匴ŽqŠjŒ¤‹†Š.

3775. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j “ñŒ´Žq•ªŽqƒCƒIƒ““dŽqՓˉߒö‚ÌŒ´Žqƒf[ƒ^. ‚–ØGˆêi•¨—j: ƒvƒ‰ƒYƒ}’†‚Ì…‘f•ªŽq‚ÌU‚é•‘‚¢‚ɂ‚¢‚Ä‚ÌŒ¤‹†‰ï i94.08.24j, “߉Ï.

3776. mŒ¤‹†‰ïi’n•ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j ƒCƒIƒ“•ªŽq‚Æ“dŽq‚ÌÕ“Ë‚É‚æ‚é‰ð—£‚¨‚æ‚ÑU“®‘JˆÚ‰ß’ö. ‚–ØGˆêi•¨—j: Œ´Žq•ªŽqÕ“Ë‘f‰ß’öŒ¤‹†‰ï i95.03.15j, “ŒŠC.


<<36 ‰»Šw>>

3777. m–|–ón i‹¤’˜j ¶–½‰ÈŠw‚Ì‚½‚ß‚ÌŠî‘b‰»Šw|—L‹@¥¶‰»Šw•Ò; ˆÉ“¡r—mi‹³—{•”jCˆÉ“¡—CŽqi‘n‰¿‘åjC‰ª–{‹`‹vi‹³—{•”jC–kŽRŒ›ŽOi“ŒH‘åjC´–씣i‰q¶Šw•”jC¼–ìVŽmi‰»j. ŠÛ‘PC“Œ‹žC95.03.25”­s.

3778. m–|–ón i‹¤’˜j ¶–½‰ÈŠw‚Ì‚½‚ß‚ÌŠî‘b‰»Šw|–³‹@•¨—‰»Šw•Ò; ˆÉ“¡r—mi‹³—{•”jCˆÉ“¡—CŽqi‘n‰¿‘åjC‰ª–{‹`‹vi‹³—{•”jC–kŽRŒ›ŽOi“ŒH‘åjC´–씣i‰q¶Šw•”jC¼–ìVŽmi‰»j. ŠÛ‘PC“Œ‹žC95.03.25”­s.

3779. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j ‚‘¬‹C—¬’†ÕŒ‚–@‚É‚æ‚é—±Žq•¡‡‰»‚É‚¨‚¯‚éÓd‹C‘ŠŒÝì—p‚ƃtƒ@ƒ“ƒfƒ‹ƒ[ƒ‹ƒX‘ŠŒÝì—p. –{“cG—²C¬Î^ƒC–{“c“ñ—ti“Œ—‘åjC¼–ìVŽmi‰»j: ‘æ11‰ñ»Ü‚Æ—±ŽqÝŒvƒVƒ“ƒ|ƒWƒEƒ€ i94.10.20j, –L‹´, —vŽ|W, p.193`198, 1994.

3780. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ¶‘Ì“àƒAƒuƒm[ƒ}ƒ‹ƒOƒ[ƒX‚É‚æ‚Á‚Ķ¬‚·‚郊ƒ“Ž_ƒJƒ‹ƒVƒEƒ€Œn”÷Œ‹». ¼–ìVŽmi‰»jCÄ“¡º•FC‚ŠÝŒ›“ñi®ŠOjC¬Î^ƒi“Œ—‘åj: ‘æ68‰ñ“ú–{‰»Šw‰ïH‹G”N‰ï i94.10.01j, –¼ŒÃ‰®, —\eW, p.473, 1994.

3781. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ˜A‘±Ž®’†˜a”½‰ž‚É‚æ‚é˜Z•û»ŒnƒqƒhƒƒLƒVƒAƒpƒ^ƒCƒgŒ‹»‚̇¬. ¼–ìVŽmi‰»jC¬Î^ƒi“Œ—‘åj: ‘æ47‰ñƒRƒƒCƒh‚¨‚æ‚ÑŠE–ʉ»Šw“¢˜_‰ï i94.10.09j, ‰ªŽR, —vŽ|W, p.538`539, 1994.

3782. mŠwpÜi‘“àÜjn ‘æ1‰ñÞ—¿‹ZpŒ¤‹†‹¦‰ï˜_•¶Ü; •²‘Ì‚Ì•\–ʉüŽ¿‚ÉŠÖ‚·‚錤‹†, –{“cG—²CÎâ—²Žji“Œ—‘åjC¼–ìVŽmi‰»j.


<<38 ¶•¨Šw>>

3783. mŒ´’˜n Role of mesenchymal nidogen for epithelial morphogenesis in vitro. P. EkblomCM. EkblomCL. FeckerCG. KleinCH-Y ZhangiUppsala Univ.jC–å’J—Tˆêi‰ðjCM.-L. ChuiThomas Jefferson Univ.jCU. MayerCR. TimpliMax-Planck-Institutj: Development, 120: 2003`2014, 1994.

3784. mŒ´’˜n Four kinds of sex chromosomes in Rana rugosa. Nishioka M.CHanada H.CMiura I.iL“‡‘åjC—´è³Žmi¶•¨j: Sci. Rep. Lab. Amphibian Biol. Hiroshima Univ., 13: 1`34, 1994.

3785. mŠw‰ïi‘Ûjn iƒVƒ“ƒ|ƒWƒEƒ€“™j Photon emission during cleavage of frog eggs: comparative study of cortical photons between nuclear division and cytoplasmic fission. —´è³Žmi¶•¨jC‘åŠÑMi¶—j: International AG Gurwitsch Conference i94.09.28`10.02j, Moscow, Russia, Conference Abstracts, p.23, 1994.

3786. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Distinct roles of laminin-1 domains during epithelial morphogenesis. –å’J—Tˆêi‰ðjCKuniko KadoyaiUppsala Univ.jCR. TimpCP. EkblomiMax-Planck-Institutj: ‘æ8‰ñ‘Û×–E•ª‰»‰ï‹c i94.10.23j, L“‡, Program and Abstracts, p.73, 1994.

3787. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j Karyotypes of Rana sakurai and R. tagoi. Hanada, H.COkumoto, H.CNishioka, M.CMiura, I.iL“‡‘åjC—´è³Žmi¶•¨j: The Society of Chromosome Research i94.11.04`06j, ‚’m, La Kromosomo, 45: 39, 1994.


<<39 ×–EŠw>>

3788. muÀn ƒgƒsƒbƒNƒX; ƒfƒxƒ\ŠjC‚«‚Ì‚±Šj; ‚¤‚ß‚Ú‚µŠj. ‚ŽR–¾ŽqC‘å–ì‰pŽ¡i•a‰@•a—jC‘ –{”ŽsiŽY•wj: —Õ°ŒŸ¸, 38(8): 958`959, 1994.

3789. mŠw‰ïi‘Ûjn iƒ|ƒXƒ^[u‰‰j Application of the AFM to the study of cell structure. ŽR‰È³•½i‰ðjC”É–ì‰ëŽŸiƒZƒCƒR[“dŽqH‹Æj: ‘æ13‰ñ‘Û“dŽqŒ°”÷‹¾Šw‰ï‹c i94.07.18j, ƒtƒ‰ƒ“ƒX, Electron Microscopy 1994, 3A: 33`34, 1994.

3790. mŠw‰ïi‘S‘jn i‹L”Ou‰‰j ‘Á‰t‘B•ª”å×–E‚Ì\‘¢‚Æ‹@”\‚ÉŠÖ‚·‚é“dŒ°‘gD‰»Šw“IŒ¤‹†-“Á‚É•ª”å‹@”\‚É‚¨‚¯‚éƒSƒ‹ƒW‘•’u‚Ì“®‘Ԃɂ‚¢‚Ä. ŽR‰È³•½i‰ðj: ‘æ39‰ñ“ú–{“dŽqŒ°”÷‹¾Šw‰ïƒVƒ“ƒ|ƒWƒEƒ€ i94.10.27j, –¼ŒÃ‰®, V‚µ‚¢ƒCƒ[ƒWƒ“ƒOƒTƒCƒGƒ“ƒX|•]‰¿‚Ɖž—p, p.62`65, 1994.

3791. mŠw‰ïi‘S‘jn iƒVƒ“ƒ|ƒWƒEƒ€“™j AFM‚É‚æ‚é×–EŠÏŽ@‚ÌŽŽ‚Ý. ŽR‰È³•½i‰ðjC”É–ì‰ëŽŸiƒZƒCƒR[“dŽqH‹Æj: ‘æ50‰ñ“ú–{“dŽqŒ°”÷‹¾Šw‰ïŠwpu‰‰‰ï i94.05.27j, “Œ‹ž, —\eW, p.159, 1994.

3792. mŠw‰ïi‘S‘jn iˆê”Êu‰‰j ×–Ef‚É‚æ‚ébó‘B“û“ªŠà‚Ì‘gD•ª‰»“x”»’è. ‰¡ŽR‘åC‘å–ì‰pŽ¡C•ž•”ŠwC‚ŽR–¾ŽqC–L‰i^Ÿi•a‰@•a—jCŒY•”“ŒŽ¡iŠOjC“n•Ó´Ž¡CŒK”ö’èmC‘å•”½CŠâŸºŒ[ˆêi•a—jC‘ –{”ŽsiŽY•wjC‹T’J“O i•a—j: ‘æ35‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï i94.06.03j, ¼], “ú–{—Õ°×–EŠw‰ïŽGŽ, 33(2): 231, 1994.

3793. mŠw‰ïi‘S‘jn iƒ|ƒXƒ^[u‰‰j ƒSƒ‹ƒW‘•’u‚ÌÄŒ`¬‚É—^‚¦‚éR”÷¬ŠÇÜ‚Ìì—p. ŽR‰È³•½C‹Ê–؉p–¾i‰ðj: ‘æ47‰ñ“ú–{×–E¶•¨Šw‰ï‘å‰ï i94.09.29j, ’·è, Cell Struct. Funct., 19(6): 503, 1994, —\eW, p.142, 1994.

3794. mŒ¤‹†‰ïi‘S‘jn i“Á•Êu‰‰j ×–EŽ€, ƒAƒ|ƒg[ƒVƒX‚ɂ‚¢‚Ä. ‘ –{”ŽsiŽY•wj: ‘æ27‰ñ×–EŒŸ¸Žm‹³ˆçƒZƒ~ƒi[ i94.08.20j, “Œ‹ž.

3795. mŠwpÜi‘“àÜjn “ú–{“dŽqŒ°”÷‹¾Šw‰ï£“¡Ü, ‘Á‰t‘B•ª”å×–E‚Ì\‘¢‚Æ‹@”\‚ÉŠÖ‚·‚é“dŽqŒ°”÷‹¾‘gD‰»Šw“IŒ¤‹†, ŽR‰È³•½i‰ðj.